-DOCSTART-201
SPECIMEN	O
.	O

Right	O
colon	O
.	O

CLINICAL	O
NOTES	O
.	O

PRE	O
-	O
OP	O
DIAGNOSIS	O
:	O
Cancerous	O
cecum	O
.	O

GROSS	O
DESCRIPTION	O
.	O

Received	O
fresh	O
labeled	O
"	O
right	O
colon	O
"	O
is	O
a	O
previously	O
.	O
unopened	O
31	O
cm	O
.	O
segment	O
of	O
proximal	O
right	O
colon	O
with	O
.	O
attached	O
28	O
cm	O
.	O
of	O
distal	O
ileum	O
surfaced	O
by	O
smooth	O
tan	O
-	O
pink	O
serosa	O
.	O
with	O
a	O
copious	O
amount	O
of	O
attached	O
mesentery	O
,	O
mesocolon	O
,	O
and	O
.	O
unremarkable	O
omentum	O
.	O

An	O
unremarkable	O
,	O
3	O
.	O
2	O
cm	O
.	O
appendix	O
averaging	O
.	O

0	O
.	O
6	O
cm	O
.	O
in	O
diameter	O
is	O
present	O
.	O

The	O
proximal	O
and	O
distal	O
margins	O
.	O
measure	O
4	O
.	O
2	O
and	O
7	O
.	O
0	O
cm	O
.	O
in	O
circumference	O
respectively	O
.	O

On	O
opening	O
.	O
there	O
is	O
a	O
well	O
-	O
circumscribed	O
,	O
2	B
.	I
8	I
X	I
2	I
.	I
5	I
cm	I
.	O
rubbery	O
tan	O
pink	O
-	O
red	O
.	O
tumor	O
mass	O
within	O
the	O
cecal	O
pouch	O
,	O
2	O
cm	O
.	O
distal	O
to	O
the	O
ileocecal	O
.	O
valve	O
.	O

A	O
portion	O
of	O
tumor	O
and	O
a	O
portion	O
of	O
normal	O
mucosa	O
are	O
.	O
submitted	O
for	O
tissue	O
procurement	O
as	O
requested	O
.	O

On	O
sectioning	O
,	O
the	O
.	O
tumor	O
has	O
a	O
maximal	O
thickness	O
of	O
0	B
.	I

cm	B
.	O
,	O
approaching	O
the	O
.	O
muscularis	O
.	O
and	O
extending	O
to	O
within	O
0	O
.	O
5	O
cm	O
.	O
of	O
the	O
inked	O
free	O
radial	O
serosal	O
.	O
surface	O
.	O

The	O
ileal	O
mucosa	O
and	O
uninvolved	O
colonic	O
mucosa	O
is	O
.	O
otherwise	O
unremarkable	O
glistening	O
tan	O
-	O
pink	O
with	O
regular	O
folds	O
and	O
.	O
the	O
walls	O
average	O
0	O
.	O
5	O
cm	O
.	O
in	O
thickness	O
.	O

A	O
few	O
uncomplicated	O
.	O
diverticula	O
are	O
evident	O
throughout	O
the	O
colonic	O
segment	O
.	O

Several	O
.	O
soft	O
tan	O
pink	O
tissues	O
in	O
keeping	O
with	O
lymph	O
nodes	O
measuring	O
up	O
to	O
1	O
.	O

cm	O
.	O
in	O
greatest	O
dimension	O
are	O
recovered	O
from	O
the	O
attached	O
mesentery	O
.	O
and	O
mesocolon	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
fifteen	O
.	O
blocks	O
as	O
labeled	O
.	O

RS	O
-	O
15	O
.	O

BLOCK	O
SUMMARY	O
:	O
1	O
-	O
Proximal	O
and	O
distal	O
margins	O
;	O
[	O
11	O
-	O
01	O
]	O
-	O
.	O
entire	O
.	O

lesion	O
;	O
.	O

6	O
-	O
ileum	O
;	O
7	O
-	O
ICV	O
;	O
8	O
-	O
random	O
colon	O
;	O
9	O
-	O
appendix	O
;	O
10	O
,	O
11	O
-	O
eight	O
.	O
whole	O
lymph	O
nodes	O
per	O
cassette	O
;	O
12	O
-	O
seven	O
whole	O
lymph	O
nodes	O
;	O
13	O
-	O
15	O
.	O

-	O
one	O
bisected	O
lymph	O
node	O
per	O
cassette	O
.	O

GROSS	O
DESCRIPTION	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

Histologic	O
type	O
:	O
Adenocarcinoma	O
.	O

Histologic	O
grade	O
:	O
Moderately	O
-	O
differentiated	O
.	O

Primary	O
tumor	O
(	O
pT3	O
)	O
:	O
Carcinoma	O
extends	O
through	O
the	O
muscularis	O
.	O
propria	O
into	O
the	O
subserosal	O
fat	O
.	O

Proximal	O
/	O
distal	O
/	O
radial	O
margins	O
:	O
Negative	O
.	O

Vascular	O
invasion	O
:	O
Not	O
identified	O
.	O

Regional	O
lymph	O
nodes	O
(	O
pN	O
)	O
:	O
twenty	O
-	O
three	O
negative	O
lymph	O
nodes	O
.	O

(	O
0	O
/	O
23	O
)	O
.	O

Non	O
-	O
lymph	O
node	O
pericolonic	O
tumor	O
:	O
Not	O
identified	O
.	O

Other	O
findings	O
:	O
unremarkable	O
appendix	O
,	O
ileum	O
.	O

Diverticulosis	O
.	O

5	O
.	O

DIAGNOSIS	O
.	O

Colon	O
,	O
terminal	O
ileum	O
,	O
appendix	O
,	O
right	O
hemicolectomy	O
:	O
Adenocarcinoma	O
,	O
moderately	O
-	O
differentiated	O
,	O
with	O
invasion	O
through	O
.	O
the	O
muscularis	O
propria	O
into	O
the	O
subserosal	O
fat	O
(	O
pT3	O
)	O
.	O

Margins	O
of	O
excision	O
:	O
Negative	O
.	O

Vascular	O
invasion	O
:	O
Not	O
identified	O
.	O

Twenty	O
-	O
three	O
negative	O
lymph	O
nodes	O
10	O
/	O
231	O
.	O

-DOCSTART-202
an	O
.	O

Sax	O
/	O
Rade	O
:	O
MS	O
No	O
.	O

:	O
Hosp	O
.	O

No	O
.	O

:	O
Taken	O
/	O
Beceived	O
:	O
OVARY	O
,	O
1	O
.	O
EPm	O
,	O
EXCISTOK	O
-	O
POORLY	O
ADEKOCARCEMOMA	O
.	O

MIXED	O
PAFILLARY	O
SEROUS	O
ARD	O
TYPE	O
.	O
ovany	O
,	O
siche	O
,	O
-	O
POOPLY	O
.	O

MIZED	O
PAPILLARY	O
SEROUS	O
AND	O
TYPE	O
.	O

FAELOPIAN	O
RIGHT	O
,	O
EXCISION	O
-	O
NO	O
DEFINITE	O
FALLOPIAI	O
TUBE	O
.	O

IDENTIFIED	O
.	O

FALLOFIAN	O
ruse	O
,	O
IErm	O
,	O
EXCISION	O
-	O
NO	O
ABNORMALITY	O
.	O

UTERUS	O
,	O
CERVSK	O
,	O
/	O
EXCISION	O
,	O
-	O
NO	O
ARNORMALITY	O
.	O

UTERUS	O
,	O
ENDOMETRIUM	O
,	O
EXCISION	O
-	O
INACTIVE	O
.	O

UTERUS	O
,	O
MYOMETRIUM	O
,	O
EXCISTOR	O
-	O
POORLY	O
DIPPERENTIATED	O
ADENOCAROSNOMA	O
,	O
.	O

METASTATIC	O
,	O
SEROSAL	O
IMPLANTS	O
.	O

-	O
ADENOMYOSIS	O
.	O

CMENTUM	O
,	O
EXCISION	O
-	O
POORLY	O
DIFPERENTIATED	O
ADENOOABOINOKA	O
,	O
.	O

METASTATIC	O
,	O
CONSISTENT	O
wrth	O
OVARIAN	O
PRIXARY	O
.	O

(	O
SEE	O
SYNOPTIC	O
REPORT	O
)	O
.	O

SPECTMEN	O
isi	O
SUBMITTED	O
.	O

Part	O
1	O
:	O
PS1	O
-	O
CVARY	O
,	O
-	O
.	O

Par	O
2	O
:	O
ES	O
-	O
OVARY	O
,	O
-	O
LEFT	O
.	O

RE	O
.	O

Part	O
3	O
:	O
RICHT	O
ADNEXA	O
AND	O
UTERUS	O
.	O

Faxt	O
&	O
OMENTUM	O
.	O

HISTORY	O
.	O

The	O
patient	O
is	O
2	O
.	O
with	O
bilateral	O
admexal	O
masses	O
.	O
operativo	O
procedure	O
:	O
TOT	O
&	O
A	O
abdominal	O
hysterectomy	O
with	O
bilateral	O
.	O
salpingo	O
-	O
and	O
omentectomy	O
.	O

be	O
.	O

RD	O
.	O
dross	O
(	O
continuad	O
)	O
.	O
from	O
anterios	O
and	O
pocteries	O
corvix	O
;	O
Est	O
and	O
E2	O
:	O
sections	O
from	O
.	O
anterior	O
and	O
postorior	O
encometriua	O
;	O
F1	O
:	O
dection	O
from	O
putative	O
.	O
right	O
fellopian	O
tobe	O
;	O
M1	O
and	O
M2	O
,	O
section	O
from	O
myometriam	O
to	O
the	O
.	O
tumor	O
on	O
the	O
cerosa	O
sections	O
from	O
the	O
large	O
globular	O
.	O
cystic	O
tuker	O
mass	O
.	O

The	O
fourth	O
costainer	O
is	O
labelled	O
omentum	O
"	O
and	O
consisto	O
of	O
2	O
slab	O
.	O
of	O
omestal	O
Pst	O
.	O
measuring	O
19	O
.	O
0	O
1	O
.	O

9	O
.	O
0	O
7	O
1	O
.	O
0	O
on	O
.	O

Multiple	O
.	O
groy	O
-	O
uhite	O
,	O
noft	O
tissue	O
nodulas	O
are	O
identified	O
,	O
the	O
lezgest	O
oz	O
.	O
which	O
masumes	O
1	O
.	O
2	O
x	O
1	O
.	O
2	O
3	O
$	O
.	O
0	O
cm	O
.	O

OMMENT	O
.	O

Sections	O
from	O
both	O
right	O
and	O
left	O
ovaries	O
show	O
a	O
poorly	O
.	O

different	O
á	O
ated	O
adencarsinoma	O
with	O
features	O
of	O
both	O
papillary	O
.	O
serous	O
and	O
endometricid	O
carcinoma	O
.	O

Borta	O
ovaries	O
are	O
almost	O
.	O
completely	O
replaced	O
by	O
the	O
tumor	O
and	O
show	O
tumor	O
both	O
on	O
the	O
.	O
surface	O
and	O
within	O
the	O
stroma	O
.	O

The	O
tumer	O
ds	O
repredented	O
by	O
lerge	O
.	O
neste	O
,	O
and	O
papillary	O
.	O
structured	O
concisting	O
of	O
large	O
cells	O
.	O
with	O
it	O
high	O
ratio	O
,	O
large	O
hyperchromatic	O
.	O
nucled	O
;	O
and	O
a	O
high	O
mitotic	O
rate	O
approaching	O
approximately	O
es	O
.	O
mitoses	O
in	O
20	O
high	O
power	O
fields	O
including	O
abnonmal	O
forms	O
.	O

Sectione	O
from	O
the	O
cervix	O
are	O
unremarkable	O
Sectione	O
from	O
the	O
.	O
endomatrium	O
show	O
an	O
inactive	O
endometxium	O
.	O

The	O
myometrium	O
Dear	O
the	O
.	O
serosa	O
showo	O
a	O
small	O
area	O
of	O
adenomyocio	O
.	O

Large	O
netactatio	O
.	O
implants	O
of	O
tumor	O
are	O
present	O
on	O
the	O
serosa	O
of	O
the	O
uteras	O
covering	O
.	O
approximately	O
76	O
%	O
of	O
the	O
surface	O
area	O
.	O

The	O
left	O
tallopiam	O
tube	O
.	O
shows	O
no	O
histopathologio	O
abnormality	O
while	O
no	O
definite	O
fallopian	O
.	O
tube	O
is	O
identified	O
on	O
the	O
right	O
adde	O
,	O
It	O
is	O
possible	O
that	O
the	O
.	O
artached	O
fallopian	O
tube	O
on	O
the	O
lett	O
side	O
has	O
been	O
replaced	O
.	O
completely	O
by	O
the	O
tumor	O
.	O

Metastatio	O
tumor	O
implanto	O
are	O
prasent	O
in	O
.	O
further	O
detailo	O
.	O

na	O
.	O

SYNOPTIC	O
REPORTING	O
FORM	O
FOR	O
MALIGNANT	O
OVARIAN	O
NEOPLASKS	O
.	O

A	O
neoplasm	O
ic	O
PRESENT	O
,	O
bilaterally	O
.	O

The	O
histolocid	O
DIAGNOSIS	O
is	O
:	O
Mixed	O
serous	O
adenccarcinoma	O
and	O
endometrial	O
type	O
.	O

The	O
LOCATION	O
(	O
S	O
)	O
OF	O
THE	O
PRIMARY	O
TUMOR	O
(	O
S	O
)	O
is	O
/	O
are	O
:	O
Right	O
and	O
left	O
ovary	O
(	O
synchronous	O
primary	O
tumors	O
)	O
.	O

The	O
FIGGO	O
CRADE	O
of	O
the	O
tamor	O
is	O
:	O
ITI	O
(	O
Tumor	O
composed	O
of	O
greater	O
than	O
50	O
%	O
colid	O
celledar	O
.	O
nests	O
)	O
.	O

5	O
.	O

The	O
RUCLEAR	O
(	O
BRODERS	O
'	O
)	O
GRADE	O
61	O
the	O
tumor	O
13	O
:	O

-DOCSTART-203
Addendum	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
Diagnosed	O
with	O
rectal	O
carcinoma	O
at	O
15	B
cm	I
on	O
.	O
rectal	O
carcinoma	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
SP	O
:	O
Rectum	O
and	O
rectosigmoid	O
.	O

2	O
:	O
SP	O
:	O
Additional	O
sigmoid	O
.	O

3	O
:	O
SP	O
:	O
Proximal	O
ring	O
.	O

4	O
:	O
SP	O
:	O
Distal	O
ring	O
.	O

DIAGNOSIS	O
:	O
1	O
)	O
.	O

COLON	O
,	O
RECTUM	O
AND	O
RECTOSIGMOID	O
,	O
SEGMENTAL	O
RESECTION	O
:	O
-	O
THREE	O
(	O
3	O
)	O
FOCI	O
OF	O
ADENOCARCINOMA	O
,	O
MODERATELY	O
DIFFERENTIATED	O
,	O
OF	O
.	O

SIGMOID	O
AND	O
RECTOSIGMOID	O
.	O

-	O
THE	O
TUMORS	O
MEASURE	O
2	B
.	I
9	I
X	I
1	I
.	I
8	I
X	I
0	I
.	I
8	I
CM	I
,	O
0	B
.	I
4	I
x	I
0	I
.	I
4	I
x	I
0	I
.	I
2	I
CM	I
,	O
AND	O
0	B
.	I
7	I
X	I
.	I

0	B
.	I
5	I
X	I
0	I
.	I
2	I
CM	I
,	O
RESPECTIVELY	O
.	O

-	O
GROSS	O
CONFIGURATIONS	O
ARE	O
POLYPOID	O
.	O

-	O
PREEXISTING	O
TUBULAR	O
ADENOMA	O
IS	O
IDENTIFIED	O
.	O

-	O
TWO	O
SMALLER	O
TUMORS	O
INVADE	O
INTO	O
THE	O
SUBMUCOSA	O
(	O
pT1	O
)	O
.	O

-	O
THE	O
LARGEST	O
TUMOR	O
INVADES	O
INTO	O
MUSCULARIS	O
PROPRIA	O
(	O
pT2	O
)	O
.	O

-	O
NO	O
VASCULAR	O
INVASION	O
IS	O
IDENTIFIED	O
.	O

-	O
NO	O
PERINEURAL	O
INVASION	O
IS	O
IDENTIFIED	O
.	O

-	O
SURGICAL	O
MARGINS	O
ARE	O
FREE	O
OF	O
TUMOR	O
.	O

-	O
ADDITIONAL	O
HYPERPLASTIC	O
POLYP	O
IS	O
IDENTIFIED	O
.	O

THE	O
UNINVOLVED	O
COLONIC	O
MUCOSA	O
IS	O
UNREMARKABLE	O
.	O

-	O
LYMPH	O
NODES	O
:	O
NUMBER	O
OF	O
METASTASES	O
:	O
0	O
NUMBER	O
EXAMINED	O
:	O
8	O
(	O
0	O
/	O
8	O
)	O
.	O

(	O
ADDITIONAL	O
LYMPH	O
NODES	O
ARE	O
BEING	O
EXAMINED	O
AND	O
AN	O
ADDENDUM	O
REPORT	O
WILL	O
.	O
FOLLOW	O
)	O
.	O

2	O
)	O
.	O

COLON	O
,	O
ADDITIONAL	O
SIGMOID	O
,	O
SEGMENTAL	O
RESECTION	O
:	O
-	O
HYPERPLASTIC	O
POLYP	O
.	O

-	O
UNREMARKABLE	O
COLONIC	O
MUCOSA	O
.	O

-	O
ONE	O
BENIGN	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

3	O
)	O
.	O

COLON	O
,	O
PROXIMAL	O
RING	O
,	O
EXCISION	O
:	O
-	O
UNREMARKABLE	O
COLONIC	O
MUCOSA	O
.	O

4	O
.	O

COLON	O
,	O
DISTAL	O
RING	O
,	O
EXCISION	O
:	O
-	O
UNREMARKABLE	O
COLONIC	O
MUCOSA	O
.	O

I	O
.	O

ATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
.	O

THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
,	O
AND	O
THAT	O
I	O
HAVE	O
REVIEWED	O
AND	O
APPROVED	O
.	O

THIS	O
REPORT	O
.	O

1	O
.	O

Gross	O
Description	O
:	O
1	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
"	O
rectum	O
and	O
rectosigmoid	O
"	O
.	O

It	O
.	O
consists	O
of	O
a	O
rectosigmoid	O
colon	O
that	O
measures	O
12	O
.	O
0	O
cm	O
in	O
length	O
by	O
7	O
.	O
0	O
cm	O
.	O
in	O
circumference	O
at	O
the	O
distal	O
resection	O
margin	O
.	O

The	O
serosal	O
surface	O
is	O
pink	O
.	O
and	O
smooth	O
.	O

The	O
radial	O
resection	O
margin	O
is	O
inked	O
black	O
and	O
the	O
specimen	O
is	O
.	O
opened	O
to	O
reveal	O
a	O
pink	O
-	O
tan	O
papillary	O
tumor	O
measuring	O
2	B
.	I
9	I
cm	I
in	O
length	O
by	O
.	O

1	B
.	I
8	I
cm	I
in	O
width	O
by	O
0	B
.	I
4	I
cm	I
,	O
located	O
3	O
.	O
5	O
cm	O
from	O
the	O
distal	O
resection	O
margin	O
.	O

There	O
is	O
a	O
smooth	O
sessile	O
polyp	O
measuring	O
0	O
.	O
4	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
cm	O
,	O
located	O
0	O
.	O
7	O
cm	O
.	O
from	O
the	O
tumor	O
,	O
and	O
5	O
.	O
0	O
cm	O
from	O
the	O
closest	O
(	O
distal	O
)	O
resection	O
margin	O
.	O

There	O
.	O

is	O
a	O
second	O
pink	O
-	O
tan	O
smooth	O
sessile	O
polyp	O
measuring	O
0	O
.	O
6	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
cm	O
,	O
.	O
located	O
1	O
.	O
2	O
cm	O
from	O
the	O
tumor	O
,	O
and	O
3	O
.	O
2	O
cm	O
from	O
the	O
distal	O
resection	O
margin	O
.	O

(	O
arbitrarily	O
designated	O
P2	O
)	O
There	O
is	O
a	O
third	O
pink	O
-	O
tan	O
smooth	O
sessile	O
polyp	O
.	O
measuring	O
0	O
.	O
7	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
2	O
cm	O
,	O
1	O
.	O
0	O
cm	O
distal	O
to	O
the	O
tumor	O
,	O
and	O
1	O
.	O
8	O
cm	O
from	O
.	O
the	O
distal	O
resection	O
margin	O
(	O
arbitrarily	O
designated	O
P3	O
)	O
.	O

The	O
three	O
polyps	O
.	O
are	O
blocked	O
out	O
and	O
entirely	O
submitted	O
.	O

The	O
tumor	O
is	O
sectioned	O
to	O
reveal	O
a	O
.	O
well	O
defined	O
pink	O
-	O
white	O
extension	O
to	O
depth	O
of	O
0	O
.	O
8	O
cm	O
grossly	O
not	O
involving	O
.	O
the	O
underlying	O
fat	O
,	O
and	O
1	O
.	O
2	O
cm	O
from	O
the	O
inked	O
radial	O
resection	O
margin	O
.	O

Representative	O
sections	O
of	O
the	O
tumor	O
are	O
submitted	O
.	O

Remaining	O
mucosa	O
is	O
.	O
otherwise	O
grossly	O
unremarkable	O
.	O

The	O
specimen	O
is	O
submitted	O
for	O
lymph	O
nodes	O
.	O
and	O
possible	O
lymph	O
nodes	O
are	O
submitted	O
.	O

TPS	O
is	O
taken	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
PM	O
-	O
proximal	O
margin	O
.	O

DM	O
distal	O
margin	O
.	O

RM	O
-	O
-	O
radial	O
margin	O
.	O

T	O
-	O
-	O
tumor	O
.	O

P1	O
,	O
P2	O
,	O
P3polyps	O
submitted	O
from	O
proximal	O
to	O
distal	O
.	O

T	O
tumor	O
.	O

U	O
-	O
undesignated	O
.	O

LN	O
.	O
lymph	O
nodes	O
.	O

RM	O
-	O
radial	O
margin	O
.	O

2	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
"	O
Additional	O
sigmoid	O
"	O
and	O
consists	O
.	O
of	O
a	O
previously	O
opened	O
portion	O
of	O
bowel	O
measuring	O
5	O
.	O
6	O
cm	O
in	O
length	O
by	O
5	O
.	O
3	O
cm	O
.	O
in	O
circumference	O
.	O

There	O
is	O
attached	O
pericolic	O
fat	O
extending	O
6	O
.	O
2	O
cm	O
in	O
.	O
length	O
.	O

The	O
mucosa	O
reveals	O
a	O
central	O
pink	O
-	O
tar	O
smooth	O
sessile	O
polyp	O
.	O
measuring	O
0	O
.	O
5	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
cm	O
,	O
2	O
.	O
8	O
cm	O
from	O
the	O
nearest	O
unoriented	O
resection	O
.	O
margin	O
.	O

The	O
polyp	O
is	O
blocked	O
out	O
entirely	O
submitted	O
.	O

The	O
remaining	O
mucosa	O
is	O
.	O
otherwise	O
grossly	O
unremarkable	O
.	O

Representative	O
sections	O
including	O
margins	O
.	O
are	O
.	O

submitted	O
.	O

The	O
specimen	O
is	O
submitted	O
for	O
lymph	O
dissection	O
,	O
and	O
all	O
.	O
identified	O
lymph	O
nodes	O
are	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
M1	O
-	O
margin	O
one	O
.	O

M2	O
-	O
opposing	O
margin	O
.	O

P	O
-	O
polyp	O
.	O

U	O
-	O
undesignated	O
.	O

LN	O
-	O
lymph	O
nodes	O
.	O

3	O
)	O
The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
proximal	O
ring	O
"	O
and	O
.	O
consists	O
of	O
a	O
silver	O
metal	O
anastomotic	O
pin	O
measuring	O
7	O
.	O
5	O
x	O
2	O
.	O
8	O
x	O
1	O
.	O
5	O
cm	O
.	O

At	O
.	O
the	O
center	O
of	O
the	O
pin	O
,	O
a	O
plastic	O
piece	O
is	O
noted	O
.	O

A	O
ring	O
of	O
pink	O
tan	O
soft	O
.	O
tissue	O
is	O
attached	O
measuring	O
2	O
.	O
0	O
x	O
1	O
.	O
8	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
mucosal	O
surface	O
.	O

is	O
.	O
pink	O
tan	O
and	O
focally	O
hemorrhagic	O
and	O
the	O
serosal	O
surface	O
is	O
pink	O
tan	O
and	O
.	O
smooth	O
.	O

Several	O
sutures	O
and	O
staples	O
are	O
noted	O
.	O

The	O
sutures	O
and	O
staples	O
are	O
.	O
removed	O
and	O
the	O
soft	O
tissue	O
is	O
entirely	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
-	O
undesignated	O
.	O

4	O
)	O
The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
distal	O
ring	O
"	O
and	O
consists	O
.	O
of	O
a	O
ring	O
of	O
pink	O
tan	O
soft	O
tissue	O
measuring	O
1	O
.	O
8	O
x	O
1	O
.	O
8	O
x	O
0	O
.	O
7	O
cm	O
.	O

Multiple	O
.	O
sutures	O
and	O
staples	O
are	O
attached	O
.	O

The	O
mucosal	O
surface	O
is	O
pink	O
tan	O
and	O
.	O
focally	O
hemorrhagic	O
.	O

The	O
sutures	O
and	O
staples	O
are	O
removed	O
and	O
the	O
soft	O
tissue	O
.	O

is	O
entirely	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
U	O
-	O
-	O
undesignated	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
SP	O
:	O
Rectum	O
and	O
rectosigmoid	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

5	O
.	O

ADD	O
.	O

9	O
.	O

1	O
.	O

BLN	O
.	O

2	O
.	O

2	O
.	O

DM	O
.	O

2	O
.	O

6	O
.	O

LN	O
.	O

12	O
.	O

1	O
.	O

P1	O
.	O

1	O
.	O

1	O
.	O

P2	O
.	O

1	O
.	O

1	O
.	O

P3	O
.	O

1	O
.	O

2	O
.	O

PM	O
.	O

2	O
.	O

1	O
.	O

RM	O
.	O

1	O
.	O

3	O
.	O

T	O
.	O

3	O
.	O

1	O
.	O

U	O
.	O

1	O
.	O

Part	O
2	O
:	O
SP	O
:	O
Additional	O
sigmoid	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

4	O
.	O
add	O
.	O

8	O
.	O

1	O
.	O

LN	O
.	O

4	O
.	O

2	O
.	O

M1	O
.	O

2	O
.	O

2	O
.	O

M2	O
.	O

2	O
.	O

1	O
.	O

U	O
.	O

1	O
.	O

Part	O
3	O
:	O
SP	O
:	O
Proximal	O
ring	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

2	O
.	O

u	O
.	O

2	O
.	O

Part	O
4	O
:	O
SP	O
:	O
Distal	O
ring	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

2	O
.	O

u	O
.	O

2	O
.	O

Procedures	O
/	O
Addenda	O
:	O
Addendum	O
.	O

Addendum	O
Diagnosis	O
.	O

PART	O
#	O
1	O
COLON	O
,	O
RECTUM	O
AND	O
RECTOSIGMOID	O
,	O
RESECTION	O
:	O
EIGHT	O
ADDITIONAL	O
LYMPH	O
NODES	O
ARE	O
IDENTIFIED	O
;	O
THE	O
FINAL	O
LYMPH	O
NODE	O
COUNT	O
IS	O
.	O

0	O
/	O
16	O
,	O
pNO	O
.	O

-DOCSTART-204
SPECIMEN	O
(	O
S	O
)	O
SUBMITTED	O
/	O
PROCEDURES	O
ORDERED	O
:	O
CLINICAL	O
HISTORY	O
:	O
male	O
,	O
here	O
for	O
left	O
side	O
craniotomy	O
for	O
tumor	O
.	O

GROSS	O
DESCRIPTION	O
:	O
Received	O
the	O
following	O
specimens	O
in	O
the	O
Department	O
of	O
Pathology	O
,	O
labeled	O
with	O
.	O
the	O
patient	O
'	O
s	O
name	O
and	O
.	O

A	O
.	O

Brain	O
tumor	O
.	O

B	O
.	O

Brain	O
tumor	O
.	O

A	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
and	O
consists	O
of	O
a	O
dome	O
-	O
shaped	O
portion	O
of	O
edematous	O
beige	O
to	O
gray	O
-	O
.	O
tan	O
homogenous	O
tissue	O
that	O
is	O
3	O
.	O
2x2	O
.	O
5x2	O
.	O
0cm	O
.	O

A	O
representative	O
portion	O
is	O
submitted	O
for	O
frozen	O
.	O
section	O
.	O

Frozen	O
section	O
diagnosis	O
is	O
"	O
Infiltrating	O
glioma	O
,	O
most	O
likely	O
astrocytic	O
,	O
with	O
features	O
suspicious	O
.	O
for	O
anaplasia	O
,	O
"	O
by	O
Dr	O
.	O
The	O
frozen	O
tissue	O
is	O
submitted	O
in	O
cassette	O
FSA1	O
,	O
and	O
representative	O
tissue	O
.	O

is	O
submitted	O
in	O
cassettes	O
A2	O
-	O
A4	O
.	O

A	O
representative	O
portion	O
is	O
submitted	O
for	O
the	O
.	O

B	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
and	O
consists	O
of	O
a	O
3	O
.	O
6	O
X	O
3	O
.	O
3	O
x	O
0	O
.	O
9	O
cm	O
portion	O
of	O
homogenous	O
beige	O
to	O
.	O
gray	O
-	O
tan	O
soft	O
tissue	O
with	O
focal	O
areas	O
of	O
yellow	O
to	O
white	O
softening	O
.	O

A	O
representative	O
portion	O
is	O
submitted	O
.	O
in	O
cassettes	O
B1	O
-	O
B4	O
,	O
and	O
a	O
portion	O
is	O
submitted	O
to	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

"	O
Brain	O
tumor	O
"	O
:	O
Anaplastic	O
astrocytoma	O
(	O
WHO	O
Grade	O
III	O
)	O
(	O
see	O
comment	O
)	O
.	O

B	O
.	O

"	O
Brain	O
tumor	O
"	O
:	O
Anaplastic	O
astrocytoma	O
(	O
WHO	O
Grade	O
III	O
)	O
.	O

COMMENT	O
:	O
This	O
highly	O
infiltrative	O
astrocytoma	O
shows	O
evidence	O
of	O
anaplastic	O
transformation	O
as	O
well	O
as	O
.	O
areas	O
of	O
diffuse	O
low	O
grade	O
histology	O
.	O

Areas	O
of	O
increased	O
cellularity	O
and	O
pleomorphism	O
are	O
.	O
especially	O
striking	O
in	O
slides	O
A3	O
and	O
A4	O
.	O

A	O
conspicuous	O
gemistocytic	O
appearance	O
of	O
the	O
tumor	O
cells	O
is	O
.	O
apparent	O
throughout	O
(	O
GFAP	O
-	O
immunoreactive	O
)	O
.	O

Although	O
only	O
a	O
few	O
mitotic	O
figures	O
are	O
apparent	O
in	O
this	O
.	O
well	O
sampled	O
glioma	O
,	O
the	O
Ki	O
-	O
67	O
labeling	O
index	O
is	O
around	O
9	O
%	O
(	O
range	O
:	O
6	O
-	O
13	O
%	O
)	O
in	O
highly	O
cellular	O
areas	O
.	O

These	O
.	O
results	O
support	O
the	O
diagnosis	O
.	O

"	O
I	O
or	O
my	O
qualified	O
designee	O
,	O
have	O
performed	O
the	O
gross	O
examination	O
and	O
.	O
description	O
and	O
I	O
have	O
personally	O
reviewed	O
the	O
gross	O
description	O
and	O
specimen	O
preparations	O
referenced	O
.	O
herein	O
,	O
and	O
have	O
personally	O
issued	O
this	O
report	O
.	O
"	O
.	O

Resident	O
/	O
Prosector	O
/	O
Pathologist	O
:	O
Note	O
:	O
Test	O
systems	O
have	O
been	O
developed	O
and	O
their	O
performance	O
characteristics	O
determined	O
by	O
.	O

Some	O
tests	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
.	O

Administration	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
clearance	O
is	O
not	O
necessary	O
.	O

These	O
tests	O
are	O
used	O
for	O
.	O
clinical	O
purposes	O
and	O
should	O
not	O
be	O
regarded	O
as	O
investigational	O
or	O
for	O
research	O
.	O

This	O
laboratory	O
is	O
.	O
certified	O
under	O
the	O
Clinical	O
Laboratory	O
Improvement	O
Amendments	O
of	O
.	O

a	O
qualified	O
to	O
.	O
perform	O
high	O
complexity	O
clinical	O
laboratory	O
testing	O
.	O

-DOCSTART-205
Diagnosis	O
.	O

A	O
:	O
Liver	O
,	O
segments	O
4	O
-	O
8	O
,	O
resection	O
.	O

Number	O
of	O
tumors	O
:	O
one	O
.	O

Tumor	O
histologic	O
type	O
:	O
poorly	O
differentiated	O
carcinoma	O
,	O
favor	O
.	O
hepatocellular	O
carcinoma	O
(	O
see	O
comment	O
)	O
.	O

Histologic	O
grade	O
:	O
poorly	O
differentiated	O
,	O
grade	O
4	O
of	O
4	O
.	O

(	O
Edmondson	O
-	O
Steiner	O
classification	O
)	O
.	O

Tumor	O
size	O
:	O
11	B
cm	I
.	O

Tumor	O
location	O
:	O
right	O
hepatic	O
lobe	O
.	O

Tumor	O
necrosis	O
:	O
focal	O
(	O
approximately	O
10	O
%	O
by	O
gross	O
.	O
examination	O
)	O
.	O

Vascular	O
invasion	O
:	O
present	O
,	O
extensive	O
.	O

Perineural	O
invasion	O
:	O
not	O
identified	O
.	O

Capsular	O
invasion	O
:	O
not	O
identified	O
.	O

Satellite	O
lesions	O
:	O
not	O
identified	O
.	O

Margins	O
:	O
Parenchymal	O
margin	O
:	O
negative	O
but	O
extremely	O
close	O
(	O
0	O
.	O
13	O
mm	O
)	O
.	O

(	O
possibly	O
superseded	O
by	O
specimen	O
B	O
)	O
.	O

Vascular	O
margins	O
:	O
negative	O
.	O

Bile	O
duct	O
margins	O
:	O
negative	O
.	O

Lymph	O
nodes	O
:	O
none	O
identified	O
.	O

Background	O
liver	O
:	O
moderate	O
macrovesicular	O
steatosis	O
.	O

(	O
approximately	O
40	O
%	O
)	O
.	O
focal	O
ballooning	O
degeneration	O
of	O
.	O
hepatocytes	O
,	O
and	O
at	O
least	O
bridging	O
fibrosis	O
(	O
see	O
comment	O
)	O
.	O

Additional	O
findings	O
:	O
none	O
.	O

AJCC	O
Pathologic	O
TNM	O
stage	O
:	O
pT2	O
pNX	O
.	O

NOTE	O
:	O
This	O
pathologic	O
stage	O
assessment	O
is	O
based	O
on	O
information	O
.	O
available	O
at	O
the	O
time	O
of	O
this	O
report	O
and	O
is	O
subject	O
to	O
change	O
.	O
pending	O
clinical	O
review	O
and	O
additional	O
information	O
.	O

B	O
:	O
Liver	O
,	O
segment	O
4B	O
,	O
excision	O
.	O

-	O
No	O
carcinoma	O
identified	O
.	O

-	O
Moderate	O
macrovesicular	O
steatosis	O
.	O

Comment	O
:	O
Immunostains	O
are	O
performed	O
on	O
a	O
section	O
of	O
tumor	O
(	O
block	O
A5	O
)	O
.	O

The	O
.	O
malignant	O
cells	O
are	O
positive	O
for	O
cytokeratin	O
AE1	O
/	O
AE3	O
,	O
CK8	O
/	O
18	O
,	O
.	O
and	O
HepParl	O
.	O

MOC	O
-	O
31	O
shows	O
patchy	O
moderate	O
staining	O
.	O

CD10	O
is	O
.	O
negative	O
.	O

The	O
immunophenotype	O
shows	O
overlapping	O
features	O
between	O
.	O
hepatocellular	O
carcinoma	O
and	O
cholangiocarcinoma	O
;	O
however	O
,	O
given	O
.	O
the	O
strong	O
HepPar1	O
staining	O
,	O
a	O
poorly	O
differentiated	O
.	O
hepatocellular	O
carcinoma	O
is	O
favored	O
.	O

Special	O
stains	O
are	O
performed	O
on	O
a	O
section	O
of	O
background	O
liver	O
.	O

(	O
block	O
A9	O
)	O
.	O

A	O
trichrome	O
stain	O
shows	O
bridging	O
fibrosis	O
with	O
areas	O
.	O
suggestive	O
of	O
possible	O
early	O
nodule	O
formation	O
.	O

There	O
is	O
a	O
single	O
.	O
focus	O
of	O
minor	O
centrilobular	O
perisinusoidal	O
fibrosis	O
.	O

A	O
.	O
reticulin	O
stain	O
shows	O
no	O
significant	O
hepatic	O
plate	O
expansion	O
.	O

An	O
.	O
iron	O
stain	O
shows	O
mild	O
to	O
moderately	O
increased	O
iron	O
staining	O
.	O
within	O
hepatocytes	O
(	O
grade	O
2	O
of	O
4	O
)	O
and	O
increased	O
iron	O
staining	O
.	O
within	O
Kupffer	O
cells	O
.	O

A	O
PAS	O
-	O
D	O
stain	O
shows	O
no	O
PAS	O
positive	O
.	O
cytoplasmic	O
inclusions	O
.	O

Clinical	O
History	O
:	O
year	O
-	O
old	O
male	O
with	O
a	O
clinical	O
diagnosis	O
of	O
hepatocellular	O
.	O
carcinoma	O
.	O

Gross	O
Description	O
:	O
Received	O
are	O
two	O
appropriately	O
labeled	O
containers	O
.	O

Container	O
A	O
:	O
Specimen	O
Type	O
:	O
lobectomy	O
,	O
right	O
.	O

Specimen	O
Weight	O
:	O
850	O
grams	O
.	O

Measurement	O
:	O
18	O
X	O
13	O
X	O
11	O
cm	O
.	O

Orientation	O
:	O
The	O
specimen	O
is	O
oriented	O
anatomically	O
.	O

The	O
cut	O
.	O
surface	O
is	O
inked	O
blue	O
.	O

The	O
specimen	O
is	O
received	O
with	O
a	O
stitch	O
in	O
.	O
the	O
center	O
of	O
the	O
cut	O
surface	O
,	O
which	O
is	O
inked	O
red	O
.	O

Capsule	O
:	O
focally	O
thinned	O
where	O
the	O
mass	O
abuts	O
over	O
a	O
region	O
4	O
.	O
5	O
.	O

X	O
4	O
.	O
5	O
cm	O
near	O
the	O
dome	O
;	O
the	O
capsule	O
is	O
brown	O
and	O
smooth	O
.	O

Mass	O
:	O
An	O
11	O
.	O
2	O
X	O
8	O
.	O
6	O
X	O
7	O
.	O
2	O
cm	O
yellow	O
/	O
tan	O
,	O
poorly	O
circumscribed	O
.	O
mass	O
is	O
present	O
.	O

The	O
mass	O
has	O
a	O
central	O
scar	O
and	O
focal	O
.	O
hemorrhage	O
.	O

Less	O
than	O
10	O
%	O
of	O
the	O
mass	O
is	O
necrotic	O
.	O

The	O
mass	O
.	O
abuts	O
but	O
does	O
not	O
penetrate	O
through	O
the	O
capsule	O
.	O

Less	O
.	O
than	O
1	O
mm	O
from	O
the	O
blue	O
inked	O
surgical	O
margin	O
.	O

Adjacent	O
liver	O
tissue	O
:	O
brown	O
and	O
grossly	O
unremarkable	O
without	O
.	O
nodularity	O
or	O
fibrosis	O
.	O

Major	O
portal	O
vein	O
/	O
hepatic	O
vein	O
:	O
not	O
involved	O
.	O

Gallbladder	O
:	O
not	O
present	O
.	O

Block	O
summary	O
:	O
A1	O
-	O
vascular	O
margins	O
,	O
cut	O
surface	O
.	O

A2	O
-	O
vascular	O
margins	O
,	O
capsule	O
.	O

A3	O
-	O
mass	O
in	O
closest	O
approach	O
to	O
blue	O
inked	O
surgical	O
margin	O
.	O

A4	O
-	O
mass	O
in	O
relation	O
to	O
capsule	O
.	O

A5	O
-	O
-	O
-	O
representative	O
sections	O
of	O
mass	O
.	O

A9	O
-	O
sections	O
of	O
grossly	O
unremarkable	O
liver	O
taken	O
away	O
from	O
mass	O
.	O

Container	O
B	O
is	O
additionally	O
labeled	O
"	O
liver	O
,	O
Segment	O
4B	O
.	O

"	O
It	O
.	O
holds	O
a	O
28	O
.	O
4	O
gram	O
,	O
7	O
.	O
2	O
X	O
2	O
.	O
7	O
X	O
2	O
.	O
6	O
cm	O
approximately	O
wedge	O
-	O
shaped	O
.	O
piece	O
of	O
liver	O
.	O

One	O
surface	O
is	O
a	O
tan	O
smooth	O
serosal	O
surface	O
,	O
and	O
.	O
the	O
remaining	O
two	O
surfaces	O
are	O
cut	O
parenchymal	O
surfaces	O
.	O

One	O
of	O
.	O
the	O
cut	O
surfaces	O
is	O
designated	O
by	O
the	O
surgeon	O
with	O
the	O
stitch	O
.	O
at	O
the	O
definitive	O
margin	O
.	O

The	O
definitive	O
margin	O
is	O
inked	O
blue	O
,	O
.	O
and	O
the	O
opposite	O
surface	O
is	O
inked	O
black	O
.	O

Serial	O
sectioning	O
.	O
reveals	O
a	O
tan	O
firm	O
parenchymal	O
surface	O
without	O
masses	O
,	O
cysts	O
or	O
.	O
other	O
lesions	O
.	O

Block	O
summary	O
:	O
B1	O
-	O
B2	O
-	O
one	O
full	O
thickness	O
section	O
,	O
bisected	O
.	O

B3	O
-	O
B4	O
-	O
-	O
one	O
full	O
thickness	O
section	O
,	O
bisected	O
.	O

B5	O
-	O
B6	O
-	O
-	O
additional	O
representative	O
sections	O
of	O
blue	O
inked	O
.	O
representative	O
margin	O
.	O

-DOCSTART-206
Diagnosis	O
.	O

A	O
:	O
Thyroid	O
,	O
total	O
thyroidectomy	O
.	O

Tumor	O
histologic	O
type	O
:	O
papillary	O
.	O

Tumor	O
size	O
:	O
2	B
.	I
8	I
cm	I
.	O

Tumor	O
growth	O
pattern	O
:	O
circumscribed	O
.	O

Tumor	O
focality	O
:	O
unifocal	O
,	O
right	O
superior	O
pole	O
.	O

Extent	O
of	O
invasion	O
:	O
Capsular	O
Invasion	O
:	O
not	O
encapsulated	O
.	O

Lymphovascular	O
:	O
not	O
identified	O
.	O

Blood	O
vascular	O
:	O
not	O
identified	O
.	O

Extra	O
thyroidal	O
extension	O
:	O
present	O
(	O
A1	O
,	O
A3	O
)	O
.	O

Surgical	O
margins	O
:	O
-	O
Not	O
involved	O
,	O
focally	O
to	O
1	O
mm	O
of	O
the	O
anterior	O
and	O
posterior	O
.	O
margins	O
of	O
the	O
right	O
superior	O
pole	O
.	O

Status	O
of	O
thyroid	O
gland	O
away	O
from	O
tumor	O
:	O
nodular	O
hyperplasia	O
.	O

Lymph	O
nodes	O
:	O
submitted	O
separately	O
.	O

AJCC	O
Stage	O
:	O
pT3	O
pN1b	O
.	O

NOTE	O
:	O
This	O
pathologic	O
stage	O
assessment	O
is	O
based	O
on	O
information	O
.	O
available	O
at	O
the	O
time	O
of	O
this	O
report	O
,	O
and	O
is	O
subject	O
to	O
change	O
.	O
pending	O
clinical	O
review	O
and	O
additional	O
information	O
.	O

B	O
:	O
Lymph	O
node	O
,	O
right	O
neck	O
level	O
3	O
,	O
excision	O
.	O

-	O
Metastatic	O
papillary	O
thyroid	O
carcinoma	O
(	O
1	O
/	O
1	O
)	O
,	O
7mm	O
diameter	O
,	O
.	O
without	O
extracapsular	O
extension	O
.	O

Clinical	O
History	O
:	O
-	O
year	O
-	O
old	O
female	O
with	O
malignant	O
thyroid	O
neoplasm	O
.	O

Gross	O
Description	O
:	O
Specimen	O
A	O
is	O
labeled	O
"	O
total	O
right	O
thyroid	O
,	O
stitch	O
superior	O
"	O
.	O

Specimen	O
fixation	O
:	O
Formalin	O
.	O

Type	O
of	O
specimen	O
:	O
Total	O
thyroidectomy	O
.	O

Size	O
and	O
weight	O
of	O
specimen	O
:	O
24	O
.	O
4	O
grams	O
,	O
composed	O
of	O
a	O
4	O
.	O
8	O
x	O
2	O
.	O
2	O
.	O

X	O
2	O
.	O
3	O
cm	O
right	O
lobe	O
,	O
4	O
.	O
2	O
X	O
1	O
.	O
7	O
X	O
1	O
.	O
7	O
cm	O
left	O
lobe	O
,	O
central	O
.	O
contiguous	O
isthmus	O
and	O
a	O
2	O
.	O
2	O
x	O
0	O
.	O
8	O
X	O
0	O
.	O
5	O
cm	O
pyramidal	O
lobe	O
.	O

Orientation	O
:	O
Anterior	O
/	O
blue	O
,	O
posterior	O
/	O
black	O
,	O
and	O
isthmus	O
/	O
yellow	O
.	O

The	O
specimen	O
is	O
sectioned	O
from	O
superior	O
towards	O
inferior	O
.	O

Tumor	O
location	O
:	O
Right	O
superior	O
pole	O
.	O

Focality	O
:	O
Unifocal	O
.	O

Dominant	O
tumor	O
:	O
Yes	O
.	O

Tumor	O
description	O
:	O
Solid	O
white	O
/	O
tan	O
with	O
a	O
gritty	O
cut	O
surface	O
and	O
.	O
irregular	O
borders	O
.	O

Tumor	O
size	O
:	O
2	B
.	I
8	I
X	I
1	I
.	I
9	I
X	I
1	I
.	I
7	I
cm	I
.	O

Confinement	O
/	O
non	O
-	O
confinement	O
:	O
:	O
Appears	O
confined	O
to	O
the	O
thyroid	O
.	O
although	O
it	O
expands	O
the	O
right	O
superior	O
pole	O
anteriorly	O
with	O
.	O
focally	O
adherent	O
cauterized	O
fibrous	O
tissue	O
.	O

Distance	O
of	O
tumor	O
to	O
surgical	O
margins	O
:	O
Focally	O
abuts	O
the	O
.	O
anterior	O
blue	O
inked	O
margin	O
and	O
the	O
posterior	O
black	O
inked	O
margin	O
.	O
as	O
well	O
as	O
the	O
superior	O
pole	O
of	O
the	O
right	O
thyroid	O
.	O

Appearance	O
of	O
thyroid	O
gland	O
away	O
from	O
tumor	O
:	O
Dark	O
red	O
/	O
brown	O
and	O
.	O
unremarkable	O
with	O
the	O
exception	O
of	O
a	O
0	O
.	O
6	O
cm	O
gelatinous	O
cyst	O
in	O
.	O
the	O
left	O
upper	O
pole	O
,	O
lined	O
by	O
smooth	O
glistening	O
borders	O
.	O

The	O
.	O
isthmus	O
and	O
pyramidal	O
lobe	O
are	O
grossly	O
unremarkable	O
.	O

Parathyroids	O
:	O
Not	O
identified	O
.	O

Tissue	O
submitted	O
for	O
special	O
investigations	O
:	O
Tumor	O
is	O
given	O
to	O
.	O
tissue	O
procurement	O
.	O

Lymph	O
nodes	O
:	O
Submitted	O
separately	O
.	O

Digital	O
photograph	O
taken	O
:	O
No	O
.	O

Block	O
Summary	O
:	O
Inking	O
:	O
Anterior	O
/	O
blue	O
,	O
posterior	O
/	O
black	O
isthmus	O
/	O
yellow	O
.	O

A1	O
-	O
Perpendicular	O
sections	O
of	O
right	O
superior	O
pole	O
.	O

A2	O
-	O
Next	O
section	O
,	O
right	O
superior	O
pole	O
.	O

A3	O
-	O
Next	O
section	O
.	O

A4	O
-	O
A5	O
-	O
Inferior	O
edge	O
of	O
tumor	O
.	O

A6	O
-	O
Representative	O
sections	O
from	O
pyramidal	O
lobe	O
.	O

A7	O
-	O
A8	O
-	O
-	O
Representative	O
sections	O
from	O
left	O
lobe	O
.	O

Specimen	O
B	O
is	O
labeled	O
"	O
right	O
neck	O
lymph	O
node	O
level	O
3	O
"	O
and	O
is	O
a	O
.	O

1	O
.	O
2	O
X	O
0	O
.	O
9	O
X	O
0	O
.	O

4	O
cm	O
firm	O
gray	O
/	O
tan	O
lymph	O
node	O
candidate	O
with	O
a	O
.	O
small	O
amount	O
of	O
attached	O
fat	O
and	O
is	O
serially	O
sectioned	O
to	O
reveal	O
.	O

a	O
solid	O
tan	O
/	O
gray	O
cut	O
surface	O
,	O
B1	O
,	O
.	O

-DOCSTART-207
Diagnosis	O
:	O
Right	O
kidney	O
,	O
radical	O
nephrectomy	O
.	O

Histologic	O
tumor	O
type	O
/	O
subtype	O
:	O
renal	O
cell	O
carcinoma	O
,	O
clear	O
cell	O
subtype	O
;	O
see	O
comment	O
.	O

Histologic	O
grade	O
(	O
if	O
applicable	O
)	O
:	O
Fuhrman	O
grade	O
3	O
of	O
4	O
.	O

Tumor	O
size	O
(	O
greatest	O
dimension	O
)	O
:	O
5	B
.	I
5	I
cm	I
.	O

Extent	O
of	O
tumor	O
invasion	O
:	O
Capsular	O
invasion	O
/	O
perirenal	O
adipose	O
tissue	O
:	O
tumor	O
focally	O
invades	O
capsule	O
;	O
perirenal	O
adipose	O
tissue	O
is	O
negative	O
for	O
.	O
carcinoma	O
.	O

Gerota	O
'	O
s	O
fascia	O
:	O
negative	O
for	O
carcinoma	O
.	O

Renal	O
vein	O
:	O
positive	O
for	O
carcinoma	O
.	O

Ureter	O
:	O
negative	O
for	O
carcinoma	O
.	O

Venous	O
(	O
large	O
vessel	O
)	O
:	O
positive	O
for	O
carcinoma	O
.	O

Lymphatic	O
(	O
small	O
vessel	O
)	O
:	O
positive	O
for	O
carcinoma	O
.	O

Histologic	O
assessment	O
of	O
surgical	O
margins	O
:	O
Perirenal	O
adipose	O
tissue	O
:	O
negative	O
for	O
carcinoma	O
.	O

Gerota	O
'	O
S	O
fascia	O
:	O
negative	O
for	O
carcinoma	O
.	O

Renal	O
vein	O
:	O
positive	O
for	O
carcinoma	O
.	O

Renal	O
artery	O
:	O
negative	O
for	O
carcinoma	O
.	O

Ureter	O
:	O
negative	O
for	O
carcinoma	O
.	O

Adrenal	O
gland	O
:	O
not	O
present	O
.	O

Lymph	O
nodes	O
:	O
none	O
identified	O
.	O

Other	O
significant	O
findings	O
:	O
Mild	O
glomerulosclerosis	O
and	O
interstitial	O
fibrosis	O
.	O

AJCC	O
Staging	O
:	O
pT3a	O
.	O

pNx	O
.	O

This	O
staging	O
information	O
is	O
based	O
on	O
information	O
available	O
at	O
the	O
time	O
of	O
this	O
report	O
,	O
and	O
is	O
subject	O
to	O
change	O
.	O
pending	O
clinical	O
review	O
and	O
additional	O
information	O
.	O

Comment	O
:	O
Immunohistochemical	O
stains	O
are	O
performed	O
and	O
demonstrate	O
the	O
tumor	O
is	O
negative	O
for	O
Hales	O
colloidal	O
iron	O
,	O
CK7	O
,	O
.	O

CD117	O
,	O
and	O
RCC	O
while	O
being	O
positive	O
for	O
vimentin	O
and	O
with	O
equivocal	O
staining	O
for	O
E	O
-	O
cadherin	O
.	O

The	O
histologic	O
and	O
.	O
immunohistochemical	O
findings	O
are	O
most	O
consistent	O
with	O
renal	O
cell	O
carcinoma	O
,	O
clear	O
cell	O
subtype	O
.	O

Clinical	O
History	O
:	O
with	O
a	O
clinical	O
diagnosis	O
of	O
a	O
renal	O
tumor	O
.	O

As	O
,	O
the	O
patient	O
has	O
a	O
large	O
right	O
upper	O
pole	O
renal	O
mass	O
that	O
extends	O
to	O
the	O
.	O
left	O
renal	O
vein	O
and	O
into	O
the	O
inferior	O
vena	O
cava	O
.	O

Gross	O
Description	O
:	O
Received	O
is	O
one	O
appropriately	O
labeled	O
container	O
.	O

Specimen	O
fixation	O
:	O
formalin	O
.	O

Type	O
of	O
specimen	O
:	O
radical	O
.	O

Side	O
of	O
specimen	O
:	O
right	O
.	O

Size	O
and	O
weight	O
of	O
specimen	O
:	O
The	O
weight	O
is	O
930	O
grams	O
;	O
the	O
specimen	O
measures	O
26	O
.	O
5	O
x	O
16	O
.	O
0	O
x	O
9	O
.	O
5	O
cm	O
overall	O
;	O
the	O
.	O
kidney	O
measures	O
9	O
.	O
2	O
x	O
6	O
.	O
0	O
X	O
5	O
.	O
0	O
cm	O
.	O

Orientation	O
:	O
The	O
perirenal	O
adipose	O
tissue	O
has	O
been	O
previously	O
inked	O
blue	O
.	O

Presence	O
/	O
absence	O
of	O
adrenal	O
gland	O
:	O
absent	O
.	O

Tumor	O
description	O
/	O
site	O
:	O
Anatomic	O
site	O
:	O
renal	O
cortex	O
;	O
upper	O
pole	O
;	O
The	O
pole	O
varies	O
from	O
yellow	O
to	O
red	O
to	O
dark	O
brown	O
.	O
with	O
focal	O
cysts	O
and	O
necrosis	O
evident	O
.	O

The	O
tumor	O
is	O
encapsulated	O
and	O
extends	O
to	O
the	O
hilar	O
areas	O
and	O
through	O
the	O
renal	O
.	O
vein	O
.	O

Tumor	O
size	O
:	O
5	B
.	I
5	I
x	I
4	I
.	I
7	I
X	I
4	I
.	I
0	I
cm	I
.	O

Presence	O
/	O
absence	O
of	O
multicentricity	O
:	O
absent	O
.	O

Confinement	O
/	O
non	O
-	O
confinement	O
to	O
the	O
kidney	O
:	O
The	O
tumor	O
is	O
predominantly	O
confined	O
to	O
the	O
cortex	O
of	O
the	O
kidney	O
and	O
.	O

is	O
seen	O
extending	O
into	O
and	O
through	O
and	O
the	O
lumen	O
of	O
the	O
renal	O
vein	O
.	O

Extent	O
of	O
invasion	O
:	O
Perirenal	O
adipose	O
tissue	O
:	O
tumor	O
does	O
not	O
grossly	O
involve	O
.	O

Gerota	O
'	O
S	O
fascia	O
:	O
tumor	O
does	O
not	O
grossly	O
involve	O
.	O

Renal	O
vein	O
:	O
positive	O
for	O
gross	O
tumor	O
.	O

Ureter	O
:	O
does	O
not	O
grossly	O
involve	O
.	O

Other	O
organs	O
:	O
n	O
/	O
a	O
.	O

Surgical	O
margins	O
:	O
Perirenal	O
adipose	O
tissue	O
:	O
negative	O
,	O
0	O
.	O
5	O
cm	O
at	O
closest	O
approach	O
.	O

Renal	O
vein	O
:	O
positive	O
,	O
A	O
portion	O
of	O
polypoid	O
tumor	O
grossly	O
extends	O
through	O
the	O
lumen	O
and	O
measures	O
2	B
.	I
5	I
X	I
1	I
.	I
5	I
X	I
1	I
.	I
0	I
.	I

cm	B
,	O
.	O

Renal	O
artery	O
:	O
negative	O
,	O
0	O
.	O
3	O
cm	O
at	O
closest	O
approach	O
.	O

Ureter	O
:	O
negative	O
,	O
1	O
.	O
5	O
cm	O
at	O
closest	O
approach	O
.	O

Description	O
of	O
kidney	O
away	O
from	O
tumor	O
:	O
The	O
remainder	O
of	O
the	O
kidney	O
appears	O
red	O
to	O
tan	O
in	O
color	O
with	O
no	O
other	O
.	O
lesions	O
or	O
masses	O
identified	O
;	O
The	O
average	O
cortical	O
measurement	O
is	O
0	O
.	O
8	O
cm	O
and	O
the	O
average	O
medullary	O
measurement	O
.	O

is	O
1	O
.	O
2	O
cm	O
.	O

Lymph	O
nodes	O
(	O
hilar	O
)	O
:	O
none	O
identified	O
.	O

Other	O
significant	O
findings	O
:	O
none	O
.	O

Tissue	O
submitted	O
for	O
special	O
investigations	O
:	O
yes	O
.	O

Digital	O
photograph	O
taken	O
:	O
no	O
.	O

Block	O
summary	O
:	O
(	O
Inking	O
:	O
blue	O
=	O
perirenal	O
fat	O
)	O
.	O

Al	O
-	O
ureter	O
and	O
artery	O
margin	O
.	O

A2	O
-	O
tumor	O
and	O
perirenal	O
fat	O
,	O
closest	O
approach	O
.	O

A3	O
-	O
A7	O
-	O
tumor	O
with	O
capsule	O
.	O

A8	O
-	O
central	O
tumor	O
.	O

A9	O
-	O
tumor	O
with	O
overlying	O
perirenal	O
fat	O
,	O
additional	O
section	O
.	O

A10	O
-	O
A11	O
-	O
perpendicular	O
section	O
through	O
tumor	O
extension	O
into	O
renal	O
vein	O
(	O
at	O
hilum	O
)	O
.	O

A12	O
-	O
hilum	O
,	O
en	O
face	O
.	O

A13	O
-	O
hilum	O
,	O
perpendicular	O
sections	O
.	O

A14	O
-	O
normal	O
kidney	O
and	O
urothelium	O
.	O

A15	O
-	O
ureter	O
,	O
additional	O
.	O

Grossing	O
Pathologist	O
:	O
Light	O
Microscopy	O
:	O
Light	O
microscopic	O
examination	O
is	O
performed	O
.	O

Appropriate	O
internal	O
and	O
/	O
or	O
external	O
positive	O
and	O
negative	O
controls	O
have	O
been	O
evaluated	O
.	O

Some	O
of	O
the	O
.	O
immunohistochemical	O
reagents	O
used	O
in	O
this	O
case	O
may	O
be	O
classified	O
as	O
analyte	O
specific	O
reagents	O
(	O
ASR	O
)	O
.	O

These	O
were	O
.	O
developed	O
and	O
have	O
performance	O
characteristics	O
determined	O
by	O
the	O
.	O

These	O
reagents	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
US	O
Food	O
and	O
Drug	O
.	O

Administration	O
(	O
FDA	O
)	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

These	O
tests	O
are	O
.	O
used	O
for	O
clinical	O
purposes	O
.	O

They	O
should	O
not	O
be	O
regarded	O
as	O
investigational	O
or	O
for	O
research	O
.	O

This	O
laboratory	O
is	O
.	O
certified	O
under	O
the	O
Clinical	O
Laboratory	O
Improvement	O
Amendments	O
of	O
.	O

(	O
CLIA	O
-	O
88	O
)	O
as	O
qualified	O
to	O
perform	O
high	O
.	O
complexity	O
clinical	O
laboratory	O
testing	O
.	O

-DOCSTART-208
P	O
.	O
25	O
/	O
33	O
.	O

DIAGNOSIS	O
:	O
BREAST	O
,	O
RIGHT	O
,	O
MODIFIED	O
RADICAL	O
MASTECTOMY	O
-	O
.	O

A	O
.	O

INVASIVE	O
DUCTAL	O
CARCINOMA	O
WITH	O
ASSOCIATED	O
CALCIFICATIONS	O
.	O

B	O
.	O

NOTTINGHAM	O
GRADE	O
3	O
(	O
TUBULE	O
FORMATION	O
:	O
3	O
,	O
NUCLEAR	O
PLEOMORPHISM	O
:	O
3	O
,	O
MITOTIC	O
ACTIVITY	O
:	O
3	O
;	O
TOTAL	O
.	O
SCORE	O
:	O
9	O
/	O
9	O
)	O
.	O

C	O
.	O

INVASIVE	O
TUMOR	O
MEASURES	O
2	B
.	I
5	I
X	I
2	I
.	I
3	I
X	I
2	I
.	I
0	I
CM	I
.	O

D	O
.	O

DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
(	O
DCIS	O
)	O
,	O
NUCLEAR	O
GRADE	O
3	O
,	O
SOLID	O
,	O
CRIBRIFORM	O
MICROPAPILLARY	O
AND	O
CLEAR	O
.	O

CELL	O
TYPES	O
WITH	O
COMEDONECROSIS	O
AND	O
ASSOCIATED	O
CALCIFICATIONS	O
.	O

E	O
.	O

THE	O
DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
(	O
DCIS	O
)	O
CONSTITUTES	O
50	O
%	O
OF	O
THE	O
TOTAL	O
TUMOR	O
VOLUME	O
AND	O
IS	O
.	O

PRESENT	O
ADMIXED	O
WITH	O
THE	O
INVASIVE	O
COMPONENT	O
.	O

F	O
.	O

THE	O
DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
(	O
DCIS	O
)	O
IS	O
PRESENT	O
IN	O
12	O
/	O
22	O
SLIDES	O
.	O

G	O
.	O

NO	O
LYMPHOVASCULAR	O
SPACE	O
INVASION	O
IS	O
IDENTIFIED	O
.	O

H	O
.	O

RESECTION	O
MARGINS	O
ARE	O
NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
(	O
DCIS	O
)	O
IS	O
4	B
.	I
0	I
MM	I
.	O

FROM	O
THE	O
NEAREST	O
ANTERIOR	O
MARGIN	O
,	O
THE	O
INVASIVE	O
CARCINOMA	O
IS	O
GREATER	O
THAN	O
1	O
.	O
0	O
CM	O
FROM	O
ALL	O
.	O

MARGINS	O
.	O

I	O
.	O

THE	O
NIPPLE	O
IS	O
INVOLVED	O
BY	O
DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
.	O

J	O
.	O

SKIN	O
IS	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

K	O
.	O

NON	O
-	O
NEOPLASTIC	O
BREAST	O
:	O
INTRADUCTAL	O
PAPILLOMA	O
AND	O
FIBROCYSTIC	O
CHANGES	O
WITH	O
.	O

FIBROADENOMATOID	O
NODULES	O
,	O
.	O

L	O
.	O

BIOPSY	O
SITE	O
CHANGES	O
WITH	O
FAT	O
NECROSIS	O
.	O

M	O
.	O

METASTATIC	O
CARCINOMA	O
INVOLVING	O
FOUR	O
OF	O
TWENTY	O
-	O
SIX	O
LYMPH	O
NODES	O
(	O
4	O
/	O
26	O
)	O
.	O

N	O
.	O

THE	O
LARGEST	O
METASTATIC	O
FOCUS	O
MEASURES	O
2	O
.	O
0	O
CM	O
.	O

O	O
.	O

EXTRACAPSULAR	O
EXTENSION	O
IS	O
IDENTIFIED	O
AND	O
MEASURES	O
1	O
MM	O
.	O

P	O
.	O

THE	O
INVASIVE	O
TUMOR	O
CELLS	O
TESTED	O
POSITIVE	O
FOR	O
ESTROGEN	O
AND	O
WEAKLY	O
POSITIVE	O
FOR	O
.	O

PROGESTERONE	O
RECEPTORS	O
AND	O
NEGATIVE	O
FOR	O
HER	O
-	O
2	O
,	O
AS	O
PER	O
PREVIOUS	O
PATHOLOGY	O
REPORT	O
.	O

LASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
-	O
PRIMARY	O
INVASIVE	O
CARCINOMA	O
OF	O
BREAST	O
.	O

LATERALITY	O
:	O
Right	O
.	O

PROCEDURE	O
:	O
Modified	O
radical	O
mastectomy	O
.	O

Lower	O
outer	O
quadrant	O
.	O

SIZE	O
OF	O
TUMOR	O
:	O
MULTICENTRICITY	O
/	O
MULTIFOCALITY	O
OF	O
INVASIVE	O
FOCI	O
:	O
Maximum	O
dimension	O
invasive	O
component	O
:	O
2	B
5	I
cm	I
.	O

TUMOR	O
TYPE	O
(	O
invasive	O
component	O
)	O
:	O
NOTTINGHAM	O
SCORE	O
:	O
Ductal	O
adenocarcinoma	O
,	O
NOS	O
.	O

Nuclear	O
grade	O
:	O
3	O
.	O

Tubule	O
formation	O
:	O
3	O
.	O

Mitolic	O
activity	O
score	O
:	O
3	O
.	O

Total	O
Nottingham	O
score	O
:	O
9	O
.	O

Nottingham	O
grade	O
(	O
1	O
,	O
2	O
,	O
3	O
)	O
:	O
3	O
.	O

ANGIOLYMPHATIC	O
INVASION	O
:	O
DERMAL	O
LYMPHATIC	O
INVASION	O
;	O
.	O

Yes	O
,	O
malignant	O
zones	O
.	O

TUMOR	O
TYPE	O
,	O
IN	O
SITU	O
:	O
Cribriform	O
.	O

Solid	O
.	O

Micropapillary	O
.	O

Comedo	O
.	O

DCIS	O
admixed	O
with	O
invasive	O
carc	O
í	O
noma	O
.	O

SURGICAL	O
MARGINS	O
INVOLVED	O
BY	O
INVASIVE	O
COMPONENT	O
:	O
Percent	O
of	O
tumor	O
occupled	O
by	O
in	O
situ	O
component	O
50	O
%	O
.	O

SURG	O
MARGINS	O
INVOLVED	O
BY	O
IN	O
SITU	O
COMPONENT	O
:	O
PAGET	O
'	O
S	O
DISEASE	O
OF	O
NIPPLE	O
:	O
Distance	O
of	O
in	O
silu	O
disease	O
to	O
closest	O
margin	O
:	O
40	O
mm	O
.	O

LYMPH	O
NODES	O
POSITIVE	O
:	O
4	O
.	O

LYMPH	O
NODES	O
EXAMINED	O
:	O
26	O
.	O

METHOD	O
(	O
S	O
)	O
OF	O
LYMPH	O
NODE	O
EXAMINATION	O
:	O
H	O
/	O
E	O
levels	O
.	O

SIZE	O
OF	O
NODAL	O
METASTASES	O
:	O
Diameter	O
of	O
largest	O
lymph	O
nodo	O
metastasis	O
:	O
20	O
mm	O
.	O

LYMPH	O
NODE	O
METASTASIS	O
(	O
-	O
ES	O
)	O
WITH	O
EXTRACAPSULAR	O
EXTENSION	O
:	O
SKIN	O
INVOLVED	O
(	O
ULCERATION	O
)	O
:	O
NON	O
-	O
NEOPLASTIC	O
BREAST	O
TISSUE	O
:	O
Papillonia	O
,	O
FCD	O
,	O
Other	O
:	O
Fibroadenomatoid	O
nodules	O
.	O

T	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
N	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pN2a	O
.	O

M	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pMX	O
.	O

ESTROGEN	O
RECEPTORS	O
:	O
positive	O
.	O

PROGEST	O
É	O
RONE	O
RECEPTORS	O
:	O
positive	O
.	O

HER2	O
/	O
NEU	O
:	O

-DOCSTART-209
Gender	O
:	O
M	O
.	O

Examination	O
result	O
No	O
.	O

Surgery	O
and	O
Laryngological	O
Oncology	O
Dept	O
.	O

Clinical	O
diagnosis	O
(	O
suspicion	O
)	O
Laryngeal	O
carcinoma	O
.	O

Date	O
of	O
admission	O
:	O
Material	O
:	O
1	O
)	O
Material	O
:	O
larynx	O
.	O

Please	O
mark	O
surgical	O
margins	O
-	O
lower	O
(	O
trachea	O
)	O
.	O

Method	O
of	O
collection	O
:	O
Collection	O
of	O
.	O
specimens	O
for	O
laboratory	O
examination	O
.	O

Histopathological	O
diagnosis	O
.	O

Invasive	O
keratinising	O
squamous	O
cell	O
carcinoma	O
(	O
G3	O
)	O
of	O
the	O
larynx	O
.	O

Incision	O
lines	O
free	O
of	O
neoplastic	O
lesions	O
.	O

pT3	O
.	O

(	O
8071	O
/	O
3	O
T	O
-	O
24100	O
)	O
.	O

.	O
codes	O
according	O
to	O
(	O
CD	O
-	O
O	O
-	O
3	O
or	O
SNOMED	O
.	O

Macroscopic	O
description	O
:	O
Surgical	O
specimen	O
sized	O
9	O
.	O
5	O
x	O
7	O
.	O
0	O
X	O
3	O
.	O
5cm	O
,	O
including	O
larynx	O
with	O
the	O
hyoid	O
bone	O
and	O
part	O
of	O
the	O
trachea	O
1	O
.	O
5	O
cm	O
in	O
.	O
length	O
.	O

Tumour	O
found	O
in	O
the	O
glottal	O
region	O
,	O
sized	O
4	B
.	I
5	I
x	I
2	I
.	I
5	I
x	I
1	I
.	I
2cm	I
invading	O
the	O
subglottal	O
region	O
,	O
glottis	O
,	O
supraglottal	O
.	O
region	O
,	O
aryepiglottic	O
fold	O
on	O
the	O
left	O
side	O
.	O

Results	O
of	O
intraoperative	O
examination	O
:	O
Margins	O
at	O
the	O
side	O
of	O
1	O
wire	O
and	O
2	O
wires	O
(	O
top	O
)	O
cancerous	O
lesions	O
.	O

Final	O
reply	O
to	O
be	O
given	O
after	O
the	O
analysis	O
of	O
paraffin	O
specimens	O
.	O

Pathologist	O
:	O
I	O
.	O

-DOCSTART-210
CLINICAL	O
INFORMATION	O
.	O

The	O
patient	O
is	O
with	O
a	O
history	O
of	O
hepatocellular	O
carginomg	O
.	O
undergoes	O
resection	O
of	O
the	O
left	O
liver	O
lobe	O
.	O

GROSS	O
DESCRIPTIONS	O
.	O

One	O
appropriately	O
labeled	O
,	O
formalin	O
-	O
filled	O
,	O
container	O
is	O
received	O
.	O

It	O
holds	O
a	O
362	O
gram	O
,	O
13	O
.	O
5	O
x	O
10	O
.	O
5	O
x	O
5	O
.	O
0	O
.	O

cm	O
.	O

tan	O
/	O
gray	O
liver	O
lobe	O
with	O
an	O
8	B
.	I
0	I
x	I
7	I
.	I
5	I
x	I
5	I
.	I
0	I
intact	O
tumor	O
mass	O
protruding	O
from	O
the	O
surface	O
.	O

There	O
is	O
a	O
.	O
roughly	O
spherical	O
defect	O
in	O
the	O
base	O
of	O
the	O
specimen	O
where	O
tumor	O
was	O
given	O
to	O
tissue	O
procurement	O
.	O

The	O
.	O
surgical	O
margin	O
has	O
been	O
inked	O
black	O
.	O

The	O
cut	O
tumor	O
surface	O
demonstrates	O
central	O
regions	O
of	O
.	O

yellow	O
/	O
orange	O
necrosis	O
and	O
hemorrhage	O
.	O

The	O
tumor	O
appears	O
well	O
circumscribed	O
and	O
its	O
closest	O
distance	O
.	O
to	O
the	O
surgical	O
margin	O
is	O
1	O
.	O
2	O
cm	O
.	O

No	O
other	O
masses	O
are	O
identified	O
in	O
the	O
hepatic	O
parenchyma	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
as	O
per	O
block	O
summary	O
.	O

BLOCK	O
SUMMARY	O
.	O

1	O
-	O
5	O
tumor	O
.	O

6	O
-	O
uninvolved	O
parenchyma	O
.	O

7	O
-	O
8	O
-	O
surgical	O
margin	O
.	O

LIGHT	O
MICROSCOPY	O
.	O

Light	O
microscopic	O
examination	O
is	O
performed	O
.	O

Sections	O
show	O
a	O
well	O
circumscribed	O
and	O
apparently	O
encapsulated	O
tumor	O
nodule	O
composed	O
of	O
enlarged	O
.	O
hyperchromatic	O
hepatocytes	O
arranged	O
predominantly	O
in	O
a	O
trabecular	O
pattern	O
.	O

There	O
is	O
both	O
a	O
micro	O
-	O
.	O
trabecular	O
as	O
well	O
as	O
a	O
macro	O
-	O
trabecular	O
pattern	O
.	O

Focal	O
pseudo	O
-	O
acinar	O
structures	O
are	O
also	O
.	O
seen	O
.	O

There	O
are	O
focal	O
areas	O
of	O
tumor	O
necrosis	O
and	O
hemorrhage	O
.	O

Focal	O
changes	O
suspicious	O
for	O
.	O
lymphovascular	O
space	O
invasion	O
are	O
observed	O
in	O
the	O
capsule	O
(	O
section	O
#	O
8	O
)	O
.	O

There	O
was	O
a	O
single	O
nodule	O
of	O
.	O
tumor	O
without	O
any	O
apparent	O
satellite	O
lesions	O
.	O

The	O
tumor	O
appears	O
to	O
be	O
well	O
differentiated	O
and	O
does	O
not	O
.	O
involve	O
in	O
the	O
surgical	O
margins	O
.	O

The	O
adjacent	O
liver	O
tissue	O
has	O
a	O
normal	O
hepatitic	O
architecture	O
without	O
.	O
significant	O
fibrosis	O
.	O

Steatosis	O
was	O
also	O
absent	O
.	O

DIAGNOSIS	O
.	O

LIVER	O
MASS	O
,	O
LEFT	O
LOBE	O
,	O
PARTIAL	O
HEPATITIC	O
RESECTION	O
.	O

-	O
HEPATOCELLULAR	O
CARCINOMA	O
,	O
WELL	O
DIFFERENTIATED	O
,	O
PREDOMINANTLY	O
.	O

TRABECULAR	O
PATTERN	O
,	O
8	B
.	I
0	I
CM	I
IN	O
GREATEST	O
DIMENSION	O
.	O

-	O
SURGICAL	O
MARGINS	O
CLEAR	O
.	O

-DOCSTART-211
STOMACH	O
TISSUE	O
CHECKLIST	O
.	O

11	O
.	O

Specimen	O
type	O
:	O
Subtotal	O
gastrectomy	O
.	O

Tumor	O
site	O
:	O
Fundus	O
.	O

Tumor	O
size	O
:	O
0	B
X	I
0	I
X	I
8	I
.	I
5	I
cm	I
.	O

Tumor	O
features	O
:	O
Ulcerated	O
.	O

Histologic	O
type	O
:	O
Adenocarcinoma	O
.	O

Histologic	O
grade	O
:	O
Poorly	O
differentiated	O
.	O

Tumor	O
extent	O
:	O
Subserosa	O
.	O

Lymph	O
nodes	O
:	O
1	O
/	O
15	O
positive	O
for	O
metastasis	O
(	O
Greater	O
and	O
lesser	O
.	O
omentum	O
1	O
/	O
15	O
)	O
.	O

Lymphatic	O
invasion	O
:	O
Not	O
specified	O
.	O

Venous	O
invasion	O
:	O
Absent	O
.	O

Perineural	O
invasion	O
:	O
Not	O
specified	O
.	O

Margins	O
:	O
Uninvolved	O
.	O

Evidence	O
of	O
neo	O
-	O
adjuvant	O
treatment	O
:	O
Not	O
specified	O
.	O

Additional	O
pathologic	O
findings	O
:	O
Not	O
specified	O
.	O

Comments	O
:	O
None	O
.	O

-DOCSTART-212
PRIMARY	O
SITE	O
:	O
Esophagus	O
.	O

1	O
.	O

Specimen	O
:	O
thoracic	O
and	O
abdominal	O
esophagus	O
and	O
proximal	O
stomach	O
.	O

Procedure	O
:	O
Esophagogastrectomy	O
.	O

Tumor	O
site	O
:	O
distal	O
esophagus	O
and	O
stomach	O
.	O

Tumor	O
size	O
(	O
greatest	O
dimension	O
)	O
:	O
7	B
,	I
8	I
cm	I
.	O

Histologic	O
type	O
:	O
Squamous	O
cell	O
carcinoma	O
,	O
ulcerated	O
.	O

Histologic	O
grade	O
:	O
G2	O
moderately	O
differentiated	O
.	O

Microscopic	O
tumor	O
extension	O
:	O
tumor	O
invades	O
mucosa	O
,	O
submucosa	O
,	O
muscularis	O
propria	O
.	O
and	O
adventitia	O
.	O

Lymph	O
-	O
vascular	O
invasion	O
:	O
not	O
identified	O
.	O

Perineural	O
invasion	O
:	O
not	O
identified	O
.	O

Margins	O
:	O
Proximal	O
margin	O
:	O
uninvolved	O
by	O
carcinoma	O
.	O

Distal	O
margin	O
:	O
uninvolved	O
by	O
carcinoma	O
.	O

Circumferential	O
(	O
radial	O
margin	O
)	O
:	O
involved	O
by	O
invasive	O
carcinoma	O
.	O

Regional	O
lymph	O
nodes	O
from	O
lesser	O
curvature	O
with	O
conglomerate	O
:	O
Number	O
examined	O
:	O
08	O
.	O

Number	O
positive	O
for	O
neoplasia	O
:	O
03	O
.	O

2	O
.	O

"	O
Lymph	O
nodes	O
of	O
the	O
hepatic	O
artery	O
"	O
:	O
Number	O
examined	O
:	O
06	O
.	O

Number	O
positive	O
for	O
neoplasia	O
:	O
00	O
.	O

3	O
.	O

"	O
Margin	O
of	O
the	O
stomach	O
"	O
:	O
Uninvolved	O
by	O
carcinoma	O
.	O

-DOCSTART-213
M	O
.	O

Path	O
Report	O
.	O

ACCESSION	O
NO	O
.	O

:	O
Final	O
Diagnosis	O
(	O
es	O
)	O
:	O
(	O
A	O
)	O
Left	O
kidney	O
and	O
adrenal	O
gland	O
,	O
radical	O
nephrectomy	O
:	O
1	O
)	O
Papillary	O
renal	O
cell	O
carcinoma	O
(	O
5	B
.	I
5	I
cm	I
)	O
,	O
Type	O
2	O
,	O
.	O

Fuhrman	O
grade	O
3	O
of	O
4	O
(	O
see	O
Synoptic	O
Report	O
)	O
.	O

2	O
)	O
Tumor	O
focally	O
invades	O
renal	O
sinus	O
.	O

3	O
)	O
Separate	O
tumor	O
focus	O
located	O
in	O
proximal	O
ureter	O
(	O
0	B
.	I
7	I
.	I
cm	I
)	O
.	O

4	O
)	O
Pathologic	O
stage	O
:	O
pT3a	O
N1	O
MX	O
.	O

5	O
)	O
Adrenal	O
gland	O
with	O
no	O
pathologic	O
abnormality	O
.	O

(	O
B	O
)	O
Left	O
adrenal	O
gland	O
,	O
completion	O
adrenalectomy	O
:	O
1	O
)	O
Benign	O
adrenal	O
gland	O
.	O

2	O
)	O
No	O
malignancy	O
identified	O
.	O

(	O
C	O
)	O
Lymph	O
nodes	O
,	O
para	O
-	O
aortic	O
,	O
excision	O
:	O
1	O
)	O
Metastatic	O
papillary	O
renal	O
cell	O
carcinoma	O
involving	O
two	O
.	O
of	O
two	O
lymph	O
nodes	O
(	O
2	O
/	O
2	O
)	O
.	O

2	O
)	O
Extracapsular	O
extension	O
identified	O
.	O

(	O
D	O
)	O
Lymph	O
nodes	O
,	O
para	O
-	O
aortic	O
,	O
excision	O
:	O
1	O
)	O
Metastatic	O
papillary	O
renal	O
cell	O
carcinoma	O
involving	O
ten	O
of	O
.	O
sixteen	O
lymph	O
nodes	O
(	O
10	O
/	O
16	O
)	O
.	O

2	O
)	O
Extracapsular	O
extension	O
identified	O
.	O

3	O
)	O
Vascular	O
invasion	O
present	O
.	O

(	O
E	O
)	O
Lymph	O
nodes	O
,	O
interaortocaval	O
,	O
excision	O
:	O
1	O
)	O
Metastatic	O
papillary	O
renal	O
cell	O
carcinoma	O
involving	O
two	O
.	O
of	O
two	O
lymph	O
nodes	O
(	O
2	O
/	O
2	O
)	O
.	O

2	O
)	O
Vascular	O
invasion	O
present	O
.	O

(	O
F	O
)	O
Ureter	O
,	O
left	O
distal	O
,	O
ureterectomy	O
:	O
Benign	O
ureter	O
,	O
negative	O
.	O
for	O
malignancy	O
.	O

Synoptic	O
Report	O
:	O
Laterality	O
:	O
Left	O
.	O

Specimen	O
Procedure	O
:	O
Radical	O
nephrectomy	O
.	O

Tumor	O
Site	O
:	O
Middle	O
,	O
.	O

Tumor	O
Size	O
:	O
5	B
.	I
5	I
x	I
5	I
.	I
0	I
x	I
4	I
.	I
5	I
cm	I
.	O

Tumor	O
Focality	O
:	O
Multifocal	O
(	O
kidney	O
and	O
ureter	O
)	O
.	O

Macroscopic	O
Extent	O
of	O
Tumor	O
:	O
Limited	O
to	O
kidney	O
.	O

Histologic	O
Type	O
:	O
Papiliary	O
renal	O
cell	O
carcinoma	O
.	O

Sarcomatoid	O
Features	O
:	O
Not	O
identified	O
.	O

Tumor	O
Necrosis	O
:	O
Present	O
,	O
5	O
%	O
.	O

Histologic	O
Grade	O
(	O
Fuhrman	O
Nuclear	O
Grade	O
)	O
:	O
Grade	O
3	O
,	O
Type	O
2	O
.	O

Microscopic	O
Extent	O
of	O
Tumor	O
:	O
Renal	O
sinus	O
,	O
focal	O
.	O

Lymphvascular	O
Invasion	O
:	O
Present	O
.	O

Margins	O
:	O
Ureteric	O
:	O
Negative	O
.	O

Vascular	O
:	O
Negative	O
.	O

Soft	O
Tissue	O
:	O
Negative	O
.	O

Regional	O
lymph	O
nodes	O
:	O
Printed	O
from	O
.	O

Page	O
:	O
1	O
of	O
6	O
.	O

M	O
.	O

Number	O
examined	O
:	O
20	O
.	O

Number	O
positive	O
:	O
14	O
.	O

Pathologic	O
Staging	O
:	O
pT3a	O
N1	O
MX	O
.	O

Pathologic	O
Findings	O
in	O
Non	O
-	O
Neoplastic	O
Kidney	O
:	O
Mild	O
,	O
patchy	O
,	O
.	O
interstitial	O
,	O
chronic	O
inflammation	O
.	O

Immunohistochemistry	O
:	O
RCC	O
:	O
Positive	O
.	O

PAX	O
-	O
8	O
:	O
Positive	O
.	O

CD10	O
:	O
Positive	O
.	O

CK5	O
:	O
Negative	O
.	O

p63	O
:	O
Negative	O
.	O

Comments	O
:	O
The	O
morphologic	O
features	O
and	O
immunohistochemical	O
profile	O
.	O
supports	O
the	O
diagnosis	O
of	O
papillary	O
renal	O
cell	O
carcinoma	O
.	O

Although	O
spread	O
into	O
the	O
ureter	O
is	O
unusual	O
for	O
renal	O
cell	O
.	O
carcinoma	O
,	O
the	O
main	O
kidney	O
mass	O
and	O
tumor	O
within	O
the	O
ureter	O
.	O
share	O
the	O
same	O
immunohistochemical	O
profile	O
and	O
morphologic	O
.	O
appearance	O
,	O
representing	O
the	O
same	O
tumor	O
.	O

This	O
case	O
has	O
been	O
reviewed	O
and	O
the	O
diagnosis	O
agreed	O
upon	O
by	O
.	O
consulting	O
departmental	O
surgical	O
pathology	O
staff	O
.	O

The	O
gross	O
description	O
and	O
all	O
microscopic	O
slides	O
have	O
been	O
.	O
reviewed	O
and	O
interpreted	O
by	O
the	O
undersigned	O
pathologist	O
'	O
.	O

Specimen	O
(	O
s	O
)	O
Receiveu	O
.	O

A	O
:	O
Left	O
kidney	O
and	O
adrenal	O
gland	O
.	O

B	O
:	O
Left	O
adrenal	O
gland	O
.	O

C	O
:	O
Para	O
-	O
aortic	O
lymph	O
nodes	O
.	O

D	O
:	O
Para	O
-	O
aortic	O
lymph	O
nodes	O
.	O

E	O
:	O
Part	O
of	O
interaorta	O
caval	O
.	O

F	O
:	O
Distal	O
ureter	O
,	O
left	O
.	O

Clinical	O
History	O
:	O
Left	O
kidney	O
cancer	O
.	O

Intraoperative	O
Consultation	O
:	O
FSA1	O
-	O
FSA2	O
:	O
Left	O
kidney	O
mass	O
:	O
Carcinoma	O
,	O
favor	O
urothelial	O
(	O
2	O
.	O
blocks	O
)	O
.	O

FSC1	O
-	O
FSC2	O
:	O
Paraaortic	O
lymph	O
node	O
:	O
Metastatic	O
carcinoma	O
,	O
favor	O
.	O
papillary	O
renal	O
cell	O
carcinoma	O
(	O
2	O
blocks	O
)	O
.	O

Gross	O
Description	O
:	O
(	O
A	O
)	O
(	O
left	O
kidney	O
and	O
adrenal	O
gland	O
)	O
.	O

Specimen	O
components	O
and	O
dimensions	O
:	O
Received	O
fresh	O
for	O
frozen	O
.	O
section	O
analysis	O
is	O
a	O
kidney	O
and	O
perinephric	O
fat	O
measuring	O
29	O
.	O
0	O
.	O

Printed	O
from	O
:	O
Page	O
:	O
2	O
of	O
6	O
.	O

M	O
.	O

x	O
23	O
.	O
0	O
x	O
6	O
.	O
0	O
cm	O
.	O

The	O
specimen	O
weighs	O
1	O
,	O
270	O
gm	O
.	O

The	O
kidney	O
.	O
itself	O
measures	O
12	O
.	O
0	O
x	O
6	O
.	O
5	O
x	O
5	O
.	O
0	O
cm	O
.	O

The	O
attached	O
adrenal	O
gland	O
.	O
measures	O
4	O
.	O
5	O
x	O
1	O
.	O
5	O
x	O
1	O
.	O
0	O
cm	O
.	O

The	O
attached	O
ureter	O
measures	O
5	O
.	O
5	O
.	O

cm	O
in	O
length	O
and	O
has	O
an	O
average	O
diameter	O
of	O
0	O
.	O
4	O
cm	O
.	O

The	O
kidney	O
.	O
has	O
been	O
shelled	O
out	O
of	O
the	O
perinephric	O
fat	O
and	O
bivalved	O
by	O
the	O
.	O
surgeon	O
.	O

The	O
perinephric	O
fat	O
is	O
inked	O
black	O
.	O

The	O
capsular	O
.	O
surface	O
of	O
the	O
kidney	O
is	O
tan	O
-	O
brown	O
.	O

There	O
are	O
multiple	O
small	O
.	O
white	O
granular	O
lesions	O
ranging	O
in	O
size	O
from	O
0	O
.	O
1	O
to	O
0	O
.	O
5	O
cm	O
on	O
the	O
.	O
surface	O
.	O

A	O
portion	O
of	O
the	O
tumor	O
appears	O
to	O
be	O
pushing	O
the	O
.	O
capsule	O
out	O
and	O
this	O
area	O
measures	O
4	O
.	O
5	O
x	O
3	O
.	O
0	O
x	O
2	O
.	O
6	O
cm	O
.	O

It	O
does	O
.	O
not	O
appear	O
to	O
be	O
grossly	O
invading	O
through	O
the	O
capsule	O
.	O

Size	O
,	O
appearance	O
and	O
location	O
of	O
tumor	O
:	O
Bivalving	O
the	O
specimen	O
.	O
reveals	O
a	O
tan	O
-	O
white	O
to	O
pink	O
friable	O
mass	O
(	O
5	B
.	I
5	I
x	I
5	I
.	I
0	I
x	I
4	I
.	I
5	I
cm	I
)	O
.	O
present	O
within	O
the	O
center	O
of	O
the	O
kidney	O
.	O

There	O
is	O
an	O
additional	O
.	O
small	O
tan	O
-	O
pink	O
nodule	O
(	O
0	B
.	I
7	I
x	I
0	I
.	I
5	I
x	I
0	I
.	I
4	I
cm	I
)	O
at	O
the	O
proximal	O
.	O
ureter	O
.	O

A	O
representative	O
section	O
of	O
the	O
smaller	O
mass	O
is	O
.	O
submitted	O
in	O
FSA1	O
.	O

A	O
representative	O
section	O
of	O
the	O
large	O
tumor	O
.	O

is	O
submitted	O
in	O
FSA2	O
.	O

Renal	O
capsule	O
/	O
Renal	O
sinus	O
:	O
The	O
tumor	O
appears	O
to	O
be	O
extending	O
.	O
the	O
capsule	O
,	O
but	O
does	O
not	O
appear	O
to	O
grossly	O
invade	O
through	O
the	O
.	O
capsule	O
into	O
the	O
perinephric	O
fat	O
.	O

The	O
tumor	O
appears	O
to	O
abut	O
the	O
.	O
renal	O
sinus	O
;	O
however	O
,	O
no	O
gross	O
invasion	O
is	O
identified	O
.	O

The	O
.	O
small	O
mass	O
on	O
the	O
ureter	O
does	O
not	O
appear	O
to	O
grossly	O
invade	O
into	O
.	O
the	O
ureter	O
.	O

Renal	O
vein	O
:	O
Not	O
clearly	O
identified	O
.	O

Other	O
findings	O
:	O
None	O
.	O

Uninvolved	O
tissues	O
:	O
The	O
adrenal	O
gland	O
appears	O
golden	O
yellow	O
.	O
with	O
small	O
punctate	O
hemorrhage	O
areas	O
present	O
.	O

The	O
uninvolved	O
.	O
renal	O
parenchyma	O
appears	O
tan	O
-	O
brown	O
.	O

The	O
medulla	O
is	O
tan	O
-	O
pink	O
.	O

The	O
average	O
cortical	O
thickness	O
is	O
0	O
.	O
9	O
cm	O
.	O

The	O
uninvolved	O
ureter	O
.	O
serosa	O
is	O
tan	O
-	O
pink	O
,	O
smooth	O
and	O
glistening	O
.	O

The	O
uninvolved	O
.	O
ureter	O
mucosa	O
is	O
tan	O
-	O
white	O
and	O
striated	O
.	O

Lymph	O
nodes	O
:	O
Five	O
potential	O
lymph	O
nodes	O
are	O
identified	O
in	O
the	O
.	O
hilum	O
fat	O
ranging	O
in	O
size	O
from	O
0	O
.	O
4	O
to	O
1	O
.	O
1	O
cm	O
.	O

The	O
larger	O
nodes	O
.	O
are	O
firm	O
and	O
suspicious	O
for	O
tumor	O
involvement	O
.	O

Blocks	O
submitted	O
:	O
FSA1	O
-	O
FSA2	O
-	O
representative	O
tumor	O
(	O
large	O
mass	O
and	O
smaller	O
.	O
ureteral	O
mass	O
,	O
respectively	O
)	O
.	O

A3	O
-	O
representative	O
shave	O
margin	O
of	O
all	O
vascular	O
structures	O
.	O
identified	O
.	O

A4	O
-	O
entire	O
small	O
lesion	O
found	O
on	O
the	O
ureter	O
and	O
cross	O
sections	O
.	O

A5	O
-	O
A6	O
-	O
representative	O
sections	O
of	O
the	O
tumor	O
and	O
its	O
.	O
relationship	O
to	O
the	O
sinus	O
fat	O
.	O

A7	O
-	O
representative	O
section	O
of	O
the	O
tumor	O
and	O
its	O
relationship	O
to	O
.	O
the	O
renal	O
pelvis	O
and	O
sinus	O
fat	O
.	O

A8	O
-	O
representative	O
section	O
of	O
the	O
tumor	O
and	O
its	O
relationship	O
to	O
.	O
the	O
uninvolved	O
renal	O
parenchyma	O
.	O

A9	O
-	O
A10	O
-	O
representative	O
section	O
of	O
the	O
tumor	O
and	O
in	O
its	O
.	O
relationship	O
to	O
the	O
capsule	O
where	O
it	O
protrudes	O
.	O

A11	O
-	O
representative	O
section	O
of	O
perinephric	O
fat	O
.	O

Printed	O
from	O
:	O
Page	O
:	O
3	O
of	O
6	O
.	O

M	O
.	O

A12	O
-	O
representative	O
section	O
of	O
grossly	O
uninvolved	O
renal	O
.	O
parenchyma	O
and	O
uninvolved	O
ureter	O
.	O

A13	O
-	O
five	O
potential	O
lymph	O
nodes	O
intact	O
.	O

A14	O
-	O
adrenal	O
gland	O
.	O

(	O
B	O
)	O
(	O
left	O
adrenal	O
giand	O
)	O
Received	O
in	O
formalin	O
is	O
a	O
portion	O
of	O
.	O
adrenal	O
gland	O
measuring	O
5	O
.	O
5	O
x	O
3	O
.	O
5	O
x	O
3	O
.	O
5	O
cm	O
.	O

The	O
adrenal	O
gland	O
.	O

is	O
golden	O
yellow	O
with	O
red	O
hemorrhagic	O
tissue	O
within	O
the	O
center	O
.	O

Serial	O
sectioning	O
of	O
the	O
adrenal	O
gland	O
demonstrates	O
no	O
grossly	O
.	O
identified	O
masses	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
.	O
cassettes	O
B1	O
-	O
B3	O
.	O

(	O
C	O
)	O
(	O
para	O
-	O
aortic	O
lymph	O
nodes	O
)	O
Received	O
fresh	O
for	O
frozen	O
.	O
section	O
is	O
tan	O
-	O
red	O
tissue	O
measuring	O
5	O
.	O
0x	O
2	O
.	O
5	O
x	O
2	O
.	O
0	O
cm	O
.	O

Three	O
.	O
firm	O
lymph	O
nodes	O
are	O
identified	O
ranging	O
in	O
size	O
from	O
1	O
.	O
2	O
to	O
4	O
.	O
0	O
.	O

cm	O
.	O
the	O
smallest	O
lymph	O
node	O
is	O
inked	O
black	O
and	O
submitted	O
intact	O
.	O
along	O
with	O
one	O
representative	O
section	O
of	O
the	O
middle	O
-	O
sized	O
lymph	O
.	O
node	O
in	O
FSC1	O
.	O

A	O
representative	O
section	O
of	O
the	O
largest	O
lymph	O
.	O
node	O
is	O
submitted	O
in	O
FSC2	O
.	O

The	O
remainder	O
of	O
the	O
middle	O
-	O
sized	O
.	O
lymph	O
node	O
is	O
serially	O
sectioned	O
and	O
submitted	O
entirely	O
in	O
.	O
cassette	O
C3	O
.	O

The	O
largest	O
lymph	O
node	O
is	O
serially	O
sectioned	O
and	O
.	O
submitted	O
in	O
cassettes	O
C4	O
-	O
C6	O
.	O

(	O
D	O
)	O
(	O
para	O
-	O
aortic	O
lymph	O
nodes	O
)	O
Received	O
in	O
formalin	O
are	O
two	O
.	O
fragments	O
of	O
tan	O
-	O
red	O
fibroadipose	O
tissue	O
measuring	O
7	O
.	O
0	O
x	O
10	O
.	O
5	O
x	O
.	O

4	O
.	O
0	O
cm	O
.	O

There	O
are	O
multiple	O
surgical	O
clips	O
and	O
sutures	O
present	O
.	O

Additionally	O
present	O
are	O
fragments	O
of	O
a	O
vascular	O
structure	O
.	O

Sixteen	O
potential	O
lymph	O
nodes	O
are	O
identified	O
which	O
are	O
firm	O
and	O
.	O
rang	O
in	O
size	O
from	O
0	O
.	O
4	O
to	O
6	O
.	O
0	O
cm	O
.	O

Blocks	O
are	O
submitted	O
as	O
.	O
follows	O
:	O
D1	O
-	O
representative	O
sections	O
of	O
the	O
vascular	O
structures	O
.	O
identified	O
within	O
the	O
specimen	O
.	O

D2	O
-	O
six	O
potential	O
lymph	O
nodes	O
intact	O
.	O

D3	O
-	O
three	O
potential	O
lymph	O
nodes	O
intact	O
.	O

D4	O
-	O
one	O
matted	O
lymph	O
node	O
bisected	O
.	O

D5	O
-	O
one	O
potential	O
lymph	O
node	O
bisected	O
.	O

D6	O
-	O
D8	O
-	O
one	O
lymph	O
node	O
serially	O
sectioned	O
.	O

D9	O
-	O
D10	O
-	O
one	O
lymph	O
node	O
serially	O
sectioned	O
.	O

D11	O
-	O
D14	O
-	O
one	O
lymph	O
node	O
serially	O
sectioned	O
.	O

D15	O
-	O
D16	O
-	O
representative	O
sections	O
of	O
one	O
lymph	O
node	O
.	O

D17	O
-	O
D19	O
-	O
representative	O
sections	O
of	O
the	O
largest	O
lymph	O
node	O
.	O

(	O
E	O
)	O
(	O
part	O
of	O
interaortocaval	O
)	O
Received	O
in	O
formalin	O
is	O
one	O
.	O
fragment	O
of	O
tan	O
-	O
pink	O
fibroadipose	O
tissue	O
measuring	O
5	O
.	O
5	O
x	O
5	O
.	O
5	O
x	O
.	O

3	O
.	O
0	O
cm	O
.	O

Two	O
large	O
firm	O
matted	O
lymph	O
nodes	O
are	O
identified	O
.	O
ranging	O
in	O
size	O
from	O
3	O
.	O
0	O
x	O
5	O
.	O
5	O
cm	O
.	O

Blocks	O
are	O
submitted	O
as	O
.	O
follows	O
:	O
E1	O
-	O
E2	O
-	O
representative	O
sections	O
from	O
the	O
smaller	O
matted	O
lymph	O
.	O
node	O
.	O

E3	O
-	O
E5	O
-	O
representative	O
sections	O
of	O
the	O
larger	O
matted	O
lymph	O
node	O
.	O

(	O
F	O
)	O
(	O
distal	O
ureter	O
,	O
left	O
)	O
Received	O
in	O
formalin	O
is	O
a	O
portion	O
of	O
.	O
ureter	O
measuring	O
5	O
.	O
0	O
cm	O
in	O
length	O
and	O
having	O
a	O
diameter	O
ranging	O
.	O
from	O
0	O
.	O
6	O
to	O
0	O
.	O
5	O
cm	O
.	O

There	O
is	O
a	O
stapled	O
and	O
suture	O
on	O
one	O
end	O
of	O
.	O
the	O
ureter	O
.	O

This	O
end	O
of	O
the	O
ureter	O
is	O
inked	O
blue	O
.	O

The	O
ureter	O
.	O

Printed	O
from	O
:	O
Page	O
:	O
4	O
of	O
6	O
.	O

M	O
.	O

is	O
serially	O
sectioned	O
.	O

Blocks	O
are	O
submitted	O
as	O
follows	O
:	O
F1	O
-	O
the	O
inked	O
blue	O
margin	O
which	O
was	O
the	O
one	O
with	O
a	O
staple	O
and	O
.	O
suture	O
on	O
it	O
as	O
well	O
as	O
the	O
opposite	O
margin	O
.	O

F2	O
-	O
the	O
remainder	O
of	O
the	O
specimen	O
serially	O
sectioned	O
.	O

Microscopic	O
Description	O
:	O
Complete	O
microscopic	O
evaluation	O
has	O
been	O
performed	O
.	O

Appropriately	O
reacting	O
controls	O
have	O
been	O
performed	O
and	O
.	O
evaluated	O
for	O
all	O
stains	O
on	O
this	O
case	O
as	O
required	O
.	O

Histopathology	O
has	O
a	O
list	O
of	O
IH	O
antibodies	O
that	O
are	O
regulated	O
as	O
.	O
analyte	O
specific	O
reagents	O
(	O
ASR	O
'	O
s	O
)	O
.	O

These	O
assays	O
were	O
developed	O
.	O
and	O
their	O
performance	O
characteristics	O
determined	O
by	O
the	O
.	O

They	O
.	O
have	O
not	O
been	O
cleared	O
by	O
the	O
US	O
Food	O
and	O
Drug	O
Aaministration	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
.	O
necessary	O
for	O
the	O
ASR	O
'	O
s	O
.	O

These	O
tests	O
are	O
not	O
investigational	O
.	O
and	O
are	O
used	O
in	O
standard	O
clinical	O
care	O
.	O

In	O
cases	O
where	O
.	O

Immunohistochernistry	O
testing	O
is	O
performed	O
,	O
the	O
following	O
.	O
antibodies	O
and	O
their	O
respective	O
clones	O
may	O
be	O
used	O
to	O
determine	O
.	O
therapy	O
for	O
the	O
patient	O
:	O
EFGR	O
(	O
3c6	O
)	O
,	O
ER	O
(	O
SP1	O
)	O
,	O
PR	O
(	O
1E2	O
)	O
,	O
.	O

Her2neu	O
(	O
4B5	O
)	O
,	O
CD117	O
(	O
Poly	O
)	O
CD20	O
(	O
L26	O
)	O
Ki67	O
(	O
30	O
-	O
9	O
)	O
.	O

Uniess	O
otherwise	O
stated	O
in	O
the	O
report	O
,	O
all	O
tissue	O
tested	O
for	O
.	O

ERPR	O
by	O
IHC	O
,	O
Her2	O
by	O
IHC	O
and	O
/	O
or	O
HER2	O
by	O
FISH	O
have	O
been	O
fixed	O
as	O
.	O
per	O
C	O
.	O
A	O
.	O
P	O
.	O
requirements	O
for	O
a	O
minimum	O
of	O
6	O
hours	O
and	O
a	O
maximum	O
.	O
of	O
48	O
hours	O
.	O

ER	O
,	O
PR	O
,	O
Ki	O
-	O
67	O
,	O
p53	O
are	O
reported	O
as	O
a	O
semi	O
-	O
quantitative	O
.	O
percentage	O
of	O
positively	O
stained	O
nuclei	O
.	O

Her	O
-	O
2	O
/	O
neu	O
and	O
EGFR	O
are	O
.	O
scored	O
as	O
follows	O
:	O
No	O
staining	O
at	O
all	O
is	O
scored	O
as	O
(	O
0	O
)	O
,	O
weak	O
,	O
.	O
incomplete	O
membrane	O
staining	O
in	O
any	O
proportion	O
of	O
cells	O
is	O
.	O
scored	O
as	O
(	O
1	O
+	O
)	O
,	O
less	O
than	O
strong	O
but	O
complete	O
staining	O
in	O
any	O
.	O
proportion	O
of	O
cells	O
or	O
complete	O
strong	O
staining	O
in	O
less	O
than	O
30	O
%	O
.	O
of	O
cells	O
is	O
scored	O
as	O
(	O
2	O
+	O
)	O
,	O
and	O
strong	O
complete	O
staining	O
in	O
more	O
.	O
that	O
30	O
%	O
of	O
cells	O
is	O
scored	O
as	O
(	O
3	O
+	O
)	O
.	O

All	O
studies	O
are	O
performed	O
.	O
on	O
tissue	O
fixed	O
in	O
10	O
%	O
neutral	O
buffered	O
formalin	O
and	O
embedded	O
in	O
.	O
paraffin	O
unless	O
otherwise	O
stated	O
in	O
the	O
report	O
.	O

Printed	O
from	O
:	O
Page	O
:	O
5	O
of	O
6	O
.	O

-DOCSTART-214
INTERPRETATION	O
AND	O
DIAGNOSIS	O
:	O
1	O
,	O
2	O
.	O

LEFT	O
UPPER	O
LOBE	O
AND	O
LEFT	O
UPPER	O
LOBE	O
#	O
2	O
:	O
SPECIMEN	O
TYPE	O
:	O
Wedge	O
resection	O
and	O
completion	O
lobectomy	O
.	O

TUMOR	O
SITE	O
:	O
Left	O
upper	O
lobe	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Adenocarcinoma	O
,	O
Nos	O
.	O

TUMOR	O
SIZE	O
:	O
Greatest	O
dimension	O
:	O
3	B
.	I
0	I
cm	I
.	O

LOCATION	O
,	O
SIZE	O
AND	O
HISTOLOGIC	O
TYPE	O
OF	O
.	O

ADDITIONAL	O
SEPARATE	O
TUMOR	O
NODULES	O
,	O
IF	O
ANY	O
.	O

None	O
identified	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
G2	O
:	O
Moderately	O
differentiated	O
.	O

LYMPH	O
NODES	O
:	O
Metastatic	O
carcinoma	O
in	O
2	O
of	O
17	O
lymph	O
nodes	O
(	O
see	O
parts	O
4	O
&	O
6	O
)	O
.	O

DIRECT	O
EXTENSION	O
OF	O
TUMOR	O
:	O
Visceral	O
pleura	O
(	O
supported	O
by	O
Movats	O
stain	O
)	O
.	O

EXTENT	O
OF	O
INVASION	O
.	O

PRIMARY	O
TUMOR	O
:	O
pT2	O
:	O
Tumor	O
invades	O
visceral	O
pleura	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
:	O
pN2	O
:	O
Metastasis	O
in	O
ipsilateral	O
mediastinal	O
or	O
subcarinal	O
lymph	O
nodes	O
.	O

DISTANT	O
METASTASIS	O
:	O
pMX	O
:	O
Cannot	O
be	O
assessed	O
.	O

MARGINS	O
:	O
Margins	O
uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

VENOUS	O
/	O
ARTERIAL	O
(	O
LARGE	O
VESSEL	O
)	O
INVASION	O
:	O
Indeterminate	O
.	O

LYMPHATIC	O
(	O
SMALL	O
VESSEL	O
)	O
INVASION	O
:	O
Indeterminate	O
.	O

ADDITIONAL	O
FINDINGS	O
.	O

Respiratory	O
bronchiolitis	O
.	O

3	O
.	O

LYMPH	O
NODE	O
,	O
STATION	O
9	O
(	O
EXCISION	O
)	O
:	O
ONE	O
(	O
1	O
)	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
.	O

FOR	O
TUMOR	O
.	O

4	O
.	O

LYMPH	O
NODE	O
,	O
LEVEL	O
10	O
(	O
EXCISION	O
)	O
:	O
METASTATIC	O
ADENOCARCINOMA	O
.	O

INVOLVING	O
ONE	O
(	O
1	O
)	O
OF	O
ONE	O
(	O
1	O
)	O
LYMPH	O
NODE	O
.	O

5	O
.	O

LYMPH	O
NODE	O
,	O
LEVEL	O
12	O
(	O
EXCISION	O
)	O
:	O
ONE	O
(	O
1	O
)	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
.	O

FOR	O
TUMOR	O
.	O

6	O
.	O

LYMPH	O
NODE	O
,	O
L4	O
(	O
DISSECTION	O
)	O
:	O
METASTATIC	O
ADENOCARCINOMA	O
INVOLVING	O
.	O

ONE	O
(	O
1	O
)	O
OF	O
FIVE	O
(	O
5	O
)	O
LYMPH	O
NODES	O
.	O

7	O
.	O

LYMPH	O
NODE	O
,	O
LEVEL	O
7	O
(	O
EXCISION	O
)	O
:	O
ONE	O
(	O
1	O
)	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
.	O

TUMOR	O
.	O

8	O
.	O

LYMPH	O
NODES	O
,	O
L9	O
(	O
DISSECTION	O
)	O
:	O
TWO	O
(	O
2	O
)	O
LYMPH	O
NODES	O
AND	O
ASSOCIATED	O
.	O

FIBROADIPOSE	O
TISSUE	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

9	O
.	O

LYMPH	O
NODE	O
,	O
LEVEL	O
5	O
(	O
EXCISION	O
)	O
:	O
ONE	O
(	O
1	O
)	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
.	O

TUMOR	O
.	O

GROSS	O
DESCRIPTION	O
.	O

PART	O
#	O
1	O
:	O
FS	O
:	O
LEFT	O
UPPER	O
LOBE	O
.	O

Resident	O
Pathologist	O
:	O
FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
Left	O
upper	O
lobe	O
:	O
Non	O
-	O
small	O
cell	O
carcinoma	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
.	O
and	O
designated	O
.	O
left	O
upper	O
lobe	O
.	O

It	O
consists	O
of	O
a	O
63	O
.	O
7	O
gms	O
,	O
13	O
.	O
5	O
x	O
5	O
x	O
4	O
.	O
2	O
cm	O
wedge	O
.	O
shaped	O
lung	O
tissue	O
.	O

The	O
margin	O
is	O
closed	O
with	O
staples	O
.	O

The	O
staples	O
.	O
are	O
removed	O
and	O
the	O
margins	O
are	O
inked	O
black	O
.	O

The	O
pleural	O
surface	O
has	O
a	O
.	O

2	O
.	O
5	O
cm	O
area	O
of	O
stellate	O
puckering	O
with	O
a	O
firm	O
area	O
of	O
lung	O
parenchyma	O
.	O
suspicious	O
for	O
tumor	O
below	O
it	O
.	O

The	O
pleura	O
is	O
inked	O
black	O
.	O

Upon	O
serial	O
.	O
sectioning	O
,	O
there	O
is	O
a	O
3	O
x	O
1	O
.	O
7	O
x	O
1	O
.	O
5	O
cm	O
white	O
tan	O
poorly	O
circumscribed	O
.	O
stellate	O
subpleural	O
mass	O
,	O
that	O
is	O
0	O
.	O
3	O
cm	O
from	O
the	O
stapled	O
margin	O
.	O

The	O
.	O
mass	O
does	O
not	O
appear	O
to	O
involved	O
the	O
pleural	O
surface	O
.	O

A	O
representative	O
.	O
section	O
of	O
the	O
mass	O
is	O
submitted	O
for	O
frozen	O
section	O
.	O

The	O
remaining	O
.	O
lung	O
is	O
red	O
brown	O
and	O
non	O
-	O
crepitant	O
.	O

Representative	O
sections	O
are	O
.	O
submitted	O
with	O
approximately	O
80	O
%	O
of	O
the	O
tumor	O
submitted	O
.	O

SUMMARY	O
OF	O
SECTIONS	O
:	O
1	O
.	O

-	O
FSC	O
.	O

-	O
1	O
.	O

M	O
.	O

-	O
A	O
-	O
D	O
.	O

-	O
1	O
.	O

(	O
PUCKERED	O
PLEURA	O
WITH	O
SUBPLEURAL	O
MASS	O
)	O
.	O

-	O
E	O
.	O

-	O
1	O
.	O

(	O
PERPENDICULAR	O
TUMOR	O
CLOSEST	O
TO	O
RESECTION	O
.	O
MARGIN	O
)	O
.	O

2	O
.	O

-	O
F	O
-	O
G	O
.	O

1	O
EA	O
.	O

(	O
NON	O
-	O
INVOLVED	O
LUNG	O
)	O
.	O

8	O
.	O

-	O
-	O
TOTAL	O
-	O
8	O
.	O

PART	O
#	O
2	O
:	O
FS	O
:	O
LEFT	O
UPPER	O
LOBE	O
#	O
2	O
.	O

Resident	O
Pathologist	O
:	O
FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
Left	O
upper	O
lobe	O
#	O
2	O
:	O
Bronchial	O
margin	O
and	O
one	O
(	O
1	O
)	O
lymph	O
node	O
,	O
.	O
negative	O
for	O
tumor	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
.	O
and	O
deignated	O
.	O
left	O
upper	O
lobe	O
#	O
2	O
.	O

It	O
consists	O
of	O
a	O
320	O
gms	O
,	O
15	O
x	O
12	O
x	O
4	O
cm	O
.	O
completion	O
lobectomy	O
specimen	O
.	O

The	O
lung	O
is	O
diffusely	O
non	O
-	O
crepitant	O
.	O

The	O
pleura	O
is	O
slightly	O
hemorrhagic	O
and	O
mottled	O
with	O
anthracotic	O
.	O
pigmentation	O
.	O

No	O
mass	O
is	O
palpated	O
within	O
this	O
portion	O
of	O
specimen	O
.	O

Additionally	O
,	O
no	O
pleura	O
puckering	O
is	O
identified	O
.	O

There	O
is	O
a	O
stapled	O
.	O
margin	O
consistent	O
with	O
the	O
area	O
from	O
where	O
the	O
initial	O
wedge	O
.	O
resection	O
was	O
taken	O
.	O

There	O
is	O
a	O
1	O
.	O
2	O
cm	O
portion	O
of	O
bifurcating	O
.	O
bronchus	O
present	O
which	O
appears	O
patent	O
.	O

No	O
tumor	O
is	O
identified	O
within	O
.	O
the	O
lumen	O
.	O

A	O
shave	O
of	O
this	O
bronchi	O
are	O
taken	O
.	O

Multiple	O
red	O
brown	O
.	O
hilar	O
lymph	O
nodes	O
are	O
are	O
identified	O
ranging	O
in	O
size	O
from	O
0	O
.	O
5	O
to	O
1	O
.	O
4	O
.	O

cm	O
.	O

None	O
of	O
these	O
appear	O
grossly	O
positive	O
.	O

The	O
entire	O
pleural	O
margin	O
.	O

is	O
inked	O
black	O
.	O

Upon	O
serial	O
sectioning	O
,	O
the	O
lung	O
has	O
a	O
uniform	O
.	O
congested	O
red	O
brown	O
with	O
focal	O
emphysematous	O
changes	O
and	O
diffuse	O
.	O
anthracotic	O
pigmentation	O
.	O

The	O
hilar	O
vessels	O
are	O
remarkable	O
.	O

No	O
.	O
masses	O
or	O
lesions	O
are	O
identified	O
.	O

Representative	O
sections	O
are	O
.	O
submitted	O
.	O

SUMMARY	O
OF	O
SECTIONS	O
:	O
1	O
.	O

-	O
FSC	O
-	O
1	O
.	O

1	O
.	O

-	O
A	O
.	O

-	O
3	O
.	O

2	O
.	O

-	O
-	O
B	O
-	O
C	O
.	O

1	O
.	O

EA	O
.	O

(	O
PERPENDICULAR	O
OF	O
GROSSLY	O
NORMAL	O
LUNG	O
)	O
.	O

INCLUDING	O
MARGIN	O
OF	O
WEDGE	O
RESECTION	O
)	O
.	O

M	O
.	O

-	O
D	O
-	O
F	O
.	O

1	O
EA	O
.	O

(	O
ADDITIONAL	O
LEFT	O
UPPER	O
LOBE	O
LUNG	O
)	O
.	O

-	O
G	O
.	O

-	O
2	O
.	O

(	O
ONE	O
POTENTIAL	O
HILAR	O
LYMPH	O
NODE	O
BISECTED	O
)	O
.	O

-	O
H	O
.	O

-	O
4	O
.	O

(	O
ONE	O
POTENTIAL	O
HILAR	O
LYMPH	O
NODE	O
)	O
.	O

-	O
I	O
.	O

-	O
2	O
.	O

(	O
ONE	O
POTENTIAL	O
HILAR	O
LYMPH	O
NODES	O
,	O
?	O
POS	O
.	O
BISECTED	O
)	O
.	O

10	O
.	O

-	O
TOTAL	O
-	O
17	O
.	O

PART	O
#	O
3	O
:	O
STATION	O
9	O
.	O

Resident	O
Pathologist	O
:	O
The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
.	O
and	O
designated	O
.	O
station	O
9	O
.	O

It	O
consists	O
of	O
one	O
unoriented	O
fragment	O
of	O
yellow	O
,	O
to	O
red	O
.	O
brown	O
fibrofatty	O
tissue	O
measuring	O
0	O
.	O
4	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
2cm	O
.	O

Upon	O
dissection	O
.	O
two	O
potential	O
lymph	O
nodes	O
are	O
identified	O
with	O
a	O
red	O
brown	O
color	O
.	O

One	O
.	O
measures	O
4	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
.	O
and	O
the	O
other	O
lymph	O
nodes	O
measuring	O
0	O
.	O
2	O
.	O

x	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
.	O

Neither	O
lymph	O
nodes	O
appear	O
grossly	O
positive	O
.	O

The	O
.	O
specimen	O
is	O
submitted	O
in	O
its	O
entirety	O
.	O

SUMMARY	O
OF	O
SECTIONS	O
:	O
1	O
.	O

-	O
A	O
.	O

2	O
.	O

1	O
.	O

-	O
TOTAL	O
-	O
2	O
.	O

PART	O
#	O
4	O
:	O
LEVEL	O
10	O
.	O

Resident	O
Pathologist	O
:	O
The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
.	O
and	O
designated	O
.	O
level	O
10	O
.	O

It	O
consists	O
of	O
one	O
unoriented	O
nodular	O
fragment	O
of	O
yellow	O
red	O
.	O
tan	O
fibrofatty	O
tissue	O
measuring	O
2	O
.	O
5	O
x	O
1	O
.	O
2	O
x	O
0	O
.	O
8	O
cm	O
.	O

Upon	O
lymph	O
node	O
.	O
dissection	O
,	O
one	O
tan	O
white	O
to	O
tan	O
black	O
lymph	O
node	O
is	O
identified	O
.	O

The	O
lymph	O
node	O
appears	O
to	O
have	O
a	O
diffuse	O
anthracotic	O
pigment	O
within	O
it	O
.	O
and	O
.	O

multiple	O
firm	O
nodular	O
areas	O
consistent	O
with	O
metastatic	O
tumor	O
.	O
has	O
harvested	O
a	O
portion	O
of	O
the	O
tumor	O
for	O
tumor	O
bank	O
.	O

The	O
lymph	O
.	O
node	O
measures	O
1	O
.	O
9	O
X	O
1	O
.	O
6	O
x	O
1	O
cm	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
and	O
.	O
submitted	O
in	O
its	O
entirety	O
.	O

SUMMARY	O
OF	O
SECTIONS	O
:	O
1	O
.	O

-	O
A	O
.	O

-	O
2	O
.	O

1	O
.	O

-	O
B	O
.	O

2	O
(	O
ONE	O
POSITIVE	O
LEVEL	O
10	O
NODE	O
SERIALLY	O
SECTIONED	O
)	O
.	O

2	O
.	O

-	O
-	O
TOTAL	O
-	O
4	O
.	O

PART	O
#	O
5	O
:	O
LEVEL	O
12	O
.	O

Resident	O
Pathologist	O
:	O
The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
.	O
and	O
designated	O
.	O
level	O
12	O
.	O

It	O
consists	O
of	O
one	O
unoriented	O
and	O
severely	O
cauterized	O
.	O
fragment	O
of	O
yellow	O
red	O
to	O
black	O
fibrofatty	O
tissue	O
measuring	O
0	O
.	O
!	O

5	O
x	O
0	O
.	O
4	O
.	O

x	O
0	O
.	O
4	O
cm	O
.	O

Grossly	O
one	O
potential	O
lymph	O
node	O
measuring	O
0	O
.	O
4	O
cm	O
in	O
.	O
greatest	O
dimension	O
is	O
identified	O
.	O

The	O
specimen	O
is	O
submitted	O
in	O
its	O
.	O
entirety	O
.	O

SUMMARY	O
OF	O
SECTIONS	O
.	O

-	O
A	O
.	O

-	O
1	O
(	O
ONE	O
POTENTIAL	O
LEVEL	O
12	O
LYMPH	O
NODE	O
)	O
.	O

-	O
-	O
TOTAL	O
-	O
-	O
1	O
.	O

PART	O
#	O
6	O
:	O
L4	O
.	O

Resident	O
Pathologist	O
:	O
Th	O
specimen	O
is	O
received	O
fresh	O
labeled	O
.	O
and	O
designated	O
.	O

L4	O
.	O

It	O
consists	O
of	O
multiple	O
fragments	O
of	O
yellow	O
tan	O
to	O
red	O
brown	O
,	O
.	O
black	O
fibroadipose	O
tissue	O
measuring	O
in	O
aggregate	O
1	O
.	O
5	O
X	O
1	O
x	O
0	O
.	O
5	O
cm	O
.	O

Grossly	O
,	O
upon	O
dissection	O
,	O
six	O
potential	O
lymph	O
nodes	O
are	O
identified	O
.	O
measuring	O
in	O
size	O
from	O
0	O
.	O
2	O
x	O
0	O
.	O
4	O
cm	O
in	O
greatest	O
dimension	O
.	O

Multiple	O
.	O
lymph	O
nodes	O
have	O
a	O
black	O
pigmentation	O
consistent	O
with	O
anthracosis	O
.	O

However	O
,	O
none	O
of	O
the	O
nodes	O
appears	O
grossly	O
positive	O
.	O

The	O
specimen	O
is	O
.	O
submitted	O
in	O
its	O
entirety	O
in	O
lens	O
paper	O
.	O

SUMMARY	O
OF	O
SECTIONS	O
:	O
1	O
.	O

-	O
A	O
.	O

-	O
6	O
(	O
SIX	O
POTENTIAL	O
L4	O
NODES	O
)	O
.	O

-	O
TOTAL	O
-	O
6	O
.	O

PART	O
#	O
7	O
:	O
LEVEL	O
7	O
.	O

Resident	O
Pathologist	O
:	O
The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
.	O
and	O
designated	O
.	O
level	O
7	O
.	O

It	O
consists	O
of	O
one	O
unoriented	O
soft	O
yellow	O
pink	O
tan	O
to	O
dark	O
.	O
red	O
black	O
fibroadipose	O
tissue	O
measuring	O
1	O
.	O
3	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
4	O
cm	O
.	O

Upon	O
lymph	O
.	O
node	O
dissection	O
,	O
one	O
potential	O
lymph	O
node	O
is	O
identified	O
consistent	O
.	O

it	O
has	O
a	O
dark	O
red	O
black	O
parenchyma	O
consistent	O
with	O
anthracosis	O
.	O

The	O
.	O
node	O
does	O
not	O
appear	O
grossly	O
positive	O
.	O

The	O
specimen	O
is	O
submitted	O
in	O
.	O
its	O
entirety	O
.	O

SUMMARY	O
OF	O
SECTIONS	O
:	O
PART	O
#	O
8	O
:	O
L9	O
.	O

Resident	O
Pathologist	O
:	O
The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
.	O
and	O
designated	O
.	O

L9	O
.	O

It	O
consists	O
of	O
a	O
one	O
unoriented	O
fragment	O
of	O
yellow	O
tan	O
red	O
to	O
.	O
dark	O
red	O
to	O
black	O
fibroadipose	O
tissue	O
measuring	O
1	O
.	O
5	O
x	O
1	O
x	O
0	O
.	O
4	O
cm	O
.	O

Upon	O
dissection	O
,	O
one	O
potential	O
lymph	O
node	O
is	O
identified	O
.	O

SUMMARY	O
OF	O
SECTIONS	O
:	O
1	O
.	O

-	O
A	O
.	O

-	O
1	O
.	O

(	O
ONE	O
NODE	O
BISECTED	O
)	O
.	O

-	O
B	O
.	O

-	O
3	O
.	O

(	O
SMALLER	O
POTENTIAL	O
NODE	O
AND	O
SOFT	O
TISSUE	O
)	O
.	O

2	O
.	O

-	O
TOTAL	O
-	O
5	O
.	O

PART	O
#	O
9	O
:	O
LEVEL	O
5	O
.	O

Resident	O
Pathologist	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
.	O
and	O
designated	O
.	O
level	O
5	O
.	O

It	O
consists	O
of	O
one	O
unoriented	O
fragment	O
of	O
dark	O
red	O
brown	O
to	O
.	O
black	O
tissue	O
measuring	O
1	O
.	O
0	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
potential	O
lymph	O
node	O
.	O
does	O
not	O
appear	O
grossly	O
positive	O
.	O

The	O
specimen	O
is	O
bisected	O
to	O
reveal	O
.	O

a	O
soft	O
fleshy	O
tan	O
to	O
red	O
brown	O
variegated	O
parenchyma	O
.	O

The	O
entire	O
.	O
specimen	O
is	O
submitted	O
.	O

SUMMARY	O
OF	O
SECTIONS	O
:	O
1	O
.	O

A	O
.	O

-	O
2	O
.	O

1	O
.	O

-	O
TOTAL	O
-	O
2	O
.	O
printed	O
.	O

-DOCSTART-215
Ref	O
.	O

Physiciam	O
:	O
Clinical	O
Diagnosis	O
&	O
History	O
:	O
Left	O
renal	O
mass	O
>	O
6	O
cm	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
SP	O
:	O
Kidney	O
,	O
left	O
,	O
total	O
nephrectomy	O
.	O

2	O
:	O
SP	O
:	O
Lymph	O
nodes	O
,	O
preaortic	O
and	O
para	O
-	O
aortic	O
,	O
dissection	O
.	O

3	O
:	O
SP	O
:	O
Adrenal	O
gland	O
and	O
suprahilar	O
lymph	O
node	O
,	O
left	O
,	O
excision	O
.	O

4	O
:	O
SP	O
:	O
Lymph	O
nodes	O
,	O
left	O
hilar	O
,	O
dissection	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

SP	O
:	O
Kidney	O
,	O
left	O
,	O
total	O
nephrectoiny	O
:	O
Tumor	O
Type	O
:	O
Renal	O
cell	O
carcinoma	O
-	O
Unclassified	O
type	O
.	O

Angiomyolipoma	O
,	O
1	B
cm	I
in	O
greatest	O
dimension	O
.	O

SEE	O
COMMENT	O
.	O

Fuhrman	O
Nuclear	O
Grade	O
:	O
High	O
nuclear	O
grade	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
diameter	O
is	O
6	B
,	I
5	I
cm	I
.	O

Local	O
Invasion	O
(	O
for	O
renal	O
cortical	O
types	O
)	O
:	O
Not	O
Identified	O
.	O

Renal	O
Vein	O
Invasion	O
:	O
Not	O
identified	O
.	O

Surgical	O
Margins	O
:	O
Free	O
of	O
tumor	O
.	O

The	O
renal	O
artery	O
exhibits	O
moderate	O
atherosclerotic	O
changes	O
with	O
stenosis	O
at	O
the	O
margin	O
.	O

Non	O
-	O
Neoplastic	O
Kidney	O
:	O
Mild	O
arterionephrosclerosis	O
and	O
benign	O
simple	O
cortical	O
cysts	O
(	O
PAS	O
stain	O
supports	O
)	O
.	O

Adrenal	O
Gland	O
:	O
See	O
part	O
3	O
.	O

Lymph	O
Nodes	O
:	O
See	O
parts	O
2	O
&	O
4	O
.	O

Staging	O
for	O
renal	O
cell	O
carcinomaloncocytoma	O
:	O
p	O
T1	O
Tumor	O
<	O
=	O
7	O
,	O
0	O
cm	O
in	O
greatest	O
dimension	O
limited	O
to	O
the	O
kidney	O
.	O

COMMENT	O
:	O
The	O
tumor	O
exhibits	O
predominat	O
papillary	O
features	O
with	O
focal	O
solid	O
and	O
clear	O
cell	O
morphology	O
Tumor	O
cells	O
have	O
large	O
.	O
eosinophilic	O
to	O
clear	O
cytoplasm	O
and	O
pleomorphic	O
nuclei	O
with	O
open	O
chromatin	O
and	O
occasional	O
nuleoli	O
.	O

8y	O
immunostains	O
,	O
the	O
tumor	O
.	O
was	O
reactive	O
with	O
CD10	O
and	O
CA	O
-	O
IX	O
but	O
negative	O
for	O
AE1	O
:	O
AE3	O
,	O
EMA	O
,	O
CK7	O
and	O
racemase	O
.	O

Staining	O
for	O
TFE3	O
and	O
TFEB	O
(	O
for	O
.	O
translocation	O
renal	O
cell	O
carcinomas	O
)	O
was	O
also	O
negative	O
.	O

This	O
overlapping	O
morphology	O
and	O
immunoprofile	O
does	O
not	O
allow	O
for	O
placing	O
.	O
this	O
tumor	O
in	O
any	O
of	O
the	O
well	O
recognized	O
categories	O
and	O
is	O
thus	O
deignated	O
UNCLASSIFIED	O
TYPE	O
.	O

The	O
morphology	O
along	O
with	O
the	O
.	O
presence	O
of	O
an	O
angiomvolinoma	O
however	O
is	O
cominiscent	O
of	O
tamors	O
that	O
we	O
encountered	O
in	O
patients	O
with	O
tuberous	O
sclerosis	O
.	O

This	O
.	O
case	O
was	O
reviewed	O
at	O
.	O

2	O
.	O

SP	O
:	O
Lymph	O
nodes	O
,	O
preaortic	O
and	O
para	O
-	O
aortic	O
,	O
dissection	O
:	O
Lymph	O
Nodes	O
:	O
Not	O
involved	O
.	O

Number	O
of	O
nodes	O
examined	O
:	O
17	O
.	O

Segment	O
of	O
benign	O
ureter	O
.	O

3	O
,	O
SP	O
:	O
Adrenal	O
gland	O
and	O
suprahilar	O
lymph	O
node	O
,	O
left	O
,	O
excision	O
:	O
Benign	O
adrenal	O
gland	O
and	O
periadrenal	O
adipose	O
tissue	O
.	O

No	O
lymph	O
nodes	O
identified	O
.	O

4	O
.	O

SP	O
:	O
Lymph	O
nodes	O
,	O
left	O
hilar	O
,	O
dissection	O
:	O
Lymph	O
Nodes	O
:	O
Not	O
involved	O
.	O

Number	O
of	O
nodes	O
examined	O
:	O
4	O
.	O

Some	O
of	O
the	O
and	O
ISH	O
tests	O
were	O
developed	O
and	O
their	O
performance	O
characteristics	O
were	O
determined	O
by	O
the	O
Department	O
of	O
Pathology	O
They	O
have	O
.	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
US	O
Food	O
and	O
Drug	O
Administration	O
The	O
FDA	O
has	O
determined	O
that	O
such	O
clearance	O
of	O
approval	O
is	O
not	O
necessary	O
These	O
tests	O
are	O
.	O
hould	O
not	O
be	O
regarded	O
as	O
investigational	O
or	O
for	O
research	O
.	O

This	O
latoratory	O
is	O
certified	O
under	O
the	O
Clinical	O
Laboratory	O
improvement	O
.	O

S	O
qualified	O
to	O
perform	O
high	O
complexity	O
clinical	O
laboratory	O
testing	O
.	O

IATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
is	O
BASEI	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
.	O

AND	O
THAT	O
THAVE	O
.	O

REVIEWED	O
AND	O
APPROVED	O
THIS	O
REPORT	O
.	O

Special	O
Studies	O
:	O
Special	O
Stain	O
.	O

Comment	O
.	O

CA	O
-	O
1X	O
.	O

CD10	O
.	O

AE1	O
:	O
AE3	O
.	O

EMA	O
.	O

CK7	O
.	O

CD117	O
.	O

RACEMASE	O
.	O

IMM	O
H	O
&	O
E	O
.	O

IMM	O
RECUT	O
.	O

PAS	O
.	O

NEG	O
CONT	O
.	O

HMB	O
-	O
45	O
.	O

A103	O
-	O
1	O
.	O

HMB	O
-	O
45	O
.	O

A103	O
-	O
1	O
.	O

IMM	O
RECUT	O
.	O

NEG	O
CONT	O
.	O

IMM	O
RECUT	O
.	O

NEG	O
CONT	O
.	O

Gross	O
Description	O
:	O
1	O
)	O
The	O
specimen	O
is	O
rece	O
Uney	O
"	O
and	O
consists	O
of	O
a	O
kidney	O
with	O
attached	O
ureter	O
,	O
renal	O
vessels	O
and	O
perinephric	O
.	O
fat	O
weighing	O
812	O
9	O
in	O
total	O
measuring	O
22	O
x	O
13	O
x	O
8	O
cm	O
overall	O
.	O

The	O
kidney	O
measures	O
12	O
.	O
2	O
x	O
9	O
x	O
4	O
cm	O
.	O

The	O
attached	O
ureter	O
.	O
measures	O
7	O
cm	O
in	O
length	O
and	O
0	O
.	O
6	O
cm	O
in	O
diameter	O
.	O

The	O
attached	O
renal	O
vein	O
measures	O
2	O
cm	O
in	O
length	O
and	O
1	O
cm	O
in	O
diameter	O
.	O

The	O
.	O
renal	O
vessels	O
and	O
ureter	O
margins	O
are	O
grossly	O
unremarkable	O
.	O

An	O
adrenal	O
gland	O
is	O
not	O
identified	O
.	O

The	O
kidney	O
is	O
inked	O
black	O
and	O
.	O
bivalved	O
to	O
reveal	O
a	O
hemorrhagic	O
golden	O
yellow	O
and	O
red	O
tumor	O
at	O
mid	O
portion	O
measuring	O
6	B
.	I
5	I
x	I
6	I
x	I
4	I
.	I
5	I
cm	I
.	O

Sections	O
through	O
the	O
.	O
remainder	O
of	O
the	O
kidney	O
reveal	O
a	O
pink	O
brown	O
parenchyma	O
,	O
with	O
a	O
well	O
-	O
defined	O
cortico	O
-	O
medullary	O
junction	O
.	O

There	O
is	O
a	O
second	O
nodule	O
.	O

in	O
.	O
the	O
lower	O
pole	O
measuring	O
1	O
X	O
0	O
.	O
6	O
x	O
0	O
.	O
6	O
cm	O
showing	O
a	O
tan	O
gray	O
cut	O
surface	O
.	O

The	O
cortex	O
measures	O
1	O
cm	O
and	O
the	O
calyces	O
appear	O
.	O
normal	O
.	O

No	O
lymph	O
nodes	O
are	O
identified	O
in	O
the	O
perinephric	O
fat	O
.	O

The	O
specimen	O
is	O
photographed	O
.	O

Representative	O
sections	O
are	O
.	O
submitted	O
for	O
TPS	O
and	O
for	O
permanent	O
sections	O
.	O

Summary	O
of	O
sections	O
:	O
UM	O
.	O
.	O
.	O
ureteral	O
margin	O
,	O
VM	O
-	O
vascular	O
margin	O
,	O
T	O
-	O
tumor	O
,	O
TSF	O
tumor	O
with	O
sinus	O
fat	O
.	O

RP	O
renal	O
pelvis	O
representative	O
sections	O
,	O
K	O
-	O
-	O
representative	O
sections	O
kidney	O
,	O
T2	O
-	O
second	O
cortical	O
nodule	O
.	O

2	O
)	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
preaortic	O
and	O
para	O
-	O
aortic	O
lymph	O
nodes	O
"	O
and	O
consists	O
of	O
multiple	O
pink	O
tan	O
firm	O
.	O
lymph	O
nodes	O
ranging	O
from	O
0	O
.	O
5	O
to	O
3	O
.	O
8	O
cm	O
in	O
greatest	O
dimension	O
.	O

All	O
identified	O
lymph	O
nodes	O
are	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
LN	O
-	O
-	O
lymph	O
nodes	O
,	O
BLN	O
-	O
-	O
bisected	O
lymph	O
nodes	O
,	O
QLN	O
-	O
-	O
quadrisected	O
lymph	O
node	O
.	O

3	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
as	O
"	O
Left	O
adrenal	O
gland	O
suprahilar	O
lymph	O
node	O
'	O
and	O
consists	O
of	O
a	O
fragmented	O
piece	O
of	O
.	O
adipose	O
tissue	O
measuring	O
9	O
x	O
7	O
.	O
5	O
x	O
1	O
.	O
5	O
cm	O
,	O
containing	O
an	O
adrenal	O
gland	O
measuring	O
6	O
x	O
3	O
.	O
5	O
X	O
1	O
cm	O
The	O
cut	O
section	O
of	O
adrenal	O
.	O
reveals	O
a	O
golden	O
yellow	O
cortex	O
and	O
dark	O
brown	O
medulla	O
,	O
which	O
is	O
grossly	O
unremarkable	O
.	O

The	O
specimen	O
is	O
representatively	O
.	O
submitted	O
as	O
follows	O
.	O

Summary	O
of	O
Sections	O
:	O
A	O
-	O
adrenal	O
,	O
F	O
-	O
fat	O
.	O

4	O
)	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
hilar	O
lymph	O
node	O
,	O
left	O
"	O
and	O
consists	O
of	O
four	O
pink	O
tan	O
firm	O
lymph	O
nodes	O
ranging	O
.	O
from	O
0	O
.	O
5	O
lo	O
1	O
cm	O
in	O
greatest	O
dimension	O
.	O

All	O
identified	O
lymph	O
nodes	O
are	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
LN	O
-	O
-	O
lymph	O
nodes	O
,	O
BLN	O
-	O
-	O
bisected	O
lymph	O
node	O
.	O

Summary	O
of	O
Sections	O
;	O
.	O

Part	O
1	O
:	O
SP	O
:	O
Kidney	O
,	O
left	O
,	O
total	O
nephrectomy	O
.	O

Block	O
.	O

Sect	O
.	O

Sito	O
.	O

PCs	O
.	O

2	O
.	O

k	O
.	O

2	O
.	O

2	O
.	O

2	O
.	O

7	O
.	O

t	O
.	O

7	O
.	O

3	O
.	O

12	O
.	O

3	O
.	O

5	O
.	O
tsf	O
.	O

5	O
.	O

1	O
.	O

um	O
.	O

1	O
.	O

1	O
.	O

vm	O
.	O

Part	O
2	O
:	O
SP	O
:	O
Lymph	O
nodes	O
,	O
preaortic	O
and	O
para	O
-	O
aortic	O
,	O
dissection	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

3	O
.	O

BLN	O
.	O

LN	O
.	O

13	O
.	O

4	O
.	O

QLN	O
.	O

4	O
.	O

Part	O
3	O
:	O
SP	O
:	O
Adrenal	O
gland	O
and	O
suprahilar	O
lymph	O
node	O
,	O
left	O
,	O
excision	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

ad	O
.	O

2	O
.	O

3	O
.	O

f	O
.	O

3	O
.	O

Part	O
4	O
:	O
SP	O
:	O
Lymph	O
nodes	O
,	O
left	O
hilar	O
,	O
dissection	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

BLN	O
.	O

2	O
.	O

2	O
.	O

LN	O
.	O

3	O
.	O

-DOCSTART-216
DIAGNOSIS	O
:	O
1	O
)	O
MARGIN	O
,	O
LEFT	O
ANTERIOR	O
TONGUE	O
,	O
EXCISION	O
:	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
.	O

2	O
)	O
MARGIN	O
,	O
LEFT	O
BASE	O
OF	O
TONGUE	O
,	O
EXCISION	O
:	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
.	O

3	O
)	O
MANDIBLE	O
,	O
TONGUE	O
,	O
SUPERIOR	O
NECK	O
,	O
RADICAL	O
RESECTION	O
:	O
INVASIVE	O
.	O

WELL	O
-	O
DIFFERENTIATED	O
KERATINIZING	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
,	O
8	B
.	I
5	I
CM	I
IN	O
.	O

GREATEST	O
EXTENT	O
,	O
INVOLVING	O
THE	O
SKIN	O
AND	O
FLOOR	O
OF	O
MOUTH	O
WITH	O
EROSION	O
INTO	O
.	O

THE	O
MANDIBLE	O
AND	O
MUCOSAL	O
ULCERATION	O
;	O
PERINEURAL	O
INVASION	O
PRESENT	O
,	O
.	O

NEGATIVE	O
FOR	O
DEFINITIVE	O
LYMPHOVASCULAR	O
.	O

INVASION	O
;	O
TONSIL	O
UNINVOLVED	O
;	O
.	O

TUMOR	O
EXTENDS	O
TO	O
LESS	O
THAN	O
0	O
.	O
1	O
CM	O
FROM	O
THE	O
SUPERIOR	O
LATERAL	O
RESECTION	O
.	O

MARGIN	O
;	O
HOWEVER	O
,	O
ALL	O
INKED	O
RESECTION	O
MARGINS	O
NEGATIVE	O
FOR	O
TUMOR	O
(	O
SEE	O
.	O
COMMENT	O
)	O
.	O

4	O
)	O
LYMPH	O
NODE	O
,	O
LEVEL	O
2	O
POSTERIOR	O
,	O
EXCISION	O
:	O
7	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
.	O

MALIGNANCY	O
.	O

5	O
)	O
LYMPH	O
NODE	O
,	O
LEFT	O
NECK	O
LEVEL	O
2	O
,	O
3	O
EXCISION	O
:	O
1	O
OF	O
6	O
LYMPH	O
NODES	O
INVOLVED	O
.	O

BY	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
,	O
MICROSCOPIC	O
FOCUS	O
PRESENT	O
WITHIN	O
A	O
1	O
.	O
5	O
CM	O
.	O

LYMPH	O
NODE	O
(	O
NEGATIVE	O
FOR	O
EXTRANODAL	O
EXTENSION	O
)	O
.	O

6	O
)	O
LYMPH	O
NODE	O
,	O
LEFT	O
LEVEL	O
4	O
,	O
EXCISION	O
:	O
8	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
.	O

MALIGNANCY	O
.	O

7	O
)	O
LYMPH	O
NODE	O
,	O
POSTERIOR	O
LEVEL	O
3	O
,	O
EXCISION	O
:	O
7	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
.	O

MALIGNANCY	O
.	O

8	O
)	O
LYMPH	O
NODE	O
,	O
LEFT	O
NECK	O
LEVEL	O
4	O
,	O
EXCISION	O
:	O
2	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
.	O

MALIGNANCY	O
.	O

COMMENT	O
:	O
These	O
findings	O
correspond	O
to	O
AJCC	O
6th	O
edition	O
pathologic	O
stage	O
I	O
.	O

V	O
A	O
(	O
pT4aN1M	O
n	O
/	O
a	O
)	O
.	O

CLINICAL	O
DATA	O
.	O

Clinical	O
Features	O
/	O
Dx	O
:	O
unspecified	O
.	O

Operator	O
:	O
Operation	O
:	O
unspecified	O
.	O

Operative	O
Findings	O
:	O
unspecified	O
.	O

Operative	O
Diagnosis	O
:	O
unspecified	O
.	O

Tissue	O
Submitted	O
:	O
1	O
)	O
left	O
anterior	O
tongue	O
margin	O
,	O
2	O
)	O
left	O
base	O
of	O
.	O
tongue	O
margin	O
,	O
3	O
)	O
left	O
composite	O
.	O
jaw	O
-	O
neck	O
-	O
tongue	O
,	O
4	O
)	O
level	O
2	O
posterior	O
,	O
5	O
)	O
left	O
.	O
neck	O
levels	O
2	O
-	O
3	O
,	O
6	O
)	O
left	O
neck	O
level	O
4	O
,	O
7	O
)	O
.	O
posterior	O
level	O
3	O
,	O
8	O
)	O
left	O
neck	O
level	O
4	O
lymph	O
.	O
nodes	O
.	O

GROSS	O
DESCRIPTION	O
:	O
1	O
)	O
SOURCE	O
:	O
Left	O
Anterior	O
Tongue	O
Margin	O
.	O

The	O
specimen	O
labeled	O
,	O
"	O
left	O
anterior	O
tongue	O
margin	O
,	O
"	O
is	O
received	O
fresh	O
.	O
and	O
is	O
comprised	O
of	O
a	O
0	O
.	O
2	O
X	O
0	O
.	O
1	O
X	O
0	O
.	O
1	O
cm	O
piece	O
of	O
mucosal	O
tissue	O
.	O

The	O
.	O
specimen	O
is	O
entirely	O
submitted	O
for	O
frozen	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
1AFSC	O
,	O
entirely	O
submitted	O
,	O
1	O
/	O
1	O
.	O

2	O
)	O
SOURCE	O
:	O
Left	O
Base	O
of	O
Tongue	O
Margin	O
.	O

The	O
specimen	O
labeled	O
,	O
"	O
left	O
base	O
of	O
tongue	O
margin	O
,	O
"	O
is	O
received	O
fresh	O
.	O
and	O
is	O
comprised	O
of	O
a	O
2	O
.	O
8	O
X	O
1	O
.	O
0	O
X	O
0	O
.	O
4	O
cm	O
strip	O
of	O
mucosal	O
tissue	O
with	O
.	O
underlying	O
soft	O
tissues	O
.	O

The	O
specimen	O
is	O
submitted	O
entirely	O
for	O
frozen	O
.	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
2AFSC	O
,	O
entirely	O
submitted	O
,	O
1	O
/	O
1	O
.	O

3	O
)	O
SOURCE	O
:	O
Left	O
Composite	O
,	O
Jaw	O
-	O
Neck	O
-	O
Tongue	O
.	O

The	O
specimen	O
labeled	O
,	O
"	O
left	O
composite	O
resection	O
,	O
tongue	O
,	O
jaw	O
,	O
neck	O
,	O
"	O
is	O
.	O
received	O
fresh	O
and	O
is	O
comprised	O
of	O
a	O
mandibular	O
resection	O
extending	O
from	O
.	O
the	O
right	O
mandible	O
anterior	O
to	O
the	O
mental	O
foramen	O
,	O
to	O
the	O
left	O
angle	O
of	O
.	O
the	O
mandible	O
.	O

Attached	O
is	O
the	O
base	O
of	O
the	O
tongue	O
,	O
floor	O
of	O
mouth	O
,	O
and	O
a	O
.	O
significant	O
portion	O
of	O
soft	O
tissue	O
from	O
the	O
left	O
anterior	O
lateral	O
.	O

chin	O
/	O
superior	O
neck	O
.	O

The	O
left	O
tonsil	O
is	O
attached	O
.	O

The	O
specimen	O
measures	O
.	O

11	O
.	O
0	O
cm	O
superficial	O
to	O
deep	O
(	O
anterior	O
to	O
posterior	O
)	O
,	O
10	O
.	O
0	O
cm	O
superior	O
to	O
.	O
inferior	O
,	O
and	O
6	O
.	O
5	O
cm	O
medial	O
to	O
lateral	O
.	O

The	O
overlying	O
skin	O
is	O
pink	O
-	O
tan	O
,	O
.	O
hair	O
-	O
bearing	O
,	O
and	O
possesses	O
an	O
ulcerated	O
mass	O
,	O
measuring	O
8	O
.	O
5	O
X	O
5	O
.	O
8	O
.	O
surface	O
centimeters	O
.	O

The	O
specimen	O
is	O
inked	O
as	O
follows	O
on	O
the	O
resection	O
.	O
surfaces	O
:	O
anterior	O
-	O
yellow	O
,	O
posterior	O
-	O
green	O
,	O
superior	O
-	O
red	O
,	O
.	O
inferior	O
-	O
black	O
,	O
lateral	O
-	O
blue	O
,	O
medial	O
-	O
orange	O
.	O

The	O
left	O
palatal	O
tonsil	O
is	O
.	O
present	O
attached	O
to	O
the	O
specimen	O
,	O
and	O
measures	O
2	O
.	O
6	O
X	O
1	O
.	O
3	O
X	O
2	O
.	O
2	O
cm	O
.	O

The	O
.	O
specimen	O
is	O
sectioned	O
to	O
show	O
the	O
mass	O
lesion	O
extending	O
deep	O
into	O
the	O
.	O
specimen	O
to	O
a	O
depth	O
of	O
5	O
.	O
5	O
cm	O
and	O
is	O
comprised	O
of	O
a	O
soft	O
,	O
white	O
-	O
tan	O
.	O
parenchyma	O
with	O
an	O
infiltrative	O
border	O
.	O

This	O
process	O
surrounds	O
and	O
.	O
apparently	O
invades	O
the	O
mandibular	O
bone	O
.	O

The	O
process	O
comes	O
within	O
0	O
.	O
3	O
cm	O
.	O
of	O
the	O
lateral	O
superior	O
resection	O
margin	O
(	O
blue	O
)	O
.	O

The	O
tonsil	O
is	O
appears	O
.	O
free	O
of	O
this	O
process	O
.	O

A	O
portion	O
of	O
the	O
tumor	O
is	O
retained	O
for	O
research	O
.	O
purposes	O
.	O

Representative	O
tumor	O
is	O
retained	O
in	O
RPMI	O
,	O
glutaraldehyde	O
,	O
and	O
.	O
frozen	O
at	O
-	O
-	O
80	O
degrees	O
for	O
possible	O
future	O
studies	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
.	O

Appropriate	O
sections	O
are	O
decalcified	O
.	O

Summary	O
of	O
sections	O
:	O
3A	O
,	O
anterior	O
medial	O
bony	O
margin	O
en	O
face	O
,	O
1	O
/	O
1	O
;	O
3B	O
,	O
.	O
posterior	O
bony	O
margin	O
en	O
face	O
,	O
1	O
/	O
1	O
;	O
3C	O
,	O
lateral	O
margin	O
,	O
2	O
/	O
1	O
;	O
3D	O
,	O
.	O
inferior	O
margin	O
,	O
1	O
/	O
1	O
;	O
3E	O
,	O
inferior	O
margin	O
,	O
1	O
/	O
1	O
;	O
3F	O
,	O
deep	O
margin	O
,	O
2	O
/	O
1	O
;	O
.	O

3G	O
,	O
medial	O
margin	O
,	O
2	O
/	O
1	O
;	O
3H	O
,	O
superior	O
margin	O
,	O
1	O
/	O
1	O
;	O
3I	O
,	O
tonsillar	O
margin	O
,	O
.	O

1	O
/	O
1	O
;	O
3J	O
,	O
anterior	O
(	O
superficial	O
)	O
margin	O
,	O
2	O
/	O
1	O
;	O
3K	O
,	O
possible	O
hypoglossal	O
.	O
nerve	O
margin	O
versus	O
tendon	O
,	O
1	O
/	O
1	O
;	O
3L	O
,	O
floor	O
of	O
mouth	O
(	O
red	O
ink	O
in	O
floor	O
of	O
.	O
mouth	O
is	O
not	O
true	O
margin	O
,	O
red	O
ink	O
on	O
tongue	O
muscle	O
is	O
true	O
margin	O
)	O
,	O
1	O
/	O
1	O
;	O
.	O

3M	O
-	O
N	O
,	O
mandibular	O
involvement	O
,	O
2	O
/	O
2	O
;	O
30	O
,	O
skin	O
,	O
1	O
/	O
1	O
;	O
3P	O
,	O
tonsil	O
,	O
1	O
/	O
1	O
;	O
3Q	O
,	O
.	O
representative	O
sections	O
,	O
2	O
/	O
1	O
.	O

4	O
)	O
SOURCE	O
:	O
Level	O
2	O
Posterior	O
.	O

Received	O
fresh	O
is	O
a	O
3	O
.	O
5	O
X	O
2	O
.	O
5	O
X	O
1	O
.	O
3	O
cm	O
portion	O
of	O
partially	O
.	O
circumscribed	O
,	O
yellow	O
-	O
tan	O
,	O
lobular	O
,	O
adipose	O
tissue	O
with	O
a	O
nodularity	O
.	O
noted	O
on	O
palpation	O
.	O

The	O
dissected	O
lymph	O
nodes	O
range	O
in	O
size	O
from	O
0	O
.	O
4	O
cm	O
.	O

up	O
to	O
the	O
largest	O
,	O
1	O
.	O
1	O
cm	O
in	O
greatest	O
length	O
.	O

The	O
lymph	O
nodes	O
are	O
.	O
submitted	O
in	O
total	O
.	O

Summary	O
of	O
sections	O
:	O
4A	O
,	O
two	O
lymph	O
nodes	O
,	O
each	O
bisected	O
,	O
4	O
/	O
1	O
;	O
4B	O
,	O
three	O
.	O
lymph	O
nodes	O
,	O
one	O
bisected	O
,	O
4	O
/	O
1	O
.	O

5	O
)	O
SOURCE	O
:	O
Left	O
Neck	O
Level	O
2	O
,	O
3	O
.	O

Received	O
fresh	O
labeled	O
,	O
"	O
left	O
neck	O
level	O
2	O
,	O
3	O
,	O
"	O
is	O
a	O
4	O
.	O
5	O
X	O
2	O
.	O
5	O
X	O
1	O
.	O
8	O
cm	O
.	O
portion	O
of	O
yellow	O
-	O
tar	O
fibrofatty	O
tissue	O
,	O
with	O
a	O
nodularity	O
noted	O
on	O
.	O
palpation	O
.	O

The	O
specimen	O
is	O
dissected	O
for	O
lymph	O
nodes	O
.	O

The	O
dissected	O
.	O
lymph	O
nodes	O
range	O
in	O
size	O
from	O
1	O
.	O
4	O
cm	O
in	O
greatest	O
dimension	O
up	O
to	O
3	O
.	O
0	O
cm	O
.	O
in	O
greatest	O
dimension	O
.	O

The	O
lymph	O
nodes	O
are	O
submitted	O
entirely	O
.	O

Summary	O
of	O
sections	O
:	O
5A	O
,	O
two	O
lymph	O
nodes	O
,	O
each	O
bisected	O
,	O
4	O
/	O
1	O
;	O
5B	O
,	O
one	O
.	O
lymph	O
node	O
,	O
bisected	O
,	O
2	O
/	O
1	O
;	O
5C	O
-	O
D	O
,	O
one	O
lymph	O
node	O
,	O
bisected	O
,	O
1	O
/	O
1	O
each	O
.	O

6	O
)	O
SOURCE	O
:	O
Left	O
Level	O
4	O
.	O

Received	O
fresh	O
labeled	O
,	O
"	O
left	O
level	O
4	O
,	O
"	O
is	O
a	O
5	O
.	O
0	O
X	O
4	O
.	O
0	O
X	O
1	O
.	O
4	O
cm	O
portion	O
.	O
of	O
partially	O
circumscribed	O
,	O
yellow	O
-	O
gray	O
,	O
fibrofatty	O
tissue	O
,	O
with	O
a	O
.	O
nodularity	O
noted	O
on	O
palpation	O
.	O

The	O
dissected	O
lymph	O
nodes	O
range	O
from	O
0	O
.	O
3	O
.	O

cm	O
up	O
to	O
the	O
largest	O
,	O
1	O
.	O
4	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
lymph	O
nodes	O
are	O
.	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
6A	O
,	O
three	O
lymph	O
nodes	O
,	O
two	O
bisected	O
,	O
5	O
/	O
1	O
;	O
6B	O
,	O
three	O
.	O
lymph	O
nodes	O
,	O
two	O
bisected	O
,	O
5	O
/	O
1	O
;	O
6C	O
,	O
four	O
lymph	O
nodes	O
,	O
4	O
/	O
1	O
.	O

7	O
)	O
SOURCE	O
:	O
Posterior	O
Level	O
3	O
.	O

Received	O
fresh	O
labeled	O
,	O
"	O
posterior	O
level	O
3	O
,	O
"	O
is	O
a	O
3	O
.	O
0	O
X	O
3	O
.	O
0	O
X	O
1	O
.	O
2	O
cm	O
.	O
portion	O
of	O
partially	O
circumscribed	O
,	O
yellow	O
-	O
tan	O
,	O
lobular	O
,	O
fibrofatty	O
.	O
tissue	O
,	O
with	O
a	O
nodularity	O
noted	O
on	O
palpation	O
.	O

The	O
dissected	O
lymph	O
nodes	O
.	O
range	O
in	O
size	O
from	O
0	O
.	O
3	O
to	O
0	O
.	O
6	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
lymph	O
nodes	O
.	O
are	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
7A	O
,	O
four	O
lymph	O
nodes	O
,	O
4	O
/	O
1	O
;	O
7B	O
,	O
three	O
lymph	O
nodes	O
,	O
.	O

3	O
/	O
1	O
.	O

8	O
)	O
SOURCE	O
:	O
Left	O
Neck	O
Level	O
4	O
Lymph	O
node	O
.	O

Received	O
fresh	O
labeled	O
,	O
"	O
left	O
neck	O
level	O
4	O
lymph	O
node	O
,	O
"	O
is	O
a	O
3	O
.	O
5	O
X	O
2	O
.	O
0	O
X	O
.	O

1	O
.	O
2	O
cm	O
portion	O
of	O
partially	O
circumscribed	O
,	O
yellow	O
-	O
tan	O
,	O
lobular	O
,	O
adipose	O
.	O
tissue	O
,	O
with	O
a	O
nodularity	O
noted	O
on	O
palpation	O
.	O

Serial	O
sectioning	O
shows	O
a	O
.	O
red	O
-	O
brown	O
cut	O
surface	O
,	O
grossly	O
consistent	O
with	O
a	O
portion	O
of	O
muscle	O
,	O
and	O
.	O

a	O
single	O
lymph	O
node	O
,	O
2	O
.	O
0	O
X	O
1	O
.	O
2	O
X	O
1	O
.	O
0	O
cm	O
.	O

The	O
lymph	O
node	O
is	O
bisected	O
and	O
.	O
submitted	O
in	O
total	O
.	O

Summary	O
of	O
sections	O
:	O
8A	O
,	O
2	O
/	O
1	O
.	O

2	O
.	O

Slides	O
and	O
report	O
reviewed	O
by	O
Attending	O
Pathologist	O
.	O

SURGICAL	O
PATHOLOGY	O
INTRAOPERATIVE	O
CONSULTATION	O
.	O

1	O
)	O
SOURCE	O
:	O
Left	O
Anterior	O
Tongue	O
Margin	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
BENIGN	O
.	O

2	O
)	O
SOURCE	O
:	O
Left	O
Base	O
of	O
Tongue	O
Margin	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
BENIGN	O
.	O

The	O
following	O
special	O
studies	O
were	O
performed	O
on	O
this	O
case	O
and	O
the	O
.	O
interpretation	O
is	O
incorporated	O
in	O
the	O
diagnostic	O
report	O
above	O
:	O
1xDECALCIFICATION	O
.	O

SNOMED	O
:	O
T	O
-	O
51000	O
,	O
T	O
-	O
51000	O
,	O
M	O
-	O
80703	O
,	O
.	O

-DOCSTART-217
PATIENT	O
HISTORY	O
:	O
The	O
patient	O
is	O
a	O
.	O

-	O
old	O
female	O
.	O

Date	O
of	O
last	O
menstrual	O
period	O
:	O
Not	O
given	O
.	O

PRE	O
OP	O
DIAGNOSIS	O
:	O
Breast	O
cancer	O
.	O

POST	O
OP	O
DIAGNOSIS	O
:	O
Same	O
.	O

PROCEDURE	O
:	O
Right	O
sentinel	O
node	O
biopsy	O
,	O
right	O
segmental	O
mastectomy	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
RIGHT	O
SENTINEL	O
LYMPH	O
NODE	O
#	O
1	O
,	O
BIOPSY	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
2	O
:	O
RIGHT	O
NON	O
-	O
SENTINEL	O
LYMPH	O
NODE	O
#	O
2	O
,	O
BIOPSY	O
-	O
.	O

FIBROADIPOSE	O
TISSUE	O
,	O
NO	O
LYMPH	O
NODE	O
IDENTIFIED	O
.	O

PART	O
3	O
:	O
RIGHT	O
NON	O
-	O
SENTINEL	O
LYMPH	O
NODE	O
#	O
1	O
,	O
BIOPSY	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
4	O
:	O
RIGHT	O
NON	O
-	O
SENTINEL	O
LYMPH	O
NODE	O
#	O
3	O
,	O
BIOPSY	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
5	O
:	O
RIGHT	O
SENTINEL	O
LYMPH	O
NODE	O
#	O
2	O
,	O
BIOPSY	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
6	O
:	O
RIGHT	O
SENTINEL	O
LYMPH	O
NODE	O
#	O
3	O
,	O
BIOPSY	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
7	O
:	O
RIGHT	O
BREAST	O
,	O
BIOPSIES	O
X4	O
-	O
.	O

A	O
.	O

ONE	O
OUT	O
OF	O
4	O
LYMPH	O
NODES	O
POSITIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
1	O
/	O
4	O
)	O
.	O

B	O
.	O

BENIGN	O
FIBROADIPOSE	O
TISSUE	O
(	O
see	O
comment	O
)	O
.	O

PART	O
8	O
:	O
RIGHT	O
BREAST	O
,	O
SEGMENTAL	O
MASTECTOMY	O
-	O
.	O

A	O
.	O

INFILTRATING	O
DUCT	O
CARCINOMA	O
.	O

1	B
.	I
4	I
CM	I
IN	O
GREATEST	O
DIMENSION	O
AS	O
MEASURED	O
ON	O
THE	O
SLIDE	O
,	O
.	O

NOTTINGHAM	O
SCORE	O
7	O
/	O
9	O
(	O
TUBULES	O
3	O
,	O
NUCLEI	O
3	O
,	O
MITOSIS	O
1	O
)	O
ASSOCIATED	O
WITH	O
MICROCALCIFICATIONS	O
.	O

B	O
.	O

LYMPHOVASCULAR	O
INVASION	O
IDENTIFIED	O
.	O

C	O
.	O

DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
,	O
SOLID	O
AND	O
CRIBRIFORM	O
TYPE	O
,	O
NUCLEAR	O
GRADE	O
2	O
ASSOCIATED	O
WITH	O
.	O

MICROCALCIFICATIONS	O
AND	O
COMPRISING	O
LESS	O
THAN	O
5	O
%	O
OF	O
TUMOR	O
.	O

D	O
.	O

SURGICAL	O
MARGINS	O
NEGATIVE	O
.	O

E	O
.	O

INFILTRATING	O
DUCT	O
CARCINOMA	O
APPROACHES	O
ANTERIOR	O
MARGIN	O
WITHIN	O
0	O
.	O
3	O
CM	O
.	O

F	O
.	O

CHANGES	O
CONSISTENT	O
WITH	O
PREVIOUS	O
CORE	O
BIOPSY	O
SITE	O
.	O

G	O
.	O

TUMOR	O
IS	O
ESTROGEN	O
RECEPTOR	O
POSITIVE	O
,	O
PROGESTERONE	O
RECEPTOR	O
POSITIVE	O
AND	O
HER	O
-	O
2	O
/	O
NEU	O
.	O

NEGATIVE	O
AS	O
PER	O
PREVIOUS	O
CORE	O
BIOPSY	O
REPORT	O
.	O

H	O
.	O

UNREMARKABLE	O
SKIN	O
.	O

I	O
.	O

FIBROCYSTIC	O
CHANGES	O
.	O

COMMENT	O
:	O
One	O
lymph	O
node	O
in	O
specimen	O
number	O
7	O
contains	O
micrometastatic	O
carcinoma	O
that	O
measures	O
less	O
than	O
0	O
.	O
2	O
cm	O
in	O
diameter	O
.	O

-DOCSTART-218
DIAGNOSIS	O
:	O
A	O
.	O

Uterus	O
,	O
bilateral	O
ovaries	O
,	O
and	O
fallopian	O
tubes	O
;	O
.	O
hysterectomy	O
.	O
and	O
bilateral	O
salpingo	O
-	O
oophorectomy	O
:	O
FIGO	O
grade	O
II	O
(	O
of	O
.	O
III	O
)	O
.	O
endometrial	O
adenocarcinoma	O
,	O
endometrioid	O
type	O
,	O
is	O
.	O
identified	O
forming	O
.	O

a	O
mass	O
(	O
4	B
.	I
4	I
x	I
3	I
.	I
9	I
x	I
1	I
.	I
2	I
cm	I
)	O
,	O
located	O
in	O
the	O
posterior	O
.	O
uterine	O
wall	O
.	O

The	O
tumor	O
invades	O
0	O
.	O
1	O
cm	O
into	O
the	O
myometrium	O
(	O
total	O
wall	O
.	O
thickness	O
.	O
2	O
.	O
2	O
cm	O
)	O
.	O

The	O
tumor	O
does	O
not	O
involve	O
the	O
endocervix	O
or	O
.	O
cervix	O
.	O

Lymphovascular	O
space	O
invasion	O
is	O
not	O
identified	O
.	O

The	O
.	O
margins	O
are	O
.	O
negative	O
for	O
tumor	O
.	O

The	O
cervix	O
,	O
bilateral	O
ovaries	O
,	O
.	O
fallopian	O
tubes	O
.	O
and	O
appendix	O
are	O
unremarkable	O
.	O

[	O
AJCCpT1bNOMX	O
]	O
.	O

B	O
.	O

Lymph	O
nodes	O
,	O
right	O
pelvic	O
,	O
biopsy	O
:	O
Multiple	O
(	O
5	O
)	O
right	O
.	O
pelvic	O
.	O

lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
.	O

C	O
.	O

Lymph	O
nodes	O
,	O
left	O
pelvic	O
,	O
biopsy	O
:	O
Multiple	O
(	O
6	O
)	O
left	O
.	O
pelvic	O
.	O

lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
.	O

This	O
final	O
pathology	O
report	O
is	O
based	O
on	O
the	O
.	O

ross	O
/	O
macroscopic	O
.	O
examination	O
and	O
frozen	O
section	O
histologic	O
evaluation	O
of	O
.	O
the	O
.	O

specimen	O
(	O
s	O
)	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

Received	O
fresh	O
labeled	O
"	O
uterus	O
,	O
bilateral	O
fallopian	O
.	O
tubes	O
and	O
.	O

ovaries	O
"	O
is	O
a	O
190	O
.	O
0	O
gram	O
uterus	O
with	O
attached	O
bilateral	O
.	O
tubes	O
and	O
.	O
ovaries	O
and	O
an	O
unremarkable	O
cervix	O
.	O

The	O
uterine	O
serosa	O
is	O
.	O
smooth	O
.	O

There	O
is	O
a	O
4	O
.	O
4	O
x	O
3	O
.	O
9	O
x	O
1	O
.	O
2	O
cm	O
polypoid	O
mass	O
in	O
the	O
fundus	O
.	O
of	O
the	O
.	O
endometrial	O
cavity	O
with	O
2	O
.	O
2	O
cm	O
myometrial	O
thickness	O
.	O

There	O
are	O
no	O
.	O
leiomyomas	O
.	O

There	O
is	O
a	O
3	O
.	O
0	O
x	O
2	O
.	O
0	O
x	O
1	O
.	O
2	O
cm	O
right	O
ovary	O
.	O
with	O
a	O
smooth	O
.	O
outer	O
surface	O
and	O
a	O
solid	O
cut	O
surface	O
with	O
a	O
7	O
.	O
0	O
x	O
0	O
.	O
8	O
cm	O
.	O
right	O
.	O

fallopian	O
tube	O
.	O

There	O
is	O
a	O
4	O
.	O
2	O
x	O
2	O
.	O
8	O
x	O
1	O
.	O
7	O
cm	O
left	O
ovary	O
.	O
with	O
a	O
.	O
ragged	O
outer	O
surface	O
and	O
cystic	O
.	O

There	O
is	O
a	O
solid	O
cut	O
.	O
surface	O
with	O
.	O

a	O
6	O
.	O
5	O
x	O
0	O
.	O
8	O
cm	O
left	O
fallopian	O
tube	O
.	O

Representative	O
.	O
sections	O
are	O
.	O
submitted	O
.	O

B	O
.	O

Received	O
fresh	O
labeled	O
"	O
right	O
pelvic	O
lymph	O
nodes	O
"	O
is	O
a	O
.	O

10	O
.	O
0	O
x	O
.	O

7	O
.	O
0	O
X	O
2	O
.	O
0	O
cm	O
aggregate	O
of	O
adipose	O
and	O
lymphatic	O
tissue	O
.	O

All	O
.	O
lymphatic	O
tissue	O
submitted	O
.	O

C	O
.	O

Received	O
fresh	O
labeled	O
"	O
left	O
pelvic	O
lymph	O
nodes	O
"	O
is	O
a	O
.	O

6	O
.	O
0	O
x	O
4	O
.	O
0	O
.	O

X	O
.	O

0	O
.	O
9	O
cm	O
aggregate	O
of	O
adipose	O
and	O
lymphatic	O
tissue	O
.	O

All	O
.	O
lymphatic	O
.	O

tissue	O
submitted	O
.	O

BLOCK	O
SUMMARY	O
.	O

Part	O
A	O
:	O
Uterus	O
,	O
bilateral	O
fallopian	O
tubes	O
and	O
ovaries	O
.	O

1	O
Endometrial	O
mass	O
1	O
.	O

2	O
Endometrial	O
mass	O
2	O
.	O

3	O
Endometrial	O
mass	O
3	O
.	O

4	O
Endometrial	O
mass	O
.	O

4	O
.	O

5	O
Lt	O
tube	O
and	O
ovary	O
.	O

6	O
Rt	O
tube	O
and	O
ovary	O
.	O

7	O
Lower	O
uterine	O
segment	O
.	O

8	O
Cervix	O
6	O
:	O
00	O
.	O

9	O
Endometrial	O
mass	O
5	O
.	O

Part	O
B	O
:	O
Right	O
Pelvic	O
Lymph	O
Nodes	O
.	O

1	O
Rt	O
pelvic	O
LNs	O
-	O
-	O
1	O
(	O
B1	O
)	O
.	O

2	O
Rt	O
pelvic	O
LNs	O
-	O
1	O
(	O
B2	O
)	O
.	O

3	O
Rt	O
pelvic	O
LNs	O
-	O
lof2	O
(	O
B3	O
)	O
.	O

4	O
Rt	O
pelvic	O
LNs	O
-	O
2of2	O
-	O
(	O
B3	O
)	O
.	O

5	O
Rt	O
pelvic	O
LNs	O
-	O
2	O
(	O
B4	O
)	O
.	O

Part	O
C	O
:	O
Left	O
Pelvic	O
Lymph	O
Nodes	O
.	O

1	O
Lt	O
pelvic	O
LN5	O
(	O
C1	O
)	O
.	O

2	O
Lt	O
pelvic	O
LN5	O
(	O
C2	O
)	O
.	O

3	O
Lt	O
pelvic	O
LN2	O
(	O
C3	O
)	O
.	O

4	O
Lt	O
pelvic	O
LN2	O
(	O
C4	O
)	O
.	O

5	O
Lt	O
pelvic	O
LN1	O
(	O
C5	O
)	O
.	O

-DOCSTART-219
DIAGNOSIS	O
:	O
Right	O
adrenal	O
mass	O
(	O
excision	O
)	O
:	O
Pheochromocytoma	O
with	O
areas	O
.	O
suggestive	O
of	O
diverged	O
differentiation	O
.	O

NOTE	O
:	O
Immunohistochemistry	O
studies	O
were	O
performed	O
and	O
were	O
positive	O
for	O
.	O

Chromogranin	O
,	O
Synaptophysin	O
and	O
S	O
-	O
100	O
and	O
negative	O
for	O
C	O
-	O
Kit	O
and	O
NFTP	O
.	O

The	O
case	O
was	O
reviewed	O
by	O
.	O

The	O
immunoperoxidase	O
tests	O
performed	O
here	O
were	O
developed	O
and	O
their	O
.	O
performance	O
characteristics	O
determined	O
by	O
the	O
Specialized	O
Diagnostics	O
.	O

Unit	O
of	O
the	O
Laboratory	O
of	O
Pathology	O
,	O
They	O
have	O
not	O
been	O
cleared	O
or	O
.	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O

The	O
FDA	O
has	O
also	O
.	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
:	O
This	O
.	O
laboratory	O
is	O
certified	O
under	O
the	O
Clinical	O
Laboratory	O
Improvement	O
.	O

Amendments	O
of	O
1988	O
(	O
CLIA	O
)	O
as	O
qualified	O
to	O
perform	O
high	O
complexity	O
.	O
clinical	O
laboratory	O
testing	O
.	O

CLINICAL	O
INFORMATION	O
:	O
Brief	O
Clinical	O
History	O
:	O
pt	O
with	O
VHL	O
Requestor	O
.	O

Requestor	O
Phone	O
/	O
Pager	O
:	O
Specimen	O
Taken	O
For	O
.	O

Protocol	O
:	O
01	O
-	O
Yes	O
.	O

Allocate	O
Order	O
to	O
Protocol	O
:	O
PROCEDURE	O
:	O
Operative	O
Findings	O
:	O
Large	O
right	O
renal	O
mass	O
Post	O
-	O
Operative	O
.	O

Diagnosis	O
:	O
pheochromocytoma	O
Pre	O
-	O
Operative	O
Diagnosis	O
:	O
Pheochromocytoma	O
.	O

SPECIMENS	O
SUBMITTED	O
:	O
1	O
.	O

ADRENAL	O
MASS	O
,	O
RIGHT	O
.	O

GROSS	O
DESCRIPTION	O
:	O
Received	O
is	O
a	O
single	O
formalin	O
filled	O
container	O
.	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
medical	O
record	O
number	O
and	O
"	O
right	O
.	O
adrenal	O
mass	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
an	O
8	O
.	O
7	O
x	O
6	O
.	O
1	O
X	O
3	O
.	O
6	O
cm	O
red	O
/	O
brown	O
.	O
nodular	O
piece	O
of	O
tissue	O
with	O
a	O
ribbon	O
of	O
golden	O
-	O
appearing	O
tissue	O
.	O
measuring	O
2	O
.	O
2	O
X	O
0	O
.	O
4	O
cm	O
,	O
grossly	O
consistent	O
with	O
normal	O
adrenal	O
.	O

The	O
.	O
specimen	O
weighs	O
90	O
.	O
5	O
grams	O
.	O

Further	O
examination	O
of	O
the	O
specimen	O
reveals	O
.	O
that	O
the	O
main	O
tumor	O
mass	O
is	O
6	B
.	I
7	I
x	I
6	I
.	I
0	I
x	I
3	I
.	I
5	I
cm	I
with	O
an	O
additional	O
rim	O
of	O
.	O
tissue	O
grossly	O
resembling	O
normal	O
adrenal	O
measuring	O
7	O
.	O
2	O
cm	O
in	O
length	O
x	O
.	O

0	O
.	O
6	O
cm	O
.	O

The	O
external	O
surface	O
is	O
entirely	O
inked	O
in	O
black	O
and	O
the	O
.	O
specimen	O
is	O
bisected	O
to	O
reveal	O
a	O
variegated	O
brown	O
,	O
tan	O
and	O
yellow	O
cut	O
.	O
surface	O
with	O
area	O
of	O
deep	O
red	O
measuring	O
2	O
.	O
8	O
cm	O
in	O
greatest	O
dimensions	O
.	O

Central	O
portions	O
of	O
the	O
tumor	O
measuring	O
5	B
.	I
0	I
x	I
3	I
.	I
0	I
X	I
1	I
.	I
0	I
cm	I
in	O
aggregate	O
.	O
are	O
procured	O
for	O
.	O

A	O
central	O
portion	O
of	O
tumor	O
,	O
measuring	O
.	O

1	B
.	I
5	I
X	I
0	I
.	I
5	I
x	I
0	I
.	I
3	I
cm	I
,	O
is	O
procured	O
for	O
.	O

Small	O
sections	O
of	O
grossly	O
.	O
normal	O
-	O
appearing	O
adrenal	O
measuring	O
0	O
.	O
6	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
3	O
cm	O
are	O
procured	O
for	O
.	O
for	O
.	O

The	O
procurement	O
was	O
done	O
by	O
.	O

on	O
.	O
,	O
the	O
specimen	O
is	O
received	O
as	O
noted	O
above	O
.	O
and	O
representative	O
sections	O
are	O
submitted	O
in	O
white	O
cassettes	O
for	O
.	O
permanent	O
processing	O
as	O
follows	O
:	O
Conficential	O
Patient	O
Information	O
,	O
Unanthorized	O
IS	O
by	O
th	O
:	O
I	O
Privacy	O
Act	O
or	O
.	O

Do	O
not	O
file	O
in	O
Medical	O
Record	O
.	O
tumor	O
with	O
capsule	O
.	O
tumor	O
with	O
relation	O
to	O
normal	O
.	O
normal	O
,	O
.	O
area	O
of	O
hemorrhage	O
and	O
firm	O
white	O
area	O
.	O

Gross	O
dictated	O
by	O
.	O

No	O
consultants	O
.	O

#	O
.	O

#	O
.	O

Paticat	O
Information	O
,	O
Unauthorized	O
disclosure	O
is	O
prohibitad	O
or	O
the	O
Privaci	O
Act	O
of	O
1979	O
.	O

Do	O
not	O
file	O
in	O
Medical	O
Record	O
.	O

-DOCSTART-220
Clinical	O
Diagnosis	O
&	O
History	O
:	O
year	O
old	O
female	O
with	O
left	O
thyroid	O
mass	O
,	O
FNA	O
consistent	O
with	O
atypical	O
cells	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
SP	O
:	O
Thyroid	O
,	O
Total	O
thyroidectomy	O
.	O

2	O
:	O
SP	O
:	O
Delphine	O
node	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

SP	O
:	O
Thyroid	O
,	O
Total	O
thyroidectomy	O
:	O
Tumor	O
Type	O
:	O
Papillary	O
carcinoma	O
,	O
follicular	O
variant	O
.	O

Histologic	O
Grade	O
:	O
Well	O
differentiated	O
.	O

Mitotic	O
Activity	O
:	O
Not	O
identified	O
.	O

Tumor	O
Necrosis	O
:	O
Not	O
identified	O
.	O

Tumor	O
Location	O
:	O
Left	O
lobe	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
diameter	O
is	O
2	B
.	I
0	I
cm	I
.	O

Tumor	O
Encapsulation	O
:	O
Completely	O
surrounded	O
.	O

Capsular	O
Invasion	O
:	O
Focal	O
invasion	O
.	O

Single	O
focus	O
of	O
capsular	O
invasion	O
.	O

Blood	O
Vessel	O
Invasion	O
:	O
Not	O
identified	O
.	O

Extrathyroid	O
Extension	O
:	O
Not	O
identified	O
.	O

Surgical	O
Margins	O
:	O
Free	O
of	O
tumor	O
.	O

Tumor	O
Multicentricity	O
:	O
Separate	O
focus	O
of	O
papillary	O
microcarcinoma	O
,	O
encapsulated	O
,	O
non	O
-	O
invasive	O
in	O
right	O
lobe	O
(	O
0	B
.	I
7	I
cm	I
)	O
.	O

Non	O
-	O
Neoplastic	O
Thyroid	O
:	O
B	O
ü	O
jing	O
.	O
Typer	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
year	O
old	O
female	O
with	O
left	O
thyroid	O
mass	O
,	O
FNA	O
consistent	O
with	O
atypical	O
cells	O
.	O
this	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
SP	O
:	O
Thyroid	O
,	O
Total	O
thyroidectomy	O
.	O

2	O
:	O
SP	O
:	O
Delphine	O
node	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

SP	O
:	O
Thyroid	O
,	O
Total	O
thyroidectomy	O
:	O
Tumor	O
Type	O
:	O
Papillary	O
carcinoma	O
,	O
follicular	O
variant	O
.	O

Histologic	O
Grade	O
:	O
Well	O
differentiated	O
.	O

Mitotic	O
Activity	O
:	O
Not	O
identified	O
.	O

Tumor	O
Necrosis	O
:	O
Not	O
identified	O
.	O

Tumor	O
Location	O
:	O
Left	O
lobe	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
diameter	O
is	O
2	B
.	I
0	I
cm	I
.	O

Tumor	O
Encapsulation	O
:	O
Completely	O
surrounded	O
.	O

Capsular	O
Invasion	O
:	O
Focal	O
invasion	O
.	O

Single	O
focus	O
of	O
capsular	O
invasion	O
.	O

Blood	O
Vessel	O
Invasion	O
:	O
Not	O
identified	O
.	O

Extrathyroid	O
Extension	O
:	O
Not	O
identified	O
.	O

Surgical	O
Margins	O
:	O
Free	O
of	O
tumor	O
.	O

Tumor	O
Multicentricity	O
:	O
Separate	O
focus	O
of	O
papillary	O
microcarcinoma	O
,	O
encapsulated	O
,	O
non	O
-	O
invasive	O
in	O
right	O
lobe	O
(	O
0	B
.	I
7	I
cm	I
)	O
.	O

Non	O
-	O
Neoplastic	O
Thyroid	O
:	O
Exhibits	O
noduler	O
hyperpiasia	O
.	O

Parathyroid	O
Glands	O
:	O
Not	O
identified	O
.	O

-	O
Four	O
benign	O
lymph	O
nodes	O
(	O
0	O
/	O
4	O
)	O
.	O

2	O
.	O

SP	O
:	O
Lymph	O
node	O
,	O
Delphine	O
;	O
Excision	O
:	O
-	O
One	O
benign	O
lymph	O
node	O
(	O
0	O
/	O
1	O
)	O
.	O

IATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
.	O

AND	O
THAT	O
I	O
HAVE	O
.	O

REVIEWED	O
AND	O
APPROVED	O
THIS	O
REPORT	O
.	O

Gross	O
Description	O
:	O
1	O
)	O
.	O

The	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
Total	O
thyroid	O
"	O
and	O
consists	O
of	O
a	O
thyroid	O
weighing	O
24	O
g	O
.	O

The	O
right	O
external	O
lobe	O
measures	O
surface	O
is	O
5	O
,	O
5	O
x	O
.	O
specimen	O
the	O
left	O
lobe	O
measures	O
4	O
.	O
3	O
x	O
2	O
.	O
3	O
x	O
2	O
.	O
3	O
cm	O
and	O
the	O
isthmus	O
measures	O
2	O
.	O
0	O
x	O
2	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
.	O

The	O
inked	O
blue	O
.	O

2	O
.	O
0	O
x	O
2	O
.	O
0	O
cm	O
,	O
thin	O
fibrous	O
capsule	O
.	O

The	O
posterior	O
surface	O
of	O
the	O
specimen	O
is	O
inked	O
black	O
,	O
and	O
the	O
anterior	O
identified	O
is	O
in	O
the	O
.	O
covered	O
by	O
reveals	O
a	O
a	O
1	O
.	O
5	O
x	O
1	O
.	O
1	O
x	O
1	O
.	O
0	O
cm	O
yellow	O
tinged	O
fluid	O
filled	O
cyst	O
with	O
a	O
1	O
.	O
2	O
cm	O
papillary	O
excrescence	O
,	O
nodules	O
identified	O
right	O
in	O
the	O
lobe	O
.	O

The	O
cyst	O
Sectioning	O
through	O
the	O
remaining	O
tissue	O
reveals	O
a	O
2	B
,	I
0	I
x	I
2	I
.	I
0	I
x	I
1	I
.	I
4	I
cm	I
encapsulated	O
yellow	O
-	O
tan	O
tumor	O
sections	O
.	O

Sectioning	O
wall	O
lining	O
is	O
white	O
and	O
trabecular	O
.	O

There	O
are	O
two	O
0	O
.	O
3	O
cm	O
in	O
greatest	O
dimension	O
white	O
-	O
tan	O
firm	O
in	O
the	O
left	O
lobe	O
.	O
right	O
lobe	O
.	O
the	O
anterior	O
and	O
posterior	O
capsule	O
.	O

The	O
remaining	O
thyroid	O
parenchyma	O
is	O
red	O
tan	O
and	O
beefy	O
.	O

Representative	O
sectioned	O
and	O
entirely	O
of	O
.	O
abutting	O
the	O
specimen	O
are	O
submitted	O
for	O
TPS	O
,	O
and	O
a	O
photograph	O
has	O
been	O
taken	O
.	O

The	O
remaining	O
tissue	O
is	O
serially	O
.	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
C	O
-	O
-	O
cyst	O
.	O

T	O
-	O
left	O
lobe	O
tumor	O
.	O

RN	O
-	O
-	O
right	O
lobe	O
nodules	O
.	O

RL	O
right	O
lobe	O
.	O

LL	O
left	O
lobe	O
.	O

I	O
-	O
isthmus	O
.	O

2	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
Delphine	O
node	O
"	O
and	O
consists	O
of	O
yellow	O
-	O
pink	O
portion	O
of	O
soft	O
tissue	O
measuring	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
x	O
.	O

0	O
.	O
1	O
cm	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
U	O
-	O
undesignated	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
.	O

1	O
:	O
SP	O
:	O
Thyroid	O
,	O
Total	O
thyroidectomy	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

4	O
.	O

C	O
.	O

5	O
.	O

3	O
.	O

I	O
.	O

4	O
.	O

6	O
.	O

LL	O
.	O

8	O
.	O

7	O
.	O

RL	O
.	O

13	O
.	O

2	O
.	O

RN	O
.	O

4	O
.	O

4	O
.	O

6	O
.	O

Part	O
2	O
:	O
SP	O
:	O
Delphine	O
node	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

-DOCSTART-221
BREAST	O
TISSUE	O
CHECKLIST	O
.	O

Specimen	O
type	O
:	O
Radical	O
mastectomy	O
.	O

Specimen	O
size	O
:	O
Not	O
specified	O
.	O

Tumor	O
site	O
:	O
Breast	O
.	O

Tumor	O
size	O
:	O
3	B
.	I
2	I
X	I
2	I
.	I
5	I
X	I
1	I
.	I
5	I
cm	I
.	O

Grossly	O
evident	O
lesion	O
:	O
Yes	O
.	O

Histologic	O
type	O
:	O
Infiltrating	O
ductal	O
and	O
lobular	O
carcinoma	O
.	O

Histologic	O
grade	O
:	O
Tumor	O
extent	O
:	O
Not	O
specified	O
.	O

Lymph	O
nodes	O
:	O
0	O
/	O
8	O
positive	O
for	O
metastasis	O
(	O
Regional	O
0	O
/	O
8	O
)	O
.	O

Right	O
)	O
lower	O
.	O

Extracapsular	O
invasion	O
of	O
the	O
lymph	O
nodes	O
:	O
Not	O
specified	O
.	O
outer	O
.	O

Margins	O
:	O
Not	O
specified	O
.	O
quasrant	O
.	O

Nottingham	O
Histologic	O
Score	O
.	O

Tubule	O
formation	O
:	O
Not	O
specified	O
.	O

Nuclear	O
pleomorphism	O
:	O
Not	O
specified	O
.	O

Mitotic	O
count	O
(	O
25x	O
)	O
:	O
Not	O
specified	O
.	O

Mitotic	O
count	O
(	O
40x	O
)	O
:	O
Not	O
specified	O
.	O

Total	O
Nottingham	O
Score	O
:	O
Score	O
cannot	O
be	O
determined	O
.	O

Evidence	O
of	O
neo	O
-	O
adjuvant	O
treatment	O
:	O
Not	O
specified	O
.	O

Additional	O
pathologic	O
findings	O
:	O
Not	O
specified	O
.	O

Comments	O
:	O
None	O
.	O

-DOCSTART-222
Diagnosis	O
:	O
A	O
:	O
Tongue	O
base	O
mucosa	O
,	O
biopsy	O
.	O

-	O
No	O
tumor	O
seen	O
.	O

B	O
:	O
Posterior	O
ventral	O
tongue	O
,	O
biopsy	O
.	O

-	O
No	O
tumor	O
seen	O
.	O

C	O
:	O
Lower	O
mouth	O
mucosa	O
,	O
biopsy	O
.	O

-	O
No	O
tumor	O
seen	O
.	O

D	O
:	O
Base	O
of	O
tongue	O
B	O
,	O
biopsy	O
.	O

-	O
No	O
tumor	O
seen	O
.	O

E	O
:	O
Midline	O
ventral	O
tongue	O
mucosa	O
,	O
biopsy	O
.	O

-	O
No	O
tumor	O
seen	O
.	O

F	O
:	O
Lymph	O
node	O
,	O
left	O
neck	O
Level	O
1	O
,	O
biopsy	O
.	O

-	O
Metastatic	O
squamous	O
cell	O
carcinoma	O
in	O
1	O
of	O
9	O
lymph	O
nodes	O
.	O

(	O
1	O
/	O
9	O
)	O
;	O
maximum	O
size	O
of	O
metastasis	O
1	O
.	O
0	O
cm	O
;	O
extracapsular	O
.	O
extension	O
identified	O
.	O

-	O
Benign	O
salivary	O
gland	O
tissue	O
present	O
.	O

G	O
:	O
Lymph	O
node	O
,	O
left	O
neck	O
Level	O
2	O
,	O
biopsy	O
.	O

-	O
Metastatic	O
squamous	O
cell	O
carcinoma	O
in	O
1	O
of	O
2	O
lymph	O
nodes	O
.	O

(	O
1	O
/	O
2	O
)	O
;	O
maximum	O
size	O
of	O
metastasis	O
0	O
.	O
9	O
cm	O
;	O
extracapsular	O
.	O
extension	O
identified	O
.	O

H	O
:	O
Lymph	O
node	O
,	O
left	O
neck	O
Level	O
3	O
,	O
biopsy	O
.	O

Metastatic	O
squamous	O
cell	O
carcinoma	O
in	O
1	O
of	O
37	O
lymph	O
nodes	O
.	O

(	O
1	O
/	O
37	O
)	O
;	O
maximum	O
size	O
of	O
metastasis	O
0	O
.	O
2	O
cm	O
;	O
negative	O
for	O
definite	O
.	O
extracapsular	O
extension	O
.	O

I	O
:	O
Tongue	O
,	O
left	O
hemiglossectomy	O
.	O

Tumor	O
histologic	O
type	O
/	O
subtype	O
:	O
invasive	O
moderately	O
.	O
differentiated	O
keratinizing	O
squamous	O
cell	O
carcinoma	O
.	O

Primary	O
site	O
:	O
tongue	O
.	O

Size	O
:	O
5	B
.	I
4	I
cm	I
by	O
gross	O
examination	O
.	O

Extent	O
of	O
invasion	O
:	O
Angiolymphatic	O
invasion	O
present	O
.	O

Perineural	O
Invasion	O
:	O
present	O
.	O

Bone	O
invasion	O
:	O
not	O
applicable	O
.	O

Carcinoma	O
in	O
situ	O
:	O
not	O
identified	O
.	O

Surgical	O
Margins	O
:	O
All	O
surgical	O
margins	O
negative	O
for	O
definite	O
.	O
involvement	O
by	O
carcinoma	O
;	O
the	O
anterior	O
tip	O
is	O
close	O
but	O
negative	O
.	O
for	O
definite	O
carcinoma	O
(	O
see	O
comment	O
)	O
.	O

Lymph	O
nodes	O
:	O
Total	O
lymph	O
node	O
count	O
for	O
all	O
specimens	O
is	O
3	O
of	O
48	O
.	O
involved	O
by	O
metastatic	O
squamous	O
cell	O
carcinoma	O
,	O
separately	O
.	O
submitted	O
in	O
specimens	O
F	O
,	O
G	O
and	O
H	O
.	O

Size	O
of	O
largest	O
metastasis	O
:	O
1	O
.	O
0	O
cm	O
.	O

Extra	O
-	O
capsular	O
extension	O
:	O
focally	O
present	O
in	O
specimens	O
F	O
and	O
G	O
.	O

Other	O
significant	O
findings	O
:	O
The	O
carcinoma	O
is	O
deeply	O
invasive	O
.	O
into	O
the	O
skeletal	O
muscle	O
within	O
the	O
hemiglossectomy	O
The	O
tumor	O
.	O
extends	O
far	O
anteriorly	O
,	O
very	O
close	O
to	O
the	O
anterior	O
tip	O
.	O

In	O
the	O
.	O
anterior	O
tip	O
,	O
the	O
carcinoma	O
is	O
present	O
beneath	O
an	O
intact	O
surface	O
.	O
squamous	O
mucosa	O
.	O

AJCC	O
PATHOLOGIC	O
TNM	O
STAGE	O
:	O
pT4a	O
pN2b	O
.	O

NOTE	O
:	O
This	O
pathologic	O
stage	O
assessment	O
is	O
based	O
on	O
information	O
.	O
available	O
at	O
the	O
time	O
of	O
this	O
report	O
,	O
and	O
is	O
subject	O
to	O
change	O
.	O
pending	O
clinical	O
review	O
and	O
additional	O
information	O
.	O

Comment	O
:	O
The	O
frozen	O
section	O
diagnoses	O
are	O
confirmed	O
.	O

The	O
surgical	O
resection	O
margins	O
are	O
free	O
of	O
definite	O
involvement	O
.	O
by	O
tumor	O
.	O

The	O
tumor	O
does	O
extend	O
deeply	O
into	O
the	O
muscle	O
of	O
the	O
.	O
hemiglossectomy	O
specimen	O
and	O
extends	O
far	O
anteriorly	O
.	O

An	O
anterior	O
.	O
tip	O
section	O
was	O
taken	O
and	O
submitted	O
en	O
face	O
initially	O
which	O
.	O
revealed	O
a	O
focus	O
of	O
submucosal	O
invasive	O
squamous	O
cell	O
carcinoma	O
.	O

This	O
section	O
is	O
subsequently	O
bisected	O
and	O
submitted	O
as	O
.	O
perpendicular	O
sections	O
revealing	O
the	O
invasive	O
carcinoma	O
to	O
be	O
.	O
present	O
beneath	O
an	O
intact	O
anterior	O
surface	O
squamous	O
mucosa	O
.	O

The	O
.	O
inked	O
true	O
margins	O
in	O
the	O
anterior	O
tip	O
section	O
are	O
negative	O
for	O
.	O
definite	O
tumor	O
.	O

Intraoperative	O
Consult	O
Diagnosis	O
:	O
A	O
frozen	O
section	O
was	O
requested	O
by	O
.	O

FSA1	O
:	O
Tongue	O
base	O
mucosa	O
,	O
biopsy	O
.	O

-	O
Chronic	O
inflammatory	O
infiltrate	O
.	O

No	O
tumor	O
seen	O
.	O

FSB1	O
:	O
Posterior	O
ventral	O
tongue	O
,	O
biopsy	O
.	O

-	O
No	O
tumor	O
seen	O
.	O

FSC1	O
:	O
Lower	O
mouth	O
mucosa	O
,	O
biopsy	O
.	O

-	O
No	O
tumor	O
seen	O
.	O

FSD1	O
:	O
Base	O
of	O
tongue	O
,	O
B	O
,	O
biopsy	O
.	O

-	O
No	O
tumor	O
seen	O
.	O

FSE1	O
:	O
Midline	O
ventral	O
tongue	O
mucosa	O
,	O
biopsy	O
.	O

-	O
No	O
tumor	O
seen	O
.	O

Frozen	O
Section	O
Pathologist	O
:	O
MD	O
.	O

Clinical	O
History	O
:	O
with	O
left	O
sided	O
tongue	O
lesion	O
;	O
biopsy	O
showed	O
.	O
moderately	O
differentiated	O
squamous	O
cell	O
carcinoma	O
.	O

Gross	O
Description	O
:	O
Received	O
are	O
nine	O
appropriately	O
labeled	O
containers	O
.	O

Containers	O
.	O

A	O
-	O
E	O
are	O
received	O
fresh	O
for	O
frozen	O
section	O
.	O

Container	O
A	O
holds	O
a	O
1	O
X	O
0	O
.	O
4	O
X	O
0	O
.	O
4	O
cm	O
red	O
/	O
tan	O
soft	O
tissue	O
.	O
fragment	O
;	O
block	O
FSA1	O
,	O
NTR	O
.	O

Container	O
B	O
holds	O
a	O
0	O
.	O

0	O
.	O
5	O
X	O
0	O
.	O
3	O
cm	O
red	O
/	O
tan	O
soft	O
tissue	O
.	O
fragment	O
;	O
block	O
FSB1	O
,	O
.	O

Container	O
C	O
holds	O
a	O
0	O
.	O

0	O
.	O
3	O
X	O
0	O
.	O
3	O
cm	O
red	O
/	O
tan	O
soft	O
tissue	O
.	O
fragment	O
;	O
block	O
FSC1	O
,	O
.	O

Container	O
D	O
holds	O
a	O
0	O
.	O

0	O
.	O
3	O
X	O
0	O
.	O
3	O
cm	O
red	O
/	O
tan	O
soft	O
tissue	O
.	O
fragment	O
;	O
block	O
FSD1	O
,	O
.	O

Container	O
E	O
holds	O
a	O
1	O
.	O

0	O
.	O
3	O
X	O
0	O
.	O
3	O
cm	O
red	O
/	O
tan	O
soft	O
tissue	O
.	O
fragment	O
;	O
block	O
FSE1	O
,	O
.	O

Container	O
F	O
is	O
additionally	O
labeled	O
"	O
left	O
neck	O
,	O
Level	O
1	O
.	O
"	O
It	O
.	O
holds	O
an	O
8	O
.	O
3	O
X	O
6	O
.	O
1	O
X	O
2	O
.	O
0	O
cm	O
unoriented	O
aggregate	O
of	O
brown	O
/	O
tan	O
.	O
fibroadipose	O
tissue	O
.	O

There	O
is	O
10	O
.	O
7	O
gram	O
(	O
4	O
.	O
9	O
X	O
2	O
.	O
9	O
X	O
1	O
.	O
7	O
cm	O
)	O
.	O
gland	O
.	O

The	O
outside	O
surface	O
is	O
inked	O
entirely	O
in	O
blue	O
.	O

Nine	O
lymph	O
node	O
candidates	O
,	O
ranging	O
in	O
size	O
from	O
3	O
.	O
4	O
X	O
1	O
.	O
9	O
X	O
1	O
.	O
1	O
.	O

cm	O
to	O
0	O
.	O
5	O
X	O
0	O
.	O
4	O
X	O
0	O
.	O
2	O
cm	O
are	O
identified	O
.	O

The	O
largest	O
node	O
on	O
.	O
sectioning	O
is	O
white	O
and	O
firm	O
with	O
areas	O
of	O
hemorrhage	O
.	O

The	O
.	O
submandibular	O
gland	O
on	O
sectioning	O
is	O
tan	O
and	O
lobulated	O
.	O

Block	O
summary	O
:	O
F1	O
-	O
largest	O
node	O
,	O
representative	O
sections	O
.	O

F2	O
-	O
largest	O
node	O
,	O
representative	O
sections	O
.	O

F3	O
,	O
F4	O
-	O
second	O
largest	O
node	O
,	O
serially	O
sectioned	O
and	O
entirely	O
.	O
submitted	O
.	O

F5	O
-	O
one	O
lymph	O
node	O
,	O
bisected	O
.	O

F6	O
-	O
three	O
lymph	O
node	O
candidates	O
.	O

F7	O
-	O
three	O
lymph	O
node	O
candidates	O
.	O

F8	O
-	O
submandibular	O
gland	O
,	O
representative	O
sections	O
.	O

F9	O
-	O
submandibular	O
gland	O
,	O
representative	O
sections	O
.	O

Container	O
G	O
is	O
additionally	O
labeled	O
"	O
left	O
neck	O
,	O
Level	O
2	O
.	O
"	O
It	O
.	O
holds	O
a	O
5	O
.	O
0	O
X	O
4	O
.	O
6	O
X	O
2	O
.	O
0	O
cm	O
aggregate	O
of	O
brown	O
/	O
tan	O
fibrofatty	O
.	O
tissue	O
.	O

There	O
are	O
three	O
lymph	O
node	O
candidates	O
palpated	O
ranging	O
.	O
in	O
size	O
from	O
2	O
.	O
1	O
X	O
1	O
.	O
1	O
X	O
1	O
.	O
0	O
cm	O
to	O
0	O
.	O
5	O
X	O
0	O
.	O
2	O
X	O
0	O
.	O
2	O
cm	O
.	O

On	O
.	O
sectioning	O
the	O
largest	O
node	O
has	O
a	O
white	O
/	O
tan	O
firm	O
area	O
.	O

On	O
.	O
sectioning	O
,	O
the	O
second	O
largest	O
node	O
is	O
homogeneously	O
pink	O
/	O
tan	O
.	O

Block	O
summary	O
:	O
G1	O
-	O
largest	O
node	O
,	O
representative	O
sections	O
.	O

G2	O
-	O
second	O
largest	O
node	O
,	O
serially	O
sectioned	O
.	O

G3	O
-	O
second	O
largest	O
node	O
,	O
serially	O
sectioned	O
.	O

G4	O
-	O
smallest	O
node	O
.	O

Container	O
H	O
is	O
additionally	O
labeled	O
"	O
left	O
neck	O
Level	O
3	O
.	O
'	O
It	O
.	O
holds	O
a	O
9	O
.	O
3	O
X	O
4	O
.	O
5	O
X	O
2	O
.	O
0	O
cm	O
aggregate	O
of	O
brown	O
/	O
tan	O
fibrofatty	O
.	O
tissue	O
.	O

The	O
are	O
twenty	O
lymph	O
node	O
candidates	O
palpated	O
ranging	O
in	O
.	O
size	O
from	O
2	O
.	O
8	O
X	O
1	O
.	O
9	O
X	O
0	O
.	O
7	O
cm	O
to	O
0	O
.	O
3	O
X	O
0	O
.	O
3	O
X	O
0	O
.	O
3	O
cm	O
.	O

On	O
.	O
sectioning	O
,	O
the	O
largest	O
node	O
is	O
hemorrhagic	O
.	O

Block	O
summary	O
:	O
H1	O
,	O
H2	O
-	O
largest	O
node	O
,	O
serially	O
sectioned	O
,	O
entirely	O
submitted	O
.	O

H3	O
-	O
second	O
largest	O
node	O
,	O
bisected	O
and	O
entirely	O
submitted	O
.	O

H4	O
-	O
three	O
lymph	O
node	O
candidates	O
.	O

H5	O
-	O
three	O
lymph	O
node	O
candidates	O
.	O

H6	O
.	O

-	O
three	O
lymph	O
node	O
candidates	O
.	O

H7	O
-	O
four	O
lymph	O
node	O
candidates	O
.	O

H8	O
-	O
five	O
lymph	O
node	O
candidates	O
.	O

Container	O
I	O
is	O
additionally	O
labeled	O
"	O
left	O
hemiglossectomy	O
,	O
long	O
.	O

stitch	O
/	O
lateral	O
,	O
short	O
/	O
anterior	O
.	O

"	O
It	O
holds	O
a	O
6	O
.	O
5	O
X	O
3	O
.	O
6	O
X	O
3	O
.	O
0	O
cm	O
.	O
segment	O
of	O
tongue	O
with	O
long	O
stitch	O
designating	O
lateral	O
and	O
short	O
.	O
stitch	O
designating	O
anterior	O
.	O

The	O
inking	O
scheme	O
is	O
blue	O
=	O
lateral	O
,	O
.	O

green	O
=	O
medial	O
,	O
black	O
=	O
deep	O
.	O

The	O
surface	O
of	O
the	O
tongue	O
is	O
patchy	O
,	O
.	O
white	O
with	O
areas	O
of	O
firm	O
micronodularity	O
measuring	O
4	O
.	O
5	O
X	O
2	O
.	O
5	O
cm	O
.	O
in	O
the	O
lateral	O
anterior	O
segment	O
.	O

The	O
remaining	O
surface	O
is	O
.	O
unremarkable	O
.	O

On	O
sectioning	O
,	O
the	O
tumor	O
occupies	O
approximately	O
.	O

70	O
%	O
of	O
the	O
total	O
specimen	O
.	O

The	O
tumor	O
is	O
white	O
/	O
tan	O
and	O
firm	O
with	O
.	O
areas	O
of	O
hemorrhage	O
.	O

The	O
tumor	O
is	O
2	B
.	I
5	I
cm	I
medial	O
to	O
lateral	O
,	O
2	B
.	I
1	I
.	I

cm	B
from	O
the	O
tongue	O
surface	O
to	O
deep	O
margin	O
,	O
5	B
.	I
4	I
cm	I
anterior	O
to	O
.	O
posterior	O
.	O

The	O
tumor	O
grossly	O
extends	O
to	O
the	O
blue	O
inked	O
surface	O
.	O
which	O
is	O
representative	O
of	O
ulcerated	O
tumor	O
at	O
the	O
mucosal	O
.	O
surface	O
and	O
not	O
a	O
true	O
margin	O
,	O
and	O
also	O
extends	O
close	O
to	O
the	O
.	O
black	O
inked	O
deep	O
margin	O
.	O

The	O
tumor	O
extends	O
to	O
within	O
0	O
.	O
4	O
cm	O
of	O
.	O
the	O
closest	O
green	O
inked	O
medial	O
margin	O
.	O

The	O
tumor	O
extensively	O
.	O
involves	O
the	O
lateral	O
mucosal	O
surface	O
with	O
extensive	O
ulceration	O
.	O

The	O
tumor	O
is	O
white	O
-	O
tan	O
and	O
firm	O
and	O
extends	O
far	O
into	O
the	O
.	O
anterior	O
aspect	O
of	O
the	O
specimen	O
,	O
very	O
close	O
to	O
the	O
anterior	O
tip	O
.	O
of	O
the	O
resection	O
specimen	O
.	O

The	O
remaining	O
uninvolved	O
tongue	O
is	O
.	O
tan	O
-	O
brown	O
with	O
a	O
whorled	O
muscular	O
appearance	O
.	O

Block	O
summary	O
:	O
Il	O
-	O
anterior	O
tip	O
,	O
initially	O
submitted	O
en	O
face	O
,	O
subsequently	O
.	O
bisected	O
as	O
perpendicular	O
margin	O
specimen	O
.	O

I2	O
-	O
posterior	O
tip	O
,	O
en	O
face	O
.	O

I3	O
-	O
representative	O
sections	O
of	O
tumor	O
with	O
all	O
margins	O
.	O

I4	O
-	O
tumor	O
with	O
closest	O
green	O
inked	O
medial	O
margin	O
.	O

I5	O
-	O
tumor	O
with	O
closest	O
blue	O
inked	O
lateral	O
margin	O
.	O

I6	O
-	O
tumor	O
with	O
closest	O
black	O
inked	O
deep	O
margin	O
.	O

I7	O
-	O
mass	O
with	O
closest	O
overlying	O
tongue	O
surface	O
.	O

-DOCSTART-223
Clinical	O
Diagnosis	O
&	O
History	O
:	O
RLQ	O
tenderness	O
,	O
CT	O
scan	O
revealed	O
mass	O
at	O
hepatic	O
flexure	O
at	O
colon	O
and	O
mass	O
.	O
at	O
segment	O
7	O
.	O

Colonoscopy	O
revealed	O
mass	O
of	O
colon	O
.	O

Biopsy	O
shown	O
increased	O
.	O
lymphoplasmacytic	O
infiltration	O
at	O
lamina	O
propria	O
.	O

Carcinoma	O
of	O
hepatic	O
.	O
flexure	O
with	O
liver	O
mass	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
Lymph	O
node	O
,	O
base	O
of	O
superior	O
mesentery	O
artery	O
,	O
excision	O
.	O

2	O
:	O
Lymph	O
node	O
,	O
middle	O
colic	O
,	O
excision	O
.	O

3	O
:	O
Colon	O
,	O
right	O
,	O
nemi	O
-	O
colectomy	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

Lymph	O
node	O
,	O
base	O
of	O
superior	O
mesentery	O
artery	O
,	O
excision	O
.	O

-	O
Metastatic	O
moderately	O
differentiated	O
adenocarcinoma	O
in	O
one	O
of	O
two	O
lymph	O
.	O
nodes	O
(	O
1	O
/	O
2	O
)	O
.	O

2	O
.	O

Lymph	O
node	O
,	O
middle	O
colic	O
,	O
excision	O
.	O

-	O
One	O
benign	O
lymph	O
node	O
(	O
0	O
/	O
1	O
)	O
.	O

3	O
.	O

Colon	O
,	O
right	O
,	O
hemi	O
-	O
colectomy	O
:	O
Tumor	O
Type	O
:	O
Adenocarcinoma	O
.	O

Histologic	O
Grade	O
:	O
Moderately	O
differentiated	O
.	O

Tumor	O
Location	O
:	O
Cecum	O
.	O

Tumor	O
Size	O
:	O
Length	O
is	O
8	B
cm	I
.	O

Width	O
is	O
6	B
cm	I
.	O

Maximal	O
thickness	O
is	O
1	B
.	I
8	I
cm	I
.	O

Tumor	O
Budding	O
:	O
Extensive	O
.	O

Increased	O
Tumor	O
Infiltrating	O
Lymphocytes	O
:	O
Absent	O
.	O

Precursor	O
Lesions	O
:	O
Not	O
identified	O
.	O

Deepest	O
Tumor	O
Invasion	O
:	O
Subserosal	O
adipose	O
tissue	O
and	O
/	O
or	O
mesenteric	O
fat	O
.	O

Gross	O
Tumor	O
Perforation	O
:	O
Not	O
identified	O
.	O

Lymphovascular	O
Invasion	O
:	O
Identified	O
.	O

Large	O
Venous	O
Invasion	O
:	O
Not	O
Identified	O
.	O

Perineural	O
Invasion	O
:	O
Identified	O
.	O

Surgical	O
Margins	O
:	O
Free	O
of	O
tumor	O
.	O

Polyps	O
/	O
Mucosa	O
Dysplasia	O
(	O
away	O
from	O
the	O
carcinoma	O
)	O
:	O
Not	O
Identified	O
.	O

Non	O
-	O
Neoplastic	O
Bowel	O
:	O
Unremarkable	O
.	O

Appendix	O
:	O
Not	O
identified	O
.	O

Lymph	O
Nodes	O
:	O
Number	O
with	O
metastasis	O
:	O
12	O
.	O

Total	O
number	O
examined	O
:	O
72	O
.	O

Tumor	O
deposits	O
in	O
pericolorectal	O
soft	O
tissue	O
:	O
Identified	O
.	O

Identified	O
;	O
number	O
:	O
1	O
.	O

Tumor	O
Staging	O
(	O
AJCC	O
7th	O
Edition	O
)	O
:	O
pT3	O
(	O
Tumor	O
invades	O
through	O
the	O
muscularis	O
propria	O
into	O
.	O
pericolorectal	O
tissues	O
)	O
.	O

Lymph	O
Node	O
Stage	O
(	O
AJCC	O
7th	O
Edition	O
)	O
:	O
N2b	O
(	O
Metastasis	O
in	O
seven	O
or	O
more	O
regional	O
lymph	O
nodes	O
)	O
.	O

Note	O
:	O
Results	O
of	O
immunohistochemical	O
staining	O
for	O
DNA	O
mismatch	O
repair	O
.	O
proteins	O
are	O
as	O
follows	O
:	O
MLH1	O
Staining	O
present	O
in	O
tumor	O
.	O

MSH2	O
:	O
Staining	O
present	O
in	O
tumor	O
.	O

MSH6	O
:	O
Staining	O
present	O
in	O
tumor	O
.	O

PMS2	O
:	O
Staining	O
present	O
in	O
tumor	O
.	O

Conclusion	O
:	O
Immunohistochemical	O
staining	O
for	O
the	O
tested	O
DNA	O
mismatch	O
repair	O
.	O
proteins	O
is	O
retained	O
in	O
the	O
tumor	O
.	O

Some	O
of	O
the	O
immunohistochemistry	O
and	O
ISH	O
tests	O
were	O
developed	O
and	O
their	O
.	O
performance	O
characteristics	O
were	O
determined	O
by	O
the	O
Department	O
of	O
Pathology	O
.	O

They	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
US	O
Food	O
and	O
Drug	O
.	O

Administration	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
.	O
not	O
necessary	O
.	O

These	O
tests	O
are	O
used	O
for	O
clinical	O
purposes	O
.	O

They	O
should	O
not	O
.	O

be	O
regarded	O
as	O
investigational	O
or	O
for	O
research	O
.	O

This	O
laboratory	O
is	O
certified	O
.	O
under	O
the	O
Clinical	O
Laboratory	O
Improvement	O
Amendments	O
of	O
.	O

(	O
CLIA	O
-	O
.	O

as	O
.	O
qualified	O
to	O
perform	O
high	O
complexity	O
clinical	O
laboratory	O
testing	O
.	O

I	O
ATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
.	O

THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
,	O
AND	O
THAT	O
I	O
HAVE	O
REVIEWED	O
AND	O
APPROVED	O
.	O

THIS	O
REPORT	O
.	O

Gross	O
Description	O
:	O
1	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
labeled	O
"	O
base	O
of	O
.	O
superior	O
mesenteric	O
artery	O
lymph	O
node	O
"	O
are	O
two	O
lymph	O
nodes	O
each	O
measure	O
0	O
.	O
5	O
.	O

cm	O
greatest	O
dimension	O
.	O

The	O
lymph	O
nodes	O
are	O
entirely	O
submitted	O
for	O
frozen	O
.	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
FSC	O
-	O
frozen	O
section	O
control	O
.	O

D	O
.	O

2	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
labeled	O
"	O
middle	O
colic	O
.	O
lymph	O
node	O
"	O
is	O
a	O
1	O
.	O
0	O
cm	O
lymph	O
node	O
.	O

The	O
lymph	O
node	O
is	O
bisected	O
and	O
entirely	O
.	O
summit	O
of	O
the	O
frozen	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
FSC	O
-	O
frozen	O
section	O
control	O
.	O

3	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
Right	O
hemi	O
-	O
colectomy	O
"	O
and	O
.	O
consists	O
of	O
a	O
segment	O
of	O
terminal	O
ileum	O
,	O
cecum	O
and	O
ascending	O
colon	O
.	O

The	O
.	O
terminal	O
ileum	O
measures	O
14	O
cm	O
in	O
length	O
and	O
3	O
cm	O
in	O
circumference	O
at	O
the	O
.	O
proximal	O
resected	O
margin	O
.	O

The	O
remaining	O
colon	O
measures	O
40	O
in	O
length	O
with	O
a	O
.	O
circumference	O
of	O
6	O
cm	O
at	O
the	O
distal	O
resected	O
margin	O
.	O

The	O
appendix	O
is	O
not	O
.	O
present	O
.	O

The	O
intestinal	O
serosa	O
is	O
pink	O
tan	O
and	O
smooth	O
.	O

Focally	O
hemorrhagic	O
.	O
lobulated	O
yellow	O
tan	O
adipose	O
tissue	O
spans	O
the	O
length	O
of	O
the	O
specimen	O
.	O
measuring	O
up	O
to	O
5	O
cm	O
in	O
thickness	O
.	O

The	O
specimen	O
is	O
opened	O
to	O
reveal	O
a	O
.	O
circumferential	O
mass	O
lesion	O
measuring	O
6	O
cm	O
in	O
length	O
and	O
8	O
cm	O
in	O
width	O
.	O

The	O
.	O
mass	O
is	O
located	O
in	O
the	O
cecum	O
,	O
23	O
cm	O
from	O
the	O
proximal	O
margin	O
and	O
15	O
cm	O
from	O
.	O
the	O
distal	O
margin	O
.	O

Sectioning	O
shows	O
that	O
the	O
tumor	O
invades	O
the	O
fat	O
.	O

The	O
.	O
depth	O
of	O
invasion	O
is	O
1	O
.	O
8	O
cm	O
grossly	O
.	O

Right	O
underneath	O
the	O
mass	O
is	O
a	O
4	O
x	O
2	O
.	O
5	O
.	O

x	O
2	O
cm	O
conglomerate	O
of	O
five	O
nodules	O
with	O
yellow	O
/	O
white	O
cut	O
surface	O
(	O
distance	O
.	O
from	O
tumor	O
surface	O
to	O
the	O
deepest	O
portion	O
of	O
the	O
conglomerate	O
is	O
4	O
.	O
8	O
cm	O
)	O
.	O

The	O
remaining	O
mucosa	O
is	O
unremarkable	O
.	O

The	O
specimen	O
is	O
submitted	O
for	O
lymph	O
.	O
node	O
dissection	O
.	O

The	O
attached	O
adipose	O
tissue	O
is	O
thoroughly	O
examined	O
and	O
all	O
.	O
identified	O
lymph	O
nodes	O
are	O
submitted	O
.	O

Representative	O
sections	O
of	O
the	O
.	O
specimen	O
are	O
submitted	O
for	O
permanent	O
sections	O
and	O
for	O
TPS	O
.	O

Summary	O
of	O
sections	O
:	O
P	O
-	O
proximal	O
margin	O
shave	O
.	O

D	O
-	O
distal	O
margin	O
shave	O
.	O

T	O
-	O
tumor	O
.	O

RS	O
representative	O
sections	O
.	O

LN	O
-	O
lymph	O
nodes	O
.	O

BLN	O
-	O
bisected	O
lymph	O
nodes	O
.	O

C	O
-	O
conglomerate	O
of	O
5	O
nodes	O
,	O
representative	O
section	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
Lymph	O
node	O
,	O
base	O
of	O
superior	O
mesentery	O
artery	O
,	O
excision	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

FSC	O
.	O

1	O
.	O

Part	O
2	O
:	O
Lymph	O
node	O
,	O
middle	O
colic	O
,	O
excision	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O
fsc	O
.	O

1	O
.	O

Part	O
3	O
:	O
Colon	O
,	O
right	O
,	O
hemi	O
-	O
colectomy	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

5	O
.	O

BLN	O
.	O

5	O
.	O

1	O
.	O

C	O
.	O

1	O
.	O

1	O
.	O

D	O
.	O

1	O
.	O

10	O
.	O

LN	O
.	O

20	O
.	O

1	O
.	O

P	O
.	O

1	O
.	O

1	O
.	O

RS	O
.	O

1	O
.	O

6	O
.	O

T	O
.	O

6	O
.	O

Intraoperative	O
Consultation	O
:	O
Note	O
:	O
The	O
diagnoses	O
given	O
in	O
this	O
section	O
pertain	O
only	O
to	O
the	O
tissue	O
sample	O
.	O
examined	O
at	O
the	O
time	O
of	O
the	O
intraoperative	O
consultation	O
.	O

1	O
.	O

Frozen	O
Section	O
Diagnosis	O
:	O
Base	O
of	O
superior	O
mesentery	O
artery	O
lymph	O
node	O
.	O

Positive	O
for	O
metastatic	O
adenocarcinoma	O
.	O

Permanent	O
Diagnosis	O
:	O
SAME	O
.	O

2	O
.	O

Frozen	O
Section	O
Diagnosis	O
:	O
Middle	O
colic	O
lymph	O
node	O
.	O

Benign	O
.	O

Permanent	O
Diagnosis	O
:	O
SAME	O
.	O

-DOCSTART-224
Diagnosis	O
:	O
A	O
:	O
Adrenal	O
gland	O
,	O
left	O
,	O
robotic	O
laparoscopic	O
adrenalectomy	O
.	O

Histologic	O
tumor	O
type	O
:	O
Pheochromocytoma	O
.	O

Tumor	O
size	O
(	O
greatest	O
dimension	O
)	O
:	O
3	B
.	I
4	I
cm	I
,	O
gross	O
measurement	O
.	O

Tumor	O
gland	O
weight	O
:	O
Estimated	O
18	O
g	O
(	O
estimated	O
,	O
see	O
comment	O
)	O
.	O

Specimen	O
integrity	O
:	O
Disrupted	O
.	O

Specimen	O
size	O
:	O
119	O
g	O
,	O
13	O
X	O
7	O
X	O
4	O
cm	O
.	O

Specimen	O
laterality	O
:	O
Left	O
.	O

Invasive	O
properties	O
:	O
Capsule	O
:	O
Not	O
identified	O
.	O

Extra	O
-	O
adrenal	O
tissues	O
:	O
Not	O
identified	O
.	O

Lymphovascular	O
:	O
Not	O
identified	O
.	O

Blood	O
vascular	O
:	O
Not	O
identified	O
.	O

Histologic	O
assessment	O
of	O
surgical	O
margins	O
:	O
Not	O
involved	O
by	O
tumor	O
.	O

Status	O
of	O
adrenal	O
gland	O
away	O
from	O
tumor	O
:	O
Unremarkable	O
.	O

Lymph	O
nodes	O
:	O
Number	O
of	O
lymph	O
nodes	O
involved	O
:	O
N	O
/	O
A	O
.	O

Number	O
of	O
lymph	O
nodes	O
examined	O
:	O
0	O
.	O

Comment	O
:	O
Immunohistochemical	O
staining	O
for	O
Ki	O
-	O
67	O
-	O
revealed	O
a	O
labelling	O
.	O
index	O
of	O
<	O
1	O
%	O
.	O

Tumor	O
gland	O
mass	O
is	O
estimated	O
.	O

Precise	O
measurement	O
was	O
not	O
.	O
possible	O
without	O
disrupting	O
margins	O
.	O

Estimated	O
tumor	O
mass	O
is	O
.	O
approximately	O
7	O
g	O
.	O

Clinical	O
History	O
.	O
year	O
-	O
old	O
male	O
with	O
an	O
adrenal	O
mass	O
.	O

Per	O
.	O

he	O
has	O
a	O
3	O
.	O
5	O
.	O

cm	O
mass	O
in	O
the	O
left	O
adrenal	O
gland	O
.	O

Urine	O
and	O
serum	O
metanephrines	O
.	O
are	O
both	O
elevated	O
,	O
consistent	O
with	O
a	O
clinical	O
diagnosis	O
of	O
.	O
pheochromocytoma	O
.	O

Gross	O
Description	O
:	O
Received	O
is	O
one	O
appropriately	O
labeled	O
container	O
,	O
additionally	O
.	O
labeled	O
"	O
adrenals	O
.	O
'	O
.	O

Specimen	O
fixation	O
:	O
formalin	O
.	O

Type	O
of	O
specimen	O
:	O
adrenalectomy	O
.	O

Size	O
and	O
weight	O
of	O
specimen	O
:	O
Overall	O
:	O
119	O
.	O
4	O
grams	O
,	O
13	O
X	O
7	O
X	O
4	O
.	O

cm	O
;	O
Adrenal	O
gland	O
7	O
.	O
6	O
X	O
4	O
.	O
0	O
X	O
1	O
.	O
8	O
cm	O
.	O

The	O
adrenal	O
represents	O
.	O
approximately	O
15	O
%	O
of	O
the	O
entire	O
mass	O
of	O
the	O
specimen	O
.	O

Structures	O
attached	O
to	O
adrenal	O
gland	O
,	O
if	O
applicable	O
:	O
periadrenal	O
.	O
adipose	O
tissue	O
.	O

Orientation	O
:	O
The	O
specimen	O
is	O
received	O
markedly	O
disrupted	O
with	O
.	O
the	O
periadrenal	O
adipose	O
tissue	O
absent	O
over	O
a	O
3	O
.	O
0	O
X	O
1	O
.	O
5	O
cm	O
area	O
.	O

The	O
adrenal	O
gland	O
underlying	O
this	O
region	O
has	O
a	O
2	O
.	O
6	O
cm	O
linear	O
.	O
disruption	O
which	O
has	O
been	O
sutured	O
closed	O
.	O

The	O
periadrenal	O
.	O
adipose	O
tissue	O
and	O
exposed	O
adrenal	O
gland	O
are	O
inked	O
blue	O
on	O
the	O
.	O
side	O
of	O
this	O
disruption	O
.	O

The	O
periadrenal	O
adipose	O
tissue	O
is	O
.	O
inked	O
black	O
on	O
the	O
non	O
-	O
disrupted	O
side	O
.	O

However	O
,	O
given	O
the	O
.	O
disruption	O
,	O
themarginal	O
tissue	O
is	O
poorly	O
adherent	O
to	O
the	O
adrenal	O
.	O
gland	O
,	O
compromising	O
assessment	O
of	O
margins	O
.	O

Tumor	O
description	O
:	O
brown	O
,	O
well	O
circumscribed	O
and	O
grossly	O
.	O
necrotic	O
,	O
emerging	O
from	O
and	O
restricted	O
to	O
the	O
medulla	O
.	O

Tumor	O
weight	O
:	O
Tumor	O
,	O
immediately	O
adjacent	O
normal	O
adrenal	O
gland	O
.	O
and	O
immediately	O
adjacent	O
periadrenal	O
adipose	O
tissue	O
weighs	O
.	O

14	O
.	O

6	O
grams	O
(	O
after	O
removal	O
of	O
distant	O
adrenal	O
gland	O
and	O
non	O
-	O
.	O
marginal	O
periadrenal	O
adipose	O
tissue	O
.	O
Tumor	O
represents	O
.	O
approximately	O
50	O
%	O
of	O
the	O
mass	O
of	O
this	O
tissue	O
)	O
.	O

Tumor	O
size	O
:	O
3	B
.	I
4	I
X	I
2	I
.	I
0	I
X	I
1	I
.	I
6	I
cm	I
.	O

Confinement	O
/	O
Non	O
-	O
confinement	O
to	O
the	O
adrenal	O
gland	O
:	O
Grossly	O
.	O
appears	O
confined	O
,	O
however	O
,	O
disruption	O
of	O
the	O
surgical	O
margins	O
.	O
comprises	O
assessment	O
of	O
confinement	O
.	O

Distance	O
of	O
tumor	O
from	O
surgical	O
margins	O
:	O
1	O
mm	O
to	O
the	O
closest	O
.	O
black	O
inked	O
periadrenal	O
resection	O
margin	O
(	O
non	O
-	O
disrupted	O
side	O
)	O
i	O
.	O
less	O
than	O
1	O
mm	O
to	O
the	O
closest	O
blue	O
inked	O
periadrenal	O
resection	O
.	O
margin	O
(	O
disrupted	O
side	O
)	O
.	O

Appearance	O
of	O
adrenal	O
gland	O
away	O
from	O
tumor	O
:	O
Golden	O
yellow	O
/	O
tan	O
.	O
cortex	O
,	O
ranging	O
in	O
thickness	O
from	O
less	O
than	O
1	O
mm	O
to	O
1	O
mm	O
,	O
with	O
a	O
.	O
brown	O
central	O
medulla	O
.	O

No	O
additional	O
masses	O
or	O
hemorrhage	O
.	O

Lymph	O
nodes	O
:	O
none	O
identified	O
.	O

Tissue	O
submitted	O
for	O
special	O
investigations	O
Tumor	O
is	O
submitted	O
.	O
to	O
Tissue	O
Procurement	O
.	O

Digital	O
photograph	O
taken	O
:	O
not	O
taken	O
.	O

Block	O
summary	O
:	O
(	O
Inking	O
:	O
olack	O
=	O
non	O
-	O
disrupted	O
side	O
,	O
blue	O
=	O
disrupted	O
side	O
)	O
.	O

A1	O
-	O
A10	O
-	O
mass	O
,	O
entirely	O
submitted	O
;	O
Closest	O
blue	O
inked	O
margin	O
in	O
.	O

A3	O
;	O
closest	O
black	O
inked	O
margin	O
in	O
A6	O
.	O

A11	O
-	O
A12	O
-	O
representative	O
sections	O
of	O
uninvolved	O
adrenal	O
gland	O
.	O

Uninvolved	O
adrenal	O
and	O
periadrenal	O
adipose	O
remains	O
in	O
formalin	O
.	O

-DOCSTART-225
Component	O
.	O

Type	O
of	O
.	O

Histological	O
.	O
of	O
treatment	O
.	O

Tissue	O
.	O

Clinical	O
.	O

Tumor	O
.	O

Specimen	O
.	O

Specimen	O
.	O

Number	O
of	O
.	O

Amount	O
/	O
per	O
.	O

Grade	O
.	O

TNM	O
Stage	O
.	O

TNM	O
Stage	O
.	O

TNM	O
Stage	O
.	O

Treatment	O
.	O

Tumor	O
cell	O
.	O

Clinical	O
.	O

Specimen	O
.	O

Specificati	O
.	O

Container	O
.	O

Procurem	O
.	O
description	O
.	O

(	O
Chemo	O
.	O
Ethrucity	O
.	O
Anatomical	O
Site	O
.	O
Index	O
.	O
(	O
Race	O
)	O
.	O
Diagnosis	O
.	O
Matrix	O
.	O
containera	O
.	O
container	O
.	O
(	O
source	O
)	O
.	O
(	O
T	O
)	O
.	O
(	O
N	O
)	O
.	O
(	O
M	O
)	O
.	O
type	O
.	O
%	O
.	O
Format	O
.	O
Site	O
#	O
.	O
(	O
Source	O
)	O
.	O
Horm	O
Th	O
.	O
label	O
.	O
on	O
.	O
ent	O
.	O
Details	O
)	O
.	O

4	O
.	O

0	O
.	O

0	O
.	O
none	O
.	O

n	O
/	O
a	O
.	O

75	O
.	O

Caucasian	O
.	O

Male	O
.	O

Melanoma	O
.	O

Skin	O
.	O

Primary	O
.	O

Tumor	O
.	O

Tissue	O
.	O

OCT	O
.	O
block	O
.	O

1	O
.	O

200	O
.	O

mg	O
.	O

Melanoma	O
.	O

n	O
/	O
a	O
.	O

(	O
White	O
)	O
.	O
blood	O
.	O

Caucasian	O
.	O

Male	O
.	O

Melanoma	O
.	O

Blood	O
.	O

n	O
/	O
a	O
.	O

Normal	O
.	O

Blood	O
.	O
frozen	O
.	O

tube	O
.	O

1	O
.	O

4	O
.	O

ml	O
.	O

n	O
/	O
a	O
.	O

n	O
/	O
a	O
.	O

n	O
/	O
a	O
.	O

n	O
/	O
a	O
.	O

n	O
/	O
a	O
.	O
none	O
.	O

n	O
/	O
a	O
.	O

n	O
/	O
a	O
.	O
draw	O
.	O

(	O
White	O
)	O
.	O

Criteria	O
.	O

-DOCSTART-226
This	O
information	O
is	O
subject	O
to	O
all	O
Federal	O
and	O
State	O
laws	O
regarding	O
confidentiality	O
and	O
privacy	O
and	O
to	O
the	O
policies	O
and	O
procedures	O
.	O
regarding	O
patient	O
information	O
.	O

Any	O
unauthorized	O
use	O
,	O
disclosure	O
.	O
or	O
reproduction	O
of	O
this	O
information	O
is	O
strictly	O
prohibited	O
.	O

Anat	O
Path	O
Reports	O
.	O

Anat	O
Path	O
Reports	O
.	O

Document	O
Date	O
:	O
Modified	O
.	O

Histology	O
.	O

Document	O
Contains	O
Addenda	O
.	O

APRPT	O
(	O
Verified	O
)	O
.	O

Acc	O
#	O
:	O
Pulmonary	O
Big	O
.	O

F	O
.	O

Client	O
:	O
Submitting	O
.	O

Phys	O
:	O
Amended	O
Surgical	O
Pathology	O
Report	O
.	O

ADDENDUM	O
PRESENT	O
.	O

Addendum	O
Diagnosis	O
.	O

Lung	O
,	O
Right	O
Upper	O
Lobe	O
,	O
EGFR	O
Analysis	O
(	O
block	O
.	O
NEGATIVE	O
for	O
detectable	O
EGFR	O
alteration	O
.	O
Addendum	O
Comment	O
.	O
For	O
the	O
complete	O
report	O
from	O
.	O
please	O
refer	O
to	O
the	O
.	O
section	O
of	O
the	O
lab	O
result	O
flowsheet	O
.	O
in	O
the	O
.	O
This	O
analysis	O
was	O
performed	O
by	O
.	O
)	O
and	O
was	O
not	O
performed	O
at	O
.	O

The	O
results	O
are	O
being	O
reported	O
here	O
for	O
.	O
convenience	O
and	O
as	O
supplemental	O
information	O
only	O
.	O

The	O
final	O
diagnosis	O
as	O
reported	O
below	O
remains	O
unchanged	O
.	O

This	O
information	O
is	O
subject	O
to	O
all	O
Federal	O
and	O
State	O
laws	O
regarding	O
confidentiality	O
and	O
privacy	O
and	O
to	O
the	O
policies	O
and	O
procedures	O
.	O
regarding	O
patient	O
information	O
.	O

Any	O
unauthorized	O
use	O
.	O
disclosurc	O
.	O
or	O
reproduction	O
of	O
this	O
information	O
is	O
strictly	O
prohibited	O
.	O

Anat	O
Path	O
Reports	O
.	O

Final	O
Pathologic	O
Diagnosis	O
.	O

A	O
.	O

LYMPH	O
NODE	O
,	O
R10	O
/	O
SUMP	O
,	O
EXCISION	O
,	O
A1FS	O
:	O
-	O
METASTATIC	O
CARCINOMA	O
INVOLVING	O
ONE	O
OF	O
ONE	O
LYMPH	O
NODE	O
(	O
1	O
/	O
1	O
)	O
.	O

B	O
.	O

LUNG	O
,	O
RIGHT	O
UPPER	O
LOBE	O
,	O
LOBECTOMY	O
:	O
ADENOCARCINOMA	O
,	O
PREDOMINANTLY	O
MICROPAPILLARY	O
PATTERN	O
WITH	O
LESSER	O
PROPORTIONS	O
OF	O
.	O

ACINAR	O
AND	O
LEPIDIC	O
(	O
AKA	O
BAC	O
)	O
PATTERNS	O
OF	O
GROWTH	O
.	O

-	O
THE	O
TUMOR	O
IS	O
MODERATELY	O
DIFFERENTIATED	O
AND	O
MEASURES	O
6	B
X	I
5	I
.	I
1	I
X	I
4	I
.	I
1	I
CM	I
.	O

-	O
LYMPHOVASCULAR	O
INVASION	O
IS	O
IDENTIFIED	O
.	O

-	O
NO	O
PERINEURAL	O
INVASION	O
IS	O
IDENTIFIED	O
.	O

-	O
NO	O
VISCERAL	O
PLEURAL	O
INVASION	O
IS	O
IDENTIFIED	O
(	O
CONFIRMED	O
WITH	O
AN	O
ELASTIC	O
STAIN	O
)	O
.	O

-	O
BRONCHIAL	O
AND	O
VASCULAR	O
MARGINS	O
ARE	O
NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

-	O
THE	O
UNINVOLVED	O
LUNG	O
PARENCHYMA	O
SHOWS	O
NO	O
SIGNIFICANT	O
PATHOLOGIC	O
CHANGES	O
.	O

-	O
TWO	O
PERIBRONCHIAL	O
LYMPH	O
NODES	O
ARE	O
NEGATIVE	O
FOR	O
CARCINOMA	O
(	O
0	O
/	O
2	O
)	O
.	O

-	O
SEE	O
SYNOPTIC	O
.	O

C	O
.	O

LYMPH	O
NODES	O
,	O
RIGHT	O
10	O
SUMP	O
,	O
EXCISION	O
:	O
-	O
METASTATIC	O
CARCINOMA	O
INVOLVING	O
TWO	O
OF	O
TWO	O
LYMPH	O
NODES	O
(	O
2	O
/	O
2	O
)	O
.	O

D	O
.	O

LYMPH	O
NODES	O
,	O
LEVEL	O
4	O
,	O
EXCISION	O
:	O
-	O
METASTATIC	O
CARCINOMA	O
INVOLVING	O
FIVE	O
OF	O
FIVE	O
LYMPH	O
NODES	O
(	O
5	O
/	O
5	O
)	O
.	O

E	O
.	O

LYMPH	O
NODES	O
,	O
4R	O
,	O
EXCISION	O
:	O
-	O
ONE	O
LYMPH	O
NODE	O
IS	O
NEGATIVE	O
FOR	O
CARCINOMA	O
(	O
0	O
/	O
1	O
)	O
.	O

F	O
.	O

LYMPH	O
NODES	O
,	O
R7	O
,	O
EXCISION	O
:	O
-	O
ONE	O
LYMPH	O
NODE	O
NEGATIVE	O
FOR	O
CARCINOMA	O
(	O
0	O
/	O
1	O
)	O
.	O

G	O
.	O

LUNG	O
,	O
RIGHT	O
LOWER	O
LOBE	O
,	O
WEDGE	O
RESECTION	O
:	O
-	O
BENIGN	O
LUNG	O
TISSUE	O
WITH	O
MILD	O
EMPHYSEMATOUS	O
CHANGES	O
.	O

Comment	O
.	O

Per	O
.	O
both	O
parts	O
D	O
and	O
G	O
are	O
from	O
the	O
RIGHT	O
side	O
.	O

This	O
information	O
is	O
subject	O
to	O
all	O
Federal	O
and	O
State	O
laws	O
regarding	O
confidentiality	O
and	O
privacy	O
and	O
to	O
the	O
policies	O
and	O
procedures	O
.	O
regarding	O
patient	O
information	O
Any	O
unauthorized	O
use	O
.	O
disclosure	O
,	O
or	O
reproduction	O
of	O
this	O
information	O
is	O
strictly	O
prohibited	O
.	O

Anat	O
Path	O
Reports	O
.	O

Addendum	O
/	O
Signed	O
Out	O
.	O

Amendments	O
.	O

Reason	O
:	O
Wrong	O
Site	O
by	O
MD	O
.	O

Synoptic	O
Worksheet	O
.	O

B	O
.	O

Right	O
upper	O
lobe	O
,	O
bronchus	O
is	O
marked	O
with	O
stitch	O
:	O
Specimen	O
:	O
Lobe	O
(	O
s	O
)	O
of	O
lung	O
:	O
RIGHT	O
UPPER	O
LOBE	O
.	O

Procedure	O
:	O
Lobectomy	O
.	O

Specimen	O
Integrity	O
:	O
Intact	O
.	O

Specimen	O
Laterality	O
:	O
Right	O
.	O

Tumor	O
Site	O
:	O
Upper	O
lobe	O
.	O

Tumor	O
Focality	O
:	O
Unifocal	O
.	O

Histologic	O
Type	O
:	O
Adenocarcinoma	O
,	O
mixed	O
subtype	O
.	O

Histologic	O
Grade	O
:	O
G2	O
:	O
Moderately	O
differentiated	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
dimension	O
:	O
6	B
.	I
0	I
cm	I
.	O

Additional	O
dimension	O
:	O
5	B
.	I
1	I
cm	I
.	O

Additional	O
dimension	O
:	O
4	B
.	I
1	I
cm	I
.	O

Visceral	O
Pleura	O
Invasion	O
:	O
Not	O
identified	O
.	O

Tumor	O
Extension	O
:	O
Not	O
applicable	O
.	O

Bronchial	O
Margin	O
:	O
Uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

Involvement	O
by	O
squamous	O
cell	O
carcinoma	O
in	O
situ	O
(	O
CIS	O
)	O
not	O
applicable	O
.	O

Vascular	O
Margin	O
:	O
Uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

Parenchymal	O
Margin	O
:	O
Not	O
applicable	O
.	O

Parietal	O
Pleural	O
Margin	O
:	O
Not	O
applicable	O
.	O

Chest	O
Wall	O
Margin	O
:	O
Not	O
applicable	O
.	O

Other	O
Attached	O
Tissue	O
Margin	O
:	O
Not	O
applicable	O
.	O

All	O
Margins	O
Uninvolved	O
By	O
Invasive	O
Carcinoma	O
:	O
Distance	O
of	O
invasive	O
carcinoma	O
from	O
closest	O
margin	O
:	O
10	O
mm	O
.	O

Margin	O
closest	O
to	O
invasive	O
carcinoma	O
:	O
:	O
bronchial	O
.	O

Treatment	O
Effect	O
:	O
Not	O
applicable	O
.	O

Lymph	O
-	O
Vascular	O
Invasion	O
:	O
Present	O
.	O

Extranodal	O
Extension	O
:	O
Not	O
identified	O
.	O

TNM	O
Descriptors	O
:	O
Not	O
applicable	O
.	O

Primary	O
Tumor	O
(	O
pT	O
)	O
:	O
pT2b	O
:	O
Tumor	O
greater	O
than	O
5	O
cm	O
,	O
but	O
7	O
cm	O
or	O
less	O
in	O
greatest	O
dimension	O
.	O

Regional	O
Lymph	O
Nodes	O
(	O
pN	O
)	O
:	O
pN2	O
:	O
Metastasis	O
in	O
lipsilateral	O
mediastinal	O
and	O
/	O
or	O
subcarinal	O
lymph	O
node	O
(	O
s	O
)	O
.	O

Nodes	O
examined	O
:	O
12	O
.	O

Nodes	O
involved	O
:	O
8	O
.	O

Distant	O
Metastasis	O
(	O
pM	O
)	O
:	O
Not	O
applicable	O
.	O

This	O
information	O
is	O
subject	O
to	O
all	O
Federal	O
and	O
State	O
laws	O
regarding	O
confidentiality	O
and	O
privacy	O
and	O
to	O
the	O
policies	O
and	O
procedures	O
.	O
regarding	O
patient	O
information	O
.	O

Any	O
unauthorized	O
use	O
,	O
disclosure	O
.	O
or	O
reproduction	O
of	O
this	O
information	O
is	O
strictly	O
prohibited	O
.	O

Anat	O
Path	O
Reports	O
.	O

Clinical	O
History	O
.	O

Right	O
VATS	O
,	O
lobectomy	O
.	O

Right	O
upper	O
lobe	O
lung	O
mass	O
.	O

Specimen	O
(	O
s	O
)	O
Received	O
.	O

A	O
:	O
R10	O
lymph	O
node	O
/	O
sump	O
lymph	O
node	O
.	O

B	O
:	O
Right	O
upper	O
lobe	O
,	O
bronchus	O
is	O
marked	O
with	O
stitch	O
.	O

C	O
:	O
R10	O
sump	O
lymph	O
node	O
.	O

D	O
:	O
Level	O
4	O
lymph	O
node	O
.	O

E	O
:	O
4R	O
lymph	O
node	O
.	O

F	O
:	O
R7	O
lymph	O
node	O
.	O

G	O
:	O
Right	O
lower	O
lobe	O
wedge	O
.	O

Gross	O
Description	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
for	O
intraoperative	O
consultation	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
medical	O
record	O
number	O
and	O
.	O
designated	O
"	O
R10	O
/	O
sump	O
lymph	O
node	O
.	O
"	O
It	O
consists	O
of	O
a	O
single	O
lymph	O
node	O
measuring	O
1	O
.	O
8	O
x	O
1	O
.	O
1	O
x	O
0	O
.	O
8	O
cm	O
.	O

The	O
lymph	O
node	O
is	O
.	O
submitted	O
entirely	O
for	O
frozen	O
section	O
diagnosis	O
in	O
cassette	O
"	O
A1FS	O
.	O
"	O
A	O
touch	O
prep	O
is	O
performed	O
.	O

Dictated	O
by	O
.	O

Specimen	O
B	O
is	O
received	O
fresh	O
in	O
a	O
container	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
medical	O
record	O
number	O
and	O
as	O
"	O
FS3	O
right	O
upper	O
.	O
lobe	O
.	O
"	O
The	O
specimen	O
consists	O
of	O
a	O
lobe	O
of	O
lung	O
measuring	O
13	O
.	O
8	O
x	O
9	O
.	O
5	O
x	O
4	O
.	O
5	O
cm	O
and	O
weighing	O
160	O
grams	O
.	O

Multiple	O
stapled	O
.	O
margins	O
are	O
present	O
on	O
the	O
specimen	O
and	O
a	O
stitch	O
is	O
present	O
for	O
orientation	O
.	O

Multifocally	O
abutting	O
the	O
pleura	O
is	O
a	O
multilobulated	O
.	O
firm	O
partly	O
mucoid	O
mass	O
measuring	O
6	O
.	O
0	O
x	O
5	O
.	O
1	O
x	O
4	O
.	O
1	O
cm	O
.	O

This	O
mass	O
extends	O
to	O
the	O
stapled	O
parenchymal	O
margin	O
of	O
resection	O
and	O
.	O
extends	O
to	O
within	O
1	O
.	O
0	O
cm	O
of	O
the	O
bronchial	O
and	O
vascular	O
margins	O
of	O
resection	O
.	O

The	O
lung	O
adjacent	O
to	O
and	O
distal	O
to	O
this	O
mass	O
.	O
appears	O
slightly	O
mottled	O
.	O

No	O
other	O
lesions	O
are	O
identified	O
within	O
the	O
lung	O
.	O

Tissue	O
is	O
submitted	O
for	O
Tumor	O
Bank	O
.	O

The	O
pleural	O
.	O
overlying	O
the	O
mass	O
is	O
inked	O
black	O
and	O
the	O
parenchymal	O
margin	O
of	O
resection	O
is	O
inked	O
blue	O
after	O
removal	O
of	O
the	O
staple	O
line	O
.	O

The	O
.	O
bronchial	O
margin	O
is	O
shaved	O
and	O
submitted	O
for	O
frozen	O
section	O
diagnosis	O
in	O
cassette	O
"	O
B1FS	O
.	O
"	O
Representative	O
sections	O
of	O
the	O
.	O
remainder	O
of	O
the	O
specimen	O
are	O
submitted	O
as	O
stated	O
below	O
.	O

Dictated	O
by	O
.	O

Specimen	O
C	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
medical	O
record	O
number	O
and	O
as	O
"	O
right	O
10	O
sump	O
lymph	O
node	O
.	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
multiple	O
fragments	O
of	O
dark	O
colored	O
soft	O
tissue	O
measuring	O
in	O
aggregate	O
,	O
0	O
.	O
7	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
cm	O
.	O

The	O
.	O
specimen	O
is	O
submitted	O
entirely	O
in	O
lens	O
paper	O
in	O
cassette	O
"	O
C1	O
.	O
"	O
Dictated	O
by	O
.	O

Specimen	O
D	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
medical	O
record	O
number	O
and	O
as	O
"	O
level	O
4	O
lymph	O
node	O
(	O
per	O
.	O
specimen	O
is	O
from	O
the	O
right	O
side	O
)	O
.	O
"	O
The	O
specimen	O
consists	O
of	O
multiple	O
fragments	O
of	O
fibroadipose	O
tissue	O
measuring	O
in	O
.	O
aggregate	O
,	O
4	O
.	O
2	O
x	O
2	O
.	O
9	O
x	O
0	O
.	O
5	O
cm	O
.	O

Multiple	O
lymph	O
nodes	O
are	O
identified	O
in	O
the	O
specimen	O
ranging	O
in	O
size	O
from	O
0	O
.	O
3	O
to	O
1	O
.	O
7	O
cm	O
.	O

The	O
.	O
specimen	O
is	O
submitted	O
as	O
stated	O
below	O
.	O

Dictated	O
by	O
.	O

Specimen	O
E	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
medical	O
record	O
number	O
and	O
as	O
"	O
4R	O
lymph	O
node	O
.	O
"	O
The	O
.	O
specimen	O
consists	O
of	O
a	O
single	O
lymph	O
node	O
measuring	O
1	O
.	O
2	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
specimen	O
is	O
bisected	O
and	O
submitted	O
entirely	O
in	O
.	O
cassette	O
"	O
E1	O
.	O
"	O
Dictated	O
by	O
Dr	O
.	O
Specimen	O
F	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
medical	O
record	O
number	O
and	O
as	O
"	O
R7	O
lymph	O
node	O
.	O
"	O
The	O
.	O
specimen	O
consists	O
of	O
a	O
single	O
fragment	O
of	O
soft	O
tissue	O
measuring	O
0	O
.	O
9	O
x	O
0	O
.	O
6	O
x	O
0	O
,	O
4	O
cm	O
.	O

The	O
specimen	O
is	O
submitted	O
entirely	O
in	O
.	O
cassette	O
"	O
F1	O
.	O
"	O
Dictated	O
by	O
Dr	O
.	O
This	O
information	O
is	O
subject	O
to	O
all	O
Federal	O
and	O
State	O
laws	O
regarding	O
confidentiality	O
and	O
privacy	O
and	O
to	O
the	O
policies	O
and	O
procedures	O
.	O
regarding	O
patient	O
information	O
.	O

Any	O
unauthorized	O
use	O
,	O
disclosure	O
,	O
or	O
reproduction	O
of	O
this	O
information	O
is	O
strictly	O
prohibited	O
.	O

Anat	O
Path	O
Reports	O
.	O

Specimen	O
G	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
medical	O
record	O
number	O
and	O
as	O
"	O
right	O
lower	O
lobe	O
wedge	O
.	O

(	O
per	O
.	O
this	O
specimen	O
is	O
from	O
the	O
right	O
side	O
)	O
"	O
The	O
specimen	O
consists	O
of	O
a	O
wedge	O
of	O
lung	O
measuring	O
5	O
.	O
8	O
x	O
2	O
.	O
6	O
x	O
1	O
.	O
8	O
cm	O
.	O

There	O
are	O
two	O
intersecting	O
staple	O
lines	O
on	O
the	O
specimen	O
,	O
one	O
measuring	O
5	O
.	O
5	O
cm	O
,	O
the	O
other	O
measuring	O
2	O
.	O
8	O
cm	O
.	O

There	O
is	O
a	O
0	O
.	O
7	O
cm	O
.	O
crescent	O
shaped	O
defect	O
in	O
the	O
serosa	O
,	O
and	O
the	O
serosa	O
is	O
otherwise	O
unremarkable	O
.	O

No	O
lesions	O
are	O
identified	O
in	O
the	O
lung	O
.	O
parenchyma	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
cassettes	O
"	O
G1	O
"	O
through	O
"	O
G3	O
.	O
"	O
Dictated	O
by	O
Dr	O
.	O
CASSETTE	O
SUMMARY	O
:	O
A1FS	O
:	O
One	O
lymph	O
node	O
,	O
bisected	O
.	O

B1FS	O
:	O
Bronchial	O
margin	O
.	O

B2	O
:	O
Vascular	O
margins	O
.	O

B3	O
:	O
Three	O
possible	O
parabronchial	O
lymph	O
nodes	O
submitted	O
whole	O
.	O

B4	O
:	O
Representative	O
mucoid	O
mass	O
.	O

B5	O
:	O
Mass	O
and	O
parenchymal	O
margin	O
of	O
resection	O
.	O

B6	O
:	O
Mass	O
and	O
pleura	O
.	O

B7	O
:	O
Mass	O
,	O
pleura	O
and	O
surrounding	O
lung	O
.	O

B8	O
:	O
Mass	O
and	O
surrounding	O
lung	O
.	O

B9	O
:	O
Mass	O
and	O
segmental	O
bronchus	O
.	O

B10	O
:	O
Lung	O
parenchyma	O
distant	O
from	O
mass	O
.	O

D1	O
:	O
One	O
lymph	O
node	O
,	O
trisected	O
.	O

D2	O
:	O
One	O
lymph	O
node	O
,	O
bisected	O
.	O

D3	O
:	O
Three	O
lymph	O
nodes	O
,	O
submitted	O
whole	O
.	O

Intraoperative	O
Consult	O
Diagnosis	O
.	O

A1FS	O
,	O
A1TP	O
:	O
R10	O
LYMPH	O
NODE	O
/	O
SUMP	O
LYMPH	O
NODE	O
(	O
FROZEN	O
SECTION	O
AND	O
TOUCH	O
PREPARATION	O
)	O
:	O
LYMPH	O
.	O

NODE	O
.	O

WITH	O
METASTATIC	O
ADENOCARCINOMA	O
.	O

Frozen	O
section	O
results	O
were	O
communicated	O
to	O
the	O
surgical	O
team	O
and	O
were	O
repeated	O
back	O
by	O
.	O

on	O
.	O

B1FS	O
:	O
RIGHT	O
UPPER	O
LOBE	O
(	O
FROZEN	O
SECTION	O
)	O
:	O
BRONCHIAL	O
MARGIN	O
IS	O
BENIGN	O
.	O

Frozen	O
section	O
results	O
were	O
communicated	O
to	O
the	O
surgical	O
team	O
and	O
were	O
repeated	O
back	O
by	O
-	O
.	O

on	O
.	O

Microscopic	O
Description	O
.	O

Microscopic	O
examination	O
performed	O
.	O

This	O
information	O
is	O
subject	O
to	O
all	O
Federal	O
and	O
State	O
laws	O
regarding	O
confidentiality	O
and	O
privacy	O
and	O
to	O
the	O
policies	O
and	O
procedures	O
.	O
regarding	O
patient	O
information	O
Any	O
unauthorized	O
use	O
,	O
disclosure	O
,	O
or	O
reproduction	O
of	O
this	O
information	O
is	O
strictly	O
prohibited	O
.	O

Anat	O
Path	O
Reports	O
.	O

-DOCSTART-227
Clinical	O
History	O
/	O
Diagnosis	O
:	O
Left	O
Renal	O
Mass	O
.	O

Source	O
of	O
Specimen	O
(	O
s	O
)	O
:	O
Left	O
Kidney	O
resection	O
with	O
Adrenal	O
gland	O
.	O

Gross	O
Description	O
:	O
Received	O
in	O
one	O
part	O
.	O

Source	O
of	O
Tissue	O
:	O
1	O
.	O

Labeled	O
#	O
1	O
,	O
"	O
left	O
kidney	O
and	O
adrenal	O
"	O
.	O

Gross	O
Description	O
:	O
Received	O
fresh	O
labeled	O
,	O
.	O
left	O
kidney	O
and	O
adrenal	O
"	O
.	O

It	O
consists	O
of	O
a	O
kidney	O
with	O
surrounding	O
.	O
perinephric	O
fat	O
weighing	O
a	O
total	O
of	O
844	O
grams	O
and	O
measuring	O
22	O
x	O
16	O
X	O
8	O
.	O
5	O
.	O

cm	O
.	O

The	O
attached	O
ureter	O
measures	O
9	O
.	O
5	O
cm	O
in	O
length	O
and	O
0	O
.	O
3	O
cm	O
in	O
.	O
diameter	O
.	O

The	O
ureter	O
is	O
opened	O
to	O
show	O
a	O
smooth	O
tan	O
-	O
pink	O
mucosa	O
with	O
no	O
.	O
papillary	O
structures	O
noted	O
.	O

The	O
specimen	O
is	O
bisected	O
to	O
show	O
a	O
10	O
.	O
5	O
X	O
6	O
.	O
5	O
.	O

x	O
4	O
cm	O
kidney	O
.	O

A	O
well	O
-	O
demarcated	O
,	O
golden	O
-	O
yellow	O
firm	O
3	O
.	O
5	O
x	O
3	O
x	O
3	O
cm	O
.	O
nodule	O
is	O
identified	O
at	O
the	O
superior	O
pole	O
and	O
comes	O
within	O
less	O
than	O
0	O
.	O
1	O
.	O

cm	O
of	O
the	O
renal	O
capsule	O
.	O

Grossly	O
the	O
tumor	O
appears	O
confined	O
to	O
the	O
kidney	O
.	O
and	O
does	O
not	O
appear	O
to	O
infiltrate	O
the	O
surrounding	O
perinephric	O
fat	O
.	O

The	O
.	O
remaining	O
renal	O
parenchyma	O
is	O
tan	O
-	O
pink	O
,	O
soft	O
with	O
no	O
other	O
discrete	O
masses	O
.	O
present	O
.	O

The	O
attached	O
adrenal	O
measures	O
4	O
.	O
5	O
x	O
2	O
.	O
5	O
x	O
2	O
cm	O
.	O

The	O
adrenal	O
is	O
.	O
sectioned	O
to	O
show	O
a	O
soft	O
golden	O
-	O
yellow	O
cut	O
surface	O
.	O

No	O
obvious	O
discrete	O
.	O
masses	O
are	O
present	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
1A	O
-	O
1F	O
.	O

Designation	O
of	O
Sections	O
:	O
1A	O
-	O
ureteral	O
and	O
vascular	O
margins	O
,	O
1B	O
-	O
1C	O
-	O
tumor	O
.	O
with	O
closest	O
radial	O
margin	O
inked	O
blue	O
,	O
1D	O
-	O
1E	O
-	O
tumor	O
with	O
adjacent	O
normal	O
.	O
kidney	O
,	O
1F	O
-	O
adrenal	O
gland	O
.	O

Final	O
Diagnosis	O
:	O
Left	O
kidney	O
and	O
adrenal	O
:	O
Renal	O
cell	O
-	O
carcinoma	O
,	O
conventional	O
(	O
clear	O
cell	O
)	O
type	O
,	O
.	O
nuclear	O
.	O

grade	O
II	O
/	O
IV	O
.	O

The	O
3	B
.	I
5	I
cm	I
carcinoma	O
is	O
confined	O
to	O
the	O
kidney	O
.	O

Angiolymphatic	O
invasion	O
is	O
not	O
identified	O
.	O

-	O
Surgical	O
resection	O
margins	O
are	O
free	O
of	O
carcinoma	O
.	O

Adrenal	O
gland	O
with	O
no	O
diagnostic	O
abnormalities	O
recognized	O
.	O

pTNM	O
:	O
T1a	O
Nx	O
Mx	O
.	O

FCGTL	O
:	O
Chromo15	O
,	O
Chrom45	O
,	O
Interp	O
.	O

Procedures	O
/	O
Addenda	O
.	O

FC	O
Cytogenetics	O
Solid	O
.	O

Results	O
-	O
Comments	O
.	O

CYTOGENETIC	O
ANALYSIS	O
REPORTS	O
.	O

DIAGNOSIS	O
:	O
Left	O
Renal	O
Mass	O
.	O

KARYOTYPE	O
:	O
Normal	O
.	O
karyotype	O
:	O
46	O
,	O
XY	O
[	O
18	O
]	O
.	O

Two	O
additional	O
cells	O
had	O
nonclonal	O
changes	O
.	O

One	O
metaphase	O
contained	O
an	O
.	O
extra	O
copy	O
of	O
chromosome	O
14	O
.	O

Another	O
metaphase	O
was	O
a	O
broken	O
tetraploid	O
.	O
cell	O
.	O

RESULTS	O
:	O
The	O
renal	O
mass	O
was	O
harvested	O
after	O
twelve	O
and	O
fourteen	O
days	O
in	O
.	O
culture	O
.	O

The	O
chromosomes	O
from	O
twenty	O
metaphases	O
were	O
counted	O
and	O
.	O
analyzed	O
,	O
and	O
four	O
of	O
these	O
metaphases	O
were	O
karyotyped	O
by	O
G	O
-	O
banding	O
.	O

Eighteen	O
cells	O
had	O
a	O
modal	O
chromosome	O
number	O
of	O
46	O
and	O
appeared	O
to	O
have	O
a	O
.	O
normal	O
karyotype	O
.	O

Two	O
cells	O
had	O
nonclonal	O
changes	O
.	O

One	O
of	O
these	O
.	O
metaphases	O
contained	O
an	O
extra	O
copy	O
of	O
chromosome	O
14	O
.	O

Another	O
metaphase	O
.	O
was	O
a	O
broken	O
tetraploid	O
cell	O
.	O

The	O
significance	O
of	O
a	O
single	O
abnormal	O
cell	O
.	O

is	O
unclear	O
.	O

It	O
may	O
represent	O
an	O
emerging	O
or	O
undetected	O
clonal	O
cell	O
.	O
population	O
,	O
technical	O
artifact	O
,	O
or	O
random	O
event	O
.	O

The	O
normal	O
results	O
may	O
.	O
reflect	O
an	O
overgrowth	O
of	O
normal	O
interstitial	O
tissue	O
rather	O
than	O
tumor	O
.	O

-DOCSTART-228
x	O
.	O

Submitting	O
Phyarcians	O
:	O
Patnolog	O
:	O
at	O
.	O

Intra	O
ó	O
p	O
Pathologist	O
:	O
Performing	O
PbyEician	O
:	O
CLINICAL	O
HISTORY	O
:	O
LEFT	O
UEPATOCELLULAR	O
CA	O
.	O

PRECPERATIVE	O
DIAGNOSIS	O
:	O
MEPATOCELIALAR	O
.	O

SPECIMEN	O
TYPA	O
(	O
S	O
)	O
#	O
.	O

A	O
:	O
CELIAC	O
LN	O
,	O
FS	O
(	O
1	O
)	O
.	O

E	O
:	O
NODULE	O
RT	O
LOBE	O
OF	O
LIVER	O
,	O
F9	O
121	O
.	O

C	O
:	O
CALLPLADDER	O
.	O

D	O
:	O
LT	O
LOPE	O
LIVER	O
.	O

E	O
:	O
LT	O
EEPATIC	O
VEIN	O
STUMP	O
.	O

F	O
:	O
LT	O
VEIN	O
MARGIN	O
,	O
FS	O
.	O

FIMAL	O
DIAGNOSTS	O
:	O
LYMPH	O
NODE	O
,	O
CELINC	O
,	O
BIOPSY	O
:	O
Negative	O
for	O
malignancy	O
.	O

E	O
.	O

LIVER	O
,	O
RIGHT	O
LOBE	O
NODULE	O
,	O
.	O

Negative	O
ror	O
malignancy	O
,	O
.	O

callalADDER	O
,	O
RESECTION	O
:	O
Chronte	O
cholecystitis	O
.	O

D	O
.	O

DIVER	O
,	O
LEFT	O
LOBE	O
,	O
PRSECTION	O
:	O
Well	O
iirrerentiated	O
hepatodellutar	O
carcinoma	O
.	O

See	O
Key	O
Pathologicil	O
Findings	O
.	O

LEFT	O
HEPATIC	O
VEIN	O
STUM2	O
:	O
Negative	O
for	O
malignancy	O
.	O

LEFT	O
VEIN	O
MARGIN	O
:	O
Negative	O
for	O
malignancy	O
.	O

KEY	O
PATHOLOGICAL	O
FINDINGS	O
:	O
KEY	O
PATHOLOCICAL	O
FINDINGS	O
.	O

Gpecimen	O
type	O
:	O
partial	O
resection	O
.	O

Tumor	O
configuration	O
:	O
satellite	O
nodulea	O
.	O

Cumor	O
size	O
:	O
8	O
am	O
in	O
ciximua	O
dimension	O
.	O

Hiatologic	O
type	O
:	O
hepatocellular	O
carcicoza	O
.	O

Histologic	O
grade	O
:	O
vell	O
-	O
dirTerentiated	O
.	O

Tumor	O
necrosis	O
:	O
Preaent	O
.	O

Extent	O
of	O
invasion	O
:	O
Invades	O
hepatic	O
vein	O
.	O

Perizieural	O
invasion	O
:	O
Absent	O
.	O

Parenchyman	O
margin	O
:	O
Negative	O
.	O

Bile	O
duet	O
marg	O
:	O
n	O
:	O
Not	O
asseased	O
.	O

Other	O
margina	O
;	O
.	O

Not	O
applicable	O
.	O

Venous	O
(	O
Carge	O
invasion	O
:	O
Present	O
.	O
Lymph	O
nodes	O
:	O
0	O
/	O
1	O
.	O
Pathologic	O
stage	O
:	O
T3NOMX	O
.	O
I	O
.	O
the	O
atcending	O
pathologist	O
,	O
personally	O
reviewed	O
the	O
ectire	O
.	O
pathlogy	O
case	O
and	O
readered	O
the	O
rinal	O
diageOBis	O
.	O
Electronically	O
Signed	O
out	O
by	O
.	O
OTHER	O
RELATED	O
CLINICAL	O
DATA	O
:	O
NA	O
.	O
INTRAOPERATIVE	O
DIAGNOSIS	O
:	O
FSA	O
:	O
CELIAC	O
LYMPH	O
NODE	O
:	O
Lymph	O
node	O
with	O
no	O
evidence	O
or	O
malignancy	O
.	O
FSP	O
:	O
NODULE	O
RIGHT	O
LORE	O
CP	O
LIVER	O
:	O
M	O
:	O
10	O
portal	O
inflammation	O
.	O
No	O
carcinoma	O
identitied	O
.	O
PEP	O
:	O
FINAL	O
VEIN	O
MARGIN	O
:	O
Fibrosis	O
and	O
chrente	O
)	O
inflimmation	O
.	O

No	O
evidence	O
of	O
calignancy	O
,	O
.	O
have	O
performed	O
the	O
intraoperative	O
.	O
consultations	O
and	O
iasued	O
the	O
above	O
diagnoses	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

Specimen	O
A	O
ia	O
labeled	O
celia	O
lymph	O
pode	O
,	O
FSt	O
.	O

Received	O
fresh	O
la	O
a	O
tan	O
-	O
brown	O
.	O
lymph	O
node	O
measuring	O
2	O
.	O
6	O
x	O
1	O
.	O
6	O
x	O
0	O
.	O
8	O
The	O
specimen	O
is	O
bisected	O
and	O
balt	O
or	O
the	O
.	O
specimen	O
15	O
frozen	O
,	O
The	O
:	O
rozen	O
section	O
residue	O
te	O
submitted	O
in	O
cassette	O
FSA	O
.	O

The	O
.	O
remaining	O
tiasue	O
1a	O
aubnitted	O
in	O
cassette	O
A	O
.	O

B	O
.	O

Specimen	O
a	O
is	O
labaled	O
nodule	O
right	O
Tobe	O
of	O
liver	O
,	O
PS	O
.	O

Received	O
fregh	O
are	O
two	O
.	O
tan	O
-	O
brown	O
cylindrical	O
fragments	O
of	O
sort	O
tiasue	O
measuring	O
fros	O
0	O
.	O
8	O
up	O
to	O
1	O
.	O
5	O
em	O
in	O
.	O
length	O
each	O
with	O
an	O
average	O
diateter	O
of	O
0	O
.	O
1	O
on	O
The	O
apecimen	O
18	O
frozen	O
In	O
it	O
'	O
s	O
.	O
entirety	O
and	O
the	O
frozen	O
section	O
residue	O
is	O
subnitted	O
in	O
cassette	O
PSB	O
.	O

Specimen	O
C	O
is	O
labeled	O
gallbladder	O
"	O
.	O

Received	O
freah	O
le	O
an	O
oblong	O
;	O
atibladder	O
.	O
measuring	O
10	O
.	O
0	O
x	O
3	O
.	O
5	O
x	O
1	O
,	O
3	O
.	O
cm	O
.	O

The	O
serosal	O
surface	O
is	O
green	O
-	O
t	O
á	O
n	O
and	O
unremarkable	O
.	O

Thare	O
are	O
multiple	O
lymph	O
nodes	O
attached	O
to	O
the	O
gillbladder	O
,	O
The	O
cyat	O
:	O
C	O
duct	O
18	O
.	O
identifted	O
and	O
Deasures	O
1	O
.	O
7	O
ca	O
in	O
length	O
.	O

The	O
apecimen	O
18	O
opented	O
to	O
reveal	O
a	O
.	O
green	O
-	O
tan	O
trabeculir	O
mucosa	O
.	O

The	O
specimen	O
138	O
3	O
wall	O
thicknesa	O
or	O
0	O
.	O
8	O
cm	O
.	O

NO	O
.	O
lesiona	O
or	O
calcult	O
are	O
grosaly	O
appreciated	O
.	O

Representative	O
Bections	O
are	O
surzitted	O
.	O
as	O
follows	O
:	O
Cl	O
:	O
dalibladder	O
,	O
neck	O
,	O
tundus	O
,	O
and	O
cystic	O
tuct	O
margin	O
.	O

C2	O
:	O
Four	O
single	O
lyzph	O
podes	O
.	O

D	O
.	O

Specimen	O
D	O
is	O
Tabeled	O
:	O
eft	O
Tobe	O
liver	O
Received	O
trean	O
.	O

is	O
a	O
.	O
hepatolobectomy	O
weighing	O
716	O
.	O
0	O
gin	O
,	O
18	O
.	O
5	O
3	O
.	O
5	O
x	O
6	O
.	O
0	O
cm	O
.	O

The	O
capsule	O
3	O
:	O
the	O
liver	O
18	O
.	O
diatorted	O
by	O
multiple	O
white	O
-	O
tan	O
nodules	O
measuring	O
from	O
1	O
.	O
5	O
up	O
Lo	O
9	O
.	O
0	O
cm	O
in	O
greatest	O
.	O
dimension	O
.	O

The	O
hepatic	O
vein	O
appeara	O
to	O
be	O
involved	O
by	O
tumor	O
.	O

The	O
resection	O
zargin	O
.	O

18	O
inked	O
black	O
and	O
the	O
apecimen	O
is	O
serially	O
sectioced	O
to	O
reveal	O
a	O
7	O
.	O
5	O
X5	O
x	O
4	O
em	O
.	O
tumor	O
mass	O
composed	O
or	O
confluent	O
nodules	O
with	O
satellite	O
nodules	O
throughout	O
the	O
.	O
parenchyes	O
.	O

The	O
nodules	O
are	O
white	O
-	O
tan	O
aort	O
,	O
necrotic	O
,	O
hemorrhagic	O
cut	O
surface	O
.	O

The	O
.	O
nodules	O
are	O
located	O
1	O
,	O
4	O
em	O
from	O
the	O
closeat	O
inked	O
resect	O
é	O
d	O
The	O
uninvelved	O
.	O
liver	O
parenchyma	O
la	O
tan	O
-	O
brown	O
and	O
unrecarkable	O
.	O

Representative	O
sections	O
are	O
.	O
submitted	O
to	O
the	O
Tiasue	O
Procurement	O
Laboratory	O
,	O
Representative	O
aections	O
are	O
.	O
submitted	O
38	O
follows	O
:	O
D1	O
;	O
.	O

Tumor	O
in	O
relation	O
to	O
the	O
hepatic	O
vein	O
and	O
artery	O
.	O

Tumor	O
in	O
relation	O
to	O
the	O
inked	O
resected	O
margin	O
.	O

D31	O
.	O

Section	O
of	O
the	O
tumor	O
in	O
relation	O
to	O
the	O
capsuie	O
.	O

D4	O
:	O
Uninvolved	O
liver	O
parecchyma	O
.	O

E	O
,	O
.	O

Specimen	O
E	O
is	O
labeled	O
left	O
thepatic	O
vein	O
atump	O
'	O
-	O
Recetved	O
treah	O
1a	O
the	O
lert	O
.	O
hepatic	O
vein	O
stuxp	O
measuring	O
3	O
.	O
0	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
4	O
The	O
specimen	O
has	O
a	O
aingle	O
atapled	O
.	O
margio	O
line	O
.	O

The	O
specisen	O
Le	O
received	O
Laked	O
on	O
ane	O
s	O
:	O
de	O
.	O

The	O
Inked	O
cargin	O
.	O
designates	O
the	O
true	O
margin	O
.	O

The	O
margin	O
is	O
reinked	O
blue	O
and	O
sucmitted	O
in	O
toto	O
.	O

In	O
.	O
caszette	O
E	O
.	O

F	O
.	O

Specimen	O
F	O
18	O
labeled	O
Frinal	O
vein	O
margin	O
-	O
liver	O
,	O
Received	O
fresh	O
13	O
3	O
.	O
red	O
-	O
brown	O
Irregular	O
fragment	O
or	O
sort	O
cessuring	O
1	O
.	O
5	O
x	O
0	O
.	O
8	O
x0	O
.	O
3	O
em	O
.	O

The	O
.	O
specimed	O
18	O
frozen	O
in	O
ite	O
entirety	O
and	O
the	O
frozen	O
section	O
residue	O
18	O
-	O
Bubmitted	O
in	O
.	O
cassette	O
A	O
.	O

-DOCSTART-229
Sex	O
:	O
M	O
.	O

Source	O
of	O
Specimen	O
(	O
s	O
)	O
.	O

1	O
:	O
Left	O
pelvic	O
Lymph	O
Node	O
.	O

2	O
:	O
Right	O
pelvic	O
Lymph	O
Node	O
.	O

3	O
:	O
Prostate	O
and	O
Seminal	O
Vessicles	O
.	O

Gross	O
Description	O
:	O
Received	O
in	O
three	O
parts	O
.	O

Source	O
of	O
tissue	O
:	O
1	O
.	O

Labeled	O
#	O
1	O
,	O
"	O
left	O
pelvic	O
lymph	O
nodes	O
"	O
.	O

Gross	O
Description	O
:	O
Received	O
fresh	O
labeled	O
"	O
,	O
left	O
.	O
pelvic	O
lymph	O
nodes	O
"	O
consists	O
of	O
a	O
6	O
x	O
3	O
x	O
1	O
.	O
5	O
cm	O
aggregate	O
of	O
yellow	O
.	O
lobulated	O
,	O
hemorrhagic	O
fat	O
.	O

Multiple	O
lymph	O
nodes	O
are	O
dissected	O
out	O
of	O
the	O
.	O
fat	O
ranging	O
from	O
2	O
x	O
2	O
x	O
0	O
.	O
4	O
cm	O
up	O
to	O
3	O
.	O
5	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
4	O
cm	O
.	O

The	O
lymph	O
nodes	O
.	O
are	O
entirely	O
submitted	O
in	O
cassettes	O
1A	O
-	O
IC	O
for	O
microscopic	O
evaluation	O
.	O

Source	O
of	O
tissue	O
:	O
2	O
.	O

Labeled	O
#	O
2	O
,	O
"	O
right	O
pelvic	O
lymph	O
nodes	O
"	O
.	O

Gross	O
Description	O
:	O
Received	O
fresh	O
labeled	O
"	O
,	O
.	O
right	O
pelvic	O
lymph	O
nodes	O
"	O
consists	O
of	O
a	O
4	O
x	O
3	O
x	O
1	O
cm	O
aggregate	O
of	O
yellow	O
.	O
lobulated	O
,	O
hemorrhagic	O
fat	O
.	O

Two	O
lymph	O
nodes	O
are	O
dissected	O
out	O
of	O
the	O
fat	O
.	O
measuring	O
1	O
x	O
1	O
x	O
0	O
.	O
3	O
cm	O
and	O
2	O
.	O
5	O
x	O
1	O
x	O
0	O
.	O
4	O
cm	O
.	O

The	O
lymph	O
nodes	O
are	O
.	O
entirely	O
submitted	O
in	O
cassettes	O
2A	O
for	O
microscopic	O
evaluation	O
.	O

Source	O
of	O
tissue	O
:	O
3	O
.	O

Labeled	O
#	O
3	O
,	O
"	O
prostate	O
and	O
seminal	O
vesicles	O
"	O
.	O

Gross	O
Description	O
:	O
Received	O
fresh	O
labeled	O
'	O
.	O
prostate	O
and	O
seminal	O
vesicles	O
"	O
consists	O
of	O
a	O
58	O
gram	O
,	O
5	O
x	O
4	O
.	O
5	O
X	O
4	O
cm	O
.	O
red	O
-	O
brown	O
,	O
hemorrhagic	O
prostate	O
with	O
intact	O
capsule	O
,	O
patent	O
urethra	O
and	O
.	O
bilateral	O
seminal	O
vesicles	O
and	O
vas	O
deferens	O
.	O

The	O
right	O
seminal	O
vesicle	O
.	O
measures	O
2	O
X	O
1	O
X	O
0	O
.	O
7	O
cm	O
,	O
the	O
right	O
vas	O
deferens	O
measures	O
4	O
x	O
0	O
.	O
5	O
cm	O
,	O
the	O
.	O
left	O
seminal	O
vesicle	O
measures	O
4	O
X	O
2	O
x	O
1	O
cm	O
,	O
and	O
the	O
left	O
vas	O
deferens	O
.	O
measures	O
5	O
X	O
0	O
.	O
5	O
cm	O
.	O

The	O
right	O
side	O
is	O
inked	O
yellow	O
and	O
the	O
left	O
side	O
is	O
.	O
inked	O
black	O
and	O
the	O
specimen	O
is	O
sectioned	O
revealing	O
tan	O
-	O
pink	O
,	O
rubbery	O
to	O
.	O
firm	O
cut	O
surfaces	O
with	O
multiple	O
brown	O
,	O
small	O
to	O
medium	O
calculi	O
.	O

Sectioning	O
of	O
the	O
seminal	O
vesicles	O
and	O
vas	O
deferens	O
reveals	O
tan	O
-	O
red	O
cut	O
.	O
surfaces	O
and	O
fluid	O
-	O
filled	O
spaces	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O
as	O
designated	O
for	O
microscopic	O
evaluation	O
.	O

Designation	O
of	O
Sections	O
:	O
3A	O
right	O
apex	O
.	O

3B	O
left	O
apex	O
.	O

3C	O
right	O
base	O
.	O

3D	O
left	O
base	O
.	O

3E	O
-	O
3F	O
right	O
anterior	O
mid	O
.	O

3G	O
-	O
3H	O
right	O
posterior	O
.	O
superior	O
.	O

3I	O
-	O
3J	O
left	O
anterior	O
mid	O
.	O

3K	O
-	O
3L	O
left	O
posterior	O
superior	O
.	O

3M	O
.	O
right	O
seminal	O
vesicle	O
and	O
vas	O
deferens	O
.	O

3N	O
left	O
seminal	O
vesicle	O
and	O
vasdeferens	O
.	O

Please	O
note	O
the	O
specimens	O
are	O
placed	O
in	O
formalin	O
at	O
.	O

Final	O
Diagnosis	O
:	O
1	O
.	O

Left	O
pelvic	O
lymph	O
nodes	O
:	O
-	O
No	O
tumor	O
seen	O
in	O
five	O
lymph	O
nodes	O
(	O
0	O
/	O
5	O
)	O
.	O

2	O
.	O

Right	O
pelvic	O
lymph	O
nodes	O
:	O
-	O
No	O
tumor	O
seen	O
in	O
two	O
lymph	O
nodes	O
(	O
0	O
/	O
2	O
)	O
.	O

3	O
.	O

Prostate	O
and	O
seminal	O
vesicles	O
,	O
radical	O
prostatectomy	O
:	O
-	O
Prostatic	O
adenocarcinoma	O
,	O
Gleason	O
'	O
s	O
score	O
9	O
(	O
5	O
+	O
4	O
)	O
.	O

-	O
Tumor	O
involves	O
both	O
lobes	O
.	O

Tumor	O
involves	O
the	O
apex	O
on	O
the	O
right	O
side	O
,	O
extending	O
into	O
the	O
.	O
surrounding	O
muscles	O
and	O
nerves	O
,	O
but	O
the	O
inked	O
margin	O
is	O
negative	O
.	O

-	O
Angiolymphatic	O
invasion	O
is	O
not	O
identified	O
.	O

-	O
Perineural	O
invasion	O
is	O
identified	O
.	O

-	O
Extracapsular	O
extension	O
is	O
identified	O
.	O

-	O
Tumor	O
involves	O
right	O
posterior	O
inked	O
margin	O
.	O

-	O
Left	O
and	O
right	O
seminal	O
vesicles	O
positive	O
for	O
tumor	O
.	O

-	O
Tumor	O
involves	O
80	O
%	O
of	O
tissue	O
examined	O
.	O

-	O
pT3b	O
NO	O
Mx	O
.	O

-DOCSTART-230
SPECIMENS	O
:	O
A	O
.	O

PROSTATE	O
.	O

B	O
.	O

PROSTATE	O
MARGIN	O
.	O

SPECIMEN	O
(	O
S	O
)	O
:	O
A	O
.	O

PROSTATE	O
.	O

B	O
.	O

PROSTATE	O
MARGIN	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

PROSTATE	O
.	O

Received	O
fresh	O
labeled	O
with	O
matching	O
patient	O
identifiers	O
is	O
a	O
resected	O
prostate	O
gland	O
weighing	O
48	O
9	O
and	O
.	O
measuring	O
4	O
.	O
5	O
-	O
cm	O
from	O
right	O
to	O
left	O
,	O
4	O
.	O
8	O
-	O
cm	O
from	O
anterior	O
to	O
posterior	O
,	O
and	O
3	O
.	O
5	O
-	O
cm	O
from	O
apex	O
to	O
base	O
,	O
.	O

The	O
exernal	O
capsule	O
is	O
red	O
,	O
smooth	O
and	O
intact	O
.	O

The	O
apex	O
and	O
base	O
are	O
removed	O
from	O
the	O
specimen	O
.	O
yielding	O
a	O
new	O
weight	O
of	O
23	O
g	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
from	O
apex	O
to	O
base	O
,	O
Cut	O
section	O
shows	O
.	O
firm	O
,	O
tan	O
fibrous	O
parenchyma	O
.	O

No	O
lesions	O
or	O
nodules	O
are	O
grossly	O
appreciated	O
.	O

The	O
right	O
and	O
left	O
seminal	O
.	O
vesicle	O
measure	O
2	O
.	O
3	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
5	O
,	O
and	O
2	O
.	O
9	O
x	O
1	O
.	O
7	O
x	O
0	O
,	O
5	O
cm	O
respectively	O
.	O

Both	O
are	O
bisected	O
show	O
beige	O
tan	O
.	O
cystic	O
tissue	O
.	O

The	O
right	O
and	O
left	O
vas	O
measure	O
3	O
.	O
1	O
x	O
0	O
.	O
2	O
,	O
and	O
1	O
.	O
9	O
x	O
0	O
.	O
2	O
cm	O
,	O
respectively	O
.	O

Both	O
.	O
are	O
.	O

sectioned	O
to	O
show	O
firm	O
tan	O
tube	O
structure	O
.	O

A	O
portion	O
of	O
the	O
specimen	O
is	O
submitted	O
for	O
tissue	O
.	O
procurement	O
.	O

The	O
remainder	O
is	O
entirely	O
submitted	O
for	O
microscopic	O
evaluation	O
.	O

Cassettes	O
are	O
submitted	O
.	O
as	O
follows	O
:	O
A1	O
-	O
A2	O
:	O
Right	O
apex	O
.	O

A3	O
:	O
Left	O
Apex	O
.	O

A4	O
:	O
Level	O
1	O
right	O
anterior	O
.	O

A5	O
:	O
Level	O
1	O
right	O
posterior	O
.	O

A6	O
:	O
Level	O
1	O
left	O
anterior	O
.	O

A7	O
:	O
Level	O
1	O
left	O
posterior	O
.	O

A8	O
;	O
Level	O
2	O
capsule	O
,	O
right	O
side	O
.	O

A9	O
:	O
Level	O
2	O
capsule	O
,	O
left	O
side	O
.	O

A10	O
-	O
A11	O
:	O
Right	O
lateral	O
base	O
.	O

A12	O
:	O
Right	O
base	O
.	O

A13	O
-	O
A14	O
:	O
Right	O
base	O
with	O
proximal	O
urethral	O
margin	O
.	O

A15	O
-	O
A16	O
:	O
Left	O
base	O
with	O
proximal	O
urethral	O
margin	O
.	O

A17	O
-	O
A18	O
:	O
Left	O
base	O
.	O

A19	O
-	O
A20	O
:	O
Left	O
lateral	O
base	O
.	O

A21	O
:	O
Right	O
seminal	O
vesicle	O
,	O
right	O
vas	O
.	O

A22	O
:	O
Left	O
seminal	O
vesicle	O
,	O
left	O
vas	O
.	O

B	O
.	O

PROSTATE	O
MARGIN	O
.	O

Received	O
in	O
formalin	O
in	O
a	O
container	O
labeled	O
with	O
matching	O
patient	O
Identifiers	O
is	O
a	O
fragment	O
of	O
pink	O
tan	O
.	O
unoriented	O
soft	O
tissue	O
measuring	O
0	O
.	O
7	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
1	O
cm	O
.	O

The	O
entire	O
specimen	O
is	O
submitted	O
In	O
cassette	O
B1	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

PROSTATE	O
,	O
PROSTATECTOMY	O
:	O
-	O
PROSTATIC	O
ADENOCARCINOMA	O
,	O
GLEASON	O
SCORE	O
3	O
+	O
4	O
=	O
7	O
.	O

-	O
TUMOR	O
INVOLVES	O
RIGHT	O
AND	O
LEFT	O
LOBES	O
AND	O
-	O
15	O
%	O
OF	O
THE	O
PROSTATE	O
.	O

-	O
TUMOR	O
IS	O
PRESENT	O
AT	O
THE	O
INKED	O
RIGHT	O
APICAL	O
AND	O
RIGHT	O
.	O

ANTERIOR	O
MARGINS	O
,	O
WITH	O
PERIPROSTATIC	O
FAT	O
INVOLVEMENT	O
.	O

BILATERAL	O
SEMINAL	O
VESICLES	O
AND	O
BLADDER	O
BASE	O
,	O
NO	O
TUMOR	O
SEEN	O
,	O
.	O

B	O
.	O

PROSTATE	O
MARGIN	O
,	O
EXCISION	O
:	O
-	O
PROSTATIC	O
TISSUE	O
,	O
NO	O
TUMOR	O
SEEN	O
.	O

SYNOPTIC	O
REPORT	O
-	O
PROSTATE	O
GLAND	O
.	O
right	O
and	O
left	O
lobes	O
from	O
apex	O
to	O
mid	O
.	O

WHO	O
CLASSIFICATION	O
.	O

Epithelial	O
tumors	O
.	O

Adenocarcinoma	O
8140	O
/	O
3	O
.	O

Multicentricity	O
:	O
Gland	O
Involvement	O
:	O
15	O
%	O
.	O

Gleason	O
Grade	O
/	O
Sum	O
:	O
:	O
Grade	O
3	O
+	O
4	O
,	O
Sum	O
7	O
.	O

High	O
Grade	O
PIN	O
Present	O
:	O
Perineural	O
Invasion	O
:	O
Yes	O
.	O

Vascular	O
/	O
Lymphatic	O
Invasion	O
:	O
Seminal	O
Vesicle	O
Invasion	O
:	O
Periprostatic	O
Fat	O
Involved	O
:	O
Details	O
:	O
right	O
apex	O
and	O
right	O
anterior	O
.	O

Bladder	O
Neck	O
Involved	O
:	O
Margins	O
Involvement	O
:	O
Yes	O
.	O
see	O
above	O
.	O

Linear	O
Distance	O
:	O
Diffuse	O
(	O
>	O
10mm	O
or	O
Multifocal	O
)	O
.	O

Frozen	O
Performed	O
:	O
Lymph	O
Nodes	O
:	O
Negative	O
.	O

Other	O
Pathologic	O
Findings	O
:	O
BPH	O
.	O

Pathological	O
Staging	O
(	O
pTNM	O
)	O
:	O
T	O
3a	O
.	O

N	O
:	O
X	O
.	O

M	O
X	O
.	O

CLINICAL	O
HISTORY	O
:	O
None	O
given	O
.	O

PRE	O
-	O
OPERATIVE	O
DIAGNOSIS	O
:	O
Prostate	O
cancer	O
.	O

-DOCSTART-231
Final	O
Diagnosis	O
.	O

A	O
.	O

LIVER	O
,	O
LIVER	O
SEGMENT	O
6	O
,	O
SEGMENTAL	O
RESECTION	O
:	O
Hepatocellular	O
carcinoma	O
,	O
moderately	O
differentiated	O
.	O

Tumor	O
size	O
:	O
1	B
.	I
7	I
cm	I
.	O

Margin	O
of	O
resection	O
is	O
free	O
of	O
tumor	O
(	O
tumor	O
is	O
at	O
least	O
8	O
mm	O
away	O
from	O
the	O
inked	O
,	O
.	O
cauterized	O
deep	O
margin	O
of	O
resection	O
)	O
.	O

Uninvolved	O
liver	O
with	O
chronic	O
hepatitis	O
,	O
mildly	O
active	O
with	O
transition	O
to	O
cirrhosis	O
(	O
modified	O
.	O
ISHAK	O
stage	O
3	O
of	O
4	O
)	O
,	O
compatible	O
with	O
hepatitis	O
C	O
.	O

See	O
Key	O
Pathological	O
Findings	O
.	O

B	O
.	O

LIVER	O
,	O
LIVER	O
SEGMENT	O
8	O
,	O
SEGMENTECTOMY	O
:	O
Hepatocellular	O
carcinoma	O
,	O
moderately	O
differentiated	O
.	O

Tumor	O
size	O
:	O
1	B
.	I
5	I
x	I
1	I
.	I
4	I
x	I
1	I
.	I
3	I
cm	I
.	O

Margin	O
of	O
resection	O
:	O
see	O
part	O
C	O
.	O

See	O
Key	O
Pathological	O
Findings	O
.	O

C	O
.	O

LIVER	O
,	O
SEGMENT	O
8	O
NEW	O
MARGIN	O
,	O
RESECTION	O
:	O
Liver	O
with	O
chronic	O
hepatitis	O
,	O
mildly	O
active	O
with	O
transition	O
to	O
cirrhosis	O
(	O
modified	O
.	O
ISHAK	O
stage	O
3	O
of	O
4	O
)	O
,	O
compatible	O
with	O
hepatitis	O
C	O
,	O
negative	O
for	O
carcinoma	O
.	O
the	O
attending	O
pathologist	O
,	O
personally	O
reviewed	O
all	O
.	O
slides	O
and	O
/	O
or	O
materials	O
and	O
rendered	O
the	O
final	O
diagnosis	O
.	O

Electronically	O
.	O

Ancillary	O
Studies	O
.	O

Special	O
stains	O
Trichrome	O
,	O
Reticulin	O
,	O
Iron	O
,	O
and	O
PAS	O
-	O
D	O
were	O
performed	O
with	O
adequate	O
controls	O
on	O
block	O
.	O

A8	O
and	O
were	O
reviewed	O
.	O

Key	O
Pathological	O
Findings	O
.	O

A	O
:	O
Liver	O
,	O
Resection	O
.	O

Specimen	O
:	O
Liver	O
.	O

PROCEDURE	O
:	O
Partial	O
hepatectomy	O
.	O

Minor	O
hepatectomy	O
(	O
less	O
than	O
3	O
segments	O
)	O
.	O

TUMOR	O
SIZE	O
:	O
Greatest	O
dimension	O
:	O
1	B
.	I
7	I
cm	I
.	O

TUMOR	O
FOCALITY	O
:	O
Multiple	O
(	O
specify	O
location	O
)	O
:	O
segment	O
6	O
and	O
segment	O
8	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Hepatocellular	O
carcinoma	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
GII	O
:	O
Moderately	O
differentiated	O
.	O

TUMOR	O
EXTENSION	O
(	O
select	O
all	O
that	O
apply	O
)	O
:	O
Tumor	O
confined	O
to	O
liver	O
.	O

PRIMARY	O
TUMOR	O
(	O
pT	O
)	O
:	O
pT2	O
:	O
Solitary	O
tumor	O
with	O
vascular	O
invasion	O
or	O
multiple	O
tumors	O
none	O
more	O
than	O
5	O
cm	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
(	O
pN	O
)	O
:	O
pNX	O
:	O
Cannot	O
be	O
assessed	O
.	O

DISTANT	O
METASTASIS	O
(	O
pM	O
)	O
:	O
pMX	O
:	O
Cannot	O
be	O
assessed	O
.	O

MARGINS	O
:	O
Parenchymal	O
margin	O
uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

Distance	O
of	O
invasive	O
carcinoma	O
from	O
closest	O
margin	O
:	O
8	O
mm	O
.	O

VENOUS	O
(	O
LARGE	O
VESSEL	O
)	O
INVASION	O
(	O
V	O
)	O
:	O
Absent	O
.	O

ADDITIONAL	O
PATHOLOGIC	O
FINDINGS	O
:	O
Hepatocellular	O
dysplasia	O
.	O

Cirrhosis	O
/	O
fibrosis	O
.	O

Hepatitis	O
(	O
specify	O
type	O
)	O
:	O
Hepatitis	O
C	O
.	O
Specimen	O
(	O
s	O
)	O
Received	O
.	O

A	O
.	O

LIVER	O
SEGMENT	O
6	O
.	O

B	O
.	O

LIVER	O
SEGMENT	O
8	O
.	O

C	O
.	O

LIVER	O
SEGMENT	O
8	O
NEW	O
MARGIN	O
.	O

Clinical	O
History	O
.	O

LIVER	O
CANCER	O
.	O

Preoperative	O
Diagnosis	O
.	O

Liver	O
cancer	O
.	O

Gross	O
Description	O
.	O

A	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
liver	O
segment	O
6	O
"	O
and	O
consists	O
of	O
an	O
unoriented	O
,	O
.	O
resected	O
segment	O
of	O
liver	O
,	O
65	O
.	O
5	O
g	O
,	O
and	O
6	O
.	O
9	O
x	O
6	O
.	O
0	O
x	O
4	O
.	O
5	O
cm	O
.	O

The	O
capsule	O
is	O
intact	O
and	O
pitted	O
.	O

No	O
lesion	O
.	O

is	O
grossly	O
seen	O
.	O

The	O
deep	O
margin	O
is	O
cauterized	O
and	O
inked	O
blue	O
.	O

The	O
cut	O
surfaces	O
exhibit	O
a	O
golden	O
.	O
yellow	O
,	O
circumscribed	O
,	O
circular	O
,	O
spongy	O
mass	O
(	O
1	O
.	O
7	O
cm	O
diameter	O
)	O
which	O
is	O
1	O
cm	O
from	O
deep	O
margin	O
and	O
.	O
does	O
not	O
involve	O
the	O
capsule	O
.	O

The	O
lesion	O
does	O
not	O
grossly	O
involve	O
vasculature	O
.	O

Necrosis	O
(	O
5	O
%	O
)	O
is	O
.	O
noted	O
,	O
with	O
no	O
hemorrhage	O
identified	O
.	O

Normal	O
liver	O
parenchyma	O
is	O
coarsely	O
lobulated	O
and	O
congested	O
.	O

No	O
satellite	O
lesions	O
are	O
noted	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
A1	O
-	O
A8	O
as	O
labeled	O
:	O
A1	O
:	O
Mirror	O
image	O
section	O
of	O
liver	O
lesion	O
for	O
Tissue	O
Procurement	O
.	O

Laboratory	O
.	O

A2	O
-	O
A3	O
:	O
Liver	O
lesion	O
nearest	O
deep	O
margin	O
.	O

A4	O
:	O
Liver	O
lesion	O
with	O
vasculature	O
.	O

A5	O
-	O
A6	O
:	O
Liver	O
lesion	O
with	O
necrosis	O
.	O

A7	O
:	O
Tumor	O
random	O
.	O

A8	O
:	O
Normal	O
liver	O
parenchyma	O
.	O

The	O
tissue	O
is	O
submitted	O
for	O
Tissue	O
Procurement	O
Laboratory	O
.	O

B	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
liver	O
segment	O
8	O
"	O
and	O
consists	O
of	O
an	O
unoriented	O
,	O
.	O
ovoid	O
,	O
resected	O
segment	O
of	O
liver	O
,	O
10	O
.	O
1	O
g	O
,	O
3	O
.	O
7	O
x	O
2	O
.	O
8	O
cm	O
,	O
excised	O
to	O
a	O
depth	O
of	O
2	O
cm	O
.	O

The	O
capsule	O
is	O
.	O
intact	O
,	O
smooth	O
and	O
glistening	O
.	O

The	O
margin	O
of	O
resection	O
is	O
inked	O
blue	O
.	O

The	O
cut	O
surfaces	O
exhibit	O
a	O
pale	O
.	O
gray	O
-	O
tan	O
,	O
solid	O
,	O
circumscribed	O
,	O
intraparenchymal	O
lesion	O
,	O
1	O
.	O
5	O
x	O
1	O
.	O
3	O
X	O
1	O
.	O
4	O
cm	O
.	O

The	O
lesion	O
is	O
3	O
mm	O
deep	O
.	O
from	O
capsule	O
and	O
extends	O
to	O
the	O
deep	O
margin	O
.	O

Punctate	O
necrosis	O
,	O
indicative	O
of	O
biopsy	O
site	O
is	O
noted	O
,	O
.	O
with	O
no	O
hemormhage	O
identified	O
.	O

The	O
remaining	O
parenchyma	O
is	O
normal	O
,	O
with	O
no	O
satellite	O
lesion	O
noted	O
.	O

Representative	O
sections	O
,	O
including	O
the	O
entire	O
lesion	O
are	O
submitted	O
in	O
B1	O
-	O
B5	O
as	O
labeled	O
:	O
B1	O
-	O
B2	O
:	O
Liver	O
lesion	O
nearest	O
deep	O
margin	O
.	O

B3	O
-	O
84	O
:	O
Liver	O
lesion	O
with	O
potential	O
biopsy	O
site	O
.	O

B5	O
:	O
Normal	O
liver	O
parenchyma	O
.	O

The	O
specimen	O
is	O
not	O
submitted	O
for	O
Tissue	O
Procurement	O
Laboratory	O
.	O

C	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
liver	O
segment	O
8	O
new	O
margin	O
;	O
ink	O
-	O
true	O
margin	O
"	O
and	O
.	O
consists	O
of	O
an	O
oriented	O
,	O
irregular	O
resected	O
liver	O
fragment	O
,	O
1	O
.	O
6	O
g	O
,	O
2	O
.	O
8	O
x	O
2	O
.	O
1	O
cm	O
,	O
excised	O
to	O
a	O
depth	O
of	O
1	O
.	O
1	O
.	O

cm	O
.	O

The	O
specimen	O
is	O
markedly	O
cauterized	O
and	O
the	O
deep	O
margin	O
is	O
re	O
-	O
inked	O
blue	O
.	O

A	O
capsule	O
is	O
not	O
.	O
identified	O
.	O

The	O
cut	O
surfaces	O
exhibit	O
smooth	O
,	O
coarsely	O
lobulated	O
,	O
tan	O
-	O
red	O
parenchyma	O
,	O
with	O
no	O
lesion	O
.	O
grossly	O
seen	O
.	O

Necrosis	O
is	O
not	O
identified	O
.	O

The	O
specimen	O
is	O
submitted	O
entirely	O
in	O
C1	O
-	O
C3	O
.	O

The	O
specimen	O
is	O
not	O
submitted	O
for	O
Tissue	O
Procurement	O
Laboratory	O
.	O

-DOCSTART-232
Specimen	O
Type	O
:	O
1	O
:	O
OVARIES	O
.	O

2	O
:	O
Omentum	O
.	O

Clinical	O
Details	O
:	O
No	O
details	O
given	O
.	O

Macroscopic	O
Description	O
:	O
1	O
)	O
Ovaries	O
:	O
Two	O
ovaries	O
received	O
,	O
the	O
larger	O
ovary	O
on	O
external	O
examination	O
appears	O
partly	O
solid	O
and	O
partly	O
.	O
cystic	O
and	O
measures	O
12	O
X	O
13	O
X	O
11cm	O
and	O
weighs	O
more	O
than	O
1500gms	O
.	O

On	O
external	O
.	O
examination	O
there	O
are	O
irregular	O
nodular	O
and	O
solid	O
areas	O
on	O
the	O
ovarian	O
surface	O
,	O
these	O
appear	O
.	O
to	O
be	O
areas	O
of	O
capsular	O
breach	O
.	O

The	O
external	O
surface	O
is	O
inked	O
black	O
.	O

An	O
attached	O
fallopian	O
.	O
tube	O
is	O
identified	O
and	O
measures	O
8cm	O
in	O
length	O
and	O
0	O
.	O
5cm	O
in	O
diameter	O
.	O

On	O
slicing	O
the	O
larger	O
.	O
ovary	O
it	O
is	O
partly	O
solid	O
and	O
partly	O
cystic	O
,	O
there	O
are	O
abundant	O
papillary	O
excrescences	O
and	O
.	O
formations	O
on	O
the	O
inner	O
ovarian	O
cyst	O
lining	O
and	O
the	O
solid	O
areas	O
are	O
white	O
and	O
firm	O
.	O

The	O
smaller	O
.	O
partly	O
cystic	O
ovary	O
measures	O
7	O
.	O
7	O
X	O
5	O
.	O
5	O
X	O
3cm	O
and	O
the	O
attached	O
fallopian	O
tube	O
measures	O
4cm	O
in	O
.	O
length	O
and	O
0	O
.	O
7cm	O
in	O
diameter	O
.	O

On	O
the	O
external	O
surface	O
of	O
the	O
smaller	O
ovary	O
there	O
are	O
large	O
,	O
.	O

solid	O
/	O
papillary	O
areas	O
and	O
areas	O
of	O
irregularity	O
.	O

On	O
slicing	O
the	O
ovary	O
the	O
inner	O
surface	O
shows	O
.	O
papillary	O
excrescences	O
and	O
is	O
irregular	O
.	O

The	O
smaller	O
ovary	O
weighs	O
205	O
.	O

.	O
8gms	O
.	O

BLOCKS	O
;	O
.	O

1A	O
:	O
Larger	O
ovary	O
,	O
area	O
of	O
capsular	O
breach	O
:	O
,	O
1pc	O
.	O

1B	O
:	O
Larger	O
ovary	O
with	O
irregular	O
external	O
surface	O
:	O
1	O
,	O
2pcs	O
.	O

1C	O
-	O
F	O
:	O
Larger	O
ovary	O
,	O
cyst	O
wall	O
with	O
solid	O
internal	O
projections	O
:	O
1pc	O
in	O
each	O
.	O

1G	O
-	O
H	O
:	O
Larger	O
ovary	O
,	O
cyst	O
wall	O
with	O
internal	O
solid	O
areas	O
:	O
1pc	O
in	O
each	O
.	O

1K	O
:	O
Larger	O
ovary	O
:	O
solid	O
area	O
larger	O
cyst	O
:	O
1	O
,	O
,	O
1pc	O
.	O

1L	O
:	O
RS	O
larger	O
cyst	O
wall	O
:	O
1	O
,	O
2pcs	O
.	O

1M	O
:	O
RS	O
solid	O
area	O
:	O
1	O
,	O
1pc	O
.	O

1N	O
:	O
TS	O
fallopian	O
tube	O
larger	O
cyst	O
:	O
1	O
,	O
2pcs	O
.	O

1P	O
-	O
Q	O
:	O
Smaller	O
ovary	O
,	O
irregular	O
/	O
solid	O
papillary	O
areas	O
:	O
1pc	O
in	O
each	O
.	O

1R	O
:	O
TS	O
fallopian	O
tube	O
smaller	O
ovary	O
,	O
including	O
0	O
.	O
4cm	O
cyst	O
?	O

paratubal	O
:	O
1	O
,	O
2pcs	O
.	O

1S	O
:	O
Smaller	O
ovary	O
,	O
solid	O
area	O
:	O
1	O
,	O
1pc	O
.	O

1T	O
:	O
Smaller	O
ovary	O
,	O
cyst	O
wall	O
:	O
1	O
,	O
3pcs	O
.	O

1U	O
:	O
Smaller	O
ovary	O
,	O
cyst	O
wall	O
:	O
1	O
,	O
2pcs	O
.	O

1V	O
:	O
Smaller	O
ovary	O
,	O
solid	O
area	O
:	O
1	O
,	O
1pc	O
.	O

2	O
)	O
Omentum	O
:	O
A	O
piece	O
of	O
omentum	O
measuring	O
23	O
X	O
5	O
X	O
1cm	O
.	O

On	O
slicing	O
the	O
omentum	O
white	O
nodules	O
are	O
.	O
identified	O
(	O
query	O
representing	O
tumour	O
)	O
,	O
the	O
largest	O
measuring	O
2	B
X	I
0	I
.	I
7	I
X	I
1	I
.	I
5cm	I
.	O

There	O
are	O
in	O
.	O
addition	O
multiple	O
smaller	O
nodules	O
.	O

BLOCKS	O
:	O
2A	O
:	O
RS	O
largest	O
omental	O
nodule	O
:	O
1	O
,	O
2pcs	O
.	O

2B	O
-	O
C	O
:	O
RS	O
other	O
omental	O
nodules	O
:	O
2pcs	O
in	O
each	O
.	O

2D	O
:	O
RS	O
separate	O
omental	O
nodules	O
:	O
1	O
,	O
,	O
1pc	O
.	O

2E	O
-	O
F	O
:	O
Background	O
omentum	O
:	O
1pc	O
in	O
each	O
.	O

Microscopic	O
Description	O
:	O
1	O
)	O
Ovaries	O
:	O
Both	O
ovaries	O
show	O
a	O
dense	O
infiltration	O
of	O
moderately	O
atypical	O
glandular	O
cells	O
forming	O
complex	O
.	O
papillary	O
and	O
cystic	O
structures	O
.	O

There	O
is	O
stratification	O
of	O
the	O
cells	O
lining	O
these	O
structures	O
.	O

The	O
.	O
cells	O
are	O
pleomorphic	O
,	O
hyperchromatic	O
and	O
show	O
numerous	O
mitotic	O
figures	O
.	O

There	O
is	O
invasion	O
.	O
into	O
the	O
underlying	O
stroma	O
,	O
with	O
areas	O
of	O
necrosis	O
and	O
haemorrhage	O
.	O

Psammoma	O
bodies	O
are	O
.	O
seen	O
.	O

The	O
tumour	O
extends	O
through	O
the	O
inked	O
capsular	O
surface	O
margins	O
.	O

Both	O
fallopian	O
tubes	O
.	O
show	O
no	O
evidence	O
of	O
tumour	O
invasion	O
.	O

The	O
appearances	O
are	O
those	O
of	O
a	O
moderately	O
.	O
differentiated	O
serous	O
papillary	O
cystadenocarcinoma	O
.	O

2	O
)	O
Omentum	O
:	O
The	O
omentum	O
shows	O
infiltration	O
of	O
the	O
omental	O
fat	O
by	O
atypical	O
glandular	O
cells	O
forming	O
papillary	O
.	O
structures	O
,	O
both	O
in	O
the	O
nodular	O
areas	O
,	O
as	O
well	O
as	O
in	O
the	O
background	O
omentum	O
.	O

The	O
.	O
appearances	O
are	O
similar	O
to	O
the	O
cells	O
in	O
the	O
ovarian	O
specimens	O
.	O

The	O
tumour	O
in	O
the	O
largest	O
.	O
nodule	O
measures	O
up	O
to	O
19	B
.	I
7	I
mm	I
.	O

The	O
peritoneal	O
fluid	O
contains	O
malignant	O
cells	O
.	O

Final	O
Diagnosis	O
:	O
1	O
-	O
2	O
)	O
OVARIES	O
,	O
TUBES	O
AND	O
OMENTUM	O
:	O
GRADE	O
2	O
SEROUS	O
PAPILLARY	O
CYSTADENOCARCINOMA	O
OF	O
THE	O
OVARIES	O
,	O
IN	O
.	O

BOTH	O
OVARIES	O
,	O
EXTENDING	O
THROUGH	O
THE	O
CAPSULAR	O
SURFACE	O
,	O
WITH	O
.	O

METASTASIS	O
IN	O
THE	O
OMENTUM	O
.	O

T3b	O
Nx	O
Mx	O
(	O
FIGO	O
STAGE	O
IIIC	O
)	O
.	O

-DOCSTART-233
FIN	O
:	O
SEX	O
:	O
Female	O
.	O

Attending	O
.	O

Consulting	O
:	O
Surgical	O
Pathology	O
Final	O
.	O

Collected	O
Date	O
:	O
Verified	O
Date	O
:	O
Diagnosis	O
.	O

A	O
.	O

Uterus	O
,	O
cervix	O
,	O
bilateral	O
ovary	O
and	O
fallopian	O
tube	O
;	O
total	O
hysterectomy	O
(	O
198	O
gms	O
)	O
and	O
bilateral	O
.	O
salpingo	O
-	O
oophorectomy	O
:	O
Endometrioid	O
endometrial	O
adenocarcinoma	O
.	O

FIGO	O
grade	O
III	O
/	O
III	O
.	O

pT3a	O
Tumor	O
involves	O
uterine	O
serosal	O
surface	O
,	O
parametria	O
and	O
bilateral	O
ovaries	O
.	O

-	O
lower	O
uterine	O
segment	O
and	O
cervix	O
involved	O
.	O

-	O
extensive	O
angiolymphatic	O
invasion	O
present	O
.	O

-	O
bilateral	O
fallopian	O
tubes	O
with	O
paratubal	O
cyst	O
(	O
right	O
side	O
)	O
;	O
negative	O
for	O
tumor	O
.	O

-	O
left	O
ovary	O
with	O
extensive	O
involvement	O
by	O
tumor	O
.	O

-	O
right	O
ovary	O
with	O
surface	O
involvement	O
by	O
tumor	O
.	O

-	O
2	O
lymph	O
nodes	O
positive	O
for	O
tumor	O
(	O
2	O
/	O
3	O
)	O
-	O
Parts	O
C	O
and	O
E	O
.	O

-	O
omentum	O
negative	O
for	O
tumor	O
-	O
Part	O
G	O
.	O

-	O
minimum	O
pathologic	O
stage	O
pT3a	O
N1	O
Mx	O
.	O

B	O
.	O

Cul	O
de	O
sac	O
,	O
biopsy	O
:	O
Positive	O
for	O
tumor	O
.	O

C	O
.	O

Lymph	O
node	O
,	O
right	O
pelvic	O
,	O
excisional	O
biopsy	O
:	O
Positive	O
for	O
tumor	O
.	O

(	O
1	O
/	O
1	O
)	O
.	O

D	O
.	O

Lymph	O
node	O
,	O
left	O
pelvic	O
,	O
excisional	O
biopsy	O
:	O
Negative	O
for	O
tumor	O
.	O
(	O
0	O
/	O
1	O
)	O
.	O

E	O
.	O

Lymph	O
node	O
,	O
right	O
periaortic	O
,	O
excisional	O
biopsy	O
:	O
Positive	O
for	O
tumor	O
.	O

(	O
1	O
/	O
1	O
)	O
.	O

F	O
.	O

Submitted	O
as	O
left	O
periaortic	O
lymph	O
node	O
,	O
biopsy	O
:	O
Mature	O
adipose	O
tissue	O
.	O

Surgical	O
Pathology	O
Final	O
.	O

Collected	O
Date	O
:	O
Verified	O
Date	O
:	O
No	O
lymphoid	O
tissue	O
present	O
.	O

Negative	O
for	O
tumor	O
.	O

G	O
.	O

Omentum	O
,	O
biopsy	O
:	O
Negative	O
for	O
tumor	O
.	O

Comment	O
.	O

A	O
:	O
Endometrium	O
,	O
Hysterectomy	O
,	O
Macroscopic	O
.	O

SPECIMEN	O
TYPE	O
:	O
Radical	O
hysterectomy	O
(	O
includes	O
parametria	O
)	O
.	O

TUMOR	O
SITE	O
:	O
Specify	O
location	O
(	O
s	O
)	O
,	O
if	O
known	O
:	O
uterus	O
.	O

TUMOR	O
SIZE	O
:	O
Greatest	O
dimension	O
:	O
9	B
cm	I
.	O

Additional	O
dimensions	O
:	O
6	B
x	I
3	I
.	I
2	I
cm	I
.	O

HER	O
ORGANS	O
PRESENT	O
:	O
Right	O
ovary	O
.	O

Left	O
ovary	O
.	O

Right	O
fallopian	O
tube	O
.	O

Left	O
fallopian	O
tube	O
.	O

A	O
:	O
Endometrium	O
,	O
Hysterectomy	O
,	O
Microscopic	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Endometrioid	O
adenocarcinoma	O
,	O
not	O
otherwise	O
characterized	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
G3	O
:	O
More	O
than	O
50	O
%	O
nonsquamous	O
solid	O
growth	O
.	O

MYOMETRIAL	O
INVASION	O
:	O
Invasion	O
present	O
.	O

Specify	O
depth	O
of	O
invasion	O
:	O
22	O
mm	O
.	O

Specify	O
myometrial	O
thickness	O
:	O
22	O
mm	O
.	O

PRIMARY	O
TUMOR	O
(	O
pT	O
)	O
:	O
pT3a	O
[	O
IIIA	O
]	O
:	O
Local	O
and	O
/	O
or	O
regional	O
spread	O
as	O
specified	O
in	O
T3a	O
,	O
T3b	O
,	O
and	O
FIGO	O
IIIA	O
and	O
IIIB	O
:	O
Tumor	O
.	O
involves	O
serosa	O
,	O
parametria	O
,	O
and	O
/	O
or	O
adnexa	O
(	O
direct	O
extension	O
or	O
metastasis	O
.	O
REGIONAL	O
LYMPH	O
NODES	O
(	O
pN	O
)	O
:	O
pN1	O
[	O
IIIC	O
)	O
:	O
Regional	O
lymph	O
node	O
metastasis	O
.	O

Number	O
examined	O
:	O
3	O
.	O

Number	O
involved	O
2	O
.	O

DISTANT	O
METASTASIS	O
(	O
pM	O
)	O
:	O
pMX	O
:	O
Cannot	O
be	O
assessed	O
.	O

Surgical	O
Pathology	O
Final	O
.	O

Collected	O
Date	O
:	O
Verified	O
Date	O
:	O
MARGINS	O
:	O
Involved	O
by	O
invasive	O
carcinoma	O
.	O

Specify	O
margin	O
(	O
s	O
)	O
:	O
posterior	O
uterine	O
serosal	O
.	O

VENOUS	O
/	O
LYMPHATIO	O
(	O
LARGE	O
/	O
SMALL	O
VESSEL	O
)	O
INVASION	O
(	O
V	O
/	O
L	O
)	O
:	O
Present	O
.	O

ADDITIONAL	O
PATHOLOGIC	O
FINDINGS	O
:	O
None	O
identified	O
.	O

This	O
case	O
was	O
also	O
reviewed	O
by	O
Dr	O
.	O
who	O
agrees	O
with	O
the	O
above	O
diagnosis	O
.	O

(	O
Electronic	O
Signature	O
)	O
.	O

Clinical	O
History	O
.	O

Endometrial	O
carcinoma	O
.	O

Specimen	O
.	O

A	O
)	O
Uterus	O
,	O
bilateral	O
ovaries	O
/	O
fallopian	O
tubes	O
,	O
cervix	O
.	O

B	O
)	O
Pelvic	O
cul	O
-	O
de	O
-	O
sac	O
biopsy	O
.	O

C	O
)	O
Right	O
pelvic	O
lymph	O
node	O
.	O

D	O
)	O
Left	O
pelvic	O
lymph	O
node	O
.	O

E	O
)	O
Right	O
paraaortic	O
.	O

F	O
)	O
Left	O
paraaortic	O
.	O

G	O
)	O
Omentum	O
.	O

Gross	O
Description	O
.	O

The	O
specimens	O
are	O
received	O
fresh	O
in	O
seven	O
containers	O
,	O
each	O
designated	O
with	O
the	O
patient	O
'	O
s	O
name	O
.	O

Part	O
A	O
is	O
designated	O
"	O
uterus	O
,	O
bilateral	O
tubes	O
and	O
ovaries	O
,	O
and	O
cervix	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
total	O
.	O
hysterectomy	O
specimen	O
to	O
include	O
a	O
uterus	O
with	O
attached	O
cervix	O
and	O
attached	O
bilateral	O
adnexa	O
.	O

The	O
left	O
.	O
fallopian	O
tube	O
with	O
fimbriae	O
is	O
2	O
.	O
5	O
cm	O
in	O
length	O
and	O
0	O
.	O
3	O
cm	O
in	O
diameter	O
.	O

The	O
ovary	O
is	O
tan	O
-	O
gray	O
,	O
2	O
.	O
5	O
cm	O
in	O
greatest	O
.	O
dimension	O
.	O

Bivalving	O
reveals	O
a	O
tan	O
cut	O
surface	O
with	O
normal	O
ovarian	O
architecture	O
present	O
.	O

The	O
right	O
fallopian	O
.	O
tube	O
with	O
fimbriae	O
is	O
5	O
cm	O
in	O
length	O
and	O
0	O
.	O
5	O
cm	O
in	O
diameter	O
.	O

The	O
ovary	O
is	O
tan	O
-	O
gray	O
,	O
2	O
.	O
5	O
cm	O
in	O
greatest	O
.	O
dimension	O
.	O

Serially	O
sectioning	O
reveals	O
a	O
tan	O
-	O
gray	O
cut	O
surface	O
.	O

Surgical	O
Pathology	O
Final	O
.	O

Collected	O
Date	O
:	O
Verified	O
Date	O
:	O
The	O
uterus	O
with	O
cervix	O
is	O
198	O
g	O
,	O
approximately	O
11	O
.	O
5	O
x	O
8	O
.	O
6	O
x	O
5	O
.	O
7	O
cm	O
.	O

The	O
serosa	O
is	O
tan	O
-	O
pink	O
with	O
a	O
moderate	O
.	O
amount	O
of	O
hemorrhagic	O
adhesions	O
.	O

The	O
paracervical	O
/	O
parametrial	O
margin	O
is	O
inked	O
black	O
.	O

The	O
cervix	O
is	O
tan	O
-	O
pink	O
,	O
.	O

3	O
.	O
5	O
X	O
3	O
.	O
0	O
x	O
1	O
.	O
5	O
cm	O
.	O

Upon	O
bivalving	O
,	O
the	O
endocervical	O
canal	O
is	O
1	O
.	O
5	O
cm	O
and	O
the	O
endometrial	O
cavity	O
is	O
entirely	O
.	O
replaced	O
by	O
tan	O
-	O
gray	O
mass	O
extending	O
.	O
and	O
involving	O
the	O
lower	O
uterine	O
cavity	O
,	O
2	O
.	O
5	O
cm	O
from	O
the	O
squamocolumnar	O
.	O
junction	O
.	O

Sectioning	O
the	O
anterior	O
endometrium	O
/	O
myometrium	O
and	O
mass	O
,	O
the	O
mass	O
is	O
1	O
.	O
2	O
cm	O
in	O
thickness	O
,	O
it	O
.	O
involves	O
50	O
%	O
of	O
the	O
myometrium	O
,	O
1	O
.	O
2	O
cm	O
from	O
the	O
serosa	O
.	O

Sectioning	O
the	O
posterior	O
endometrium	O
/	O
myometrium	O
.	O
and	O
mass	O
,	O
the	O
mass	O
extends	O
to	O
and	O
there	O
is	O
serosal	O
involvement	O
,	O
the	O
mass	O
is	O
approximately	O
3	O
.	O
2	O
cm	O
in	O
depth	O
.	O

There	O
also	O
appears	O
to	O
be	O
parametrial	O
involvement	O
(	O
black	O
ink	O
)	O
.	O

Tissue	O
was	O
taken	O
according	O
to	O
the	O
.	O
and	O
.	O

protocol	O
.	O

The	O
specimen	O
is	O
submitted	O
as	O
per	O
code	O
of	O
sections	O
.	O

CODE	O
OF	O
SECTIONS	O
:	O
A1	O
.	O

Left	O
fallopian	O
tube	O
and	O
ovary	O
.	O

A2	O
.	O

Right	O
fallopian	O
tube	O
and	O
ovary	O
.	O

A3	O
.	O

Anterior	O
cervix	O
.	O

A4	O
-	O
A5	O
.	O

Anterior	O
endometrium	O
/	O
myometrium	O
,	O
mass	O
,	O
deepest	O
invasion	O
.	O

A6	O
.	O

Right	O
parametrial	O
margin	O
.	O

Posterior	O
cervix	O
.	O

-	O
A10	O
.	O

Posterior	O
endometrium	O
/	O
myometrium	O
,	O
mass	O
,	O
deepest	O
invasion	O
(	O
serosal	O
.	O
involvement	O
)	O
.	O

A11	O
.	O

Parametrial	O
margin	O
involvement	O
.	O

Part	O
B	O
is	O
designated	O
"	O
pelvic	O
cul	O
-	O
de	O
-	O
sac	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
portion	O
of	O
yellow	O
-	O
gray	O
to	O
red	O
membranous	O
.	O
tissue	O
,	O
1	O
.	O
2	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
a	O
single	O
cassette	O
.	O

Part	O
C	O
is	O
designated	O
"	O
right	O
pelvic	O
lymph	O
node	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
portion	O
of	O
tan	O
-	O
gray	O
to	O
yellow	O
.	O
rubbery	O
tissue	O
,	O
2	O
.	O
5	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
7	O
cm	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
a	O
single	O
cassette	O
.	O

Part	O
D	O
is	O
designated	O
"	O
left	O
pelvic	O
lymph	O
node	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
lobulated	O
adipose	O
tissue	O
,	O
4	O
.	O
5	O
x	O
3	O
.	O
0	O
x	O
.	O

1	O
.	O
5	O
cm	O
.	O

Sectioning	O
reveals	O
a	O
lymph	O
node	O
with	O
possible	O
tumor	O
involvement	O
,	O
2	O
.	O
5	O
X	O
2	O
.	O
0	O
x	O
1	O
.	O
5	O
cm	O
.	O

The	O
entire	O
.	O
lymph	O
node	O
is	O
submitted	O
in	O
cassettes	O
D1	O
-	O
D3	O
.	O

Part	O
E	O
is	O
designated	O
"	O
right	O
paraaortic	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
lobulated	O
adipose	O
tissue	O
with	O
tangray	O
.	O
rubbery	O
tissue	O
,	O
2	O
.	O
0	O
x	O
1	O
.	O
5	O
x	O
1	O
.	O
0	O
cm	O
.	O

Sectioning	O
reveals	O
a	O
possible	O
tumor	O
bisected	O
and	O
entirely	O
submitted	O
in	O
a	O
.	O
single	O
cassette	O
.	O

Part	O
F	O
is	O
designated	O
"	O
left	O
paraaortic	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
portion	O
of	O
lobulated	O
adipose	O
tissue	O
,	O
1	O
.	O
0	O
x	O
1	O
.	O
0	O
.	O

x	O
0	O
.	O
4	O
cm	O
.	O

The	O
specimen	O
is	O
submitted	O
as	O
received	O
in	O
a	O
single	O
cassette	O
.	O

Surgical	O
Pathology	O
Final	O
.	O

Collected	O
Date	O
:	O
Reccived	O
Date	O
:	O
Verified	O
Date	O
:	O
Part	O
G	O
is	O
designated	O
"	O
omentum	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
an	O
apron	O
of	O
omentum	O
,	O
22	O
X	O
12	O
X	O
4	O
cm	O
.	O

Sectioning	O
,	O
.	O
there	O
are	O
no	O
implants	O
identified	O
.	O

The	O
cut	O
surface	O
is	O
lobulated	O
adipose	O
tissue	O
.	O

Representative	O
portions	O
are	O
.	O
submitted	O
in	O
cassettes	O
G1	O
-	O
G2	O
.	O

-DOCSTART-234
adenocarcinams	O
,	O
endometrivid	O
,	O
NOS	O
8380	O
)	O
3	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

Uterus	O
,	O
bilateral	O
ovaries	O
,	O
and	O
fallopian	O
tubes	O
;	O
.	O
hysterectomy	O
and	O
.	O
bilateral	O
salpingo	O
-	O
oophorectomy	O
:	O
Endometrial	O
.	O
adenocarcinoma	O
,	O
.	O
endometrioid	O
type	O
,	O
FIGO	O
grade	O
1	O
(	O
of	O
3	O
)	O
is	O
identified	O
.	O
forming	O
a	O
mass	O
.	O

(	O
3	O
.	O
5	O
X	O
3	O
.	O
0	O
X	O
1	O
.	O
0	O
cm	O
)	O
in	O
the	O
uterine	O
fundus	O
(	O
both	O
posterior	O
.	O
and	O
.	O
anterior	O
)	O
.	O

The	O
tumor	O
invades	O
0	O
.	O
6	O
cm	O
into	O
the	O
myometrium	O
.	O

(	O
total	O
.	O
myometrial	O
thickness	O
,	O
2	O
.	O
0	O
cm	O
)	O
.	O

The	O
tumor	O
does	O
not	O
involve	O
.	O
the	O
.	O

endocervix	O
.	O

Lymphovascular	O
invasion	O
is	O
not	O
identified	O
.	O

The	O
.	O
background	O
endometrium	O
shows	O
complex	O
hyperplasia	O
with	O
.	O
atypia	O
.	O

The	O
.	O
vaginal	O
cuff	O
margin	O
is	O
negative	O
for	O
tumor	O
[	O
AJCC	O
pT1bNXMX	O
]	O
.	O

The	O
.	O
bilateral	O
ovaries	O
and	O
fallopian	O
tubes	O
show	O
no	O
diagnostic	O
.	O
abnormalities	O
.	O

B	O
.	O

C	O
.	O

Lymph	O
nodes	O
,	O
right	O
and	O
left	O
pelvic	O
,	O
excision	O
:	O
Multiple	O
left	O
.	O
pelvic	O
lymph	O
nodes	O
(	O
11	O
right	O
and	O
7	O
left	O
)	O
are	O
negative	O
for	O
.	O
tumor	O
.	O

This	O
final	O
pathology	O
report	O
is	O
based	O
on	O
the	O
.	O

gross	O
/	O
macroscopic	O
.	O
examination	O
and	O
frozen	O
section	O
histologic	O
evaluation	O
of	O
.	O
the	O
.	O

specimen	O
(	O
s	O
)	O
.	O

A	O
.	O

Received	O
fresh	O
labeled	O
"	O
uterus	O
,	O
right	O
and	O
left	O
.	O
fallopian	O
tubes	O
.	O
and	O
ovaries	O
"	O
is	O
a	O
100	O
.	O
0	O
gram	O
uterus	O
with	O
attached	O
.	O
bilateral	O
tubes	O
.	O
and	O
ovaries	O
and	O
an	O
unremarkable	O
cervix	O
.	O

The	O
uterine	O
.	O
serosa	O
is	O
.	O
smooth	O
There	O
is	O
a	O
3	O
.	O
5	O
X	O
3	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
mass	O
in	O
the	O
fundus	O
.	O
of	O
the	O
.	O
endometrial	O
cavity	O
with	O
1	O
.	O
5	O
cm	O
myometrial	O
thickness	O
.	O

There	O
are	O
.	O
multiple	O
(	O
3	O
)	O
intramural	O
leiomyomas	O
(	O
ranging	O
in	O
size	O
from	O
.	O
0	O
.	O
4	O
cm	O
to	O
.	O
1	O
.	O
0	O
cm	O
in	O
greatest	O
dimension	O
)	O
.	O

There	O
is	O
a	O
2	O
.	O
5	O
X	O
1	O
.	O
1	O
X	O
0	O
.	O
8	O
.	O

cm	O
right	O
.	O
ovary	O
with	O
a	O
smooth	O
outer	O
surface	O
and	O
a	O
cut	O
.	O
surface	O
with	O
a	O
6	O
.	O
5	O
X	O
0	O
.	O
6	O
cm	O
right	O
fallopian	O
tube	O
.	O

There	O
.	O

is	O
a	O
2	O
.	O
0	O
X	O
.	O

1	O
.	O
2	O
X	O
0	O
.	O
7	O
cm	O
left	O
ovary	O
with	O
a	O
smooth	O
outer	O
surface	O
and	O
a	O
.	O
solid	O
cut	O
.	O
surface	O
with	O
a	O
6	O
.	O
5	O
X	O
0	O
.	O
7	O
cm	O
left	O
fallopian	O
tube	O
.	O

Representative	O
.	O
sections	O
submitted	O
.	O

B	O
.	O

Received	O
fresh	O
labeled	O
"	O
right	O
pelvic	O
lymph	O
nodes	O
"	O
is	O
a	O
.	O

5	O
.	O
0	O
X	O
4	O
.	O
0	O
.	O

X	O
1	O
.	O
0	O
cm	O
aggregate	O
of	O
adipose	O
and	O
lymphatic	O
tissue	O
.	O

All	O
.	O

1	O
ymphatic	O
.	O
tissue	O
submitted	O
.	O

C	O
.	O

Received	O
fresh	O
labeled	O
"	O
left	O
pelvic	O
lymph	O
nodes	O
"	O
is	O
a	O
.	O

5	O
.	O
3	O
X	O
4	O
.	O

-	O
1	O
.	O

X	O
1	O
.	O
5	O
cm	O
aggregate	O
of	O
adipose	O
and	O
lymphatic	O
tissue	O
.	O

All	O
.	O

1	O
ymphatic	O
.	O
tissue	O
submitted	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

Received	O
fresh	O
labeled	O
"	O
uterus	O
,	O
right	O
and	O
left	O
.	O
fallopian	O
tubes	O
.	O
and	O
ovaries	O
"	O
is	O
a	O
100	O
.	O
0	O
gram	O
uterus	O
with	O
attached	O
.	O
bilateral	O
tubes	O
.	O
and	O
ovaries	O
and	O
an	O
unremarkable	O
cervix	O
.	O

The	O
uterine	O
.	O
serosa	O
is	O
.	O
smooth	O
There	O
is	O
a	O
3	O
.	O
5	O
X	O
3	O
.	O
0	O
X	O
1	O
.	O
0	O
cm	O
mass	O
in	O
the	O
fundus	O
.	O
of	O
the	O
.	O
endometrial	O
cavity	O
with	O
1	O
.	O
5	O
cm	O
myometrial	O
thickness	O
.	O

There	O
are	O
.	O
multiple	O
(	O
3	O
)	O
intramural	O
leiomyomas	O
(	O
ranging	O
in	O
size	O
from	O
.	O
0	B
.	I
4	I
cm	I
to	O
.	O
2	B
.	I
0	I
cm	I
in	O
greatest	O
dimension	O
)	O
.	O

There	O
is	O
a	O
2	O
.	O
5	O
X	O
1	O
.	O

1	O
.	O

X	O
0	O
.	O
8	O
cm	O
right	O
ovary	O
with	O
a	O
smooth	O
outer	O
surface	O
and	O
a	O
.	O
solid	O
.	O

cut	O
surface	O
with	O
a	O
6	O
.	O
5	O
X	O
0	O
.	O
6	O
cm	O
right	O
fallopian	O
tube	O
.	O

There	O
.	O

is	O
a	O
2	O
.	O
0	O
X	O
1	O
.	O
2	O
X	O
0	O
.	O
7	O
cm	O
left	O
ovary	O
with	O
a	O
smooth	O
outer	O
.	O
surface	O
and	O
a	O
.	O
solid	O
cut	O
surface	O
with	O
a	O
6	O
.	O
5	O
X	O
0	O
.	O
7	O
cm	O
left	O
fallopian	O
tube	O
.	O

Representative	O
sections	O
submitted	O
.	O

B	O
.	O

Received	O
fresh	O
labeled	O
"	O
right	O
pelvic	O
lymph	O
nodes	O
"	O
is	O
a	O
.	O

5	O
.	O
0	O
X	O
4	O
.	O
0	O
.	O

X	O
1	O
.	O
0	O
cm	O
aggregate	O
of	O
adipose	O
and	O
lymphatic	O
tissue	O
.	O

All	O
.	O
lymphatic	O
.	O

tissue	O
submitted	O
.	O

C	O
.	O

Received	O
fresh	O
labeled	O
"	O
left	O
pelvic	O
lymph	O
nodes	O
"	O
is	O
a	O
.	O

5	O
.	O
3	O
X	O
4	O
.	O
1	O
.	O

X	O
1	O
.	O
5	O
cm	O
aggregate	O
of	O
adipose	O
and	O
lymphatic	O
tissue	O
.	O

All	O
.	O

1	O
.	O
ymphatic	O
.	O
tissue	O
submitted	O
.	O

BLOCK	O
SUMMARY	O
:	O
Part	O
A	O
:	O
Uterus	O
,	O
right	O
and	O
left	O
fallopian	O
tubes	O
and	O
.	O
ovaries	O
.	O

1	O
Cervix	O
.	O

2	O
Lower	O
uterine	O
segment	O
.	O

3	O
Tumor	O
.	O

4	O
Tumor	O
.	O

5	O
Tumor	O
.	O

6	O
Tumor	O
.	O

7	O
Serosa	O
.	O

8	O
Right	O
fallopian	O
tube	O
.	O

9	O
Left	O
fallopian	O
tube	O
.	O

10	O
Right	O
ovary	O
.	O

11	O
Left	O
ovary	O
.	O

12	O
Tumor	O
.	O

13	O
Tumor	O
.	O

14	O
Normal	O
endometrium	O
.	O

Part	O
B	O
:	O
Right	O
Pelvic	O
Lymph	O
Nodes	O
.	O

1	O
Right	O
pelvic	O
Ins	O
1	O
.	O

2	O
Right	O
pelvic	O
lns	O
1	O
.	O

3	O
Right	O
pelvic	O
lns	O
1	O
.	O

4	O
Right	O
pelvic	O
lns	O
2	O
.	O

5	O
Right	O
pelvic	O
lns	O
2	O
.	O

6	O
Right	O
pelvic	O
lns1	O
.	O

Part	O
C	O
:	O
Left	O
Pelvic	O
Lymph	O
Nodes	O
.	O

1	O
Left	O
pelvic	O
lns	O
3	O
.	O

2	O
Left	O
pelvic	O
Ins	O
2	O
.	O

3	O
Left	O
pelvic	O
Ins	O
3	O
.	O

4	O
Left	O
pelvic	O
lns	O
2	O
.	O

5	O
Left	O
pelvic	O
Ins	O
1	O
.	O

-DOCSTART-235
Hospital	O
of	O
Origin	O
:	O
QC	O
Pathologist	O
:	O
FINAL	O
PATHOLOGIC	O
DIAGNOSIS	O
:	O
A	O
.	O

Right	O
and	O
left	O
pelvic	O
lymph	O
nodes	O
;	O
excision	O
:	O
No	O
metastatic	O
carcinoma	O
identified	O
in	O
four	O
lymph	O
nodes	O
.	O

(	O
0	O
/	O
4	O
)	O
.	O

B	O
.	O

Prostate	O
;	O
radical	O
prostatectomy	O
:	O
Tumor	O
Characteristics	O
:	O
1	O
.	O

Histologic	O
type	O
:	O
Prostatic	O
adenocarcinoma	O
.	O

2	O
.	O

Prostate	O
size	O
:	O
4	O
.	O
5	O
x	O
4	O
.	O
5	O
X	O
4	O
.	O
0	O
cm	O
,	O
42	O
.	O
5	O
grams	O
.	O

3	O
.	O

Tumor	O
quantitation	O
:	O
Tumor	O
involves	O
approximately	O
25	O
-	O
30	O
%	O
.	O
of	O
the	O
prostate	O
gland	O
volume	O
.	O

4	O
.	O

Gleason	O
grade	O
:	O
a	O
.	O

Primary	O
pattern	O
:	O
4	O
/	O
5	O
.	O

b	O
.	O

Secondary	O
pattern	O
:	O
5	O
/	O
5	O
.	O

c	O
.	O

Total	O
Gleason	O
score	O
:	O
9	O
/	O
10	O
.	O

5	O
.	O

Extraprostatic	O
extension	O
:	O
Focally	O
present	O
primarily	O
.	O
associated	O
with	O
peripheral	O
nerve	O
in	O
the	O
soft	O
tissue	O
.	O

6	O
.	O

Seminal	O
vesicle	O
involvement	O
:	O
Bilateral	O
.	O

7	O
.	O

Lymphovascular	O
space	O
invasion	O
:	O
Not	O
identified	O
.	O

8	O
.	O

High	O
grade	O
PIN	O
:	O
Present	O
.	O

9	O
.	O

Treatment	O
effect	O
:	O
Not	O
identified	O
.	O

Surgical	O
Margin	O
Status	O
:	O
Surgical	O
margins	O
including	O
apical	O
(	O
less	O
than	O
0	O
.	O
1	O
cm	O
)	O
,	O
.	O
bladder	O
neck	O
,	O
and	O
inked	O
prostatic	O
margin	O
negative	O
for	O
tumor	O
.	O

Lymph	O
Node	O
Status	O
:	O
1	O
.	O

Total	O
number	O
of	O
lymph	O
nodes	O
received	O
:	O
Four	O
,	O
see	O
.	O
specimen	O
A	O
.	O

2	O
.	O

Total	O
number	O
of	O
lymph	O
nodes	O
containing	O
metastatic	O
.	O
carcinoma	O
:	O
Zero	O
(	O
0	O
/	O
4	O
)	O
.	O

Other	O
:	O
pTNM	O
stage	O
:	O
pT3b	O
NO	O
.	O

COMMENTS	O
:	O
CLINICAL	O
HISTORY	O
:	O
Preoperative	O
Diagnosis	O
:	O
Postoperative	O
Diagnosis	O
:	O
Symptoms	O
/	O
Radiologic	O
Findings	O
:	O
SPECIMENS	O
:	O
A	O
.	O

Right	O
and	O
left	O
pelvic	O
lymph	O
nodes	O
.	O

B	O
.	O

Prostate	O
.	O

PROCEDURAL	O
DEMOGRAPHICS	O
:	O
Accession	O
Date	O
/	O
Time	O
:	O
GROSS	O
DESCRIPTION	O
:	O
The	O
specimen	O
is	O
received	O
in	O
two	O
formalin	O
filled	O
containers	O
.	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
.	O

A	O
.	O

Additionally	O
labeled	O
#	O
1	O
and	O
contains	O
a	O
5	O
.	O
5	O
x	O
3	O
.	O
5	O
X	O
2	O
.	O
0	O
cm	O
.	O
aggregate	O
of	O
yellow	O
-	O
tan	O
fibrofatty	O
soft	O
tissue	O
.	O

On	O
.	O
palpation	O
,	O
four	O
firm	O
fatty	O
possible	O
lymph	O
nodes	O
are	O
.	O
identified	O
ranging	O
from	O
0	O
.	O
2	O
up	O
to	O
3	O
.	O
0	O
cm	O
in	O
greatest	O
.	O
dimension	O
.	O

They	O
are	O
entirely	O
submitted	O
in	O
cassettes	O
A1	O
-	O
4	O
.	O
labeled	O
.	O

designated	O
as	O
follows	O
:	O
1	O
-	O
-	O
wwo	O
whole	O
.	O
possible	O
lymph	O
nod	O
é	O
s	O
;	O
2	O
-	O
one	O
whole	O
possible	O
bisected	O
lymph	O
.	O
node	O
;	O
3	O
-	O
4	O
-	O
-	O
one	O
whole	O
possible	O
bisected	O
lymph	O
node	O
.	O

B	O
.	O

Additionally	O
labeled	O
#	O
2	O
and	O
contains	O
.	O

a	O
42	O
,	O
5	O
.	O
gram	O
,	O
4	O
.	O
5	O
x	O
4	O
.	O
5	O
x	O
4	O
.	O
0	O
cm	O
prostate	O
received	O
with	O
attached	O
.	O
bilateral	O
adnexa	O
having	O
overall	O
dimensions	O
of	O
5	O
.	O
0	O
x	O
3	O
.	O
0	O
x	O
.	O

2	O
.	O
0	O
cm	O
.	O

The	O
capsule	O
is	O
pink	O
-	O
tan	O
smooth	O
to	O
shaggy	O
.	O

The	O
.	O
specimen	O
is	O
inked	O
as	O
follows	O
:	O
right	O
side	O
-	O
blue	O
;	O
and	O
left	O
.	O
side	O
-	O
black	O
.	O

The	O
base	O
and	O
apical	O
margins	O
are	O
coned	O
and	O
.	O
serially	O
sectioned	O
.	O

The	O
remainder	O
of	O
the	O
gland	O
is	O
serially	O
.	O
sectioned	O
from	O
apex	O
to	O
base	O
to	O
reveal	O
a	O
pink	O
-	O
tan	O
focally	O
.	O
cystic	O
cut	O
surface	O
with	O
diffuse	O
periurethral	O
nodularity	O
.	O

A	O
.	O

3	O
.	O
5	O
X	O
3	O
.	O
0	O
X	O
2	O
.	O
5	O
cm	O
yellow	O
-	O
tan	O
nodular	O
,	O
glistening	O
mass	O
is	O
.	O
present	O
within	O
the	O
right	O
base	O
and	O
partially	O
surrounds	O
the	O
.	O
right	O
seminal	O
vesicle	O
.	O

This	O
mass	O
abuts	O
the	O
inked	O
soft	O
tissue	O
.	O
margin	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
cassettes	O
.	O

B1	O
-	O
22	O
labeled	O
.	O
designated	O
as	O
follows	O
:	O
1	O
-	O
-	O
right	O
.	O

prostate	O
/	O
seminal	O
vesicle	O
junction	O
;	O
2	O
-	O
left	O
prostate	O
/	O
seminal	O
.	O
vesicle	O
junction	O
;	O
3	O
-	O
4	O
-	O
apical	O
margin	O
,	O
perpendicular	O
;	O
.	O

5	O
-	O
6	O
-	O
-	O
base	O
margin	O
,	O
perpendicular	O
;	O
7	O
-	O
10	O
-	O
mass	O
to	O
inked	O
soft	O
.	O
tissue	O
margin	O
and	O
right	O
seminal	O
vesicle	O
;	O
11	O
-	O
13	O
-	O
-	O
right	O
.	O
anterior	O
prostate	O
,	O
apex	O
to	O
base	O
;	O
B14	O
-	O
16	O
-	O
-	O
right	O
posterior	O
.	O
prostate	O
,	O
apex	O
to	O
base	O
;	O
17	O
-	O
19	O
-	O
left	O
anterior	O
prostate	O
,	O
apex	O
.	O
to	O
base	O
;	O
20	O
-	O
22	O
-	O
left	O
posterior	O
prostate	O
,	O
apex	O
to	O
base	O
.	O

Additionally	O
,	O
a	O
yellow	O
and	O
green	O
cassette	O
are	O
submitted	O
for	O
.	O

Genomics	O
research	O
each	O
labeled	O
.	O

-DOCSTART-236
TISSUE	O
DESCRIPTION	O
:	O
A1	O
B1	O
B2	O
B3	O
B4	O
.	O

Right	O
lobe	O
liver	O
(	O
1	O
,	O
585	O
grams	O
;	O
21	O
.	O
0	O
x	O
16	O
.	O
0	O
x	O
9	O
.	O
0	O
cm	O
)	O
and	O
gallbladder	O
.	O

(	O
8	O
.	O
5	O
x	O
2	O
.	O
0	O
x	O
2	O
.	O
0	O
cm	O
)	O
.	O

DIAGNOSIS	O
:	O
Liver	O
,	O
right	O
lobe	O
,	O
resection	O
:	O
Grade	O
2	O
(	O
of	O
4	O
)	O
hepatocellular	O
.	O
carcinoma	O
forming	O
a	O
4	B
.	I

x	B
3	I
.	I
8	I
x	I
3	I
.	I
7	I
cm	I
mass	O
located	O
3	O
.	O
0	O
cm	O
from	O
the	O
.	O
surgical	O
margin	O
.	O

The	O
uninvolved	O
liver	O
shows	O
moderate	O
cirrhosis	O
.	O

Gallbladder	O
,	O
cholecystectomy	O
:	O
Gallbladder	O
without	O
diagnostic	O
.	O
abnormalities	O
.	O

A	O
single	O
benign	O
cystic	O
duct	O
lymph	O
node	O
is	O
.	O
identified	O
.	O

TISSUE	O
DESCRIPTION	O
:	O
A1	O
B1	O
B2	O
B3	O
B4	O
.	O

Right	O
lobe	O
liver	O
(	O
1	O
,	O
585	O
grams	O
;	O
21	O
.	O
0	O
x	O
16	O
.	O
0	O
x	O
9	O
.	O
0	O
cm	O
)	O
and	O
gallbladder	O
.	O

(	O
8	O
.	O
5	O
x	O
2	O
.	O
0	O
x	O
2	O
.	O
0	O
cm	O
)	O
.	O

DIAGNOSIS	O
:	O
Liver	O
,	O
right	O
lobe	O
,	O
resection	O
:	O
Grade	O
2	O
(	O
of	O
4	O
)	O
hepatocellular	O
.	O
carcinoma	O
forming	O
a	O
4	B
.	I
4	I
x	I
3	I
.	I
8	I
x	I
3	I
.	I
7	I
cm	I
mass	O
located	O
3	O
.	O
0	O
cm	O
from	O
the	O
.	O
surgical	O
margin	O
.	O

The	O
uninvolved	O
liver	O
shows	O
moderate	O
cirrhosis	O
.	O

Gallbladder	O
,	O
cholecystectomy	O
:	O
Gallbladder	O
without	O
diagnostic	O
.	O
ebnormelities	O
.	O

A	O
single	O
benign	O
cystic	O
duct	O
lymph	O
node	O
is	O
.	O
identified	O
.	O

-DOCSTART-237
Addenda	O
Present	O
.	O

Accession	O
#	O
:	O
Diagnosis	O
:	O
A	O
:	O
Urethra	O
,	O
proximal	O
margin	O
,	O
biopsy	O
.	O

-	O
No	O
in	O
situ	O
or	O
invasive	O
carcinoma	O
identified	O
.	O

B	O
:	O
Lymph	O
nodes	O
,	O
right	O
pelvic	O
,	O
dissection	O
.	O

-	O
Five	O
lymph	O
nodes	O
with	O
no	O
malignancy	O
identified	O
(	O
0	O
/	O
5	O
)	O
.	O

C	O
:	O
Lymph	O
nodes	O
,	O
left	O
pelvic	O
,	O
dissection	O
.	O

-	O
Two	O
lymph	O
nodes	O
with	O
no	O
malignancy	O
identified	O
(	O
0	O
/	O
2	O
)	O
.	O

D	O
:	O
Bladder	O
and	O
prostate	O
,	O
cystoprostatectomy	O
.	O

Tumor	O
histologic	O
type	O
:	O
papillary	O
urothelial	O
carcinoma	O
.	O

Tumor	O
histologic	O
grade	O
(	O
WHO	O
classification	O
)	O
:	O
high	O
grade	O
.	O

Macroscopic	O
tumor	O
size	O
(	O
greatest	O
dimension	O
)	O
:	O
8	B
.	I
5	I
cm	I
.	O

Microscopic	O
extent	O
of	O
invasion	O
:	O
tumor	O
invades	O
the	O
lamina	O
propria	O
.	O
of	O
the	O
.	O
bladder	O
,	O
prostatic	O
ducts	O
and	O
prostatic	O
stroma	O
.	O

Tumor	O
site	O
/	O
focality	O
of	O
tumor	O
:	O
solitary	O
;	O
tumor	O
involves	O
bladder	O
.	O
and	O
.	O

prostate	O
.	O

Angiolymphatic	O
space	O
invasion	O
:	O
not	O
identified	O
.	O

Associated	O
epithelial	O
lesions	O
:	O
urothelial	O
carcinoma	O
in	O
situ	O
.	O
involves	O
the	O
bladder	O
and	O
.	O
prostatic	O
ducts	O
bilaterally	O
.	O

Ureters	O
:	O
uninvolved	O
.	O

Histologic	O
assessment	O
of	O
surgical	O
margins	O
:	O
:	O
Ureter	O
,	O
right	O
:	O
negative	O
.	O

Ureter	O
,	O
left	O
:	O
negative	O
.	O

Urethra	O
:	O
negative	O
.	O

Paravesicular	O
soft	O
tissue	O
:	O
negative	O
.	O

Prostate	O
,	O
right	O
and	O
left	O
:	O
negative	O
.	O

Lymph	O
nodes	O
:	O
Seven	O
lymph	O
nodes	O
with	O
no	O
malignancy	O
identified	O
.	O

(	O
0	O
/	O
7	O
;	O
.	O
specimens	O
A	O
and	O
B	O
)	O
.	O

Other	O
findings	O
:	O
prostatic	O
glandular	O
atrophy	O
;	O
PIN4	O
.	O
immunohistochemical	O
.	O

stain	O
pending	O
on	O
block	O
D7	O
to	O
rule	O
out	O
prostatic	O
adenocarcinoma	O
.	O

(	O
results	O
will	O
be	O
.	O
reported	O
in	O
an	O
addendum	O
)	O
.	O

AJCC	O
PATHOLOGIC	O
TNM	O
STAGE	O
:	O
pT4a	O
pNO	O
.	O

NOTE	O
:	O
This	O
pathologic	O
stage	O
assessment	O
is	O
based	O
on	O
information	O
.	O
available	O
at	O
the	O
.	O
time	O
of	O
this	O
report	O
,	O
and	O
is	O
subject	O
to	O
change	O
pending	O
clinical	O
.	O
review	O
and	O
.	O
additional	O
information	O
.	O

Intraoperative	O
Consult	O
Diagnosis	O
:	O
An	O
intraoperative	O
consultation	O
is	O
requested	O
by	O
Dr	O
.	O
in	O
.	O

at	O
.	O

on	O
.	O

FSA1	O
:	O
:	O
Urethral	O
margin	O
,	O
biopsy	O
.	O

-	O
Focal	O
urothelial	O
atypia	O
,	O
favor	O
reactive	O
,	O
cannot	O
completely	O
.	O
exclude	O
low	O
grade	O
.	O
dysplasia	O
.	O

-	O
Dr	O
.	O
concurs	O
.	O

Drs	O
.	O

a	O
.	O

Frozen	O
Section	O
Pathologist	O
:	O
,	O
MD	O
.	O

Clinical	O
History	O
:	O
yoar	O
-	O
old	O
.	O
with	O
a	O
history	O
of	O
invasive	O
high	O
grade	O
.	O
urothelial	O
carcinoma	O
with	O
.	O
focal	O
micropapillary	O
features	O
and	O
urothelial	O
carcinoma	O
in	O
situ	O
.	O
of	O
the	O
prostate	O
.	O

Gross	O
Description	O
:	O
Received	O
are	O
four	O
appropriately	O
labeled	O
containers	O
.	O

Container	O
A	O
holds	O
a	O
1	O
.	O
5	O
X	O
0	O
.	O
7	O
X	O
0	O
.	O
4	O
cm	O
partially	O
cauterized	O
.	O

red	O
/	O
tan	O
soft	O
tissue	O
.	O
fragment	O
,	O
FSA1	O
,	O
.	O

Container	O
B	O
is	O
additionally	O
labeled	O
"	O
right	O
pelvic	O
lymph	O
nodes	O
.	O

"	O
.	O

It	O
holds	O
.	O
multiple	O
brown	O
/	O
tan	O
,	O
fatty	O
,	O
lobulated	O
soft	O
tissue	O
fragments	O
which	O
.	O
measure	O
7	O
.	O
2	O
x	O
.	O

4	O
.	O
5	O
X	O
1	O
.	O
7	O
cm	O
in	O
aggregate	O
.	O

Dissection	O
reveals	O
multiple	O
lymph	O
.	O
node	O
candidates	O
,	O
.	O
the	O
largest	O
of	O
which	O
is	O
1	O
.	O
6	O
x	O
1	O
.	O
0	O
X	O
0	O
.	O
7	O
cm	O
.	O

Block	O
summary	O
:	O
B1	O
-	O
largest	O
lymph	O
node	O
candidate	O
,	O
bisected	O
.	O

B2	O
-	O
one	O
lymph	O
node	O
candidate	O
,	O
bisected	O
.	O

B3	O
-	O
two	O
lymph	O
node	O
candidates	O
.	O

B4	O
-	O
one	O
lymph	O
node	O
candidate	O
,	O
bisected	O
.	O

Tissue	O
remains	O
in	O
formalin	O
.	O

Container	O
C	O
is	O
additionally	O
labeled	O
"	O
left	O
pelvic	O
lymph	O
nodes	O
.	O

"	O
.	O

It	O
holds	O
multiple	O
.	O
tan	O
lobulated	O
fatty	O
soft	O
tissue	O
fragments	O
which	O
measure	O
5	O
.	O
2	O
X	O
.	O

4	O
.	O
0	O
X	O
1	O
.	O
8	O
cm	O
in	O
.	O
aggregate	O
.	O

Dissection	O
reveals	O
two	O
lymph	O
node	O
candidates	O
which	O
.	O
measure	O
1	O
.	O
8	O
X	O
1	O
.	O
4	O
.	O

X	O
0	O
.	O
6	O
cm	O
and	O
0	O
.	O
7	O
X	O
0	O
.	O
5	O
X	O
0	O
.	O
5	O
cm	O
,	O
respectively	O
.	O

Block	O
Summary	O
:	O
C1	O
,	O
C2	O
-	O
serial	O
sections	O
of	O
largest	O
lymph	O
node	O
candidate	O
.	O

C3	O
-	O
one	O
lymph	O
node	O
candidate	O
,	O
bisected	O
.	O

Fat	O
remains	O
in	O
formalin	O
.	O

Container	O
D	O
is	O
additionally	O
labeled	O
"	O
bladder	O
and	O
prostate	O
.	O

"	O
.	O

Specimen	O
fixation	O
:	O
formalin	O
.	O

Type	O
of	O
specimen	O
(	O
s	O
)	O
received	O
:	O
radical	O
cystoprostatectomy	O
.	O

Size	O
of	O
overall	O
specimen	O
:	O
15	O
cm	O
superior	O
to	O
inferior	O
,	O
13	O
cm	O
.	O
right	O
to	O
left	O
,	O
8	O
cm	O
.	O
anterior	O
to	O
posterior	O
.	O

Size	O
of	O
urinary	O
bladder	O
8	O
X	O
8	O
X	O
5	O
cm	O
.	O

Size	O
of	O
additional	O
organs	O
:	O
The	O
prostate	O
is	O
4	O
.	O
2	O
X	O
3	O
.	O
2	O
X	O
3	O
.	O
0	O
cm	O
.	O

Orientation	O
:	O
Right	O
=	O
blue	O
,	O
left	O
=	O
black	O
,	O
and	O
distal	O
urethral	O
.	O

margin	O
=	O
yellow	O
.	O

Tumor	O
size	O
:	O
8	B
.	I
5	I
x	I
7	I
.	I
5	I
X	I
3	I
.	I
5	I
cm	I
.	O

Tumor	O
description	O
exophytic	O
,	O
papillary	O
friable	O
nodule	O
;	O
.	O

Sectioning	O
through	O
the	O
.	O
tumor	O
reveals	O
a	O
friable	O
cut	O
surface	O
which	O
appears	O
to	O
.	O

be	O
superficial	O
.	O

The	O
underlying	O
muscle	O
wall	O
appears	O
intact	O
as	O
.	O
does	O
the	O
.	O
perivesicular	O
fat	O
.	O

Tumor	O
location	O
:	O
The	O
tumor	O
occupies	O
the	O
majority	O
of	O
the	O
.	O
urothelium	O
sparring	O
a	O
.	O
small	O
portion	O
of	O
the	O
posterior	O
and	O
left	O
wall	O
.	O

The	O
tumor	O
.	O
ends	O
inferiorly	O
at	O
the	O
prostatic	O
urethra	O
orifice	O
.	O

Distance	O
of	O
tumor	O
to	O
margins	O
:	O
Gross	O
tumor	O
is	O
2	O
.	O
2	O
cm	O
from	O
the	O
.	O
distal	O
prosthetic	O
.	O
urethral	O
margin	O
.	O

Other	O
mucosal	O
lesions	O
none	O
.	O

Description	O
of	O
other	O
organs	O
or	O
structures	O
:	O
Sectioning	O
through	O
.	O
the	O
prostate	O
.	O
reveals	O
minimal	O
periurethral	O
nodularity	O
and	O
ill	O
-	O
defined	O
white	O
.	O
indurated	O
discoloration	O
in	O
the	O
right	O
posterior	O
/	O
lateral	O
lobe	O
.	O

Digital	O
photograph	O
taken	O
:	O
not	O
taken	O
.	O

Tissue	O
submitted	O
for	O
special	O
investigation	O
:	O
Tumor	O
is	O
given	O
to	O
.	O

Block	O
summary	O
:	O
(	O
Inking	O
:	O
right	O
=	O
blue	O
,	O
left	O
=	O
black	O
,	O
distal	O
urethral	O
margin	O
=	O
yellow	O
)	O
.	O

D1	O
-	O
en	O
face	O
right	O
ureter	O
margin	O
.	O

D2	O
-	O
en	O
face	O
left	O
ureter	O
margin	O
.	O

D3	O
-	O
en	O
face	O
distal	O
urethral	O
margin	O
.	O

D4	O
-	O
D5	O
-	O
-	O
representative	O
section	O
from	O
right	O
prostate	O
.	O

D6	O
-	O
D7	O
-	O
-	O
representative	O
sections	O
from	O
left	O
prostate	O
.	O

D8	O
-	O
right	O
ureterovesicular	O
junction	O
.	O

D9	O
-	O
left	O
ureterovesicular	O
junction	O
.	O

D10	O
-	O
trigone	O
/	O
bladder	O
neck	O
with	O
underlying	O
seminal	O
vesicle	O
.	O
tissue	O
.	O

D11	O
-	O
section	O
of	O
dome	O
.	O

D12	O
-	O
right	O
wall	O
.	O

D13	O
-	O
left	O
wall	O
.	O

D14	O
-	O
posterior	O
wall	O
.	O

D15	O
-	O
additional	O
section	O
of	O
left	O
wall	O
.	O

D16	O
-	O
vas	O
deferens	O
margin	O
of	O
resection	O
.	O

D17	O
-	O
representative	O
section	O
of	O
blue	O
and	O
black	O
inked	O
deep	O
soft	O
.	O
tissue	O
margin	O
.	O

Procedures	O
/	O
Addenda	O
:	O
Addendum	O
.	O

Addendum	O
.	O

Immunohistochemical	O
stains	O
for	O
PIN4	O
.	O
show	O
an	O
.	O
intact	O
basal	O
cell	O
layer	O
,	O
supporting	O
the	O
interpretation	O
of	O
benign	O
.	O
prostatic	O
glands	O
.	O

-DOCSTART-238
DIAGNOSIS	O
:	O
1	O
.	O

Renal	O
,	O
tumor	O
#	O
1	O
,	O
left	O
,	O
partial	O
nephrectomy	O
:	O
Renal	O
cell	O
carcinoma	O
,	O
chromophobe	O
type	O
.	O

2	O
.	O

Renal	O
,	O
tumor	O
#	O
4	O
,	O
left	O
,	O
partial	O
nephrectomy	O
:	O
Renal	O
cell	O
carcinoma	O
,	O
chromophobe	O
type	O
.	O

3	O
.	O

Renal	O
,	O
tumor	O
#	O
5	O
,	O
left	O
,	O
partial	O
nephrectomy	O
:	O
Renal	O
cell	O
carcinoma	O
,	O
chromophobe	O
type	O
.	O

4	O
.	O

Renal	O
,	O
tumor	O
#	O
2	O
,	O
left	O
,	O
partial	O
nephrectomy	O
:	O
Renal	O
cell	O
carcinoma	O
,	O
chromophobe	O
type	O
.	O

5	O
.	O

Renal	O
,	O
tumor	O
#	O
3	O
,	O
left	O
,	O
partial	O
nephrectomy	O
:	O
Renal	O
cell	O
carcinoma	O
,	O
chromophobe	O
type	O
.	O

6	O
.	O

Renal	O
,	O
tumor	O
#	O
6	O
,	O
left	O
,	O
partial	O
nephrectomy	O
:	O
Renal	O
cell	O
carcinoma	O
,	O
chromophobe	O
type	O
.	O

7	O
.	O

Renal	O
,	O
tumor	O
#	O
7	O
,	O
left	O
,	O
partial	O
nephrectomy	O
:	O
Renal	O
cell	O
carcinoma	O
,	O
chromophobe	O
type	O
.	O

8	O
.	O

Renal	O
,	O
tumor	O
#	O
8	O
,	O
left	O
,	O
partial	O
nephrectomy	O
:	O
Renal	O
cell	O
carcinoma	O
,	O
clear	O
cell	O
type	O
,	O
Fuhrman	O
nuclear	O
grade	O
.	O

Il	O
/	O
III	O
.	O

Renal	O
cell	O
Carcinoma	O
,	O
Chromophobe	O
type	O
.	O

See	O
note	O
.	O

9	O
.	O

Renal	O
,	O
tumor	O
#	O
9	O
,	O
left	O
,	O
partial	O
nephrectomy	O
:	O
Renal	O
cell	O
carcinoma	O
,	O
clear	O
cell	O
type	O
,	O
Fuhrman	O
nuclear	O
grade	O
.	O

Il	O
/	O
III	O
.	O

Renal	O
cell	O
carcinoma	O
,	O
Chromophobe	O
type	O
.	O

See	O
note	O
.	O

NOTE	O
:	O
In	O
specimens	O
8	O
and	O
9	O
,	O
two	O
grossly	O
and	O
morphologically	O
different	O
tumor	O
masses	O
are	O
identified	O
;	O
one	O
is	O
a	O
.	O
clear	O
cell	O
RCC	O
and	O
the	O
other	O
one	O
an	O
RCC	O
chromophobe	O
type	O
.	O

Immunoperoxidase	O
and	O
in	O
-	O
situ	O
hybridization	O
tests	O
performed	O
here	O
and	O
used	O
for	O
diagnosis	O
were	O
developed	O
and	O
their	O
performance	O
.	O
characteristics	O
determined	O
by	O
the	O
.	O

They	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
.	O

Administration	O
.	O

The	O
FDA	O
has	O
also	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

This	O
laboratory	O
is	O
certified	O
under	O
the	O
Clinical	O
.	O

Laboratory	O
Improvement	O
Amendments	O
of	O
.	O

(	O
CLIA	O
)	O
as	O
qualified	O
to	O
perform	O
high	O
complexity	O
clinical	O
laboratory	O
testing	O
.	O

CLINICAL	O
INFORMATION	O
:	O
Brief	O
Clinical	O
History	O
:	O
yo	O
.	O
male	O
with	O
bilateral	O
renal	O
tumors	O
and	O
no	O
known	O
family	O
history	O
of	O
renal	O
.	O
cancer	O
,	O
attention	O
.	O

PROCEDURE	O
:	O
Pre	O
-	O
Operative	O
Diagnosis	O
:	O
renal	O
tumors	O
Post	O
-	O
Operative	O
Diagnosis	O
:	O
renal	O
.	O
tumors	O
Operative	O
Findings	O
:	O
diffuse	O
involvement	O
of	O
left	O
kidney	O
with	O
.	O
renal	O
tumors	O
;	O
minimal	O
normal	O
parenchyma	O
observed	O
on	O
intraoperative	O
.	O
sonogram	O
.	O

SPECIMENS	O
SUBMITTED	O
:	O
1	O
.	O

TUMOR	O
,	O
Left	O
kidney	O
#	O
1	O
(	O
1FS	O
)	O
.	O

2	O
.	O

TUMOR	O
,	O
Left	O
kidney	O
#	O
4	O
(	O
2FS	O
)	O
.	O

3	O
.	O

TUMOR	O
,	O
Left	O
kidney	O
#	O
5	O
(	O
3FS	O
)	O
.	O

4	O
.	O

TUMOR	O
,	O
Left	O
kidney	O
#	O
2	O
.	O

5	O
.	O

TUMOR	O
,	O
Left	O
kidney	O
#	O
3	O
.	O

6	O
.	O

TUMOR	O
,	O
Left	O
kdieny	O
#	O
6	O
.	O

7	O
.	O

TUMOR	O
,	O
Left	O
kidney	O
#	O
7	O
.	O

8	O
.	O

TUMOR	O
,	O
Left	O
kidney	O
#	O
8	O
.	O

9	O
.	O

TUMOR	O
,	O
Left	O
kidney	O
#	O
9	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
:	O
1	O
.	O

"	O
Tumor	O
#	O
1	O
left	O
kidney	O
"	O
.	O

1FS	O
diagnosis	O
:	O
Oncocytic	O
neoplasm	O
,	O
favoring	O
oncocytoma	O
.	O

2	O
.	O

"	O
Tumor	O
#	O
4	O
left	O
kidney	O
"	O
.	O

2FS	O
diagnosis	O
:	O
Oncocytic	O
neoplasm	O
.	O

3	O
.	O

"	O
Tumor	O
#	O
5	O
left	O
kidney	O
"	O
.	O

3FS	O
diagnosis	O
:	O
Oncocytic	O
neoplasm	O
.	O

These	O
findings	O
were	O
reported	O
by	O
.	O

GROSS	O
DESCRIPTION	O
:	O
Received	O
fresh	O
from	O
the	O
OR	O
is	O
a	O
specimen	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
medical	O
record	O
number	O
,	O
and	O
further	O
.	O
specified	O
as	O
:	O
1	O
.	O

"	O
tumor	O
#	O
1	O
left	O
kidney	O
"	O
.	O

It	O
is	O
an	O
ovoid	O
red	O
to	O
pink	O
nodular	O
tissue	O
fragment	O
measuring	O
2	O
x	O
1	O
.	O
5	O
X	O
0	O
.	O
8	O
cm	O
.	O

It	O
is	O
.	O
trisected	O
revealing	O
a	O
pink	O
-	O
tan	O
homogeneous	O
cut	O
surface	O
.	O

The	O
central	O
slice	O
is	O
frozen	O
as	O
"	O
1FS	O
"	O
.	O

Received	O
in	O
.	O
the	O
Gross	O
Pathology	O
Lab	O
is	O
a	O
specimen	O
matching	O
the	O
above	O
description	O
.	O

The	O
portion	O
submitted	O
as	O
frozen	O
.	O
section	O
is	O
transferred	O
to	O
an	O
orange	O
cassette	O
labeled	O
1FS	O
.	O

A	O
second	O
of	O
the	O
trisected	O
pieces	O
is	O
submitted	O
in	O
.	O
cassette	O
labeled	O
.	O
or	O
permanent	O
processing	O
.	O

2	O
.	O

"	O
tumor	O
#	O
4	O
left	O
kidney	O
"	O
.	O

It	O
consists	O
of	O
a	O
red	O
to	O
tan	O
2	O
.	O
5	O
x	O
1	O
.	O
8	O
x	O
1	O
cm	O
tissue	O
fragment	O
.	O

It	O
was	O
trisected	O
and	O
the	O
.	O
middle	O
section	O
is	O
submitted	O
as	O
2FS	O
.	O

Received	O
in	O
the	O
Gross	O
Pathology	O
Lab	O
is	O
a	O
specimen	O
matching	O
the	O
.	O
above	O
description	O
.	O

The	O
section	O
submitted	O
for	O
frozen	O
is	O
transferred	O
to	O
an	O
orange	O
cassette	O
labeled	O
2FS	O
for	O
.	O
permanent	O
processing	O
.	O

Representative	O
further	O
sections	O
are	O
taken	O
and	O
submitted	O
in	O
cassettes	O
2A	O
and	O
2B	O
.	O

3	O
.	O

"	O
tumor	O
#	O
5	O
left	O
kidney	O
"	O
.	O

It	O
consists	O
of	O
a	O
red	O
-	O
tan	O
5	O
X	O
5	O
X	O
3	O
.	O
5	O
-	O
cm	O
tissue	O
fragment	O
.	O

It	O
was	O
bisected	O
to	O
reveal	O
a	O
.	O
red	O
to	O
tan	O
hemorrhagic	O
cut	O
surface	O
.	O

Representative	O
sections	O
are	O
frozen	O
as	O
3FS	O
.	O

Received	O
in	O
the	O
Gross	O
.	O

Pathology	O
Lab	O
is	O
a	O
specimen	O
matching	O
the	O
above	O
description	O
.	O

The	O
frozen	O
specimen	O
was	O
transferred	O
to	O
an	O
.	O
orange	O
cassette	O
labeled	O
3FS	O
for	O
permanent	O
processing	O
.	O

Cassettes	O
3A	O
-	O
3G	O
contains	O
representative	O
.	O
sections	O
of	O
the	O
tumor	O
.	O

4	O
.	O

"	O
tumor	O
#	O
2	O
left	O
kidney	O
"	O
.	O

It	O
is	O
a	O
dome	O
-	O
shaped	O
red	O
to	O
pink	O
nodular	O
tissue	O
fragment	O
measuring	O
2	O
x	O
1	O
.	O
4	O
x	O
0	O
.	O
7	O
.	O

cm	O
.	O

It	O
is	O
bisected	O
revealing	O
a	O
homogeneous	O
tan	O
to	O
pink	O
cut	O
surface	O
with	O
central	O
hemorrhage	O
.	O

Approximately	O
60	O
%	O
of	O
the	O
tissue	O
is	O
procured	O
for	O
UOB	O
.	O

Gross	O
photographs	O
are	O
taken	O
and	O
the	O
remainder	O
of	O
.	O
the	O
specimen	O
is	O
placed	O
in	O
formalin	O
and	O
submitted	O
to	O
Pathology	O
for	O
permanent	O
processing	O
.	O

In	O
the	O
Gross	O
.	O

Pathology	O
Lab	O
a	O
specimen	O
matching	O
the	O
above	O
description	O
is	O
received	O
.	O

It	O
is	O
entirely	O
submitted	O
in	O
a	O
.	O
cassette	O
labeled	O
.	O
or	O
permanent	O
processing	O
.	O

5	O
.	O

"	O
Tumor	O
#	O
3	O
left	O
kidney	O
"	O
.	O

It	O
is	O
a	O
dome	O
-	O
shaped	O
red	O
to	O
pink	O
nodular	O
tissue	O
fragment	O
measuring	O
1	O
.	O
8	O
X	O
1	O
.	O
4	O
X	O
0	O
.	O
5	O
.	O

cm	O
.	O

It	O
is	O
bisected	O
revealing	O
a	O
hemorrhagic	O
maroon	O
/	O
red	O
cut	O
surface	O
.	O

Approximately	O
50	O
%	O
of	O
the	O
tissue	O
is	O
.	O
procured	O
for	O
UOB	O
.	O

Gross	O
photographs	O
are	O
taken	O
and	O
the	O
remainder	O
of	O
the	O
specimen	O
is	O
placed	O
into	O
.	O
formalin	O
and	O
submitted	O
to	O
Pathology	O
for	O
permanent	O
processing	O
.	O

Received	O
in	O
the	O
Gross	O
Pathology	O
Lab	O
is	O
a	O
.	O
specimen	O
matching	O
the	O
above	O
description	O
.	O

A	O
representative	O
section	O
is	O
submitted	O
in	O
a	O
cassette	O
labeled	O
.	O
or	O
permanent	O
processing	O
.	O

6	O
.	O

"	O
Tumor	O
#	O
6	O
left	O
kidney	O
"	O
.	O

The	O
specimen	O
is	O
a	O
spherical	O
pink	O
to	O
red	O
nodular	O
tissue	O
fragment	O
measuring	O
4	O
.	O
8	O
x	O
.	O

4	O
.	O
8	O
x	O
4	O
.	O
7	O
cm	O
.	O

It	O
is	O
bisected	O
revealing	O
a	O
focally	O
disrupted	O
tan	O
to	O
pink	O
nodular	O
tissue	O
fragment	O
that	O
is	O
.	O
homogeneous	O
.	O

The	O
surface	O
is	O
tan	O
to	O
pink	O
and	O
fleshy	O
.	O

Approximately	O
30	O
%	O
of	O
the	O
tissue	O
is	O
procured	O
for	O
.	O

UOB	O
.	O

Gross	O
photographs	O
are	O
taken	O
and	O
the	O
remainder	O
of	O
the	O
specimen	O
is	O
placed	O
into	O
formalin	O
and	O
.	O
submitted	O
to	O
Pathology	O
for	O
permanent	O
processing	O
.	O

Received	O
in	O
the	O
Gross	O
Pathology	O
Lab	O
is	O
a	O
specimen	O
.	O
matching	O
the	O
above	O
description	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
cassettes	O
6A	O
-	O
6E	O
.	O

Cassette	O
6A	O
.	O
contains	O
a	O
portion	O
of	O
adjacent	O
tissue	O
that	O
has	O
a	O
distinct	O
smooth	O
creamy	O
texture	O
compared	O
to	O
the	O
rest	O
of	O
the	O
.	O
lesion	O
.	O

7	O
.	O

"	O
Tumor	O
#	O
7	O
left	O
kidney	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
2	O
fragments	O
that	O
are	O
red	O
to	O
tan	O
soft	O
tissue	O
and	O
1	O
yellow	O
.	O
to	O
pink	O
soft	O
tissue	O
fragment	O
measuring	O
from	O
2	O
.	O
5	O
to	O
4	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
largest	O
fragment	O
is	O
.	O
bisected	O
revealing	O
a	O
variegated	O
maroon	O
to	O
pink	O
hemorrhagic	O
cut	O
surface	O
measuring	O
4	O
.	O
5	O
X	O
3	O
.	O
5	O
x	O
3	O
.	O

Approximately	O
50	O
%	O
of	O
tissue	O
from	O
the	O
largest	O
fragment	O
is	O
procured	O
for	O
UOB	O
.	O

Gross	O
photographs	O
are	O
.	O
taken	O
and	O
the	O
remainder	O
of	O
the	O
specimen	O
is	O
placed	O
into	O
formalin	O
and	O
submitted	O
to	O
Pathology	O
for	O
.	O
permanent	O
processing	O
.	O

Received	O
in	O
the	O
Gross	O
Pathology	O
Lab	O
is	O
a	O
specimen	O
matching	O
the	O
above	O
.	O
description	O
.	O

Representative	O
sections	O
are	O
taken	O
and	O
submitted	O
in	O
cassettes	O
labeled	O
7A	O
-	O
7F	O
for	O
permanent	O
.	O
processing	O
.	O

8	O
.	O

"	O
Tumor	O
#	O
8	O
left	O
kidney	O
"	O
is	O
a	O
focally	O
disrupted	O
ovoid	O
pink	O
to	O
tan	O
nodular	O
tissue	O
fragment	O
measuring	O
5	O
.	O
5	O
X	O
5	O
X	O
.	O

3	O
.	O
5	O
cm	O
.	O

It	O
is	O
bisected	O
revealing	O
a	O
tan	O
-	O
pink	O
fleshy	O
cut	O
surface	O
with	O
a	O
well	O
-	O
circumscribed	O
yellow	O
to	O
tan	O
.	O
spherical	O
nodule	O
,	O
1	O
.	O
2	O
cm	O
in	O
greatest	O
diameter	O
,	O
at	O
the	O
periphery	O
.	O

Approximately	O
50	O
%	O
of	O
the	O
tissue	O
,	O
.	O
spherical	O
tan	O
nodule	O
,	O
and	O
20	O
%	O
of	O
the	O
rest	O
of	O
the	O
specimen	O
are	O
procured	O
.	O

The	O
remainder	O
of	O
the	O
specimen	O
.	O

is	O
placed	O
into	O
formalin	O
and	O
submitted	O
to	O
Pathology	O
for	O
permanent	O
processing	O
.	O

Received	O
in	O
the	O
Gross	O
.	O

Pathology	O
Lab	O
is	O
a	O
specimen	O
matching	O
the	O
above	O
description	O
.	O

Representative	O
sections	O
of	O
the	O
specimen	O
.	O
are	O
taken	O
and	O
submitted	O
in	O
cassettes	O
8A	O
-	O
8E	O
.	O

Please	O
note	O
that	O
8E	O
contains	O
a	O
representative	O
section	O
of	O
the	O
.	O
nodule	O
described	O
.	O

9	O
.	O

"	O
Tumor	O
#	O
9	O
left	O
kidney	O
"	O
.	O

It	O
is	O
a	O
binodular	O
pink	O
to	O
tan	O
tissue	O
fragment	O
overall	O
measuring	O
2	O
x	O
1	O
.	O
5	O
x	O
1	O
.	O
5	O
cm	O
.	O

One	O
nodule	O
is	O
well	O
-	O
circumscribed	O
and	O
solid	O
homogeneous	O
and	O
tan	O
measuring	O
1	O
.	O
3	O
cm	O
.	O

The	O
other	O
is	O
ill	O
-	O
.	O
defined	O
,	O
hemorrhagic	O
,	O
and	O
variegated	O
maroon	O
to	O
tan	O
and	O
measuring	O
1	O
.	O
2	O
cm	O
.	O

Approximately	O
50	O
%	O
of	O
tissue	O
.	O

is	O
procured	O
for	O
UOB	O
.	O

Gross	O
photographs	O
are	O
taken	O
and	O
the	O
remainder	O
of	O
the	O
specimen	O
is	O
placed	O
into	O
.	O
formalin	O
and	O
submitted	O
to	O
Pathology	O
for	O
permanent	O
processing	O
.	O

Received	O
in	O
Pathology	O
is	O
a	O
specimen	O
.	O
matching	O
the	O
above	O
description	O
.	O

The	O
two	O
fragments	O
are	O
submitted	O
in	O
white	O
cassettes	O
labeled	O
9A	O
and	O
9B	O
.	O

AZR1	O
.	O
dentification	O
.	O

4	O
of	O
5	O
.	O

NIH	O
-	O
2772	O
(	O
7	O
/	O
97	O
)	O
.	O

P	O
.	O
A	O
.	O

09	O
-	O
25	O
-	O
0099	O
.	O

File	O
in	O
Section	O
3	O
:	O
Tissue	O
Examination	O
.	O

-DOCSTART-239
Med	O
Rec	O
.	O

#	O
:	O
Report	O
Name	O
:	O
:	O
Surg	O
Path	O
Case	O
-	O
STATUS	O
:	O
Final	O
.	O

ES	O
NOTE	O
.	O

Collect	O
/	O
Perform	O
:	O
Department	O
:	O
Physician	O
who	O
Performed	O
Procedure	O
:	O
Requesting	O
Physician	O
:	O
Attending	O
Pathologist	O
:	O
DIAGNOSIS	O
:	O
Cervix	O
,	O
biopsy	O
:	O
-	O
Fragments	O
of	O
invasive	O
poorly	O
differentiated	O
squamous	O
carcinoma	O
.	O

-	O
Orientation	O
precludes	O
measurement	O
of	O
depth	O
of	O
invasion	O
.	O

COMMENT	O
:	O
There	O
is	O
a	O
copious	O
amount	O
of	O
sampled	O
tigsue	O
,	O
almost	O
all	O
of	O
which	O
.	O

is	O
composed	O
of	O
.	O
tumor	O
.	O

A	O
p63	O
stain	O
is	O
strongly	O
positive	O
supporting	O
the	O
diagnosis	O
.	O

CLINICAL	O
INFORMATION	O
:	O
Cervical	O
cancer	O
.	O

GROSS	O
DESCRIPTION	O
:	O
The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
"	O
cervical	O
biopsy	O
.	O

It	O
consists	O
of	O
a	O
.	O

2	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
4	O
cm	O
.	O
irregular	O
portion	O
of	O
tan	O
rubbery	O
tissue	O
.	O

One	O
aspect	O
demonstrates	O
apparent	O
.	O
tan	O
smooth	O
mucosa	O
.	O

The	O
tissue	O
is	O
inked	O
and	O
serially	O
sectioned	O
.	O

The	O
cut	O
.	O
surfaces	O
are	O
tan	O
and	O
smooth	O
.	O

Also	O
received	O
are	O
two	O
tan	O
rubbery	O
tissue	O
.	O
fragments	O
measuring	O
0	O
.	O
5	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
cm	O
in	O
aggregate	O
.	O

The	O
specimen	O
is	O
.	O
entirely	O
submitted	O
in	O
three	O
cassettes	O
as	O
follows	O
:	O
1A	O
-	O
1B	O
-	O
largest	O
portion	O
of	O
tissue	O
,	O
sectioned	O
.	O

1C	O
separately	O
received	O
tissue	O
fragments	O
.	O

The	O
following	O
special	O
studies	O
were	O
performed	O
on	O
this	O
case	O
and	O
the	O
.	O
interpretation	O
is	O
incorporated	O
in	O
the	O
diagnostic	O
report	O
above	O
:	O
Report	O
Name	O
:	O
I	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
diagnostic	O
evaluation	O
of	O
the	O
.	O
above	O
specimen	O
(	O
s	O
)	O
and	O
have	O
rendered	O
the	O
final	O
diagnosis	O
(	O
es	O
)	O
.	O

Note	O
:	O
The	O
histology	O
,	O
immunochemistry	O
and	O
in	O
situ	O
hybridization	O
components	O
.	O
for	O
this	O
case	O
were	O
performed	O
at	O
.	O

The	O
Attending	O
Pathologist	O
reviewed	O
this	O
case	O
and	O
made	O
the	O
diagnosis	O
.	O

Where	O
applicable	O
,	O
immunohistochemistry	O
and	O
in	O
situ	O
hybridization	O
teats	O
were	O
.	O
developed	O
and	O
the	O
performance	O
characteristics	O
determined	O
by	O
the	O
.	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
US	O
Food	O
and	O
Drug	O
Administration	O
.	O
and	O
the	O
results	O
should	O
be	O
correlated	O
with	O
other	O
clinical	O
and	O
laboratory	O
.	O
data	O
.	O

Appropriate	O
controls	O
were	O
performed	O
for	O
all	O
immunohistochemistry	O
;	O
in	O
.	O
situ	O
hybridization	O
and	O
histochemical	O
tests	O
.	O

-DOCSTART-240
Sex	O
:	O
F	O
.	O

Case	O
type	O
:	O
Surgical	O
Case	O
.	O

DIAGNOSIS	O
.	O

(	O
A	O
)	O
THYROID	O
,	O
TOTAL	O
THYROIDECTOMY	O
:	O
PAPILLARY	O
THYROID	O
CARCINOMA	O
(	O
3	B
.	I
0	I
X	I
2	I
.	I
0	I
CM	I
)	O
INVOLVING	O
THE	O
RIGHT	O
LOBE	O
OF	O
THE	O
THYROID	O
.	O

EXTRATHYROIDAL	O
EXTENSION	O
PRESENT	O
.	O

Margins	O
of	O
resection	O
free	O
of	O
tumor	O
.	O

VASCULAR	O
INVASION	O
IDENTIFIED	O
.	O

METASTATIC	O
PAPILLARY	O
CARCINOMA	O
IN	O
SIX	O
OF	O
SEVEN	O
EXAMINED	O
PERITHYROIDAL	O
LYMPH	O
NODES	O
(	O
6	O
/	O
7	O
)	O
.	O

(	O
B	O
)	O
TISSUE	O
DESIGNATED	O
RULE	O
OUT	O
PARATHYROID	O
,	O
EXCISION	O
:	O
Parathyroid	O
tissue	O
present	O
.	O

(	O
C	O
)	O
RIGHT	O
PARATRACHEAL	O
LYMPH	O
NODES	O
,	O
NODE	O
DISSECTION	O
:	O
METASTATIC	O
PAPILLARY	O
CARCINOMA	O
IN	O
NINE	O
OF	O
TWELVE	O
EXAMINED	O
LYMPH	O
NODES	O
(	O
9	O
/	O
12	O
)	O
;	O
NO	O
.	O

EXTRACAPSULAR	O
EXTENSION	O
PRESENT	O
.	O

(	O
D	O
)	O
RIGHT	O
BUCCAL	O
LESION	O
,	O
EXCISION	O
:	O
One	O
benign	O
lymph	O
node	O
with	O
no	O
tumor	O
present	O
(	O
0	O
/	O
1	O
)	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
.	O

GROSS	O
DESCRIPTION	O
.	O

(	O
A	O
)	O
TOTAL	O
THYROIDECTOMY	O
-	O
A	O
total	O
thyroidectomy	O
specimen	O
consisting	O
of	O
a	O
right	O
lobe	O
(	O
5	O
.	O
0	O
x	O
2	O
.	O
5	O
x	O
2	O
.	O
0	O
cm	O
)	O
,	O
unremarkable	O
.	O
isthmus	O
(	O
2	O
.	O
0	O
x	O
2	O
.	O
0	O
x	O
0	O
.	O
5	O
cm	O
)	O
with	O
possible	O
pyramidal	O
lobe	O
,	O
and	O
left	O
lobe	O
(	O
3	O
.	O
0	O
x	O
2	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
)	O
.	O

The	O
cut	O
surface	O
of	O
the	O
right	O
lobe	O
shows	O
a	O
well	O
defined	O
,	O
soft	O
,	O
papillary	O
lesion	O
(	O
3	O
.	O
0	O
x	O
2	O
.	O
0x	O
2	O
.	O
0	O
.	O
cm	O
)	O
.	O
involving	O
.	O

the	O
.	O
middle	O
.	O

and	O
.	O
the	O
lower	O
third	O
of	O
the	O
lobe	O
.	O

The	O
cut	O
surface	O
of	O
the	O
isthmus	O
and	O
the	O
left	O
lobe	O
are	O
unremarkable	O
.	O

SECTION	O
CODE	O
:	O
A1	O
-	O
A5	O
,	O
tumor	O
,	O
right	O
lobe	O
;	O
A6	O
-	O
A8	O
,	O
remnant	O
of	O
unremarkable	O
left	O
lobe	O
;	O
A9	O
,	O
possible	O
pyramidal	O
lobe	O
;	O
A10	O
,	O
.	O
isthmus	O
,	O
in	O
toto	O
;	O
A11	O
,	O
left	O
lobe	O
,	O
in	O
toto	O
.	O

Sampling	O
of	O
the	O
tumor	O
and	O
unremarkable	O
thyroid	O
parenchyma	O
was	O
performed	O
for	O
the	O
tumor	O
bank	O
.	O

(	O
B	O
)	O
RULE	O
OUT	O
PARATHYROID	O
-	O
A	O
0	O
.	O
3	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
cm	O
pink	O
fragment	O
of	O
soft	O
tissue	O
.	O

Specimen	O
is	O
submitted	O
in	O
toto	O
in	O
B	O
for	O
frozen	O
.	O
section	O
.	O

Also	O
prepared	O
are	O
two	O
touch	O
preps	O
.	O

FS	O
/	O
DX	O
:	O
PARATHYROID	O
TISSUE	O
.	O

(	O
C	O
)	O
.	O

RIGHT	O
PARATRACHEAL	O
DISSECTION	O
-	O
An	O
irregular	O
fragment	O
of	O
fibrous	O
adipose	O
tissue	O
measuring	O
4	O
.	O
0	O
x	O
2	O
.	O
5x0	O
.	O
8	O
cm	O
.	O

The	O
.	O
specimen	O
is	O
serially	O
sectioned	O
and	O
ten	O
lymph	O
nodes	O
are	O
identified	O
ranging	O
from	O
(	O
0	O
.	O
3	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
to	O
1	O
.	O
0	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
4	O
cm	O
)	O
.	O

SECTION	O
CODE	O
:	O
C1	O
,	O
four	O
lymph	O
nodes	O
;	O
C2	O
,	O
four	O
lymph	O
nodes	O
;	O
C3	O
,	O
two	O
lymph	O
nodes	O
.	O

(	O
D	O
)	O
RIGHT	O
BUCCAL	O
LESION	O
-	O
A	O
yellow	O
-	O
pink	O
node	O
measuring	O
0	O
.	O
8	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
4	O
cm	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
D	O
.	O

COOLEY	O
,	O
CHERYL	O
.	O

Sex	O
:	O
F	O
.	O

Case	O
type	O
:	O
Surgical	O
Case	O
.	O

CLINICAL	O
HISTORY	O
.	O

Papillary	O
thyroid	O
cancer	O
.	O

SNOMED	O
CODES	O
.	O

T	O
-	O
B6000	O
,	O
M	O
-	O
80503	O
,	O
M	O
-	O
80506	O
.	O

"	O
Some	O
tests	O
reported	O
here	O
may	O
have	O
been	O
developed	O
and	O
performance	O
characteristics	O
determined	O
by	O
.	O
hase	O
tests	O
have	O
not	O
been	O
specifically	O
cleared	O
or	O
approved	O
.	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O
"	O
.	O

Released	O
by	O
:	O

-DOCSTART-241
bepartment	O
of	O
Pathology	O
&	O
Laboratory	O
Medicine	O
.	O

Addendum	O
-	O
Please	O
See	O
End	O
of	O
Report	O
.	O

Reason	O
for	O
Addendum	O
#	O
1	O
:	O
Additional	O
studies	O
/	O
stains	O
/	O
opinion	O
(	O
s	O
)	O
.	O

DIAGNOSIS	O
:	O
A	O
,	O
G	O
,	O
H	O
.	O

BRAIN	O
,	O
RIGHT	O
TEMPORAL	O
,	O
EXCISIONAL	O
BIOPSY	O
:	O
Glioblastoma	O
multiforme	O
,	O
WHO	O
grade	O
IV	O
.	O

B	O
.	O

BRAIN	O
,	O
RIGHT	O
TEMPORAL	O
,	O
EXCISIONAL	O
BIOPSY	O
:	O
Glioblastoma	O
multiforme	O
,	O
WHO	O
grade	O
IV	O
.	O

Proportion	O
of	O
the	O
tumor	O
-	O
95	O
%	O
.	O

Proportion	O
of	O
necrosis	O
-	O
10	O
%	O
.	O

C	O
.	O

BRAIN	O
,	O
RIGHT	O
TEMPORAL	O
,	O
EXCISIONAL	O
BIOPSY	O
:	O
Glioblastoma	O
multiforme	O
,	O
WHO	O
grade	O
IV	O
.	O

Proportion	O
of	O
the	O
tumor	O
-	O
100	O
%	O
.	O

Proportion	O
of	O
necrosis	O
-	O
30	O
%	O
.	O

D	O
.	O

BRAIN	O
,	O
RIGHT	O
TEMPORAL	O
,	O
EXCISIONAL	O
BIOPSY	O
:	O
Glioblastoma	O
multiforme	O
,	O
WHO	O
grade	O
IV	O
.	O

Proportion	O
of	O
the	O
tumor	O
-	O
100	O
%	O
of	O
cortex	O
and	O
white	O
matter	O
infiltrated	O
by	O
the	O
tumor	O
.	O

Proportion	O
of	O
necrosis	O
-	O
0	O
%	O
.	O

E	O
.	O

BRAIN	O
,	O
RIGHT	O
TEMPORAL	O
,	O
EXCISIONAL	O
BIOPSY	O
:	O
Glioblastoma	O
multiforme	O
,	O
WHO	O
grade	O
IV	O
.	O

Proportion	O
of	O
the	O
tumor	O
-	O
100	O
%	O
.	O

Proportion	O
of	O
necrosis	O
-	O
25	O
%	O
.	O

F	O
.	O

BRAIN	O
,	O
RIGHT	O
TEMPORAL	O
,	O
EXCISIONAL	O
BIOPSY	O
:	O
Glioblastoma	O
multiforme	O
,	O
WHO	O
grade	O
IV	O
.	O

Proportion	O
of	O
the	O
tumor	O
-	O
100	O
%	O
.	O

Proportion	O
of	O
necrosis	O
-	O
0	O
%	O
.	O

COMMENT	O
:	O
A	O
high	O
percentage	O
of	O
tumor	O
cells	O
(	O
greater	O
than	O
20	O
%	O
)	O
immunostaining	O
for	O
MGMT	O
has	O
been	O
reported	O
to	O
be	O
associated	O
.	O
with	O
a	O
relatively	O
diminished	O
response	O
to	O
Temodar	O
.	O

Hence	O
,	O
the	O
low	O
5	O
%	O
result	O
in	O
.	O
this	O
case	O
suggests	O
a	O
likelihood	O
of	O
this	O
tumor	O
being	O
responsive	O
to	O
Temodar	O
.	O

Recent	O
studies	O
have	O
shown	O
that	O
co	O
-	O
expression	O
of	O
EGFRvIII	O
and	O
PTEN	O
as	O
detected	O
by	O
immunostaining	O
was	O
.	O
significantly	O
correlated	O
with	O
a	O
clinical	O
response	O
of	O
glioblastomas	O
to	O
EGFR	O
kinase	O
inhibitors	O
.	O

Hence	O
the	O
loss	O
of	O
PTEN	O
in	O
this	O
case	O
suggests	O
a	O
diminished	O
probability	O
of	O
response	O
to	O
.	O

EGFR	O
-	O
kinase	O
inhibitors	O
.	O

Patient	O
Case	O
(	O
s	O
)	O
:	O
Page	O
UI	O
,	O
.	O

PATIENT	O
NOTIFIED	O
OF	O
RESULTS	O
.	O

DR	O
:	O
NURSE	O
:	O
Addendum	O
-	O
Please	O
See	O
End	O
of	O
Report	O
.	O

Recent	O
studies	O
indicated	O
an	O
adverse	O
prognostic	O
significance	O
of	O
increased	O
expression	O
of	O
laminin	O
beta	O
1	O
and	O
decreased	O
.	O
expression	O
of	O
laminin	O
beta	O
2	O
predicting	O
a	O
worse	O
survival	O
of	O
patients	O
with	O
gliomas	O
.	O
between	O
laminin	O
-	O
8	O
and	O
glial	O
tumor	O
grade	O
,	O
recurrence	O
,	O
and	O
patient	O
survival	O
.	O

Accordingly	O
,	O
elevated	O
expression	O
of	O
beta	O
1	O
and	O
suppressed	O
expression	O
of	O
beta	O
2	O
in	O
this	O
tumor	O
predict	O
more	O
.	O
aggressive	O
behavior	O
.	O

Retained	O
expression	O
of	O
PTEN	O
was	O
found	O
to	O
be	O
associated	O
with	O
a	O
more	O
favorable	O
prognosis	O
in	O
patients	O
with	O
high	O
.	O
grade	O
gliomas	O
.	O

Molecular	O
subclasses	O
of	O
high	O
-	O
grade	O
glioma	O
.	O
predict	O
prognosis	O
,	O
delineate	O
a	O
pattern	O
of	O
disease	O
progression	O
,	O
and	O
resemble	O
stages	O
in	O
neurogenesis	O
.	O

Cancer	O
Cell	O
.	O

Presence	O
of	O
activated	O
(	O
phosphorylated	O
p42	O
/	O
44	O
Mitogen	O
-	O
Activated	O
Protein	O
Kinase	O
(	O
pMAPK	O
)	O
has	O
been	O
shown	O
to	O
be	O
.	O
associated	O
with	O
a	O
relative	O
resistance	O
of	O
glioblastoma	O
multiforme	O
to	O
radiation	O
therapy	O
.	O

Prognostic	O
Associations	O
of	O
Activated	O
Mitogen	O
-	O
Activated	O
Protein	O
Kinase	O
and	O
Akt	O
Pathways	O
in	O
.	O

Glioblastoma	O
.	O

Correspondingly	O
,	O
presence	O
of	O
a	O
large	O
fraction	O
of	O
cells	O
immunonegative	O
to	O
pMAPK	O
antibody	O
in	O
this	O
case	O
suggests	O
a	O
.	O
likelihood	O
of	O
this	O
tumor	O
being	O
responsive	O
to	O
radiation	O
therapy	O
.	O

The	O
use	O
of	O
these	O
tests	O
in	O
guiding	O
therapy	O
has	O
limitations	O
.	O

Review	O
of	O
the	O
relevant	O
literature	O
and	O
clinical	O
correlation	O
.	O

is	O
.	O
advised	O
.	O

These	O
test	O
results	O
do	O
not	O
obligate	O
or	O
preclude	O
use	O
of	O
the	O
relevant	O
therapeutic	O
agents	O
.	O

IDC2a	O
:	O
Selected	O
slides	O
were	O
reviewed	O
in	O
consultation	O
with	O
.	O

HISTORY	O
:	O
Temporal	O
tumor	O
.	O

MICROSCOPIC	O
:	O
Sections	O
disclose	O
necrotizing	O
malignant	O
neoplasm	O
featuring	O
striking	O
microvascular	O
proliferation	O
and	O
composed	O
of	O
.	O
diffuse	O
infiltration	O
of	O
hyperchromatic	O
elongate	O
astrocytic	O
nuclei	O
showing	O
numerous	O
mitotic	O
figures	O
.	O

The	O
tumor	O
.	O
displays	O
extensive	O
infiltration	O
with	O
focal	O
extension	O
to	O
the	O
pia	O
.	O

IMMUNOSTAINS	O
:	O
MGMT	O
(	O
G3	O
)	O
:	O
3	O
%	O
.	O

PTEN	O
(	O
G3	O
)	O
:	O
Loss	O
(	O
I	O
+	O
)	O
.	O

pMAPK	O
(	O
G3	O
)	O
:	O
10	O
%	O
of	O
tumor	O
nuclei	O
and	O
15	O
%	O
of	O
tumor	O
cell	O
cytoplasm	O
is	O
positive	O
.	O

Laminin	O
beta	O
-	O
1	O
(	O
8	O
/	O
411	O
)	O
(	O
G3	O
)	O
:	O
Upregulated	O
(	O
3	O
+	O
in	O
endothelial	O
cells	O
)	O
.	O

Laminin	O
beta	O
-	O
2	O
(	O
9	O
/	O
421	O
)	O
(	O
G3	O
)	O
:	O
Focal	O
loss	O
(	O
0	O
-	O
1	O
+	O
staining	O
in	O
endothelial	O
cells	O
)	O
.	O

GROSS	O
:	O
A	O
.	O

RIGHT	O
TEMPORAL	O
TUMOR	O
FS	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
"	O
right	O
temporal	O
"	O
,	O
and	O
received	O
fresh	O
in	O
the	O
Operating	O
Room	O
for	O
frozen	O
.	O
section	O
consultation	O
and	O
subsequently	O
fixed	O
in	O
formalin	O
is	O
a	O
1	O
.	O
5	O
x	O
2	O
.	O
1	O
x	O
0	O
.	O
4	O
cm	O
aggregate	O
of	O
multiple	O
pink	O
-	O
tan	O
soft	O
.	O
tissue	O
fragments	O
ranging	O
from	O
0	O
.	O
1	O
to	O
1	O
.	O
1	O
cm	O
in	O
greatest	O
dimension	O
.	O

Entirely	O
submitted	O
.	O

A1	O
.	O

Frozen	O
section	O
remnant	O
-	O
1	O
.	O

A2	O
.	O

Remaining	O
tissue	O
-	O
multiple	O
.	O

B	O
.	O

RIGHT	O
TEMPORAL	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
"	O
right	O
temporal	O
"	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
0	O
.	O
9	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
3	O
cm	O
pink	O
-	O
tan	O
.	O
soft	O
tissue	O
fragment	O
.	O

Entirely	O
embedded	O
.	O

Addendum	O
-	O
Please	O
See	O
End	O
of	O
Report	O
.	O

Slide	O
key	O
:	O
B1	O
.	O

Frozen	O
section	O
remnant	O
-	O
1	O
.	O

C	O
.	O

RIGHT	O
TEMPORAL	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
"	O
right	O
temporal	O
"	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
0	O
.	O
5	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
cm	O
pink	O
-	O
gray	O
.	O
soft	O
tissue	O
fragments	O
.	O

Entirely	O
embedded	O
.	O

CI	O
.	O

1	O
.	O

D	O
.	O

RIGHT	O
TEMPORAL	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
"	O
right	O
temporal	O
"	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
0	O
.	O
4	O
X	O
0	O
.	O
2	O
x	O
0	O
.	O
3	O
cm	O
gray	O
-	O
tan	O
.	O
soft	O
tissue	O
fragment	O
.	O

Entirely	O
embedded	O
.	O

Slide	O
key	O
:	O
DI	O
.	O

I	O
.	O

E	O
.	O

RIGHT	O
TEMPORAL	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
"	O
right	O
temporal	O
"	O
,	O
and	O
received	O
in	O
formalin	O
are	O
two	O
soft	O
pink	O
-	O
tan	O
tissue	O
.	O
fragments	O
measuring	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
1	O
cm	O
and	O
0	O
.	O
5	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
1	O
cm	O
.	O

Entirely	O
embedded	O
.	O

E1	O
.	O

2	O
.	O

F	O
.	O

RIGHT	O
TEMPORAL	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
"	O
right	O
temporal	O
"	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
0	O
.	O
5	O
X	O
0	O
.	O
4	O
X	O
0	O
.	O
1	O
cm	O
pink	O
-	O
gray	O
.	O
soft	O
tissue	O
fragment	O
.	O

Entirely	O
submitted	O
.	O

F1	O
.	O

1	O
.	O

G	O
.	O

RIGHT	O
TEMPORAL	O
/	O
PERMANENT	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
"	O
right	O
temporal	O
"	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
4	O
.	O
2	O
x	O
3	O
.	O
5	O
x	O
1	O
.	O
5	O
cm	O
aggregate	O
.	O
of	O
multiple	O
pink	O
-	O
gray	O
soft	O
tissue	O
fragments	O
with	O
focal	O
areas	O
of	O
hemorrhage	O
on	O
their	O
surfaces	O
.	O

The	O
segments	O
range	O
in	O
.	O
size	O
from	O
0	O
.	O
1	O
cm	O
to	O
2	O
.	O
4	O
cm	O
in	O
greatest	O
dimension	O
.	O

Entirely	O
embedded	O
.	O

Slide	O
key	O
:	O
G1	O
.	O

4	O
.	O

G2	O
.	O

3	O
.	O

G3	O
.	O

Multiple	O
.	O

G4	O
.	O

3	O
.	O

H	O
.	O

RIGHT	O
TEMPORAL	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
"	O
right	O
temporal	O
tumor	O
"	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
3	B
.	I
5	I
x	I
4	I
.	I
0	I
X	I
1	I
.	I
8	I
cm	I
.	O
aggregate	O
of	O
multiple	O
pink	O
-	O
tan	O
soft	O
tissue	O
fragments	O
ranging	O
from	O
0	O
.	O
5	O
to	O
3	O
.	O
2	O
cm	O
in	O
greatest	O
dimension	O
.	O

Along	O
the	O
.	O
outer	O
surfaces	O
of	O
the	O
fragment	O
are	O
focal	O
areas	O
of	O
hemorrhage	O
.	O

Entirely	O
embedded	O
.	O

HI	O
.	O

4	O
.	O

H2	O
.	O

2	O
.	O

H3	O
.	O

4	O
.	O

H4	O
.	O

2	O
.	O

Gross	O
dictated	O
by	O
.	O

OPERATIVE	O
CALL	O
.	O

OPERATIVE	O
CONSULT	O
(	O
FROZEN	O
)	O
:	O
PART	O
A	O
.	O

RIGHT	O
TEMPORAL	O
FS	O
:	O
Glioblastoma	O
.	O

Addendum	O
-	O
Please	O
See	O
End	O
of	O
Report	O
.	O

If	O
this	O
report	O
includes	O
immunohistochemical	O
test	O
results	O
.	O
please	O
note	O
the	O
following	O
:	O
Numerous	O
imunuohistochemical	O
tests	O
were	O
developed	O
and	O
their	O
performance	O
characteristics	O
determined	O
by	O
.	O

Il	O
of	O
Pathology	O
and	O
Laboratory	O
Medicine	O
.	O

Those	O
immuohistochemical	O
tests	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
.	O

U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
(	O
FDA	O
)	O
,	O
and	O
FDA	O
approval	O
is	O
not	O
required	O
.	O

I	O
have	O
personally	O
examined	O
the	O
specimen	O
.	O
interpreted	O
the	O
results	O
.	O
reviewed	O
the	O
report	O
and	O
signed	O
it	O
electronically	O
.	O

FADDENDUM	O
.	O

FISH	O
(	O
FLUORESCENCE	O
IN	O
SITU	O
HYBRIDIZATION	O
)	O
for	O
EGFR	O
.	O

Number	O
of	O
cells	O
analyzed	O
:	O
40	O
.	O

Ratio	O
of	O
EGFR	O
/	O
CEP	O
:	O
1	O
.	O
1	O
.	O

Percentage	O
of	O
cells	O
with	O
>	O
4	O
copies	O
of	O
EGFR	O
:	O
72	O
.	O
5	O
%	O
.	O

Amplification	O
:	O
NO	O
.	O

High	O
Level	O
of	O
Polysomy	O
:	O
YES	O
.	O

INTERPRETATION	O
:	O
1	O
.	O

Samples	O
are	O
interpreted	O
as	O
Positive	O
if	O
:	O
a	O
.	O

EGFR	O
to	O
CEP	O
7	O
signal	O
ratio	O
is	O
>	O
2	O
.	O
0	O
in	O
>	O
10	O
%	O
of	O
analyzed	O
cells	O
.	O

b	O
.	O

When	O
high	O
level	O
of	O
polysomy	O
(	O
>	O
four	O
copies	O
of	O
EGFR	O
in	O
>	O
40	O
%	O
of	O
cells	O
)	O
is	O
present	O
.	O

2	O
.	O

Samples	O
are	O
interpreted	O
as	O
Negative	O
if	O
EGFR	O
to	O
CEP	O
7	O
signal	O
ratio	O
is	O
<	O
2	O
.	O
0	O
or	O
in	O
the	O
absence	O
of	O
high	O
.	O
level	O
of	O
polysomy	O
(	O
>	O
four	O
copies	O
of	O
EGFR	O
)	O
.	O

3	O
.	O

Samples	O
are	O
considered	O
inconclusive	O
,	O
requiring	O
consult	O
with	O
the	O
pathologist	O
,	O
when	O
EGFR	O
to	O
CEP	O
7	O
.	O
signal	O
ratio	O
is	O
>	O
2	O
.	O
0	O
in	O
<	O
10	O
%	O
of	O
analyzed	O
cells	O
or	O
when	O
high	O
level	O
of	O
polysomy	O
(	O
>	O
four	O
copies	O
of	O
.	O
EGFR	O
)	O
is	O
present	O
in	O
<	O
40	O
%	O
of	O
cells	O
.	O

These	O
cases	O
also	O
need	O
to	O
be	O
co	O
-	O
read	O
.	O

Addendum	O
-	O
Please	O
See	O
End	O
of	O
Report	O
.	O

REFERENCES	O
.	O

I	O
have	O
personally	O
examined	O
the	O
specimen	O
.	O
interpreted	O
the	O
results	O
.	O
reviewed	O
the	O
report	O
and	O
signed	O
it	O
electronically	O
.	O

-DOCSTART-242
Pathology	O
Report	O
-	O
Summary	O
:	O
Material	O
:	O
Lung	O
,	O
left	O
,	O
upper	O
lobe	O
:	O
19	O
.	O
0	O
X	O
17	O
.	O
0	O
X	O
5	O
.	O
5	O
cm	O
.	O

Tumor	O
:	O
4	B
.	I
8	I
X	I
4	I
.	I
2	I
X	I
3	I
.	I
8	I
cm	I
.	O

Diagnosis	O
:	O
Squamous	O
Cell	O
Carcinoma	O
(	O
NOS	O
)	O
,	O
partially	O
basaloid	O
.	O

pT2a	O
,	O
pNO	O
(	O
0	O
/	O
23	O
)	O
,	O
pMx	O
,	O
G3	O
.	O

Supplementary	O
examination	O
:	O
EGFR	O
mutation	O
analysis	O
(	O
sanger	O
sequencing	O
,	O
Ex	O
18	O
-	O
21	O
)	O
.	O

EGFR	O
mutation	O
positive	O
.	O

p	O
.	O
L856R	O
(	O
c	O
.	O
2573T	O
>	O
G	O
)	O
.	O

-DOCSTART-243
(	O
Ver	O
ified	O
)	O
.	O

A	O
-	O
D	O
.	O

Liver	O
,	O
right	O
lobectomy	O
:	O
HEPATOCELLULAR	O
CARCINOMA	O
.	O

Tumor	O
number	O
:	O
one	O
.	O

Satellite	O
nodule	O
:	O
no	O
.	O

Gross	O
type	O
:	O
nodular	O
with	O
per	O
inodular	O
extension	O
.	O

Size	O
(	O
on	O
)	O
:	O
7	B
.	I
5x6	I
.	I
5x4	I
.	I
0cm	I
.	O

Differentiation	O
:	O
The	O
worst	O
differentiation	O
:	O
Edmondson	O
grade	O
IV	O
.	O

Differentiation	O
:	O
The	O
major	O
differentiation	O
:	O
Edmondson	O
grade	O
III	O
.	O

Histologic	O
type	O
:	O
Macrotrabecular	O
,	O
Microtrabecular	O
,	O
Pseudoglandular	O
.	O

Cell	O
type	O
:	O
Hepatic	O
.	O

Clear	O
.	O

Tumor	O
necrosis	O
:	O
no	O
.	O

Hemorrhage	O
:	O
yes	O
(	O
less	O
than	O
5	O
%	O
)	O
.	O

Fatity	O
change	O
:	O
no	O
.	O

Fibrous	O
capsule	O
:	O
partial	O
.	O

Infiltration	O
of	O
capsule	O
:	O
yes	O
.	O

Septum	O
formation	O
:	O
yes	O
.	O

Surgical	O
margin	O
invasion	O
:	O
no	O
(	O
margin	O
of	O
the	O
clearance	O
5	O
.	O
5	O
cm	O
)	O
.	O

Serosa	O
invasion	O
:	O
no	O
.	O

Portal	O
vein	O
invasion	O
:	O
no	O
.	O

Bile	O
duct	O
invasion	O
:	O
no	O
.	O

Hepatic	O
vein	O
invasion	O
:	O
no	O
.	O

Hepatic	O
artery	O
invasion	O
:	O
no	O
.	O

Microvesse	O
|	O
invasion	O
:	O
yes	O
.	O

Intrahepatic	O
metastasis	O
:	O
no	O
.	O

Multicenteric	O
occurrence	O
:	O
no	O
.	O

T	O
stage	O
:	O
pT2	O
.	O

N	O
stage	O
:	O
No	O
metastasis	O
in	O
all	O
1	O
Tymph	O
node	O
(	O
pNO	O
)	O
.	O

[	O
0	O
/	O
1	O
:	O
per	O
ipor	O
tal	O
vein	O
(	O
0	O
/	O
1	O
)	O
]	O
.	O

Non	O
-	O
tumor	O
liver	O
.	O

Chronic	O
hepatitis	O
:	O
yes	O
.	O

Etilogy	O
:	O
HBV	O
.	O

Grade	O
,	O
lobular	O
:	O
minimal	O
.	O

Grade	O
,	O
portoperiportal	O
:	O
none	O
.	O

Stage	O
(	O
tibrosis	O
)	O
:	O
septal	O
.	O

Cirrhosis	O
:	O
no	O
.	O

Dysplastic	O
nodule	O
:	O
no	O
.	O

(	O
Verified	O
)	O
.	O

Ductal	O
epithelial	O
dysplasia	O
:	O
no	O
.	O

Other	O
liver	O
disease	O
:	O
no	O
.	O

Gallbladder	O
:	O
No	O
pathologic	O
abnormality	O
.	O

Falciforin	O
Ligament	O
:	O
No	O
pathologic	O
abnormality	O
.	O

<	O
Immunohistochemical	O
stain	O
results	O
>	O
.	O

Iron	O
(	O
block	O
A11	O
)	O
:	O
Negative	O
.	O

Cytokeratin	O
7	O
(	O
block	O
A11	O
)	O
:	O
Positive	O
in	O
bile	O
ducts	O
.	O

Cytokeratin	O
19	O
(	O
block	O
A5	O
)	O
:	O
Negative	O
.	O

Cytokeratin	O
7	O
(	O
block	O
A5	O
)	O
:	O
Focal	O
positive	O
.	O

Hepatocyte	O
(	O
block	O
A5	O
)	O
:	O
Positive	O
.	O

A	O
.	O

The	O
speciment	O
received	O
in	O
formali	O
consists	O
of	O
a	O
lobectomy	O
of	O
liver	O
.	O
measuring	O
.	O

16x12x8cm	O
and	O
weighing	O
800gm	O
.	O

The	O
external	O
surface	O
shows	O
a	O
huge	O
capsular	O
.	O
mass	O
.	O

The	O
parenchyme	O
resection	O
margins	O
are	O
clear	O
.	O

The	O
vascular	O
resection	O
.	O
margin	O
also	O
clear	O
.	O

On	O
section	O
,	O
there	O
is	O
an	O
nodular	O
mass	O
with	O
perinodular	O
.	O
extension	O
.	O

measuring	O
7	O
.	O
5x6	O
.	O
5x4cm	O
.	O

The	O
mass	O
is	O
5	O
.	O
5cm	O
apart	O
from	O
parenchyme	O
.	O
resection	O
margin	O
.	O

The	O
remaining	O
parenchyme	O
shows	O
cirrhotic	O
change	O
.	O

Representative	O
sections	O
are	O
embedded	O
.	O

(	O
A1	O
-	O
Periportal	O
vain	O
lymph	O
node	O
.	O
A2	O
to	O
8	O
-	O
tumor	O
one	O
plane	O
,	O
A9	O
and	O
10	O
-	O
tumor	O
with	O
capsuie	O
.	O
A11	O
-	O
background	O
liver	O
)	O
.	O

B	O
.	O

The	O
specimen	O
.	O
received	O
in	O
formalir	O
consists	O
of	O
a	O
gallbladder	O
.	O
measuring	O
8cm	O
.	O
in	O
length	O
and	O
3cm	O
in	O
diameter	O
.	O

The	O
capsular	O
surface	O
is	O
unremarkable	O
.	O

The	O
wall	O
measures	O
0	O
.	O

.	O
2cm	O
in	O
maximal	O
thickness	O
.	O

The	O
mucosa	O
is	O
greenish	O
velvety	O
.	O

There	O
is	O
no	O
stone	O
or	O
polyo	O
Representative	O
sections	O
are	O
embedded	O
in	O
.	O
one	O
cassette	O
.	O

C	O
.	O

The	O
specimen	O
received	O
in	O
formalin	O
consists	O
of	O
compartmentalized	O
Tymph	O
nodes	O
.	O

All	O
Tymph	O
nodes	O
found	O
are	O
entirely	O
embedded	O
.	O

(	O
C	O
-	O
LN	O
)	O
.	O

0	O
.	O

The	O
soecimen	O
received	O
in	O
formalin	O
consists	O
of	O
a	O
Tump	O
of	O
adipose	O
tissue	O
.	O
clinically	O
labeled	O
as	O
"	O
falciform	O
higament	O
"	O
measuring	O
4x3xicm	O
.	O

On	O
serial	O
section	O
.	O
there	O
is	O
no	O
definite	O
mass	O
.	O

Representat	O
ive	O
sections	O
are	O
embedded	O
in	O
a	O
cassette	O
.	O

H	O
&	O
E	O
(	O
14	O
)	O
.	O

MT	O
(	O
1	O
)	O
,	O
RTC	O
(	O
1	O
)	O
.	O

D	O
-	O
PAS	O
(	O
1	O
)	O
.	O

Tron	O
(	O
1	O
)	O
.	O

Cytokeratin	O
7	O
(	O
7	O
)	O
.	O

Cytokeratin	O
19	O
(	O
1	O
)	O
.	O
tron	O
(	O
1	O
)	O
.	O

(	O
Ver	O
if	O
fied	O
)	O
.	O

-DOCSTART-244
DIAGNOSIS	O
:	O
1	O
.	O

Kidney	O
,	O
right	O
,	O
"	O
tumor	O
#	O
1	O
"	O
(	O
excision	O
)	O
:	O
Cyst	O
with	O
fibrosis	O
.	O

2	O
.	O

Kidney	O
,	O
right	O
,	O
"	O
tumor	O
#	O
2	O
"	O
(	O
excision	O
)	O
:	O
Renal	O
cell	O
carcinoma	O
,	O
clear	O
cell	O
type	O
,	O
Furhman	O
nuclear	O
grade	O
II	O
.	O

3	O
.	O

Kidney	O
,	O
right	O
,	O
"	O
tumor	O
#	O
3	O
"	O
(	O
excision	O
)	O
:	O
Renal	O
cell	O
carcinoma	O
,	O
clear	O
cell	O
type	O
,	O
Furhman	O
nuclear	O
grade	O
II	O
.	O

4	O
.	O

Kidney	O
,	O
right	O
,	O
"	O
tumor	O
#	O
4	O
"	O
(	O
excision	O
)	O
:	O
Fibrous	O
tissue	O
.	O

5	O
.	O

Kidney	O
,	O
right	O
,	O
"	O
tumor	O
#	O
5	O
"	O
(	O
excision	O
)	O
:	O
Renal	O
cell	O
carcinoma	O
,	O
clear	O
cell	O
type	O
,	O
Furhman	O
nuclear	O
grade	O
II	O
.	O

6	O
.	O

Kidney	O
,	O
right	O
,	O
"	O
tumor	O
#	O
6	O
"	O
(	O
excision	O
)	O
:	O
Renal	O
cell	O
carcinoma	O
,	O
clear	O
cell	O
type	O
,	O
Furhman	O
nuclear	O
grade	O
II	O
.	O

7	O
.	O

Kidney	O
,	O
right	O
,	O
"	O
tumor	O
#	O
7	O
"	O
(	O
excision	O
)	O
:	O
Renal	O
cyst	O
lined	O
by	O
atypical	O
cells	O
.	O

8	O
.	O

Kidney	O
,	O
right	O
,	O
"	O
tumor	O
#	O
8	O
"	O
(	O
excision	O
)	O
:	O
Renal	O
cyst	O
lined	O
by	O
atypical	O
cells	O
.	O

9	O
.	O

Kidney	O
,	O
right	O
,	O
"	O
tumor	O
#	O
9	O
"	O
(	O
excision	O
)	O
:	O
Renal	O
cell	O
carcinoma	O
,	O
clear	O
cell	O
type	O
,	O
Furhman	O
nuclear	O
grade	O
.	O

II	O
.	O

10	O
.	O

Kidney	O
,	O
right	O
,	O
"	O
tumor	O
#	O
10	O
"	O
(	O
excision	O
)	O
:	O
Renal	O
cell	O
carcinoma	O
,	O
clear	O
cell	O
type	O
,	O
Furhman	O
nuclear	O
grade	O
II	O
.	O

11	O
.	O

Kidney	O
,	O
right	O
,	O
"	O
tumor	O
#	O
11	O
"	O
(	O
excision	O
)	O
:	O
Renal	O
cell	O
carcinoma	O
,	O
clear	O
cell	O
type	O
,	O
Furhman	O
nuclear	O
grade	O
II	O
.	O

12	O
.	O

Kidney	O
,	O
right	O
,	O
"	O
tumor	O
#	O
12	O
"	O
(	O
excision	O
)	O
:	O
Fibrous	O
tissue	O
and	O
renal	O
parenchyma	O
.	O

13	O
.	O

Kidney	O
,	O
right	O
,	O
"	O
tumor	O
#	O
13	O
"	O
(	O
excision	O
)	O
:	O
Renal	O
cell	O
carcinoma	O
,	O
clear	O
cell	O
type	O
,	O
Furhman	O
nuclear	O
grade	O
II	O
.	O

NOTE	O
:	O
CLINICAL	O
INFORMATION	O
:	O
Brief	O
Clinical	O
History	O
:	O
history	O
of	O
VHL	O
,	O
bilateral	O
renal	O
massess	O
.	O

Specimen	O
Taken	O
For	O
Protocol	O
:	O
Yes	O
Allocate	O
Order	O
to	O
Protocol	O
:	O
PROCEDURE	O
:	O
SPECIMENS	O
SUBMITTED	O
:	O
1	O
.	O

KIDNEY	O
,	O
RIGHT	O
,	O
Tumor	O
.	O

2	O
.	O

KIDNEY	O
,	O
RIGHT	O
,	O
Tumor	O
.	O

3	O
.	O

KIDNEY	O
,	O
RIGHT	O
,	O
Tumor	O
.	O

4	O
.	O

KIDNEY	O
,	O
RIGHT	O
,	O
Tumor	O
.	O

5	O
.	O

KIDNEY	O
,	O
RIGHT	O
,	O
Tumor	O
.	O

6	O
.	O

KIDNEY	O
,	O
RIGHT	O
,	O
Tumor	O
.	O

7	O
.	O

KIDNEY	O
,	O
RIGHT	O
,	O
Tumor	O
.	O

8	O
.	O

KIDNEY	O
,	O
RIGHT	O
,	O
Tumor	O
.	O

9	O
.	O

KIDNEY	O
,	O
RIGHT	O
,	O
Tumor	O
.	O

10	O
.	O

KIDNEY	O
,	O
RIGHT	O
,	O
Tumor	O
.	O

11	O
.	O

KIDNEY	O
,	O
RIGHT	O
,	O
Tumor	O
.	O

12	O
.	O

KIDNEY	O
,	O
RIGHT	O
,	O
Tumor	O
.	O

13	O
.	O

KIDNEY	O
,	O
RIGHT	O
,	O
Tumor	O
.	O

GROSS	O
DESCRIPTION	O
:	O
Received	O
are	O
13	O
containers	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
medical	O
record	O
.	O
number	O
,	O
and	O
further	O
specified	O
as	O
:	O
1	O
.	O

"	O
Tumor	O
#	O
1	O
right	O
kidney	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
cystic	O
soft	O
tissue	O
mass	O
that	O
has	O
been	O
opened	O
to	O
.	O
reveal	O
a	O
smooth	O
cavity	O
that	O
appears	O
loculated	O
.	O

The	O
specimen	O
measures	O
1	B
.	I
5	I
X	I
1	I
.	I
2	I
x	I
1	I
.	I
0	I
cm	I
.	O

The	O
.	O
specimen	O
is	O
serially	O
sectioned	O
and	O
representative	O
sections	O
are	O
submitted	O
in	O
white	O
cassette	O
labeled	O
.	O
for	O
permanent	O
processing	O
.	O

2	O
.	O

"	O
Tumor	O
#	O
2	O
right	O
kidney	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
red	O
-	O
tan	O
soft	O
tissue	O
mass	O
measuring	O
1	B
.	I
3	I
x	I
1	I
.	I
0	I
X	I
1	I
.	I
0	I
.	I

cm	B
.	O

75	O
%	O
of	O
the	O
tumor	O
is	O
procured	O
for	O
the	O
UOB	O
Lab	O
.	O

The	O
remaining	O
specimen	O
is	O
sent	O
to	O
Surgical	O
.	O

Pathology	O
.	O

In	O
Surgical	O
Pathology	O
,	O
the	O
specimen	O
received	O
matches	O
the	O
above	O
description	O
.	O

The	O
cut	O
.	O
surface	O
of	O
the	O
tumor	O
reveals	O
a	O
yellow	O
solid	O
tumor	O
mass	O
.	O

The	O
specimen	O
is	O
sectioned	O
and	O
entirely	O
.	O
submitted	O
in	O
white	O
cassette	O
labeled	O
.	O
for	O
permanent	O
processing	O
.	O

3	O
.	O

"	O
Tumor	O
#	O
3	O
right	O
kidney	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
0	B
.	I
8	I
x	I
0	I
.	I
5	I
x	I
0	I
.	I
2	I
cm	I
soft	O
tissue	O
mass	O
.	O

50	O
%	O
of	O
the	O
.	O
tumor	O
is	O
procured	O
by	O
the	O
.	O

The	O
remaining	O
tissue	O
is	O
sent	O
to	O
Surgical	O
Pathology	O
.	O

In	O
Surgical	O
.	O

Pathology	O
,	O
the	O
specimen	O
received	O
matches	O
the	O
above	O
description	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
.	O
white	O
cassette	O
labeled	O
.	O
for	O
permanent	O
processing	O
.	O
rage	O
2	O
of	O
4	O
.	O

4	O
.	O

"	O
Tumor	O
#	O
4	O
right	O
kidney	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
red	O
-	O
tan	O
soft	O
tissue	O
mass	O
measuring	O
0	B
.	I
5	I
x	I
0	I
.	I
5	I
x	I
0	I
.	I
3	I
.	I

cm	B
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
white	O
cassette	O
labeled	O
.	O
for	O
permanent	O
.	O
processing	O
.	O

5	O
.	O

"	O
Tumor	O
#	O
5	O
right	O
kidney	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
red	O
-	O
tan	O
soft	O
tissue	O
mass	O
measuring	O
1	B
.	I
5	I
X	I
1	I
.	I
5	I
x	I
1	I
.	I
2	I
.	I

cm	B
.	O

Approximately	O
60	O
%	O
of	O
the	O
tumor	O
is	O
procured	O
for	O
the	O
.	O

The	O
remaining	O
specimen	O
is	O
sent	O
to	O
.	O

Surgical	O
Pathology	O
.	O

In	O
Surgical	O
Pathology	O
,	O
the	O
specimen	O
received	O
matches	O
the	O
above	O
description	O
.	O

The	O
.	O
cut	O
surface	O
of	O
the	O
tumor	O
reveals	O
a	O
yellow	O
solid	O
tumor	O
nodule	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
and	O
.	O
entirely	O
submitted	O
in	O
white	O
cassette	O
labeled	O
.	O
for	O
permanent	O
processing	O
.	O

6	O
.	O

"	O
Tumor	O
#	O
6	O
right	O
kidney	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
red	O
-	O
tan	O
soft	O
tissue	O
mass	O
measuring	O
0	B
.	I
8	I
x	I
0	I
.	I
8	I
X	I
0	I
.	I
5	I
.	I

cm	B
.	O

Approximately	O
50	O
%	O
of	O
the	O
specimen	O
is	O
procured	O
by	O
the	O
.	O

The	O
remaining	O
specimen	O
is	O
sent	O
to	O
.	O

Surgical	O
Pathology	O
.	O

In	O
Surgical	O
Pathology	O
,	O
the	O
specimen	O
received	O
matches	O
the	O
above	O
description	O
.	O

The	O
.	O
specimen	O
is	O
entirely	O
submitted	O
in	O
white	O
cassette	O
labelec	O
.	O
for	O
permanent	O
processing	O
.	O

7	O
.	O

"	O
Tumor	O
#	O
7	O
right	O
kidney	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
red	O
-	O
tan	O
soft	O
tissue	O
mass	O
measuring	O
1	B
.	I
0	I
X	I
1	I
.	I
0	I
x	I
0	I
.	I
5	I
.	I

cm	B
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
white	O
cassette	O
labeled	O
.	O
for	O
permanent	O
.	O
processing	O
.	O

8	O
.	O

"	O
Tumor	O
#	O
8	O
right	O
kidney	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
red	O
-	O
tan	O
soft	O
tissue	O
fragment	O
measuring	O
0	B
.	I
6	I
x	I
0	I
.	I
2	I
X	I
.	I

0	B
.	I
2	I
cm	I
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
white	O
cassette	O
labeled	O
.	O
for	O
permanent	O
.	O
processing	O
.	O

9	O
.	O

"	O
Tumor	O
#	O
9	O
right	O
kidney	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
1	B
.	I
0	I
X	I
0	I
.	I
8	I
x	I
0	I
.	I
6	I
cm	I
soft	O
tissue	O
fragment	O
.	O

Approximately	O
60	O
%	O
is	O
procured	O
for	O
the	O
The	O
remaining	O
specimen	O
is	O
sent	O
to	O
Surgical	O
Pathology	O
.	O

In	O
Surgical	O
Pathology	O
,	O
the	O
specimen	O
received	O
matches	O
the	O
above	O
description	O
.	O

The	O
specimen	O
is	O
entirely	O
.	O
submitted	O
in	O
white	O
cassette	O
labeled	O
.	O
for	O
permanent	O
processing	O
.	O

10	O
.	O

"	O
Tumor	O
#	O
10	O
right	O
kidney	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
red	O
-	O
tan	O
soft	O
tissue	O
mass	O
measuring	O
3	B
x	I
3	I
x	I
3	I
cm	I
.	O

Approximately	O
75	O
%	O
is	O
procured	O
by	O
the	O
.	O

The	O
remaining	O
specimen	O
is	O
sent	O
to	O
Surgical	O
Pathology	O
.	O

In	O
Surgical	O
Pathology	O
,	O
the	O
specimen	O
received	O
matches	O
the	O
above	O
description	O
.	O

The	O
cut	O
surface	O
of	O
the	O
.	O
tumor	O
reveals	O
a	O
yellow	O
necrotic	O
cut	O
surface	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
and	O
representative	O
.	O
section	O
is	O
submitted	O
in	O
white	O
cassette	O
labeled	O
.	O
for	O
permanent	O
processing	O
.	O

11	O
.	O

"	O
Tumor	O
#	O
11	O
right	O
kidney	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
red	O
-	O
tan	O
soft	O
tissue	O
mass	O
measuring	O
1	B
x	I
1	I
X	I
1	I
cm	I
.	O

Approximately	O
50	O
%	O
of	O
the	O
tumor	O
is	O
procured	O
by	O
the	O
.	O

The	O
remaining	O
specimen	O
is	O
sent	O
.	O

to	O
.	O

Surgical	O
Pathology	O
.	O

In	O
Surgical	O
Pathology	O
,	O
the	O
specimen	O
received	O
matches	O
the	O
above	O
description	O
.	O

The	O
.	O
specimen	O
is	O
serially	O
sectioned	O
to	O
reveal	O
a	O
yellow	O
-	O
red	O
cut	O
surface	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
.	O
white	O
cassette	O
labeled	O
.	O
for	O
permanent	O
processing	O
.	O

12	O
.	O

"	O
Tumor	O
#	O
12	O
right	O
kidney	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
red	O
-	O
tan	O
soft	O
tissue	O
mass	O
measuring	O
0	B
.	I
6	I
X	I
0	I
.	I
5	I
X	I
0	I
.	I
4	I
.	O

cm	O
.	O

Approximately	O
50	O
%	O
of	O
the	O
tumor	O
is	O
procured	O
by	O
the	O
.	O

The	O
remaining	O
specimen	O
is	O
sent	O
to	O
.	O

Surgical	O
Pathology	O
.	O

In	O
Surgical	O
Pathology	O
,	O
the	O
specimen	O
received	O
matches	O
the	O
above	O
description	O
.	O

The	O
.	O
specimen	O
is	O
entirely	O
submitted	O
in	O
white	O
cassette	O
labeled	O
.	O
for	O
permanent	O
processing	O
.	O

13	O
.	O

"	O
Tumor	O
#	O
13	O
right	O
kidney	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
red	O
-	O
tan	O
soft	O
tissue	O
mass	O
measuring	O
1	B
.	I
7	I
x	I
1	I
.	I
2	I
X	I
1	I
.	I
2	I
.	O

cm	O
.	O

Approximately	O
50	O
%	O
of	O
the	O
tumor	O
is	O
procured	O
for	O
the	O
.	O

The	O
remaining	O
specimen	O
is	O
sent	O
to	O
.	O

Surgical	O
Pathology	O
.	O

In	O
Surgical	O
Pathology	O
,	O
the	O
specimen	O
received	O
matches	O
the	O
above	O
description	O
.	O

The	O
.	O
specimen	O
is	O
serially	O
sectioned	O
to	O
reveal	O
a	O
yellow	O
-	O
red	O
cut	O
surface	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O
in	O
white	O
cassette	O
labeled	O
.	O
for	O
permanent	O
processing	O
.	O

No	O
consultants	O
.	O

-DOCSTART-245
Specimen	O
#	O
:	O
F	O
.	O

Race	O
:	O
BLACK	O
.	O

AMENDED	O
.	O

SPECIMEN	O
:	O
A	O
:	O
LEFT	O
SENTINEL	O
LYMPH	O
NODE	O
B	O
:	O
LEFT	O
BREAST	O
TISSUE	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
A	O
.	O

LYMPH	O
NODE	O
,	O
LEFT	O
SENTINEL	O
,	O
EXCISION	O
:	O
-	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
BY	O
IMMUNOHISTOCHEMISTRY	O
.	O

B	O
.	O

BREAST	O
,	O
LEFT	O
,	O
LUMPECTOMY	O
:	O
-	O
INFILTRATING	O
DUCTAL	O
CARCINOMA	O
,	O
MODERATELY	O
DIFFERENTIATED	O
BY	O
COMBINED	O
.	O

HISTOLOGIC	O
CRITERIA	O
.	O

-	O
MAXIMUM	O
TUMOR	O
DIMENSION	O
=	O
2	B
.	I
0	I
CM	I
.	O

-	O
ASSOCIATED	O
DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
,	O
NUCLEAR	O
GRADE	O
2	O
WITH	O
NECROSIS	O
.	O

-	O
SURGICAL	O
MARGINS	O
ARE	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

MICROCALCIFICATIONS	O
IDENTIFIED	O
IN	O
THE	O
DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
.	O

AND	O
THE	O
INFILTRATING	O
CARCINOMA	O
COMPONENTS	O
.	O

ESTROGEN	O
RECEPTOR	O
POSITIVE	O
(	O
80	O
%	O
nuclear	O
staining	O
)	O
.	O

PROGESTERONE	O
RECEPTOR	O
:	O
POSITIVE	O
(	O
90	O
%	O
nuclear	O
staining	O
)	O
.	O

(	O
SEE	O
COMMENT	O
)	O
.	O

AMMENDMENT	O
2	O
:	O
FOLLOWING	O
INTRADEPARTMENTAL	O
REVIEW	O
,	O
RESULTS	O
OF	O
HER2	O
STUDIES	O
.	O

ARE	O
REVISED	O
.	O

HER2	O
BY	O
IMMUNOHISTOCHEMISTRY	O
:	O
WEAKLY	O
POSITIVE	O
(	O
2	O
+	O
)	O
.	O

HER2	O
BY	O
FISH	O
:	O
NOT	O
AMPLIFIED	O
(	O
1	O
.	O
1	O
)	O
.	O

COMMENT	O
:	O
Estrogen	O
and	O
progesterone	O
receptors	O
were	O
evaluated	O
by	O
immunohistochemical	O
.	O
methods	O
.	O

A	O
positive	O
test	O
is	O
defined	O
as	O
easily	O
discernable	O
nuclear	O
.	O
staining	O
in	O
more	O
than	O
58	O
of	O
the	O
tumor	O
cells	O
.	O

The	O
specimen	O
was	O
evaluated	O
for	O
HER	O
-	O
2	O
/	O
Neu	O
(	O
c	O
-	O
erbB2	O
)	O
overexpression	O
by	O
.	O
immunohistochemical	O
methods	O
(	O
DAKO	O
Hercep	O
Test	O
)	O
.	O

Staining	O
is	O
interpreted	O
.	O
on	O
a	O
scale	O
of	O
0	O
to	O
3	O
+	O
with	O
positivity	O
defined	O
as	O
2	O
+	O
or	O
greater	O
.	O

Specimens	O
.	O
with	O
a	O
weakly	O
positive	O
(	O
2	O
+	O
)	O
Hercep	O
Test	O
are	O
further	O
evaluated	O
by	O
.	O

Specimen	O
#	O
.	O

FINAL	O
DIAGNOSIS	O
(	O
continued	O
)	O
:	O
fluorescence	O
in	O
situ	O
hybridization	O
(	O
PathVysion	O
FISH	O
assay	O
)	O
to	O
detect	O
.	O
presence	O
or	O
absence	O
of	O
Her	O
-	O
2	O
/	O
neu	O
-	O
gene	O
amplification	O
.	O

CLINICAL	O
DIAGNOSIS	O
AND	O
HISTORY	O
:	O
-	O
year	O
-	O
old	O
.	O
female	O
with	O
T1NOMO	O
infiltrating	O
ductal	O
.	O
carcinoma	O
of	O
left	O
breast	O
on	O
physical	O
exam	O
and	O
core	O
biopsy	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

LEFT	O
SENTINEL	O
LYMPH	O
NODE	O
received	O
fresh	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
.	O
name	O
,	O
designated	O
"	O
LEFT	O
SENTINEL	O
LYMPH	O
NODE	O
"	O
consists	O
of	O
a	O
2	O
.	O
0	O
cm	O
x	O
0	O
.	O
7	O
cm	O
.	O

x	O
0	O
.	O
4	O
cm	O
soft	O
,	O
tan	O
tissue	O
fragment	O
.	O

Bisected	O
.	O

1CF	O
.	O

B	O
.	O

LEFT	O
BREAST	O
TISSUE	O
received	O
fresh	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
.	O
designated	O
"	O
LEFT	O
BREAST	O
TISSUE	O
"	O
consists	O
of	O
a	O
piece	O
of	O
fibrofatty	O
tissue	O
,	O
.	O
measuring	O
9	O
.	O
7	O
cm	O
anterior	O
to	O
posterior	O
,	O
6	O
.	O
8	O
cm	O
medial	O
to	O
lateral	O
,	O
and	O
5	O
.	O
0	O
.	O

cm	O
superior	O
to	O
inferior	O
.	O

The	O
overlying	O
ellipse	O
of	O
brown	O
skin	O
,	O
with	O
a	O
0	O
.	O
4	O
.	O

cm	O
linear	O
incision	O
,	O
measures	O
2	O
.	O
6	O
cm	O
x	O
0	O
.	O
8	O
cm	O
.	O

Ink	O
code	O
:	O
Red	O
=	O
lateral	O
,	O
.	O

yellow	O
=	O
medial	O
,	O
black	O
=	O
posterior	O
,	O
blue	O
=	O
superior	O
,	O
and	O
green	O
=	O
inferior	O
.	O

The	O
.	O
specimen	O
is	O
sectioned	O
anterior	O
to	O
posterior	O
revealing	O
a	O
2	B
.	I
0	I
cm	I
tumor	O
,	O
with	O
.	O
ell	O
-	O
defined	O
margins	O
and	O
white	O
,	O
gritty	O
cut	O
surface	O
,	O
0	O
.	O
4	O
cm	O
from	O
the	O
.	O
nearest	O
margin	O
superior	O
.	O

The	O
remaining	O
tissue	O
is	O
mostly	O
fatty	O
with	O
a	O
few	O
.	O
patches	O
of	O
white	O
fibrous	O
tissue	O
.	O

One	O
section	O
of	O
skin	O
,	O
one	O
section	O
of	O
.	O
grossly	O
normal	O
fibrous	O
tissue	O
,	O
and	O
two	O
sections	O
of	O
tumor	O
are	O
submitted	O
for	O
.	O
the	O
CBCP	O
protocol	O
(	O
matching	O
paraffin	O
section	O
=	O
B1	O
,	O
B2	O
,	O
and	O
B3	O
-	O
B4	O
,	O
.	O
respectively	O
)	O
.	O

Slide	O
key	O
:	O
B1	O
:	O
Representative	O
skin	O
.	O

B2	O
:	O
Grossly	O
normal	O
fibrous	O
tissue	O
.	O

B3	O
-	O
B4	O
:	O
Tumor	O
.	O

B5	O
-	O
B6	O
:	O
Anterior	O
margin	O
.	O

B7	O
:	O
Representative	O
fibrous	O
tissue	O
.	O

B8	O
-	O
B9	O
:	O
Tumor	O
.	O

B10	O
-	O
B12	O
:	O
Section	O
of	O
B3	O
.	O

B13	O
-	O
B14	O
:	O
Representative	O
sections	O
.	O

B15	O
-	O
B16	O
:	O
Section	O
of	O
B4	O
.	O

B17	O
:	O
Representative	O
sections	O
.	O

B18	O
-	O
B22	O
Posterior	O
.	O
margin	O
.	O

22CF	O
.	O

-DOCSTART-246
Diagnosis	O
:	O
Kidney	O
,	O
left	O
,	O
laparoscopic	O
radical	O
nephrectomy	O
.	O

Histologic	O
tumor	O
type	O
/	O
subtype	O
:	O
renal	O
cell	O
carcinoma	O
,	O
clear	O
.	O
cell	O
type	O
.	O

Histologic	O
grade	O
(	O
if	O
applicable	O
)	O
:	O
Fuhrman	O
grade	O
3	O
of	O
4	O
.	O

Tumor	O
size	O
(	O
greatest	O
dimension	O
)	O
:	O
5	B
cm	I
.	O

Extent	O
of	O
tumor	O
invasion	O
:	O
Capsular	O
invasion	O
/	O
perirenal	O
adipose	O
tissue	O
:	O
negative	O
for	O
.	O
carcinoma	O
.	O

S	O
fascia	O
:	O
negative	O
for	O
carcinoma	O
.	O

Renal	O
vein	O
:	O
negative	O
for	O
carcinoma	O
.	O

Ureter	O
:	O
negative	O
for	O
carcinoma	O
.	O

Venous	O
(	O
large	O
vessel	O
)	O
:	O
positive	O
for	O
renal	O
cell	O
carcinoma	O
.	O

(	O
A8	O
)	O
.	O

Lymphatic	O
(	O
small	O
vessel	O
)	O
:	O
negative	O
for	O
carcinoma	O
.	O

Sinus	O
adipose	O
tissue	O
:	O
positive	O
for	O
renal	O
cell	O
carcinoma	O
.	O

Adjacent	O
organs	O
:	O
negative	O
for	O
carcinoma	O
.	O

Histologic	O
assessment	O
of	O
surgical	O
margins	O
:	O
Perirenal	O
adipose	O
tissue	O
:	O
negative	O
for	O
carcinoma	O
.	O

Gerota	O
'	O
S	O
fascia	O
:	O
negative	O
for	O
carcinoma	O
.	O

Renal	O
vein	O
:	O
negative	O
for	O
carcinoma	O
.	O

Renal	O
artery	O
:	O
negative	O
for	O
carcinoma	O
.	O

Ureter	O
:	O
negative	O
for	O
carcinoma	O
.	O

Adrenal	O
gland	O
:	O
Negative	O
for	O
carcinoma	O
.	O

Lymph	O
nodes	O
:	O
none	O
identified	O
.	O

Other	O
significant	O
findings	O
:	O
simple	O
renal	O
cyst	O
.	O

AJCC	O
Staging	O
:	O
pT3a	O
.	O

pNx	O
.	O

pMx	O
.	O

This	O
staging	O
information	O
is	O
based	O
on	O
information	O
available	O
.	O
at	O
the	O
time	O
of	O
this	O
report	O
,	O
and	O
is	O
subject	O
to	O
change	O
.	O
pending	O
clinical	O
review	O
and	O
additional	O
information	O
.	O

Clinical	O
History	O
:	O
The	O
patient	O
is	O
who	O
presents	O
with	O
left	O
renal	O
mass	O
.	O

Gross	O
Description	O
:	O
Specimen	O
fixation	O
:	O
Formalin	O
.	O

Type	O
of	O
specimen	O
:	O
Laparoscopic	O
radical	O
nephrectomy	O
.	O

Side	O
of	O
specimen	O
:	O
Left	O
.	O

Size	O
and	O
weight	O
of	O
specimen	O
:	O
800	O
grams	O
;	O
overall	O
26	O
X	O
13	O
.	O

X	O
.	O

11	O
.	O
5	O
cm	O
;	O
kidney	O
11	O
X	O
8	O
X	O
6	O
cm	O
;	O
adrenal	O
4	O
.	O
5	O
X	O
1	O
.	O
5	O
cm	O
.	O

Orientation	O
:	O
The	O
external	O
surface	O
of	O
the	O
specimen	O
is	O
inked	O
.	O
blue	O
,	O
the	O
adrenal	O
gland	O
is	O
dotted	O
with	O
yellow	O
ink	O
.	O

Presence	O
/	O
absence	O
of	O
adrenal	O
gland	O
:	O
Present	O
.	O

Tumor	O
description	O
/	O
site	O
:	O
The	O
tumor	O
involves	O
the	O
renal	O
.	O
cortex	O
,	O
medulla	O
,	O
and	O
pelvis	O
,	O
with	O
a	O
pushing	O
border	O
into	O
the	O
.	O
perirenal	O
adipose	O
tissue	O
(	O
there	O
is	O
no	O
infiltrating	O
tumor	O
.	O
beyond	O
the	O
capsule	O
into	O
the	O
perirenal	O
fat	O
)	O
;	O
the	O
tumor	O
has	O
.	O

an	O
overall	O
central	O
location	O
that	O
does	O
not	O
favor	O
either	O
the	O
.	O
superior	O
or	O
inferior	O
poles	O
;	O
the	O
tumor	O
is	O
orange	O
/	O
yellow	O
,	O
.	O
ell	O
-	O
circumscribed	O
,	O
and	O
firm	O
to	O
palpation	O
;	O
areas	O
of	O
.	O
hemorrhage	O
and	O
necrosis	O
are	O
identified	O
.	O

Tumor	O
size	O
:	O
5	B
X	I
4	I
.	I
5	I
X	I
4	I
.	I
0	I
cm	I
.	O

Presence	O
/	O
absence	O
of	O
multicentricity	O
:	O
The	O
tumor	O
is	O
unifocal	O
.	O

Confinement	O
/	O
non	O
-	O
confinement	O
to	O
the	O
kidney	O
:	O
The	O
tumor	O
has	O
a	O
.	O
pushing	O
border	O
but	O
does	O
not	O
invade	O
through	O
the	O
renal	O
.	O
capsule	O
(	O
the	O
tumor	O
is	O
close	O
to	O
the	O
blue	O
inked	O
surgical	O
.	O
margin	O
of	O
resection	O
)	O
.	O

Extent	O
of	O
invasion	O
:	O
Perirenal	O
adipose	O
tissue	O
:	O
Negative	O
.	O

Gerota	O
'	O
S	O
fascia	O
:	O
Negative	O
.	O

Renal	O
vein	O
:	O
Negative	O
.	O

Ureter	O
:	O
Negative	O
.	O

Other	O
organs	O
:	O
The	O
tumor	O
does	O
not	O
involve	O
the	O
adrenal	O
gland	O
.	O

Surgical	O
margins	O
:	O
Perirenal	O
adipose	O
tissue	O
:	O
Negative	O
.	O

Renal	O
vein	O
:	O
Negative	O
.	O

Renal	O
artery	O
:	O
Negative	O
.	O

Ureter	O
:	O
Negative	O
.	O

Description	O
of	O
kidney	O
away	O
from	O
tumor	O
:	O
The	O
remainder	O
of	O
the	O
.	O
normal	O
kidney	O
demonstrates	O
a	O
normal	O
cortex	O
to	O
medulla	O
ratio	O
.	O
and	O
is	O
unremarkable	O
.	O

Lymph	O
nodes	O
(	O
hilar	O
)	O
:	O
No	O
hilar	O
lymph	O
nodes	O
are	O
appreciated	O
.	O

Other	O
significant	O
findings	O
:	O
None	O
.	O

Tissue	O
submitted	O
for	O
special	O
investigations	O
:	O
Normal	O
and	O
.	O
neoplastic	O
tissue	O
are	O
submitted	O
to	O
tissue	O
procurement	O
for	O
.	O
special	O
investigation	O
.	O

Digital	O
photograph	O
taken	O
:	O
None	O
taken	O
.	O

Block	O
Summary	O
:	O
A1	O
-	O
Distal	O
vascular	O
margins	O
and	O
ureter	O
.	O

A2	O
-	O
Tumor	O
with	O
close	O
approach	O
to	O
blue	O
surgical	O
ink	O
and	O
.	O
extension	O
from	O
cortex	O
into	O
perirenal	O
fat	O
.	O

A3	O
-	O
Additional	O
section	O
of	O
tumor	O
and	O
perirenal	O
fat	O
.	O

A4	O
-	O
Section	O
of	O
tumor	O
near	O
interface	O
of	O
medulla	O
and	O
renal	O
.	O
pelvis	O
.	O

A5	O
-	O
Representative	O
section	O
of	O
tumor	O
with	O
adjacent	O
cortex	O
.	O
and	O
perirenal	O
fat	O
.	O

A6	O
-	O
Representative	O
section	O
of	O
adrenal	O
gland	O
.	O

A7	O
-	O
Representative	O
section	O
of	O
large	O
vessel	O
with	O
hemorrhage	O
.	O
and	O
adjacent	O
kidney	O
/	O
tumor	O
.	O

A8	O
-	O
Additional	O
representative	O
section	O
of	O
tumor	O
near	O
.	O
interface	O
of	O
medulla	O
and	O
pelvis	O
.	O

A9	O
-	O
Section	O
of	O
uninvolved	O
kidney	O
with	O
simple	O
cyst	O
.	O

-DOCSTART-247
Female	O
.	O

Admission	O
Date	O
:	O
Discharge	O
Date	O
:	O
Collected	O
Date	O
/	O
Time	O
:	O
Received	O
Date	O
/	O
Time	O
:	O
Final	O
Diagnosis	O
.	O

A	O
.	O

LUNG	O
,	O
RIGHT	O
LOWER	O
LOBE	O
,	O
LOBECTOMY	O
:	O
-	O
INVASIVE	O
AND	O
IN	O
SITU	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
,	O
1	B
.	I
3	I
CM	I
,	O
SEE	O
SYNOPTIC	O
REPORT	O
.	O

-	O
FOUR	O
LYMPH	O
NODES	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
(	O
0	O
/	O
4	O
)	O
.	O

B	O
.	O

LYMPH	O
NODES	O
,	O
LEVEL	O
7	O
,	O
RESECTION	O
:	O
THREE	O
LYMPH	O
NODES	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
(	O
0	O
/	O
3	O
)	O
.	O

C	O
.	O

LYMPH	O
NODES	O
,	O
LEVEL	O
10	O
,	O
RESECTION	O
:	O
FOUR	O
LYMPH	O
NODES	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
(	O
0	O
/	O
4	O
)	O
.	O

D	O
.	O

LUNG	O
,	O
RIGHT	O
MIDDLE	O
LOBE	O
,	O
WEDGE	O
RESECTION	O
:	O
-	O
LUNG	O
WITH	O
EMPHYSEMATOUS	O
CHANGES	O
,	O
ALVEOLAR	O
HEMORRHAGE	O
.	O

E	O
.	O

LYMPH	O
NODES	O
,	O
R4	O
,	O
RESECTION	O
:	O
-	O
ONE	O
LYMPH	O
NODE	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
(	O
0	O
/	O
1	O
)	O
.	O

F	O
.	O

LYMPH	O
NODE	O
,	O
R2	O
,	O
RESECTION	O
:	O
-	O
ONE	O
LYMPH	O
NODE	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
(	O
0	O
/	O
1	O
)	O
.	O

(	O
Electronic	O
signature	O
)	O
.	O

Verified	O
:	O
Synoptic	O
Report	O
.	O

SPECIMEN	O
:	O
Lung	O
.	O

PROCEDURE	O
:	O
Lobectomy	O
.	O

SPECIMEN	O
INTEGRITY	O
:	O
Intact	O
.	O

Print	O
Date	O
/	O
Time	O
:	O
Distribute	O
to	O
:	O
Patient	O
T	O
locations	O
:	O
Collected	O
Date	O
/	O
Time	O
:	O
Received	O
Date	O
/	O
Time	O
:	O
SPECIMENLATERALITY	O
:	O
Right	O
.	O

TUMOR	O
SITE	O
:	O
Lower	O
lobe	O
.	O

TUMOR	O
SIZE	O
:	O
Greatest	O
dimension	O
:	O
1	B
.	I
3	I
cm	I
.	O

TUMOR	O
FOCALITY	O
:	O
Unifocal	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Squamous	O
cell	O
carcinoma	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
G2	O
:	O
Moderately	O
differentiated	O
.	O

VISCERAL	O
PLEURA	O
INVASION	O
:	O
Not	O
identified	O
.	O

TUMOR	O
EXTENSION	O
:	O
Tumor	O
involves	O
main	O
bronchus	O
2	O
cm	O
or	O
more	O
distal	O
to	O
the	O
carina	O
.	O

BRONCHIAL	O
MARGIN	O
:	O
Cannot	O
be	O
assessed	O
.	O

VASCULAR	O
MARGIN	O
:	O
Cannot	O
be	O
assessed	O
.	O

PARENCHYMAL	O
MARGIN	O
:	O
Uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

PARIETAL	O
PLEURAL	O
MARGIN	O
:	O
Not	O
applicable	O
.	O

CHEST	O
WALL	O
MARGIN	O
:	O
Not	O
applicable	O
.	O

TREATMENT	O
EFFECT	O
:	O
Not	O
applicable	O
.	O

LYMPH	O
-	O
VASCULAR	O
INVASION	O
:	O
Not	O
identified	O
.	O

PRIMARY	O
TUMOR	O
(	O
pT	O
)	O
:	O
pTla	O
:	O
Tumor	O
2	O
cm	O
or	O
less	O
in	O
greatest	O
dimension	O
,	O
surrounded	O
by	O
lung	O
or	O
visceral	O
pleura	O
,	O
without	O
bronchoscopic	O
evidence	O
of	O
.	O
invasion	O
more	O
proximal	O
than	O
the	O
lobar	O
bronchus	O
(	O
ie	O
,	O
not	O
in	O
the	O
main	O
bronchus	O
)	O
;	O
or	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
(	O
pN	O
)	O
:	O
pNO	O
:	O
No	O
regional	O
lymph	O
node	O
metastasis	O
.	O

Number	O
examined	O
:	O
13	O
.	O

Number	O
involved	O
:	O
0	O
.	O

DISTANT	O
METASTASIS	O
(	O
pM	O
)	O
:	O
Not	O
applicable	O
.	O

Source	O
of	O
Specimen	O
.	O

A	O
.	O

Right	O
Lower	O
Lobe	O
.	O

B	O
.	O

Level	O
7	O
.	O

C	O
.	O

Level	O
10	O
.	O

Print	O
Date	O
/	O
Time	O
:	O
Collected	O
Date	O
/	O
Time	O
:	O
Received	O
Date	O
/	O
Time	O
:	O
D	O
.	O

Right	O
Middle	O
Lobe	O
.	O

E	O
.	O

R4	O
.	O

F	O
.	O

R2	O
.	O

Clinical	O
Information	O
.	O

PRE	O
-	O
OP	O
DIAGNOSIS	O
:	O
Lung	O
cancer	O
.	O

POST	O
-	O
OP	O
DIAGNOSIS	O
:	O
Same	O
.	O

TYPE	O
OF	O
PROCEDURE	O
:	O
Bronchoscopy	O
,	O
right	O
VATS	O
.	O

R	O
é	O
moval	O
right	O
lower	O
lobe	O
.	O

Gross	O
Description	O
.	O

Specimen	O
is	O
received	O
in	O
6	O
parts	O
:	O
A	O
.	O

The	O
specimen	O
is	O
labeled	O
"	O
RIGHT	O
LOWER	O
LOBE	O
"	O
and	O
is	O
received	O
unfixed	O
.	O

It	O
consists	O
of	O
a	O
lobe	O
of	O
the	O
lung	O
measuring	O
15	O
x	O
12	O
x	O
8	O
.	O

cm	O
and	O
weighing	O
280	O
g	O
.	O

The	O
pleural	O
surface	O
is	O
pink	O
-	O
purple	O
and	O
smooth	O
and	O
shows	O
multiple	O
anthracotic	O
markings	O
.	O

The	O
bronchial	O
and	O
.	O
vascular	O
margins	O
are	O
stapled	O
shut	O
.	O

The	O
soft	O
tissue	O
margin	O
of	O
resection	O
measuring	O
2	O
cm	O
,	O
4	O
cm	O
,	O
4	O
.	O
5	O
cm	O
and	O
5	O
cm	O
.	O

A	O
1	O
.	O
3	O
x	O
1	O
.	O
2	O
x	O
1	O
.	O
2	O
cm	O
an	O
ill	O
-	O
defined	O
gray	O
-	O
tan	O
mass	O
is	O
identified	O
2	O
cm	O
away	O
from	O
the	O
bronchial	O
margin	O
of	O
resection	O
and	O
3	O
cm	O
away	O
from	O
.	O
the	O
closest	O
pleural	O
surface	O
.	O

Pleural	O
surface	O
closest	O
to	O
the	O
mass	O
is	O
covered	O
with	O
smooth	O
surface	O
without	O
any	O
papillary	O
excrescences	O
.	O
and	O
.	O

is	O
.	O
inked	O
.	O

Remaining	O
portion	O
of	O
the	O
lung	O
shows	O
dark	O
red	O
tan	O
congested	O
parenchyma	O
without	O
other	O
lesions	O
.	O

At	O
the	O
hilum	O
0	O
.	O
7	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
5	O
.	O

cm	O
and	O
0	O
.	O
6	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
5	O
cm	O
lymph	O
nodes	O
are	O
identified	O
.	O

Representative	O
sections	O
are	O
submitted	O
as	O
follows	O
:	O
A1	O
=	O
bronchial	O
and	O
vascular	O
margin	O
of	O
resection	O
.	O

A2	O
=	O
soft	O
tissue	O
margin	O
of	O
resection	O
.	O

A3	O
-	O
A5	O
=	O
mass	O
,	O
entirely	O
submitted	O
.	O

A	O
6	O
=	O
random	O
section	O
of	O
the	O
lung	O
.	O

A7	O
=	O
2	O
lymph	O
nodes	O
.	O

A8	O
=	O
closest	O
pleural	O
surface	O
to	O
the	O
mass	O
.	O

B	O
.	O

The	O
.	O
specimen	O
is	O
labeled	O
"	O
LEVEL	O
VII	O
"	O
and	O
is	O
received	O
in	O
formalin	O
.	O

It	O
consists	O
of	O
3	O
black	O
tan	O
lymph	O
nodes	O
ranging	O
from	O
0	O
.	O
5	O
x	O
0	O
.	O
5	O
x	O
.	O

0	O
.	O
3	O
-	O
0	O
.	O
6	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
cm	O
.	O

Entirely	O
submitted	O
in	O
cassette	O
B1	O
.	O

C	O
.	O

The	O
.	O
specimen	O
is	O
labeled	O
"	O
LEVEL	O
X	O
"	O
and	O
is	O
received	O
in	O
formalin	O
.	O

It	O
consists	O
of	O
4	O
black	O
tan	O
lymph	O
nodes	O
measuring	O
0	O
.	O
5	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
-	O
.	O

0	O
.	O
8	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
cm	O
.	O

Entirely	O
submitted	O
in	O
cassette	O
C1	O
.	O

D	O
.	O

The	O
.	O
specimen	O
is	O
labeled	O
"	O
RIGHT	O
MIDDLE	O
:	O
LOBE	O
"	O
and	O
is	O
received	O
in	O
formalin	O
.	O

It	O
consists	O
of	O
a	O
wedge	O
shaped	O
piece	O
of	O
lung	O
tissue	O
.	O
measuring	O
3	O
.	O
5	O
x	O
1	O
x	O
0	O
.	O
7	O
cm	O
which	O
3	O
.	O
5	O
cm	O
stapled	O
margin	O
of	O
resection	O
.	O

In	O
the	O
center	O
portion	O
1	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
5	O
cm	O
irregular	O
fragmented	O
area	O
.	O

is	O
noted	O
which	O
is	O
0	O
.	O
3	O
cm	O
away	O
from	O
the	O
stapled	O
margin	O
of	O
resection	O
which	O
is	O
inked	O
red	O
.	O

Entirely	O
submitted	O
in	O
cassettes	O
D1	O
-	O
D2	O
.	O

E	O
.	O

The	O
specimen	O
is	O
labeled	O
"	O
R4	O
"	O
and	O
is	O
received	O
in	O
formalin	O
.	O

It	O
consists	O
of	O
a	O
single	O
black	O
lymph	O
node	O
measuring	O
2	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
6	O
cm	O
.	O

Sectioned	O
and	O
entirely	O
submitted	O
in	O
cassette	O
E1	O
.	O

F	O
.	O

The	O
specimen	O
is	O
labeled	O
"	O
R2	O
"	O
and	O
is	O
received	O
in	O
formalin	O
.	O

It	O
consists	O
of	O
a	O
single	O
black	O
tan	O
lymph	O
node	O
measuring	O
0	O
.	O
7	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
5	O
.	O

Print	O
Date	O
/	O
Time	O
:	O
Collected	O
Date	O
/	O
Time	O
:	O
Received	O
Date	O
/	O
Time	O
:	O
cm	O
.	O

Sectioned	O
and	O
entirely	O
submitted	O
in	O
cassette	O
F1	O
.	O

Special	O
Stains	O
/	O
Slides	O
.	O

TTF	O
-	O
1	O
:	O
negative	O
in	O
tumor	O
cells	O
.	O

Napsin	O
A	O
:	O
negative	O
in	O
tumor	O
cells	O
.	O

p63	O
:	O
positive	O
in	O
tumor	O
cells	O
.	O

INTERPRETATION	O
:	O
Squamous	O
cell	O
carcinoma	O
.	O

Immunohistochemical	O
studies	O
were	O
performed	O
on	O
formalin	O
fixed	O
,	O
paraffin	O
-	O
embedded	O
tissue	O
(	O
Block	O
A3	O
)	O
with	O
adequate	O
positive	O
and	O
.	O
negative	O
control	O
sections	O
.	O

The	O
performance	O
characteristics	O
of	O
these	O
antibodies	O
were	O
determined	O
by	O
the	O
.	O

They	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
The	O
FDA	O
has	O
determined	O
that	O
such	O
.	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

These	O
tests	O
are	O
used	O
for	O
clinical	O
purposes	O
.	O

They	O
should	O
not	O
be	O
regarded	O
as	O
investigational	O
or	O
for	O
research	O
.	O

This	O
laboratory	O
is	O
.	O
certified	O
under	O
the	O
Clinical	O
Laboratory	O
Improvement	O
Amendments	O
of	O
1988	O
(	O
CLIA	O
-	O
88	O
)	O
as	O
qualified	O
to	O
perform	O
high	O
-	O
complexity	O
clinical	O
laboratory	O
testing	O
.	O

14	O
H	O
&	O
E	O
.	O

3ihc	O
.	O

Tissue	O
Code	O
.	O

-DOCSTART-248
Specimen	O
#	O
:	O
(	O
Age	O
:	O
Racer	O
.	O

SPECIMEN	O
:	O
A	O
:	O
RIGHT	O
BREAST	O
B	O
:	O
SENTINEL	O
NODE	O
#	O
1	O
RIGHT	O
AXILLA	O
.	O

C	O
:	O
NON	O
SENTINEL	O
LYMPH	O
NODE	O
RIGHT	O
AXILLA	O
.	O

D	O
:	O
SENTINEL	O
NODE	O
#	O
2	O
RIGHT	O
AXILLA	O
.	O

E	O
:	O
NON	O
-	O
SENTINEL	O
NODE	O
#	O
2	O
RIGHT	O
AXILLA	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
A	O
.	O

BREAST	O
,	O
RIGHT	O
,	O
MASTECTOMY	O
:	O
-	O
-	O
TUMOR	O
TYPE	O
:	O
INFILTRATING	O
DUCTAL	O
CARCINOMA	O
,	O
NO	O
SPECIAL	O
TYPE	O
.	O

-	O
NOTTINGHAM	O
GRADE	O
:	O
MODERATELY	O
DIFFERENTIATED	O
(	O
G2	O
)	O
.	O

-	O
NOTTINGHAM	O
SCORE	O
:	O
7	O
/	O
9	O
.	O

(	O
Tubules	O
=	O
3	O
,	O
Nuclei	O
=	O
2	O
,	O
Mitoses	O
=	O
2	O
i	O
mitotic	O
count	O
8	O
per	O
10	O
HPF	O
at	O
.	O
40x	O
power	O
,	O
Slide	O
A5	O
)	O
.	O

-	O
TUMOR	O
SIZE	O
(	O
GREATEST	O
DIMENSION	O
)	O
:	O
3	B
.	I
0	I
CM	I
(	O
Gross	O
measurement	O
)	O
.	O

-	O
TUMOR	O
NECROSIS	O
:	O
FOCALLY	O
PRESENT	O
IN	O
INFILTRATING	O
COMPONENT	O
.	O

-	O
MICROCALCIFICATIONS	O
PRESENT	O
IN	O
CARCINOMA	O
AND	O
BENIGN	O
BREAST	O
TISSUE	O
.	O

-	O
VENOUS	O
/	O
LYMPHATIC	O
INVASION	O
:	O
PRESENT	O
,	O
EXTENSIVE	O
.	O

-	O
MARGINS	O
:	O
NEGATIVE	O
.	O

-	O
DISTANCE	O
OF	O
INFILTRATING	O
TUMOR	O
FROM	O
THE	O
NEAREST	O
MARGIN	O
IS	O
2	O
.	O
5	O
MM	O
,	O
.	O

FROM	O
THE	O
DEEP	O
MARGIN	O
(	O
Slide	O
A8	O
)	O
.	O

SEE	O
COMMENT	O
.	O

-	O
INTRADUCTAL	O
COMPONENT	O
:	O
PRESENT	O
.	O

-	O
DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
WITH	O
APOCRINE	O
FEATURES	O
,	O
HIGH	O
NUCLEAR	O
GRADE	O
.	O

(	O
G3	O
)	O
CRIBRIFORM	O
AND	O
SOLID	O
TYPES	O
WITHOUT	O
DEFINITE	O
NECROSIS	O
.	O

-	O
LYMPH	O
NODES	O
:	O
SEE	O
PARTS	O
B	O
-	O
E	O
.	O

-	O
NIPPLE	O
INVOLVEMENT	O
:	O
PRESENT	O
WITHIN	O
THE	O
STROMA	O
.	O

-	O
SKIN	O
INVOLVEMENT	O
ABSENT	O
.	O

-	O
MULTICENTRICITY	O
ABSENT	O
.	O

-	O
ESTROGEN	O
RECEPTORS	O
:	O
POSITIVE	O
(	O
95	O
-	O
100	O
%	O
Nuclear	O
staining	O
,	O
per	O
.	O

-	O
PROGESTERONE	O
RECEPTORS	O
POSITIVE	O
(	O
10	O
%	O
Nuclear	O
staining	O
,	O
per	O
.	O

-	O
HER2	O
by	O
IHC	O
:	O
NEGATIVE	O
(	O
1	O
+	O
;	O
per	O
.	O

-	O
HER2	O
BY	O
FISH	O
:	O
NOT	O
PERFORMED	O
.	O

-	O
PATHOLOGIC	O
STAGE	O
:	O
pT2	O
N1a	O
Mx	O
.	O

-	O
ADDITIONAL	O
PATHOLOGIC	O
CHANGES	O
:	O
-	O
FIBROCYSTIC	O
CHANGES	O
INCLUDING	O
STROMAL	O
FIBROSIS	O
,	O
MICROCYSTS	O
AND	O
.	O

APOCRINE	O
METAPLASIA	O
.	O

-	O
NODULAR	O
SCLEROSING	O
ADENOSIS	O
.	O

-	O
MODERATE	O
-	O
FLORII	O
USUAL	O
DUCTAL	O
HYPERPLASIA	O
.	O

FOR	O
OFFICIAL	O
USE	O
ONLY	O
-	O
PERSONAL	O
DATA	O
-	O
PRIVACY	O
ACT	O
OF	O
.	O

Specimen	O
#	O
:	O
FINAL	O
DIAGNOSIS	O
(	O
continued	O
)	O
:	O
-	O
-	O
FIBROADENOMATOID	O
CHANGE	O
.	O

-	O
COLUMNAR	O
CELL	O
CHANGE	O
WITHOUT	O
ATYPIA	O
.	O

B	O
.	O

LYMPH	O
NODE	O
,	O
RIGHT	O
AXILLA	O
(	O
#	O
1	O
)	O
,	O
,	O
SENTINEL	O
BIOPSY	O
:	O
-	O
ONE	O
LYMPH	O
NODE	O
POSITIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
.	O

-	O
LARGEST	O
METASTATIC	O
FOCUS	O
:	O
1	O
.	O
5	O
CM	O
.	O

-	O
MICROSCOPIC	O
FOCUS	O
(	O
0	O
.	O
8	O
MM	O
)	O
OF	O
EXTRANODAL	O
EXTENSION	O
BY	O
CARCINOMA	O
.	O

IDENTIFIED	O
.	O

-	O
SEE	O
COMMENT	O
.	O

C	O
.	O

LYMPH	O
NODE	O
,	O
RIGHT	O
AXILLA	O
,	O
NON	O
-	O
SENTINEL	O
BIOPSY	O
;	O
.	O

-	O
ONE	O
OF	O
TWO	O
LYMPH	O
NODES	O
POSITIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
.	O

-	O
LARGEST	O
METASTATIC	O
FOCUS	O
=	O
1	O
.	O
1	O
CM	O
.	O

-	O
NEGATIVE	O
FOR	O
EXTRANODAL	O
EXTENSION	O
BY	O
CARCINOMA	O
.	O

D	O
.	O

LYMPH	O
NODE	O
,	O
RIGHT	O
AXILLA	O
(	O
#	O
2	O
)	O
SENTINEL	O
BIOPSY	O
:	O
-	O
ONE	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
BY	O
H	O
AND	O
E	O
AND	O
.	O

IMMUNOHISTOCHEMISTRY	O
.	O

-	O
SEE	O
COMMENT	O
.	O

E	O
.	O

LYMPH	O
NODE	O
,	O
RIGHT	O
AXILLA	O
(	O
#	O
2	O
)	O
NON	O
-	O
SENTINEL	O
BIOPSY	O
.	O

-	O
TWO	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
BY	O
H	O
AND	O
E	O
.	O

Comment	O
:	O
Part	O
A	O
-	O
The	O
tumor	O
that	O
is	O
closest	O
to	O
the	O
margin	O
is	O
present	O
.	O
within	O
a	O
lymphatic	O
space	O
.	O

Parts	O
B	O
and	O
D	O
are	O
examined	O
per	O
the	O
.	O
sentinel	O
node	O
protocol	O
,	O
with	O
four	O
.	O
step	O
sections	O
and	O
intervening	O
sections	O
examined	O
by	O
immunohistochemistry	O
.	O
for	O
pancytokeratin	O
(	O
x2	O
)	O
Control	O
stains	O
are	O
reviewed	O
.	O

CLINICAL	O
DIAGNOSIS	O
AND	O
HISTORY	O
:	O
yo	O
.	O
diagnosed	O
with	O
right	O
breast	O
cancer	O
.	O

PRE	O
-	O
OPERATIVE	O
DIAGNOSIS	O
:	O
right	O
breast	O
cancer	O
.	O

FOR	O
OFFICIAL	O
USE	O
ONLY	O
-	O
PERSONAL	O
DATA	O
-	O
PRIVACY	O
ACT	O
OF	O
.	O

FOR	O
OFFICIAL	O
USE	O
ONLY	O
-	O
PERSONAL	O
DATA	O
-	O
PRIVACY	O
ACT	O
O	O
!	O
.	O

Specimen	O
#	O
:	O
POST	O
-	O
OPERATIVE	O
DIAGNOSIS	O
:	O
none	O
provided	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
:	O
Received	O
fresh	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
.	O
and	O
.	O

designated	O
"	O
Right	O
Breast	O
,	O
long	O
-	O
lateral	O
,	O
short	O
-	O
superior	O
,	O
double	O
-	O
deep	O
.	O

stitches	O
"	O
consists	O
of	O
a	O
344	O
gm	O
mastectomy	O
specimen	O
oriented	O
with	O
short	O
.	O
stitch	O
superior	O
,	O
long	O
stitch	O
lateral	O
.	O

The	O
specimen	O
measures	O
20	O
.	O
0	O
cm	O
.	O
superior	O
to	O
inferior	O
,	O
18	O
.	O
0	O
cm	O
medial	O
to	O
lateral	O
,	O
and	O
3	O
.	O
0	O
cm	O
anterior	O
to	O
.	O
posterior	O
.	O

The	O
darkly	O
pigmented	O
superficial	O
skin	O
ellipse	O
measures	O
9	O
.	O
5	O
x	O
.	O

3	O
.	O
5	O
cm	O
and	O
displays	O
a	O
1	O
.	O
0	O
cm	O
centrally	O
located	O
,	O
flat	O
nipple	O
free	O
of	O
.	O
discharge	O
.	O

The	O
deep	O
margin	O
is	O
inked	O
black	O
and	O
the	O
superficial	O
margin	O
is	O
.	O
inked	O
blue	O
.	O

Serial	O
sections	O
reveal	O
a	O
centrally	O
located	O
,	O
well	O
-	O
defined	O
mass	O
.	O
measuring	O
3	O
.	O
0	O
cm	O
(	O
superior	O
to	O
inferior	O
)	O
x	O
2	O
.	O
5	O
x	O
2	O
.	O
5	O
cm	O
.	O

The	O
mass	O
is	O
.	O
subjacent	O
to	O
(	O
and	O
continuous	O
with	O
)	O
the	O
nipple	O
and	O
comes	O
to	O
within	O
1	O
.	O
3	O
.	O

cm	O
.	O
of	O
the	O
deep	O
margin	O
.	O

The	O
cut	O
surface	O
is	O
pink	O
-	O
white	O
,	O
firm	O
and	O
gritty	O
with	O
.	O
peripheral	O
congestion	O
.	O

The	O
fibrous	O
tissue	O
surrounding	O
the	O
mass	O
is	O
markedly	O
.	O
dense	O
and	O
diffusely	O
nodular	O
,	O
suggestive	O
of	O
an	O
additional	O
focal	O
lesion	O
.	O

The	O
.	O
remainder	O
of	O
the	O
specimen	O
is	O
composed	O
moderately	O
of	O
dense	O
fibrous	O
tissue	O
.	O
admixed	O
with	O
lobulated	O
,	O
yellow	O
-	O
tan	O
adipose	O
tissue	O
.	O

No	O
lymph	O
nodes	O
are	O
.	O
identified	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Cassette	O
Summary	O
:	O
A1	O
-	O
nipple	O
with	O
subjacent	O
mass	O
;	O
A2	O
-	O
mass	O
with	O
deep	O
.	O
margin	O
;	O
A3	O
-	O
A5	O
-	O
mass	O
;	O
A6	O
-	O
mass	O
with	O
skin	O
;	O
A7	O
-	O
A8	O
-	O
deep	O
margin	O
to	O
tumor	O
,	O
.	O
central	O
breast	O
;	O
A9	O
-	O
lower	O
mid	O
,	O
adjacent	O
(	O
inferior	O
)	O
to	O
tumor	O
;	O
A10	O
-	O
margin	O
.	O
of	O
A9	O
;	O
A11	O
-	O
-	O
central	O
breast	O
,	O
adjacent	O
(	O
medial	O
)	O
to	O
tumor	O
;	O
A12	O
-	O
margin	O
of	O
.	O

A11	O
;	O
A13	O
-	O
-	O
upper	O
outer	O
quadrant	O
,	O
4	O
.	O
5	O
cm	O
from	O
tumor	O
;	O
A14	O
-	O
margin	O
of	O
A13	O
.	O

A15	O
-	O
lower	O
outer	O
quadrant	O
,	O
4	O
.	O
5	O
cm	O
from	O
tumor	O
;	O
A16	O
-	O
lower	O
inner	O
quadrant	O
.	O
with	O
deep	O
adjacent	O
to	O
tumor	O
;	O
A17	O
-	O
upper	O
inner	O
quadrant	O
adjacent	O
to	O
.	O
tumor	O
;	O
.	O

Matched	O
sections	O
of	O
A1	O
,	O
A3	O
-	O
A7	O
,	O
A9	O
,	O
A11	O
,	O
A13	O
and	O
A15	O
-	O
A17	O
are	O
submitted	O
in	O
.	O

OCT	O
for	O
.	O
protocol	O
.	O

B	O
:	O
Received	O
fresh	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
.	O
and	O
.	O

designated	O
"	O
Sentinel	O
Node	O
#	O
1	O
Right	O
Axilla	O
"	O
consists	O
or	O
a	O
1	O
.	O
5	O
x	O
1	O
.	O
2	O
x	O
.	O

0	O
.	O
7	O
.	O

cm	O
possible	O
lymph	O
node	O
.	O

The	O
lymph	O
node	O
is	O
bisected	O
to	O
reveal	O
a	O
firm	O
,	O
.	O
tan	O
-	O
white	O
cut	O
surface	O
.	O

The	O
specimen	O
is	O
submitted	O
in	O
cassette	O
B1	O
.	O

A	O
.	O
matched	O
section	O
of	O
section	O
of	O
B1	O
is	O
submitted	O
in	O
OCT	O
for	O
.	O
protocol	O
.	O

C	O
:	O
Received	O
fresh	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
.	O
and	O
.	O

designated	O
'	O
Non	O
-	O
Sentinel	O
Lymph	O
Node	O
Right	O
Axilla	O
"	O
consists	O
of	O
two	O
possible	O
.	O
lymph	O
nodes	O
measuring	O
1	O
.	O
5	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
5	O
cm	O
and	O
0	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
cut	O
surface	O
of	O
the	O
larger	O
possible	O
lymph	O
node	O
is	O
pink	O
-	O
white	O
and	O
firm	O
.	O

The	O
lymph	O
nodes	O
are	O
submitted	O
as	O
follows	O
:	O
Cassette	O
Summary	O
:	O
C1	O
-	O
one	O
lymph	O
node	O
;	O
C2	O
-	O
one	O
lymph	O
node	O
bisected	O
.	O

A	O
matched	O
section	O
of	O
C1	O
is	O
submitted	O
in	O
OCT	O
for	O
.	O
protocol	O
.	O

FOR	O
OFFICIAL	O
USE	O
ONLY	O
-	O
PERSONAL	O
DATA	O
-	O
PRIVACY	O
ACT	O
OF	O
.	O

FOR	O
OFFICIAL	O
US	O
#	O
ONLY	O
-	O
PERSONAL	O
DATA	O
-	O
PRIVACY	O
ACT	O
o	O
.	O

Specimen	O
#	O
:	O
GROSS	O
DESCRIPTION	O
(	O
continued	O
)	O
:	O
D	O
:	O
Recei	O
1	O
in	O
formalin	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
.	O
designated	O
"	O
Sentinel	O
Node	O
#	O
2	O
Right	O
Axilla	O
"	O
consists	O
of	O
one	O
.	O
irregular	O
shaped	O
fragment	O
of	O
yellow	O
lobular	O
adipose	O
tissue	O
measuring	O
1	O
.	O

5	O
.	O

cm	O
in	O
greatest	O
dimension	O
.	O

Sectioning	O
reveals	O
one	O
possible	O
lymph	O
node	O
.	O
measuring	O
0	O
.	O
6	O
cm	O
in	O
greatest	O
dimension	O
.	O

Specimen	O
submitted	O
in	O
its	O
.	O
entirety	O
.	O

E	O
:	O
Received	O
fresh	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
.	O
and	O
.	O

designated	O
"	O
Non	O
-	O
Sentinel	O
Node	O
#	O
2	O
"	O
consists	O
of	O
two	O
possible	O
lymph	O
nodes	O
.	O
measuring	O
2	O
.	O
0	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
7	O
cm	O
and	O
0	O
.	O
7	O
cm	O
in	O
greatest	O
dimension	O
.	O

Sectioning	O
.	O
of	O
both	O
possible	O
lymph	O
nodes	O
reveals	O
a	O
pink	O
-	O
tan	O
unremarkable	O
cut	O
surface	O
.	O

The	O
lymph	O
nodes	O
are	O
entirely	O
submitted	O
as	O
follows	O
:	O
Cassette	O
Summary	O
:	O
E1	O
-	O
E2	O
-	O
one	O
lymph	O
node	O
;	O
E3	O
-	O
one	O
lymph	O
node	O
bisected	O
.	O

A	O
matched	O
section	O
of	O
E2	O
is	O
submitted	O
in	O
OCT	O
for	O
.	O
protocol	O
.	O

FOR	O
OFFICIAL	O
USE	O
ONLY	O
-	O
PERSONAL	O
DATA	O
-	O
PRIVACY	O
.	O

-DOCSTART-249
Male	O
.	O

Clinical	O
diagnosis	O
:	O
Melanoma	O
.	O

Gross	O
description	O
:	O
The	O
material	O
presented	O
-	O
skin	O
,	O
left	O
leg	O
,	O
lower	O
thigh	O
region	O
,	O
surgical	O
resection	O
.	O

Microscopic	O
description	O
:	O
Received	O
material	O
is	O
malignant	O
melanoma	O
with	O
features	O
of	O
mixed	O
epitheloid	O
and	O
.	O
spindle	O
cell	O
melanoma	O
.	O

Grade	O
3	O
,	O
Clark	O
II	O
-	O
III	O
,	O
Breslow	O
0	O
,	O
79mm	O
,	O
Tumor	O
content	O
.	O

80	O
%	O
with	O
5	O
%	O
stroma	O
present	O
.	O

Final	O
diagnosis	O
:	O
Mixed	O
epitheloid	O
and	O
spindle	O
cell	O
melanoma	O
.	O

Confidential	O
.	O

-DOCSTART-250
STOMACH	O
TISSUE	O
CHECKLIST	O
.	O

Specimen	O
type	O
:	O
Gastrectomy	O
.	O

Tumor	O
Site	O
:	O
Not	O
specified	O
.	O

Tumor	O
configuration	O
:	O
Ulcerating	O
.	O

Tumor	O
size	O
:	O
11	B
.	I

cm	B
in	O
diameter	O
.	O

Histologic	O
type	O
:	O
Adenocarcinoma	O
.	O

Histologic	O
grade	O
:	O
Poorly	O
differentiated	O
.	O

Extent	O
of	O
invasion	O
:	O
Liver	O
.	O

Lymph	O
nodes	O
:	O
2	O
.	O
nodes	O
negative	O
for	O
malignancy	O
.	O

Margins	O
-	O
Proximal	O
margin	O
:	O
Not	O
specified	O
.	O

Distal	O
margin	O
:	O
Not	O
specified	O
.	O

Omental	O
(	O
radial	O
)	O
margin	O
:	O
Not	O
.	O
specified	O
.	O

Lymphatic	O
invasion	O
:	O
Not	O
specified	O
.	O

Venous	O
invasion	O
:	O
Not	O
specified	O
.	O

Perineural	O
invasion	O
:	O
Not	O
specified	O
.	O

Additional	O
pathologic	O
.	O
findings	O
:	O
Not	O
specified	O
.	O

Comments	O
:	O
None	O
.	O

-DOCSTART-251
AMENDED	O
.	O

CLINICAL	O
HISTORY	O
.	O
with	O
possible	O
stroke	O
and	O
seizures	O
,	O
has	O
.	O
heterogenously	O
enhancing	O
left	O
temporal	O
tumor	O
with	O
edema	O
and	O
mass	O
effect	O
.	O

OPERATIVE	O
DIAGNOSES	O
.	O

Not	O
Given	O
.	O

Operation	O
/	O
Specimen	O
:	O
A	O
:	O
Brain	O
,	O
Left	O
temporal	O
,	O
biopsy	O
.	O

B	O
:	O
Brain	O
,	O
left	O
temporal	O
tumor	O
,	O
biopsy	O
.	O

PATHOLOGICAL	O
DIAGNOSIS	O
:	O
A	O
and	O
B	O
.	O

Brain	O
,	O
left	O
temporal	O
,	O
excisional	O
biopsies	O
:	O
Glioblastoma	O
.	O

See	O
Comment	O
.	O

COMMENT	O
.	O

The	O
specimens	O
are	O
fragments	O
of	O
an	O
astrocytic	O
neoplastic	O
proliferation	O
that	O
.	O
focally	O
infiltrates	O
and	O
extensively	O
effaces	O
the	O
brain	O
tissue	O
.	O

The	O
neoplasm	O
.	O
has	O
nuclear	O
anaplasia	O
,	O
mitotic	O
figures	O
,	O
microvascular	O
cellular	O
proliferation	O
.	O
with	O
necrosis	O
and	O
thrombosis	O
,	O
and	O
zones	O
of	O
tumor	O
necrosis	O
,	O
i	O
.	O
e	O
.	O
a	O
.	O
glioblastoma	O
.	O

Special	O
stains	O
to	O
better	O
characterize	O
the	O
neoplasm	O
have	O
been	O
requested	O
and	O
.	O
results	O
will	O
be	O
reported	O
as	O
an	O
addendum	O
.	O

AMENDMENTS	O
.	O

Amended	O
:	O
Reason	O
:	O
Report	O
,	O
Dictation	O
,	O
Typographical	O
Error	O
.	O

The	O
case	O
was	O
signed	O
out	O
before	O
the	O
gross	O
was	O
transcribed	O
.	O

Previous	O
Signout	O
Date	O
:	O
PROCEDURES	O
/	O
ADDENDA	O
.	O

Immunohistology	O
.	O

Interpretation	O
.	O

Brain	O
,	O
Immunohistochemistry	O
:	O
MIB	O
-	O
1	O
proliferation	O
index	O
"	O
.	O

See	O
Results	O
and	O
Comment	O
(	O
below	O
)	O
.	O

Results	O
-	O
Comments	O
.	O

IMMUNOHISTOCHEMISTRY	O
:	O
The	O
GFAP	O
depicts	O
gliofibrillogenesis	O
by	O
the	O
neoplastic	O
.	O
cells	O
.	O

The	O
tumor	O
cells	O
do	O
not	O
over	O
express	O
the	O
p53	O
protein	O
.	O

With	O
the	O
MIB	O
-	O
1	O
.	O
there	O
is	O
a	O
proliferation	O
index	O
of	O
about	O
23	O
%	O
in	O
the	O
more	O
active	O
areas	O
.	O

Comment	O
:	O
The	O
results	O
are	O
those	O
of	O
a	O
glioblastoma	O
.	O

INTRA	O
-	O
OPERATIVE	O
CONSULTATION	O
.	O

A	O
.	O

Brain	O
,	O
touch	O
prep	O
and	O
smears	O
:	O
High	O
histological	O
grade	O
glioma	O
.	O

glioblastoma	O
)	O
.	O

GROSS	O
DESCRIPTION	O
.	O

A	O
.	O

"	O
Brain	O
,	O
Left	O
temporal	O
,	O
biopsy	O
,	O
received	O
fresh	O
,	O
four	O
fragments	O
,	O
0	O
.	O
6	O
cm	O
.	O
across	O
in	O
aggregate	O
.	O

Semi	O
firm	O
,	O
glistening	O
,	O
tannish	O
-	O
grey	O
.	O

In	O
total	O
,	O
A1	O
.	O

B	O
.	O

SPECIMEN	O
:	O
Left	O
temporal	O
tumor	O
.	O

FIXATIVE	O
:	O
None	O
.	O

GENERAL	O
:	O
Several	O
fragments	O
of	O
tan	O
rubbery	O
brain	O
parenchyma	O
with	O
red	O
clotted	O
.	O
blood	O
,	O
3	O
cm	O
in	O
loose	O
aggregate	O
.	O

SECTIONS	O
:	O
B1	O
-	O
B3	O
all	O
submitted	O
.	O

ICD	O
-	O
9	O
(	O
s	O
)	O
:	O
225	O
.	O
0	O
225	O
.	O
0	O
.	O

Histo	O
Data	O
.	O

Part	O
A	O
:	O
Brain	O
,	O
Left	O
temporal	O
,	O
biopsy	O
.	O

Stain	O
/	O
cnt	O
.	O

Block	O
.	O

Comment	O
.	O

FS	O
H	O
/	O
E	O
X	O
1	O
.	O

1	O
.	O

mGFAP	O
-	O
DA	O
x	O
1	O
.	O

H	O
/	O
E	O
x	O
1	O
.	O

1	O
.	O

MIB1	O
-	O
DA	O
x	O
1	O
.	O

1	O
.	O

P53D07	O
X	O
1	O
.	O

1	O
.	O

H	O
/	O
E	O
x	O
1	O
.	O

2	O
.	O

Part	O
B	O
:	O
Brain	O
,	O
left	O
temporal	O
tumor	O
,	O
biopsy	O
.	O

Stain	O
/	O
cnt	O
.	O

Block	O
.	O

Comment	O
.	O

H	O
/	O
E	O
X	O
1	O
.	O

1	O
.	O

H	O
/	O
E	O
x	O
1	O
.	O

2	O
.	O

H	O
/	O
E	O
X	O
1	O
.	O

3	O
.	O

-DOCSTART-252
Short	O
descriptive	O
translation	O
of	O
the	O
pathology	O
review	O
reported	O
by	O
the	O
.	O

Pathoanatomical	O
review	O
.	O

Date	O
report	O
:	O
Material	O
:	O
right	O
adrenal	O
.	O

This	O
is	O
a	O
soft	O
tan	O
and	O
necrotic	O
tumor	O
with	O
a	O
diameter	O
of	O
5	B
cm	I
with	O
focal	O
areas	O
of	O
more	O
solid	O
,	O
.	O
white	O
to	O
gray	O
tissue	O
.	O

Histologically	O
,	O
this	O
is	O
a	O
pleomorph	O
tumor	O
in	O
part	O
composed	O
of	O
zellballen	O
where	O
single	O
giant	O
.	O
cells	O
are	O
present	O
.	O

A	O
capsule	O
is	O
not	O
found	O
.	O

Immunohistochemically	O
,	O
the	O
tumor	O
exhibits	O
a	O
diffuse	O
staining	O
for	O
synaptohpysin	O
and	O
.	O
chromogranin	O
.	O

Focally	O
,	O
the	O
AE1	O
/	O
3	O
stains	O
positive	O
.	O

Single	O
sustentacular	O
cells	O
are	O
identified	O
by	O
.	O
positive	O
staining	O
for	O
S100	O
.	O

Only	O
the	O
adjacent	O
adrenal	O
parenchyma	O
stains	O
positive	O
for	O
MART1	O
.	O
and	O
inhibin	O
.	O

With	O
Ki67	O
,	O
a	O
proliferation	O
index	O
of	O
5	O
%	O
is	O
found	O
.	O

Final	O
diagnosis	O
:	O
pheochromocytoma	O
.	O

-DOCSTART-253
86	O
-	O
6851	O
.	O

A	O
.	O

Labeled	O
left	O
upper	O
lobe	O
lesion	O
.	O

Sections	O
show	O
a	O
.	O

Received	O
fresh	O
for	O
intraoperative	O
.	O
poorly	O
differentiated	O
.	O
consultation	O
is	O
a	O
previously	O
incised	O
and	O
.	O
invasive	O
.	O

diffusely	O
ragged	O
wedge	O
of	O
lung	O
.	O
adenocarcinoma	O
with	O
.	O
measuring	O
7	B
X	I
3	I
X	I
2	I
.	I
2	I
cm	I
.	O

There	O
are	O
2	O
.	O
both	O
.	O

firm	O
gray	O
and	O
brown	O
lesion	O
measuring	O
.	O
acinar	O
and	O
solid	O
.	O

1	O
.	O
0	O
and	O
1	O
.	O
4	O
cm	O
in	O
greatest	O
dimension	O
.	O
growth	O
patterns	O
.	O

The	O
.	O
tumor	O
extends	O
to	O
the	O
.	O

B	O
.	O

Labeled	O
left	O
upper	O
lobe	O
bronchial	O
.	O
subpleura	O
.	O

margin	O
.	O

Received	O
fresh	O
for	O
.	O

Immunohistochemica	O
.	O
intraoperative	O
consultation	O
is	O
a	O
150	O
g	O
lobe	O
.	O
stains	O
are	O
performed	O
.	O
of	O
lung	O
measuring	O
approximately	O
.	O
with	O
appropriate	O
.	O

15	O
X	O
10	O
X	O
4	O
cm	O
.	O
the	O
pleural	O
surface	O
is	O
tan	O
.	O
control	O
reactions	O
.	O
to	O
red	O
and	O
smooth	O
to	O
slightly	O
.	O
to	O
confirm	O
this	O
.	O
wrinkled	O
with	O
two	O
staple	O
lines	O
adjacent	O
to	O
.	O
histologic	O
impression	O
.	O
the	O
hilum	O
measuring	O
3	O
.	O
8	O
and	O
13	O
.	O

The	O
malignant	O
cells	O
.	O

cm	O
in	O
length	O
.	O

The	O
larger	O
passes	O
through	O
a	O
.	O
are	O
positive	O
for	O
.	O

2	O
.	O
5	O
X	O
2	O
.	O
2	O
cm	O
firm	O
white	O
-	O
tan	O
to	O
.	O
cytokeratin	O
7	O
,	O
TTF	O
-	O
1	O
,	O
.	O
red	O
mass	O
that	O
comes	O
to	O
within	O
2	O
.	O
0	O
cm	O
of	O
.	O

Napsin	O
-	O
A	O
while	O
.	O
the	O
bronchial	O
margin	O
.	O

Immediately	O
.	O
negative	O
for	O
.	O
adjacent	O
to	O
the	O
bronchial	O
margin	O
is	O
a	O
1	O
.	O
5	O
.	O
cytokeratin	O
5	O
/	O
6	O
.	O

The	O
.	O

cm	O
gray	O
-	O
white	O
lymph	O
node	O
grossly	O
.	O
malignant	O
cells	O
show	O
.	O
positive	O
for	O
metastatic	O
tumor	O
.	O

The	O
.	O
rare	O
focal	O
positivity	O
.	O
bronchial	O
margin	O
and	O
adjacent	O
lymph	O
.	O
for	O
p63	O
.	O

An	O
elastin	O
.	O
node	O
.	O

stain	O
shows	O
.	O
are	O
sampled	O
for	O
frozen	O
section	O
.	O

The	O
.	O

no	O
convincing	O
.	O
background	O
lung	O
is	O
tan	O
to	O
red	O
and	O
.	O
penetration	O
of	O
the	O
.	O
spongy	O
with	O
no	O
other	O
nodules	O
or	O
masses	O
.	O
visceral	O
pleural	O
elastic	O
.	O
lesions	O
.	O

Another	O
hilar	O
lymph	O
node	O
is	O
.	O
layer	O
by	O
the	O
.	O
not	O
identified	O
.	O
tumor	O
.	O

LUNG	O
CARCINOMA	O
CHECKLIST	O
.	O

LUNG	O
TISSUE	O
.	O

1	O
.	O

Tumor	O
type	O
:	O
Adenocarcinoma	O
.	O

CHECKLIST	O
.	O

2	O
.	O

Histologic	O
grade	O
:	O
Poorly	O
.	O
differentiated	O
.	O

Specimen	O
type	O
:	O
3	O
.	O

Tumor	O
location	O
:	O
Left	O
upper	O
lobe	O
.	O

Lobectomy	O
.	O

4	O
.	O

Tumor	O
size	O
:	O
2	B
.	I
5	I
X	I
2	I
.	I
2	I
cm	I
.	O

Tumor	O
site	O
:	O
Lung	O
.	O

5	O
.	O

Angiolymphatic	O
invasion	O
:	O
Yes	O
.	O

Tumor	O
size	O
:	O
2	B
.	I
5	I
X	I
2	I
.	I
2	I
.	O

6	O
.	O

Bronchial	O
margin	O
:	O
The	O
bronchus	O
.	O

cm	O
.	O

is	O
free	O
of	O
tumor	O
.	O

However	O
,	O
a	O
.	O

Histologic	O
type	O
:	O
peribronchial	O
lymph	O
node	O
at	O
the	O
.	O

Adenocarcinoma	O
.	O
resection	O
margin	O
contained	O
.	O

Histologic	O
grade	O
:	O
metastatic	O
tumor	O
.	O

Poorly	O
differentiated	O
.	O
with	O
extranodal	O
extension	O
into	O
.	O

Tumor	O
extent	O
:	O
Not	O
.	O
peribronchial	O
soft	O
tissues	O
.	O
specified	O
.	O

7	O
.	O

Parenchymal	O
margin	O
:	O
Involved	O
.	O

Other	O
tumor	O
nodules	O
:	O
by	O
carcinoma	O
.	O

Not	O
specified	O
.	O

8	O
.	O

Vascular	O
margins	O
:	O
Free	O
of	O
tumor	O
.	O

Lymph	O
nodes	O
:	O
1	O
/	O
7	O
.	O

9	O
.	O

Pleural	O
involvement	O
:	O
Subpleural	O
.	O
positive	O
for	O
metastasis	O
.	O

10	O
.	O

Lymph	O
nodes	O
:	O
One	O
of	O
two	O
.	O

(	O
Regional	O
1	O
/	O
7	O
)	O
.	O
peribronchial	O
lymph	O
nodes	O
positive	O
.	O

Lymphatic	O
invasion	O
:	O
for	O
.	O

Present	O
.	O
metastatic	O
tumor	O
(	O
1	O
/	O
2	O
)	O
.	O

One	O
benign	O
.	O

Venous	O
invasion	O
:	O
para	O
-	O
aortic	O
lymph	O
node	O
(	O
0	O
/	O
1	O
)	O
.	O

Four	O
.	O

Present	O
.	O
benign	O
hilar	O
lymph	O
nodes	O
(	O
0	O
/	O
4	O
)	O
.	O

Margins	O
:	O
Involved	O
.	O

11	O
.	O

Size	O
of	O
largest	O
metastatic	O
.	O

Evidence	O
of	O
neo	O
-	O
.	O
deposit	O
:	O
1	O
.	O
3	O
cm	O
.	O
adjuvant	O
treatment	O
:	O
12	O
.	O

TNM	O
:	O
pT1b	O
,	O
pN1	O
,	O
pMX	O
.	O

Not	O
specified	O
.	O

Additional	O
pathologic	O
.	O
findings	O
:	O
Not	O
specified	O
.	O

Comments	O
:	O
None	O
.	O

-DOCSTART-254
Dept	O
.	O

MRN	O
:	O
Encounter	O
.	O

#	O
:	O
Department	O
:	O
Surgical	O
Pathology	O
Request	O
.	O

(	O
Order	O
.	O
Result	O
Narrative	O
.	O
ADDENDUM	O
.	O
ADDENDUM	O
REPORT	O
.	O
)	O
:	O
THIS	O
ADDENDUM	O
REPORT	O
SUPERSEDES	O
THE	O
REPORT	O
ISSUED	O
.	O

THE	O
DIAGNOSIS	O
IS	O
UNCHANGED	O
.	O

An	O
immunohistochemical	O
study	O
for	O
EGFR	O
demonstrates	O
moderate	O
to	O
strong	O
labeling	O
of	O
.	O
nearly	O
all	O
tumor	O
cells	O
with	O
an	O
H	O
score	O
of	O
220	O
(	O
5	O
%	O
at	O
0	O
,	O
0	O
%	O
at	O
1	O
+	O
,	O
65	O
%	O
at	O
2	O
+	O
,	O
30	O
%	O
.	O
at	O
3	O
+	O
)	O
.	O
one	O
of	O
our	O
.	O
pathologists	O
,	O
has	O
also	O
reviewed	O
this	O
.	O
additional	O
study	O
and	O
she	O
concurs	O
with	O
the	O
above	O
assessment	O
.	O

FINAL	O
DIAGNOSIS	O
.	O

A	O
)	O
Left	O
tongue	O
,	O
pharynx	O
and	O
neck	O
zones	O
1	O
,	O
2	O
and	O
3	O
soft	O
tissue	O
,	O
near	O
total	O
.	O
glossectomy	O
,	O
partial	O
pharyngectomy	O
,	O
left	O
neck	O
dissection	O
:	O
Left	O
tongue	O
and	O
oral	O
pharynx	O
,	O
glossectomy	O
and	O
pharyngectomy	O
.	O

Invasive	O
well	O
to	O
moderately	O
-	O
differentiated	O
squamous	O
cell	O
carcinoma	O
(	O
7	B
cm	I
)	O
.	O
involving	O
the	O
left	O
posterolateral	O
tongue	O
,	O
pharynx	O
and	O
soft	O
palate	O
;	O
tumor	O
extends	O
.	O
to	O
the	O
right	O
/	O
midline	O
lingual	O
specimen	O
margin	O
(	O
see	O
parts	O
B	O
-	O
F	O
and	O
J	O
for	O
separately	O
.	O
submitted	O
and	O
final	O
margins	O
)	O
.	O

Left	O
neck	O
zones	O
1	O
,	O
2	O
,	O
3	O
,	O
dissection	O
:	O
Zone	O
1	O
:	O
Five	O
lymph	O
nodes	O
,	O
negative	O
for	O
carcinoma	O
(	O
0	O
/	O
5	O
)	O
.	O

-	O
Zone	O
2	O
:	O
One	O
lymph	O
node	O
,	O
negative	O
for	O
tumor	O
(	O
0	O
/	O
1	O
)	O
.	O

-	O
Zone	O
3	O
:	O
Metastatic	O
squamous	O
cell	O
carcinoma	O
(	O
0	O
.	O
41	O
cm	O
)	O
involving	O
one	O
of	O
six	O
lymph	O
.	O
nodes	O
(	O
1	O
/	O
6	O
)	O
.	O

-	O
Squamous	O
cell	O
carcinoma	O
abutting	O
but	O
not	O
invading	O
the	O
submandibular	O
gland	O
.	O
capsule	O
.	O

B	O
)	O
True	O
midline	O
tongue	O
margin	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
carcinoma	O
.	O

C	O
)	O
Left	O
true	O
vallecula	O
margin	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
carcinoma	O
.	O

D	O
)	O
True	O
midline	O
pharyngeal	O
margin	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
carcinoma	O
.	O

E	O
)	O
Left	O
true	O
superior	O
tonsil	O
margin	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
carcinoma	O
.	O

F	O
)	O
Medial	O
posterior	O
mobile	O
tongue	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
carcinoma	O
.	O

G	O
)	O
Right	O
neck	O
soft	O
tissue	O
,	O
dissection	O
:	O
-	O
Zone	O
1	O
:	O
Six	O
lymph	O
nodes	O
,	O
negative	O
for	O
carcinoma	O
(	O
0	O
/	O
6	O
)	O
.	O

-	O
Zone	O
2a	O
Ten	O
lymph	O
nodes	O
,	O
negative	O
for	O
tumor	O
(	O
0	O
/	O
10	O
)	O
.	O

-	O
Zone	O
2b	O
:	O
Twenty	O
lymph	O
nodes	O
,	O
negative	O
for	O
carcinoma	O
(	O
0	O
/	O
20	O
)	O
.	O

-	O
Zone	O
3	O
:	O
Eight	O
lymph	O
nodes	O
,	O
negative	O
for	O
carcinoma	O
(	O
0	O
/	O
8	O
)	O
.	O

-	O
Zone	O
4	O
:	O
Six	O
lymph	O
nodes	O
,	O
negative	O
for	O
carcinoma	O
(	O
0	O
/	O
6	O
)	O
.	O

H	O
)	O
Teeth	O
,	O
#	O
22	O
,	O
24	O
and	O
25	O
,	O
extractions	O
:	O
-	O
Three	O
teeth	O
without	O
significant	O
histopathologic	O
changes	O
.	O

I	O
)	O
Additional	O
left	O
posterior	O
neck	O
,	O
zones	O
2	O
and	O
3	O
,	O
dissection	O
:	O
-	O
Zone	O
2b	O
:	O
Nineteen	O
lymph	O
nodes	O
,	O
negative	O
for	O
carcinoma	O
(	O
0	O
/	O
19	O
)	O
.	O

-	O
Zone	O
3	O
:	O
Metastatic	O
squamous	O
cell	O
carcinoma	O
(	O
0	O
.	O
46	O
cm	O
)	O
involving	O
one	O
of	O
eight	O
.	O
lymph	O
nodes	O
(	O
1	O
/	O
8	O
)	O
with	O
focal	O
extranodal	O
extension	O
.	O

J	O
)	O
Additional	O
right	O
anterior	O
tongue	O
margin	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
carcinoma	O
.	O

COMMENTS	O
.	O

The	O
results	O
of	O
studies	O
for	O
HPV	O
and	O
EGFR	O
will	O
be	O
reported	O
as	O
an	O
addendum	O
.	O
one	O
of	O
our	O
.	O
surgical	O
pathologists	O
,	O
has	O
also	O
.	O
reviewed	O
slides	O
from	O
this	O
case	O
and	O
she	O
concurs	O
with	O
the	O
above	O
diagnosis	O
.	O
was	O
notified	O
of	O
our	O
findings	O
by	O
secure	O
electronic	O
mail	O
.	O

CLINICAL	O
HISTORY	O
.	O

The	O
patient	O
is	O
a	O
.	O

-	O
year	O
-	O
old	O
male	O
with	O
biopsy	O
-	O
proven	O
left	O
base	O
of	O
tongue	O
squamous	O
.	O
cell	O
carcinoma	O
.	O

DIAGNOSTIC	O
SUMMARY	O
.	O

-	O
Specimen	O
:	O
Portions	O
of	O
tongue	O
,	O
oropharynx	O
and	O
soft	O
palate	O
,	O
left	O
and	O
right	O
neck	O
.	O
lymph	O
nodes	O
and	O
teeth	O
.	O

-	O
Procedure	O
:	O
Near	O
total	O
glossectomy	O
,	O
partial	O
pharyngectomy	O
,	O
partial	O
palatectomy	O
,	O
.	O
left	O
neck	O
dissection	O
(	O
1	O
-	O
3	O
)	O
,	O
right	O
neck	O
dissection	O
(	O
1	O
-	O
3	O
)	O
and	O
teeth	O
extractions	O
.	O

-	O
Specimen	O
Laterality	O
:	O
Left	O
and	O
midline	O
tongue	O
,	O
right	O
and	O
left	O
neck	O
tissue	O
.	O

-	O
Tumor	O
Site	O
:	O
Oropharynx	O
including	O
left	O
posterolateral	O
tongue	O
,	O
posterior	O
pharynx	O
.	O
and	O
soft	O
palate	O
.	O

-	O
Tumor	O
Focality	O
:	O
Single	O
focus	O
.	O

-	O
Tumor	O
Size	O
:	O
7	B
cm	I
.	O

-	O
Histologic	O
Type	O
:	O
Squamous	O
cell	O
carcinoma	O
.	O

-	O
Histologic	O
Grade	O
:	O
G1	O
-	O
2	O
(	O
Well	O
to	O
moderately	O
-	O
differentiated	O
.	O

-	O
Margins	O
:	O
Though	O
carcinoma	O
involves	O
the	O
midline	O
/	O
right	O
lingual	O
margin	O
in	O
the	O
main	O
.	O
resection	O
specimen	O
(	O
part	O
A	O
)	O
,	O
separately	O
submitted	O
lingual	O
margins	O
(	O
parts	O
B	O
,	O
F	O
and	O
.	O
J	O
)	O
are	O
uninvolved	O
by	O
carcinoma	O
.	O

-	O
Lymph	O
-	O
Vascular	O
Invasion	O
:	O
Not	O
identified	O
.	O

-	O
Perineural	O
Invasion	O
:	O
Present	O
.	O

-	O
Lymph	O
Nodes	O
,	O
Extranodal	O
Extension	O
:	O
Focally	O
present	O
.	O

-	O
Pathologic	O
Staging	O
for	O
Oropharynx	O
Lesion	O
(	O
pTNM	O
)	O
.	O

-	O
-	O
Primary	O
Tumor	O
:	O
pT3	O
(	O
Tumor	O
>	O
4	O
cm	O
in	O
greatest	O
dimension	O
or	O
extension	O
to	O
the	O
.	O
lingual	O
surface	O
of	O
epiglottis	O
)	O
.	O

-	O
-	O
Regional	O
Lymph	O
Nodes	O
:	O
pN2b	O
(	O
Metastasis	O
in	O
multiple	O
ipsilateral	O
lymph	O
nodes	O
,	O
.	O
none	O
>	O
6	O
cm	O
)	O
.	O

-	O
-	O
89	O
lymph	O
nodes	O
examined	O
,	O
2	O
involved	O
.	O

-	O
-	O
Distant	O
Metastasis	O
(	O
pM	O
)	O
:	O
Not	O
applicable	O
.	O

GROSS	O
DESCRIPTION	O
.	O

A	O
)	O
Received	O
fresh	O
,	O
labeled	O
.	O
and	O
designated	O
"	O
left	O
near	O
-	O
.	O
total	O
glossectomy	O
and	O
partiar	O
pharyngectomy	O
Tert	O
neck	O
dissection	O
zones	O
1	O
,	O
2	O
,	O
3	O
"	O
,	O
.	O

is	O
a	O
glossectomy	O
,	O
pharyngectomy	O
,	O
neck	O
dissection	O
specimen	O
.	O

The	O
tongue	O
is	O
9	O
.	O
5	O
cm	O
.	O
anterior	O
to	O
posterior	O
,	O
4	O
.	O
5	O
cm	O
left	O
to	O
right	O
and	O
3	O
.	O
4	O
cm	O
superior	O
to	O
inferior	O
.	O

The	O
.	O
pharyngectomy	O
specimen	O
is	O
6	O
.	O
8	O
cm	O
anterior	O
to	O
posterior	O
,	O
3	O
.	O
0	O
cm	O
left	O
to	O
right	O
and	O
.	O

3	O
.	O
9	O
cm	O
superior	O
to	O
inferior	O
.	O

The	O
neck	O
dissection	O
is	O
8	O
.	O
0	O
x	O
6	O
.	O
1	O
x	O
3	O
.	O
4	O
cm	O
.	O

The	O
.	O
specimen	O
is	O
oriented	O
per	O
the	O
specimen	O
container	O
as	O
follows	O
:	O
Single	O
stitch	O
superior	O
tonsil	O
margin	O
,	O
double	O
long	O
stitch	O
left	O
vallecula	O
,	O
double	O
.	O
short	O
stitch	O
neck	O
dissection	O
zone	O
3	O
.	O

There	O
is	O
another	O
single	O
stitch	O
that	O
is	O
.	O
oriented	O
in	O
person	O
by	O
a	O
member	O
of	O
the	O
surgical	O
team	O
as	O
a	O
prominent	O
lymph	O
node	O
in	O
.	O
zone	O
1A	O
on	O
the	O
left	O
side	O
.	O

The	O
specimen	O
is	O
inked	O
as	O
follows	O
:	O
Right	O
side	O
of	O
tongue	O
margin	O
=	O
red	O
.	O

Base	O
of	O
tongue	O
margin	O
=	O
blue	O
.	O

Inferior	O
portion	O
of	O
tongue	O
margin	O
=	O
black	O
.	O

Vallecula	O
margin	O
=	O
orange	O
.	O

Posterolateral	O
oropharynx	O
margin	O
=	O
green	O
.	O

Superior	O
tonsillar	O
margin	O
=	O
yellow	O
.	O

Floor	O
of	O
mouth	O
margin	O
=	O
orange	O
.	O

Lateral	O
oropharynx	O
margin	O
=	O
black	O
.	O

Gross	O
photographs	O
are	O
taken	O
.	O

The	O
neck	O
dissection	O
tissue	O
is	O
removed	O
and	O
the	O
resultant	O
exposed	O
tissue	O
is	O
inked	O
.	O
yellow	O
.	O

The	O
tongue	O
,	O
left	O
floor	O
of	O
mouth	O
and	O
left	O
oropharynx	O
contain	O
a	O
large	O
.	O
ulcerated	O
mass	O
with	O
deep	O
furrows	O
and	O
papillary	O
structures	O
.	O

This	O
irregular	O
.	O
ulcerated	O
mass	O
measures	O
7	O
x	O
4	O
.	O
5	O
cm	O
.	O

The	O
ulcerations	O
extend	O
1	O
.	O
8	O
cm	O
into	O
the	O
.	O
tongue	O
from	O
the	O
surface	O
.	O

The	O
lesion	O
is	O
1	O
.	O
4	O
cm	O
from	O
the	O
right	O
tongue	O
margin	O
,	O
0	O
.	O
8	O
.	O

cm	O
from	O
the	O
anterior	O
floor	O
of	O
mouth	O
margin	O
,	O
0	O
.	O
9	O
cm	O
from	O
the	O
superior	O
tonsillar	O
.	O
margin	O
,	O
2	O
.	O
3	O
cm	O
from	O
the	O
posterolateral	O
oral	O
pharynx	O
margin	O
,	O
1	O
.	O
6	O
cm	O
from	O
the	O
.	O
vallecula	O
margin	O
,	O
and	O
1	O
.	O
4	O
cm	O
from	O
the	O
base	O
of	O
tongue	O
margin	O
.	O

Small	O
portions	O
.	O

of	O
.	O
tissue	O
have	O
been	O
taken	O
from	O
the	O
lesion	O
as	O
well	O
as	O
uninvolved	O
tongue	O
for	O
tissue	O
.	O
banking	O
.	O

The	O
tongue	O
is	O
serially	O
sectioned	O
to	O
reveal	O
a	O
white	O
,	O
fibrotic	O
,	O
.	O
spiculated	O
lesion	O
that	O
extends	O
to	O
within	O
0	O
.	O
4	O
cm	O
of	O
the	O
deep	O
margin	O
.	O

Representative	O
sections	O
are	O
submitted	O
as	O
follows	O
:	O
(	O
A1	O
)	O
Tumor	O
to	O
right	O
tongue	O
margin	O
.	O

(	O
A2	O
)	O
Tumor	O
to	O
base	O
of	O
tongue	O
margin	O
.	O

(	O
A3	O
)	O
Tumor	O
to	O
vallecula	O
margin	O
.	O

(	O
A4	O
)	O
Tumor	O
to	O
posterolateral	O
oral	O
pharynx	O
margin	O
.	O

(	O
A5	O
)	O
Tumor	O
to	O
superior	O
tonsillar	O
margin	O
.	O

(	O
A6	O
)	O
Tumor	O
to	O
anterior	O
floor	O
of	O
mouth	O
margin	O
,	O
includes	O
inked	O
surface	O
denoting	O
.	O
where	O
the	O
neck	O
dissection	O
was	O
removed	O
(	O
yellow	O
ink	O
not	O
a	O
surgical	O
margin	O
)	O
.	O

(	O
A7	O
-	O
A10	O
)	O
Right	O
side	O
of	O
tongue	O
shave	O
margin	O
from	O
anterior	O
to	O
posterior	O
(	O
en	O
face	O
)	O
.	O

(	O
A11	O
)	O
Remaining	O
inferior	O
portion	O
of	O
right	O
side	O
of	O
tongue	O
shave	O
margin	O
(	O
en	O
face	O
)	O
.	O

(	O
A12	O
-	O
A13	O
)	O
Tumor	O
.	O

(	O
A14	O
)	O
Tumor	O
to	O
deep	O
margin	O
.	O

(	O
A15	O
)	O
Sutured	O
1A	O
left	O
lymph	O
node	O
,	O
bisected	O
.	O

(	O
A16	O
)	O
Remaining	O
tissue	O
of	O
zone	O
la	O
.	O

(	O
A17	O
)	O
Remaining	O
tissue	O
of	O
zone	O
la	O
.	O

(	O
A18	O
)	O
Two	O
candidate	O
lymph	O
nodes	O
,	O
zone	O
1b	O
.	O

(	O
A19	O
)	O
Zone	O
1b	O
after	O
removing	O
from	O
oropharynx	O
,	O
trisected	O
(	O
yellow	O
ink	O
not	O
a	O
.	O
surgical	O
margin	O
)	O
.	O

(	O
A20	O
-	O
A23	O
)	O
Remaining	O
tissue	O
,	O
zone	O
1b	O
.	O

(	O
A24	O
)	O
Submandibular	O
gland	O
.	O

(	O
A25	O
-	O
A30	O
)	O
Anterior	O
zone	O
2	O
,	O
anterior	O
to	O
posterior	O
.	O

Zone	O
3	O
:	O
(	O
A31	O
)	O
One	O
lymph	O
node	O
,	O
bisected	O
.	O

(	O
A32	O
)	O
One	O
lymph	O
node	O
,	O
bisected	O
.	O

(	O
A33	O
)	O
One	O
lymph	O
node	O
,	O
bisected	O
.	O

(	O
A34	O
)	O
One	O
lymph	O
node	O
,	O
bisected	O
.	O

(	O
A35	O
-	O
A50	O
)	O
Remaining	O
tissue	O
.	O

Received	O
fresh	O
for	O
frozen	O
section	O
diagnosis	O
,	O
labeled	O
.	O
are	O
five	O
specimens	O
.	O

B	O
)	O
Designated	O
"	O
true	O
midline	O
tongue	O
margin	O
,	O
"	O
is	O
a	O
portion	O
of	O
red	O
-	O
brown	O
tissue	O
.	O
measuring	O
1	O
.	O
2	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
3	O
cm	O
.	O

The	O
specimen	O
is	O
submitted	O
entirely	O
for	O
frozen	O
.	O
section	O
diagnosis	O
and	O
resubmitted	O
for	O
permanent	O
section	O
diagnosis	O
in	O
cassette	O
.	O

(	O
FSB1	O
)	O
.	O

C	O
)	O
Designated	O
"	O
left	O
true	O
vallecula	O
margin	O
,	O
"	O
is	O
a	O
portion	O
of	O
red	O
-	O
brown	O
soft	O
tissue	O
.	O
measuring	O
1	O
.	O
9	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
3	O
cm	O
.	O

The	O
specimen	O
is	O
submitted	O
entirely	O
for	O
frozen	O
.	O
section	O
diagnosis	O
and	O
resubmitted	O
for	O
permanent	O
section	O
diagnosis	O
in	O
cassette	O
.	O

(	O
FSC1	O
)	O
.	O

D	O
)	O
Designated	O
"	O
true	O
midline	O
pharyngeal	O
margin	O
,	O
"	O
is	O
a	O
portion	O
of	O
red	O
-	O
brown	O
soft	O
.	O
tissue	O
measuring	O
1	O
.	O
6	O
x	O
1	O
.	O
4	O
x	O
0	O
.	O
3	O
cm	O
.	O

The	O
specimen	O
is	O
submitted	O
entirely	O
for	O
.	O
frozen	O
section	O
diagnosis	O
and	O
resubmitted	O
for	O
permanent	O
section	O
diagnosis	O
in	O
.	O
cassette	O
(	O
FSD1	O
)	O
.	O

E	O
)	O
Designated	O
"	O
left	O
true	O
superior	O
tonsil	O
margin	O
,	O
"	O
is	O
a	O
portion	O
of	O
pink	O
-	O
white	O
soft	O
.	O
tissue	O
measuring	O
2	O
.	O
2	O
x	O
1	O
x	O
0	O
.	O
3	O
cm	O
.	O

The	O
specimen	O
is	O
submitted	O
entirely	O
for	O
frozen	O
.	O
section	O
diagnosis	O
and	O
resubmitted	O
for	O
permanent	O
section	O
diagnosis	O
in	O
cassette	O
.	O

(	O
FSE1	O
)	O
.	O

F	O
)	O
Designated	O
"	O
medial	O
posterior	O
mobile	O
tongue	O
,	O
"	O
is	O
a	O
portion	O
of	O
pink	O
-	O
white	O
soft	O
.	O
muscular	O
tissue	O
measuring	O
1	O
.	O
4	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
4	O
cm	O
.	O

The	O
specimen	O
is	O
submitted	O
entirely	O
.	O
for	O
frozen	O
section	O
diagnosis	O
and	O
resubmitted	O
for	O
permanent	O
section	O
diagnosis	O
in	O
.	O
cassette	O
(	O
FSF1	O
)	O
.	O

In	O
formalin	O
,	O
labeled	O
.	O
are	O
four	O
specimens	O
.	O

G	O
)	O
Designated	O
"	O
right	O
neck	O
dissection	O
,	O
"	O
is	O
a	O
12	O
.	O
5	O
x	O
7	O
.	O
0	O
x	O
3	O
.	O
0	O
cm	O
neck	O
dissection	O
,	O
.	O
which	O
is	O
oriented	O
per	O
the	O
specimen	O
container	O
as	O
follows	O
:	O
single	O
stitch	O
=	O
zone	O
1	O
,	O
.	O
double	O
long	O
stitch	O
=	O
zone	O
2b	O
,	O
double	O
short	O
stitch	O
=	O
zone	O
4	O
.	O

(	O
G1	O
)	O
Lymph	O
node	O
,	O
bisected	O
,	O
zone	O
1	O
.	O

(	O
G2	O
)	O
Lymph	O
node	O
,	O
bisected	O
,	O
zone	O
1	O
.	O

(	O
G3	O
)	O
Four	O
candidate	O
lymph	O
nodes	O
,	O
zone	O
1	O
.	O

(	O
G4	O
)	O
Three	O
candidate	O
lymph	O
nodes	O
,	O
zone	O
1	O
.	O

(	O
G5	O
-	O
G6	O
)	O
Representative	O
sections	O
of	O
submandibular	O
gland	O
,	O
zone	O
.	O

1	O
.	O

(	O
G7	O
-	O
G10	O
)	O
Remaining	O
tissue	O
,	O
zone	O
1	O
.	O

(	O
G11	O
-	O
G12	O
)	O
Two	O
candidate	O
lymph	O
nodes	O
,	O
bisected	O
;	O
a	O
larger	O
and	O
a	O
smaller	O
,	O
zone	O
2a	O
.	O

(	O
G13	O
)	O
Five	O
candidate	O
lymph	O
nodes	O
,	O
zone	O
2a	O
.	O

(	O
G14	O
-	O
G18	O
)	O
Residual	O
tissue	O
,	O
zone	O
2a	O
.	O

(	O
G19	O
)	O
One	O
lymph	O
node	O
,	O
bisected	O
,	O
zone	O
2b	O
.	O

(	O
G20	O
)	O
Three	O
candidate	O
lymph	O
nodes	O
,	O
zone	O
2b	O
.	O

(	O
G21	O
-	O
G24	O
)	O
Remaining	O
tissue	O
,	O
zone	O
2b	O
.	O

(	O
G25	O
)	O
One	O
lymph	O
node	O
bisected	O
and	O
inked	O
black	O
,	O
and	O
two	O
candidate	O
lymph	O
nodes	O
,	O
.	O
zone	O
3	O
.	O

(	O
G26	O
)	O
Remaining	O
tissue	O
,	O
zone	O
3	O
.	O

(	O
G27	O
)	O
Four	O
candidate	O
lymph	O
nodes	O
,	O
zone	O
4	O
.	O

(	O
G28	O
)	O
Remaining	O
tissues	O
,	O
zone	O
4	O
.	O

H	O
)	O
Designated	O
"	O
teeth	O
#	O
22	O
,	O
24	O
and	O
25	O
,	O
n	O
are	O
three	O
teeth	O
,	O
ranging	O
from	O
1	O
.	O
8	O
x	O
0	O
.	O
6	O
.	O

x	O
.	O

0	O
.	O
6	O
cm	O
to	O
2	O
.	O
0	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
3	O
cm	O
.	O

The	O
smallest	O
tooth	O
is	O
fractured	O
longitudinally	O
.	O
with	O
a	O
pink	O
,	O
firm	O
material	O
in	O
the	O
core	O
of	O
the	O
tooth	O
.	O

The	O
specimen	O
is	O
submitted	O
.	O
in	O
its	O
entirety	O
,	O
after	O
decalcification	O
,	O
as	O
follows	O
:	O
(	O
H1	O
)	O
Previously	O
fractured	O
tooth	O
.	O

(	O
H2	O
-	O
H3	O
)	O
Remaining	O
two	O
teeth	O
.	O

I	O
)	O
Designated	O
"	O
additional	O
left	O
posterior	O
neck	O
dissection	O
,	O
zones	O
2	O
and	O
3	O
,	O
"	O
is	O
a	O
.	O

0	O
.	O
8	O
x	O
6	O
.	O
5	O
x	O
1	O
.	O
5	O
cm	O
neck	O
dissection	O
.	O

It	O
is	O
oriented	O
per	O
the	O
specimen	O
container	O
as	O
.	O
follows	O
:	O
single	O
stitch	O
=	O
zone	O
2b	O
,	O
double	O
stitch	O
=	O
zone	O
3	O
.	O

The	O
specimen	O
is	O
.	O
submitted	O
in	O
its	O
entirety	O
as	O
follows	O
:	O
(	O
I1	O
-	O
I2	O
)	O
Lymph	O
node	O
,	O
bisected	O
,	O
zone	O
2b	O
.	O

(	O
I3	O
-	O
I4	O
)	O
Remaining	O
tissue	O
,	O
zone	O
2b	O
.	O

(	O
I5	O
-	O
I6	O
)	O
Two	O
lymph	O
nodes	O
bisected	O
,	O
the	O
larger	O
and	O
a	O
smaller	O
,	O
zone	O
2b	O
.	O

(	O
I7	O
-	O
I8	O
)	O
One	O
lymph	O
node	O
bisected	O
,	O
zone	O
2b	O
.	O

(	O
I9	O
)	O
Four	O
candidate	O
lymph	O
nodes	O
,	O
zone	O
2b	O
.	O

(	O
I10	O
)	O
Five	O
candidate	O
lymph	O
nodes	O
,	O
zone	O
2b	O
.	O

(	O
I11	O
-	O
I12	O
)	O
Remaining	O
tissues	O
,	O
zone	O
2b	O
.	O

(	O
I13	O
)	O
Three	O
lymph	O
nodes	O
,	O
the	O
largest	O
is	O
bisected	O
,	O
zone	O
3	O
.	O

(	O
I14	O
)	O
Three	O
lymph	O
nodes	O
,	O
the	O
largest	O
is	O
bisected	O
,	O
zone	O
3	O
.	O

(	O
115	O
-	O
I16	O
)	O
Remaining	O
tissues	O
,	O
zone	O
3	O
.	O

J	O
)	O
Designated	O
"	O
additional	O
right	O
anterior	O
tongue	O
margin	O
,	O
"	O
is	O
a	O
3	O
.	O
5	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
6	O
cm	O
.	O
tongue	O
tissue	O
.	O

No	O
orientation	O
is	O
provided	O
.	O

The	O
specimen	O
is	O
submitted	O
in	O
its	O
.	O
entirety	O
in	O
cassettes	O
(	O
J1	O
-	O
J2	O
)	O
.	O

INTRAOPERATIVE	O
DIAGNOSIS	O
.	O

FSB1	O
:	O
Negative	O
for	O
malignancy	O
.	O

FSC1	O
:	O
Negative	O
for	O
malignancy	O
.	O

FSD1	O
:	O
Negative	O
for	O
malignancy	O
.	O

FSE1	O
:	O
Negative	O
for	O
malignancy	O
.	O

FSF1	O
:	O
Negative	O
for	O
malignancy	O
.	O

Intra	O
-	O
Operative	O
Diagnosis	O
Reviewed	O
and	O
Interpreted	O
By	O
:	O
I	O
certify	O
that	O
(	O
1	O
)	O
all	O
services	O
on	O
this	O
form	O
were	O
rendered	O
and	O
are	O
hereby	O
.	O
approved	O
for	O
billing	O
,	O
(	O
2	O
)	O
all	O
specimens	O
/	O
slides	O
have	O
been	O
examined	O
/	O
reviewed	O
,	O
(	O
3	O
)	O
.	O
the	O
medical	O
record	O
has	O
been	O
documented	O
for	O
these	O
services	O
,	O
and	O
(	O
4	O
)	O
the	O
rendering	O
.	O
of	O
the	O
services	O
and	O
the	O
documentation	O
in	O
the	O
medical	O
record	O
are	O
in	O
accordance	O
.	O
with	O
.	O

guidelines	O
.	O

Final	O
Diagnosis	O
Reviewed	O
and	O
Interpreted	O
by	O
:	O
Pathology	O
Resident	O
.	O

Some	O
tests	O
used	O
in	O
this	O
case	O
were	O
developed	O
in	O
and	O
their	O
performance	O
.	O
characteristics	O
determined	O
by	O
the	O
.	O

The	O
procedures	O
and	O
reagents	O
have	O
been	O
validated	O
.	O
by	O
evaluation	O
of	O
both	O
negative	O
and	O
positive	O
controls	O
.	O

This	O
testing	O
has	O
not	O
been	O
.	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
(	O
FDA	O
)	O
.	O

The	O
FDA	O
has	O
.	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

Test	O
results	O
are	O
.	O
used	O
for	O
clinical	O
purposes	O
.	O

They	O
should	O
not	O
be	O
regarded	O
as	O
investigational	O
or	O
for	O
.	O
research	O
.	O

The	O
.	O

is	O
accredited	O
by	O
the	O
.	O

College	O
of	O
American	O
Pathologists	O
and	O
is	O
certified	O
under	O
the	O
Clinical	O
Laboratory	O
.	O

Improvement	O
Amendments	O
of	O
1988	O
(	O
CLIA	O
-	O
88	O
)	O
as	O
qualified	O
to	O
perform	O
high	O
complexity	O
.	O
clinical	O
laboratory	O
testing	O
.	O

"	O
I	O
certify	O
that	O
(	O
1	O
)	O
all	O
services	O
on	O
this	O
form	O
were	O
rendered	O
and	O
are	O
hereby	O
.	O
approved	O
for	O
billing	O
,	O
(	O
2	O
)	O
all	O
specimens	O
/	O
slide	O
have	O
been	O
examined	O
/	O
reviewed	O
,	O
(	O
3	O
)	O
.	O
the	O
medical	O
record	O
has	O
been	O
documented	O
for	O
these	O
services	O
,	O
and	O
(	O
4	O
)	O
the	O
rendering	O
.	O
of	O
the	O
services	O
and	O
the	O
documentation	O
in	O
the	O
medical	O
record	O
are	O
in	O
accordance	O
.	O
with	O
.	O

guidelines	O
.	O

Lab	O
and	O
Collection	O
.	O

Surgical	O
Pathology	O
Request	O
on	O
.	O

Result	O
History	O
.	O

SURGICAL	O
PATHOLOGY	O
REQUEST	O
on	O
.	O

Specimen	O
Information	O
.	O

Specimen	O
#	O
.	O

Received	O
Date	O
and	O
Time	O
.	O

Surgical	O
Pathology	O
Request	O
.	O
year	O
old	O
.	O

Provider	O
Not	O
In	O
System	O
.	O

Provider	O
Status	O
.	O

Surgery	O
Report	O
.	O

Lab	O
Printout	O
.	O

Open	O
Hard	O
Copy	O
Result	O
Report	O
.	O

Surgical	O
Pathology	O
Request	O
)	O
.	O

View	O
Order	O
Information	O
.	O

Dept	O
.	O

MRN	O
:	O
Encounter	O
.	O

#	O
:	O
Department	O
:	O
Lab	O
Collection	O
Information	O
.	O

Lab	O
IDs	O
.	O

Specimen	O
#	O
.	O

Surgical	O
Pathology	O
Request	O
.	O

Date	O
and	O
.	O

Authorizing	O
:	O
System	O
,	O
Provider	O
.	O

Time	O
:	O
Lab	O
.	O

Not	O
In	O
.	O

Department	O
:	O
Diagnoses	O
.	O

Oral	O
-	O
mouth	O
cancer	O
.	O

145	O
.	O
9	O
.	O

Smoking	O
hx	O
.	O

V15	O
.	O
82	O
.	O

Alcohol	O
abuse	O
.	O

305	O
.	O
00	O
.	O

Squamous	O
cell	O
carcinoma	O
of	O
lateral	O
tongue	O
.	O

141	O
.	O
2	O
.	O

Squamous	O
cell	O
cancer	O
of	O
retromolar	O
trigone	O
.	O

145	O
.	O
6	O
.	O

Release	O
Date	O
/	O
Time	O
.	O

Start	O
Date	O
/	O
Time	O
.	O

End	O
Date	O
/	O
Time	O
.	O

Comments	O
.	O

Frequency	O
.	O

Duration	O
.	O

Priority	O
.	O

ONCE	O
.	O

1	O
occurrence	O
.	O

Routine	O
.	O

Normal	O
.	O

Authorizing	O
Provider	O
.	O

System	O
,	O
Provider	O
Not	O
In	O
.	O

System	O
,	O
Provider	O
Not	O
In	O
.	O

Attending	O
Provider	O
(	O
s	O
)	O
.	O

Admitting	O
Provider	O
.	O

View	O
Order	O
Information	O
.	O

There	O
are	O
no	O
specimens	O
.	O

Reprint	O
Requisitions	O
.	O

Surgical	O
Pathology	O
Request	O
.	O

-DOCSTART-255
Result	O
Date	O
:	O
Encounter	O
.	O
info	O
:	O
Clinic	O
Number	O
:	O
DIAGNOSIS	O
:	O
A	O
.	O

Ascending	O
and	O
proximal	O
transverse	O
colon	O
,	O
appendix	O
:	O
Specimen	O
:	O
Terminal	O
ileum	O
,	O
cecum	O
,	O
ascending	O
and	O
transverse	O
colon	O
.	O

Procedure	O
:	O
Right	O
hemi	O
-	O
and	O
transverse	O
colectomy	O
.	O

Tumor	O
site	O
:	O
Ascending	O
colon	O
,	O
12	O
cm	O
from	O
ileocecal	O
valve	O
.	O

Tumor	O
size	O
:	O
3	B
.	I
0	I
cm	I
in	O
greatest	O
dimension	O
.	O

Tumor	O
histologic	O
type	O
:	O
Adenocarcinoma	O
.	O

Histologic	O
grade	O
:	O
Moderately	O
differentiated	O
(	O
grade	O
2	O
of	O
3	O
)	O
.	O

Microscopic	O
tumor	O
extension	O
:	O
Invasive	O
adenocarcinoma	O
,	O
extends	O
into	O
.	O
the	O
submucosa	O
.	O

No	O
evidence	O
of	O
carcinoma	O
penetrating	O
into	O
the	O
.	O
underlying	O
muscularis	O
propria	O
.	O

Margins	O
:	O
Proximal	O
small	O
bowel	O
and	O
distal	O
colonic	O
margins	O
;	O
negative	O
.	O
for	O
tumor	O
.	O

Distance	O
to	O
mesorectal	O
margin	O
:	O
Not	O
applicable	O
.	O

Lymph	O
-	O
vascular	O
invasion	O
:	O
Not	O
identified	O
.	O

Perineural	O
invasion	O
:	O
Not	O
identified	O
.	O

Tumor	O
deposits	O
(	O
discontinuous	O
extramural	O
extension	O
)	O
:	O
Not	O
present	O
.	O

Macroscopic	O
completeness	O
of	O
mesorectum	O
(	O
if	O
applicable	O
)	O
:	O
Not	O
.	O
applicable	O
.	O

Lymph	O
nodes	O
:	O
A	O
total	O
of	O
twenty	O
-	O
two	O
regional	O
lymph	O
nodes	O
,	O
negative	O
.	O
for	O
metastatic	O
adenocarcinoma	O
(	O
0	O
/	O
22	O
)	O
.	O

Response	O
to	O
treatment	O
:	O
Not	O
applicable	O
.	O

Additional	O
findings	O
:	O
Separate	O
inflammatory	O
polyp	O
,	O
0	O
.	O
6	O
cm	O
in	O
.	O
greatest	O
dimension	O
,	O
distal	O
to	O
the	O
main	O
tumor	O
mass	O
.	O

Appendix	O
,	O
with	O
.	O
fibrous	O
obliteration	O
.	O

Pathologic	O
staging	O
:	O
pT1	O
,	O
pNO	O
.	O

Ancillary	O
testing	O
:	O
Not	O
performed	O
.	O

Block	O
(	O
s	O
)	O
containing	O
malignancy	O
suitable	O
for	O
further	O
testing	O
:	O
Block	O
.	O

A5	O
.	O

B	O
.	O

Left	O
kidney	O
tumor	O
:	O
Procedure	O
/	O
laterality	O
:	O
Left	O
partial	O
nephrectomy	O
.	O

Histologic	O
type	O
:	O
Papillary	O
renal	O
cell	O
carcinoma	O
,	O
with	O
eosinophilic	O
.	O
cytoplasm	O
.	O

Nuclear	O
grade	O
(	O
Fuhrman	O
,	O
1	O
-	O
4	O
)	O
:	O
2	O
of	O
4	O
.	O

Tumor	O
size	O
:	O
7	B
.	I
0	I
cm	I
in	O
greatest	O
dimension	O
.	O

Tumor	O
site	O
:	O
Upper	O
pole	O
.	O

Tumor	O
focality	O
:	O
Unifocal	O
.	O

Sarcomatoid	O
features	O
:	O
Not	O
present	O
.	O

Tumor	O
necrosis	O
:	O
Not	O
present	O
.	O

Microscopic	O
tumor	O
extension	O
:	O
Extension	O
into	O
perinephric	O
tissue	O
Not	O
present	O
.	O

Extension	O
beyond	O
Gerota	O
'	O
s	O
fascia	O
:	O
Not	O
present	O
.	O

Extension	O
into	O
renal	O
sinus	O
:	O
Not	O
present	O
.	O

Extension	O
into	O
renal	O
vein	O
:	O
Not	O
present	O
.	O

Extension	O
into	O
collecting	O
system	O
:	O
Not	O
present	O
.	O

Extension	O
into	O
adrenal	O
gland	O
(	O
if	O
applicable	O
)	O
:	O
Not	O
applicable	O
.	O

Surgical	O
margins	O
:	O
Fatty	O
soft	O
tissue	O
margins	O
;	O
negative	O
for	O
tumor	O
.	O

Lymph	O
-	O
vascular	O
invasion	O
:	O
Not	O
identified	O
.	O

Lymph	O
nodes	O
:	O
None	O
present	O
.	O

Pathologic	O
findings	O
in	O
nonneoplastic	O
kidney	O
:	O
No	O
specific	O
pathologic	O
.	O
features	O
.	O

Pathologic	O
staging	O
:	O
pT1b	O
,	O
pNX	O
.	O

Biorepository	O
sample	O
(	O
if	O
applicable	O
)	O
:	O
Representative	O
section	O
of	O
.	O
tumor	O
and	O
normal	O
kidney	O
are	O
shown	O
on	O
block	O
B6	O
.	O

Block	O
(	O
s	O
)	O
containing	O
malignancy	O
suitable	O
for	O
additional	O
testing	O
:	O
B4	O
.	O

DIAGNOSIS	O
COMMENT	O
:	O
Selected	O
slides	O
of	O
the	O
colectomy	O
and	O
nephrectomy	O
specimens	O
reviewed	O
.	O
with	O
.	O

CLINICAL	O
INFORMATION	O
:	O
Hepatic	O
flexure	O
cancer	O
and	O
left	O
kidney	O
renal	O
cell	O
carcinoma	O
.	O

SPECIMEN	O
(	O
S	O
)	O
:	O
A	O
:	O
Ascending	O
and	O
proximal	O
transverse	O
colon	O
,	O
appendix	O
.	O

B	O
:	O
Lt	O
kidney	O
tumor	O
.	O

PRELIMINARY	O
INTRAOPERATIVE	O
DIAGNOSIS	O
:	O
Intraoperative	O
Pathologist	O
(	O
s	O
)	O
:	O
A	O
.	O

Ascending	O
proximal	O
transverse	O
colon	O
and	O
appendix	O
,	O
gross	O
.	O
consultation	O
:	O
Margins	O
grossly	O
clear	O
.	O

Tumor	O
identified	O
(	O
approximately	O
.	O
3	B
.	I
cm	I
)	O
.	O

Relatively	O
flat	O
polyp	O
identified	O
more	O
distally	O
.	O

B	O
.	O

Left	O
kidney	O
tumor	O
,	O
frozen	O
section	O
diagnosis	O
:	O
Papillary	O
renal	O
.	O
cell	O
carcinoma	O
,	O
no	O
sarcomatoid	O
features	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

Received	O
fresh	O
labeled	O
and	O
"	O
ascending	O
and	O
.	O
proximal	O
transverse	O
colon	O
,	O
appendix	O
.	O

Specimen	O
:	O
Terminal	O
ileum	O
,	O
cecum	O
,	O
ascending	O
and	O
transverse	O
colon	O
.	O

Procedure	O
:	O
Right	O
hemi	O
-	O
and	O
transverse	O
colectomy	O
.	O

Dimensions	O
:	O
5	O
.	O
5	O
cm	O
of	O
terminal	O
ileum	O
and	O
50	O
cm	O
of	O
large	O
bowel	O
.	O

Tumor	O
site	O
:	O
Ascending	O
colon	O
,	O
12	O
cm	O
distal	O
to	O
ileocecal	O
valve	O
.	O

Tumor	O
configuration	O
:	O
Flat	O
,	O
granular	O
,	O
pink	O
-	O
tan	O
.	O

Tumor	O
size	O
:	O
3	B
x	I
2	I
.	I
5	I
X	I
0	I
.	I
5	I
cm	I
.	O

Tumor	O
distance	O
to	O
nearest	O
margin	O
:	O
Proximal	O
,	O
17	O
cm	O
.	O

Distance	O
to	O
mesorectal	O
margin	O
(	O
if	O
applicable	O
)	O
:	O
Not	O
applicable	O
.	O

Macroscopic	O
completeness	O
of	O
mesorectum	O
:	O
Not	O
applicable	O
.	O

Tumor	O
extension	O
into	O
fat	O
:	O
Not	O
grossly	O
identified	O
.	O

Tumor	O
extension	O
to	O
inked	O
free	O
surface	O
:	O
No	O
.	O

Tumor	O
perforation	O
:	O
No	O
.	O

Tumor	O
deposits	O
in	O
fat	O
:	O
No	O
.	O

Additional	O
mass	O
/	O
polyp	O
(	O
s	O
)	O
:	O
Yes	O
;	O
0	O
.	O
6	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
3	O
cm	O
situated	O
8	O
cm	O
.	O
distal	O
to	O
the	O
main	O
tumor	O
.	O

Lymph	O
nodes	O
:	O
Twenty	O
-	O
three	O
possible	O
lymph	O
nodes	O
from	O
0	O
.	O
2	O
cm	O
to	O
0	O
.	O
8	O
.	O

cm	O
.	O

Gross	O
notes	O
:	O
Additional	O
findings	O
:	O
A	O
grossly	O
unremarkable	O
5	O
x	O
0	O
.	O

6	O
-	O
cm	O
appendix	O
.	O
encased	O
by	O
slightly	O
hemorrhagic	O
fat	O
.	O

Block	O
key	O
for	O
specimen	O
A	O
:	O
A1	O
)	O
sample	O
of	O
each	O
surgical	O
margin	O
;	O
.	O

A2	O
-	O
A5	O
)	O
entire	O
main	O
tumor	O
;	O
A6	O
)	O
polyp	O
;	O
A7	O
)	O
appendix	O
;	O
A8	O
)	O
eight	O
lymph	O
.	O
nodes	O
;	O
A9	O
)	O
four	O
lymph	O
nodes	O
;	O
A10	O
)	O
eight	O
lymph	O
nodes	O
;	O
A110	O
three	O
.	O
lymph	O
nodes	O
.	O

B	O
.	O

Received	O
fresh	O
labeled	O
and	O
"	O
left	O
kidney	O
tumor	O
.	O
'	O
.	O

Procedure	O
:	O
Partial	O
nephrectomy	O
.	O

Specimen	O
laterality	O
:	O
Left	O
.	O

Tumor	O
site	O
:	O
Upper	O
pole	O
.	O

Tumor	O
size	O
:	O
7	B
x	I
5	I
x	I
5	I
cm	I
.	O

Tumor	O
focality	O
:	O
Unifocal	O
.	O

Gross	O
extent	O
of	O
tumor	O
:	O
Extension	O
into	O
perinephric	O
tissue	O
:	O
:	O
Absent	O
.	O

Extension	O
beyond	O
Gerota	O
'	O
s	O
fascia	O
:	O
Absent	O
.	O

Extension	O
into	O
renal	O
sinus	O
:	O
Absent	O
.	O

Extension	O
into	O
renal	O
vein	O
:	O
Absent	O
.	O

Extension	O
into	O
collecting	O
system	O
:	O
Absent	O
.	O

Adrenal	O
gland	O
:	O
Not	O
identified	O
.	O

Gross	O
notes	O
:	O
Gross	O
tumor	O
characteristics	O
:	O
Soft	O
,	O
gray	O
-	O
brown	O
,	O
predominately	O
.	O
solid	O
.	O

Kidney	O
weight	O
:	O
325	O
g	O
with	O
fat	O
,	O
135	O
g	O
without	O
fat	O
.	O

Specimen	O
dimensions	O
:	O
Overall	O
11	O
x	O
8	O
x	O
7	O
cm	O
.	O

Distance	O
to	O
margin	O
:	O
0	O
.	O
3	O
cm	O
grossly	O
from	O
parenchymal	O
margin	O
.	O

Lymph	O
nodes	O
:	O
None	O
identified	O
.	O

Inking	O
details	O
:	O
The	O
parenchymal	O
margin	O
and	O
the	O
Gerota	O
'	O
s	O
fascia	O
.	O
surface	O
are	O
inked	O
blue	O
.	O

Biorepository	O
sample	O
submitted	O
:	O
Yes	O
,	O
see	O
block	O
key	O
.	O

Block	O
key	O
for	O
specimen	O
B	O
:	O
B1	O
)	O
Frozen	O
section	O
sample	O
of	O
tumor	O
;	O
.	O

B2	O
-	O
B4	O
)	O
additional	O
samples	O
of	O
tumor	O
;	O
B5	O
)	O
inked	O
fatty	O
soft	O
tissue	O
.	O
margin	O
;	O
B6	O
)	O
mirror	O
images	O
of	O
biorepository	O
sample	O
(	O
normal	O
and	O
.	O
tumor	O
)	O
.	O

Support	O
for	O
the	O
diagnosis	O
in	O
this	O
case	O
may	O
have	O
included	O
the	O
.	O
use	O
of	O
Immunohistochemistry	O
tests	O
that	O
were	O
developed	O
and	O
whose	O
.	O
performance	O
characteristics	O
were	O
determined	O
by	O
.	O

They	O
have	O
not	O
been	O
cleared	O
.	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
(	O
FDA	O
)	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
.	O
necessary	O
.	O

These	O
tests	O
should	O
not	O
be	O
regarded	O
as	O
investigational	O
.	O
or	O
for	O
research	O
.	O

This	O
laboratory	O
is	O
certified	O
under	O
the	O
Clinical	O
.	O

Laboratory	O
Improvement	O
Amendments	O
of	O
1988	O
(	O
'	O
CLIA	O
'	O
)	O
as	O
qualified	O
.	O
to	O
perform	O
high	O
complexity	O
clinical	O
laboratory	O
testing	O
.	O

-DOCSTART-256
Final	O
Diagnosis	O
:	O
A	O
-	O
C	O
.	O

Brain	O
,	O
right	O
frontal	O
#	O
1	O
-	O
#	O
3	O
,	O
biopsies	O
:	O
Low	O
grade	O
oligoastrocytoma	O
(	O
WHO	O
grade	O
II	O
)	O
,	O
astrocytic	O
predominant	O
.	O

Special	O
Stains	O
:	O
Neurofilament	O
:	O
The	O
tumor	O
demonstrates	O
an	O
infiltrative	O
pattern	O
of	O
growth	O
.	O

p53	O
:	O
Moderate	O
to	O
high	O
labeling	O
.	O

Ki67	O
/	O
MIB	O
-	O
1	O
:	O
Low	O
to	O
moderate	O
labeling	O
index	O
.	O

Fluorescence	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
studies	O
for	O
1p19q	O
deletion	O
have	O
been	O
ordered	O
on	O
paraffin	O
sections	O
and	O
.	O
will	O
be	O
performed	O
by	O
the	O
.	O

For	O
interpretation	O
,	O
see	O
Synthesis	O
in	O
Labs	O
under	O
Genetics	O
.	O

Interpreted	O
by	O
:	O
Preliminary	O
Frozen	O
Section	O
Consultation	O
:	O
A	O
.	O

Brain	O
,	O
right	O
frontal	O
#	O
1	O
,	O
smears	O
:	O
Low	O
-	O
grade	O
glial	O
lesion	O
with	O
oligodendroglial	O
features	O
.	O

Hold	O
over	O
for	O
.	O

ALL	O
EMBEDDED	O
.	O
continued	O
next	O
page	O
.	O
classification	O
on	O
permanent	O
sections	O
.	O

Intraoperative	O
cytologic	O
smear	O
(	O
s	O
)	O
interpretation	O
performed	O
by	O
:	O
Gross	O
Description	O
:	O
A	O
.	O

Received	O
fresh	O
labeled	O
"	O
right	O
frontal	O
brain	O
"	O
is	O
a	O
2	O
.	O
5	O
x	O
2	O
.	O
3	O
x	O
0	O
.	O
7	O
cm	O
portion	O
of	O
brain	O
.	O

Smears	O
prepared	O
.	O

All	O
.	O
submitted	O
.	O

Grossed	O
by	O
.	O

B	O
.	O

Received	O
fresh	O
labeled	O
"	O
deep	O
right	O
frontal	O
white	O
matter	O
-	O
brain	O
"	O
is	O
a	O
2	O
.	O
5	O
x	O
1	O
.	O
6	O
x	O
0	O
.	O
4	O
cm	O
aggregate	O
of	O
neural	O
.	O
tissue	O
.	O

Smears	O
prepared	O
.	O

All	O
submitted	O
for	O
permanent	O
sections	O
only	O
.	O

Grossed	O
b	O
.	O

C	O
.	O

Received	O
fresh	O
labeled	O
"	O
right	O
frontal	O
lesion	O
#	O
2	O
-	O
brain	O
"	O
is	O
a	O
1	O
.	O
6	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
3	O
cm	O
aggregate	O
of	O
neural	O
tissue	O
.	O

Smears	O
prepared	O
.	O

All	O
submitted	O
for	O
permanent	O
sections	O
only	O
.	O

Grossed	O
by	O
.	O

Block	O
Summary	O
:	O
Part	O
A	O
:	O
Right	O
frontal	O
lesion	O
-	O
brain	O
.	O

1	O
Rt	O
frontal	O
lesion	O
1	O
.	O

2	O
Rt	O
frontal	O
lesion	O
2	O
.	O

3	O
Rt	O
frontal	O
lesion	O
3	O
.	O

4	O
Rt	O
frontal	O
lesion	O
4	O
.	O

Part	O
B	O
:	O
Deep	O
right	O
frontal	O
white	O
matter	O
-	O
brain	O
.	O

1	O
Deep	O
rt	O
frontal	O
brain	O
1	O
.	O

2	O
Deep	O
rt	O
frontal	O
brain	O
2	O
.	O

3	O
Deep	O
rt	O
frontal	O
brain	O
3	O
.	O

Part	O
C	O
:	O
Right	O
frontal	O
lesion	O
#	O
2	O
-	O
brain	O
.	O

1	O
At	O
frontal	O
lesion	O
#	O
2	O
-	O
1	O
.	O

2	O
Rt	O
frontal	O
lesion	O
#	O
2	O
-	O
2	O
.	O

ALL	O
EMBEDDED	O
.	O

Page	O
of	O
2	O
.	O
caseis	O
.	O

-DOCSTART-257
Diagnosis	O
(	O
es	O
)	O
:	O
Total	O
gastrectomy	O
specimen	O
with	O
an	O
ulcerated	O
carcinoma	O
of	O
the	O
esophagogastric	O
junction	O
of	O
.	O
maximum	O
diameter	O
6	B
.	I
5	I
cm	I
localized	O
subcardially	O
in	O
the	O
area	O
of	O
the	O
posterior	O
wall	O
on	O
the	O
.	O
greater	O
curvature	O
side	O
,	O
of	O
the	O
histological	O
type	O
of	O
a	O
poorly	O
differentiated	O
adenocarcinoma	O
.	O

Invasive	O
tumor	O
dissemination	O
within	O
all	O
gastric	O
wall	O
layers	O
as	O
far	O
as	O
the	O
adjacent	O
perigastric	O
.	O
fatty	O
tissue	O
and	O
with	O
lymphatic	O
tumor	O
spread	O
.	O

Oral	O
and	O
aboral	O
resection	O
margin	O
and	O
greater	O
omentum	O
tumor	O
-	O
free	O
.	O

Antrum	O
and	O
corpus	O
with	O
non	O
-	O
florid	O
,	O
moderate	O
chronic	O
gastritis	O
,	O
foveolar	O
hyperplasia	O
and	O
.	O
focal	O
intestinal	O
metaplasia	O
,	O
and	O
partial	O
mucosal	O
atrophy	O
.	O

No	O
evidence	O
of	O
Helicobacter	O
.	O
pylori	O
.	O

Twenty	O
-	O
four	O
regional	O
lymph	O
nodes	O
tumor	O
-	O
free	O
with	O
uncharacteristically	O
reactive	O
.	O
changes	O
.	O

Therefore	O
tumor	O
stage	O
pT2b	O
pNO	O
(	O
0	O
/	O
23	O
)	O
.	O

-DOCSTART-258
CLINICAL	O
DATA	O
:	O
Maxillary	O
cancer	O
.	O

Per	O
.	O
patient	O
is	O
a	O
history	O
of	O
squamous	O
cell	O
.	O
carcinoma	O
of	O
the	O
maxilla	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
)	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
labeled	O
"	O
.	O
.	O
.	O
for	O
intraoperative	O
.	O

consultation	O
"	O
designated	O
"	O
right	O
buccal	O
margin	O
"	O
is	O
a	O
2	O
X	O
0	O
.	O

4	O
X	O
0	O
.	O
2	O
cm	O
portion	O
.	O
of	O
pink	O
-	O
tan	O
soft	O
tissue	O
.	O

The	O
specimen	O
is	O
inked	O
blue	O
.	O

The	O
specimen	O
is	O
.	O
bisected	O
and	O
then	O
submitted	O
entirely	O
for	O
frozen	O
section	O
,	O
and	O
following	O
frozen	O
.	O
section	O
evaluation	O
,	O
the	O
residue	O
is	O
submitted	O
entirely	O
in	O
cassette	O
AFS1	O
.	O

B	O
)	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
labeled	O
"	O
.	O
.	O
.	O
"	O
,	O
designated	O
"	O
right	O
.	O
maxillary	O
tumor	O
"	O
is	O
a	O
5	B
.	I
6	I
cm	I
ML	I
x	I
4	I
.	I
2	I
cm	I
AP	I
x	I
3	I
.	I
6	I
cm	I
SI	O
portion	O
of	O
maxillary	O
.	O
bone	O
,	O
hard	O
and	O
soft	O
palate	O
,	O
floor	O
of	O
ethmoid	O
sinus	O
,	O
and	O
single	O
tooth	O
.	O

The	O
.	O
anterior	O
soft	O
tissue	O
and	O
bony	O
margin	O
is	O
inked	O
blue	O
,	O
the	O
lateral	O
bone	O
and	O
soft	O
.	O
tissue	O
margin	O
is	O
inked	O
black	O
,	O
the	O
posterior	O
soft	O
tissue	O
and	O
bone	O
margin	O
is	O
.	O
inked	O
orange	O
,	O
and	O
the	O
medial	O
soft	O
tissue	O
margin	O
is	O
inked	O
green	O
.	O

The	O
mucosa	O
.	O
of	O
the	O
palate	O
is	O
tan	O
-	O
pink	O
and	O
focally	O
hemorrhagic	O
with	O
a	O
focal	O
area	O
(	O
2	O
.	O
1	O
X	O
.	O
2	O
.	O
0	O
cm	O
)	O
that	O
is	O
granular	O
and	O
has	O
an	O
irregular	O
appearance	O
with	O
dark	O
brown	O
.	O
discoloration	O
.	O

Margins	O
are	O
taken	O
for	O
the	O
anterior	O
,	O
lateral	O
,	O
medial	O
,	O
and	O
.	O
posterior	O
soft	O
tissue	O
margins	O
,	O
and	O
then	O
the	O
specimen	O
is	O
serially	O
sectioned	O
.	O
from	O
medial	O
to	O
lateral	O
to	O
reveal	O
a	O
2	O
.	O
0	O
x	O
2	O
.	O
1	O
x	O
2	O
.	O
6	O
cm	O
,	O
white	O
,	O
firm	O
,	O
ill	O
-	O
.	O
defined	O
mass	O
that	O
is	O
eroded	O
through	O
the	O
maxillary	O
bone	O
.	O

After	O
serial	O
.	O
sections	O
through	O
the	O
mass	O
are	O
taken	O
,	O
the	O
remaining	O
specimen	O
consists	O
of	O
two	O
.	O
thin	O
bones	O
,	O
and	O
a	O
tooth	O
.	O

Cassette	O
list	O
:	O
B1	O
-	O
anterior	O
soft	O
tissue	O
margin	O
;	O
.	O

B2	O
-	O
lateral	O
soft	O
tissue	O
margin	O
;	O
B3	O
-	O
posterior	O
soft	O
tissue	O
margin	O
;	O
B4	O
-	O
.	O
medial	O
soft	O
tissue	O
margin	O
;	O
B5	O
-	O
posterior	O
portion	O
of	O
the	O
mass	O
;	O
B6	O
-	O
.	O
representative	O
section	O
through	O
the	O
mass	O
;	O
B7	O
-	O
additional	O
representative	O
.	O
section	O
through	O
the	O
mass	O
;	O
B8	O
-	O
additional	O
section	O
through	O
the	O
mass	O
.	O

The	O
bony	O
.	O
anterior	O
,	O
posterior	O
,	O
and	O
lateral	O
margins	O
are	O
submitted	O
for	O
decalcification	O
.	O
prior	O
to	O
further	O
processing	O
,	O
and	O
then	O
submitted	O
in	O
cassettes	O
B8	O
-	O
B10	O
.	O

C	O
)	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
for	O
frozen	O
labeled	O
"	O
.	O
.	O
.	O
,	O
deep	O
margin	O
"	O
are	O
.	O
fragments	O
of	O
dark	O
red	O
soft	O
tissue	O
admixed	O
with	O
fragments	O
of	O
bone	O
measuring	O
.	O

4	O
.	O
5	O
X	O
1	O
.	O
5	O
X	O
1	O
cm	O
in	O
aggregate	O
dimension	O
.	O

Representative	O
sections	O
of	O
soft	O
.	O
tissue	O
are	O
submitted	O
for	O
frozen	O
.	O

Frozen	O
section	O
residue	O
is	O
submitted	O
in	O
.	O
block	O
CFS1	O
.	O

D	O
)	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
for	O
frozen	O
labeled	O
"	O
.	O
.	O
.	O
,	O
posterior	O
margin	O
"	O
.	O
are	O
2	O
dark	O
red	O
fragments	O
of	O
soft	O
tissue	O
measuring	O
1	O
.	O
5	O
X	O
1	O
X	O
0	O
.	O
2	O
cm	O
in	O
.	O
aggregate	O
dimension	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
for	O
frozen	O
.	O

Frozen	O
.	O
section	O
residue	O
is	O
submitted	O
in	O
block	O
DFS1	O
.	O

E	O
)	O
Received	O
fresh	O
in	O
a	O
container	O
for	O
frozen	O
labeled	O
"	O
.	O
.	O
.	O
.	O
lingual	O
nerve	O
"	O
is	O
a	O
.	O

0	O
.	O
5	O
cm	O
tan	O
,	O
irregular	O
soft	O
tissue	O
which	O
is	O
marked	O
with	O
blue	O
ink	O
and	O
entirely	O
.	O
submitted	O
for	O
frozen	O
.	O

Frozen	O
section	O
residue	O
is	O
submitted	O
in	O
block	O
.	O

F	O
)	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
for	O
frozen	O
labeled	O
"	O
.	O
.	O
.	O
,	O
superior	O
margin	O
"	O
is	O
.	O

a	O
1	O
.	O
2	O
X	O
0	O
.	O
8	O
x	O
0	O
.	O
2	O
cm	O
tan	O
,	O
irregular	O
soft	O
tissue	O
which	O
is	O
marked	O
with	O
blue	O
ink	O
.	O
and	O
entirelv	O
submitted	O
for	O
frozen	O
.	O

Frozen	O
section	O
residue	O
is	O
submitted	O
in	O
.	O
block	O
.	O

G	O
)	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
for	O
frozen	O
labeled	O
"	O
.	O
.	O
.	O
.	O
lateral	O
margin	O
"	O
is	O
.	O

a	O
0	O
.	O
8	O
X	O
0	O
.	O
5	O
x	O
0	O
.	O
1	O
cm	O
tan	O
,	O
irregular	O
soft	O
tissue	O
which	O
is	O
marked	O
with	O
black	O
.	O
ink	O
and	O
entirely	O
submitted	O
for	O
frozen	O
.	O

Frozen	O
section	O
residue	O
is	O
submitted	O
.	O
in	O
block	O
.	O

H	O
)	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
for	O
frozen	O
labeled	O
"	O
.	O
.	O
.	O
.	O
.	O
anterior	O
margin	O
"	O
is	O
.	O

a	O
0	O
.	O
6	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
1	O
cm	O
tan	O
,	O
irregular	O
soft	O
tissue	O
which	O
is	O
marked	O
with	O
orange	O
.	O
ink	O
and	O
entirelv	O
submitted	O
for	O
frozen	O
.	O

Frozen	O
section	O
residue	O
is	O
submitted	O
.	O
in	O
block	O
.	O

I	O
)	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
for	O
frozen	O
labeled	O
"	O
.	O
.	O
.	O
,	O
deep	O
margin	O
"	O
is	O
a	O
.	O

0	O
.	O
5	O
X	O
0	O
.	O
5	O
x	O
0	O
.	O
1	O
cm	O
tan	O
,	O
irregular	O
soft	O
tissue	O
which	O
is	O
marked	O
with	O
blue	O
ink	O
.	O
and	O
entirely	O
submitted	O
for	O
frozen	O
.	O

Frozen	O
section	O
residue	O
is	O
submitted	O
in	O
.	O
block	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
for	O
frozen	O
labeled	O
"	O
.	O
.	O
.	O
,	O
medial	O
margin	O
"	O
is	O
a	O
.	O

1	O
.	O
2	O
cm	O
tan	O
,	O
irregular	O
soft	O
tissue	O
which	O
is	O
marked	O
with	O
black	O
ink	O
and	O
entirely	O
.	O
submitted	O
for	O
frozen	O
.	O

Frozen	O
section	O
residue	O
is	O
submitted	O
in	O
block	O
.	O

K	O
)	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
for	O
frozen	O
labeled	O
"	O
.	O
.	O
.	O
.	O
posterior	O
deep	O
.	O

margin	O
"	O
is	O
a	O
0	O
.	O
7	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
2	O
cm	O
tan	O
,	O
irregular	O
soft	O
tissue	O
which	O
is	O
marked	O
.	O
with	O
black	O
ink	O
and	O
entirely	O
submitted	O
for	O
frozen	O
.	O

Frozen	O
section	O
residue	O
.	O

is	O
.	O
submitted	O
in	O
block	O
.	O

L	O
)	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
for	O
frozen	O
labeled	O
"	O
.	O
.	O
.	O
,	O
deep	O
medial	O
.	O

margin	O
"	O
is	O
a	O
1	O
x	O
0	O
.	O
6	O
X	O
0	O
.	O

cm	O
tan	O
,	O
irregular	O
soft	O
tissue	O
which	O
is	O
marked	O
with	O
.	O
orange	O
ink	O
and	O
entirely	O
submitted	O
for	O
frozen	O
.	O

Frozen	O
section	O
residue	O
is	O
.	O
submitted	O
in	O
block	O
.	O

M	O
)	O
.	O

Received	O
in	O
a	O
container	O
of	O
formalin	O
labeled	O
"	O
.	O
.	O
.	O
,	O
right	O
maxillary	O
.	O

mucosa	O
"	O
are	O
multiple	O
hemorrhagic	O
,	O
rubbery	O
fragments	O
of	O
soft	O
tissue	O
admixed	O
.	O
with	O
a	O
portion	O
of	O
cartilage	O
.	O

Specimen	O
measures	O
2	O
x	O
2	O
x	O
0	O
.	O
5	O
cm	O
in	O
aggregate	O
.	O
dimension	O
.	O

Soft	O
tissue	O
minus	O
the	O
cartilage	O
is	O
entirely	O
submitted	O
in	O
cassette	O
.	O

M1	O
.	O

N	O
)	O
Received	O
in	O
a	O
container	O
of	O
formalin	O
labeled	O
"	O
.	O
,	O
tooth	O
#	O
5	O
"	O
is	O
a	O
2	O
.	O
2	O
x	O
0	O
.	O
6	O
.	O

X	O
0	O
.	O
2	O
cm	O
premolar	O
designated	O
as	O
"	O
#	O
5	O
.	O
"	O
There	O
is	O
silver	O
amalgam	O
on	O
the	O
.	O
lateral	O
side	O
of	O
the	O
crown	O
.	O

No	O
soft	O
tissue	O
is	O
received	O
.	O

Specimen	O
is	O
reviewed	O
.	O
by	O
Dr	O
.	O
Gross	O
only	O
.	O

O	O
)	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
for	O
frozen	O
labeled	O
"	O
.	O
.	O
.	O
,	O
new	O
medial	O
.	O
mucosa	O
margin	O
"	O
is	O
a	O
0	O
.	O
8	O
X	O
0	O
.	O
5	O
X	O
0	O
.	O
1	O
cm	O
tan	O
,	O
irregular	O
soft	O
tissue	O
which	O
is	O
.	O
marked	O
with	O
black	O
ink	O
and	O
entirely	O
submitted	O
for	O
frozen	O
.	O

Frozen	O
section	O
.	O
residue	O
is	O
submitted	O
in	O
block	O
.	O

P	O
)	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
for	O
frozen	O
labeled	O
"	O
.	O
.	O
.	O
,	O
new	O
superior	O
.	O

margin	O
"	O
is	O
a	O
1	O
X	O
0	O
.	O
3	O
X	O
0	O
.	O
3	O
cm	O
tan	O
,	O
irregular	O
soft	O
tissue	O
which	O
is	O
marked	O
with	O
.	O
blue	O
ink	O
and	O
entirely	O
submitted	O
for	O
frozen	O
.	O

Frozen	O
section	O
residue	O
is	O
.	O
submitted	O
in	O
block	O
.	O

Q	O
)	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
for	O
frozen	O
labeled	O
"	O
.	O
.	O
.	O
.	O
.	O
new	O
deep	O
margin	O
"	O
is	O
.	O

a	O
0	O
.	O
6	O
cm	O
tan	O
,	O
irregular	O
soft	O
tissue	O
which	O
is	O
marked	O
with	O
black	O
ink	O
and	O
.	O
entirely	O
submitted	O
for	O
frozen	O
.	O

Frozen	O
section	O
residue	O
is	O
submitted	O
in	O
block	O
.	O

R	O
)	O
Received	O
fresh	O
in	O
a	O
container	O
for	O
frozen	O
labeled	O
"	O
.	O
.	O
.	O
.	O
.	O

palate	O
"	O
is	O
a	O
0	O
.	O
6	O
cm	O
.	O
tan	O
,	O
irregular	O
soft	O
tissue	O
which	O
is	O
marked	O
with	O
blue	O
ink	O
and	O
entirely	O
.	O
submitted	O
for	O
frozen	O
.	O

Frozen	O
section	O
residue	O
is	O
submitted	O
in	O
block	O
.	O

S	O
)	O
.	O

Received	O
in	O
a	O
container	O
of	O
formalin	O
labeled	O
"	O
.	O
.	O
.	O
,	O
repeat	O
medial	O
.	O

resection	O
"	O
are	O
a	O
few	O
variegated	O
,	O
hemorrhagic	O
,	O
rubbery	O
portions	O
of	O
soft	O
tissue	O
.	O
measuring	O
2	O
.	O

6	O
x	O
2	O
x	O
0	O
.	O
5	O
cm	O
in	O
aggregate	O
dimension	O
.	O

There	O
are	O
congested	O
,	O
.	O
friable	O
cut	O
surfaces	O
.	O

No	O
obvious	O
masses	O
are	O
identified	O
.	O

Specimen	O
is	O
.	O
entirely	O
submitted	O
in	O
2	O
cassettes	O
.	O

Received	O
in	O
a	O
container	O
of	O
formalin	O
labeled	O
"	O
.	O
.	O
.	O
.	O
.	O
medial	O
maxillary	O
.	O

wall	O
"	O
is	O
a	O
2	O
X	O
1	O
.	O
5	O
x	O
0	O
.	O
2	O
cm	O
tan	O
,	O
firm	O
,	O
irregular	O
fragment	O
of	O
cartilage	O
with	O
a	O
.	O
scant	O
amount	O
of	O
attached	O
apparent	O
bone	O
.	O

Specimen	O
is	O
sectioned	O
and	O
has	O
dark	O
.	O
red	O
cut	O
surfaces	O
and	O
no	O
masses	O
are	O
appreciated	O
.	O

The	O
specimen	O
is	O
entirely	O
.	O
submitted	O
in	O
cassette	O
T1	O
following	O
decalcification	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
:	O
AFS	O
)	O
No	O
carcinoma	O
identified	O
(	O
cautery	O
artifact	O
present	O
)	O
.	O

CFS	O
)	O
Deep	O
margin	O
positive	O
for	O
carcinoma	O
.	O

DFS	O
)	O
Posterior	O
margin	O
positive	O
for	O
carcinoma	O
.	O

EFS	O
)	O
Lingual	O
nerve	O
positive	O
for	O
carcinoma	O
.	O

FFS	O
)	O
Superior	O
margin	O
positive	O
for	O
carcinoma	O
;	O
bone	O
involved	O
.	O

GFS	O
)	O
Lateral	O
margin	O
negative	O
.	O

HFS	O
)	O
Anterior	O
margin	O
negative	O
.	O

IFS	O
)	O
.	O

Deep	O
lateral	O
margin	O
negative	O
.	O

JFS	O
)	O
Medial	O
margin	O
positive	O
for	O
carcinoma	O
.	O

KFS	O
)	O
Posterior	O
deep	O
margin	O
positive	O
for	O
carcinoma	O
.	O

LFS	O
)	O
Deep	O
medial	O
margin	O
negative	O
.	O

OFS	O
)	O
New	O
medial	O
mucosal	O
margin	O
negative	O
.	O

PFS	O
)	O
New	O
superior	O
margin	O
negative	O
.	O

QFS	O
)	O
New	O
deep	O
margin	O
negative	O
.	O

RFS	O
)	O
Palate	O
negative	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
A	O
)	O
.	O

Right	O
buccal	O
margin	O
,	O
excision	O
:	O
Squamous	O
mucosa	O
with	O
no	O
evidence	O
of	O
in	O
.	O
situ	O
or	O
invasive	O
carcinoma	O
.	O

B	O
)	O
Right	O
maxillary	O
tumor	O
,	O
maxillectomy	O
:	O
Poorly	O
differentiated	O
invasive	O
.	O
squamous	O
cell	O
carcinoma	O
with	O
the	O
following	O
features	O
:	O
1	O
.	O

2	O
.	O
6	O
cm	O
.	O

2	O
.	O

Extent	O
:	O
Carcinoma	O
erodes	O
through	O
the	O
maxillary	O
bone	O
.	O

3	O
.	O

Margins	O
:	O
a	O
.	O

Carcinoma	O
involves	O
the	O
orange	O
-	O
inked	O
posterior	O
specimen	O
margin	O
,	O
the	O
.	O
green	O
-	O
inked	O
medial	O
specimen	O
margin	O
and	O
the	O
black	O
-	O
inked	O
lateral	O
specimen	O
soft	O
.	O
tissue	O
margins	O
;	O
see	O
comment	O
.	O

b	O
.	O

The	O
anterior	O
soft	O
tissue	O
margin	O
is	O
negative	O
for	O
carcinoma	O
.	O

C	O
.	O

Carcinoma	O
involves	O
the	O
medial	O
maxillary	O
bone	O
margin	O
(	O
hard	O
palate	O
)	O
;	O
.	O
anterior	O
maxillary	O
bone	O
margin	O
and	O
bones	O
.	O
of	O
the	O
maxillary	O
sinus	O
are	O
negative	O
for	O
carcinoma	O
.	O

4	O
.	O

Extensive	O
lymphovascular	O
invasion	O
is	O
identified	O
.	O

5	O
.	O

Focal	O
perineural	O
invasion	O
is	O
present	O
.	O

6	O
.	O

The	O
minimum	O
pathologic	O
stage	O
is	O
pT4a	O
,	O
pNx	O
,	O
pMx	O
(	O
AJCC	O
,	O
2002	O
,	O
6th	O
edition	O
)	O
.	O

C	O
,	O
D	O
,	O
E	O
,	O
F	O
,	O
J	O
,	O
,	O
K	O
)	O
Mucosa	O
,	O
sites	O
as	O
designated	O
,	O
biopsies	O
:	O
Multiple	O
designated	O
.	O
margins	O
positive	O
for	O
poorly	O
differentiated	O
squamous	O
cell	O
carcinoma	O
,	O
.	O
including	O
:	O
1	O
.	O

Deep	O
margin	O
.	O

2	O
.	O

Posterior	O
margin	O
.	O

3	O
.	O

Lingual	O
nerve	O
.	O

4	O
.	O

Superior	O
margin	O
.	O

5	O
.	O

Medial	O
margin	O
.	O

Posterior	O
deep	O
margin	O
.	O

G	O
,	O
H	O
,	O
I	O
,	O
L	O
,	O
M	O
,	O
O	O
,	O
P	O
,	O
Q	O
-	O
T	O
)	O
Mucosa	O
,	O
sites	O
as	O
designated	O
,	O
biopsies	O
:	O
Multiple	O
.	O
designated	O
mucosal	O
margins	O
with	O
no	O
evidence	O
of	O
in	O
situ	O
or	O
invasive	O
carcinoma	O
,	O
.	O
including	O
:	O
1	O
.	O

Lateral	O
margin	O
.	O

2	O
.	O

Anterior	O
margin	O
.	O

3	O
.	O

Deep	O
lateral	O
margin	O
.	O

4	O
.	O

Deep	O
medial	O
margin	O
.	O

5	O
.	O

Right	O
maxillary	O
mucosa	O
.	O

6	O
.	O

New	O
medial	O
mucosal	O
margin	O
.	O

7	O
.	O

New	O
superior	O
margin	O
.	O

8	O
.	O

New	O
deep	O
margin	O
.	O

9	O
.	O

Palate	O
.	O

10	O
.	O

Repeat	O
medial	O
resection	O
.	O

11	O
.	O

Medial	O
maxillary	O
wall	O
.	O

N	O
)	O
.	O

Tooth	O
#	O
5	O
,	O
extraction	O
(	O
gross	O
only	O
)	O
:	O
Tooth	O
with	O
silver	O
amalgam	O
and	O
.	O
gross	O
diagnostic	O
alterations	O
.	O

COMMENT	O
:	O
Evaluation	O
of	O
the	O
maxillectomy	O
specimen	O
(	O
B	O
)	O
was	O
supplemented	O
by	O
.	O
intraoperative	O
evaluation	O
of	O
multiple	O
surgical	O
margins	O
by	O
frozen	O
section	O
.	O

Although	O
several	O
specimen	O
margins	O
are	O
positive	O
(	O
see	O
above	O
)	O
final	O
surgical	O
.	O
margins	O
should	O
be	O
based	O
on	O
a	O
correlation	O
of	O
all	O
examined	O
specimens	O
in	O
the	O
.	O
surgical	O
context	O
.	O

Procedures	O
used	O
to	O
establish	O
the	O
diagnosis	O
:	O
Routine	O
.	O

-DOCSTART-259
1	O
)	O
TOTAL	O
THYROID	O
(	O
THYROIDECTOMY	O
)	O
:	O
SPECIMEN	O
TYPE	O
:	O
Total	O
thyroidectomy	O
.	O

TUMOR	O
SITE	O
:	O
Right	O
lobe	O
.	O

Site	O
:	O
thyroid	O
C739	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Papillary	O
carcinoma	O
.	O

TUMOR	O
SIZE	O
(	O
LARGEST	O
NODULE	O
)	O
:	O
Greatest	O
dimension	O
:	O
2	B
.	I
5	I
cm	I
.	O

FOCALITY	O
:	O
Unifocal	O
.	O

LYMPH	O
NODES	O
(	O
ALL	O
PARTS	O
)	O
:	O
Metastatic	O
carcinoma	O
in	O
2	O
of	O
18	O
lymph	O
nodes	O
.	O

EXTENT	O
OF	O
INVASION	O
(	O
STAGING	O
)	O
PRIMARY	O
TUMOR	O
:	O
pT2	O
:	O
Tumor	O
>	O
2	O
.	O
0	O
cm	O
but	O
less	O
than	O
or	O
equal	O
to	O
4	O
.	O
0	O
cm	O
limited	O
to	O
thyroid	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
:	O
pN1a	O
:	O
Nodal	O
metastasis	O
to	O
Level	O
VI	O
(	O
pretracheal	O
,	O
paratracheal	O
,	O
.	O
prelaryngeal	O
/	O
Delphian	O
)	O
nodes	O
.	O

DISTANT	O
METASTASIS	O
:	O
pMx	O
:	O
Cannot	O
be	O
assessed	O
.	O

MARGINS	O
:	O
Margins	O
are	O
uninvolved	O
.	O

VENOUS	O
/	O
LYMPHATIC	O
INVASION	O
:	O
Absent	O
.	O

ADDITIONAL	O
PATHOLOGIC	O
FINDINGS	O
:	O
One	O
benign	O
parathyroid	O
gland	O
.	O

GROSS	O
DESCRIPTION	O
.	O

PART	O
#	O
1	O
:	O
TOTAL	O
THYROID	O
.	O

Dictated	O
:	O
The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
xxxx	O
,	O
and	O
designated	O
.	O

"	O
Total	O
Thyroid	O
,	O
Stitch	O
Marks	O
Right	O
Thyroid	O
Tumor	O
.	O
"	O
The	O
specimen	O
consists	O
of	O
a	O
grossly	O
.	O
identifiable	O
thyroid	O
measuring	O
7	O
.	O
4	O
x	O
5	O
.	O
3	O
x	O
2	O
.	O
0	O
cm	O
and	O
weighing	O
16	O
.	O
37	O
grams	O
.	O

The	O
anterior	O
.	O

is	O
inked	O
orange	O
and	O
the	O
posterior	O
inked	O
black	O
.	O

Serial	O
sectioning	O
reveals	O
a	O
2	B
.	I
5	I
x	I
2	I
.	I
4	I
x	I
1	I
.	I
5	I
.	I

cm	B
tumor	O
in	O
the	O
right	O
middle	O
lobe	O
,	O
with	O
a	O
tan	O
to	O
white	O
focally	O
hemorrhagic	O
and	O
necrotic	O
.	O
appearance	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
and	O
submitted	O
in	O
its	O
entirety	O
.	O

There	O
is	O
also	O
.	O

a	O
1	O
.	O
1	O
x	O
1	O
.	O
1	O
x	O
1	O
.	O
0	O
cm	O
piece	O
of	O
fibroadipose	O
tissue	O
.	O

Blunt	O
dissection	O
reveals	O
seven	O
(	O
7	O
)	O
.	O
potential	O
lymph	O
nodes	O
.	O

The	O
remainder	O
of	O
the	O
fat	O
is	O
submitted	O
.	O
in	O
its	O
entirety	O
.	O

SUMMARY	O
OF	O
SECTIONS	O
:	O
1	O
A	O
.	O

-	O
3	O
(	O
LEFT	O
INFERIOR	O
MARGIN	O
)	O
.	O

1	O
B	O
-	O
2	O
(	O
LEFT	O
,	O
SERIALLY	O
SECTIONED	O
FROM	O
INFERIOR	O
TO	O
SUPERIOR	O
)	O
.	O

1	O
C	O
.	O

-	O
2	O
.	O

(	O
LEFT	O
LOBE	O
)	O
.	O

1	O
D	O
.	O

4	O
.	O

(	O
LEFT	O
SUPERIOR	O
MARGIN	O
)	O
.	O

1	O
E	O
.	O

M	O
.	O

(	O
ISTHMUS	O
)	O
.	O

1	O
F	O
.	O

-	O
-	O
6	O
.	O

(	O
RIGHT	O
INFERIOR	O
MARGIN	O
)	O
.	O

1	O
G	O
.	O

2	O
.	O

(	O
RIGHT	O
LOBE	O
)	O
.	O

1	O
H	O
.	O

-	O
2	O
.	O

(	O
RIGHT	O
LOBE	O
)	O
.	O

1	O
I	O
.	O

-	O
2	O
.	O

(	O
RIGHT	O
INFERIOR	O
TUMOR	O
)	O
.	O

1	O
J	O
.	O

-	O
2	O
.	O

(	O
RIGHT	O
TUMOR	O
)	O
.	O

1	O
K	O
.	O

-	O
M	O
(	O
RIGHT	O
LOBE	O
SUPERIOR	O
ASPECT	O
OF	O
TUMOR	O
AND	O
SUPERIOR	O
.	O
MARGIN	O
)	O
.	O

1	O
L	O
.	O

-	O
7	O
(	O
SEVEN	O
POTENTIAL	O
LYMPH	O
NODES	O
)	O
.	O

1	O
M	O
-	O
M	O
(	O
REMAINING	O
FAT	O
)	O
.	O

13	O
-	O
TOTAL	O
-	O
MULTIPLE	O
.	O

-DOCSTART-260
REVISED	O
REPORT	O
(	O
Addendum	O
/	O
Procedure	O
included	O
)	O
.	O

TISSUE	O
DESCRIPTION	O
:	O
A1	O
A2	O
A3	O
A4	O
A5	O
.	O

Portion	O
of	O
liver	O
segment	O
VIII	O
(	O
110	O
grams	O
,	O
8	O
.	O
5	O
x	O
8	O
.	O
5	O
x	O
6	O
.	O
0	O
cm	O
)	O
.	O

DIAGNOSIS	O
:	O
Liver	O
,	O
segment	O
VIII	O
,	O
excision	O
:	O
Grade	O
3	O
(	O
of	O
4	O
)	O
hepatocellular	O
.	O
carcinoma	O
,	O
usual	O
type	O
,	O
forming	O
a	O
5	B
.	I
0	I
x	I
4	I
.	I
5	I
x	I
4	I
.	I
0	I
cm	I
mass	O
.	O

The	O
tumor	O
.	O

is	O
located	O
in	O
segment	O
VIII	O
.	O

The	O
hepatic	O
capsule	O
is	O
free	O
of	O
tumor	O
.	O

The	O
surgical	O
margins	O
are	O
free	O
of	O
tumor	O
,	O
the	O
clearance	O
being	O
1	O
.	O
6	O
cm	O
.	O
grossly	O
.	O

Extratumoral	O
vascular	O
invasion	O
is	O
not	O
identified	O
.	O

The	O
.	O
tumor	O
is	O
not	O
encapsulated	O
,	O
infiltration	O
of	O
parenchyma	O
being	O
of	O
.	O
pushing	O
type	O
.	O

Non	O
-	O
neoplastic	O
liver	O
will	O
be	O
reported	O
in	O
an	O
addendum	O
.	O

ADDENDUM	O
:	O
The	O
non	O
-	O
neoplastic	O
liver	O
is	O
consistent	O
with	O
primary	O
biliary	O
.	O
cirrhosis	O
stage	O
4	O
(	O
of	O
4	O
)	O
.	O

Iron	O
is	O
negative	O
for	O
hemosiderosis	O
.	O

Trichrome	O
stain	O
highlights	O
bridging	O
fibrosis	O
with	O
regenerative	O
.	O
nodules	O
.	O

-DOCSTART-261
MRN	O
#	O
:	O
SPECIME	O
.	O

DIAGNOSIS	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

Right	O
sentinel	O
lymph	O
nodes	O
,	O
one	O
lymph	O
node	O
:	O
No	O
evidence	O
of	O
metastatic	O
carcinoma	O
.	O

Confirms	O
frozen	O
section	O
diagnosis	O
and	O
confirmed	O
by	O
negative	O
staining	O
for	O
pancytokeratin	O
.	O

B	O
.	O

Right	O
breast	O
mastectomy	O
:	O
Multiple	O
areas	O
of	O
invasive	O
papillary	O
carcinoma	O
.	O

Largest	O
area	O
size	O
3	B
cm	I
.	O

Architectural	O
score	O
:	O
1	O
of	O
3	O
.	O

Nuclear	O
score	O
:	O
2	O
of	O
3	O
.	O

Mitotic	O
score	O
:	O
1	O
of	O
3	O
.	O

Total	O
score	O
:	O
4	O
of	O
9	O
=	O
grade	O
1	O
.	O

Additional	O
areas	O
of	O
in	O
situ	O
and	O
invasive	O
papillary	O
carcinoma	O
located	O
in	O
other	O
quadrants	O
of	O
the	O
breast	O
.	O

The	O
largest	O
area	O
of	O
confluent	O
carcinoma	O
measures	O
0	B
.	I
8	I
cm	I
.	O

No	O
evidence	O
of	O
skin	O
of	O
nipple	O
involvement	O
.	O

Overlying	O
skin	O
contains	O
a	O
large	O
seborrheic	O
keratosis	O
.	O

Deep	O
margin	O
of	O
excision	O
is	O
free	O
of	O
carcinoma	O
.	O

TNM	O
:	O
T2pNO	O
(	O
i	O
-	O
)	O
MX	O
.	O

CLINICAL	O
INFORMATION	O
.	O

CLINICAL	O
HISTORY	O
:	O
Preoperative	O
Diagnosis	O
:	O
Right	O
modified	O
radical	O
mastectomy	O
with	O
sentinel	O
node	O
mapping	O
with	O
frozen	O
section	O
.	O

Adenocarcinoma	O
,	O
with	O
papillary	O
subtype	O
.	O

(	O
Papiliary	O
carcinoma	O
)	O
.	O

ER	O
positive	O
,	O
PR	O
positive	O
.	O

Postoperative	O
Diagnosis	O
:	O
Symptoms	O
/	O
Radiokogic	O
Findings	O
:	O
SPECIMENS	O
:	O
A	O
.	O

Sentinel	O
node	O
right	O
,	O
count	O
4600	O
with	O
frozen	O
section	O
.	O

B	O
.	O

Right	O
breast	O
tissue	O
1453	O
grams	O
.	O

SPECIMEN	O
DATA	O
.	O

GROSS	O
DESCRIPTION	O
:	O
The	O
specimen	O
is	O
received	O
in	O
two	O
containers	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
.	O

A	O
.	O

Container	O
A	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
,	O
additionally	O
labeled	O
'	O
right	O
sentinel	O
node	O
'	O
and	O
contains	O
a	O
2	O
.	O
5	O
x	O
2	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
aggregate	O
of	O
yellow	O
-	O
tan	O
.	O
fibrofatty	O
soft	O
tissue	O
.	O

On	O
palpation	O
,	O
a	O
1	O
.	O
3	O
cm	O
firm	O
fatty	O
nodule	O
is	O
identified	O
consistent	O
with	O
possible	O
lymph	O
node	O
.	O

The	O
nodule	O
is	O
bisected	O
and	O
entirely	O
.	O
submitted	O
for	O
frozen	O
section	O
.	O

The	O
residual	O
is	O
entirely	O
resubmitted	O
for	O
permanent	O
section	O
in	O
cassette	O
A	O
labeled	O
.	O

B	O
.	O

Container	O
B	O
is	O
received	O
with	O
formalin	O
additionally	O
labeled	O
'	O
right	O
breast	O
tissue	O
'	O
and	O
consists	O
of	O
a	O
1439	O
.	O
4	O
gram	O
,	O
27	O
.	O
5	O
x	O
19	O
.	O
0	O
x	O
6	O
.	O
5	O
cm	O
simple	O
mastectomy	O
.	O
specimen	O
partially	O
surfaced	O
by	O
pink	O
-	O
tan	O
wrinkled	O
skin	O
which	O
bears	O
a	O
central	O
1	O
.	O
5	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
2	O
cm	O
slightly	O
raised	O
nipple	O
.	O

Orientation	O
is	O
not	O
offered	O
or	O
possible	O
.	O

Located	O
0	O
.	O
7	O
cm	O
from	O
the	O
skin	O
edge	O
and	O
7	O
.	O
8	O
cm	O
from	O
the	O
nipple	O
is	O
a	O
1	O
.	O
3	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
5	O
cm	O
gray	O
-	O
brown	O
raised	O
skin	O
lesion	O
.	O

Additional	O
skin	O
lesions	O
are	O
not	O
.	O
identified	O
.	O

The	O
deep	O
margin	O
is	O
inked	O
and	O
the	O
specimen	O
is	O
serially	O
sectioned	O
to	O
reveal	O
a	O
2	O
.	O
8	O
:	O
x	O
1	O
.	O
5	O
x	O
1	O
.	O
0	O
cm	O
cystic	O
lesion	O
containing	O
pink	O
-	O
tan	O
friable	O
soft	O
.	O
tissue	O
,	O
along	O
with	O
a	O
radiographic	O
clip	O
.	O

This	O
lesion	O
resides	O
4	O
.	O
5	O
cm	O
from	O
the	O
skin	O
surface	O
and	O
2	O
.	O
2	O
cm	O
from	O
the	O
inked	O
deep	O
margin	O
.	O

Multiple	O
additional	O
pink	O
-	O
.	O
tan	O
rubbery	O
lesions	O
are	O
identified	O
diffusely	O
scattered	O
throughout	O
the	O
specimen	O
and	O
involve	O
all	O
four	O
quadrants	O
.	O

The	O
largest	O
of	O
these	O
remaining	O
lesions	O
is	O
.	O

3	O
.	O
0	O
x	O
1	O
.	O
8	O
x	O
1	O
.	O
8	O
cm	O
and	O
approaches	O
to	O
within	O
0	O
.	O
4	O
cm	O
of	O
the	O
inked	O
deep	O
margin	O
.	O

The	O
uninvolved	O
areas	O
are	O
comprised	O
of	O
yellow	O
-	O
tan	O
adipose	O
tissue	O
admixed	O
.	O
with	O
moderate	O
amounts	O
of	O
interspersed	O
gray	O
-	O
white	O
fibrous	O
tissue	O
.	O

Discrete	O
axillary	O
tail	O
is	O
not	O
present	O
,	O
however	O
,	O
five	O
firm	O
fatty	O
possible	O
lymph	O
nodes	O
are	O
.	O
identified	O
along	O
one	O
edge	O
of	O
the	O
specimen	O
.	O

These	O
possible	O
lymph	O
nodes	O
range	O
from	O
1	O
.	O
0	O
up	O
to	O
1	O
.	O
4	O
cm	O
in	O
greatest	O
dimension	O
.	O

Also	O
received	O
in	O
the	O
same	O
container	O
are	O
two	O
portions	O
of	O
pink	O
-	O
tan	O
wrinkled	O
skin	O
with	O
yellow	O
-	O
tan	O
subcutaneous	O
fibroadipose	O
tissue	O
.	O

These	O
tissues	O
are	O
8	O
.	O
0	O
x	O
.	O

2	O
.	O
0	O
x	O
1	O
.	O
3	O
cm	O
and	O
16	O
.	O
0	O
x	O
3	O
.	O
0	O
x	O
2	O
.	O
0	O
cm	O
.	O
The	O
cut	O
surfaces	O
are	O
yellow	O
-	O
tan	O
fibrofattywith	O
no	O
discrete	O
lesions	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
.	O
cassettes	O
B1	O
through	O
13	O
labeled	O
.	O
esignated	O
as	O
follows	O
:	O
1	O
,	O
nipple	O
;	O
2	O
,	O
skin	O
lesion	O
,	O
entirely	O
;	O
3	O
and	O
4	O
,	O
radiographically	O
located	O
lesion	O
;	O
5	O
and	O
6	O
,	O
.	O
largest	O
additional	O
lesion	O
to	O
inked	O
usep	O
margin	O
,	O
perpendicular	O
;	O
7	O
through	O
10	O
,	O
additional	O
representative	O
lesions	O
from	O
all	O
four	O
quadrants	O
;	O
11	O
,	O
two	O
whole	O
.	O
possible	O
lymph	O
nodes	O
;	O
12	O
,	O
two	O
whole	O
possible	O
bisected	O
lymph	O
nodes	O
(	O
one	O
inked	O
)	O
:	O
13	O
.	O
one	O
whole	O
possible	O
bisected	O
lymph	O
node	O
.	O

Additionally	O
,	O
a	O
yellow	O
,	O
.	O
green	O
and	O
blue	O
cassette	O
are	O
submitted	O
for	O
genomics	O
research	O
each	O
labeled	O
.	O

ININA	O
-	O
OPERATIVE	O
CONSULTATION	O
:	O
FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
Part	O
A	O
:	O
No	O
neoplasm	O
identified	O
(	O
0	O
/	O
1	O
)	O
per	O
Dr	O
.	O

-DOCSTART-262
Results	O
Viewer	O
.	O

Encounter	O
Num	O
.	O

COPY	O
ONLY	O
DO	O
NOT	O
FILE	O
.	O
of	O
specimon	O
.	O

A	O
.	O

USERUO	O
,	O
CERVTX	O
,	O
BILATERAL	O
FALLOPIAN	O
TUBES	O
&	O
OVARIES	O
FOR	O
.	O

GROSS	O
-	O
.	O

B	O
.	O

VAGINAL	O
CUFF	O
TISSUE	O
-	O
.	O

C	O
.	O

SIGMOID	O
SURFACE	O
TISSUE	O
-	O
.	O

D	O
.	O

CUL	O
-	O
DE	O
-	O
SAC	O
TISSUE	O
-	O
.	O

F	O
.	O

LEFT	O
ADENEXAL	O
TISSUE	O
-	O
.	O

F	O
.	O

RIGIT	O
SIDE	O
WALL	O
TISSUE	O
-	O
.	O

G	O
.	O

RIGHT	O
PELVIC	O
LYMPII	O
NODES	O
-	O
.	O

H	O
.	O

LEFT	O
PELVIC	O
LYMPH	O
NODE	O
-	O
.	O

1	O
.	O

RICHT	O
STDE	O
WALL	O
TISSUE	O
#	O
2	O
-	O
.	O

J	O
.	O

OMENT	O
'	O
IM	O
-	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
A	O
.	O

UTERUS	O
,	O
CERVIX	O
,	O
BILATERAL	O
FALLOPIAN	O
TUBES	O
&	O
OVARIES	O
FOR	O
.	O

GROSS	O
-	O
.	O

ENDOMETRIAL	O
CARCINOMA	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
SEROUS	O
TYPE	O
,	O
ADMIXED	O
WITH	O
CLEAR	O
CELL	O
AND	O
100	O
%	O
indometrial	O
carcinoma	O
,	O
.	O

ENDOMETRIOTD	O
COMPONENTS	O
.	O

GRADE	O
:	O
3	O
/	O
3	O
.	O

DEPTE	O
OF	O
INVASION	O
:	O
14	O
MM	O
.	O

NEARLY	O
959	O
OF	O
MYCMETRIUM	O
.	O

ICD	O
-	O
0	O
-	O
3	O
.	O

THICKNESS	O
:	O
15	O
MM	O
.	O

AT	O
TUMOR	O
GITE	O
.	O

INVAGION	O
OF	O
CERVICAL	O
STROMAL	O
:	O
PRESENT	O
.	O

Pre	O
.	O

Results	O
Viewer	O
.	O

INVASION	O
OF	O
VAGINA	O
:	O
NOT	O
SEEN	O
IN	O
PART	O
"	O
B	O
"	O
.	O

INVASIVE	O
IMPLANTS	O
,	O
SEEN	O
TN	O
UTERINE	O
SEROSA	O
,	O
BILATERAL	O
ADNEXAE	O
,	O
.	O

CUL	O
-	O
DE	O
-	O
SAC	O
,	O
RIGHT	O
SIDE	O
WALL	O
(	O
PARTS	O
"	O
F	O
"	O
AND	O
"	O
I	O
"	O
)	O
,	O
AND	O
PERICOLIC	O
.	O

SOFT	O
TISSUE	O
(	O
PART	O
"	O
C	O
"	O
)	O
.	O

METASTATIC	O
CARCINOMA	O
ALSO	O
NOTED	O
IN	O
OMENTUM	O
.	O

TUMOP	O
.	O

SIZE	O
:	O
3	B
.	I
5	I
CM	I
IN	O
GREATEST	O
DIMENSION	O
.	O

TNM	O
STAGE	O
(	O
AJCC	O
,	O
Edition	O
)	O
:	O
pT3b	O
,	O
pN1	O
,	O
pM1	O
.	O

(	O
SMALI	O
VESSEL	O
)	O
INVASION	O
:	O
PRESENT	O
.	O

LYMPH	O
NODE	O
(	O
S	O
)	O
INCLUDED	O
IN	O
ALL	O
PARTS	O
:	O
NUMBER	O
INVOLVED	O
:	O
1	O
.	O

NUMBER	O
EXAMINED	O
:	O
2	O
.	O

SPECIMEN	O
TYPE	O
:	O
HYSTERECTOMY	O
AND	O
BILATERAL	O
.	O

LEENGO	O
-	O
OOPHORECTOMY	O
.	O

SIZE	O
OF	O
UTERUS	O
:	O
6	O
x	O
4	O
.	O
5	O
x	O
3	O
CM	O
.	O

ADENOMYOSIS	O
.	O

NO	O
TUMOR	O
SEEN	O
AT	O
RESECTION	O
MARGINS	O
OF	O
THE	O
SPECIMEN	O
.	O

B	O
.	O

VAGINAL	O
CUFF	O
TISSUE	O
-	O
.	O

FIBROUS	O
TISSUE	O
,	O
INFLAMED	O
WITH	O
CAUTERY	O
ARTIFACT	O
.	O

C	O
.	O

SIGMOID	O
SURFACE	O
TISSUE	O
-	O
.	O

INVASIVE	O
CARCINOMA	O
AS	O
SEEN	O
IN	O
PART	O
"	O
A	O
"	O
.	O

D	O
.	O

CUL	O
-	O
DE	O
-	O
SAC	O
TESSUE	O
-	O
.	O

INVASIVE	O
CARCINOMA	O
AS	O
SEEN	O
IN	O
PART	O
"	O
A	O
"	O
.	O

F	O
.	O

LEFT	O
ADENEXAL	O
TISSUE	O
-	O
.	O

INVAGIVE	O
CARCINOMA	O
AS	O
SEEN	O
IN	O
PART	O
"	O
A	O
"	O
.	O

:	O
RIGHT	O
SIDE	O
WALL	O
TISSUE	O
-	O
.	O

INVASIVE	O
CARCINOMA	O
AS	O
SEEN	O
IN	O
PART	O
"	O
A	O
"	O
.	O

G	O
.	O

RIGHT	O
PELVIC	O
LYMPH	O
NODES	O
-	O
.	O

LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

H	O
.	O

OFFT	O
PELVIC	O
LYMPH	O
NODE	O
-	O
.	O

LYMPH	O
NODE	O
with	O
MICROME	O
/	O
TASTASIS	O
.	O

NO	O
EXTRANODAL	O
INVASION	O
GEEN	O
.	O

CFE	O
NOTE	O
.	O

NOTE	O
:	O
THE	O
MICROMETASTASIS	O
CONSISTS	O
OF	O
P	O
.	O
ARE	O
MINUTE	O
CLUSTERS	O
OF	O
.	O

TUMOR	O
CELLS	O
.	O

ON	O
IMMUNOSTAINING	O
,	O
THE	O
TUMOR	O
CELIS	O
ARE	O
POSTTIVE	O
FOR	O
.	O

KERATINS	O
.	O

Appropriate	O
positive	O
controls	O
were	O
stained	O
along	O
side	O
sections	O
.	O
from	O
this	O
case	O
,	O
The	O
control	O
tissue	O
was	O
examined	O
and	O
judged	O
to	O
.	O

be	O
technically	O
acceptable	O
.	O

Prep	O
.	O

Results	O
Viewer	O
-	O
.	O

1	O
.	O

1	O
<	O
THE	O
STDE	O
WALL	O
TISSUE	O
#	O
2	O
-	O
.	O

INVASIVE	O
CARCINOMA	O
AS	O
SEEN	O
IN	O
PART	O
"	O
A	O
"	O
.	O

OMENTUM	O
.	O

INVASIVE	O
CARCINOMA	O
AS	O
SEEN	O
IN	O
PART	O
"	O
A	O
"	O
.	O
signed	O
Others	O
.	O

Brocen	O
Section	O
.	O

A	O
.	O

DLERUS	O
,	O
CERVIX	O
,	O
BILATERAL	O
FALLOPIAN	O
TUBES	O
AND	O
OVARIES	O
,	O
GROSS	O
.	O

EKAM	O
:	O
-	O
:	O
-	O
CM	O
FRIABLE	O
PAPILLATION	O
OCCUPYING	O
THE	O
ENTIRE	O
ENDOMETRIAL	O
.	O

VAVITY	O
AND	O
INVADING	O
INTO	O
THE	O
MYOMETRIUM	O
(	O
>	O
50	O
%	O
)	O
;	O
.	O

SCIORTENED	O
CERVIX	O
(	O
S	O
/	O
P	O
LEEP	O
)	O
,	O
NO	O
TUMOR	O
SEEN	O
GROSSLY	O
IN	O
THE	O
.	O

CERVIK	O
.	O

SECTIONS	O
OF	O
TUMOR	O
AND	O
CERVIX	O
TAKEN	O
FOR	O
RESEARCH	O
STUD	O
'	O
.	O

Frozen	O
soction	O
performed	O
by	O
Lr	O
.	O

Case	O
Clinical	O
Information	O
.	O

PAPILLARY	O
SEROUS	O
UTERINE	O
CANCER	O
.	O

Gross	O
Description	O
.	O

A	O
.	O

Received	O
in	O
formalin	O
labeled	O
"	O
uterus	O
,	O
cervix	O
,	O
bilateral	O
.	O
cuces	O
and	O
ovaries	O
"	O
is	O
a	O
hysterectomy	O
specimen	O
with	O
attached	O
.	O
bilateral	O
adnexae	O
,	O
weigning	O
a	O
total	O
of	O
80	O
grams	O
.	O

The	O
uterus	O
.	O

5	O
em	O
Licm	O
Cundus	O
to	O
exocervix	O
,	O
3	O
cm	O
como	O
to	O
comm	O
and	O
.	O

4	O
.	O
5	O
cm	O
anterior	O
to	O
posterior	O
.	O

The	O
right	O
fallopian	O
tube	O
measures	O
.	O

1	O
X	O
0	O
.	O
5	O
am	O
.	O

The	O
right	O
ovary	O
is	O
yellow	O
/	O
tan	O
and	O
cystic	O
in	O
.	O
apceatance	O
and	O
measures	O
2	O
.	O
5	O
x	O
2	O
x	O
1	O
.	O
5	O
cm	O
.	O

The	O
left	O
fallopian	O
.	O
unbe	O
measures	O
1	O
.	O
5	O
%	O
0	O
.	O
5	O
cm	O
.	O

The	O
left	O
ovary	O
is	O
yellow	O
/	O
tar	O
firm	O
.	O
and	O
mensures	O
2	O
&	O
1	O
.	O
1	O
x	O
1	O
cm	O
.	O

The	O
exocervix	O
measures	O
1	O
.	O
5	O
%	O
1	O
.	O
2	O
X	O
.	O

1	O
.	O
.	O
.	O
.	O
m	O
.	O

The	O
utorus	O
has	O
been	O
previously	O
bivalved	O
to	O
show	O
.	O
)	O
.	O
endocervical	O
canal	O
measuring	O
1	O
.	O
5	O
x	O
0	O
.	O
1	O
cm	O
.	O
endemetria	O
caviry	O
has	O
been	O
previously	O
sectioned	O
and	O
is	O
.	O

remerKab	O
.	O

is	O
for	O
a	O
gray	O
/	O
tan	O
,	O
Triable	O
papillary	O
mass	O
meaturing	O
?	O
.	O
.	O

The	O
mycmetrium	O
is	O
0	O
.	O
5	O
em	O
in	O
thickness	O
.	O

Sect	O
the	O
endomyometrium	O
shows	O
chat	O
the	O
.	O
resion	O
invotues	O
of	O
the	O
myoretrium	O
.	O

The	O
right	O
fallopian	O
.	O

:	O
sectally	O
sectioned	O
showing	O
an	O
unremarkable	O
riupoint	O
.	O

Prepared	O
.	O

Results	O
Viewer	O
.	O

Tumen	O
.	O

The	O
right	O
ovary	O
is	O
serially	O
sectioned	O
to	O
show	O
a	O
cyst	O
.	O
with	O
a	O
clear	O
fluid	O
.	O

No	O
excrescence	O
or	O
papillation	O
is	O
grossly	O
.	O
identified	O
.	O

The	O
left	O
fallopian	O
tube	O
is	O
serially	O
sectioned	O
to	O
.	O
show	O
an	O
unremarkable	O
pinpoint	O
lumen	O
.	O

The	O
left	O
ovary	O
is	O
serially	O
.	O
sectioned	O
to	O
show3	O
a	O
gray	O
/	O
tan	O
atrophic	O
parenchyma	O
.	O

The	O
boecimen	O
.	O

is	O
.	O
represented	O
as	O
follows	O
:	O
cervix	O
is	O
coned	O
,	O
radially	O
sectioned	O
.	O
and	O
submitted	O
as	O
12	O
-	O
3	O
:	O
00	O
in	O
Al	O
,	O
3	O
-	O
6	O
:	O
00	O
in	O
A2	O
-	O
A3	O
,	O
6	O
-	O
9	O
:	O
00	O
ir	O
.	O

A1	O
,	O
.	O

9	O
-	O
12	O
:	O
00	O
in	O
A5	O
-	O
A6	O
;	O
anterior	O
lower	O
uterine	O
segment	O
in	O
A7	O
;	O
anterior	O
.	O
endomyometrium	O
and	O
tumor	O
at	O
its	O
deepest	O
.	O
invasion	O
in	O
A8	O
-	O
A11	O
;	O
.	O
posterior	O
lower	O
uterine	O
segment	O
in	O
A12	O
;	O
posterior	O
endomyometrium	O
.	O
and	O
tumor	O
at	O
its	O
deepest	O
invasion	O
in	O
A13	O
-	O
A16	O
;	O
right	O
fallopian	O
.	O
tabe	O
,	O
ovary	O
and	O
imbria	O
in	O
A17	O
;	O
and	O
left	O
fallopian	O
tube	O
,	O
ovary	O
.	O
and	O
fimbria	O
in	O
Ala	O
.	O

B	O
.	O

Received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
.	O

"	O
vaginal	O
cuff	O
tissue	O
"	O
is	O
a	O
gray	O
/	O
tan	O
tissue	O
fragment	O
measuring	O
1	O
.	O

x	O
1	O
)	O
em	O
.	O

Wrapped	O
and	O
entirely	O
submitted	O
in	O
B1	O
.	O

C	O
.	O

Received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
.	O

"	O
sigmoid	O
surface	O
tissue	O
"	O
is	O
d	O
gray	O
/	O
tan	O
,	O
fibrous	O
Lissue	O
Eragment	O
.	O
measuring	O
3	O
x	O
2	O
cm	O
.	O

Entirely	O
submitted	O
in	O
C1	O
-	O
C3	O
.	O

D	O
.	O

Received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
.	O

"	O
cul	O
-	O
de	O
-	O
sac	O
"	O
are	O
gray	O
/	O
tan	O
fibrous	O
tissue	O
fragments	O
measuring	O
=	O
.	O

x	O
.	O

1	O
.	O
5	O
cm	O
.	O

Sectioned	O
.	O

Entirely	O
submitted	O
in	O
D1	O
-	O
D2	O
.	O

E	O
.	O

Received	O
in	O
formalin	O
Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
.	O

"	O
left	O
adnexal	O
tissue	O
"	O
is	O
a	O
gray	O
/	O
tan	O
,	O
friable	O
tissue	O
fragment	O
.	O
measuring	O
2	O
2	O
.	O

1	O
.	O
2	O
cm	O
.	O

Entirely	O
submitted	O
in	O
E1	O
.	O

:	O
-	O
Received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
.	O

"	O
right	O
side	O
wall	O
"	O
is	O
a	O
gray	O
/	O
brown	O
,	O
fibrous	O
and	O
hemorrhagic	O
.	O
tissue	O
measuring	O
0	O
.	O
9	O
1	O
0	O
.	O
7	O
cm	O
.	O

Entirely	O
submitted	O
in	O
Fl	O
.	O

G	O
.	O

Recoived	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
.	O

"	O
right	O
pelvic	O
lymph	O
nodes	O
"	O
is	O
a	O
yellow	O
/	O
tan	O
fibroadipose	O
tianue	O
.	O
measuring	O
0	O
.	O
7	O
2	O
0	O
.	O
5	O
cm	O
consistent	O
with	O
lymphoid	O
tissue	O
.	O

Bisected	O
,	O
wrapped	O
and	O
entirely	O
submitted	O
in	O
G1	O
.	O

IL	O
.	O

Received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
.	O

"	O
loit	O
polvic	O
lymph	O
node	O
"	O
is	O
a	O
yellow	O
/	O
tar	O
fibroadipose	O
tinaue	O
.	O
heasuring	O
1	O
.	O
5	O
%	O
0	O
.	O

cm	O
consistent	O
with	O
lymph	O
node	O
.	O

One	O
lymph	O
.	O
node	O
is	O
grossly	O
identified	O
measuring	O
0	O
.	O
7	O
x	O
0	O
.	O
4	O
cm	O
.	O

Bisected	O
,	O
.	O
wlapped	O
and	O
entirely	O
submitted	O
in	O
H1	O
.	O

I	O
.	O

Received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
.	O

"	O
right	O
side	O
wall	O
#	O
2	O
"	O
is	O
a	O
yellow	O
/	O
tan	O
,	O
fibrous	O
and	O
homorrbagic	O
.	O
fragment	O
measuring	O
1	O
.	O
5	O
x	O
1	O
cm	O
.	O

Entirely	O
submitted	O
in	O
11	O
.	O

I	O
.	O

Received	O
in	O
tormail	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
.	O

"	O
omontum	O
"	O
is	O
a	O
yollow	O
/	O
tan	O
,	O
fixm	O
and	O
fibroadipose	O
tissue	O
.	O
measuring	O
20	O
y	O
4	O
x	O
2	O
cm	O
.	O

Sectioned	O
to	O
show	O
three	O
gray	O
/	O
tan	O
.	O
redules	O
.	O

The	O
largest	O
measures	O
3	O
x	O
2	O
cm	O
;	O
the	O
smallest	O
,	O
1	O
.	O
5	O
x	O
1	O
.	O

em	O
consistent	O
with	O
metastatic	O
disease	O
.	O

Represented	O
in	O
J1	O
-	O
J2	O
.	O

Prepared	O
.	O
procequre	O
.	O

A	O
.	O

AA	O
ROUTINE	O
the	O
X1	O
BLOCK	O
.	O

1	O
.	O

A	O
.	O

AA	O
BONTINE	O
BAF	O
31	O
BLOCK	O
.	O

2	O
.	O

HUE	O
x1	O
.	O

A	O
.	O

AA	O
BOOTENE	O
HIF	O
X1	O
BLOCK	O
.	O

3	O
.	O

H	O
&	O
S	O
X1	O
.	O

A	O
.	O

AA	O
ROUTINE	O
H	O
&	O
E	O
X1	O
BLOCK	O
.	O

4	O
.	O

RAE	O
x1	O
.	O

A	O
.	O

AA	O
ROUTINE	O
H	O
&	O
E	O
X1	O
BLOCK	O
.	O

5	O
.	O

A	O
&	O
E	O
X1	O
.	O

A	O
.	O

AA	O
ROUTINE	O
H	O
&	O
E	O
X1	O
BLOCK	O
.	O

6	O
.	O

H	O
&	O
E	O
x1	O
.	O

A	O
.	O

AA	O
ROUTINE	O
HAE	O
X1	O
BLOCK	O
.	O
7	O
.	O

H	O
&	O
E	O
X1	O
.	O

A	O
.	O

AA	O
ROJTINE	O
H	O
&	O
E	O
X1	O
BLOCK	O
.	O

8	O
.	O

H	O
&	O
E	O
X1	O
.	O

A	O
.	O

AA	O
ROUTINE	O
H	O
&	O
E	O
X1	O
BLOCK	O
.	O
9	O
.	O

HaE	O
31	O
.	O

A	O
.	O

AA	O
ROVTINE	O
HIEE	O
X1	O
BLOCK	O
.	O

10	O
.	O

HICE	O
XI	O
.	O

A	O
.	O

AA	O
HAF	O
.	O

X1	O
BLOCK	O
.	O

11	O
.	O

H	O
&	O
E	O
X1	O
.	O

A	O
.	O

AA	O
HSE	O
x1	O
BLOCK	O
.	O
12	O
.	O

1163	O
x1	O
.	O

A	O
.	O

AA	O
ROTPINE	O
H	O
&	O
E	O
X1	O
BLOCK	O
.	O

13	O
.	O

H	O
&	O
E	O
X1	O
.	O

A	O
.	O

AA	O
ROUPINE	O
H	O
&	O
E	O
X1	O
BLOCK	O
.	O
14	O
.	O

x1	O
.	O

A	O
.	O

AA	O
ROUTING	O
HICE	O
X1	O
BLOCK	O
.	O
15	O
.	O
its	O
X1	O
.	O

in	O
.	O

AA	O
ROUTINE	O
IME	O
X1	O
BLOCK	O
.	O

16	O
.	O

HTEE	O
31	O
.	O

A	O
.	O

AA	O
POUTTNE	O
HAF	O
X1	O
BLOCK	O
.	O
17	O
.	O

H	O
&	O
E	O
K1	O
.	O

A	O
.	O

AA	O
ROVEINE	O
H	O
&	O
E	O
X1	O
BLOCK	O
.	O

18	O
.	O

H4E	O
21	O
.	O

B	O
.	O

AA	O
ROUTINE	O
HaE	O
31	O
BLOCK	O
.	O

HSE	O
X1	O
A	O
RECUTS	O
.	O

c	O
.	O

AA	O
ROUTINE	O
H	O
&	O
E	O
X1	O
BLOCK	O
.	O

L	O
.	O

HSE	O
71	O
.	O

C	O
.	O

All	O
ROUTINE	O
H	O
&	O
E	O
X1	O
BLOCK	O
.	O

2	O
.	O

STAE	O
y1	O
.	O

:	O
AA	O
ROUTINE	O
lixE	O
X1	O
BLOCK	O
.	O

3	O
.	O

H	O
&	O
P	O
K1	O
.	O

Results	O
Viewer	O
-	O
.	O

Page	O
old	O
.	O

D	O
.	O

AA	O
ROUPINE	O
H	O
&	O
E	O
X1	O
BLOCK	O
.	O

1	O
.	O

HSS	O
X1	O
.	O

D	O
.	O

AA	O
ROUTINE	O
HsE	O
X1	O
BLOCK	O
.	O

2	O
.	O

H	O
&	O
E	O
X1	O
.	O

E	O
.	O

AA	O
ROUTINE	O
H	O
&	O
E	O
X1	O
BLOCK	O
.	O

HAE	O
X1	O
.	O

"	O
.	O

AA	O
ROUTINE	O
I	O
&	O
E	O
X1	O
BLOCK	O
.	O

HAE	O
31	O
.	O

i	O
;	O
AA	O
ROUTINE	O
H	O
&	O
E	O
X1	O
BLOCK	O
.	O

HiE	O
X1	O
.	O

11	O
.	O

AA	O
ROUTINE	O
HuE	O
X1	O
BLOCK	O
.	O

H	O
&	O
E	O
X1	O
AE1	O
/	O
AE3	O
.	O

L	O
.	O

AA	O
ROUPINE	O
HAE	O
X1	O
BLOCK	O
.	O

J	O
.	O

AA	O
ROUTINE	O
H	O
&	O
E	O
X1	O
BLOCK	O
.	O

1	O
.	O

x1	O
.	O

J	O
.	O

AA	O
ROUTINE	O
IISE	O
X1	O
BLOCK	O
.	O

2	O
.	O

H	O
&	O
E	O
x1	O
.	O

Prepared	O
f	O
.	O

-DOCSTART-263
MEDICAL	O
RECORD	O
.	O

PROCEDURE	O
DATE	O
:	O
SEX	O
:	O
F	O
.	O

SIGN	O
-	O
OUT	O
DATE	O
:	O
ATTENDING	O
:	O
REQUESTING	O
:	O
CONTACT	O
NO	O
:	O
(	O
MD	O
)	O
.	O

ROOM	O
:	O
COPIES	O
TO	O
:	O
DIAGNOSIS	O
:	O
1	O
.	O

Lymph	O
node	O
,	O
paraaortic	O
(	O
excision	O
)	O
:	O
Reactive	O
lymph	O
node	O
.	O

No	O
tumor	O
seen	O
.	O

2	O
.	O

Kidney	O
,	O
left	O
base	O
"	O
mass	O
"	O
(	O
excision	O
)	O
:	O
Necrotic	O
debris	O
.	O

3	O
.	O

Kidney	O
,	O
left	O
,	O
deeper	O
base	O
"	O
mass	O
"	O
(	O
excision	O
)	O
:	O
Kidney	O
parenchyma	O
.	O

No	O
tumor	O
seen	O
.	O

4	O
.	O

Kidney	O
and	O
adrenal	O
,	O
left	O
,	O
morcellated	O
(	O
nephrectomy	O
-	O
morcellated	O
)	O
:	O
Renal	O
cell	O
carcinoma	O
,	O
chromophobe	O
type	O
,	O
.	O

"	O
Furhman	O
nuclear	O
grade	O
II	O
with	O
extensive	O
necrosis	O
and	O
acute	O
and	O
chronic	O
inflammation	O
.	O

Diffuse	O
interstitial	O
.	O
nephritis	O
.	O

Vascular	O
and	O
ureteral	O
margins	O
free	O
of	O
tumor	O
.	O

Focal	O
ureteritis	O
.	O

No	O
capsular	O
invasion	O
seen	O
.	O

Adrenal	O
gland	O
.	O

No	O
tumor	O
seen	O
.	O

NOTE	O
:	O
Kidney	O
Nephrectomy	O
Summary	O
Table	O
Macroscopic	O
.	O

Specimen	O
Type	O
:	O
Nephrectomy	O
-	O
morcellated	O
.	O

Laterality	O
:	O
Left	O
.	O

Tumor	O
Size	O
:	O
4	B
cm	I
.	O

Focality	O
:	O
Unifocal	O
.	O

Macro	O
Extent	O
of	O
Tumor	O
:	O
Confined	O
to	O
kidney	O
.	O

Microscopic	O
.	O

Histologic	O
Type	O
:	O
Renal	O
cell	O
carcinoma	O
,	O
chromophobe	O
type	O
,	O
.	O

Histologic	O
Grade	O
;	O
.	O

Furhman	O
nuclear	O
grade	O
Il	O
.	O

-	O
age	O
1	O
of	O
3	O
.	O

MEDICAL	O
RECORD	O
.	O

Date	O
or	O
Report	O
:	O
Extent	O
of	O
Invasion	O
.	O

Primary	O
Tumor	O
(	O
pT	O
)	O
:	O
pT1a	O
.	O

Regional	O
Lymph	O
Nodes	O
(	O
pN	O
)	O
:	O
pNO	O
.	O

Distant	O
Metastisis	O
(	O
pM	O
)	O
:	O
pMx	O
.	O

Margins	O
:	O
Vascular	O
,	O
ureteral	O
and	O
inked	O
surgical	O
margins	O
free	O
of	O
tumor	O
.	O

CLINICAL	O
INFORMATION	O
:	O
Brief	O
Clinical	O
History	O
:	O
female	O
wiht	O
left	O
renal	O
mass	O
.	O

Specimen	O
Taken	O
For	O
Protocol	O
:	O
Allocate	O
Order	O
to	O
Protocol	O
:	O
PROCEDURE	O
:	O
Operative	O
Findings	O
:	O
left	O
upper	O
pole	O
mass	O
Post	O
-	O
Operative	O
Diagnosis	O
:	O
left	O
renal	O
mass	O
Pre	O
-	O
Operative	O
Diagnosis	O
:	O
left	O
renal	O
mass	O
.	O

SPECIMENS	O
SUBMITTED	O
:	O
1	O
.	O

ROUTINE	O
+	O
6FS	O
,	O
Peri	O
-	O
aortic	O
lymph	O
node	O
(	O
1FS	O
)	O
.	O

2	O
.	O

SERIAL	O
5	O
+	O
6FS	O
,	O
Left	O
kidney	O
mass	O
(	O
2FS	O
)	O
.	O

3	O
.	O

ROUTINE	O
+	O
3FS	O
,	O
Left	O
kidney	O
mass	O
(	O
3FS	O
)	O
.	O

4	O
.	O

KIDNEY	O
,	O
Left	O
adrenal	O
morgellated	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
:	O
1	O
.	O

1FS	O
Diagnosis	O
:	O
Lymph	O
nodes	O
,	O
no	O
definitive	O
tumor	O
seen	O
on	O
frozen	O
section	O
.	O

The	O
Frozen	O
Sections	O
were	O
performed	O
by	O
.	O

2FS	O
Diagnosis	O
:	O
Fragments	O
of	O
probable	O
epithelioid	O
tumor	O
cells	O
with	O
coagulative	O
necrosis	O
;	O
definitive	O
characterization	O
.	O
deferred	O
to	O
permanent	O
.	O

3FS	O
Diagnosis	O
:	O
Portion	O
of	O
renal	O
cortical	O
tissue	O
with	O
focal	O
mild	O
interstitial	O
inflammation	O
,	O
no	O
definitive	O
tumor	O
seen	O
on	O
.	O
frozen	O
sections	O
.	O

The	O
Frozen	O
Sections	O
were	O
performed	O
by	O
.	O

GROSS	O
DESCRIPT	O
Received	O
are	O
4	O
formalin	O
-	O
filled	O
containers	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
medical	O
record	O
.	O
number	O
,	O
and	O
further	O
described	O
as	O
follows	O
:	O
1	O
.	O

"	O
Paraaortic	O
lymph	O
node	O
"	O
.	O

The	O
specimen	O
is	O
a	O
tan	O
to	O
red	O
/	O
brown	O
soft	O
tissue	O
fragment	O
measuring	O
1	O
.	O
6	O
x	O
1	O
.	O
2	O
x	O
0	O
.	O
2	O
.	O

cm	O
.	O

The	O
specimen	O
is	O
frozen	O
in	O
toto	O
as	O
1FS	O
.	O

In	O
Surgical	O
Pathology	O
,	O
the	O
specimen	O
is	O
entirely	O
transferred	O
into	O
an	O
.	O
orange	O
cassette	O
labeled	O
.	O
for	O
permanent	O
processing	O
.	O

MEDICAL	O
RECORD	O
.	O

Nam	O
.	O

2	O
.	O

Left	O
kidney	O
mass	O
base	O
"	O
.	O

The	O
specimen	O
is	O
multiple	O
(	O
3	O
)	O
tan	O
tissue	O
fragments	O
measuring	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
1	O
cm	O
in	O
.	O
aggregate	O
.	O

The	O
specimen	O
is	O
frozen	O
in	O
toto	O
.	O

In	O
Surgical	O
Pathology	O
,	O
the	O
specimen	O
is	O
transferred	O
into	O
an	O
orange	O
.	O
cassette	O
labeled	O
.	O
for	O
permanent	O
processing	O
.	O

3	O
.	O

"	O
Left	O
kidney	O
mass	O
deeper	O
base	O
"	O
.	O

The	O
specimen	O
is	O
a	O
piece	O
of	O
red	O
/	O
brown	O
tissue	O
measuring	O
1	O
.	O
0	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
4	O
cm	O
.	O

The	O
specimen	O
is	O
frozen	O
in	O
toto	O
as	O
3FS	O
.	O

In	O
Surgical	O
Pathology	O
,	O
the	O
specimen	O
is	O
entirely	O
transferred	O
to	O
an	O
orange	O
.	O
cassette	O
labeleo	O
.	O
for	O
permanent	O
processing	O
.	O

4	O
.	O

"	O
Kidney	O
and	O
adrenal	O
-	O
morcellated	O
"	O
Received	O
is	O
a	O
specimen	O
labeled	O
"	O
left	O
kidney	O
and	O
adrenal	O
morcellated	O
"	O
The	O
.	O
specimen	O
consists	O
of	O
a	O
simple	O
nephrectomy	O
specimen	O
three	O
pieces	O
measuring	O
16	O
x	O
10	O
x	O
5	O
cm	O
in	O
aggregate	O
.	O

The	O
.	O
adrenal	O
gland	O
is	O
identified	O
.	O

The	O
ureteral	O
and	O
vascular	O
structures	O
are	O
identified	O
by	O
surgical	O
staples	O
.	O

The	O
specimen	O
.	O

is	O
inked	O
black	O
and	O
bisected	O
revealing	O
a	O
4	B
cm	I
diameter	O
tumor	O
mass	O
with	O
a	O
tan	O
-	O
yellow	O
,	O
soft	O
,	O
necrotic	O
cut	O
surface	O
.	O

50	O
%	O
of	O
the	O
tumor	O
is	O
procured	O
for	O
.	O

Representative	O
normal	O
is	O
procured	O
for	O
Research	O
.	O

Procurement	O
.	O
was	O
performed	O
by	O
.	O

on	O
.	O

to	O
.	O

The	O
vascular	O
/	O
ureteral	O
margins	O
are	O
submitted	O
.	O
in	O
white	O
cassettes	O
.	O

4A	O
-	O
C	O
.	O

The	O
most	O
distal	O
end	O
of	O
the	O
ureter	O
is	O
submitted	O
in	O
white	O
cassette	O
.	O

4D	O
.	O

Sections	O
of	O
the	O
most	O
inferior	O
aspect	O
of	O
the	O
tumor	O
and	O
kidney	O
.	O
inferior	O
aspect	O
of	O
the	O
tumor	O
(	O
most	O
adjacent	O
to	O
.	O
the	O
kidney	O
)	O
are	O
submitted	O
in	O
white	O
cassettes	O
.	O

A	O
section	O
of	O
adrenal	O
gland	O
is	O
submitted	O
in	O
4G	O
.	O

Representative	O
sections	O
of	O
fat	O
are	O
submitted	O
in	O
4H	O
.	O

A	O
representative	O
section	O
of	O
normal	O
kidney	O
renal	O
parenchyma	O
.	O

is	O
submitted	O
in	O
4I	O
.	O

Representative	O
sections	O
of	O
the	O
tumor	O
are	O
also	O
submitted	O
in	O
4J	O
-	O
4Q	O
for	O
permanent	O
processing	O
.	O

Gross	O
dictated	O
by	O
.	O

No	O
consultants	O
.	O

-DOCSTART-264
Diagnosis	O
:	O
A	O
,	O
B	O
:	O
Lung	O
,	O
right	O
upper	O
lobe	O
lesion	O
,	O
wedge	O
biopsy	O
.	O

-	O
Adenocarcinoma	O
,	O
moderately	O
differentiated	O
,	O
2	B
.	I
5	I
cm	I
diameter	O
,	O
.	O
consistent	O
with	O
lung	O
primary	O
,	O
without	O
pleural	O
invasion	O
,	O
surgical	O
.	O
margins	O
not	O
involved	O
.	O

Intraoperative	O
Consult	O
Diagnosis	O
:	O
n	O
section	O
was	O
requested	O
by	O
Dr	O
.	O
in	O
OR	O
.	O

on	O
.	O

at	O
.	O

FSA1	O
:	O
Right	O
upper	O
lobe	O
mass	O
,	O
wedge	O
biopsy	O
.	O

-	O
Adenocarcinoma	O
,	O
moderately	O
differentiated	O
.	O

-	O
Defer	O
to	O
special	O
stains	O
to	O
exclude	O
metastasis	O
.	O

Drs	O
.	O

at	O
.	O

Frozen	O
Section	O
Pathologist	O
:	O
M	O
.	O
D	O
.	O
,	O
PhD	O
.	O

Clinical	O
History	O
.	O

The	O
patient	O
is	O
a	O
.	O

-	O
+	O
year	O
-	O
old	O
female	O
with	O
a	O
right	O
upper	O
lobe	O
lung	O
.	O
mass	O
.	O

CIS	O
:	O
PMHx	O
.	O
for	O
grade	O
3	O
,	O
ductal	O
breast	O
.	O
inoma	O
(	O
ER	O
.	O
weak	O
,	O
PR	O
negative	O
,	O
HER2	O
score	O
0	O
)	O
diagnosed	O
in	O
.	O
eviewed	O
.	O

here	O
as	O
OS06	O
-	O
)	O
.	O

Positive	O
smoking	O
history	O
prior	O
.	O

Gross	O
Description	O
:	O
Received	O
are	O
two	O
appropriately	O
labeled	O
containers	O
.	O

Container	O
A	O
:	O
Received	O
for	O
frozen	O
section	O
is	O
an	O
8	O
.	O
0	O
X	O
4	O
.	O
5	O
X	O
3	O
.	O
0	O
.	O

cm	O
wedge	O
of	O
lung	O
.	O

There	O
is	O
an	O
.	O
11	O
-	O
defined	O
,	O
slightly	O
firm	O
and	O
tan	O
.	O
nodule	O
at	O
the	O
resection	O
edge	O
.	O

This	O
measures	O
2	O
.	O
5	O
X	O
1	O
.	O
8	O
X	O
0	O
.	O
5	O
cm	O
.	O

The	O
tissue	O
beneath	O
the	O
stapled	O
tissue	O
is	O
submitted	O
in	O
blocks	O
A1	O
.	O
and	O
A2	O
.	O

Representative	O
sections	O
of	O
the	O
nodule	O
are	O
submitted	O
in	O
.	O
blocks	O
A3	O
and	O
A4	O
.	O

A	O
portion	O
of	O
the	O
nodule	O
is	O
frozen	O
as	O
FSA1	O
.	O

Container	O
B	O
is	O
additionally	O
labeled	O
"	O
right	O
lung	O
,	O
upper	O
lobe	O
.	O
wedge	O
.	O

"	O
The	O
specimen	O
is	O
received	O
as	O
a	O
54	O
.	O
9	O
gram	O
aggregate	O
of	O
two	O
.	O
pieces	O
of	O
lung	O
tissue	O
.	O

The	O
first	O
piece	O
measures	O
4	O
.	O
3	O
X	O
1	O
.	O
7	O
X	O
0	O
.	O
9	O
.	O

cm	O
.	O

The	O
larger	O
piece	O
measures	O
8	O
.	O
5	O
X	O
8	O
.	O
0	O
X	O
2	O
.	O
9	O
cm	O
.	O

Blue	O
ink	O
has	O
.	O
been	O
applied	O
to	O
the	O
area	O
of	O
previous	O
wedge	O
biopsy	O
.	O

There	O
is	O
an	O
.	O
area	O
of	O
defect	O
in	O
between	O
the	O
two	O
pieces	O
,	O
representing	O
the	O
.	O
initial	O
wedge	O
biopsy	O
.	O

Within	O
the	O
lung	O
tissue	O
,	O
there	O
is	O
a	O
.	O
subpleural	O
hard	O
white	O
/	O
firm	O
mass	O
,	O
3	O
.	O
5	O
X	O
3	O
.	O
0	O
X	O
3	O
.	O
0	O
cm	O
in	O
greatest	O
.	O
gross	O
dimensions	O
.	O

Sections	O
of	O
normal	O
lung	O
and	O
the	O
large	O
mass	O
.	O
were	O
submitted	O
for	O
Tissue	O
procurement	O
.	O

The	O
staple	O
lines	O
are	O
.	O
removed	O
and	O
the	O
tissue	O
beneath	O
is	O
submitted	O
in	O
blocks	O
B1	O
and	O
B2	O
.	O

B3	O
-	O
B5	O
-	O
-	O
representative	O
sections	O
through	O
tumor	O
.	O

Light	O
Microscopy	O
:	O
Light	O
microscopic	O
examination	O
is	O
performed	O
by	O
Dr	O
.	O
The	O
frozen	O
section	O
diagnosis	O
is	O
confirmed	O
.	O

Sections	O
show	O
a	O
gland	O
-	O
forming	O
carcinoma	O
,	O
without	O
mucinous	O
.	O
differentiation	O
.	O

Features	O
favor	O
lung	O
over	O
breast	O
primaries	O
.	O

To	O
.	O
clarify	O
lineage	O
,	O
immunohistochemistry	O
was	O
performed	O
,	O
and	O
shows	O
.	O
immunoreactivity	O
for	O
TTF	O
-	O
1	O
and	O
HER2	O
,	O
with	O
no	O
reactivity	O
for	O
.	O

GCDFP	O
or	O
ER	O
.	O

This	O
immunophenotype	O
supports	O
lung	O
primary	O
.	O

-DOCSTART-265
Pre	O
-	O
Op	O
Diagnosis	O
.	O

Right	O
lung	O
cancer	O
.	O

Post	O
-	O
Op	O
Diagnosis	O
.	O

Same	O
.	O

Clinical	O
History	O
.	O

Nothing	O
indicated	O
on	O
requisition	O
.	O

Gross	O
Description	O
:	O
Six	O
parts	O
.	O

Container	O
labeled	O
.	O

1	O
-	O
level	O
9	O
lymph	O
node	O
"	O
are	O
two	O
.	O
nodular	O
portions	O
of	O
gray	O
tan	O
to	O
black	O
tissue	O
from	O
1	O
.	O
0	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
cm	O
.	O
and	O
1	O
.	O
1	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
3	O
cm	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
a	O
.	O
single	O
cassette	O
.	O

Container	O
labeled	O
.	O

2	O
-	O
level	O
7	O
lymph	O
node	O
"	O
are	O
1	O
.	O
2	O
x	O
.	O

1	O
.	O
0	O
x	O
0	O
.	O
4	O
cm	O
of	O
gray	O
yellow	O
to	O
brown	O
black	O
fleshy	O
and	O
fatty	O
tissue	O
.	O
fragments	O
entirely	O
submitted	O
in	O
a	O
single	O
cassette	O
.	O

Container	O
labeled	O
.	O

3	O
-	O
level	O
10	O
lymph	O
node	O
"	O
are	O
three	O
.	O
irregular	O
fragments	O
of	O
soft	O
fleshy	O
gray	O
black	O
tissue	O
from	O
0	O
.	O
6	O
x	O
0	O
.	O
2	O
.	O

x	O
0	O
.	O
2	O
cm	O
to	O
0	O
.	O
6	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
3	O
cm	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
.	O
in	O
a	O
single	O
cassette	O
.	O

Container	O
labeled	O
.	O

4	O
-	O
right	O
lung	O
lower	O
lobe	O
"	O
is	O
a	O
.	O
previously	O
partially	O
inked	O
partially	O
sectioned	O
portion	O
of	O
.	O
recognizable	O
pulmonary	O
parenchyma	O
grossly	O
consistent	O
with	O
right	O
.	O
lower	O
lobe	O
.	O

The	O
specimen	O
as	O
received	O
weighs	O
180	O
grams	O
and	O
measures	O
.	O

13	O
.	O
8	O
x	O
8	O
.	O
2	O
x	O
5	O
.	O
1	O
cm	O
.	O

The	O
margin	O
of	O
resection	O
is	O
bifurcation	O
of	O
the	O
.	O
tertiary	O
bronchi	O
.	O

This	O
is	O
surrounded	O
by	O
a	O
few	O
mottled	O
fleshy	O
gray	O
.	O
brown	O
to	O
black	O
nodules	O
up	O
to	O
1	O
.	O
1	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
.	O
pleura	O
is	O
wrinkled	O
and	O
gray	O
tan	O
.	O

Noted	O
on	O
the	O
anterior	O
aspect	O
near	O
.	O
the	O
base	O
is	O
a	O
previously	O
inked	O
portion	O
of	O
pleura	O
with	O
moderate	O
.	O
anthracotic	O
streaking	O
.	O

This	O
is	O
previously	O
sectioned	O
to	O
reveal	O
an	O
.	O
underlying	O
3	O
.	O
5	O
3	O
.	O
3	O
x	O
2	O
.	O
6	O
cm	O
lobulated	O
nodular	O
fibrotic	O
lesion	O
with	O
.	O

a	O
markedly	O
necrotic	O
gray	O
tan	O
cut	O
surface	O
.	O

The	O
lesion	O
is	O
seen	O
at	O
its	O
.	O
nearest	O
point	O
0	O
.	O
2	O
cm	O
from	O
the	O
anterior	O
inked	O
pleura	O
,	O
0	O
.	O
2	O
cm	O
from	O
the	O
.	O
medial	O
pleura	O
,	O
and	O
0	O
.	O
1	O
cm	O
from	O
the	O
basal	O
pleura	O
.	O

The	O
lesion	O
does	O
.	O
not	O
grossly	O
appear	O
to	O
extend	O
through	O
the	O
pleura	O
in	O
any	O
of	O
these	O
.	O
areas	O
.	O

The	O
lesion	O
is	O
noted	O
at	O
its	O
nearest	O
point	O
4	O
.	O
3	O
cm	O
from	O
the	O
.	O
nearest	O
bronchial	O
margin	O
.	O

A	O
bronchial	O
connection	O
is	O
grossly	O
.	O
identified	O
.	O

The	O
remaining	O
parenchyma	O
is	O
spongy	O
and	O
tan	O
pink	O
with	O
.	O
moderate	O
anthracotic	O
streaking	O
.	O

No	O
additional	O
gross	O
lesions	O
are	O
.	O
identified	O
.	O

Also	O
received	O
in	O
the	O
same	O
container	O
are	O
two	O
tissue	O
.	O
cassettes	O
each	O
labeled	O
.	O

Representative	O
sections	O
are	O
.	O
submitted	O
labeled	O
as	O
follows	O
:	O
A	O
-	O
shaved	O
bronchial	O
margin	O
and	O
.	O
peribronchial	O
nodules	O
,	O
B	O
-	O
lesion	O
to	O
anterior	O
pleura	O
,	O
C	O
-	O
lesion	O
to	O
.	O
medial	O
pleura	O
,	O
D	O
-	O
lesion	O
to	O
basal	O
pleura	O
,	O
E	O
-	O
lesion	O
with	O
bronchial	O
.	O
connection	O
,	O
F	O
-	O
representative	O
lesion	O
,	O
G	O
-	O
random	O
uninvolved	O
.	O
parenchyma	O
.	O

Container	O
labeled	O
.	O

5	O
-	O
level	O
8	O
lymph	O
node	O
"	O
are	O
2	O
.	O
9	O
x	O
.	O

2	O
.	O
1	O
x	O
1	O
.	O
5	O
cm	O
of	O
fragmented	O
lobulated	O
fleshy	O
gray	O
black	O
tissue	O
.	O
fragments	O
which	O
are	O
sectioned	O
and	O
entirely	O
submitted	O
in	O
four	O
.	O
cassettes	O
.	O

Container	O
labeled	O
.	O

6	O
-	O
level	O
4	O
lymph	O
node	O
"	O
are	O
2	O
.	O
1	O
.	O

x	O
.	O

1	O
.	O
6	O
x	O
0	O
.	O
7	O
cm	O
of	O
gray	O
yellow	O
fleshy	O
and	O
fatty	O
tissue	O
fragments	O
which	O
.	O
are	O
entirely	O
submitted	O
in	O
a	O
single	O
cassette	O
.	O

Microscopic	O
Description	O
:	O
The	O
slides	O
labeled	O
.	O
are	O
examined	O
.	O

See	O
diagnosis	O
.	O

Final	O
Diagnosis	O
.	O

Lymph	O
node	O
,	O
level	O
9	O
(	O
biopsy	O
)	O
:	O
Anthrasilicosis	O
and	O
mild	O
reactive	O
sinus	O
histiocytosis	O
,	O
no	O
.	O
metastatic	O
carcinoma	O
identified	O
within	O
one	O
(	O
0	O
/	O
1	O
)	O
lymph	O
node	O
.	O

PAS	O
.	O

4	O
.	O

Lymph	O
node	O
,	O
level	O
7	O
(	O
biopsy	O
)	O
:	O
Anthrasilicosis	O
and	O
mild	O
reactive	O
sinus	O
histiocytosis	O
,	O
no	O
.	O
metastatic	O
carcinoma	O
identified	O
within	O
four	O
(	O
0	O
/	O
4	O
)	O
lymph	O
nodes	O
.	O

PAS	O
4	O
.	O

Lymph	O
node	O
,	O
level	O
10	O
(	O
biopsy	O
)	O
:	O
Anthrasilicosis	O
and	O
mild	O
reactive	O
lymphoid	O
hyperplasia	O
,	O
no	O
.	O
metastatic	O
carcinoma	O
identified	O
within	O
three	O
(	O
0	O
/	O
3	O
)	O
lymph	O
nodes	O
.	O

PAS	O
4	O
.	O

Lung	O
,	O
right	O
lower	O
lobe	O
(	O
lobectomy	O
)	O
:	O
Tumor	O
characteristics	O
:	O
Histologic	O
type	O
:	O
Large	O
cell	O
carcinoma	O
consistent	O
with	O
squamous	O
.	O
cell	O
carcinoma	O
with	O
areas	O
of	O
necrosis	O
(	O
see	O
comment	O
)	O
.	O

Location	O
of	O
tumor	O
:	O
Right	O
lower	O
lobe	O
near	O
base	O
.	O

Size	O
:	O
3	B
.	I
5	I
x	I
3	I
.	I
3	I
x	I
2	I
.	I
6	I
cm	I
in	O
greatest	O
dimension	O
.	O

Grade	O
:	O
Poorly	O
differentiated	O
.	O

Pleural	O
invasion	O
:	O
Not	O
identified	O
.	O

Lymphovascular	O
space	O
invasion	O
:	O
Yes	O
.	O

Surgical	O
margin	O
status	O
:	O
Tumor	O
distance	O
from	O
bronchial	O
margin	O
:	O
4	O
.	O
3	O
cm	O
.	O

Tumor	O
distance	O
from	O
parenchymal	O
(	O
stapled	O
)	O
margin	O
:	O
Not	O
.	O
applicable	O
.	O

Tumor	O
distance	O
from	O
pleural	O
surface	O
:	O
Less	O
than	O
1	O
mm	O
(	O
see	O
.	O
comment	O
)	O
.	O

Lymph	O
node	O
status	O
:	O
Total	O
number	O
of	O
bronchial	O
lymph	O
nodes	O
examined	O
:	O
3	O
.	O

Total	O
number	O
of	O
lymph	O
nodes	O
containing	O
metastatic	O
carcinoma	O
:	O
o	O
.	O

(	O
0	O
/	O
3	O
)	O
.	O

See	O
above	O
and	O
below	O
diagnoses	O
for	O
remaining	O
lymph	O
nodes	O
.	O

PAS	O
9	O
.	O

Other	O
findings	O
:	O
Area	O
of	O
subpleural	O
fibrosis	O
.	O

PAS	O
4	O
.	O

Emphysematous	O
changes	O
.	O

PAS	O
4	O
.	O

Lymph	O
node	O
,	O
level	O
8	O
(	O
biopsy	O
)	O
:	O
Multiple	O
fragments	O
of	O
lymph	O
nodes	O
demonstrating	O
anthrasilicosis	O
,	O
.	O
reactive	O
sinus	O
histiocytosis	O
,	O
no	O
metastatic	O
carcinoma	O
.	O
identified	O
(	O
see	O
comment	O
)	O
.	O

Lymph	O
nodes	O
demonstrating	O
granulomas	O
(	O
see	O
comment	O
)	O
.	O

PAS	O
6	O
.	O

Lymph	O
node	O
,	O
level	O
4	O
(	O
biopsy	O
)	O
:	O
Anthrasilicosis	O
and	O
reactive	O
sinus	O
histiocytosis	O
,	O
no	O
metastatic	O
.	O
carcinoma	O
identified	O
within	O
two	O
(	O
0	O
/	O
2	O
)	O
lymph	O
nodes	O
.	O

PAS	O
4	O
SPC	O
-	O
A	O
.	O

CPT	O
:	O
88309	O
,	O
88305	O
x5	O
,	O
88312	O
x2	O
.	O

Stage	O
:	O
pT2NO	O
.	O

Comments	O
.	O

Sections	O
show	O
a	O
poorly	O
differentiated	O
large	O
cell	O
carcinoma	O
with	O
.	O
squamous	O
differentiation	O
(	O
poorly	O
differentiated	O
squamous	O
cell	O
.	O
carcinoma	O
)	O
.	O

This	O
extends	O
to	O
within	O
less	O
than	O
1	O
mm	O
of	O
the	O
pleural	O
.	O
surface	O
,	O
but	O
does	O
not	O
invade	O
the	O
pleura	O
.	O

A	O
focus	O
of	O
lymphovascular	O
.	O
space	O
invasion	O
is	O
identified	O
.	O

Lymph	O
nodes	O
from	O
level	O
8	O
were	O
.	O
received	O
multiply	O
fragmented	O
and	O
it	O
is	O
impossible	O
to	O
ascertain	O
an	O
.	O
accurate	O
node	O
count	O
.	O

No	O
metastatic	O
carcinoma	O
is	O
identified	O
.	O

Occasional	O
granulomas	O
are	O
present	O
from	O
the	O
level	O
8	O
lymph	O
nodes	O
,	O
.	O
specimen	O
#	O
5	O
.	O

An	O
acid	O
fast	O
and	O
GMS	O
stain	O
are	O
performed	O
which	O
.	O
demonstrate	O
no	O
acid	O
fast	O
bacilli	O
(	O
with	O
appropriate	O
positive	O
.	O
control	O
)	O
.	O

No	O
fungal	O
organisms	O
are	O
identified	O
(	O
with	O
appropriate	O
.	O
positive	O
control	O
)	O
.	O

Clinical	O
correlation	O
and	O
follow	O
up	O
is	O
.	O
recommended	O
.	O

At	O
the	O
request	O
of	O
the	O
undersigned	O
pathologist	O
,	O
these	O
slides	O
have	O
.	O
been	O
additionally	O
reviewed	O
by	O
Dr	O
.	O
who	O
concurs	O
with	O
the	O
.	O
diagnosis	O
.	O

This	O
test	O
has	O
been	O
finalized	O
at	O
the	O
.	O

Campus	O
.	O

-DOCSTART-266
Encounter	O
Date	O
:	O
Results	O
:	O
PATHOLOGYNON	O
GYN	O
.	O

CYTOLOGY	O
.	O

Lab	O
.	O

SURGICAL	O
PATHOLOGY	O
Case	O
Number	O
:	O
Procedures	O
/	O
Addenda	O
Present	O
.	O

CLINICAL	O
INFORMATION	O
:	O
Neoplasm	O
of	O
unspecified	O
nature	O
of	O
brain	O
.	O

ICD	O
-	O
9	O
code	O
:	O
239	O
.	O
6	O
.	O

INTRAPROCEDURAL	O
CONSULTATION	O
:	O
A	O
.	O

Right	O
brain	O
tumor	O
(	O
frozen	O
section	O
)	O
:	O
High	O
-	O
grade	O
malignant	O
neoplasm	O
.	O
consistent	O
with	O
glioblastoma	O
multiforme	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

Received	O
fresh	O
,	O
labeled	O
.	O
and	O
designated	O
"	O
A	O
.	O
right	O
.	O

brain	O
tumor	O
"	O
,	O
is	O
a	O
1	B
.	I
0x1	I
.	I
0x0	I
.	I
2cm	I
aggregate	O
of	O
pink	O
-	O
tan	O
hemorrhagic	O
soft	O
.	O
tissue	O
fragments	O
.	O

A	O
frozen	O
section	O
was	O
performed	O
on	O
one	O
aspect	O
of	O
the	O
tissue	O
.	O
and	O
is	O
submitted	O
in	O
AFS	O
,	O
The	O
remaining	O
tissue	O
was	O
submitted	O
in	O
one	O
cassette	O
.	O

B	O
.	O

Received	O
fresh	O
on	O
.	O

is	O
approximately	O
30	O
CC	O
of	O
clear	O
light	O
.	O
orange	O
fluid	O
,	O
labeled	O
.	O

(	O
B	O
)	O
"	O
.	O

Prepared	O
are	O
one	O
cellblock	O
and	O
.	O
one	O
ThinPrep	O
slide	O
.	O

C	O
.	O

Received	O
fresh	O
,	O
labeled	O
.	O
and	O
designated	O
"	O
C	O
.	O

CUSA	O
.	O

contents	O
"	O
,	O
is	O
a	O
6	O
.	O
2x3	O
.	O
0x1	O
.	O
3cr	O
aggregate	O
of	O
pink	O
-	O
tan	O
hemorrhagic	O
soft	O
tissue	O
.	O
fragments	O
,	O
which	O
are	O
entirely	O
submitted	O
in	O
three	O
cassettes	O
.	O

D	O
.	O

Received	O
in	O
formalin	O
,	O
labeled	O
.	O
and	O
designated	O
"	O
D	O
.	O
connective	O
dura	O
"	O
,	O
is	O
a	O
1	O
.	O
3x1	O
.	O
0x0	O
.	O
1cm	O
fragment	O
of	O
hemorrhagic	O
dura	O
,	O
which	O
.	O

is	O
.	O
entirely	O
submitted	O
in	O
one	O
cassette	O
.	O

E	O
.	O

Received	O
fresh	O
,	O
labeled	O
.	O
and	O
designated	O
"	O
E	O
.	O
right	O
brain	O
.	O

tumor	O
"	O
,	O
is	O
a	O
3	B
.	I
5x2	I
.	I
5x0	I
.	I
9	I
cm	I
aggregate	O
of	O
hemorrhagic	O
pink	O
-	O
tan	O
soft	O
tissue	O
.	O
fragments	O
.	O

Specimen	O
is	O
submitted	O
in	O
its	O
entirety	O
in	O
two	O
cassettes	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
:	O
The	O
immunohistochemical	O
tests	O
reported	O
were	O
developed	O
and	O
performance	O
.	O
characteristics	O
determined	O
by	O
.	O

They	O
have	O
not	O
been	O
.	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O

The	O
FDA	O
has	O
.	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

These	O
tests	O
may	O
.	O

be	O
used	O
for	O
clinical	O
purposes	O
.	O

They	O
should	O
not	O
be	O
regarded	O
as	O
.	O
investigational	O
or	O
for	O
research	O
use	O
only	O
.	O

is	O
certified	O
.	O
under	O
the	O
Clinical	O
Laboratory	O
Improvement	O
Amendments	O
of	O
.	O

(	O
CLIA	O
)	O
as	O
.	O
qualified	O
to	O
perform	O
high	O
complexity	O
clinical	O
laboratory	O
testing	O
.	O

FINAL	O
PATHOLOGIC	O
DIAGNOSIS	O
:	O
Encounter	O
Date	O
:	O
A	O
.	O

RIGHT	O
BRAIN	O
TUMOR	O
:	O
C	O
.	O

CUSA	O
CONTENTS	O
:	O
E	O
.	O

RIGHT	O
BRAIN	O
TUMOR	O
:	O
Glioblastoma	O
,	O
WHO	O
grade	O
IV	O
/	O
IV	O
,	O
with	O
the	O
following	O
features	O
:	O
-	O
Degree	O
of	O
cellularity	O
:	O
High	O
.	O

-	O
Microvascular	O
proliferation	O
:	O
present	O
.	O

-	O
Necrosis	O
:	O
present	O
.	O

Mitotic	O
activity	O
:	O
high	O
,	O
at	O
least	O
20	O
per	O
10	O
high	O
power	O
fields	O
.	O

Other	O
features	O
:	O
MGMT	O
studies	O
(	O
PCR	O
and	O
immunohistochemistry	O
)	O
and	O
FISH	O
.	O
studies	O
are	O
pending	O
.	O

-	O
Please	O
see	O
comment	O
section	O
.	O

B	O
.	O

CYST	O
ASPIRATE	O
(	O
including	O
evaluation	O
of	O
cellblock	O
)	O
:	O
-	O
Proteinaceous	O
fluid	O
.	O

D	O
.	O

CONNECTIVE	O
DURA	O
:	O
-	O
Fibrous	O
connective	O
tissue	O
consistent	O
with	O
dura	O
showing	O
infiltrating	O
.	O
glioblastoma	O
.	O

COMMENT	O
:	O
In	O
addition	O
to	O
the	O
usual	O
features	O
of	O
glioblastoma	O
,	O
there	O
is	O
a	O
region	O
of	O
small	O
.	O
clustered	O
cells	O
in	O
part	O
E	O
reminiscent	O
of	O
neuronal	O
or	O
primitive	O
.	O
neuroectodermal	O
differentiation	O
.	O

Immunostains	O
reveal	O
delicate	O
synaptophysin	O
.	O
positivity	O
and	O
decreased	O
GFAP	O
expression	O
compared	O
to	O
the	O
opposite	O
findings	O
.	O

in	O
.	O
the	O
high	O
-	O
grade	O
glial	O
component	O
.	O

These	O
changes	O
are	O
supportive	O
of	O
focal	O
.	O
primitive	O
neuronal	O
differentiation	O
.	O

P53	O
immunostains	O
show	O
staining	O
in	O
both	O
.	O
components	O
.	O

In	O
part	O
D	O
,	O
the	O
glioblastoma	O
invades	O
the	O
apparent	O
dura	O
.	O

Foci	O
suggestive	O
of	O
.	O
vascular	O
invasion	O
by	O
tumor	O
were	O
raised	O
and	O
immunostains	O
to	O
GFAP	O
and	O
CD31	O
.	O
applied	O
to	O
further	O
characterize	O
the	O
tumor	O
.	O

The	O
tumor	O
is	O
GFAP	O
positive	O
and	O
the	O
.	O
dura	O
is	O
richly	O
vascular	O
.	O

The	O
suspected	O
areas	O
are	O
not	O
represented	O
in	O
the	O
.	O
sections	O
studied	O
,	O
however	O
,	O
and	O
the	O
question	O
of	O
vascular	O
invasion	O
cannot	O
be	O
.	O
confirmed	O
.	O

PROCEDURESIADDENDA	O
:	O
ICC	O
-	O
IMMUNOHISTOCHEMISTRY	O
Date	O
Ordered	O
:	O
Date	O
Complete	O
:	O
Interpretation	O
.	O

At	O
the	O
request	O
of	O
.	O
representative	O
sections	O
of	O
the	O
tumor	O
(	O
E	O
)	O
were	O
.	O
submitted	O
for	O
MGMT	O
Immunohistochemistry	O
.	O

The	O
result	O
is	O
approximately	O
50	O
%	O
of	O
.	O
the	O
tumor	O
is	O
positive	O
.	O

Endothelial	O
cells	O
serve	O
as	O
a	O
positive	O
internal	O
.	O
control	O
.	O

Results	O
-	O
Comments	O
.	O

E	O
.	O

RIGHT	O
BRAIN	O
TUMOR	O
,	O
IMMUNOHISTOCHEMISTRY	O
RESULTS	O
:	O
-	O
TUMOR	O
IS	O
POSTIVE	O
FOR	O
MGMT	O
BY	O
IMMUNOHISTOCHEMISTRY	O
.	O

(	O
APPROXIMATELY	O
50	O
%	O
)	O
.	O

MGMT	O
by	O
PCR	O
.	O

Date	O
Complete	O
:	O
Interpretation	O
.	O

{	O
Not	O
Entered	O
}	O
.	O

Results	O
-	O
Comments	O
.	O

E	O
.	O

RIGHT	O
BRAIN	O
TUMOR	O
,	O
MGMT	O
Methylation	O
Assay	O
Result	O
:	O
Gene	O
Methylation	O
NOT	O
detected	O
.	O

Please	O
see	O
full	O
report	O
from	O
.	O
for	O
additional	O
details	O
accession	O
.	O

Lab	O
Inquiry	O
.	O

View	O
Complete	O
Results	O
.	O

Dept	O
Phone	O
:	O
Description	O
.	O

Encounte	O
.	O

Department	O
.	O

Encounter	O
.	O

PATHOLOGY	O
/	O
NON	O
GYN	O
CYTOLOGY	O
.	O

Patient	O
Patient	O
Name	O
Sex	O
.	O

Information	O
.	O

Admitted	O
Date	O
.	O

CSN	O
.	O

Released	O
By	O
.	O

Department	O
.	O

Information	O
.	O

-DOCSTART-267
This	O
is	O
an	O
unequivocal	O
finding	O
in	O
the	O
sense	O
of	O
an	O
adenocarcinoma	O
of	O
the	O
colon	O
with	O
extensive	O
.	O
necrosis	O
and	O
poor	O
differentiation	O
(	O
thus	O
corresponding	O
to	O
G3	O
)	O
with	O
penetration	O
of	O
all	O
parietal	O
.	O
layers	O
and	O
vascular	O
infiltration	O
(	O
thus	O
corresponding	O
to	O
pT3	O
,	O
L1	O
,	O
V1	O
)	O
with	O
free	O
resection	O
margins	O
.	O
in	O
the	O
mucosal	O
region	O
with	O
a	O
regular	O
mucosa	O
,	O
submucosa	O
and	O
muscularis	O
and	O
free	O
resection	O
.	O
margins	O
in	O
the	O
mesenchymal	O
region	O
and	O
three	O
lymph	O
node	O
metastases	O
(	O
corresponding	O
to	O
pN1	O
)	O
.	O

In	O
addition	O
,	O
there	O
were	O
diverticular	O
formations	O
.	O

Tumor	O
classification	O
:	O
ICDO	O
-	O
DA	O
-	O
M	O
.	O

G3	O
.	O

pT3	O
.	O

L1	O
,	O
V1	O
.	O

pN1	O
(	O
3	O
of	O
13	O
lymph	O
nodes	O
)	O
.	O

-DOCSTART-268
FINAL	O
PATHOLOGIC	O
DIAGNOSIS	O
.	O

A	O
.	O

Breast	O
,	O
right	O
,	O
modified	O
radical	O
mastectomy	O
:	O
-	O
Invasive	O
ductal	O
carcinoma	O
,	O
grade	O
III	O
/	O
III	O
,	O
5	B
.	I
0	I
cm	I
in	O
greatest	O
dimension	O
,	O
.	O
present	O
1	O
.	O
0	O
mm	O
from	O
posterior	O
inked	O
surgical	O
margin	O
,	O
other	O
margins	O
widely	O
free	O
.	O

(	O
see	O
pathologic	O
parameters	O
and	O
comment	O
below	O
)	O
.	O

Ductal	O
carcinoma	O
in	O
-	O
situ	O
,	O
high	O
grade	O
,	O
solid	O
type	O
with	O
associated	O
central	O
.	O
necrosis	O
and	O
calcifications	O
,	O
surgical	O
margins	O
negative	O
.	O

-	O
Previous	O
biopsy	O
site	O
identified	O
.	O

-	O
Metastatic	O
carcinoma	O
involving	O
two	O
of	O
twelve	O
lymph	O
nodes	O
(	O
2	O
/	O
12	O
)	O
.	O

B	O
.	O

Breast	O
,	O
right	O
,	O
deep	O
margin	O
re	O
-	O
excision	O
:	O
-	O
Skeletal	O
muscle	O
and	O
fibroadipose	O
tissue	O
,	O
negative	O
for	O
carcinoma	O
.	O

C	O
.	O

Breast	O
,	O
right	O
'	O
additional	O
tissue	O
under	O
superiomedial	O
skin	O
flap	O
,	O
'	O
excision	O
:	O
-	O
Breast	O
and	O
fibroadipose	O
tissue	O
,	O
negative	O
for	O
carcinoma	O
.	O

D	O
.	O

Skin	O
,	O
right	O
'	O
chest	O
wall	O
at	O
corner	O
of	O
incision	O
,	O
'	O
excision	O
:	O
-	O
Skin	O
and	O
fibroadipose	O
tissue	O
,	O
negative	O
for	O
carcinoma	O
.	O

Breast	O
Pathologic	O
Parameters	O
.	O

1	O
.	O

Invasive	O
carcinoma	O
:	O
A	O
.	O

Gross	O
measurement	O
:	O
5	B
.	I
0	I
cm	I
.	O

B	O
.	O

Composite	O
histologic	O
(	O
modified	O
SBR	O
)	O
grade	O
:	O
III	O
/	O
III	O
.	O

C	O
.	O

Associated	O
intraductal	O
carcinoma	O
in	O
situ	O
(	O
DCIS	O
)	O
.	O

-	O
High	O
grade	O
,	O
solid	O
type	O
with	O
associated	O
central	O
necrosis	O
and	O
.	O
calcifications	O
.	O

-	O
Within	O
main	O
mass	O
.	O

2	O
.	O

Surgical	O
margins	O
:	O
Free	O
of	O
tumor	O
.	O

-	O
DCIS	O
3	O
.	O
0	O
mm	O
from	O
closest	O
margin	O
(	O
posterior	O
)	O
.	O

-	O
Invasive	O
carcinoma	O
1	O
.	O
0	O
mm	O
from	O
closest	O
margin	O
(	O
posterior	O
)	O
on	O
mastectomy	O
,	O
.	O
separately	O
submitted	O
deep	O
margin	O
re	O
-	O
excision	O
(	O
specimen	O
B	O
)	O
negative	O
for	O
carcinoma	O
.	O

-	O
Additional	O
margins	O
widely	O
free	O
.	O

3	O
.	O

Blood	O
vessel	O
and	O
lymphatic	O
invasion	O
:	O
Present	O
.	O

4	O
.	O

Nipple	O
:	O
Uninvolved	O
.	O

5	O
.	O

Skin	O
:	O
Uninvolved	O
.	O

6	O
.	O

Skeletal	O
muscle	O
:	O
Focally	O
involved	O
.	O

7	O
.	O

Axillary	O
lymph	O
nodes	O
:	O
Metastatic	O
carcinoma	O
involving	O
two	O
of	O
twelve	O
lymph	O
.	O
nodes	O
(	O
2	O
/	O
12	O
)	O
.	O

-	O
Size	O
of	O
largest	O
metastatic	O
deposit	O
:	O
1	O
.	O
1	O
cm	O
.	O

-	O
Extranodal	O
extension	O
:	O
Present	O
(	O
2	O
.	O
0	O
mm	O
)	O
.	O

8	O
.	O

Special	O
studies	O
.	O

-	O
ER	O
:	O
Weak	O
expression	O
in	O
30	O
%	O
of	O
invasive	O
tumor	O
nuclei	O
.	O

-	O
PR	O
:	O
No	O
expression	O
in	O
invasive	O
tumor	O
nuclei	O
.	O

-	O
Ki	O
-	O
67	O
:	O
50	O
%	O
proliferation	O
rate	O
.	O

-	O
Her2	O
/	O
neu	O
antigen	O
(	O
FISH	O
)	O
:	O
Amplified	O
(	O
ratio	O
:	O
3	O
.	O
8	O
)	O
.	O

9	O
.	O

pTNM	O
(	O
AJCC	O
,	O
7th	O
edition	O
,	O
2010	O
)	O
:	O
pT2	O
,	O
N1a	O
,	O
MX	O
.	O

Clinical	O
History	O
:	O
The	O
patient	O
is	O
a	O
.	O
year	O
-	O
old	O
female	O
with	O
right	O
breast	O
invasive	O
ductal	O
carcinoma	O
.	O
with	O
axillary	O
nodal	O
metastases	O
who	O
undergoes	O
right	O
modified	O
radical	O
mastectomy	O
.	O

Comment	O
.	O

The	O
5	B
.	I
0	I
cm	I
mass	O
identified	O
on	O
gross	O
examination	O
is	O
comprised	O
of	O
both	O
invasive	O
.	O
and	O
in	O
-	O
situ	O
carcinoma	O
with	O
extensive	O
necrosis	O
and	O
calcifications	O
.	O

Specimens	O
Received	O
:	O
A	O
:	O
Right	O
breast	O
and	O
axillary	O
contents	O
.	O

B	O
:	O
Additional	O
deep	O
margin	O
.	O

C	O
:	O
Additional	O
tissue	O
under	O
superiomedial	O
skin	O
flap	O
.	O

D	O
:	O
Skin	O
at	O
corner	O
of	O
incision	O
;	O
r	O
chest	O
wall	O
.	O

Gross	O
Description	O
:	O
The	O
specimens	O
are	O
received	O
in	O
four	O
containers	O
each	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
.	O
name	O
and	O
medical	O
record	O
number	O
.	O

A	O
.	O

The	O
first	O
container	O
is	O
additionally	O
identified	O
as	O
,	O
'	O
right	O
breast	O
and	O
.	O
axillary	O
contents	O
'	O
.	O

Received	O
fresh	O
and	O
placed	O
in	O
formalin	O
is	O
a	O
730	O
g	O
simple	O
.	O
mastectomy	O
specimen	O
.	O

The	O
specimen	O
is	O
oriented	O
with	O
a	O
double	O
short	O
suture	O
.	O
designating	O
the	O
superior	O
aspect	O
and	O
a	O
double	O
long	O
suture	O
designating	O
the	O
lateral	O
.	O
aspect	O
.	O

The	O
breast	O
measures	O
23	O
cm	O
from	O
medial	O
to	O
lateral	O
,	O
21	O
cm	O
from	O
superior	O
.	O
to	O
inferior	O
,	O
and	O
4	O
.	O
5	O
cm	O
from	O
anterior	O
to	O
posterior	O
.	O

On	O
the	O
anterior	O
surface	O
is	O
.	O

20	O
X	O
8	O
.	O
5	O
cm	O
ellipse	O
of	O
skin	O
with	O
a	O
4	O
.	O
2	O
X	O
4	O
.	O
0	O
cm	O
areola	O
and	O
a	O
1	O
.	O
3	O
X	O
1	O
.	O
3	O
X	O
0	O
.	O
5	O
cm	O
.	O
nipple	O
.	O

The	O
nipple	O
-	O
areolar	O
complex	O
reveals	O
no	O
evidence	O
of	O
ulceration	O
or	O
.	O
retraction	O
.	O

There	O
is	O
an	O
attached	O
6	O
.	O
5	O
X	O
5	O
.	O
5	O
X	O
1	O
.	O
5	O
cm	O
portion	O
of	O
apparent	O
axillary	O
.	O
tail	O
on	O
the	O
lateral	O
aspect	O
of	O
the	O
specimen	O
.	O

There	O
is	O
an	O
attached	O
4	O
.	O
5	O
X	O
1	O
.	O
8	O
X	O
0	O
.	O
2	O
.	O

cm	O
skeletal	O
muscle	O
consisting	O
of	O
pectoralis	O
at	O
the	O
deep	O
margin	O
at	O
junction	O
of	O
.	O
upper	O
-	O
outer	O
quadrant	O
and	O
lower	O
-	O
outer	O
quadrant	O
in	O
slice3	O
-	O
5	O
The	O
specimen	O
is	O
.	O
inked	O
as	O
follows	O
:	O
anterior	O
-	O
superior	O
-	O
blue	O
;	O
.	O
anterior	O
-	O
inferior	O
-	O
green	O
;	O
.	O
posterior	O
-	O
black	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
from	O
lateral	O
(	O
slice	O
#	O
1	O
)	O
to	O
medial	O
(	O
slice	O
#	O
11	O
)	O
.	O
to	O
reveal	O
a	O
5	O
.	O
0	O
X	O
3	O
.	O
8	O
X	O
3	O
.	O
5	O
cm	O
pink	O
-	O
tan	O
,	O
firm	O
mass	O
(	O
lesion	O
#	O
1	O
)	O
extending	O
from	O
.	O
upper	O
-	O
outer	O
quadrant	O
to	O
lower	O
-	O
outer	O
quadrant	O
in	O
slices	O
3	O
-	O
7	O
.	O

The	O
mass	O
is	O
1	O
.	O
6	O
cm	O
.	O
from	O
the	O
anterior	O
-	O
inferior	O
margin	O
and	O
abuts	O
the	O
posterior	O
margin	O
.	O

Surrounding	O
.	O
the	O
mass	O
is	O
a	O
10x7x4	O
cm	O
ill	O
-	O
defined	O
,	O
pink	O
area	O
composing	O
of	O
dilated	O
ducts	O
.	O
and	O
fibrotic	O
tissue	O
in	O
slices	O
4	O
-	O
9	O
and	O
the	O
most	O
prominent	O
in	O
slice	O
7	O
-	O
8	O
.	O

The	O
.	O
ill	O
-	O
defined	O
area	O
(	O
lesion	O
#	O
2	O
)	O
extends	O
towards	O
anterior	O
aspect	O
and	O
is	O
0	O
.	O
6	O
cm	O
from	O
.	O
the	O
closest	O
anterior	O
margin	O
and	O
2	O
.	O
0	O
cm	O
from	O
the	O
closest	O
posterior	O
margin	O
.	O

The	O
.	O
remainder	O
of	O
the	O
specimen	O
consists	O
of	O
approximately	O
10	O
%	O
dense	O
gray	O
-	O
white	O
fibrous	O
.	O
breast	O
parenchyma	O
and	O
90	O
%	O
lobulated	O
yellow	O
adipose	O
tissue	O
.	O

No	O
additional	O
masses	O
.	O
or	O
nodules	O
are	O
grossly	O
identified	O
.	O

Within	O
the	O
axillary	O
tail	O
are	O
identified	O
.	O
several	O
lymph	O
node	O
candidates	O
measuring	O
from	O
0	O
.	O
3	O
-	O
2	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

Block	O
summary	O
:	O
A1	O
:	O
Lesion	O
#	O
1	O
,	O
slice	O
3	O
.	O

A2	O
:	O
Lesion	O
#	O
1	O
,	O
slice	O
4	O
.	O

A3	O
:	O
Lesion	O
#	O
1	O
abutting	O
posterior	O
margin	O
,	O
slice	O
5	O
.	O

A4	O
:	O
Lesion	O
#	O
1	O
,	O
slice	O
6	O
.	O

A5	O
:	O
Lesion	O
#	O
1	O
,	O
slice	O
7	O
.	O

A6	O
:	O
Lesion	O
#	O
2	O
,	O
slice	O
4	O
.	O

A7	O
:	O
Lesion	O
#	O
2	O
,	O
slice	O
5	O
.	O

A8	O
:	O
Lesion	O
#	O
2	O
,	O
slice	O
6	O
.	O

A9	O
:	O
Lesion	O
#	O
2	O
,	O
slice	O
7	O
.	O

A10	O
:	O
Lesion	O
#	O
2	O
,	O
slice	O
8	O
.	O

A11	O
:	O
Lesion	O
#	O
2	O
,	O
slice	O
9	O
.	O

A12	O
:	O
Representative	O
adjacent	O
medial	O
to	O
lesion	O
#	O
2	O
,	O
slice	O
10	O
.	O

A13	O
:	O
Representative	O
adjacent	O
lateral	O
to	O
lesion	O
#	O
2	O
,	O
slice	O
3	O
.	O

A14	O
:	O
upper	O
-	O
outer	O
quadrant	O
slice	O
2	O
.	O

A15	O
:	O
lower	O
-	O
outer	O
quadrant	O
slice	O
1	O
.	O

A16	O
:	O
upper	O
-	O
inner	O
quadrant	O
slice	O
11	O
.	O

A17	O
:	O
lower	O
-	O
inner	O
quadrant	O
slice	O
10	O
.	O

A18	O
:	O
nipple	O
.	O

A19	O
:	O
skin	O
.	O

A20	O
:	O
One	O
lymph	O
node	O
.	O

A21	O
-	O
A23	O
:	O
4	O
lymph	O
node	O
candidates	O
,	O
each	O
cassette	O
.	O

A24	O
-	O
A26	O
:	O
One	O
lymph	O
node	O
,	O
serial	O
section	O
.	O

B	O
.	O

The	O
second	O
container	O
is	O
additionally	O
identified	O
as	O
,	O
'	O
additional	O
deep	O
margin	O
;	O
.	O
underlying	O
palpable	O
tumor	O
:	O
Received	O
in	O
formalin	O
is	O
a	O
3	O
.	O
9	O
g	O
,	O
4	B
.	I
2	I
X	I
2	I
.	I
2x0	I
.	I
8	I
cm	I
.	O
yellow	O
-	O
tan	O
,	O
soft	O
tissue	O
fragment	O
with	O
one	O
short	O
stitch	O
designating	O
as	O
new	O
true	O
.	O
deep	O
margin	O
(	O
inked	O
blue	O
)	O
and	O
attached	O
clips	O
on	O
original	O
margin	O
(	O
inked	O
black	O
)	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
and	O
entirely	O
submitted	O
as	O
B1	O
-	O
B5	O
.	O

C	O
.	O

The	O
third	O
container	O
is	O
additionally	O
identified	O
as	O
,	O
'	O
additional	O
tissue	O
under	O
.	O
superiomedial	O
skin	O
flap	O
'	O
.	O

Received	O
in	O
formalin	O
is	O
an	O
unoriented	O
2	O
.	O
3	O
g	O
,	O
4	O
.	O
8	O
X	O
1	O
.	O
2	O
.	O

x	O
1	O
.	O
1	O
cm	O
portion	O
of	O
yellow	O
-	O
tan	O
fibroadipose	O
tissue	O
,	O
which	O
is	O
serially	O
sectioned	O
.	O
and	O
entirely	O
submitted	O
C1	O
-	O
C2	O
.	O

D	O
.	O

The	O
fourth	O
container	O
is	O
additionally	O
identified	O
as	O
,	O
'	O
skin	O
at	O
corner	O
of	O
.	O
incision	O
;	O
right	O
chest	O
wall	O
'	O
.	O

Received	O
fresh	O
and	O
placed	O
in	O
formalin	O
is	O
an	O
.	O
unoriented	O
V	O
-	O
shaped	O
ellipse	O
of	O
wrinkled	O
,	O
tan	O
-	O
brown	O
skin	O
measuring	O
4	O
.	O
5	O
X	O
1	O
.	O
5	O
cm	O
.	O
adjunct	O
with	O
3	O
.	O
2	O
X	O
1	O
.	O
5	O
cm	O
excised	O
to	O
a	O
depth	O
of	O
1	O
.	O
3	O
cm	O
.	O

The	O
specimen	O
is	O
serial	O
.	O
sectioned	O
and	O
review	O
grossly	O
unremarkable	O
parenchyma	O
.	O

The	O
representative	O
section	O
.	O

is	O
submitted	O
as	O
D1	O
.	O

Tissue	O
fixed	O
for	O
at	O
least	O
6	O
hours	O
in	O
10	O
%	O
NBF	O
and	O
no	O
more	O
than	O
72	O
hours	O
.	O

-DOCSTART-269
Right	O
eye	O
enucleation	O
.	O

Macroscopy	O
.	O

The	O
eyeball	O
measures	O
25	O
mm	O
of	O
diameter	O
before	O
fixation	O
,	O
with	O
a	O
posterior	O
segment	O
of	O
optic	O
.	O
nerve	O
of	O
6	O
mm	O
.	O

At	O
the	O
section	O
,	O
at	O
the	O
lateral	O
and	O
posterior	O
part	O
of	O
the	O
eyeball	O
,	O
slightly	O
distant	O
.	O
from	O
the	O
ciliary	O
body	O
,	O
distant	O
from	O
the	O
intraocular	O
emergence	O
of	O
the	O
optic	O
nerve	O
,	O
a	O
tumor	O
is	O
.	O
found	O
which	O
is	O
massively	O
protruding	O
in	O
the	O
vitreous	O
cavity	O
.	O

It	O
measures	O
16	B
mm	I
main	O
line	O
for	O
.	O

12	B
mm	I
of	O
maximum	O
thickness	O
and	O
is	O
partly	O
cystic	O
.	O

The	O
anterior	O
chamber	O
is	O
free	O
.	O

Samples	O
have	O
.	O
been	O
made	O
for	O
cryopreservation	O
and	O
cytogenetic	O
studies	O
.	O

Two	O
samples	O
have	O
been	O
made	O
for	O
.	O
cryopreservation	O
and	O
the	O
specimen	O
has	O
been	O
then	O
included	O
entirely	O
after	O
fixation	O
.	O

Microscopy	O
.	O

The	O
tumor	O
seen	O
macroscopically	O
correspond	O
to	O
a	O
malignant	O
proliferation	O
made	O
nearly	O
only	O
.	O
with	O
medium	O
or	O
large	O
epithelioid	O
cells	O
,	O
with	O
large	O
eosinophilic	O
cytoplasm	O
sometimes	O
loaded	O
.	O
with	O
melanin	O
pigment	O
.	O

The	O
nuclei	O
are	O
irregular	O
in	O
shape	O
and	O
size	O
sometimes	O
monstrous	O
.	O

They	O
.	O
are	O
often	O
strongly	O
nucleolated	O
.	O
A	O
few	O
mitotic	O
figures	O
are	O
observed	O
.	O

The	O
tumor	O
proliferation	O
,	O
.	O
stuck	O
to	O
the	O
internal	O
face	O
of	O
the	O
sclera	O
,	O
infiltrates	O
the	O
most	O
internal	O
sheaths	O
on	O
less	O
than	O
one	O
.	O
third	O
of	O
its	O
thickness	O
.	O

The	O
tumor	O
proliferation	O
stays	O
distant	O
to	O
the	O
ciliary	O
body	O
which	O
is	O
free	O
as	O
.	O
well	O
as	O
the	O
iris	O
and	O
the	O
anterior	O
chamber	O
.	O

At	O
the	O
posterior	O
part	O
it	O
stays	O
distant	O
to	O
the	O
.	O
intraocular	O
emergence	O
of	O
the	O
optic	O
nerve	O
which	O
is	O
free	O
on	O
its	O
entire	O
course	O
(	O
pre	O
and	O
post	O
.	O
laminar	O
,	O
optic	O
foramen	O
meningeal	O
sheaths	O
and	O
cut	O
end	O
)	O
no	O
extrascl	O
é	O
rale	O
extension	O
was	O
.	O
observed	O
.	O

Conclusion	O
.	O

Choroidal	O
melanoma	O
with	O
epitheloid	O
cells	O
measuring	O
16	B
mm	I
main	O
line	O
by	O
12	B
mm	I
maximal	O
.	O
thickness	O
.	O

The	O
tumor	O
proliferation	O
infiltrates	O
the	O
internal	O
part	O
of	O
the	O
sclera	O
on	O
less	O
than	O
one	O
third	O
.	O
No	O
extra	O
.	O
ocular	O
extension	O
was	O
seen	O
.	O

The	O
ciliary	O
body	O
,	O
the	O
iris	O
and	O
the	O
anterior	O
chamber	O
as	O
well	O
as	O
the	O
optic	O
nerve	O
on	O
its	O
entire	O
.	O
course	O
(	O
pre	O
and	O
post	O
laminar	O
,	O
optic	O
foramen	O
,	O
meningeal	O
sheaths	O
and	O
cut	O
end	O
)	O
are	O
free	O
.	O

-DOCSTART-270
PATHOLOGICAL	O
DTAGNOSTS	O
:	O
A	O
,	O
B	O
.	O

RIGHT	O
TEMPORAL	O
LOBE	O
,	O
BIOPSY	O
:	O
OLIGODENDROGLIOMA	O
(	O
WHO	O
GRADE	O
2	O
)	O
.	O

(	O
MIB	O
-	O
.	O
1	O
:	O
4	O
%	O
)	O
.	O

Operation	O
/	O
Specimen	O
:	O
Right	O
temporal	O
tumor	O
lobe	O
.	O

Clinical	O
History	O
and	O
Pre	O
-	O
Op	O
Dx	O
:	O
None	O
provided	O
.	O

GROSS	O
PATHOLOGY	O
:	O
A	O
.	O

Multiple	O
0	O
.	O
5	O
to	O
1	O
.	O
2	O
cm	O
tissue	O
fragments	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
,	O
Frozen	O
section	O
diagnosis	O
Glioma	O
.	O

All	O
.	O
submitted	O
in	O
1	O
and	O
2	O
.	O

B	O
.	O

SPECIMEN	O
:	O
Right	O
temporal	O
tumor	O
lobe	O
.	O

FIXATIVE	O
:	O
Saline	O
.	O

GENERAL	O
:	O
Multiple	O
fragments	O
of	O
tan	O
-	O
gray	O
soft	O
tissue	O
,	O
smooth	O
and	O
.	O
shiny	O
1	B
.	I
5	I
x	I
1	I
X	I
0	I
.	I
3	I
cm	I
.	O

SECTIONS	O
:	O
X1	O
-	O
all	O
submitted	O
.	O

MICROSCOPIC	O
:	O
Frozen	O
section	O
diagnosis	O
is	O
confirmed	O
.	O

This	O
tumor	O
is	O
an	O
.	O
oligodendroglioma	O
involving	O
the	O
white	O
matter	O
and	O
cortex	O
.	O

The	O
tumor	O
is	O
.	O
moderately	O
cellular	O
with	O
mild	O
nuclear	O
pleomorphism	O
.	O

Mitotic	O
figure	O
is	O
.	O
rare	O
.	O

Vascular	O
endothelial	O
hyperplasia	O
and	O
tumor	O
necrosis	O
are	O
not	O
.	O
present	O
.	O

This	O
tumor	O
is	O
classified	O
as	O
oligodendroglioma	O
WHO	O
grade	O
2	O
.	O

-DOCSTART-271
F	O
.	O

Urology	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
year	O
old	O
female	O
,	O
history	O
of	O
TCC	O
in	O
.	O
,	O
TCC	O
Ta	O
HG	O
,	O
after	O
6x	O
BCG	O
,	O
now	O
with	O
bladder	O
tumor	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
Bladder	O
,	O
right	O
lateral	O
wall	O
,	O
TURB	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

Bladder	O
,	O
right	O
lateral	O
wall	O
,	O
TURB	O
:	O
Tumor	O
Type	O
:	O
Invasive	O
urothelial	O
carcinoma	O
,	O
NOS	O
.	O
with	O
sarcomatoid	O
and	O
anaplastic	O
features	O
.	O

Histologic	O
Grade	O
:	O
High	O
grade	O
.	O

Pattern	O
of	O
growth	O
of	O
the	O
non	O
-	O
invasive	O
component	O
:	O
Flat	O
(	O
in	O
situ	O
carcinoma	O
)	O
.	O

Local	O
Invasion	O
:	O
Muscularis	O
propria	O
.	O

Vascular	O
Invasion	O
:	O
Not	O
identified	O
.	O

I	O
ATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
,	O
AND	O
THAT	O
I	O
HAVE	O
.	O

REVIEWED	O
AND	O
APPROVED	O
THIS	O
REPORT	O
.	O

Gross	O
Description	O
:	O
1	O
.	O

The	O
specimen	O
is	O
received	O
in	O
.	O
labeled	O
"	O
right	O
lateral	O
wall	O
"	O
,	O
and	O
consists	O
of	O
multiple	O
pieces	O
of	O
tan	O
soft	O
tissue	O
.	O
measuring	O
3	O
.	O
0	O
x	O
2	O
.	O
0	O
x	O
0	O
.	O
7	O
cm	O
in	O
aggregate	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
two	O
cassettes	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
Bladder	O
,	O
right	O
lateral	O
wall	O
,	O
TURB	O
.	O

Blocks	O
Block	O
Designation	O
.	O

PCs	O
.	O

2	O
.	O

2	O
.	O

-DOCSTART-272
SPECIMENS	O
:	O
A	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
1	O
LEFT	O
AXILLA	O
.	O

B	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
2	O
LEFT	O
AXILLA	O
.	O

C	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
3	O
LEFT	O
AXILLA	O
.	O

D	O
.	O

LEFT	O
BREAST	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
#	O
1	O
LEFT	O
AXILLA	O
,	O
EXCISION	O
:	O
-	O
METASTATIC	O
ADENOCARCINOMA	O
,	O
IDENTIFIED	O
IN	O
ONE	O
LYMPH	O
NODE	O
(	O
MICROMETASTASES	O
,	O
.	O
1	O
.	O
8	O
MM	O
IN	O
GREATEST	O
DIAMETER	O
)	O
.	O

B	O
.	O
,	O
C	O
.	O

SENTINEL	O
LYMPH	O
NODES	O
#	O
2	O
-	O
3	O
,	O
LEFT	O
AXILLA	O
,	O
EXCISION	O
:	O
-	O
TWO	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
(	O
0	O
/	O
2	O
)	O
.	O

D	O
.	O

LEFT	O
BREAST	O
,	O
MASTECTOMY	O
:	O
-	O
WELL	O
DIFFERENTIATED	O
INFILTRATING	O
DUCTAL	O
CARCINOMA	O
,	O
(	O
1	B
.	I
5	I
.	I
CM	I
IN	O
GREATEST	O
DIAMETER	O
,	O
SBR	O
GRADE	O
1	O
)	O
.	O

-	O
MULTIFOCAL	O
INTERMEDIATE	O
GRADE	O
DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
(	O
CRIBRIFORM	O
,	O
.	O
MICROPAPILLARY	O
,	O
AND	O
PAPILLARY	O
PATTERNS	O
)	O
.	O

-	O
PROLIFERATIVE	O
TYPE	O
FIBROCYSTIC	O
CHANGES	O
.	O

-	O
ATYPICAL	O
DUCTAL	O
HYPERPLASIA	O
.	O

-	O
ATYPICAL	O
LOBULAR	O
HYPERPLASIA	O
.	O

-	O
CHANGES	O
CONSISTENT	O
WITH	O
PREVIOUS	O
BIOPSY	O
SITE	O
,	O
UPPER	O
INNER	O
.	O

QUADRANT	O
,	O
WITH	O
ORGANIZING	O
HEMATOMA	O
.	O

-	O
THREE	O
ADDITIONAL	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
(	O
0	O
/	O
3	O
)	O
.	O

SEE	O
.	O

COMMENT	O
.	O

SPECIMEN	O
(	O
S	O
)	O
:	O
A	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
1	O
LEFT	O
AXILLA	O
.	O

B	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
2	O
LEFT	O
AXILLA	O
.	O

C	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
3	O
LEFT	O
AXILLA	O
.	O

D	O
.	O

LEFT	O
BREAST	O
.	O

CLINICAL	O
HISTORY	O
:	O
year	O
old	O
with	O
left	O
breast	O
ca	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
1	O
LEFT	O
AXILLA	O
.	O

Received	O
fresh	O
for	O
touch	O
prep	O
evaluation	O
labeled	O
with	O
the	O
patient	O
name	O
designated	O
"	O
A	O
-	O
sentinel	O
lymph	O
.	O
node	O
#	O
1	O
left	O
axilla	O
"	O
is	O
a	O
beige	O
-	O
tan	O
lymph	O
node	O
measuring	O
1	O
.	O
6	O
x	O
1	O
.	O
2	O
x	O
0	O
.	O
7	O
cm	O
.	O

The	O
specimen	O
is	O
bisected	O
,	O
.	O
touch	O
preps	O
are	O
performed	O
.	O

The	O
entire	O
specimen	O
is	O
submitted	O
in	O
a	O
cassette	O
labeled	O
A1	O
.	O

B	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
2	O
LEFT	O
AXILLA	O
.	O

Received	O
fresh	O
for	O
touch	O
prep	O
evaluation	O
labeled	O
with	O
the	O
patient	O
name	O
designated	O
"	O
B	O
-	O
sentinel	O
lymph	O
.	O
node	O
#	O
2	O
left	O
axilla	O
"	O
is	O
a	O
fragment	O
of	O
yellow	O
beige	O
soft	O
tissue	O
measuring	O
2	O
.	O
2	O
x	O
1	O
.	O
8	O
x	O
0	O
.	O
5	O
cm	O
.	O

A	O
tan	O
lymph	O
.	O
node	O
is	O
identified	O
and	O
measures	O
0	O
.	O
6	O
x	O
0	O
.	O
5	O
X	O
0	O
.	O
4	O
cm	O
.	O

The	O
lymph	O
node	O
is	O
bisected	O
,	O
touch	O
preps	O
are	O
.	O
performed	O
.	O

The	O
entire	O
specimen	O
is	O
submitted	O
in	O
cassette	O
labeled	O
B1	O
.	O

C	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
3	O
LEFT	O
AXILLA	O
.	O

Received	O
fresh	O
for	O
touch	O
prep	O
evaluation	O
labeled	O
with	O
the	O
patient	O
name	O
designated	O
"	O
C	O
-	O
sentinel	O
lymph	O
.	O
node	O
#	O
3	O
left	O
axilla	O
"	O
is	O
a	O
tan	O
lymph	O
node	O
measuring	O
1	O
.	O
3	O
x	O
0	O
.	O
9	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
specimen	O
is	O
bisected	O
,	O
touch	O
.	O
preps	O
are	O
performed	O
.	O

The	O
entire	O
specimen	O
is	O
submitted	O
in	O
a	O
cassette	O
labeled	O
C1	O
.	O

D	O
.	O

LEFT	O
BREAST	O
.	O

Received	O
fresh	O
for	O
tissue	O
procurement	O
labeled	O
with	O
the	O
patient	O
name	O
designated	O
"	O
D	O
-	O
left	O
breast	O
"	O
is	O
a	O
.	O
mastectomy	O
specimen	O
weighing	O
228	O
grams	O
measuring	O
15	O
.	O
3	O
x	O
15	O
.	O
0	O
X	O
3	O
.	O
0	O
cm	O
.	O

The	O
axilla	O
measures	O
5	O
.	O
0	O
x	O
.	O

3	O
.	O
5	O
x	O
1	O
.	O
0	O
cm	O
.	O

The	O
specimen	O
is	O
received	O
with	O
orientation	O
,	O
a	O
black	O
suture	O
indicating	O
the	O
axillary	O
tail	O
.	O

The	O
.	O
specimen	O
is	O
inked	O
as	O
follows	O
:	O
posterior	O
deep	O
margin	O
,	O
black	O
;	O
anterior	O
,	O
blue	O
.	O

The	O
overlying	O
ellipse	O
of	O
.	O
beige	O
-	O
tan	O
skin	O
measures	O
8	O
.	O
0	O
x	O
2	O
.	O
5	O
cm	O
.	O

The	O
light	O
beige	O
areola	O
measures	O
2	O
.	O
0	O
cm	O
in	O
diameter	O
.	O

The	O
.	O
everted	O
nipple	O
measures	O
0	O
.	O
9	O
cm	O
in	O
diameter	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
from	O
medial	O
to	O
lateral	O
.	O

Cut	O
section	O
shows	O
a	O
firm	O
,	O
granular	O
beige	O
-	O
tan	O
mass	O
in	O
the	O
lower	O
outer	O
quadrant	O
approaching	O
the	O
deep	O
.	O
margin	O
at	O
a	O
distance	O
of	O
0	O
.	O
2	O
cm	O
.	O

The	O
mass	O
measures	O
1	B
.	I
5	I
x	I
1	I
.	I
3	I
x	I
1	I
.	I
2	I
cm	I
and	O
is	O
located	O
4	O
.	O
5	O
cm	O
from	O
the	O
.	O
axilla	O
.	O

Extending	O
from	O
the	O
area	O
of	O
the	O
mass	O
through	O
the	O
central	O
portion	O
and	O
to	O
the	O
medial	O
,	O
beige	O
-	O
tan	O
.	O
fibrous	O
parenchyma	O
is	O
demonstrated	O
.	O

In	O
the	O
upper	O
inner	O
quadrant	O
there	O
is	O
a	O
hemorrhagic	O
well	O
-	O
.	O
circumscribed	O
area	O
measuring	O
2	O
.	O
4	O
x	O
1	O
.	O
6	O
x	O
1	O
.	O
0	O
cm	O
.	O

This	O
area	O
approaches	O
the	O
deep	O
margin	O
at	O
a	O
distance	O
.	O
of	O
0	O
.	O
2	O
cm	O
and	O
is	O
located	O
4	O
.	O
8	O
cm	O
from	O
the	O
lesion	O
.	O

A	O
portion	O
of	O
the	O
specimen	O
is	O
submitted	O
for	O
tissue	O
.	O
procurement	O
.	O

Representative	O
sections	O
are	O
submitted	O
as	O
follows	O
:	O
D1	O
-	O
D4	O
:	O
sections	O
of	O
the	O
lesion	O
and	O
overlying	O
posterior	O
margin	O
lower	O
outer	O
quadrant	O
.	O

D5	O
-	O
D9	O
:	O
representative	O
sections	O
of	O
central	O
fibrous	O
tissue	O
.	O

D10	O
-	O
D17	O
:	O
the	O
entire	O
hemorrhagic	O
area	O
in	O
the	O
upper	O
inner	O
quadrant	O
.	O

D18	O
-	O
D20	O
:	O
representative	O
sections	O
from	O
the	O
upper	O
outer	O
quadrant	O
.	O

D21	O
-	O
D23	O
:	O
representative	O
sections	O
from	O
the	O
lower	O
inner	O
quadrant	O
.	O

D24	O
-	O
D25	O
:	O
sections	O
of	O
nipple	O
.	O

D26	O
:	O
representative	O
section	O
of	O
skin	O
.	O

D27	O
-	O
D30	O
:	O
possible	O
axillary	O
lymph	O
nodes	O
.	O

COMMENT	O
:	O
Re	O
-	O
examination	O
of	O
the	O
original	O
touch	O
-	O
prep	O
examined	O
at	O
the	O
time	O
of	O
the	O
intra	O
-	O
operative	O
consultation	O
again	O
.	O
was	O
interpreted	O
as	O
no	O
evidence	O
of	O
malignant	O
cells	O
on	O
this	O
slide	O
.	O

The	O
permanent	O
sections	O
from	O
the	O
lymph	O
.	O
node	O
however	O
,	O
show	O
a	O
micrometastases	O
,	O
(	O
1	O
.	O
8	O
mm	O
)	O
.	O

Gross	O
examination	O
of	O
the	O
breast	O
reveals	O
an	O
ill	O
.	O
defined	O
mass	O
in	O
the	O
lower	O
outer	O
quadrant	O
measuring	O
1	O
.	O
5	O
x	O
1	O
.	O
3	O
x	O
1	O
.	O
0	O
cm	O
in	O
greatest	O
extent	O
.	O

In	O
addition	O
,	O
in	O
.	O
the	O
upper	O
inner	O
quadrant	O
there	O
is	O
a	O
hemorrhagic	O
area	O
measuring	O
2	O
.	O
4	O
x	O
1	O
.	O
6	O
x	O
1	O
cm	O
.	O

BREAST	O
CANCER	O
TEMPLATE	O
:	O
Specimen	O
type	O
:	O
Mastectomy	O
.	O

Needle	O
localization	O
:	O
Laterality	O
:	O
Left	O
.	O

INVASIVE	O
TUMOR	O
:	O
Present	O
.	O

Multifocal	O
:	O
Histologic	O
type	O
:	O
Ductal	O
.	O

Tumor	O
Size	O
(	O
cm	O
)	O
:	O
1	B
.	I
5	I
x	I
1	I
.	I
3	I
x	I
1	I
.	I
2	I
cm	I
.	O

Tumor	O
site	O
:	O
Lower	O
outer	O
quadrant	O
.	O

Grade	O
,	O
Tubular	O
:	O
2	O
.	O

Grade	O
,	O
Nuclear	O
:	O
2	O
.	O

Grade	O
,	O
Mitotic	O
:	O
1	O
.	O

Modified	O
Scarff	O
Bloom	O
Richardson	O
grade	O
:	O
I	O
.	O

Necrosis	O
:	O
Absent	O
.	O

Invasion	O
Vasc	O
/	O
Lymphatic	O
:	O
None	O
identified	O
.	O

DCIS	O
COMPONENT	O
:	O
DCIS	O
Quantity	O
:	O
Estimated	O
20	O
%	O
.	O

DCIS	O
Type	O
:	O
Cribriform	O
,	O
micropapillary	O
and	O
.	O
papillary	O
.	O

DCIS	O
Location	O
:	O
DCIS	O
is	O
associated	O
with	O
the	O
.	O
invasive	O
tumor	O
with	O
separate	O
foci	O
.	O
seen	O
away	O
from	O
the	O
invasive	O
.	O
tumor	O
in	O
the	O
central	O
region	O
of	O
the	O
.	O
breast	O
.	O

Nuclear	O
grade	O
:	O
Intermediate	O
.	O

Necrosis	O
:	O
None	O
identified	O
.	O

Location	O
of	O
Ca	O
+	O
+	O
:	O
DCIS	O
and	O
benign	O
epithelium	O
.	O

Margins	O
:	O
Negative	O
.	O

Distance	O
from	O
closest	O
margin	O
:	O
DCIS	O
extends	O
to	O
within	O
2	O
mm	O
of	O
.	O
carcinoma	O
extends	O
to	O
within	O
3	O
mm	O
.	O
of	O
the	O
deep	O
margin	O
.	O

Specimens	O
Involved	O
.	O

Specimens	O
:	O
D	O
:	O
LEFT	O
BREAST	O
.	O

HER2	O
Status	O
Results	O
,	O
Immunohistochemistry	O
Evaluation	O
.	O

SPECIMEN	O
.	O

Surgical	O
Excision	O
.	O

Block	O
Number	O
:	O
Block	O
.	O

D4	O
.	O

TEST	O
RESULTS	O
.	O

Interpretation	O
:	O
Negative	O
.	O

Intensity	O
:	O
1	O
+	O
.	O

%	O
Tumor	O
Staining	O
:	O
40	O
%	O
.	O

FISH	O
ORDERED	O
.	O

METHODOLOGY	O
.	O

Methodology	O
:	O
Fixation	O
Type	O
and	O
Length	O
:	O
Tissue	O
was	O
fixed	O
in	O
10	O
%	O
neutral	O
buffered	O
formalin	O
.	O

)	O
for	O
no	O
less	O
than	O
8	O
and	O
no	O
longer	O
than	O
24	O
hours	O
.	O

Antibody	O
and	O
Assay	O
Methodology	O
:	O
Rabbit	O
anti	O
-	O
human	O
HER2	O
,	O
HerceptestTM	O
(	O
FDA	O
-	O
approved	O
test	O
kit	O
)	O
,	O
.	O

Control	O
.	O

Slides	O
Examined	O
:	O
External	O
kit	O
-	O
slides	O
provided	O
by	O
manufacturer	O
(	O
cell	O
lines	O
with	O
high	O
,	O
low	O
and	O
negative	O
.	O
HER2	O
protein	O
expression	O
)	O
,	O
and	O
in	O
-	O
house	O
known	O
HER2	O
amplified	O
control	O
tissue	O
were	O
evaluated	O
along	O
.	O
with	O
the	O
test	O
tissue	O
.	O

These	O
control	O
slides	O
run	O
along	O
side	O
of	O
this	O
patient	O
'	O
s	O
sample	O
showed	O
appropriate	O
.	O
staining	O
.	O

Adequacy	O
of	O
Specimen	O
:	O
Adequate	O
,	O
well	O
preserved	O
,	O
clear	O
-	O
cut	O
invasive	O
carcinoma	O
identified	O
for	O
.	O

HER2	O
evaluation	O
.	O

Scoring	O
Criterion	O
and	O
Scoring	O
System	O
:	O
IHC	O
Level	O
of	O
Expression	O
(	O
Score	O
)	O
/	O
Tumor	O
Cell	O
Membrane	O
Staining	O
Pattern	O
.	O

Negative	O
(	O
0	O
)	O
/	O
Absence	O
of	O
Staining	O
.	O

Negative	O
(	O
1	O
+	O
)	O
/	O
Faint	O
Incomplete	O
membrane	O
Staining	O
,	O
>	O
10	O
%	O
of	O
Cells	O
.	O

Equivocal	O
(	O
2	O
+	O
)	O
/	O
Weak	O
complete	O
membrane	O
Staining	O
,	O
>	O
10	O
%	O
of	O
Cells	O
.	O

Positive	O
(	O
3	O
+	O
)	O
/	O
Strong	O
complete	O
membrane	O
Staining	O
,	O
>	O
10	O
%	O
of	O
Cells	O
.	O

Equivocal	O
Category	O
for	O
HER2	O
IHC	O
results	O
:	O
A	O
HER2	O
,	O
2	O
+	O
staining	O
result	O
that	O
is	O
interpreted	O
as	O
equivocal	O
.	O
may	O
not	O
indicate	O
gene	O
amplification	O
.	O

A	O
FISH	O
test	O
for	O
HER2	O
gene	O
amplification	O
will	O
be	O
ordered	O
for	O
all	O
.	O

HER2	O
IHC	O
2	O
+	O
results	O
.	O

COMMENT	O
.	O

HER2	O
analysis	O
was	O
performed	O
on	O
this	O
case	O
by	O
immunohistochemistry	O
utilizing	O
the	O
FDA	O
approved	O
.	O

HercepTest	O
(	O
TM	O
)	O
test	O
kit	O
following	O
the	O
manufacturer	O
'	O
s	O
instructions	O
listed	O
in	O
the	O
package	O
insert	O
.	O

This	O
.	O
assay	O
was	O
not	O
modified	O
,	O
and	O
adherence	O
to	O
all	O
instruction	O
and	O
guidelines	O
were	O
strictly	O
followed	O
.	O

Interpretation	O
of	O
the	O
HER2	O
immunohistochemical	O
staining	O
characteristics	O
is	O
guided	O
by	O
published	O
results	O
.	O
in	O
the	O
medical	O
literature	O
(	O
4	O
)	O
,	O
information	O
provided	O
by	O
the	O
reagent	O
manufacturer	O
and	O
by	O
internal	O
review	O
of	O
.	O
staining	O
performance	O
within	O
Pathology	O
Department	O
.	O

HER2	O
TEST	O
VALIDATION	O
.	O

This	O
HER2	O
immunohistochemical	O
assay	O
has	O
been	O
validated	O
according	O
to	O
the	O
recently	O
revised	O
.	O
recommendations	O
and	O
guidelines	O
from	O
the	O
NCCN	O
HER2	O
testing	O
in	O
Breast	O
Cancer	O
Task	O
Force	O
,	O
and	O
the	O
.	O
jointly	O
issued	O
recommendations	O
and	O
guidelines	O
from	O
ASCO	O
and	O
the	O
CAP	O
(	O
5	O
)	O
.	O

80	O
randomly	O
selected	O
.	O
breast	O
cancer	O
samples	O
were	O
tested	O
for	O
HER2	O
by	O
IHC	O
as	O
outline	O
above	O
and	O
interpreted	O
as	O
,	O
negative	O
.	O

(	O
score	O
0	O
/	O
1	O
+	O
)	O
equivocal	O
(	O
score	O
2	O
+	O
)	O
and	O
positive	O
(	O
score	O
3	O
+	O
)	O
without	O
knowledge	O
of	O
the	O
previous	O
reported	O
.	O
results	O
.	O

These	O
cases	O
were	O
also	O
blindly	O
read	O
using	O
two	O
different	O
FISH	O
assay	O
as	O
amplified	O
or	O
non	O
-	O
amplified	O
and	O
.	O
the	O
HER2	O
/	O
CEP17	O
ratios	O
were	O
recorded	O
.	O

After	O
analyzing	O
these	O
results	O
,	O
there	O
was	O
100	O
%	O
concordance	O
.	O
between	O
the	O
IHC	O
and	O
FISH	O
results	O
for	O
cases	O
that	O
were	O
interpreted	O
as	O
either	O
positive	O
or	O
negative	O
by	O
IHC	O
.	O

9	O
of	O
the	O
80	O
cases	O
were	O
interpreted	O
as	O
equivocal	O
by	O
IHC	O
and	O
of	O
these	O
3	O
/	O
9	O
(	O
33	O
%	O
)	O
were	O
non	O
-	O
amplified	O
by	O
.	O

FISH	O
and	O
6	O
/	O
9	O
(	O
66	O
%	O
)	O
were	O
found	O
to	O
be	O
amplified	O
.	O

The	O
Pathology	O
Department	O
Immunohistochemistry	O
laboratory	O
takes	O
full	O
responsibility	O
for	O
this	O
tests	O
.	O
performance	O
and	O
has	O
programs	O
in	O
place	O
to	O
regularly	O
monitor	O
the	O
proficiency	O
and	O
the	O
interpretation	O
of	O
.	O

HER2	O
assays	O
.	O

The	O
laboratory	O
also	O
participates	O
in	O
external	O
quality	O
assurance	O
HER2	O
programs	O
including	O
.	O
the	O
CAP	O
proficiency	O
testing	O
program	O
.	O

REFERENCE	O
.	O

1	O
.	O

Carlson	O
RW	O
,	O
Anderson	O
BO	O
,	O
Burstein	O
HJ	O
,	O
et	O
al	O
.	O
,	O
NCCN	O
breast	O
cancer	O
clinical	O
practice	O
guidelines	O
in	O
.	O
oncology	O
.	O

J	O
Natl	O
Compr	O
Canc	O
Netw	O
.	O

2005	O
;	O
3	O
:	O
238	O
-	O
289	O
.	O

Lobular	O
Neoplasia	O
:	O
Atypical	O
lobular	O
hyperplasia	O
.	O

Lymph	O
nodes	O
:	O
Sentinel	O
lymph	O
nodes	O
and	O
axillary	O
.	O
lymph	O
nodes	O
one	O
positive	O
,	O
(	O
1	O
/	O
6	O
)	O
.	O

Micrometastases	O
(	O
1	O
.	O
8	O
mm	O
in	O
.	O
greatest	O
diameter	O
,	O
negative	O
for	O
.	O
extranodal	O
extension	O
)	O
.	O

Non	O
-	O
neoplastic	O
areas	O
:	O
Atypical	O
ductal	O
hyperplasia	O
,	O
.	O
atypical	O
lobular	O
hyperplasia	O
,	O
.	O
columnar	O
cell	O
change	O
with	O
foci	O
of	O
.	O

BREAST	O
TUMOR	O
BIOMARKERS	O
TEMPLATE	O
.	O

Immunohistochemistry	O
for	O
ER	O
/	O
PR	O
and	O
Her	O
-	O
2	O
have	O
been	O
ordered	O
on	O
block	O
D4	O
,	O
and	O
the	O
results	O
will	O
be	O
.	O
issued	O
as	O
an	O
addendum	O
.	O

Pathologic	O
Stage	O
:	O
pT1c	O
pNimi	O
.	O

This	O
assay	O
can	O
be	O
used	O
to	O
select	O
invasive	O
breast	O
cancer	O
patients	O
for	O
hormone	O
therapy	O
(	O
1	O
)	O
.	O

ER	O
and	O
PR	O
analysis	O
was	O
performed	O
on	O
this	O
case	O
by	O
immunohistochemistry	O
utilizing	O
the	O
ER	O
(	O
ER	O
1D5	O
,	O
.	O
1	O
:	O
100	O
)	O
and	O
PR	O
(	O
PGR	O
136	O
,	O
1	O
:	O
100	O
)	O
antibody	O
provided	O
by	O
.	O
following	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O
listed	O
in	O
the	O
package	O
insert	O
.	O

This	O
assay	O
was	O
not	O
modified	O
,	O
and	O
adherence	O
to	O
all	O
instruction	O
and	O
.	O
guidelines	O
were	O
strictly	O
followed	O
.	O

Interpretation	O
of	O
the	O
ER	O
/	O
PR	O
immunohistochemical	O
staining	O
.	O
characteristics	O
is	O
guided	O
by	O
published	O
results	O
in	O
the	O
medical	O
literature	O
(	O
1	O
)	O
,	O
information	O
provided	O
by	O
the	O
.	O
reagent	O
manufacturer	O
and	O
by	O
internal	O
review	O
of	O
staining	O
performance	O
within	O
the	O
Pathology	O
Department	O
.	O

1	O
.	O

Harvey	O
JM	O
,	O
et	O
al	O
.	O

Estrogen	O
receptor	O
status	O
by	O
immunohistochemistry	O
is	O
superior	O
to	O
the	O
ligand	O
-	O
binding	O
.	O
assay	O
for	O
predicting	O
response	O
to	O
adjuvant	O
endocrine	O
therapy	O
in	O
breast	O
cancer	O
.	O

J	O
Clin	O
Oncol	O
.	O

17	O
:	O
1474	O
-	O
.	O

1481	O
,	O
1999	O
.	O

ADDENDUM	O
:	O
BREAST	O
ER	O
/	O
PR	O
-	O
1	O
.	O

Specimens	O
Involved	O
.	O

Specimens	O
:	O
D	O
:	O
LEFT	O
BREAST	O
.	O

SPECIMEN	O
.	O

Type	O
:	O
Surgical	O
Excision	O
.	O

Block	O
Number	O
:	O
D4	O
.	O

HORMONE	O
RECEPTOR	O
STATUS	O
.	O

Laboratory	O
:	O
Estrogen	O
Receptor	O
:	O
Positive	O
.	O

Allred	O
Score	O
:	O
8	O
=	O
Proportion	O
score	O
5	O
+	O
Intensity	O
score	O
3	O
.	O

Progesterone	O
Receptor	O
:	O
Positive	O
.	O

Allred	O
Score	O
:	O
8	O
=	O
Proportion	O
Score	O
5	O
+	O
Intensity	O
Score	O
3	O
.	O

The	O
Allred	O
score	O
for	O
estrogen	O
and	O
progesterone	O
receptors	O
is	O
calculated	O
by	O
adding	O
the	O
sum	O
of	O
the	O
.	O
proportion	O
score	O
(	O
0	O
=	O
no	O
staining	O
,	O
1	O
=	O
<	O
1	O
%	O
of	O
cells	O
staining	O
,	O
2	O
=	O
1	O
-	O
10	O
%	O
of	O
cells	O
staining	O
,	O
3	O
=	O
11	O
-	O
30	O
%	O
of	O
.	O
cells	O
staining	O
,	O
4	O
=	O
31	O
-	O
60	O
%	O
of	O
cells	O
staining	O
,	O
5	O
=	O
60	O
%	O
of	O
cells	O
staining	O
)	O
to	O
the	O
intensity	O
score	O
(	O
1	O
=	O
weak	O
.	O
intensity	O
of	O
staining	O
,	O
2	O
=	O
intermediate	O
intensity	O
of	O
staining	O
,	O
3	O
=	O
strong	O
intensity	O
of	O
staining	O
)	O
,	O
with	O
a	O
scoring	O
.	O
range	O
from	O
0	O
to	O
8	O
.	O

ER	O
/	O
PR	O
positive	O
is	O
defined	O
as	O
an	O
Allred	O
score	O
of	O
>	O
2	O
and	O
ER	O
/	O
PR	O
negative	O
is	O
defined	O
as	O
an	O
Allred	O
score	O
of	O
.	O
less	O
than	O
or	O
equal	O
to	O
2	O
.	O

Methodology	O
:	O
Fixation	O
Type	O
and	O
Length	O
:	O
Tissue	O
was	O
fixed	O
in	O
10	O
%	O
neutral	O
buffered	O
formalin	O
.	O
for	O
no	O
less	O
than	O
8	O
and	O
no	O
longer	O
than	O
24	O
hours	O
.	O

Antibody	O
and	O
Assay	O
Methodology	O
:	O
Mouse	O
anti	O
-	O
human	O
ER	O
and	O
PR	O
,	O
.	O

2	O
.	O

Carlson	O
RW	O
,	O
Brown	O
E	O
,	O
Burstein	O
HJ	O
,	O
et	O
al	O
.	O
,	O
NCCN	O
Task	O
Force	O
Report	O
:	O
adjuvant	O
therapy	O
for	O
breast	O
.	O
cancer	O
.	O

J	O
Natl	O
Compr	O
Canc	O
Netw	O
.	O

2006	O
;	O
4	O
:	O
S1	O
-	O
S26	O
.	O

3	O
.	O

Romond	O
EH	O
,	O
Perez	O
EA	O
,	O
Bryant	O
J	O
,	O
et	O
al	O
.	O

Trastuzumab	O
plus	O
adjuvant	O
chemotherapy	O
for	O
operable	O
.	O

HER2	O
-	O
positive	O
breast	O
cancer	O
.	O

N	O
Eng	O
J	O
Med	O
2005	O
;	O
353	O
(	O
16	O
)	O
:	O
1673	O
-	O
84	O
.	O

4	O
.	O

Leong	O
ASY	O
,	O
Formby	O
M	O
,	O
Haffajee	O
Z	O
,	O
et	O
al	O
.	O

Refinement	O
of	O
immunohistologic	O
parameters	O
for	O
Her2	O
/	O
neu	O
.	O
scoring	O
validation	O
by	O
FISH	O
and	O
CISH	O
.	O

Appl	O
Immunohistochem	O
Mol	O
Morphol	O
.	O

2006	O
;	O
14	O
:	O
384	O
-	O
389	O
.	O

5	O
.	O

Wolff	O
AC	O
,	O
Hammond	O
EH	O
,	O
Schwartz	O
JN	O
,	O
et	O
al	O
.	O
,	O
American	O
Society	O
of	O
Clinical	O
Oncology	O
/	O
College	O
of	O
.	O

American	O
Pathologists	O
Guideline	O
Recommendations	O
for	O
Human	O
Epidermal	O
Growth	O
Factor	O
Recepto	O
2	O
.	O

Testing	O
in	O
Breast	O
Cancer	O
.	O

Arch	O
of	O
Path	O
and	O
Lab	O
Med	O
2007	O
;	O
131	O
:	O
18	O
-	O
43	O
.	O

Microscopic	O
/	O
Diagnosuc	O
Dictation	O
:	O
PATHOLOGIST	O
,	O
.	O

Microscopic	O
/	O
Diagnostic	O
Dictation	O
:	O
PATHOLOGIST	O
.	O

Final	O
Review	O
:	O
PATHOLOGIST	O
,	O
.	O

Final	O
:	O
PATHOLOGIST	O
,	O
.	O

Addendum	O
:	O
,	O
.	O

Addendum	O
Review	O
:	O
PATHOLOGIST	O
.	O

Addendum	O
Final	O
:	O
PATHOLOGIST	O
.	O

Addendum	O
:	O
PATHOLOGIST	O
,	O
0	O
:	O
Addendum	O
Review	O
:	O
PATHOLOGIS	O
.	O

Addendum	O
Final	O
:	O
PATHOLOGIST	O
,	O
(	O
.	O

-DOCSTART-273
Main	O
diagnosis	O
/	O
diagnoses	O
:	O
Locally	O
advanced	O
,	O
peripheral	O
bronchopulmonary	O
,	O
histologically	O
mixed	O
adenocarcinoma	O
of	O
the	O
.	O
right	O
upper	O
lobe	O
of	O
the	O
lung	O
with	O
a	O
predominant	O
large	O
-	O
cell	O
,	O
polymorphocellular	O
and	O
partly	O
.	O
clear	O
-	O
cell	O
solid	O
component	O
,	O
with	O
bronchioloalveolar	O
growth	O
pattern	O
in	O
the	O
tumor	O
periphery	O
and	O
.	O
very	O
small	O
acinar	O
part	O
,	O
mainly	O
located	O
in	O
S1	O
and	O
satellite	O
focus	O
in	O
S3	O
.	O

TNM	O
classification	O
pT4	O
pN3	O
L1	O
V1	O
R0	O
,	O
stage	O
IIIB	O
.	O

C	O
34	O
.	O
1	O
M	O
8255	O
/	O
3	O
.	O

Comment	O
/	O
supplementary	O
remark	O
:	O
The	O
main	O
tumor	O
shows	O
a	O
large	O
cicatricial	O
area	O
and	O
has	O
invaded	O
small	O
blood	O
vessels	O
located	O
in	O
.	O
the	O
tumor	O
and	O
also	O
lymph	O
nodes	O
.	O

There	O
are	O
lymph	O
node	O
metastases	O
in	O
samples	O
1	O
.	O
)	O
to	O
4	O
.	O
)	O
,	O
6	O
.	O
)	O
to	O
.	O

8	O
.	O
)	O
and	O
10	O
.	O
)	O
.	O

The	O
visceral	O
pleura	O
and	O
resection	O
margins	O
of	O
the	O
bronchus	O
and	O
vessels	O
of	O
the	O
.	O
main	O
preparation	O
and	O
also	O
the	O
lymph	O
nodes	O
of	O
samples	O
5	O
.	O
)	O
to	O
9	O
.	O
)	O
are	O
tumor	O
-	O
free	O
.	O

-DOCSTART-274
Diagnosis	O
/	O
diagnoses	O
:	O
Total	O
gastrectomy	O
preparation	O
with	O
the	O
inclusion	O
of	O
an	O
extensive	O
,	O
widespread	O
,	O
ulcerated	O
,	O
.	O
poorly	O
differentiated	O
adenocarcinoma	O
(	O
intestinal	O
type	O
)	O
with	O
a	O
maximum	O
diameter	O
of	O
9	B
cm	I
and	O
.	O
extending	O
as	O
far	O
as	O
the	O
pylorus	O
with	O
infiltration	O
of	O
the	O
perigastric	O
fatty	O
tissue	O
and	O
.	O
circumscribed	O
penetration	O
of	O
the	O
overlying	O
serosa	O
.	O

Thirteen	O
regional	O
lymph	O
node	O
metastases	O
.	O

Tumor	O
-	O
free	O
oral	O
resection	O
margin	O
covered	O
with	O
unremarkable	O
squamous	O
epithelium	O
and	O
also	O
.	O
tumor	O
-	O
free	O
aboral	O
resection	O
margin	O
covered	O
with	O
characteristic	O
duodenal	O
mucosa	O
.	O

Tumor	O
-	O
free	O
.	O
omentum	O
.	O

Tumor	O
stage	O
:	O
pT3	O
pN2	O
(	O
14	O
/	O
58	O
)	O
pMX	O
;	O
.	O

-DOCSTART-275
Surgical	O
Pathology	O
Consultation	O
/	O
Department	O
of	O
Pathology	O
.	O

SPECIMEN	O
(	O
S	O
)	O
SUBMITTED	O
/	O
PROCEDURES	O
ORDERED	O
:	O
A	O
.	O

Brain	O
mass	O
(	O
88307	O
)	O
.	O

A	O
.	O

Frozen	O
Section	O
Charge	O
(	O
88331	O
)	O
.	O

B	O
.	O

Brain	O
mass	O
(	O
88307	O
)	O
.	O

CLINICAL	O
HISTORY	O
:	O
blood	O
pressure	O
in	O
200s	O
.	O

Brain	O
mass	O
at	O
left	O
.	O
temporal	O
lobe	O
.	O

GROSS	O
DESCRIPTION	O
:	O
Received	O
the	O
following	O
specimens	O
in	O
the	O
Department	O
of	O
.	O

Pathology	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
hospital	O
#	O
:	O
A	O
.	O

Brain	O
mass	O
.	O

B	O
.	O

Brain	O
mass	O
.	O

A	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
brain	O
mass	O
,	O
"	O
and	O
consists	O
.	O
of	O
a	O
1	O
.	O
0	O
X	O
0	O
.	O
8	O
X	O
0	O
.	O
6	O
cm	O
portion	O
of	O
tan	O
to	O
beige	O
soft	O
tissue	O
.	O

A	O
.	O
representative	O
portion	O
is	O
submitted	O
for	O
frozen	O
section	O
.	O

Frozen	O
section	O
.	O
diagnosis	O
is	O
,	O
"	O
Malignant	O
glioma	O
.	O
"	O
By	O
Dr	O
.	O
The	O
frozen	O
section	O
.	O
tissue	O
is	O
submitted	O
entirely	O
for	O
permanent	O
processing	O
in	O
cassette	O
FSA1	O
.	O
and	O
the	O
remaining	O
tissue	O
is	O
submitted	O
in	O
cassette	O
A2	O
.	O

B	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
brain	O
mass	O
,	O
and	O
consists	O
.	O
of	O
a	O
4	O
.	O
5	O
X	O
4	O
.	O
0	O
X	O
1	O
.	O
6	O
cm	O
irregular	O
ovoid	O
portion	O
of	O
cortical	O
gray	O
matter	O
.	O
and	O
underlying	O
subcortical	O
white	O
matter	O
.	O

Sectioning	O
reveals	O
partially	O
.	O
lodged	O
gray	O
and	O
white	O
interface	O
.	O

No	O
discrete	O
masses	O
are	O
seen	O
.	O

Representative	O
portion	O
of	O
tissue	O
is	O
submitted	O
for	O
.	O

Tumor	O
Bank	O
.	O

The	O
.	O
remaining	O
tissue	O
is	O
submitted	O
in	O
cassettes	O
B1	O
-	O
B7	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

Brain	O
mass	O
:	O
Glioblastoma	O
multiforme	O
(	O
WHO	O
Grade	O
IV	O
astrocytoma	O
)	O
.	O

B	O
.	O

Brain	O
mass	O
:	O
Glioblastoma	O
multiforme	O
(	O
WHO	O
Grade	O
IV	O
astrocytoma	O
)	O
.	O

"	O
I	O
,	O
or	O
my	O
qualified	O
designee	O
,	O
have	O
performed	O
the	O
gross	O
examination	O
and	O
.	O
description	O
and	O
I	O
have	O
personally	O
reviewed	O
the	O
gross	O
description	O
and	O
.	O
specimen	O
preparations	O
referenced	O
herein	O
,	O
and	O
have	O
personally	O
issued	O
this	O
.	O
report	O
.	O
"	O
.	O

Resident	O
/	O
Prosector	O
/	O
Pathologist	O
:	O
ICD9	O
Codes	O
:	O
191	O
.	O
9	O
.	O

Note	O
:	O
Test	O
systems	O
have	O
been	O
developed	O
and	O
their	O
performance	O
.	O
characteristics	O
determined	O
by	O
.	O

[	O
edical	O
Laboratories	O
.	O

Some	O
tests	O
.	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
.	O

Administration	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
clearance	O
is	O
not	O
.	O
necessary	O
.	O

These	O
tests	O
are	O
used	O
for	O
clinical	O
purposes	O
and	O
should	O
not	O
be	O
.	O
regarded	O
as	O
investigational	O
or	O
for	O
research	O
.	O

This	O
laboratory	O
is	O
certified	O
.	O
under	O
the	O
Clinical	O
Laboratory	O
Improvement	O
Amendments	O
of	O
.	O

as	O
.	O
qualified	O
to	O
perform	O
high	O
complexity	O
clinical	O
laboratory	O
testing	O
.	O

-DOCSTART-276
CLINICAL	O
DIAGNOSIS	O
:	O
HCC	O
.	O

Specimen	O
:	O
liver	O
.	O

Gross	O
Photo	O
:	O
0	O
.	O

GROSS	O
:	O
Specimen	O
:	O
Liver	O
:	O
20	O
.	O
5	O
x	O
9	O
.	O
5	O
x	O
3	O
.	O
5	O
cm	O
,	O
226	O
.	O
5	O
gm	O
(	O
unfixed	O
)	O
.	O

Operation	O
:	O
Left	O
lateral	O
segmentectomy	O
.	O

Lesion	O
:	O
A	O
well	O
-	O
defined	O
,	O
oval	O
,	O
lobulated	O
mass	O
.	O

Size	O
:	O
6	B
.	I
0	I
X	I
4	I
.	I
0	I
x	I
4	I
.	I
0	I
cm	I
.	O

Cut	O
surface	O
:	O
Yellowish	O
tan	O
with	O
bile	O
-	O
pigmented	O
(	O
necrosis	O
:	O
no	O
)	O
.	O

Gross	O
type	O
:	O
Expanding	O
nodular	O
.	O

Resection	O
margin	O
:	O
Not	O
involved	O
grossly	O
(	O
safety	O
margin	O
:	O
0	O
.	O
6	O
cm	O
)	O
.	O

Others	O
:	O
Satellite	O
nodule	O
:	O
No	O
.	O

Remaining	O
parenchyma	O
:	O
Unremarkable	O
.	O

Portal	O
vein	O
invasion	O
:	O
No	O
.	O

Gross	O
photo	O
:	O
Present	O
.	O

Blocks	O
.	O

T1	O
-	O
4	O
,	O
tumor	O
and	O
surrounding	O
tissue	O
X	O
4	O
.	O

L	O
,	O
remaining	O
parenchyme	O
of	O
liver	O
X	O
1	O
.	O

RM	O
,	O
resection	O
margin	O
of	O
liver	O
x	O
1	O
.	O

MICROSCOPIC	O
:	O
Hepatocellular	O
carcinoma	O
:	O
Yes	O
.	O

The	O
worst	O
differentiation	O
II	O
.	O

The	O
major	O
differentiation	O
II	O
.	O

Histologic	O
type	O
:	O
Trabecular	O
.	O

Cell	O
type	O
:	O
Hepatic	O
(	O
95	O
%	O
)	O
and	O
clear	O
(	O
5	O
%	O
)	O
.	O

Fatty	O
change	O
:	O
No	O
.	O

Fibrous	O
capsule	O
formation	O
:	O
No	O
.	O

Capsular	O
infiltration	O
:	O
No	O
.	O

Septum	O
formation	O
:	O
Yes	O
.	O

Surgical	O
resection	O
margin	O
invasion	O
:	O
No	O
.	O

Serosal	O
invasion	O
:	O
No	O
.	O

Portal	O
vein	O
invasion	O
:	O
No	O
.	O

Microvessel	O
invasion	O
:	O
No	O
.	O

Intrahepatic	O
metastasis	O
:	O
No	O
.	O

Multicentric	O
occurrence	O
:	O
No	O
.	O

Non	O
-	O
tumor	O
liver	O
pathology	O
.	O

1	O
.	O

Chronic	O
hepatitis	O
:	O
Yes	O
.	O

1	O
-	O
1	O
.	O

Etiology	O
:	O
HBV	O
.	O

1	O
-	O
2	O
.	O

Grade	O
,	O
lobular	O
:	O
Mild	O
.	O

1	O
-	O
3	O
.	O

Grade	O
,	O
portoperiportal	O
:	O
Minimal	O
.	O

1	O
-	O
4	O
.	O

Stage	O
(	O
fibrosis	O
)	O
:	O
Periportal	O
.	O

1	O
-	O
5	O
.	O

Cirrhosis	O
:	O
No	O
.	O
2	O
.	O

Dysplastic	O
nodule	O
:	O
No	O
.	O
3	O
.	O

Ductal	O
epithelial	O
dysplasia	O
:	O
No	O
.	O
4	O
.	O

Other	O
liver	O
diseases	O
:	O
No	O
.	O

NOT	O
reported	O
.	O

Gross	O
:	O
liver	O
,	O
ectomy	O
,	O
hepatocellular	O
carcinoma	O
.	O

T56000	O
,	O
P10	O
,	O
M81703	O
.	O

DIAGNOSIS	O
:	O
Liver	O
,	O
left	O
,	O
lateral	O
segmentectomy	O
:	O
Hepatocellular	O
carcinoma	O
.	O

Suggestion	O
:	O

-DOCSTART-277
LUNG	O
MALIGNANT	O
.	O

LUNG	O
UNINVOLVED	O
.	O

BLOOD	O
.	O

SERUM	O
.	O

PLASMA	O
.	O

BUFFY	O
-	O
COAT	O
.	O

Case	O
:	O
:	O
Collected	O
date	O
:	O
Result	O
date	O
:	O
Clinical	O
Information	O
.	O

The	O
patient	O
is	O
a	O
.	O
year	O
old	O
[	O
black	O
]	O
-	O
female	O
with	O
a	O
lung	O
nodule	O
.	O

Frozen	O
Section	O
Diagnosis	O
.	O

MFS1	O
:	O
Left	O
lower	O
lobe	O
,	O
resection	O
:	O
-	O
Adenocarcinoma	O
.	O

(	O
Per	O
.	O

Gross	O
Description	O
.	O

The	O
specimen	O
is	O
received	O
in	O
thirteen	O
containers	O
each	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
medical	O
record	O
.	O
number	O
.	O

The	O
first	O
container	O
is	O
labeled	O
"	O
level	O
IX	O
lymph	O
node	O
"	O
.	O

Received	O
is	O
an	O
anthracotic	O
fragment	O
of	O
tissue	O
measuring	O
1	O
.	O
5	O
.	O

x	O
0	O
.	O
8	O
x	O
0	O
.	O
3	O
cm	O
.	O

It	O
is	O
serially	O
sectioned	O
and	O
entirely	O
submitted	O
.	O

The	O
second	O
container	O
is	O
labeled	O
"	O
#	O
2	O
-	O
level	O
VIII	O
.	O
lymph	O
node	O
"	O
.	O

Received	O
is	O
an	O
anthracotic	O
tan	O
-	O
yellow	O
fragment	O
of	O
.	O
tissue	O
measuring	O
0	O
.	O
5	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
cm	O
,	O
submitted	O
in	O
total	O
.	O

The	O
third	O
container	O
is	O
labeled	O
"	O
#	O
3	O
-	O
level	O
VII	O
lymph	O
node	O
"	O
.	O

Received	O
is	O
an	O
anthrac	O
ó	O
tic	O
tan	O
-	O
gray	O
fragment	O
of	O
soft	O
.	O
tissue	O
measuring	O
0	O
,	O
8	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
4	O
cm	O
,	O
trisected	O
and	O
submitted	O
in	O
total	O
.	O

The	O
fourth	O
container	O
,	O
is	O
labeled	O
"	O
#	O
4	O
-	O
level	O
XI	O
lymph	O
node	O
"	O
.	O

Received	O
is	O
an	O
anthracotic	O
fragment	O
of	O
tissue	O
.	O
measuring	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
1	O
cm	O
,	O
submitted	O
in	O
total	O
.	O

The	O
fifth	O
container	O
is	O
labeled	O
"	O
#	O
5	O
-	O
level	O
V	O
lymph	O
node	O
"	O
Received	O
is	O
an	O
anthracotic	O
tan	O
-	O
gray	O
fragment	O
of	O
soft	O
.	O
tissue	O
measuring	O
1	O
.	O
0	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
5	O
cm	O
,	O
bisected	O
and	O
submitted	O
in	O
total	O
.	O

The	O
sixth	O
container	O
is	O
labeled	O
"	O
#	O
6	O
-	O
level	O
VI	O
lymph	O
node	O
"	O
.	O

Received	O
is	O
a	O
tan	O
-	O
yellow	O
and	O
focally	O
anthracotic	O
.	O
fragment	O
of	O
tissue	O
measuring	O
0	O
.	O
6	O
x	O
0	O
.	O
3	O
x	O
.	O
0	O
.	O
3	O
cm	O
,	O
submitted	O
in	O
total	O
.	O

The	O
seventh	O
container	O
is	O
labeled	O
"	O
#	O
7	O
-	O
level	O
XI	O
lymph	O
node	O
"	O
.	O

Received	O
is	O
an	O
anthracotic	O
fragment	O
of	O
tissue	O
.	O
measuring	O
0	O
.	O
4	O
.	O
x	O
.	O
0	O
.	O
4	O
,	O
x	O
0	O
,	O
3	O
cm	O
,	O
submitted	O
in	O
total	O
.	O

The	O
eighth	O
container	O
is	O
labeled	O
"	O
#	O
8	O
-	O
l	O
é	O
vel	O
X	O
lymph	O
node	O
"	O
.	O

Received	O
is	O
an	O
anthracotic	O
fragment	O
of	O
tissue	O
.	O
measuring	O
0	O
.	O
7	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
3	O
cm	O
,	O
submitted	O
in	O
total	O
,	O
.	O

The	O
ninth	O
container	O
is	O
labeled	O
"	O
#	O
9	O
-	O
level	O
XIII	O
lymph	O
node	O
"	O
.	O

Received	O
is	O
an	O
irregularly	O
shaped	O
anthracotic	O
.	O
fragment	O
of	O
tissue	O
measuring	O
1	O
.	O
0	O
x	O
0	O
,	O
7	O
x	O
0	O
.	O
3	O
cm	O
,	O
trisected	O
and	O
submitted	O
in	O
total	O
,	O
.	O

The	O
tenth	O
container	O
is	O
labeled	O
"	O
#	O
10	O
-	O
level	O
XI	O
lymph	O
node	O
"	O
.	O

Received	O
are	O
two	O
anthracotic	O
fragments	O
of	O
tissue	O
.	O
ranging	O
from	O
0	O
.	O
2	O
up	O
to	O
0	O
,	O
5	O
cm	O
,	O
submitted	O
in	O
total	O
.	O

The	O
eleventh	O
container	O
is	O
labeled	O
"	O
#	O
11	O
-	O
level	O
.	O

X	O
lymph	O
node	O
"	O
.	O

Received	O
is	O
a	O
single	O
anthracotic	O
fragment	O
of	O
tissue	O
.	O
measuring	O
1	O
.	O
0	O
x	O
0	O
.	O
6	O
X	O
0	O
.	O
5	O
cm	O
,	O
bisected	O
and	O
submitted	O
in	O
total	O
,	O
.	O

The	O
twelfth	O
-	O
container	O
is	O
labeled	O
"	O
#	O
12	O
-	O
level	O
X	O
lymph	O
node	O
"	O
.	O

Received	O
is	O
an	O
irregularly	O
shaped	O
anthracotic	O
.	O
fragment	O
of	O
tissue	O
measuring	O
1	O
.	O
2	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
4	O
cm	O
that	O
is	O
trisected	O
and	O
submitted	O
in	O
total	O
.	O

/	O
.	O

The	O
thirteenth	O
container	O
is	O
labeled	O
"	O
#	O
13	O
-	O
left	O
lower	O
.	O

lobe	O
"	O
.	O

Received	O
is	O
a	O
lobectomy	O
specimen	O
consistent	O
with	O
the	O
.	O
left	O
lower	O
lobe	O
measuring	O
18	O
,	O
0	O
x	O
9	O
.	O
0	O
x	O
3	O
.	O
3	O
cm	O
in	O
greatest	O
dimensions	O
,	O
The	O
pleural	O
surface	O
is	O
tan	O
-	O
pink	O
and	O
shows	O
.	O
moderate	O
to	O
severe	O
anthracotic	O
pigmentation	O
:	O
There	O
is	O
a	O
staple	O
line	O
noted	O
across	O
the	O
hilum	O
of	O
the	O
lung	O
revealing	O
.	O
unremarkable	O
bronchial	O
and	O
vascular	O
structures	O
,	O
The	O
br	O
ö	O
nchi	O
are	O
lined	O
by	O
tan	O
-	O
pink	O
gliste	O
ñ	O
ing	O
mucosa	O
without	O
.	O
distinct	O
gross	O
lesion	O
.	O

Located	O
2	O
.	O
5	O
cm	O
from	O
the	O
bronchial	O
resection	O
margin	O
;	O
there	O
is	O
an	O
intramural	O
tan	O
gritty	O
nodule	O
measuring	O
1	O
.	O
2	O
cm	O
in	O
.	O
greatest	O
dimensions	O
.	O

This	O
nodule	O
is	O
surrounded	O
by	O
red	O
-	O
brown	O
spongy	O
pulmonary	O
parenchyma	O
.	O

A	O
representative	O
.	O
section	O
of	O
this	O
nodule	O
is	O
submitted	O
for	O
frozen	O
section	O
as	O
MFS1	O
.	O

The	O
remaining	O
lung	O
reveals	O
spongy	O
and	O
.	O
moderately	O
anthracotic	O
pulmonary	O
parenchyma	O
and	O
reveals	O
no	O
other	O
mass	O
lesion	O
.	O

There	O
are	O
no	O
other	O
gross	O
.	O
lesions	O
identified	O
,	O
The	O
remaining	O
tumor	O
is	O
submitted	O
for	O
permanent	O
section	O
while	O
a	O
portion	O
of	O
tumor	O
is	O
submitted	O
.	O
for	O
frozen	O
.	O

Block	O
Summary	O
.	O

A1	O
-	O
Level	O
IX	O
lymph	O
node	O
.	O

B1	O
-	O
Level	O
VIII	O
lymph	O
node	O
.	O

C1	O
-	O
Level	O
VIHymph	O
node	O
.	O

D1	O
-	O
(	O
Level	O
XI	O
lymph	O
node	O
,	O
.	O

E1	O
-	O
Level	O
V	O
Jymph	O
node	O
.	O

F1	O
-	O
Level	O
VI	O
lymph	O
node	O
.	O

G1	O
-	O
Level	O
XI	O
lymph	O
node	O
.	O

H1	O
-	O
Level	O
X	O
lymph	O
riode	O
.	O

11	O
-	O
Level	O
XIII	O
lymph	O
node	O
,	O
.	O

J1	O
-	O
Level	O
XI	O
lymph	O
node	O
.	O

K1	O
-	O
Level	O
X	O
lymph	O
node	O
.	O

L1	O
-	O
Level	O
X	O
lymph	O
node	O
,	O
.	O

M1	O
-	O
Left	O
lower	O
Jobe	O
mass	O
,	O
.	O

M2	O
-	O
Bronchial	O
and	O
vascular	O
.	O
shave	O
margins	O
left	O
lower	O
lobe	O
.	O

M3	O
-	O
Small	O
peribronchiolar	O
,	O
lymph	O
nodes	O
.	O

M4	O
-	O
Remainder	O
of	O
left	O
lower	O
lobe	O
mass	O
,	O
.	O

M5	O
-	O
Uninvolved	O
p	O
á	O
renchyma	O
.	O

Mieroscopic	O
Description	O
.	O

A	O
microscopic	O
examination	O
has	O
been	O
performed	O
.	O

Diagnosis	O
.	O

(	O
A	O
)	O
Lymph	O
node	O
,	O
level	O
IX	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
malignancy	O
.	O

(	O
B	O
)	O
Lymph	O
node	O
,	O
level	O
VIII	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
malignancy	O
.	O

(	O
c	O
)	O
Lymph	O
node	O
,	O
level	O
VII	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
malignancy	O
.	O

(	O
D	O
)	O
Lymph	O
node	O
,	O
level	O
XI	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
malignancy	O
.	O

(	O
E	O
)	O
Lymph	O
node	O
,	O
level	O
V	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
malignancy	O
.	O

(	O
F	O
)	O
Lymph	O
node	O
,	O
level	O
VI	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
malignancy	O
.	O

(	O
G	O
)	O
Lymph	O
node	O
,	O
level	O
XI	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
malignancy	O
.	O

(	O
H	O
)	O
Lymph	O
(	O
node	O
,	O
level	O
X	O
,	O
excision	O
:	O
7	O
Negative	O
for	O
malignancy	O
.	O

(	O
I	O
)	O
Lymph	O
node	O
,	O
level	O
XIII	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
malignancy	O
.	O

(	O
J	O
)	O
Lymph	O
node	O
,	O
level	O
XI	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
malignancy	O
.	O

(	O
K	O
)	O
Lymph	O
node	O
,	O
level	O
X	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
malignancy	O
.	O

(	O
L	O
)	O
Lymph	O
:	O
node	O
,	O
level	O
X	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
malignancy	O
.	O

(	O
M	O
)	O
Lung	O
,	O
left	O
lower	O
lobe	O
,	O
lobectomy	O
:	O
-	O
Adenocarcinoma	O
(	O
1	B
.	I
2	I
cm	I
)	O
,	O
moderately	O
differentiated	O
.	O

-	O
Pleura	O
.	O

is	O
not	O
involve	O
by	O
tumor	O
.	O

-	O
Surgical	O
margin	O
negative	O
for	O
malignancy	O
.	O

-	O
Three	O
peribronchial	O
lymph	O
nodes	O
negative	O
for	O
malignancy	O
(	O
0	O
/	O
3	O
)	O
.	O

(	O
Electronically	O
signed	O
by	O
)	O
.	O

Verified	O
:	O
Synoptic	O
Report	O
.	O

SPECIMEN	O
:	O
Lobe	O
(	O
s	O
)	O
of	O
lung	O
:	O
left	O
lower	O
-	O
lobe	O
.	O

PROCEDURE	O
;	O
Lobectomy	O
.	O

SPECIMEN	O
INTEGRITY	O
:	O
Intact	O
.	O

SPECIMEN	O
LATERALITY	O
:	O
Left	O
.	O

TUMOR	O
SITE	O
:	O
Lower	O
lobe	O
.	O

TUMOR	O
SIZE	O
:	O
Grealestidimension	O
:	O
.	O
:	O
1	B
,	I
2	I
.	I
cm	I
.	O

TUMOR	O
FOCALITY	O
:	O
Unifocal	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Adenocarcinama	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
G2	O
:	O
Moderately	O
differentiated	O
.	O

VISCERAL	O
PLEURA	O
INVASION	O
:	O
Not	O
identified	O
.	O

TUMOR	O
EXTENSION	O
:	O
Not	O
identified	O
.	O

BRONCHIAL	O
MARGIN	O
:	O
Uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

VASCULAR	O
MARGIN	O
:	O
Uninvolved	O
by	O
inv	O
á	O
sive	O
carcinoma	O
.	O

PARIETAL	O
PL	O
É	O
URAL	O
MARGIN	O
:	O
Uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

LYMPH	O
NODES	O
:	O
Present	O
.	O

PRIMARY	O
TUMOR	O
(	O
pT	O
)	O
:	O
pT1a	O
:	O
Tumor	O
2	O
cm	O
or	O
less	O
in	O
greatest	O
dimension	O
,	O
surrounded	O
by	O
lung	O
or	O
visceral	O
pleura	O
,	O
.	O
without	O
bronchoscopic	O
evidence	O
of	O
invasion	O
more	O
proximal	O
than	O
the	O
lobar	O
bronchus	O
(	O
ie	O
,	O
not	O
in	O
the	O
main	O
.	O
bronchus	O
)	O
;	O
or	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
(	O
pN	O
)	O
:	O
pNO	O
:	O
No	O
regional	O
lymph	O
node	O
metastasis	O
.	O

-DOCSTART-278
FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
LYMPH	O
NODE	O
,	O
LEVEL	O
7	O
NEAR	O
BRONCHUS	O
INTERMEDIUS	O
,	O
BIOPSY	O
-	O
.	O

NO	O
TUMOR	O
PRESENT	O
IN	O
ONE	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
2	O
:	O
LYMPH	O
NODE	O
,	O
LEVEL	O
7	O
NEAR	O
CARINA	O
,	O
BIOPSY	O
-	O
.	O

NO	O
TUMOR	O
PRESENT	O
IN	O
ONE	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
3	O
:	O
LYMPH	O
NODE	O
,	O
LEVEL	O
7	O
NEAR	O
LEFT	O
MAIN	O
BRONCHUS	O
,	O
BIOPSY	O
-	O
.	O

NO	O
TUMOR	O
PRESENT	O
IN	O
ONE	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
4	O
:	O
LYMPH	O
NODE	O
,	O
PERIESOPHAGEAL	O
,	O
BIOPSY	O
-	O
.	O

A	O
.	O

BENIGN	O
FIBROADIPOSE	O
TISSUE	O
.	O

B	O
.	O

NO	O
LYMPH	O
NODE	O
IDENTIFIED	O
.	O

PART	O
5	O
:	O
SOFT	O
TISSUE	O
,	O
PERIESOPHAGEAL	O
-	O
.	O

A	O
.	O

BENIGN	O
FIBROADIPOSE	O
TISSUE	O
.	O

B	O
.	O

NO	O
TUMOR	O
PRESENT	O
.	O

PART	O
6	O
:	O
ESOPHAGUS	O
,	O
ESOPHAGECTOMY	O
-	O
.	O

A	O
.	O

MODERATELY	O
DIFFERENTIATED	O
ADENOCARCINOMA	O
,	O
3	B
.	I
5	I
CM	I
,	O
INVASIVE	O
INTO	O
BUT	O
NOT	O
THROUGH	O
THE	O
.	O

MUSCULARIS	O
PROPRIA	O
,	O
LOCATED	O
AT	O
THE	O
GASTROESOPHAGEAL	O
JUNCTION	O
.	O

B	O
.	O

ANGIOLYMPHATIC	O
AND	O
PERINEURAL	O
INVASION	O
PRESENT	O
.	O

C	O
.	O

MARGINS	O
FREE	O
OF	O
TUMOR	O
;	O
TUMOR	O
IS	O
0	O
.	O
1	O
CM	O
FROM	O
THE	O
CIRCUMFERENTIAL	O
(	O
ADVENTITIAL	O
)	O
MARGIN	O
.	O

D	O
.	O

PATHOLOGIC	O
STAGE	O
:	O
pT2	O
pN2	O
.	O

E	O
.	O

ADDITIONAL	O
FINDINGS	O
:	O
a	O
.	O

HIGH	O
-	O
GRADE	O
COLUMNAR	O
EPITHELIAL	O
DYSPLASIA	O
ASSOCIATED	O
WITH	O
THE	O
INVASIVE	O
.	O

ADENOCARCINOMA	O
.	O

b	O
.	O

NO	O
DEFINITIVE	O
BARRETT	O
'	O
S	O
MUCOSA	O
IDENTIFIED	O
.	O

F	O
.	O

GASTRIC	O
MUCOSA	O
OTHERWISE	O
WITHOUT	O
SIGNIFICANT	O
ABNORMALITY	O
.	O

PART	O
7	O
:	O
ANASTOMOTIC	O
RINGS	O
,	O
RESECTION	O
-	O
.	O

NO	O
TUMOR	O
PRESENT	O
.	O

PART	O
8	O
:	O
FINAL	O
GASTRIC	O
MARGIN	O
,	O
RESECTION	O
-	O
.	O

NO	O
TUMOR	O
PRESENT	O
.	O

PART	O
9	O
:	O
GASTROESOPHAGEAL	O
FAT	O
,	O
RESECTION	O
-	O
.	O

A	O
.	O

METASTATIC	O
ADENOCARCINOMA	O
IN	O
THREE	O
OF	O
EIGHTEEN	O
LYMPH	O
NODES	O
(	O
3	O
/	O
18	O
)	O
.	O

B	O
.	O

NON	O
-	O
NECROTIZING	O
FIBROTIC	O
GRANULOMAS	O
INVOLVING	O
ONE	O
ANTHRACOTIC	O
LYMPH	O
NODE	O
.	O

C	O
.	O

RESULTS	O
OF	O
GROCOTT	O
AND	O
AFB	O
STAINS	O
WILL	O
BE	O
REPORTED	O
IN	O
AN	O
ADDENDUM	O
.	O

PART	O
10	O
:	O
LYMPH	O
NODE	O
,	O
SUBCARINAL	O
NEAR	O
AZYGOUS	O
,	O
BIOPSY	O
-	O
.	O

NO	O
TUMOR	O
PRESENT	O
IN	O
ONE	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
11	O
:	O
LYMPH	O
NODE	O
,	O
PERIGASTRIC	O
,	O
BIOPSY	O
-	O
.	O

METASTATIC	O
ADENOCARCINOMA	O
IN	O
ONE	O
OF	O
ONE	O
LYMPH	O
NODE	O
(	O
1	O
/	O
1	O
)	O
.	O

PART	O
12	O
:	O
LYMPH	O
NODE	O
,	O
LEVEL	O
7	O
,	O
BIOPSY	O
-	O
.	O

NO	O
TUMOR	O
PRESENT	O
IN	O
ONE	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
13	O
:	O
LYMPH	O
NODE	O
,	O
SUBCARINAL	O
"	O
ON	O
ESOPHAGUS	O
"	O
,	O
BIOPSY	O
-	O
.	O

NO	O
TUMOR	O
PRESENT	O
IN	O
ONE	O
LYMPH	O
NODE	O
(	O
C	O
.	O

PART	O
14	O
:	O
LYMPH	O
NODE	O
,	O
SUBCARINAL	O
,	O
BIOPSY	O
.	O

NO	O
TUMOR	O
PRESENT	O
IN	O
ONE	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
15	O
:	O
LYMPH	O
NODE	O
,	O
NEAR	O
GASTRIC	O
CURVE	O
,	O
BIOPSY	O
-	O
.	O

METASTATIC	O
ADENOCARCINOMA	O
IN	O
ONE	O
OF	O
ONE	O
LYMPH	O
NODE	O
(	O
1	O
/	O
1	O
)	O
WITH	O
EXTRACAPSULAR	O
EXTENSION	O
.	O

PART	O
16	O
:	O
LYMPH	O
NODE	O
,	O
GASTRIC	O
FAT	O
,	O
BIOPSY	O
-	O
.	O

NO	O
TUMOR	O
PRESENT	O
IN	O
ONE	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
17	O
:	O
LYMPH	O
NODE	O
,	O
FAT	O
PAD	O
,	O
BIOPSY	O
-	O
.	O

NO	O
TUMOR	O
PRESENT	O
IN	O
ONE	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

COMPREHENSIVE	O
THERANOSTIC	O
SUMMARY	O
.	O

IMMUNOHISTOCHEMISTRY	O
:	O
Her2	O
:	O
EQUIVOCAL	O
(	O
2	O
+	O
)	O
.	O

IN	O
SITU	O
HYBRIDIZATION	O
/	O
FISH	O
:	O
HER2	O
(	O
ERBB2	O
)	O
amplification	O
:	O
NEGATIVE	O
.	O

Addendum	O
.	O

Part	O
9	O
:	O
Grocott	O
and	O
AFB	O
stains	O
are	O
negative	O
for	O
fungal	O
and	O
mycobacterial	O
organisms	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
DATA	O
-	O
PRIMARY	O
ESOPHAGEAL	O
TUMORS	O
.	O

MACROSCOPIC	O
.	O

SPECIMEN	O
TYPE	O
:	O
Esophagectomy	O
.	O

TUMOR	O
SITE	O
:	O
Tumor	O
midpoint	O
centered	O
on	O
esophagogastric	O
junction	O
.	O

TUMOR	O
SIZE	O
:	O
Greatest	O
dimension	O
:	O
3	B
.	I
5	I
cm	I
.	O

Additional	O
dimensions	O
:	O
2	B
.	I
0	I
,	O
1	B
.	I
0	I
cm	I
.	O

MICROSCOPIC	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Adenocarcinoma	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
G2	O
.	O

PATHOLOGIC	O
STAGING	O
(	O
pTNM	O
)	O
.	O

pT2	O
.	O

pN2	O
.	O

Number	O
of	O
lymph	O
nodes	O
examined	O
:	O
29	O
.	O

Number	O
of	O
lymph	O
nodes	O
involved	O
:	O
5	O
.	O

pM	O
Not	O
applicable	O
.	O

PRIOR	O
TREATMENT	O
:	O
No	O
prior	O
treatment	O
.	O

MARGINS	O
.	O

Proximal	O
margin	O
uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

Distal	O
margin	O
uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

Circumferential	O
(	O
adventitial	O
)	O
margin	O
uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

Distance	O
of	O
invasive	O
carcinoma	O
from	O
closest	O
margin	O
:	O
1	O
mm	O
.	O

Specify	O
margin	O
:	O
Circumferential	O
.	O

ANGIOLYMPHATIC	O
INVASION	O
:	O
Present	O
.	O

ADDITIONAL	O
PATHOLOGIC	O
FINDINGS	O
:	O
High	O
grade	O
dysplasia	O
.	O

SPECIAL	O
PROCEDURES	O
:	O
In	O
Situ	O
Procedure	O
.	O

Interpretation	O
.	O

HER2	O
FISH	O
STUDIES	O
PERFORMED	O
ON	O
THE	O
ADENOCARCINOMA	O
ARE	O
NEGATIVE	O
.	O

#	O
Cells	O
Analyzed	O
:	O
63	O
.	O

Ratio	O
HER2	O
/	O
CEP17	O
:	O
1	O
.	O
28	O
.	O

SNR	O
:	O
2	O
.	O
9	O
.	O

CNR	O
:	O
2	O
.	O
2	O
.	O

%	O
Hyperdiploid	O
:	O
21	O
(	O
33	O
.	O
3	O
%	O
)	O
.	O

HER2	O
IMMUNOPEROXIDASE	O
STUDIES	O
PERFORMED	O
ON	O
THE	O
ADENOCARCINOMA	O
ARE	O
EQUIVOCAL	O
.	O

IHC	O
score	O
:	O
2	O
+	O
.	O

INTERPRETATION	O
GUIDELINES	O
AND	O
PROBE	O
/	O
CLONE	O
INFORMATION	O
:	O
FISH	O
:	O
Probe	O
:	O
HER2	O
.	O

DNA	O
Probe	O
.	O

Probe	O
Description	O
:	O
The	O
.	O

HER2	O
.	O

DNA	O
probe	O
is	O
a	O
190	O
Kb	O
.	O
directly	O
labeled	O
fluorescent	O
DNA	O
probe	O
.	O
specific	O
for	O
the	O
HER2	O
.	O
gene	O
locus	O
.	O

The	O
CEP	O
17	O
DNA	O
probe	O
is	O
a	O
5	O
.	O
4	O
Kb	O
.	O
directly	O
labeled	O
.	O
fluorescent	O
DNA	O
probe	O
specific	O
for	O
the	O
alpha	O
satellite	O
DNA	O
sequence	O
at	O
the	O
centromeric	O
region	O
of	O
chromosome	O
17	O
.	O

The	O
probes	O
are	O
pre	O
-	O
mixed	O
and	O
pre	O
-	O
denatured	O
in	O
hybridization	O
buffer	O
.	O

Interpretation	O
:	O
HER2	O
negative	O
:	O
HER2	O
gene	O
/	O
chromosome	O
17	O
ratio	O
less	O
than	O
2	O
.	O
0	O
.	O

HER2	O
positive	O
:	O
HER2	O
gene	O
/	O
chromosome	O
17	O
ratio	O
greater	O
than	O
2	O
.	O
0	O
.	O

Results	O
should	O
be	O
considered	O
along	O
with	O
other	O
clinical	O
information	O
.	O
has	O
modified	O
the	O
suggested	O
manufacturer	O
protocol	O
for	O
HER2	O
FISH	O
testing	O
.	O

The	O
modifications	O
have	O
been	O
tested	O
and	O
validated	O
.	O

The	O
modifications	O
are	O
as	O
follows	O
:	O
Slides	O
are	O
deparaffinized	O
in	O
.	O

Tissue	O
is	O
.	O
digested	O
in	O
protease	O
31	O
minutes	O
;	O
Tissue	O
and	O
probe	O
are	O
co	O
-	O
denatured	O
at	O
90	O
C	O
for	O
12	O
minutes	O
;	O
Paraffin	O
pretreatment	O
reagents	O
and	O
.	O
control	O
slides	O
are	O
prepared	O
in	O
house	O
.	O

Amplified	O
,	O
non	O
-	O
amplified	O
,	O
and	O
internal	O
(	O
centromere	O
17	O
)	O
controls	O
were	O
used	O
in	O
the	O
testing	O
.	O

The	O
.	O
laboratory	O
takes	O
responsibility	O
for	O
the	O
test	O
performance	O
.	O

FISH	O
analysis	O
was	O
manually	O
performed	O
and	O
quantitatively	O
assessed	O
by	O
analysis	O
of	O
a	O
minimum	O
of	O
60	O
cells	O
using	O
the	O
HER2	O
.	O
and	O
the	O
CEP17	O
.	O
probes	O
.	O

IHC	O
:	O
anti	O
-	O
HER	O
-	O
2	O
/	O
neu	O
(	O
4B5	O
)	O
Rabbit	O
Monocional	O
Primary	O
Antibody	O
.	O

Tumors	O
are	O
considered	O
POSITIVE	O
if	O
they	O
show	O
HER2	O
protein	O
over	O
-	O
expression	O
(	O
3	O
+	O
)	O
by	O
IHC	O
.	O

IHC	O
scoring	O
for	O
HER2	O
in	O
gastric	O
and	O
GE	O
junction	O
cancer	O
by	O
type	O
of	O
diagnostic	O
specimen	O
:	O
SCORE	O
SURGICAL	O
SPECIMEN	O
-	O
STAINING	O
PATTERN	O
.	O

NEGATIVE	O
.	O

0	O
.	O

No	O
reactivity	O
or	O
membranous	O
reactivity	O
in	O
<	O
10	O
%	O
of	O
tumor	O
cells	O
.	O

1	O
+	O
.	O

Faint	O
/	O
barely	O
perceptible	O
membranous	O
reactivity	O
in	O
10	O
%	O
of	O
tumor	O
cells	O
;	O
cells	O
are	O
reactive	O
only	O
in	O
part	O
of	O
their	O
membrane	O
.	O

EQUIVOCAL	O
.	O

2	O
+	O
.	O

Weak	O
to	O
moderate	O
complete	O
,	O
basolateral	O
or	O
lateral	O
membranous	O
reactivity	O
in	O
10	O
%	O
of	O
tumor	O
cells	O
.	O

POSITIVE	O
.	O

3	O
+	O
.	O

Strong	O
complete	O
,	O
basolateral	O
or	O
lateral	O
membranous	O
reactivity	O
in	O
10	O
%	O
of	O
tumor	O
cells	O
.	O

BIOPSY	O
SPECIMEN	O
-	O
STAINING	O
PATTERN	O
.	O

NEGATIVE	O
.	O

0	O
.	O

No	O
reactivity	O
or	O
no	O
membranous	O
reactivity	O
in	O
any	O
(	O
or	O
<	O
5	O
clustered	O
)	O
tumor	O
cells	O
.	O

1	O
+	O
.	O

Tumor	O
cell	O
cluster	O
(	O
5	O
cells	O
)	O
with	O
a	O
faint	O
/	O
barely	O
perceptible	O
membranous	O
reactivity	O
irrespective	O
of	O
percentage	O
of	O
tumor	O
.	O
cells	O
stained	O
.	O

EQUIVOCAL	O
.	O

2	O
+	O
.	O

Tumor	O
cell	O
cluster	O
(	O
5	O
cells	O
)	O
with	O
a	O
weak	O
to	O
moderate	O
complete	O
,	O
basolateral	O
or	O
lateral	O
membranous	O
reactivity	O
irrespective	O
.	O
of	O
percentage	O
of	O
tumor	O
cells	O
stained	O
.	O

POSITIVE	O
.	O

3	O
+	O
.	O

Tumor	O
cell	O
cluster	O
(	O
5	O
cells	O
)	O
with	O
a	O
strong	O
complete	O
,	O
basolateral	O
or	O
lateral	O
membranous	O
reactivity	O
irrespective	O
of	O
.	O
percentage	O
of	O
tumor	O
cells	O
stained	O
.	O

-DOCSTART-279
Note	O
:	O
If	O
you	O
do	O
not	O
see	O
"	O
END	O
OF	O
PRINTED	O
REPORT	O
"	O
at	O
the	O
bottom	O
of	O
th	O
.	O
the	O
report	O
YOU	O
DO	O
NOT	O
HAVE	O
THE	O
ENTIRE	O
REPORT	O
.	O

Please	O
try	O
prin	O
.	O

CONFIDENTIAL	O
.	O

Relevant	O
.	O
information	O
.	O

Demographics	O
.	O

(	O
for	O
verification	O
.	O
Date	O
of	O
Birth	O
:	O
purposes	O
)	O
.	O

Sex	O
:	O
M	O
.	O

Collected	O
Date	O
/	O
Time	O
.	O

Received	O
Date	O
/	O
Time	O
.	O

Specimen	O
Description	O
.	O

A	O
.	O

Gallbladder	O
.	O

B	O
.	O

HCC	O
tumor	O
left	O
lobe	O
.	O

C	O
.	O

Deep	O
margin	O
.	O

D	O
.	O

Final	O
margin	O
liver	O
lobe	O
left	O
.	O

Clinical	O
Information	O
.	O

Infectious	O
patient	O
:	O
Yes	O
-	O
Hep	O
+	O
.	O

Cirrhosis	O
,	O
hepatocellular	O
carcinoma	O
?	O
.	O

Diagnosis	O
.	O

A	O
.	O

Gallbladder	O
,	O
Cholecystectomy	O
:	O
Gallbladder	O
with	O
no	O
pathologic	O
abnormality	O
.	O

B	O
.	O

Liver	O
,	O
(	O
Left	O
Lobe	O
)	O
,	O
Wedge	O
Resection	O
:	O
-	O
Hepatocellular	O
carcinoma	O
,	O
Grade	O
III	O
/	O
IV	O
.	O

The	O
tumor	O
measures	O
2	B
.	I
7	I
cm	I
in	O
maximal	O
dimension	O
.	O

Carcinoma	O
is	O
present	O
at	O
the	O
cauterized	O
/	O
inked	O
parenchymal	O
margin	O
.	O
in	O
this	O
specimen	O
(	O
see	O
comment	O
)	O
.	O

Focal	O
small	O
vessel	O
invasion	O
is	O
seen	O
within	O
the	O
tumor	O
itself	O
.	O

No	O
perineural	O
invasion	O
identified	O
.	O

Cirrhosis	O
of	O
the	O
surrounding	O
liver	O
parenchyma	O
.	O

C	O
.	O

Liver	O
,	O
(	O
Deep	O
Margin	O
)	O
,	O
Excision	O
:	O
-	O
Negative	O
for	O
hepatocellular	O
carcinoma	O
.	O

D	O
.	O

Liver	O
,	O
(	O
Final	O
Margin	O
)	O
,	O
Excision	O
:	O
-	O
Negative	O
for	O
hepatocellular	O
carcinoma	O
.	O

Verifier	O
.	O

Gross	O
Description	O
.	O

Received	O
are	O
specimen	O
containers	O
A	O
in	O
n	O
.	O
roquisitions	O
and	O
specimen	O
containers	O
are	O
.	O
labelled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
.	O

The	O
cassettes	O
and	O
AP	O
identifiers	O
are	O
.	O
labelled	O
with	O
the	O
Surgical	O
Number	O
.	O

A	O
.	O

The	O
specimen	O
is	O
designated	O
"	O
Gallbladder	O
"	O
The	O
specimen	O
is	O
received	O
fresh	O
and	O
is	O
.	O
subsequently	O
placed	O
into	O
formalin	O
and	O
consists	O
of	O
a	O
gallbladder	O
that	O
measures	O
10	O
.	O
0	O
x	O
4	O
.	O
0	O
.	O

x	O
4	O
.	O
0	O
cm	O
.	O

Opening	O
the	O
gallbladder	O
reveals	O
approximately	O
10	O
ml	O
of	O
dark	O
green	O
bile	O
.	O

The	O
.	O
serosa	O
of	O
the	O
gallbladder	O
appears	O
unremarkable	O
as	O
does	O
the	O
mucosal	O
surface	O
.	O

There	O
are	O
no	O
.	O
stones	O
present	O
.	O

A	O
section	O
of	O
mucosa	O
is	O
submitted	O
in	O
cassette	O
A1	O
.	O

B	O
.	O

The	O
specimen	O
is	O
designated	O
"	O
HCC	O
tumor	O
left	O
lobe	O
"	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
and	O
.	O

is	O
subsequently	O
placed	O
into	O
formalin	O
and	O
consists	O
of	O
a	O
piece	O
of	O
liver	O
that	O
weighs	O
43	O
.	O
8	O
.	O

g	O
.	O
and	O
measures	O
4	O
.	O
0	O
x	O
4	O
.	O
5	O
x	O
4	O
.	O
0	O
cm	O
.	O

There	O
is	O
a	O
solitary	O
firm	O
,	O
tan	O
nodule	O
present	O
at	O
the	O
.	O
inked	O
margin	O
of	O
the	O
specimen	O
and	O
this	O
nodule	O
measures	O
2	O
.	O
7	O
x	O
2	O
.	O
7	O
x	O
2	O
.	O
5	O
cm	O
.	O

The	O
surrounding	O
.	O
liver	O
parenchyma	O
is	O
cirrhotic	O
.	O

Random	O
sections	O
of	O
the	O
tumor	O
are	O
submitted	O
in	O
cassettes	O
.	O

B1	O
to	O
B5	O
.	O

B6	O
contains	O
uninvolved	O
cirrhotic	O
liver	O
parenchyma	O
.	O

C	O
.	O

The	O
specimen	O
is	O
designated	O
"	O
Deep	O
margin	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
small	O
fragment	O
.	O
of	O
firm	O
brown	O
tissue	O
that	O
measures	O
1	O
.	O
0	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
2	O
cm	O
.	O

It	O
is	O
submitted	O
in	O
toto	O
in	O
.	O
cassette	O
C1	O
.	O

D	O
.	O

The	O
specimen	O
is	O
designated	O
"	O
Final	O
margin	O
liver	O
lobe	O
left	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
.	O
firm	O
brown	O
friable	O
tissue	O
that	O
measures	O
1	O
.	O
1	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
2	O
cm	O
.	O

This	O
is	O
submitted	O
in	O
toto	O
in	O
.	O
cassette	O
D1	O
.	O

Pathclogist	O
Comment	O
.	O

Although	O
tumor	O
is	O
present	O
at	O
the	O
inked	O
margin	O
in	O
specimen	O
"	O
B	O
"	O
,	O
the	O
final	O
resection	O
.	O
margins	O
(	O
specimens	O
"	O
C	O
"	O
and	O
"	O
D	O
"	O
)	O
are	O
free	O
of	O
tumor	O
.	O

Number	O
.	O

Encounter	O
.	O

Number	O
.	O

Patient	O
Location	O
.	O

-	O
END	O
OF	O
PRINTED	O
REPORT	O
-	O
.	O

Criteria	O
.	O

is	O
.	O

Temor	O
Site	O
Diser	O
epancy	O
.	O

Drive	O
may	O
Ht	O
tory	O
.	O

Primary	O
Notad	O
.	O
asei	O
.	O

(	O
UALIFI	O
'	O
S	O
/	O
.	O

=	O
wer	O
Initiais	O
.	O

BIH	O
atc	O
Per	O
wid	O
1	O
.	O
16	O
.	O
13	O
.	O

-DOCSTART-280
clinical	O
Diagnosis	O
&	O
History	O
:	O
%	O
/	O
O	O
female	O
with	O
left	O
breast	O
mass	O
.	O

Mammo	O
showed	O
2	O
lesions	O
in	O
UOQ	O
left	O
.	O
breast	O
.	O

Core	O
biopaies	O
IDC	O
and	O
DCIS	O
.	O

Proceeding	O
to	O
MRM	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
SP	O
:	O
Left	O
breast	O
with	O
level	O
1	O
and	O
low	O
level	O
2	O
axillary	O
contents	O
.	O

2	O
:	O
SP	O
:	O
Additional	O
level	O
2	O
left	O
axillary	O
contents	O
.	O

3	O
:	O
SP	O
:	O
Left	O
level	O
2	O
and	O
level	O
3	O
axillary	O
contents	O
.	O

DIAGNOSIS	O
:	O
1	O
)	O
.	O

BREAST	O
WITH	O
LEVEL	O
I	O
AND	O
LOW	O
LEVEL	O
II	O
AXILLARY	O
CONTENTS	O
,	O
LEFT	O
;	O
.	O

MODIFIED	O
RADICAL	O
MASTECTOMY	O
AND	O
AXILLARY	O
LYMPH	O
NODE	O
DISSECTION	O
:	O
-	O
TWO	O
SEPARATE	O
TUMOR	O
NODULES	O
:	O
ONE	O
IS	O
LOCATED	O
IN	O
THE	O
UPPER	O
OUTER	O
.	O

QUADRANT	O
AND	O
SHOWS	O
AN	O
INVASIVE	O
DUCTAL	O
CARCINOMA	O
,	O
POORLY	O
DIFFERENTIATED	O
.	O

(	O
HISTOLOGIC	O
GRADE	O
III	O
/	O
III	O
,	O
NUCLEAR	O
GRADE	O
III	O
/	O
III	O
)	O
,	O
MEASURING	O
3	B
.	I
9	I
CM	I
IN	O
.	O

LARGEST	O
DIMENSION	O
GROSSLY	O
.	O

THE	O
SECOND	O
IS	O
LOCATED	O
IN	O
THE	O
UPPER	O
AND	O
LOWER	O
OUTER	O
QUADRANTS	O
AT	O
3	O
:	O
00	O
AND	O
IS	O
.	O

COMPOSED	O
OF	O
PREDOMINANTLY	O
DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
(	O
DCIS	O
)	O
WITH	O
SEVERAL	O
FOCI	O
.	O

OF	O
INVASIVE	O
DUCTAL	O
CARCINOMA	O
,	O
POORLY	O
DIFFERENTIATED	O
AND	O
SIMILAR	O
TO	O
ABOVE	O
,	O
.	O

RANGING	O
IN	O
SIZE	O
FROM	O
LESS	O
THAN	O
0	B
.	I
1	I
CM	I
TO	O
ABOUT	O
0	B
.	I
4	I
CM	I
.	O

-	O
THE	O
DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
(	O
DCIS	O
)	O
IS	O
OF	O
THE	O
SOLID	O
AND	O
CRIBRIFORM	O
TYPES	O
.	O

WITH	O
HIGH	O
NUCLEAR	O
GRADE	O
,	O
EXTENSIVE	O
NECROSIS	O
AND	O
FOCALLY	O
INVOLVES	O
A	O
LARGE	O
.	O

LACTIFEROUS	O
DUCT	O
OF	O
THE	O
NIPPLE	O
.	O

-	O
CALCIFICATIONS	O
ARE	O
PRESENT	O
IN	O
THE	O
IN	O
SITU	O
AND	O
INVASIVE	O
CARCINOMA	O
,	O
AND	O
IN	O
.	O

BENIGN	O
BREAST	O
PARENCHYMA	O
.	O

-	O
VASCULAR	O
INVASION	O
IS	O
PRESENT	O
.	O

-	O
NO	O
INVOLVEMENT	O
OF	O
THE	O
SURGICAL	O
MARGINS	O
BY	O
EITHER	O
INVASIVE	O
OR	O
IN	O
SITU	O
.	O

CARCINOMA	O
IS	O
IDENTIFIED	O
.	O

-	O
NO	O
SKIN	O
INVOLVEMENT	O
BY	O
CARCINOMA	O
IS	O
IDENTIFIED	O
.	O

-	O
THE	O
REMAINING	O
BREAST	O
TISSUE	O
SHOWS	O
PREVIOUS	O
BIOPSY	O
SITE	O
AND	O
MILD	O
.	O

FIBROCYSTIC	O
CHANGES	O
.	O

-	O
THE	O
LYMPH	O
NODE	O
STATUS	O
IS	O
AS	O
FOLLOWS	O
(	O
EXPRESSED	O
AS	O
THE	O
NUMBER	O
OF	O
POSITIVE	O
.	O
LYMPH	O
NODES	O
IN	O
RELATION	O
TO	O
THE	O
TOTAL	O
NUMBER	O
OF	O
LYMPH	O
NODES	O
EXAMINED	O
)	O
:	O
THERE	O
IS	O
EXTRANODAL	O
TUMOR	O
EXTENSION	O
(	O
>	O
2	O
MM	O
)	O
.	O

-	O
RESULTS	O
OF	O
IMMUNOHISTOCHEMICAL	O
STAINS	O
ARE	O
AS	O
FOLLOWS	O
:	O
ER	O
:	O
0	O
%	O
NUCLEAR	O
STAINING	O
.	O

PR	O
:	O
0	O
%	O
NUCLEAR	O
STAINING	O
.	O

HER	O
-	O
2	O
/	O
NEU	O
(	O
HERCEPTEST	O
)	O
:	O
NEGATIVE	O
(	O
STAINING	O
INTENSITY	O
OF	O
1	O
+	O
)	O
.	O

2	O
)	O
.	O

AXILLARY	O
CONTENTS	O
,	O
LEFT	O
ADDITIONAL	O
LEVEL	O
II	O
;	O
DISSECTION	O
:	O
TWELVE	O
BENIGN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
12	O
)	O
.	O

3	O
)	O
.	O

AXILLARY	O
CONTENTS	O
,	O
LEFT	O
LEVELS	O
II	O
AND	O
III	O
;	O
DISSECTION	O
:	O
-	O
THREE	O
BENIGN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
3	O
)	O
.	O

I	O
ATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
.	O

THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
,	O
AND	O
THAT	O
I	O
HAVE	O
REVIEWED	O
AND	O
APPROVED	O
.	O

THIS	O
REPORT	O
.	O

Special	O
Studies	O
:	O
Special	O
Stain	O
.	O

Comment	O
.	O

ER	O
-	O
C	O
.	O

PR	O
-	O
C	O
.	O

HER2	O
-	O
0	O
.	O

NEG	O
CONT	O
.	O

IMM	O
RECUT	O
.	O

NEG	O
-	O
HER2	O
.	O

Gross	O
Description	O
:	O
1	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
,	O
"	O
Left	O
breast	O
with	O
level	O
1	O
and	O
.	O
low	O
level	O
2	O
axillary	O
contents	O
,	O
stitch	O
marks	O
axillary	O
contents	O
and	O
consists	O
.	O
of	O
a	O
breast	O
with	O
attached	O
axillary	O
tail	O
.	O

The	O
breast	O
measures	O
37	O
.	O
0	O
x	O
26	O
.	O
0	O
.	O

x	O
.	O

6	O
.	O
7	O
cm	O
with	O
overlying	O
skin	O
ellipse	O
measuring	O
36	O
.	O
5	O
x	O
18	O
.	O
0	O
cm	O
.	O

Situated	O
on	O
.	O
the	O
skin	O
surface	O
is	O
an	O
everted	O
nipple	O
measuring	O
1	O
.	O
4	O
x	O
1	O
.	O
2	O
x	O
0	O
.	O
1	O
cm	O
and	O
.	O
areola	O
measuring	O
4	O
.	O
8	O
x	O
4	O
.	O
5	O
cm	O
.	O

The	O
skin	O
shows	O
no	O
visible	O
scars	O
.	O

A	O
suture	O
.	O
demarcates	O
the	O
axillary	O
tail	O
which	O
measures	O
11	O
.	O
0	O
x	O
4	O
.	O
0	O
x	O
3	O
.	O
5	O
cm	O
.	O

The	O
.	O
posterior	O
surface	O
of	O
the	O
breast	O
is	O
inked	O
black	O
and	O
the	O
specimen	O
is	O
serially	O
.	O
sectioned	O
to	O
reveal	O
a	O
white	O
tan	O
firm	O
ill	O
-	O
defined	O
mass	O
in	O
the	O
upper	O
outer	O
.	O
quadrant	O
measuring	O
3	O
.	O
9	O
x	O
3	O
.	O
7	O
x	O
3	O
.	O
3	O
cm	O
,	O
located	O
1	O
.	O
5	O
from	O
the	O
deep	O
margin	O
.	O

There	O
is	O
a	O
biopsy	O
site	O
identified	O
in	O
the	O
lower	O
outer	O
quadrant	O
,	O
corresponding	O
.	O
to	O
the	O
three	O
o	O
'	O
clock	O
position	O
,	O
measuring	O
2	O
.	O
0	O
x	O
2	O
.	O
0	O
x	O
1	O
.	O
5	O
cm	O
.	O

The	O
remaining	O
.	O
breast	O
tissue	O
shows	O
predominantly	O
yellow	O
lobulated	O
adipose	O
tissue	O
admixed	O
.	O
with	O
white	O
-	O
tan	O
fibrous	O
soft	O
tissue	O
with	O
no	O
other	O
gross	O
identifiable	O
lesions	O
.	O

The	O
axillary	O
tissue	O
is	O
dissected	O
to	O
reveal	O
several	O
grossly	O
positive	O
lymph	O
.	O
nodes	O
,	O
measuring	O
up	O
to	O
4	O
.	O
5	O
cm	O
.	O

Representative	O
sections	O
of	O
the	O
mastectomy	O
.	O
specimen	O
and	O
all	O
identified	O
axillary	O
lymph	O
nodes	O
are	O
submitted	O
(	O
the	O
large	O
.	O
grossly	O
positive	O
lymph	O
nodes	O
are	O
representatively	O
submitted	O
)	O
.	O

Tissue	O
.	O

is	O
.	O
taken	O
for	O
TPS	O
.	O

Summary	O
of	O
sections	O
:	O
N	O
-	O
nipple	O
.	O

NB	O
-	O
nipple	O
base	O
.	O

s	O
skin	O
.	O

D	O
-	O
deep	O
margin	O
.	O

T	O
tumor	O
.	O

BX	O
-	O
separate	O
biopsy	O
site	O
.	O

UIQ	O
-	O
upper	O
inner	O
quadrant	O
.	O

LIQ	O
-	O
lower	O
inner	O
quadrant	O
.	O

UOQ	O
-	O
upper	O
outer	O
quadrant	O
.	O

LOQ	O
-	O
lower	O
outer	O
quadrant	O
.	O

LN	O
-	O
individual	O
lymph	O
nodes	O
.	O

2	O
)	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
Additional	O
level	O
2	O
.	O
left	O
axillary	O
contents	O
"	O
and	O
consists	O
of	O
an	O
axillary	O
dissection	O
measuring	O
7	O
x	O
.	O

4	O
.	O
5	O
x	O
0	O
.	O
8	O
cm	O
.	O

The	O
specimen	O
consists	O
of	O
soft	O
yellow	O
-	O
tan	O
lobulated	O
tissue	O
.	O
with	O
several	O
pink	O
-	O
tan	O
lymph	O
nodes	O
identified	O
on	O
cut	O
section	O
ranging	O
from	O
0	O
.	O
2	O
.	O

cm	O
to	O
1	O
.	O
8	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
specimen	O
is	O
submitted	O
for	O
lymph	O
.	O
node	O
digest	O
dissection	O
.	O

Summary	O
of	O
sections	O
:	O
LN	O
-	O
lymph	O
nodes	O
.	O

3	O
)	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
Left	O
level	O
2	O
and	O
level	O
.	O

3	O
axillary	O
contents	O
"	O
and	O
consists	O
of	O
an	O
unoriented	O
axillary	O
dissection	O
.	O
measuring	O
7	O
.	O
5	O
x	O
4	O
.	O
7	O
x	O
1	O
.	O
8	O
cm	O
.	O

The	O
specimen	O
consists	O
of	O
yellow	O
tan	O
lobulated	O
.	O
tissue	O
,	O
which	O
on	O
sectioning	O
reveals	O
several	O
pink	O
-	O
tan	O
lymph	O
nodes	O
ranging	O
.	O
from	O
0	O
.	O
2	O
cm	O
to	O
2	O
.	O
3	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
specimen	O
is	O
submitted	O
for	O
.	O
lymph	O
node	O
dissection	O
.	O

Summary	O
of	O
sections	O
:	O
LN	O
-	O
lymph	O
nodes	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
SP	O
:	O
Left	O
breast	O
with	O
level	O
1	O
and	O
low	O
level	O
2	O
axillary	O
contents	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

3	O
.	O

BX	O
.	O

3	O
.	O

1	O
.	O

D	O
.	O

1	O
.	O

2	O
.	O

LIQ	O
.	O

2	O
.	O

4	O
.	O

LN	O
.	O

4	O
.	O

2	O
.	O

LOQ	O
.	O

2	O
.	O

1	O
.	O

N	O
.	O

1	O
.	O

1	O
.	O

NB	O
.	O

1	O
.	O

1	O
.	O

s	O
.	O

1	O
.	O

3	O
.	O

T	O
.	O

3	O
.	O

2	O
.	O

UIQ	O
.	O

2	O
.	O

2	O
.	O

2	O
.	O

Part	O
2	O
:	O
SP	O
:	O
Additional	O
level	O
2	O
left	O
axillary	O
contents	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

4	O
.	O

LN	O
.	O

4	O
.	O

2art	O
3	O
:	O
.	O

SP	O
:	O
Left	O
level	O
2	O
and	O
level	O
3	O
axillary	O
contents	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

2	O
.	O

LN	O
.	O

2	O
.	O

-DOCSTART-281
RUN	O
DATE	O
:	O
I	O
.	O

RUN	O
TIME	O
:	O
:	O
;	O
pecimen	O
Inquiry	O
.	O

CrIENT	O
.	O

LOC	O
:	O
U	O
#	O
:	O
AGE	O
/	O
SX	O
:	O
RM	O
/	O
BED	O
:	O
REG	O
DR	O
:	O
No	O
PCP	O
/	O
Family	O
Physician	O
.	O

TLOC	O
:	O
DIS	O
:	O
SPEC	O
#	O
:	O
Obtained	O
:	O
CLINICAL	O
HISTORY	O
:	O
ENDOMETRIAL	O
CANCER	O
.	O

SPECIMEN	O
/	O
PROCEDURE	O
:	O
1	O
.	O

UTERUS	O
-	O
UTERUS	O
,	O
TUBES	O
AND	O
OVARIES	O
.	O

2	O
.	O

LYMPH	O
NODE	O
-	O
RIGHT	O
PARA	O
-	O
AORTIC	O
.	O

3	O
.	O

LYMPH	O
NODE	O
-	O
LEFT	O
PARA	O
-	O
AORTIC	O
.	O

4	O
.	O

LYMPH	O
NODE	O
-	O
RIGHT	O
COMMON	O
ILIAC	O
.	O

5	O
.	O

LYMPH	O
NODE	O
-	O
RIGHT	O
PELVIC	O
.	O

6	O
.	O

LYMPH	O
NODE	O
-	O
LEFT	O
PELVIC	O
.	O

7	O
.	O

LYMPH	O
NODE	O
-	O
LEFT	O
COMMON	O
ILIAC	O
.	O

8	O
.	O

LYMPH	O
NODE	O
-	O
RIGHT	O
PELVIC	O
.	O

IMPRESSION	O
:	O
1	O
)	O
.	O

UTERUS	O
,	O
TUBES	O
AND	O
OVARIES	O
,	O
SALPINGO	O
-	O
OOPHORECTOMY	O
AND	O
HYSTERECTOMY	O
.	O

Endometrial	O
adenocarcinoma	O
,	O
endometrioid	O
type	O
,	O
FIGO	O
grade	O
II	O
,	O
nuclear	O
grade	O
2	O
.	O
involving	O
posterior	O
and	O
anterior	O
uterus	O
wall	O
and	O
extending	O
to	O
posterior	O
cervical	O
.	O
mucosa	O
,	O
with	O
myometrium	O
invasion	O
.	O

All	O
resection	O
margins	O
are	O
free	O
of	O
the	O
tumor	O
.	O

Ovaries	O
bilateral	O
,	O
without	O
tumor	O
involvement	O
.	O

Fallopian	O
tube	O
,	O
bilateral	O
,	O
without	O
involvement	O
.	O

Small	O
leiomyoma	O
of	O
myometrium	O
,	O
0	B
.	I
8	I
cm	I
.	O

2	O
)	O
.	O

LYMPH	O
NODE	O
,	O
RIGHT	O
PARA	O
-	O
AORTIC	O
,	O
DISSECTION	O
:	O
Fibrovascular	O
tissue	O
without	O
tumor	O
identified	O
.	O

No	O
lymph	O
nodes	O
identified	O
.	O

3	O
)	O
.	O

LYMPH	O
NODES	O
,	O
LEFT	O
PARA	O
-	O
AORTIC	O
,	O
DISSECTION	O
:	O
Five	O
lymph	O
nodes	O
with	O
metastasis	O
(	O
0	O
/	O
5	O
)	O
.	O

4	O
)	O
.	O

LYMPH	O
NODES	O
,	O
RIGHT	O
COMMON	O
ILIAC	O
,	O
DISSECTION	O
:	O
Three	O
lymph	O
nodes	O
without	O
metastasis	O
(	O
0	O
/	O
3	O
)	O
.	O

LYMPH	O
NODES	O
,	O
RIGHT	O
PELVIC	O
,	O
DISSECTION	O
:	O
Thirteen	O
lymph	O
nodes	O
without	O
metastasis	O
(	O
0	O
/	O
13	O
)	O
.	O

6	O
)	O
.	O

LYMPH	O
NODES	O
,	O
LEFT	O
PELVIC	O
,	O
DISSECTION	O
:	O
Eleven	O
lymph	O
nodes	O
without	O
metastasis	O
(	O
0	O
/	O
11	O
)	O
.	O

LYMPH	O
NODE	O
,	O
LEFT	O
COMMON	O
ILIAC	O
,	O
DISSECTION	O
:	O
Page	O
:	O
2	O
.	O

SPEC	O
#	O
:	O
Continued	O
)	O
.	O

CMPRESSION	O
:	O
(	O
continued	O
)	O
.	O

One	O
lymph	O
node	O
without	O
metastasis	O
(	O
0	O
/	O
1	O
)	O
.	O

8	O
)	O
.	O

LYMPH	O
NODE	O
,	O
RIGHT	O
PELVIC	O
,	O
DISECTION	O
:	O
One	O
lymph	O
node	O
without	O
metastasis	O
(	O
0	O
/	O
1	O
)	O
.	O

ENDOME	O
'	O
TRIAL	O
CARCINOMA	O
CHECKLIST	O
.	O

MACROSCOPIC	O
.	O

SPECIMEN	O
TYPE	O
.	O
tyoterectomy	O
and	O
salpingo	O
-	O
oophorectomy	O
.	O

TUMOR	O
SITE	O
.	O

Specify	O
location	O
(	O
s	O
)	O
,	O
if	O
known	O
Posterior	O
and	O
anterior	O
cavity	O
of	O
uterus	O
.	O

TUMOR	O
SIZE	O
.	O

Greatest	O
dimension	O
:	O
2	B
.	I
5	I
x	I
1	I
.	I
5	I
x	I
1	I
.	I
8	I
cm	I
.	O

OTHER	O
ORGANS	O
PRESENT	O
.	O

Right	O
ovary	O
.	O

Left	O
ovary	O
.	O

Right	O
fallopian	O
tube	O
.	O

Left	O
fallopian	O
tube	O
.	O

MICROSCOPIC	O
.	O

(	O
ISTOLOGIC	O
TYPE	O
.	O

Endometrioid	O
adenocarcinoma	O
,	O
not	O
otherwise	O
characterized	O
.	O

HISTOLOGIC	O
GRADE	O
.	O

G2	O
:	O
6	O
%	O
to	O
50	O
%	O
nonsquamous	O
solid	O
growth	O
.	O

MYOMETRIAL	O
INVASION	O
.	O

Myometrial	O
invasion	O
present	O
.	O

Maximal	O
depth	O
of	O
myometrial	O
invasion	O
:	O
2	O
mm	O
.	O

Thickness	O
of	O
myometrium	O
in	O
area	O
of	O
maximal	O
tumor	O
invasion	O
:	O
1	O
.	O

7cm	O
.	O

The	O
8	O
of	O
myometrial	O
involvement	O
:	O
12	O
%	O
.	O

EXTENT	O
OF	O
INVASION	O
.	O

PRIMARY	O
TUMOR	O
(	O
pT	O
)	O
.	O

TNM	O
(	O
FIGO	O
)	O
.	O

pT2a	O
(	O
IIA	O
)	O
:	O
Endocervical	O
glandular	O
involvement	O
only	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
(	O
pN	O
)	O
.	O

TNM	O
(	O
FIGO	O
)	O
.	O

pNO	O
:	O
No	O
regional	O
lymph	O
node	O
metastasis	O
.	O

Page	O
:	O
3	O
.	O

SPEC	O
#	O
:	O
IMPRESSION	O
:	O
(	O
continued	O
)	O
.	O

Number	O
examined	O
:	O
34	O
.	O

DISTANT	O
METASTASIS	O
(	O
pM	O
)	O
.	O

TNM	O
(	O
FIGO	O
)	O
.	O

pMX	O
:	O
Cannot	O
be	O
assessed	O
.	O

MARGINS	O
.	O

Uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

Distance	O
of	O
invasive	O
carcinoma	O
from	O
closest	O
margin	O
:	O
1	O
.	O
1	O
cm	O
.	O

(	O
Specify	O
margin	O
:	O
Cervical	O
radial	O
margin	O
.	O

VENOUS	O
/	O
LYMPILATIC	O
(	O
LARGE	O
/	O
SMALL	O
VESSEL	O
)	O
INVASION	O
(	O
V	O
/	O
L	O
)	O
.	O

Absent	O
.	O

ADDITIONAL	O
PATHOLOGIC	O
FINDINGS	O
.	O

None	O
identified	O
.	O

Pat	O
]	O
^	O
logic	O
TNM	O
(	O
AJCC	O
6th	O
Edition	O
)	O
:	O
pT2a	O
NO	O
MX	O
.	O

Entered	O
:	O
SPECIAL	O
STTAINS	O
/	O
PROCEDURES	O
:	O
Immunohistochemical	O
stains	O
are	O
performed	O
with	O
appropriate	O
positive	O
and	O
negative	O
control	O
on	O
.	O
section	O
1A	O
.	O

CD10	O
:	O
Marked	O
reduced	O
at	O
the	O
tumor	O
with	O
myometrium	O
invasion	O
.	O

GROSS	O
DESCRIPTION	O
:	O
Received	O
fresh	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
uterus	O
,	O
cervix	O
,	O
tubes	O
and	O
ovaries	O
"	O
,	O
is	O
a	O
.	O

67	O
.	O
gram	O
specimen	O
with	O
uterus	O
(	O
7	O
.	O
0	O
x	O
5	O
.	O
3	O
x	O
3	O
.	O
5	O
cm	O
)	O
,	O
left	O
ovary	O
(	O
2	O
.	O
5	O
x	O
1	O
.	O
6	O
x	O
0	O
.	O
9	O
cm	O
)	O
and	O
.	O
fallopian	O
tube	O
(	O
5	O
.	O
2	O
x	O
0	O
.	O
5	O
cm	O
)	O
,	O
and	O
right	O
ovary	O
(	O
3	O
.	O
0	O
x	O
1	O
.	O
6	O
x	O
0	O
.	O
7	O
cm	O
)	O
and	O
fallopian	O
tube	O
.	O

(	O
4	O
.	O
0	O
x	O
0	O
.	O
7	O
cm	O
)	O
.	O

The	O
serosal	O
surface	O
of	O
the	O
uterus	O
is	O
pink	O
to	O
dark	O
-	O
red	O
,	O
glistening	O
and	O
.	O

is	O
grossly	O
unremarkable	O
.	O

The	O
cervix	O
is	O
covered	O
by	O
dark	O
red	O
fibromuscular	O
tissue	O
.	O

The	O
.	O
ectocervix	O
is	O
dark	O
pink	O
,	O
smooth	O
and	O
glistening	O
.	O

The	O
uterus	O
is	O
bivalved	O
revealing	O
an	O
.	O
exophytic	O
soft	O
friable	O
,	O
yellow	O
-	O
tan	O
polypoid	O
lesion	O
,	O
2	O
.	O
5	O
x	O
1	O
.	O
5	O
x	O
1	O
.	O
8	O
cm	O
located	O
at	O
.	O
posterior	O
and	O
anterior	O
middle	O
portion	O
of	O
the	O
endometrial	O
cavity	O
.	O

The	O
remaining	O
.	O
endometrial	O
canal	O
,	O
3	O
.	O
0	O
x	O
2	O
.	O
6	O
cm	O
has	O
a	O
red	O
-	O
tan	O
glistening	O
herringbone	O
mucosa	O
.	O

Multiple	O
.	O
cuts	O
are	O
made	O
through	O
the	O
myometrium	O
,	O
1	O
.	O
5	O
cm	O
maximum	O
thickness	O
,	O
revealing	O
yellow	O
-	O
pink	O
.	O
finely	O
trabeculated	O
myometrium	O
and	O
a	O
1	O
.	O
0	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
6	O
cm	O
yellow	O
-	O
tan	O
ell	O
-	O
circumscribed	O
.	O
intramural	O
nodule	O
.	O

The	O
endocervical	O
canal	O
is	O
a	O
yellow	O
to	O
dark	O
red	O
,	O
glistening	O
.	O
herringbone	O
mucosa	O
that	O
is	O
grossly	O
unremarkable	O
.	O

The	O
endocervix	O
has	O
a	O
smooth	O
,	O
yellow	O
.	O

Page	O
:	O
4	O
.	O

SPEC	O
#	O
:	O
GROSS	O
DESCRIPTION	O
:	O
(	O
continued	O
)	O
.	O
cut	O
surface	O
.	O

The	O
external	O
surface	O
of	O
the	O
ovaries	O
are	O
yellow	O
-	O
tan	O
,	O
finely	O
nodular	O
with	O
.	O

a	O
solid	O
yellow	O
-	O
white	O
cut	O
surface	O
that	O
is	O
grossly	O
unremarkable	O
.	O

The	O
bilateral	O
.	O
fallopian	O
tubes	O
are	O
dark	O
red	O
to	O
pink	O
,	O
glistening	O
with	O
distal	O
fimbriated	O
ends	O
and	O
a	O
.	O
yellow	O
unremarkable	O
cut	O
surface	O
.	O

The	O
specimen	O
is	O
representatively	O
sampled	O
and	O
.	O
submitted	O
as	O
follows	O
:	O
CASSETTE	O
SUMMARY	O
:	O
Cassette	O
1A	O
,	O
18	O
:	O
Full	O
thickness	O
sections	O
,	O
posterior	O
uterus	O
with	O
lesion	O
in	O
two	O
.	O
cassettes	O
.	O

Cassette	O
1C	O
:	O
Full	O
thickness	O
section	O
,	O
posterior	O
uterus	O
with	O
well	O
-	O
circumscribed	O
.	O
nodule	O
.	O

Cassette	O
1D	O
,	O
1E	O
:	O
Full	O
thickness	O
sections	O
,	O
posterior	O
uterus	O
with	O
lesion	O
.	O

Cassette	O
1G	O
-	O
1K	O
:	O
Representative	O
full	O
thickness	O
sections	O
,	O
anterior	O
uterus	O
.	O

Cassette	O
1L	O
:	O
Representative	O
section	O
,	O
midportion	O
,	O
posterior	O
cervix	O
.	O

Cassette	O
1M	O
:	O
Representative	O
section	O
,	O
midportion	O
,	O
anterior	O
cervix	O
.	O

Cassette	O
1N	O
:	O
Left	O
ovary	O
and	O
fallopian	O
tube	O
,	O
representative	O
section	O
.	O

Cassette	O
1P	O
:	O
Right	O
ovary	O
and	O
fallopian	O
tube	O
,	O
representative	O
section	O
.	O

2	O
)	O
.	O

Received	O
in	O
formalin	O
,	O
labeled	O
"	O
right	O
para	O
-	O
aortic	O
lymph	O
node	O
"	O
and	O
with	O
the	O
patient	O
'	O
s	O
.	O
name	O
,	O
is	O
an	O
aggregate	O
of	O
irregular	O
portions	O
of	O
yellow	O
-	O
tan	O
lobulated	O
adipose	O
tissue	O
,	O
.	O

1	O
.	O
5	O
x	O
1	O
.	O
2	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
specimen	O
is	O
dissected	O
for	O
lymph	O
nodes	O
,	O
there	O
are	O
two	O
tan	O
.	O
ovoid	O
lymph	O
nodes	O
identified	O
,	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
and	O
0	O
.	O
7	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
cm	O
.	O

All	O
lymph	O
.	O
nodes	O
identified	O
are	O
submitted	O
in	O
cassette	O
#	O
2	O
.	O

3	O
)	O
.	O

Received	O
in	O
formalin	O
,	O
labeled	O
"	O
left	O
para	O
-	O
aortic	O
lymph	O
nodes	O
"	O
and	O
with	O
the	O
patient	O
'	O
s	O
.	O
name	O
,	O
is	O
an	O
aggregate	O
of	O
irregular	O
portions	O
of	O
yellow	O
-	O
tan	O
lobulated	O
adipose	O
tissue	O
,	O
.	O

1	O
.	O
5	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
specimen	O
is	O
dissected	O
for	O
lymph	O
nodes	O
,	O
there	O
are	O
five	O
tan	O
.	O
ovoid	O
lymph	O
nodes	O
identified	O
,	O
ranging	O
from	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
to	O
0	O
.	O
8	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
4	O
cm	O
.	O

All	O
lymph	O
nodes	O
identified	O
are	O
submitted	O
as	O
follows	O
:	O
CASSETTE	O
SUMMARY	O
:	O
Cassette	O
3A	O
:	O
Four	O
lymph	O
nodes	O
.	O

Cassette	O
3B	O
:	O
One	O
lymph	O
node	O
,	O
bivalved	O
.	O

4	O
)	O
.	O

Received	O
in	O
formalin	O
,	O
labeled	O
"	O
right	O
common	O
iliac	O
lymph	O
node	O
"	O
and	O
with	O
the	O
patient	O
'	O
s	O
.	O
name	O
,	O
are	O
two	O
irregular	O
unoriented	O
portions	O
of	O
yellow	O
-	O
tan	O
lobulated	O
adipose	O
tissue	O
,	O
.	O

0	O
.	O
8	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
4	O
cm	O
and	O
1	O
.	O
5	O
x	O
1	O
.	O

o	O
x	O
0	O
.	O
8	O
cm	O
.	O

The	O
specimen	O
is	O
dissected	O
for	O
lymph	O
.	O
nodes	O
,	O
there	O
are	O
three	O
tan	O
ovoid	O
lymph	O
nodes	O
identified	O
,	O
ranging	O
from	O
0	O
.	O
4	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
.	O

cm	O
to	O
1	O
.	O
3	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
4	O
cm	O
.	O

All	O
lymph	O
nodes	O
identified	O
are	O
submitted	O
as	O
follows	O
:	O
CASSETTE	O
SUMMARY	O
:	O
Cassette	O
4A	O
:	O
Two	O
lymph	O
nodes	O
.	O

Cassette	O
4B	O
:	O
One	O
lymph	O
node	O
,	O
bivalved	O
.	O

5	O
)	O
.	O

Received	O
in	O
formalin	O
,	O
labeled	O
"	O
right	O
pelvic	O
lymph	O
nodes	O
"	O
and	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
.	O

is	O
an	O
aggregate	O
of	O
irregular	O
portions	O
of	O
yellow	O
-	O
tan	O
lobulated	O
adipose	O
tissue	O
,	O
4	O
.	O
0	O
x	O
.	O

4	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
.	O

The	O
specimen	O
is	O
dissected	O
for	O
lymph	O
nodes	O
,	O
there	O
are	O
thirteen	O
irregular	O
.	O
pale	O
tan	O
to	O
tan	O
glistening	O
ovoid	O
lymph	O
nodes	O
identified	O
,	O
ranging	O
from	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
.	O

Page	O
:	O
5	O
.	O

SPEC	O
#	O
:	O
GROSS	O
DESCRIPTION	O
:	O
(	O
continued	O
)	O
.	O

cm	O
to	O
1	O
.	O
3	O
.	O

x	O
0	O
.	O
9	O
x	O
0	O
.	O
4	O
cm	O
.	O

All	O
lymph	O
nodes	O
identified	O
are	O
submitted	O
as	O
follows	O
:	O
CASSETTE	O
SUMMARY	O
:	O
Cassette	O
5A	O
:	O
Five	O
lymph	O
nodes	O
.	O

Cassette	O
5B	O
:	O
Five	O
lymph	O
nodes	O
.	O

Cassette	O
5C	O
:	O
Two	O
lymph	O
nodes	O
,	O
bivalved	O
,	O
one	O
inked	O
green	O
.	O

Cassette	O
5D	O
:	O
One	O
lymph	O
node	O
,	O
bivalved	O
.	O

Received	O
in	O
formalin	O
,	O
labeled	O
"	O
left	O
pelvic	O
lymph	O
nodes	O
"	O
and	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
.	O

is	O
an	O
aggregate	O
of	O
irregular	O
portions	O
of	O
yellow	O
-	O
tar	O
lobulated	O
adipose	O
tissue	O
,	O
5	O
.	O
0	O
x	O
.	O

3	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
.	O

The	O
specimen	O
is	O
dissected	O
for	O
lymph	O
nodes	O
,	O
there	O
are	O
eight	O
tan	O
ovoid	O
.	O
lymph	O
nodes	O
identified	O
,	O
ranging	O
from	O
0	O
.	O
4	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
cm	O
to	O
1	O
.	O
2	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
5	O
cm	O
.	O

All	O
.	O
lymph	O
nodes	O
identified	O
are	O
submitted	O
as	O
follows	O
:	O
CASSETTE	O
SUMMARY	O
:	O
Cassette	O
6A	O
:	O
Five	O
lymph	O
nodes	O
.	O

Cassette	O
68	O
:	O
Two	O
lymph	O
nodes	O
,	O
bivalved	O
,	O
one	O
inked	O
green	O
.	O

Cassette	O
6C	O
:	O
One	O
lymph	O
node	O
,	O
bivalved	O
.	O

Received	O
in	O
formalin	O
,	O
labeled	O
"	O
left	O
common	O
iliac	O
lymph	O
nodes	O
"	O
and	O
with	O
the	O
patient	O
'	O
s	O
.	O
name	O
,	O
are	O
three	O
irregular	O
unoriented	O
portions	O
of	O
yellow	O
-	O
tan	O
lobulated	O
adipose	O
tissue	O
,	O
.	O
ranging	O
from	O
1	O
.	O
2	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
cm	O
to	O
1	O
.	O
5	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
specimen	O
is	O
dissected	O
for	O
.	O
lymph	O
nodes	O
,	O
there	O
are	O
no	O
obvious	O
lymph	O
nodes	O
identified	O
.	O

The	O
specimen	O
is	O
entirely	O
.	O
submitted	O
in	O
one	O
cassette	O
.	O

8	O
)	O
.	O

Received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
right	O
pelvic	O
lymph	O
node	O
"	O
.	O

Received	O
is	O
a	O
.	O

1	O
.	O
7	O
x	O
1	O
x	O
0	O
.	O
5	O
cm	O
portion	O
of	O
yellow	O
gold	O
to	O
pink	O
tan	O
fibroadipose	O
tissue	O
.	O

The	O
specimen	O
.	O

is	O
dissected	O
for	O
possible	O
lymph	O
nodes	O
.	O

One	O
lymph	O
node	O
is	O
identified	O
that	O
is	O
,	O
2	O
x	O
0	O
.	O
8	O
.	O

x	O
.	O

0	O
.	O
4	O
cm	O
.	O

Entirely	O
submitted	O
in	O
cassette	O
8	O
.	O

Entered	O
:	O
COPIES	O
TO	O
:	O
No	O
PCP	O
/	O
Family	O
Physician	O
.	O

Page	O
:	O
6	O
.	O

SPEC	O
#	O
:	O
the	O
.	O

CPT	O
Codes	O
:	O
LYMPH	O
NODE	O
BIOPSY	O
(	O
M	O
)	O
/	O
.	O

LYMPH	O
NODE	O
,	O
REGIONAL	O
RESECT	O
/	O
.	O

SOFT	O
TISSUE	O
,	O
LIPOMA	O
/	O
ADIPOSE	O
.	O

UTERUS	O
W	O
/	O
WO	O
ADNEXAE	O
,	O
TUMOR	O
-	O
8	O
.	O

IHC	O
.	O

ICD9	O
Codes	O
:	O
Resident	O
Physician	O
:	O
I	O
have	O
personally	O
reviewed	O
the	O
material	O
.	O

(	O
specimen	O
/	O
slide	O
)	O
and	O
approve	O
this	O
final	O
report	O
.	O

-DOCSTART-282
Sample	O
Type	O
TUMOUR	O
.	O

Diagnosis	O
.	O
ductal	O
adenocarcinoma	O
.	O

Year	O
of	O
Sample	O
Collection	O
.	O

Age	O
at	O
Sample	O
Collection	O
(	O
yrs	O
)	O
.	O

Days	O
to	O
Procedure	O
Date	O
.	O

Days	O
to	O
Diagnosis	O
.	O

Type	O
of	O
Procedure	O
.	O

RESECT	O
.	O

Site	O
of	O
Tissue	O
/	O
Primary	O
(	O
Histology	O
)	O
.	O
pancreas	O
.	O

Tumour	O
Size	O
(	O
cm	O
)	O
.	O

3	B
.	I
3999999999999999	I
.	O

Histology	O
.	O
ductal	O
adenocarcinoma	O
.	O

Grade	O
/	O
Differentiation	O
.	O

II	O
.	O

Pathological	O
T	O
.	O

T3	O
.	O

Pathological	O
N	O
.	O
Clinical	O
M	O
.	O

M0	O
.	O

Histology	O
Comments	O
.	O
pancreatic	O
head	O
.	O

Sample	O
Type	O
BUFFY	O
.	O

Year	O
of	O
Sample	O
Collection	O
.	O

Age	O
at	O
Sample	O
Collection	O
(	O
yrs	O
)	O
.	O

Days	O
to	O
Procedure	O
Date	O
.	O

Days	O
to	O
Diagnosis	O
.	O

-DOCSTART-283
DIAGNOSIS	O
:	O
1	O
.	O

Retroperitoneal	O
mass	O
(	O
1FS	O
)	O
:	O
Splenunculus	O
.	O

2	O
.	O

Adrenal	O
mass	O
,	O
right	O
,	O
excision	O
:	O
Pheochromocytoma	O
.	O

See	O
Note	O
.	O

NOTE	O
:	O
No	O
vascular	O
or	O
capsular	O
invasion	O
seen	O
.	O

A	O
lymph	O
node	O
search	O
was	O
.	O
performed	O
in	O
periadrenal	O
adipose	O
tissue	O
and	O
no	O
lymph	O
nodes	O
were	O
.	O
identified	O
.	O

synaptophysin	O
neoplastic	O
negative	O
S100	O
for	O
stains	O
chromogranin	O
sustentacular	O
and	O
.	O

The	O
cells	O
are	O
positive	O
.	O
and	O
for	O
inhibin	O
.	O
cells	O
.	O

This	O
staining	O
pattern	O
is	O
consistent	O
with	O
a	O
pheochromocytoma	O
.	O

Immunoperoxidase	O
and	O
in	O
-	O
situ	O
hybridization	O
-	O
tests	O
-	O
performer	O
here	O
and	O
.	O
used	O
for	O
diagnosis	O
were	O
developed	O
and	O
their	O
nerformance	O
characteristics	O
.	O
determined	O
by	O
the	O
Laboratory	O
of	O
Pathology	O
,	O
.	O

They	O
have	O
not	O
been	O
.	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O

The	O
FDA	O
.	O
has	O
also	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

This	O
laboratory	O
is	O
certified	O
under	O
the	O
Clinical	O
Laboratory	O
Improvement	O
.	O

Amendments	O
of	O
1988	O
(	O
CLIA	O
)	O
as	O
qualified	O
to	O
perform	O
high	O
complexity	O
.	O
clinical	O
laboratory	O
testing	O
.	O

CLINICAL	O
INFORMATION	O
:	O
Brief	O
Clinical	O
History	O
:	O
Pheochromocytoma	O
.	O

Specimen	O
Taken	O
For	O
Protocol	O
:	O
01	O
-	O
Yes	O
Allocate	O
Order	O
to	O
Protocol	O
:	O
PROCEDURE	O
:	O
Operative	O
Findings	O
:	O
Large	O
10	B
X	I
9	I
X8	I
cm	I
right	O
adrenal	O
mass	O
.	O
and	O
a	O
2	B
X	I
.	I

1	B
.	I

.	B
5cm	I
left	O
splenule	O
Post	O
-	O
Operative	O
Diagnosis	O
:	O
Pheochromocytoma	O
.	O

Pre	O
-	O
Operative	O
Diagnosis	O
:	O
Pheochromocytoma	O
.	O

SPECIMENS	O
SUBMITTED	O
:	O
1	O
.	O

RETROPERITONEAL	O
MASS	O
,	O
Left	O
(	O
1FS	O
)	O
.	O

2	O
.	O

ADRENAL	O
GLAND	O
,	O
RIGHT	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
:	O
Received	O
fresh	O
from	O
the	O
OR	O
with	O
the	O
.	O

patient	O
'	O
s	O
name	O
,	O
medical	O
record	O
number	O
,	O
date	O
of	O
birth	O
,	O
and	O
further	O
.	O
specified	O
as	O
"	O
left	O
retroperitoneal	O
mass	O
"	O
is	O
an	O
intact	O
spherical	O
nodule	O
,	O
.	O
maroon	O
and	O
smooth	O
in	O
color	O
,	O
1	O
.	O
5	O
cm	O
in	O
diameter	O
and	O
is	O
focally	O
attached	O
.	O
to	O
pink	O
-	O
yellow	O
adipose	O
tissue	O
separately	O
measuring	O
1	O
.	O
2	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
8	O
cm	O
.	O

Diagnosis	O
(	O
1FS	O
)	O
:	O
Spleen	O
.	O

The	O
intraoperative	O
consultation	O
was	O
performed	O
.	O

GROSS	O
DESCRIPTION	O
:	O
Received	O
fresh	O
are	O
2	O
specimens	O
,	O
each	O
in	O
.	O
containers	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
medical	O
record	O
number	O
,	O
and	O
.	O
further	O
specified	O
as	O
follows	O
:	O
Received	O
fresh	O
from	O
the	O
OR	O
in	O
a	O
container	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
.	O
name	O
,	O
medical	O
record	O
number	O
,	O
and	O
further	O
.	O

Patient	O
Information	O
.	O

Unandrorized	O
disclosure	O
is	O
prohibited	O
Federal	O
Prinni	O
Actor	O
16	O
,	O
74	O
.	O

Do	O
not	O
file	O
in	O
Medical	O
Record	O
.	O

Received	O
are	O
2	O
formalin	O
-	O
filled	O
containers	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
.	O
name	O
,	O
medical	O
record	O
number	O
,	O
and	O
date	O
of	O
birth	O
.	O

These	O
specimens	O
are	O
.	O
further	O
specified	O
as	O
follows	O
:	O
1	O
.	O

"	O
Left	O
retroperitoneal	O
mass	O
"	O
are	O
2	O
fragments	O
of	O
tissue	O
that	O
.	O
appear	O
in	O
consistency	O
and	O
color	O
to	O
be	O
that	O
of	O
splenic	O
tissue	O
.	O

The	O
.	O
first	O
fragment	O
is	O
irregular	O
,	O
lobulated	O
,	O
3	O
cm	O
splenic	O
tissue	O
.	O
fragment	O
that	O
is	O
placed	O
into	O
a	O
white	O
cassette	O
labeled	O
.	O

Another	O
2	O
-	O
cm	O
fragment	O
of	O
what	O
appears	O
to	O
be	O
splenic	O
.	O
tissue	O
is	O
placed	O
into	O
a	O
white	O
cassette	O
labeled	O
.	O

This	O
.	O
tissue	O
also	O
corresponds	O
to	O
the	O
specimen	O
that	O
was	O
examined	O
as	O
a	O
.	O
frozen	O
section	O
.	O

The	O
whole	O
contents	O
of	O
the	O
section	O
examined	O
during	O
.	O
the	O
intraoperative	O
frozen	O
section	O
consultation	O
are	O
transferred	O
.	O
from	O
a	O
green	O
cassette	O
labeled	O
.	O
to	O
an	O
orange	O
cassette	O
labeled	O
.	O

2	O
.	O

"	O
Right	O
adrenal	O
for	O
esection	O
-	O
and	O
-	O
permanent	O
"	O
is	O
a	O
focally	O
.	O
disrupted	O
red	O
ovoid	O
nodular	O
tissue	O
fragment	O
measuring	O
10	O
x	O
9	O
x	O
.	O

8	O
.	O

cm	O
,	O
and	O
weighing	O
429	O
grams	O
.	O

It	O
is	O
focally	O
covered	O
by	O
adipose	O
.	O
tissue	O
and	O
the	O
cortex	O
of	O
the	O
adrenal	O
gland	O
that	O
is	O
evident	O
.	O

There	O
.	O

is	O
a	O
1	O
x	O
0	O
.	O
4	O
-	O
cm	O
focal	O
surgical	O
defect	O
on	O
the	O
external	O
surface	O
with	O
.	O
pink	O
-	O
tan	O
soft	O
friable	O
tumor	O
fragments	O
that	O
appear	O
to	O
be	O
tumor	O
.	O

It	O
.	O

is	O
bisected	O
revealing	O
a	O
heterogeneous	O
red	O
-	O
tan	O
soft	O
friable	O
and	O
.	O
rubbery	O
cut	O
surface	O
with	O
hemorrhage	O
.	O

The	O
center	O
of	O
the	O
mass	O
has	O
a	O
.	O
rubbery	O
to	O
crumbly	O
maroon	O
-	O
red	O
necrotic	O
center	O
comprising	O
50	O
%	O
of	O
.	O
the	O
nodule	O
.	O

Gross	O
photographs	O
are	O
taken	O
.	O

Approximately	O
60	O
%	O
of	O
.	O
the	O
viable	O
portion	O
of	O
the	O
nodule	O
is	O
procured	O
for	O
research	O
with	O
the	O
.	O
majority	O
going	O
to	O
I	O
.	O
and	O
a	O
4	O
-	O
mm	O
piece	O
of	O
tissue	O
to	O
.	O

Ine	O
remainder	O
of	O
the	O
specimen	O
is	O
placed	O
into	O
.	O
tormalin	O
and	O
submitted	O
to	O
Pathology	O
for	O
permanent	O
.	O

Procurement	O
.	O
was	O
performed	O
by	O
.	O

on	O
.	O

Received	O
in	O
pathology	O
is	O
the	O
above	O
mentioned	O
mass	O
that	O
is	O
cut	O
in	O
a	O
.	O
perpendicular	O
fashion	O
from	O
the	O
lateral	O
to	O
the	O
medial	O
side	O
in	O
order	O
.	O
to	O
improve	O
fixation	O
.	O

The	O
areas	O
of	O
necrotic	O
tissue	O
that	O
appear	O
to	O
.	O

be	O
consistent	O
with	O
a	O
tumor	O
are	O
apparent	O
on	O
the	O
lateral	O
surface	O
of	O
.	O
the	O
mass	O
.	O

On	O
gross	O
examination	O
,	O
there	O
does	O
appear	O
to	O
be	O
normal	O
.	O
adrenal	O
gland	O
which	O
appears	O
on	O
one	O
of	O
the	O
lateral	O
surfaces	O
and	O
.	O
appears	O
4	O
cm	O
in	O
greatest	O
diameter	O
.	O

The	O
external	O
surface	O
of	O
the	O
.	O
entire	O
mass	O
has	O
been	O
inked	O
black	O
.	O

Serial	O
sections	O
through	O
the	O
.	O
portion	O
of	O
the	O
mass	O
that	O
appears	O
to	O
have	O
adrenal	O
gland	O
in	O
addition	O
.	O
to	O
tumor	O
are	O
sectioned	O
and	O
placed	O
into	O
cassettes	O
.	O
represents	O
the	O
most	O
lateral	O
portion	O
of	O
the	O
identified	O
adrenal	O
.	O
gland	O
and	O
serial	O
sections	O
are	O
1	O
cm	O
apart	O
and	O
towards	O
the	O
medial	O
.	O
aspect	O
of	O
the	O
mass	O
.	O

The	O
first	O
section	O
in	O
does	O
not	O
appear	O
to	O
.	O
have	O
any	O
adrenal	O
tissue	O
on	O
gross	O
examination	O
,	O
however	O
,	O
the	O
next	O
.	O
section	O
that	O
will	O
be	O
placed	O
in	O
.	O
does	O
appear	O
to	O
have	O
.	O
normal	O
adrenal	O
tissue	O
.	O

The	O
irregular	O
mass	O
is	O
serially	O
sectioned	O
.	O
and	O
placed	O
into	O
white	O
cassettes	O
labeled	O
.	O

This	O
.	O
area	O
appears	O
to	O
be	O
lateral	O
to	O
normal	O
adrenal	O
tissue	O
.	O

This	O
portion	O
.	O
of	O
the	O
mass	O
is	O
approximately	O
6	O
cm	O
and	O
extends	O
from	O
what	O
appears	O
to	O
.	O

be	O
the	O
end	O
of	O
normal	O
adrenal	O
tissue	O
all	O
the	O
way	O
to	O
the	O
edge	O
of	O
the	O
.	O
mass	O
.	O

Again	O
,	O
the	O
capsule	O
is	O
inked	O
black	O
.	O

A	O
well	O
-	O
circumscribed	O
.	O
white	O
-	O
tan	O
lesion	O
is	O
located	O
within	O
the	O
realm	O
of	O
a	O
much	O
more	O
dark	O
.	O

Contidencial	O
Parient	O
Information	O
,	O
Unaurhorized	O
disclosure	O
is	O
prohibited	O
by	O
the	O
Premay	O
Act	O
it	O
.	O

JobID	O
:	O
Do	O
not	O
file	O
in	O
Medical	O
Record	O
.	O
reddish	O
brownish	O
homogeneous	O
material	O
that	O
encompasses	O
most	O
of	O
the	O
.	O
mass	O
,	O
This	O
lesion	O
is	O
placed	O
entirely	O
into	O
the	O
white	O
cassette	O
.	O

The	O
most	O
lateral	O
portion	O
of	O
the	O
mass	O
is	O
placed	O
into	O
.	O
white	O
cassette	O
labeled	O
.	O

Surrounding	O
adipose	O
tissue	O
.	O
with	O
the	O
possibility	O
of	O
harboring	O
lymph	O
nodes	O
are	O
placed	O
into	O
.	O
white	O
cassettes	O
labeled	O
.	O

An	O
additional	O
1	O
.	O
5	O
cm	O
.	O
white	O
lesion	O
that	O
is	O
well	O
-	O
circumscribed	O
and	O
within	O
the	O
larger	O
mass	O
.	O
that	O
is	O
very	O
homogeneous	O
and	O
tan	O
-	O
brown	O
in	O
color	O
is	O
sectioned	O
and	O
.	O
placed	O
into	O
white	O
cassette	O
labeled	O
.	O

Gross	O
Description	O
dictated	O
by	O
.	O

Additional	O
.	O

Gross	O
Description	O
dictated	O
by	O
:	O
No	O
consultants	O
.	O

Accessioned	O
:	O
Final	O
Report	O
Signed	O
Out	O
:	O
<	O
Resident	O
Signature	O
>	O
.	O

Date	O
Report	O
Signed	O
:	O
Princi	O
t	O
.	O

Information	O
prohibit	O
é	O
by	O
de	O
Federal	O
Print	O
"	O
ill	O
of	O
19	O
%	O
.	O

JobID	O
:	O
Requested	O
By	O
:	O
I	O
-	O
.	O

Do	O
not	O
file	O
in	O
Medical	O
Record	O
.	O

-DOCSTART-284
Result	O
date	O
:	O
;	O
PECIMEN	O
DESCRIPTION	O
.	O

;	O
PECIMEN	O
DESCRIPTION	O
.	O

Surgical	O
Fathology	O
Report	O
.	O

Pathology	O
#	O
:	O
Site	O
/	O
Client	O
:	O
(	O
Age	O
:	O
Gender	O
:	O
F	O
.	O

FINAL	O
PATHOLIGIC	O
DIAGNOSES	O
.	O

A	O
.	O

UTERUS	O
,	O
CERVIX	O
,	O
BILATERAL	O
FALLOPIAN	O
TUBES	O
AND	O
OVARIES	O
,	O
TOTAL	O
.	O

ABDOMINAL	O
HYSTERECTOMY	O
AND	O
BILATERAL	O
SALPINGO	O
-	O
OOPHORECTOMY	O
:	O
ENDOMETRIAL	O
SEROUS	O
ADENOCARCINOMA	O
.	O

TUMOR	O
SIZE	O
:	O
.	O

CM	O
IN	O
MAXIMUM	O
DIMENSION	O
.	O

TUMOR	O
INVADES	O
UP	O
TO	O
3	O
.	O
8	O
CM	O
OUT	O
OF	O
3	O
.	O
9	O
MYOMETRIAL	O
THICKNESS	O
.	O

TUMOR	O
INVOLVES	O
CERVIX	O
AND	O
LEFT	O
OVARY	O
.	O

ANGIOLYMPHAT	O
:	O
C	O
INVASION	O
IS	O
IDENTIFIED	O
.	O

ADDITIONAL	O
PATROLOGIC	O
FINDINGS	O
:	O
-	O
UTERUS	O
:	O
LEIOMYOMATA	O
WITH	O
DEGENERATIVE	O
CHANGES	O
.	O

-	O
RIGHT	O
FALLOPIAN	O
TUBE	O
WITH	O
WALTHARD	O
REST	O
.	O

-	O
RIGHT	O
OVAR	O
`	O
WITH	O
SMALL	O
SEX	O
CORD	O
-	O
STROMAL	O
TUMOR	O
,	O
CONSISTENT	O
WITH	O
.	O

FIBROTHECOMA	O
(	O
1	B
.	I
5	I
CM	I
IN	O
MAXIMUM	O
DIMENSION	O
)	O
.	O

PLEASE	O
SEE	O
COMMENT	O
AND	O
SYNOPTIC	O
REPORT	O
(	O
SDR	O
CHECKLIST	O
)	O
BELOW	O
.	O

B	O
.	O

LYMPH	O
MODE	O
,	O
LEFT	O
PELVIC	O
,	O
DISSECTION	O
:	O
METASTATIC	O
CARCINOMA	O
INVOLVING	O
TWO	O
OUT	O
OF	O
TWO	O
LYMPH	O
NODES	O
WITH	O
.	O

EXTRANODAL	O
EXTENSION	O
(	O
2	O
/	O
2	O
)	O
.	O

C	O
.	O

LYMPH	O
NODE	O
,	O
RIGHT	O
PELVIC	O
,	O
DISSECTION	O
:	O
METASTATIC	O
CARCANOMA	O
INVOLVING	O
TWO	O
OUT	O
OF	O
THREE	O
LYMPH	O
NODES	O
WITH	O
.	O

EXTRANODAL	O
EXTENSION	O
(	O
2	O
/	O
2	O
)	O
.	O

)	O
Report	O
.	O

D	O
.	O

LYMPH	O
NODE	O
,	O
RIGHT	O
PERIAORTIC	O
,	O
DISSECTION	O
:	O
METASTATIC	O
CARCINOMA	O
INVOLVING	O
THREE	O
OUT	O
OF	O
FOUR	O
LYMPH	O
NODES	O
WITH	O
.	O

EXTRANODAL	O
EXTENSION	O
(	O
3	O
/	O
4	O
)	O
.	O

PATHOLOGIC	O
STAGE	O
AND	O
CASE	O
SUMMARY	O
.	O

pN2	O
(	O
FIG0	O
11IC2	O
)	O
.	O

COMMENT	O
.	O

Sections	O
of	O
the	O
left	O
ovary	O
show	O
a	O
proliferation	O
of	O
bland	O
-	O
looking	O
spindle	O
.	O
ceils	O
arranged	O
into	O
interlacing	O
fascicles	O
.	O

Some	O
of	O
these	O
cells	O
show	O
a	O
.	O
clear	O
cytoplasm	O
.	O

No	O
pleomorphism	O
,	O
necrosis	O
or	O
cytologic	O
atypia	O
seen	O
.	O

Ocrasional	O
ritoses	O
are	O
noted	O
.	O

By	O
immunohistochemical	O
staining	O
,	O
these	O
.	O
neoplastic	O
cells	O
are	O
positive	O
for	O
calretenin	O
and	O
inhibin	O
.	O

These	O
findings	O
.	O
are	O
consistent	O
with	O
fibrothecoma	O
.	O

A	O
:	O
UTERUS	O
/	O
CERVIX	O
/	O
TUBES	O
AND	O
OVARIES	O
BILATERALLY	O
.	O

SPECIMEN	O
:	O
Uterus	O
,	O
bilateral	O
ovaries	O
.	O
and	O
fallopian	O
tubes	O
.	O

PROCEDORE	O
:	O
Specify	O
-	O
Total	O
abdominal	O
.	O
hysterectiomy	O
and	O
bilateral	O
salpingioophorectomy	O
.	O

LYMPH	O
NODE	O
SAMPLING	O
:	O
Performed	O
,	O
pelvic	O
lymph	O
.	O
nodes	O
and	O
right	O
periaortic	O
lymph	O
node	O
dissection	O
.	O

SPECIMEN	O
INTEGRITY	O
:	O
Intact	O
hysterectomy	O
.	O
apecimen	O
.	O

TOMOR	O
SITE	O
:	O
Specify	O
-	O
anterior	O
and	O
.	O
posterior	O
aspects	O
of	O
endometrial	O
cavity	O
.	O

TOMOR	O
SIZE	O
:	O
Greatest	O
dimension	O
-	O
9	B
cm	I
.	O

ADDITIONAL	O
TUMOR	O
DIMENSIONS	O
:	O
-	O
7	B
.	I
5	I
x	I
3	I
.	I
8	I
cm	I
.	O

HISTOLOGIC	O
TYPE	O
:	O
Serous	O
adenocarcinoma	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
Not	O
applicable	O
.	O

MYOMETRIAL	O
INVASION	O
:	O
Present	O
,	O
>	O
-	O
50	O
%	O
myometrial	O
.	O
invasion	O
.	O

DEPTH	O
OF	O
MYCMETRIAL	O
INVASION	O
:	O
-	O
3	O
.	O
8	O
cm	O
.	O

MYOMETRIAL	O
THICKNESS	O
:	O
-	O
3	O
.	O
9	O
cm	O
.	O

INVOLVEMENT	O
OF	O
CERVIX	O
:	O
Invasion	O
of	O
cervical	O
.	O
stromal	O
connective	O
tissue	O
.	O

OTHER	O
ORGANS	O
INVOLVEMENT	O
,	O
EXTENT	O
:	O
See	O
seperate	O
organs	O
below	O
.	O

RIGHT	O
OVARY	O
:	O
Not	O
involved	O
.	O

LEFT	O
OVARY	O
:	O
Involved	O
.	O

RIGHT	O
FALLOFIAN	O
TUBE	O
:	O
Not	O
involved	O
.	O

LEFT	O
FALLOPIAN	O
TUBE	O
:	O
Not	O
involved	O
.	O

VAGINA	O
:	O
Not	O
applicable	O
.	O

RIGHT	O
PARAMETRIOM	O
:	O
Not	O
applicable	O
.	O

LEFT	O
PARAMETRIUM	O
:	O
Not	O
applicable	O
.	O

OMENTUM	O
:	O
Not	O
applicable	O
.	O

RECTAL	O
WALL	O
:	O
Not	O
applicable	O
.	O

BLADDER	O
WALI	O
:	O
Not	O
applicable	O
.	O

PELVIC	O
WALL	O
:	O
Not	O
applicable	O
.	O

HGADDER	O
MUCCSA	O
AND	O
/	O
OR	O
BOWEL	O
MUCOSA	O
:	O
Not	O
applicable	O
.	O

OTHER	O
ORGANS	O
:	O
Not	O
applicable	O
.	O

PERITONEAI	O
ASCITIC	O
FLOID	O
:	O
See	O
cyology	O
report	O
,	O
case	O
#	O
-	O
.	O

NK111	O
-	O
(	O
103	O
.	O
104	O
,	O
105	O
)	O
-	O
.	O

MARGINS	O
:	O
Uninvolved	O
by	O
invasive	O
.	O
carcinama	O
.	O

DISTANCE	O
FROM	O
CLOSEST	O
MARGIN	O
:	O
-	O
2	O
mm	O
.	O

SPECIFY	O
CLOSEST	O
MARGIN	O
:	O
-	O
anterior	O
paracervical	O
.	O
soft	O
tissue	O
marg	O
í	O
n	O
.	O

LYMPH	O
-	O
VASCOIAR	O
INVASION	O
:	O
Present	O
.	O

PATHCLOGIC	O
STAGING	O
(	O
ptN	O
)	O
:	O
-	O
pT3a	O
,	O
pN2	O
(	O
FIGO	O
IIIC2	O
)	O
.	O

PELVIC	O
LYMPH	O
NODES	O
:	O
Number	O
examined	O
-	O
5	O
.	O

PELVIC	O
LYMPH	O
NODES	O
INVOIVED	O
:	O
Number	O
-	O
4	O
.	O

PARA	O
-	O
AORTIC	O
LYMPH	O
NODES	O
:	O
Number	O
examined	O
-	O
4	O
.	O

PARA	O
-	O
AORTIC	O
NODES	O
INVOLVED	O
:	O
Number	O
-	O
3	O
.	O

OTHER	O
LYMPH	O
NODES	O
:	O
Not	O
sampled	O
.	O

OTHER	O
NODES	O
INVOLVED	O
:	O
Not	O
applicable	O
.	O

DISTANT	O
METASTASIS	O
(	O
pM	O
)	O
:	O
Not	O
applicable	O
.	O

SPEC1FY	O
METASTASIS	O
SITE	O
(	O
S	O
)	O
:	O
Not	O
applicable	O
.	O

ADDITIONAL	O
PATHOLOGIC	O
FINDINGS	O
.	O

Specify	O
-	O
fibrothecoma	O
of	O
.	O
left	O
ovary	O
.	O

ANCILLARY	O
STUDIES	O
:	O
Specify	O
-	O
immunostains	O
,	O
see	O
.	O
diagnosis	O
comment	O
.	O

CLINICAL	O
BISTORY	O
:	O
Not	O
specified	O
.	O

COMMENT	O
(	O
S	O
)	O
:	O
-	O
none	O
.	O

All	O
tests	O
performed	O
by	O
.	O

Pathologists	O
,	O
.	O

SPECIMEN	O
(	O
S	O
)	O
.	O

A	O
:	O
UTERUS	O
/	O
CERVIX	O
/	O
TUBES	O
AND	O
OVARIES	O
BILATERALLY	O
.	O

B	O
:	O
LEFT	O
PELVIC	O
LYMPH	O
NODE	O
,	O
DISSECTION	O
.	O

C	O
:	O
RIGHT	O
PELVIC	O
LYMPH	O
NODE	O
,	O
DISSECTION	O
.	O

D	O
:	O
RIGHT	O
PERIAORTIC	O
LYMPH	O
NODE	O
.	O

PROCEDURE	O
.	O

EXPLORATORY	O
LAPAROTOMY	O
TUMOR	O
DEBULKING	O
PELVIC	O
NODE	O
DISSECTION	O
.	O

PREOPERATIVE	O
DIAGNOSIS	O
.	O

UTERINE	O
CANCER	O
.	O

POSTOPERATIVE	O
DIAGNOSIS	O
.	O

OTERINE	O
CANCER	O
.	O

GROSS	O
DESCRIPTION	O
.	O

A	O
.	O

Received	O
firesh	O
Labeled	O
uterus	O
,	O
fallopian	O
tubes	O
,	O
ovaries	O
and	O
cervix	O
,	O
.	O

is	O
a	O
650	O
q	O
total	O
hysterectomy	O
specimen	O
.	O

The	O
uterus	O
measures	O
15	O
cm	O
from	O
.	O
the	O
cervix	O
to	O
fundus	O
,	O
11	O
.	O
5	O
cm	O
from	O
cornu	O
to	O
cornu	O
and	O
9	O
.	O
5	O
cm	O
from	O
.	O
anterior	O
10	O
posterior	O
.	O

The	O
serosal	O
surface	O
is	O
bosselated	O
with	O
three	O
.	O

subserosa	O
!	O

nodules	O
ranging	O
in	O
maximum	O
dimension	O
from	O
0	O
.	O
7	O
to	O
2	O
cm	O
,	O
the	O
.	O
largest	O
one	O
measures	O
2	O
x	O
1	O
.	O
2	O
x	O
1	O
am	O
and	O
is	O
located	O
on	O
the	O
anterior	O
.	O
surface	O
.	O

The	O
subserosal	O
nodules	O
have	O
tan	O
white	O
firm	O
cut	O
surfaces	O
.	O

The	O
.	O
remaining	O
surface	O
io	O
pink	O
-	O
tan	O
and	O
smooth	O
.	O

The	O
cervix	O
measures	O
.	O

4	O
.	O

em	O
in	O
length	O
x	O
2	O
.	O
5	O
cm	O
in	O
diameter	O
.	O

The	O
cervical	O
DS	O
is	O
slit	O
-	O
like	O
and	O
.	O
measures	O
i	O
)	O
.	O

}	O
cm	O
in	O
diameter	O
.	O

The	O
anterior	O
surface	O
is	O
inked	O
yellow	O
and	O
.	O
the	O
posterior	O
surface	O
is	O
inked	O
black	O
for	O
microscopic	O
evaluation	O
.	O

The	O
.	O
uterus	O
is	O
opened	O
to	O
reveal	O
hemorrhagic	O
fluid	O
and	O
a	O
tan	O
-	O
pink	O
/	O
red	O
friable	O
.	O
mass	O
occupy	O
no	O
all	O
the	O
endometrial	O
cavity	O
on	O
both	O
anterior	O
and	O
posterior	O
.	O
aspects	O
.	O

The	O
endometrial	O
cavity	O
measures	O
9	O
cm	O
in	O
length	O
x	O
7	O
.	O
5	O
cm	O
in	O
.	O
width	O
.	O

The	O
mass	O
grossly	O
appears	O
involving	O
the	O
lower	O
uterine	O
segment	O
and	O
.	O
not	O
involving	O
the	O
cervix	O
.	O

The	O
mass	O
is	O
about	O
1	O
.	O
4	O
cm	O
from	O
the	O
anterior	O
.	O
paracervica	O
soft	O
tissue	O
margin	O
and	O
approximately	O
4	O
cm	O
from	O
the	O
cervical	O
.	O

os	O
.	O

The	O
masa	O
grossly	O
appears	O
involving	O
the	O
superficial	O
myometrium	O
with	O
.	O

a	O
.	O
maximum	O
depth	O
of	O
invasion	O
approximately	O
1	O
cm	O
out	O
of	O
5	O
cm	O
thickness	O
of	O
.	O
the	O
anterior	O
endomyometrium	O
.	O

The	O
mass	O
has	O
a	O
maximum	O
depth	O
of	O
invasion	O
.	O
on	O
the	O
posterior	O
aspect	O
of	O
approximately	O
1	O
.	O
5	O
cm	O
out	O
of	O
4	O
cm	O
.	O
endomyometr	O
.	O
um	O
thickness	O
.	O

Multiple	O
tan	O
-	O
white	O
firm	O
intramural	O
nodules	O
.	O
are	O
ident	O
:	O
fied	O
ranging	O
in	O
maximum	O
dimension	O
from	O
0	O
.	O
5	O
cm	O
to	O
5	O
cm	O
,	O
the	O
.	O
largest	O
one	O
measures	O
5	O
x	O
4	O
x	O
3	O
.	O
5	O
cm	O
and	O
is	O
located	O
on	O
the	O
posterior	O
.	O
side	O
.	O

Some	O
of	O
these	O
nodules	O
are	O
calcified	O
.	O

The	O
endomyometrium	O
ranges	O
in	O
.	O
thickness	O
forom	O
1	O
.	O
5	O
to	O
5	O
.	O
2	O
cm	O
.	O

The	O
right	O
fallopian	O
tube	O
measures	O
6	O
.	O
5	O
cm	O
.	O
in	O
length	O
x	O
approximately	O
0	O
.	O
6	O
cm	O
in	O
diameter	O
.	O

The	O
serosal	O
surface	O
is	O
.	O
pink	O
-	O
tan	O
and	O
smooth	O
.	O

Serial	O
sectioning	O
reveals	O
a	O
pinpoint	O
lumen	O
.	O

The	O
.	O
right	O
ovary	O
measures	O
3	O
x	O
2	O
x	O
1	O
cm	O
and	O
it	O
is	O
serially	O
sectioned	O
to	O
reveal	O
.	O

a	O
tan	O
-	O
yellow	O
nodule	O
measuring	O
1	O
.	O
5	O
x	O
1	O
.	O
1	O
x	O
0	O
.	O
8	O
cm	O
.	O

The	O
left	O
fallopian	O
.	O
tube	O
measures	O
7	O
cm	O
in	O
length	O
x	O
approximately	O
0	O
.	O
6	O
cm	O
in	O
diameter	O
.	O

The	O
.	O
serosal	O
surface	O
is	O
pink	O
-	O
tan	O
and	O
smooth	O
.	O

The	O
fallopian	O
tube	O
is	O
serially	O
.	O
sectioned	O
to	O
reveal	O
a	O
pinpoint	O
lumen	O
.	O

The	O
left	O
ovary	O
measures	O
3	O
x	O
2	O
x	O
.	O

1	O
.	O

cm	O
.	O

The	O
left	O
ovary	O
is	O
serially	O
sectioned	O
to	O
reveal	O
unremarkable	O
.	O
tan	O
-	O
pink	O
cut	O
surfaces	O
.	O

Representative	O
sections	O
of	O
the	O
specimen	O
are	O
.	O
submitted	O
as	O
follows	O
:	O
Cassettes	O
1	O
-	O
the	O
anterior	O
cervix	O
,	O
.	O

Cassettes	O
2	O
and	O
3	O
-	O
the	O
anterior	O
lower	O
uterine	O
segment	O
,	O
.	O

Cassette	O
4	O
-	O
the	O
closest	O
tumor	O
to	O
the	O
anterior	O
paracervical	O
soft	O
tissue	O
.	O
margin	O
,	O
.	O

Cassettes	O
5	O
-	O
6	O
-	O
anterior	O
endomyometrium	O
full	O
thickness	O
,	O
.	O

Cassettes	O
7	O
-	O
8	O
-	O
anterior	O
endomyometrium	O
full	O
thickness	O
,	O
.	O

Cassette	O
9	O
-	O
anterior	O
endomyometrium	O
full	O
thickness	O
,	O
.	O

Cassette	O
10	O
-	O
two	O
reps	O
of	O
the	O
anterior	O
endomyometrium	O
full	O
thickness	O
,	O
.	O

Cassette	O
11	O
-	O
posterior	O
cervix	O
,	O
.	O

Cassettes	O
12	O
-	O
13	O
-	O
posterior	O
endocervix	O
to	O
posterior	O
lower	O
uterine	O
.	O
segment	O
,	O
.	O

Cassettes	O
14	O
-	O
15	O
-	O
posterior	O
endomyometrium	O
,	O
.	O

Cassette	O
16	O
-	O
posterior	O
endomyometrium	O
full	O
thickness	O
,	O
.	O

Cassette	O
17	O
-	O
posterior	O
endomyometrium	O
full	O
thickness	O
,	O
.	O

Cassettes	O
18	O
and	O
19	O
-	O
representative	O
sections	O
of	O
the	O
posterior	O
.	O
endomyomet	O
.	O
rium	O
full	O
thickness	O
,	O
.	O

Cassette	O
21	O
-	O
the	O
tumor	O
to	O
the	O
closest	O
posterior	O
paracervical	O
soft	O
tissue	O
.	O
margin	O
,	O
.	O

Cassettes	O
20	O
and	O
22	O
-	O
representative	O
sections	O
of	O
the	O
largest	O
intramural	O
.	O
nodule	O
,	O
.	O

Cassette	O
23	O
-	O
-	O
representative	O
sections	O
of	O
the	O
other	O
nodules	O
including	O
the	O
.	O
subserosal	O
podules	O
.	O

Cassettes	O
24	O
-	O
26	O
-	O
the	O
right	O
fallopian	O
tube	O
,	O
submitted	O
entirely	O
,	O
.	O

Cassettes	O
27	O
-	O
28	O
-	O
the	O
right	O
ovary	O
,	O
submitted	O
entirely	O
,	O
.	O

Cassettes	O
29	O
-	O
31	O
-	O
the	O
left	O
fallopian	O
tube	O
,	O
submitted	O
entirely	O
,	O
.	O

Cassettes	O
32	O
-	O
33	O
-	O
the	O
left	O
ovary	O
,	O
submitted	O
entirely	O
.	O

B	O
.	O

Received	O
fresh	O
labeled	O
left	O
pelvic	O
lymph	O
node	O
are	O
three	O
soft	O
.	O
yellow	O
-	O
pink	O
tragments	O
of	O
adipose	O
tissue	O
aggregating	O
to	O
3	O
.	O
2	O
x	O
3	O
x	O
1	O
cm	O
.	O

Within	O
the	O
fat	O
there	O
are	O
two	O
tan	O
-	O
pink	O
possible	O
lymph	O
nodes	O
measuring	O
0	O
.	O
7	O
.	O
and	O
1	O
.	O
7	O
cm	O
in	O
greatest	O
.	O
dimension	O
.	O

The	O
smallest	O
fragment	O
of	O
tissue	O
is	O
.	O
bisected	O
revealing	O
a	O
smooth	O
walled	O
cyst	O
containing	O
clear	O
serous	O
fluid	O
.	O

The	O
specimen	O
is	O
submitted	O
as	O
follows	O
:	O
Cassette	O
B1	O
-	O
cyst	O
bisected	O
,	O
.	O

Cassette	O
B2	O
-	O
one	O
possible	O
lymph	O
node	O
,	O
bisected	O
,	O
.	O

Cassette	O
B3	O
-	O
remainder	O
of	O
soft	O
tissue	O
.	O

C	O
.	O

Received	O
fresh	O
labeled	O
right	O
pelvic	O
lymph	O
node	O
are	O
two	O
yellow	O
-	O
tan	O
.	O
lobular	O
fragments	O
of	O
adipose	O
tissue	O
measuring	O
1	O
.	O
9	O
x	O
1	O
.	O
5	O
x	O
1	O
cm	O
and	O
2	O
.	O
5	O
.	O

x	O
.	O

2	O
x	O
1	O
.	O
5	O
cm	O
.	O

Within	O
the	O
fat	O
there	O
are	O
three	O
brown	O
-	O
tan	O
possible	O
lymph	O
.	O
nodes	O
which	O
range	O
from	O
1	O
.	O
2	O
to	O
2	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
.	O
specimen	O
is	O
submitted	O
entirely	O
as	O
follows	O
:	O
Cassette	O
C1	O
-	O
one	O
possible	O
lymph	O
node	O
,	O
bisected	O
,	O
.	O

Cassette	O
C2	O
-	O
one	O
possible	O
lymph	O
node	O
,	O
bisected	O
,	O
.	O

Cassette	O
C3	O
-	O
one	O
possible	O
lymph	O
node	O
bisected	O
,	O
.	O

Cassette	O
C4	O
-	O
remainder	O
of	O
soft	O
tissue	O
.	O

D	O
.	O

Received	O
fresh	O
labeled	O
right	O
periaortic	O
lymph	O
node	O
are	O
two	O
.	O
tan	O
-	O
yellow	O
lobular	O
fragments	O
of	O
adipose	O
tissue	O
aggregating	O
to	O
3	O
.	O
5	O
x	O
3	O
x	O
.	O

1	O
cm	O
.	O

Within	O
the	O
fat	O
there	O
are	O
three	O
tan	O
-	O
pink	O
,	O
slightly	O
firm	O
possible	O
.	O
lymph	O
nodes	O
which	O
measure	O
1	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
5	O
cm	O
,	O
1	O
.	O
7	O
x	O
1	O
.	O
3	O
x	O
1	O
,	O
and	O
3	O
x	O
1	O
.	O
7	O
x	O
.	O

1	O
.	O

cm	O
.	O

The	O
largest	O
possible	O
lymph	O
node	O
is	O
bisected	O
revealing	O
solid	O
and	O
.	O
cystic	O
,	O
tan	O
-	O
yellow	O
,	O
slightly	O
gritty	O
tissue	O
.	O

The	O
specimen	O
is	O
submitted	O
.	O
entirely	O
as	O
follows	O
:	O
Cassette	O
D1	O
-	O
smallest	O
possible	O
lymph	O
node	O
,	O
bisected	O
with	O
remainder	O
of	O
.	O
soft	O
tissue	O
,	O
.	O

Cassette	O
D2	O
-	O
03	O
-	O
one	O
possible	O
lymph	O
node	O
,	O
trisected	O
,	O
divided	O
between	O
two	O
.	O
cassettes	O
,	O
.	O

Cassettes	O
D4	O
-	O
D5	O
-	O
largest	O
possible	O
lymph	O
node	O
,	O
bisected	O
,	O
divided	O
between	O
.	O
two	O
cassettes	O
.	O

CPT	O
CODE	O
(	O
S	O
;	O
:	O
A	O
:	O
83309	O
,	O
88342	O
,	O
88342	O
.	O

B	O
:	O
88307	O
.	O

C	O
:	O
88307	O
.	O

This	O
test	O
was	O
developed	O
and	O
its	O
performance	O
and	O
characteristics	O
.	O
determined	O
by	O
the	O
.	O

It	O
has	O
not	O
been	O
cleared	O
.	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
(	O
FDA	O
)	O
.	O

.	O
The	O
FDA	O
has	O
.	O
determined	O
hat	O
mich	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

This	O
test	O
.	O

is	O
used	O
for	O
clinical	O
purposes	O
.	O

It	O
should	O
not	O
be	O
regarded	O
as	O
.	O
investigational	O
or	O
for	O
research	O
.	O

This	O
laboratory	O
is	O
certified	O
under	O
the	O
.	O

Clinical	O
Laboratory	O
Improvement	O
Amendments	O
of	O
1988	O
(	O
CLIA	O
-	O
88	O
)	O
as	O
.	O
qualified	O
to	O
perform	O
high	O
complexity	O
clinical	O
laboratory	O
testing	O
.	O

Unless	O
indi	O
cated	O
as	O
evaluated	O
by	O
gross	O
examination	O
only	O
,	O
all	O
slides	O
have	O
.	O
been	O
reviowed	O
By	O
the	O
signing	O
Pathologist	O
.	O

Completed	O
Action	O
List	O
:	O
A	O
.	O

Perform	O
b	O
:	O

-DOCSTART-285
FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
ADNEXUM	O
,	O
RIGHT	O
,	O
RIGHT	O
SALPINGO	O
-	O
OOPHORECTOMY	O
-	O
.	O

A	O
.	O

OVARY	O
WITH	O
SMALL	O
INCLUSION	O
CYST	O
.	O

B	O
.	O

UNREMARKABLE	O
FALLOPIAN	O
TUBE	O
.	O

PART	O
2	O
:	O
ADNEXUM	O
,	O
LEFT	O
,	O
LEFT	O
SALPINGO	O
-	O
OOPHORECTOMY	O
-	O
.	O

A	O
.	O

OVARY	O
WITH	O
METASTATIC	O
ADENOCARCINOMA	O
.	O

B	O
.	O

UNREMARKABLE	O
FALLOPIAN	O
TUBE	O
.	O

PART	O
3	O
:	O
UTERUS	O
(	O
276	O
GRAMS	O
)	O
,	O
TOTAL	O
ABDOMINAL	O
HYSTERECTOMY	O
-	O
.	O

A	O
.	O

POORLY	O
-	O
DIFFERENTIATED	O
ADENOCARCINOMA	O
OF	O
ENDOMETRIUM	O
,	O
PAPILLARY	O
SEROUS	O
TYPE	O
,	O
FIGO	O
.	O

GRADE	O
3	O
.	O

B	O
.	O

NEOPLASM	O
INVADES	O
100	O
%	O
OF	O
MYOMETRIUM	O
POSTERIORLY	O
WITHOUT	O
SEROSAL	O
EXTENSION	O
.	O

C	O
.	O

NEOPLASM	O
INVOLVES	O
100	O
%	O
OF	O
ENDOMETRIAL	O
SURFACE	O
.	O

D	O
.	O

LYMPHOVASCULAR	O
INVASION	O
IDENTIFIED	O
.	O

E	O
.	O

PATHOLOGIC	O
STAGE	O
pT3a	O
pN1	O
pMX	O
,	O
FIGO	O
STAGE	O
3C	O
.	O

F	O
.	O

LEIOMYOMA	O
,	O
4	B
.	I
5	I
CM	I
.	O

PART	O
4	O
:	O
CERVIX	O
,	O
TOTAL	O
ABDOMINAL	O
HYSTERECTOMY	O
-	O
.	O

A	O
.	O

PAPILLARY	O
SEROUS	O
ADENOCARCINOMA	O
EXTENDING	O
INTO	O
ENDOCERVICAL	O
GLANDS	O
AND	O
DEEPLY	O
.	O

INVOLVING	O
CERVICAL	O
STROMA	O
.	O

B	O
.	O

NEOPLASM	O
EXTENDS	O
TO	O
DEEP	O
MARGIN	O
OF	O
RESECTION	O
POSTERIORLY	O
.	O

C	O
.	O

ECTOCERVICAL	O
MARGIN	O
OF	O
RESECTION	O
APPEARS	O
FREE	O
OF	O
NEOPLASM	O
.	O

PART	O
5	O
:	O
OMENTUM	O
,	O
OMENTECTOMY	O
-	O
-	O
.	O

UNREMARKABLE	O
ADIPOSE	O
TISSUE	O
,	O
NO	O
NEOPLASM	O
IDENTIFIED	O
.	O

PART	O
6	O
:	O
ABDOMINAL	O
PERITONEUM	O
,	O
LEFT	O
,	O
BIOPSY	O
A	O
-	O
.	O

UNREMARKABLE	O
ADIPOSE	O
TISSUE	O
,	O
NO	O
NEOPLASM	O
IDENTIFIED	O
.	O

PART	O
7	O
:	O
ABDOMINAL	O
PERITONEUM	O
,	O
LEFT	O
,	O
BIOPSY	O
B	O
-	O
.	O

SOFT	O
TISSUE	O
,	O
NO	O
NEOPLASM	O
IDENTIFIED	O
.	O

PART	O
8	O
:	O
PELVIC	O
PERITONEUM	O
,	O
LEFT	O
,	O
BIOPSY	O
-	O
.	O

SOFT	O
TISSUE	O
,	O
NO	O
NEOPLASM	O
IDENTIFIED	O
.	O

PART	O
9	O
:	O
ANTERIOR	O
CUL	O
-	O
DE	O
-	O
SAC	O
,	O
BIOPSY	O
-	O
.	O

FIBROADIPOSE	O
TISSUE	O
,	O
NO	O
NEOPLASM	O
IDENTIFIED	O
.	O

PART	O
10	O
:	O
PELVIC	O
PERITONEUM	O
,	O
RIGHT	O
,	O
BIOPSY	O
-	O
.	O

SOFT	O
TISSUE	O
,	O
NO	O
NEOPLASM	O
IDENTIFIED	O
.	O

PART	O
11	O
:	O
ABDOMINAL	O
PERITONEUM	O
,	O
RIGHT	O
,	O
BIOPSY	O
A	O
-	O
.	O

SOFT	O
TISSUE	O
,	O
NO	O
NEOPLASM	O
IDENTIFIED	O
.	O

PART	O
12	O
:	O
ABDOMINAL	O
PERITONEUM	O
,	O
RIGHT	O
,	O
BIOPSY	O
B	O
-	O
.	O

SOFT	O
TISSUE	O
,	O
NO	O
NEOPLASM	O
IDENTIFIED	O
.	O

PART	O
13	O
:	O
LYMPH	O
NODE	O
,	O
LEFT	O
PELVIC	O
,	O
DISSECTION	O
-	O
.	O

TWO	O
LYMPH	O
NODES	O
NEGATIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
0	O
/	O
2	O
)	O
.	O

PART	O
14	O
:	O
LYMPH	O
NODES	O
,	O
LEFT	O
PELVIC	O
,	O
DISSECTION	O
-	O
.	O

TWO	O
LYMPH	O
NODES	O
NEGATIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
0	O
/	O
2	O
)	O
.	O

PART	O
15	O
:	O
LYMPH	O
NODES	O
,	O
LEFT	O
COMMON	O
ILIAC	O
,	O
DISSECTION	O
-	O
.	O

TWO	O
OF	O
FOUR	O
LYMPH	O
NODES	O
POSITIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
2	O
/	O
4	O
)	O
,	O
ONE	O
WITH	O
EXTRACAPSULAR	O
.	O

EXTENSION	O
.	O

PART	O
16	O
:	O
LYMPH	O
NODES	O
,	O
LEFT	O
PERIAORTIC	O
,	O
DISSECTION	O
-	O
.	O

ONE	O
OF	O
THREE	O
LYMPH	O
NODES	O
POSITIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
1	O
/	O
3	O
)	O
.	O

PART	O
17	O
:	O
LYMPH	O
NODES	O
,	O
RIGHT	O
PELVIC	O
,	O
DISSECTION	O
-	O
.	O

TWO	O
OF	O
SEVEN	O
LYMPH	O
NODES	O
POSITIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
2	O
/	O
7	O
)	O
,	O
ONE	O
WITH	O
EXTRACAPSULAR	O
.	O

EXTENSION	O
.	O

PART	O
18	O
:	O
LYMPH	O
NODES	O
,	O
RIGHT	O
PELVIC	O
,	O
DISSECTION	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
POSITIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
1	O
/	O
1	O
)	O
.	O

PART	O
19	O
:	O
LYMPH	O
NODES	O
,	O
RIGHT	O
PERIAORTIC	O
,	O
DISSECTION	O
-	O
.	O

TWO	O
OF	O
TWO	O
LYMPH	O
NODES	O
POSITIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
2	O
/	O
2	O
)	O
.	O

PART	O
20	O
:	O
APPENDIX	O
,	O
APPENDECTOMY	O
-	O
.	O

FIBROUS	O
OBLITERATION	O
OF	O
DISTAL	O
APPENDICEAL	O
LUMEN	O
.	O

NO	O
NEOPLASM	O
IDENTIFIED	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
-	O
PRIMARY	O
UTERINE	O
ENDOMETRIAL	O
TUMORS	O
:	O
HYSTERECTOMY	O
SPECIMENS	O
.	O

TUMOR	O
TYPE	O
:	O
Serous	O
adenocarcinoma	O
.	O

HISTOLOGIC	O
GRADE	O
(	O
epithelial	O
neoplasm	O
)	O
[	O
combined	O
architectural	O
and	O
nuclear	O
]	O
:	O
Poorly	O
differentiated	O
(	O
FIGO	O
3	O
)	O
.	O

ARCHITECTURAL	O
GRADE	O
:	O
Poorly	O
differentiated	O
.	O

NUCLEAR	O
GRADE	O
:	O
Grade	O
3	O
.	O

TUMOR	O
SIZE	O
:	O
Maximum	O
dimension	O
:	O
6	B
.	I
5	I
cm	I
.	O

PERCENT	O
OF	O
ENDOMETRIAL	O
SURFACE	O
INVOLVEMENT	O
:	O
Anterior	O
endomyometrium	O
:	O
100	O
%	O
,	O
Posterior	O
endomyometrium	O
:	O
100	O
%	O
.	O

DEPTH	O
OF	O
INVASION	O
.	O

Greater	O
than	O
1	O
/	O
2	O
thickness	O
of	O
myometrium	O
.	O

STRUCTURES	O
INVOLVED	O
:	O
Endocervical	O
glands	O
,	O
Cervical	O
stroma	O
,	O
Adnexa	O
.	O

ANGIOLYMPHATIC	O
INVASION	O
:	O
OTHER	O
:	O
(	O
epithelial	O
,	O
smooth	O
muscle	O
,	O
others	O
)	O
,	O
Leiomyoma	O
.	O

LYMPH	O
NODES	O
POSITIVE	O
:	O
Number	O
of	O
lymph	O
nodes	O
positive	O
:	O
:	O
8	O
.	O

LYMPH	O
NODES	O
EXAMINED	O
:	O
Total	O
number	O
of	O
lymph	O
nodes	O
examined	O
:	O
21	O
.	O

LYMPH	O
NODE	O
GROUPS	O
INVOLVED	O
:	O
Pelvic	O
lymph	O
nodes	O
,	O
Right	O
,	O
Common	O
iliac	O
lymph	O
nodes	O
,	O
Left	O
,	O
Para	O
-	O
aortic	O
lymph	O
nodes	O
,	O
.	O

Right	O
,	O
Para	O
-	O
aortic	O
lymph	O
nodes	O
,	O
Left	O
.	O

EXTRANODAL	O
EXTENSION	O
:	O
T	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pT3a	O
.	O

N	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pN1	O
.	O

M	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pMX	O
.	O

FIGO	O
STAGE	O
:	O
IIIC	O
.	O

-DOCSTART-286
F	O
.	O

Pathologic	O
Interpretation	O
:	O
A	O
.	O

Sentinel	O
node	O
#	O
1	O
.	O

-	O
One	O
lymph	O
node	O
,	O
no	O
malignancy	O
seen	O
(	O
0	O
/	O
1	O
)	O
.	O

-	O
Immunostains	O
are	O
in	O
progress	O
.	O

B	O
.	O

Sentinel	O
node	O
#	O
2	O
.	O

-	O
One	O
lymph	O
node	O
,	O
no	O
malignancy	O
seen	O
(	O
0	O
/	O
1	O
)	O
.	O

-	O
Immunostains	O
are	O
in	O
progress	O
.	O

C	O
.	O

Sentinel	O
node	O
#	O
3	O
.	O

-	O
One	O
lymph	O
node	O
,	O
no	O
malignancy	O
seen	O
(	O
0	O
/	O
1	O
)	O
.	O

-	O
Immunostains	O
are	O
in	O
progress	O
.	O

D	O
.	O

Non	O
-	O
sentinel	O
lymph	O
node	O
:	O
-	O
Two	O
lymph	O
nodes	O
,	O
no	O
malignancy	O
seen	O
(	O
0	O
/	O
2	O
)	O
.	O

E	O
.	O

Right	O
breast	O
mass	O
,	O
1	O
short	O
stitch	O
superior	O
,	O
1	O
long	O
stitch	O
lateral	O
,	O
lumpectomy	O
:	O
-	O
Inflitrating	O
ductal	O
carcinoma	O
,	O
intermediate	O
nuclear	O
grade	O
,	O
2	B
.	I
0	I
cm	I
in	O
greatest	O
dimension	O
.	O

-	O
Focal	O
ductal	O
carcinoma	O
in	O
situ	O
,	O
cribriform	O
type	O
,	O
intermediate	O
nuclear	O
grade	O
with	O
necrosis	O
.	O

-	O
Margins	O
are	O
free	O
of	O
tumor	O
.	O

-	O
Lymphovascular	O
invasion	O
is	O
not	O
seen	O
.	O

-	O
AJCC	O
pT2NOMx	O
.	O

-	O
See	O
tumor	O
summary	O
.	O

-	O
Other	O
areas	O
of	O
the	O
breast	O
show	O
fibrocystic	O
changes	O
with	O
microcalcifications	O
.	O

-	O
Skin	O
with	O
scar	O
and	O
foreign	O
material	O
(	O
gel	O
foam	O
)	O
deposition	O
.	O

-	O
Changes	O
of	O
(	O
previous	O
biopsy	O
site	O
.	O

-	O
Focal	O
changes	O
of	O
previous	O
therapy	O
effect	O
noted	O
on	O
non	O
-	O
neoplastic	O
breast	O
tissue	O
and	O
a	O
small	O
portion	O
of	O
tunior	O
.	O

-	O
Immunostains	O
are	O
in	O
progress	O
.	O

F	O
.	O

Deep	O
margin	O
blue	O
true	O
deep	O
:	O
-	O
Skeletal	O
muscle	O
,	O
no	O
malignancy	O
seen	O
.	O

G	O
.	O

Internal	O
mammary	O
sentinel	O
node	O
.	O

2nd	O
intercostal	O
.	O

-	O
One	O
lymph	O
node	O
,	O
no	O
malignancy	O
seen	O
(	O
0	O
/	O
1	O
)	O
.	O

-	O
Immunostains	O
are	O
in	O
progress	O
.	O

Tumor	O
Summary	O
:	O
Specimen	O
Type	O
:	O
Excision	O
.	O

Lymph	O
Node	O
Sampling	O
:	O
Sentinel	O
lymph	O
nodes	O
and	O
one	O
non	O
-	O
sentinel	O
node	O
.	O

Specimen	O
Size	O
:	O
Greatest	O
dimension	O
:	O
7	O
.	O
2	O
cm	O
.	O

Additional	O
dimensions	O
:	O
6	O
.	O
1	O
x	O
2	O
.	O
5	O
cm	O
.	O

Laterality	O
:	O
Right	O
.	O

Tumor	O
Site	O
:	O
Not	O
specified	O
.	O

Size	O
of	O
Invasive	O
Component	O
:	O
Greatest	O
dimension	O
:	O
2	B
.	I
0	I
cm	I
.	O

Additional	O
dimensions	O
:	O
1	O
.	O
8	O
x	O
1	O
.	O
5	O
cm	O
.	O

Histologic	O
Type	O
:	O
Invasive	O
ductal	O
carcinoma	O
.	O

Histologic	O
Grade	O
:	O
Tubule	O
Formation	O
:	O
Moderate	O
10	O
%	O
to	O
75	O
%	O
(	O
score	O
=	O
2	O
)	O
.	O

Nuclear	O
Pleomorphism	O
:	O
Marked	O
variation	O
in	O
size	O
,	O
nucleoli	O
,	O
chromatin	O
clumping	O
.	O
etc	O
(	O
score	O
=	O
3	O
)	O
.	O

For	O
a	O
40x	O
objective	O
with	O
a	O
field	O
area	O
of	O
0	O
.	O
152	O
mm2	O
:	O
0	O
to	O
5	O
mitoses	O
per	O
10	O
HPF	O
(	O
score	O
=	O
1	O
)	O
.	O

Total	O
Nottingham	O
Score	O
:	O
Grade	O
II	O
:	O
6	O
-	O
7	O
points	O
.	O

Pathologic	O
Staging	O
(	O
pTNM	O
)	O
.	O

Primary	O
Tumor	O
:	O
pT2	O
.	O

SURGICAL	O
PATHOL	O
Report	O
.	O

Regional	O
Lymph	O
Nodes	O
:	O
pNO	O
.	O

Number	O
examined	O
:	O
6	O
.	O

Number	O
involved	O
:	O
0	O
.	O

Distant	O
Metastasis	O
:	O
pMX	O
.	O

Margins	O
:	O
Uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

Distance	O
from	O
closest	O
margin	O
:	O
2	O
.	O
0	O
mm	O
.	O

Specify	O
which	O
margin	O
:	O
Posterior	O
(	O
deep	O
)	O
,	O
see	O
comment	O
.	O

Venous	O
/	O
Lymphatic	O
Invasion	O
:	O
Absent	O
.	O

Microcalcifications	O
:	O
Present	O
in	O
non	O
-	O
neoplastic	O
tissue	O
.	O

"	O
Electronically	O
Signed	O
Out	O
By	O
.	O

NOTE	O
:	O
Some	O
immunohiatochemice	O
/	O
antibodies	O
are	O
analyte	O
specific	O
reagents	O
(	O
ASRs	O
)	O
validated	O
by	O
our	O
laboratory	O
(	O
Her	O
2	O
,	O
Parvo	O
,	O
H	O
.	O
pylort	O
,	O
HBcore	O
)	O
.	O

These	O
ASRs	O
are	O
clinically	O
indicatora	O
that	O
do	O
.	O
not	O
require	O
FDA	O
approval	O
.	O

These	O
clones	O
are	O
used	O
:	O
IDS	O
=	O
ER	O
,	O
POR	O
636	O
=	O
PR	O
,	O
A485	O
-	O
HER2	O
.	O

H	O
-	O
11	O
=	O
EGFR	O
,	O
CCH2	O
/	O
OOG9	O
=	O
CMV	O
,	O
F39	O
.	O
4	O
.	O

1	O
=	O
AR	O
and	O
HPV	O
by	O
ISH	O
.	O

AS	O
Immunohietochern	O
)	O
stains	O
are	O
used	O
.	O
with	O
formaho	O
or	O
molecular	O
fired	O
,	O
paraffin	O
embedded	O
tisaue	O
.	O

Detection	O
is	O
by	O
LSAB	O
.	O

The	O
results	O
are	O
read	O
by	O
a	O
pathologier	O
as	O
positive	O
or	O
negative	O
.	O

As	O
the	O
attending	O
pathologiet	O
,	O
/	O
attest	O
that	O
1	O
:	O
(	O
i	O
)	O
Examindo	O
the	O
relevant	O
.	O

proparation	O
(	O
a	O
)	O
for	O
the	O
specimen	O
(	O
s	O
)	O
;	O
and	O
(	O
4	O
)	O
Rendered	O
he	O
diagnoais	O
(	O
es	O
)	O
.	O

Procedures	O
/	O
Addenda	O
.	O

Addendum	O
.	O

Date	O
Complete	O
:	O
Addendum	O
Diagnosis	O
.	O

A	O
,	O
B	O
,	O
C	O
,	O
G	O
.	O

Immunohistochemistry	O
for	O
keratin	O
is	O
negative	O
(	O
Blocks	O
A1	O
,	O
A2	O
,	O
B1	O
,	O
B2	O
,	O
C1	O
and	O
G1	O
)	O
.	O

E	O
.	O

Tumor	O
cells	O
are	O
positive	O
for	O
ER	O
and	O
PR	O
and	O
negative	O
for	O
HER2	O
-	O
neu	O
(	O
block	O
E7	O
)	O
.	O

Intraoperative	O
Consultation	O
.	O

AFS	O
.	O

Sentinel	O
node	O
#	O
1	O
.	O
touch	O
prep	O
and	O
FS	O
:	O
Negative	O
for	O
tumor	O
.	O

BFS	O
.	O

Sentinel	O
node	O
#	O
2	O
.	O

FS	O
:	O
Negative	O
for	O
tumor	O
.	O

CFS	O
.	O

Sentinel	O
node	O
#	O
3	O
.	O

FS	O
:	O
Negative	O
for	O
tumor	O
.	O

FFS	O
.	O

Deep	O
margin	O
blue	O
true	O
deep	O
FS	O
:	O
Skeletal	O
muscle	O
,	O
no	O
malignancy	O
seen	O
.	O

Clinical	O
History	O
:	O
Patient	O
is	O
a	O
.	O
year	O
old	O
female	O
with	O
history	O
of	O
right	O
breast	O
cancer	O
.	O

Pre	O
Operativo	O
Diagnosis	O
:	O
SURGICAL	O
PATHOL	O
Report	O
.	O

Right	O
breast	O
cancer	O
.	O

Specimen	O
(	O
s	O
)	O
Received	O
:	O
A	O
:	O
sentinel	O
node	O
#	O
1	O
.	O
touch	O
prep	O
and	O
FS	O
.	O

B	O
:	O
sentinel	O
node	O
#	O
2	O
.	O

1	O
FS	O
.	O

C	O
:	O
sentinel	O
node	O
#	O
3	O
.	O

FS	O
.	O

D	O
:	O
non	O
-	O
sentinel	O
lymph	O
node	O
.	O

E	O
:	O
right	O
breast	O
mass	O
,	O
1	O
short	O
stitch	O
superior	O
,	O
1	O
long	O
stitch	O
lateral	O
fresh	O
.	O

F	O
:	O
deep	O
margin	O
blue	O
true	O
deep	O
FS	O
.	O

G	O
:	O
Internal	O
mammary	O
sentinel	O
node	O
.	O

2nd	O
intercostal	O
(	O
.	O

Gross	O
Description	O
:	O
A	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
sentinel	O
node	O
#	O
1	O
.	O
touch	O
prep	O
and	O
FS	O
'	O
consists	O
of	O
a	O
lymph	O
node	O
,	O
1	O
.	O
5	O
cm	O
in	O
greatest	O
.	O
dimension	O
.	O

Specimen	O
bisected	O
and	O
submitted	O
in	O
toto	O
in	O
two	O
cassettes	O
as	O
follows	O
.	O

1	O
.	O

Half	O
on	O
lymph	O
node	O
for	O
frozen	O
.	O

2	O
.	O

The	O
rest	O
of	O
lymph	O
node	O
for	O
permanent	O
.	O

B	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
sentinel	O
node	O
#	O
2	O
(	O
.	O
consists	O
of	O
irregular	O
shaped	O
,	O
yellow	O
-	O
tan	O
,	O
adipose	O
tissue	O
fragment	O
,	O
.	O

1	O
.	O
4	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
2	O
cm	O
.	O

Specimen	O
submitted	O
in	O
toto	O
in	O
two	O
cassettes	O
.	O

1	O
.	O

One	O
section	O
from	O
frozen	O
.	O

2	O
.	O

The	O
reminder	O
of	O
the	O
specimen	O
for	O
permanent	O
.	O

C	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
sentinel	O
node	O
#	O
3	O
.	O
consists	O
of	O
irregular	O
shaped	O
,	O
pale	O
-	O
tan	O
,	O
soft	O
tissue	O
fragment	O
,	O
0	O
.	O
4	O
x	O
0	O
.	O
3	O
.	O

x	O
0	O
.	O
2	O
cm	O
.	O

Specimen	O
bisected	O
and	O
submitted	O
in	O
toto	O
in	O
one	O
cassette	O
for	O
frozen	O
.	O

D	O
.	O

Received	O
in	O
formalin	O
and	O
labeled	O
"	O
non	O
-	O
sentinel	O
lymph	O
node	O
"	O
consists	O
of	O
two	O
irregular	O
shaped	O
,	O
yellow	O
-	O
tan	O
,	O
sof	O
tissue	O
.	O
fragment	O
,	O
1	O
.	O
4	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
3	O
cm	O
and	O
1	O
.	O
0	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
2	O
cm	O
.	O

Examination	O
of	O
the	O
specimen	O
reveal	O
two	O
possible	O
lymph	O
nodes	O
,	O
1	O
.	O
3	O
.	O

cm	O
and	O
0	O
.	O
8	O
cm	O
in	O
greatest	O
dimension	O
.	O

Specimen	O
submitted	O
in	O
toto	O
In	O
two	O
cassettes	O
as	O
follows	O
.	O

1	O
.	O

Large	O
lymph	O
node	O
bisected	O
.	O

2	O
.	O

Small	O
lymph	O
noe	O
bisected	O
.	O

E	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
right	O
breast	O
mass	O
,	O
1	O
short	O
stitch	O
superior	O
,	O
1	O
long	O
stitch	O
lateral	O
"	O
consists	O
of	O
an	O
irregular	O
by	O
.	O
shaped	O
,	O
fibro	O
-	O
adipose	O
tissue	O
fragments	O
measuring	O
7	O
.	O
2	O
x	O
6	O
.	O
1	O
x	O
2	O
.	O
5	O
cm	O
and	O
weighing	O
35	O
.	O
3	O
grams	O
.	O

Attached	O
to	O
the	O
anterior	O
.	O
aspect	O
of	O
the	O
specimen	O
there	O
is	O
a	O
very	O
thin	O
ellipse	O
of	O
skin	O
,	O
2	O
.	O
8	O
cm	O
by	O
0	O
.	O
2	O
cm	O
.	O

For	O
gross	O
purpose	O
the	O
specimen	O
is	O
inked	O
as	O
.	O
follows	O
:	O
Anterior	O
resection	O
the	O
skin	O
surrounding	O
the	O
skin	O
in	O
yellow	O
,	O
superior	O
resection	O
margin	O
is	O
inked	O
blue	O
,	O
inferior	O
.	O
resection	O
margin	O
is	O
inked	O
green	O
,	O
medial	O
resection	O
margin	O
is	O
inked	O
red	O
,	O
lateral	O
resection	O
margin	O
is	O
inked	O
orange	O
and	O
.	O
posterior	O
resection	O
margin	O
is	O
inked	O
black	O
.	O

Multiple	O
cross	O
sections	O
reveal	O
an	O
ill	O
-	O
circumscribed	O
,	O
gray	O
-	O
white	O
,	O
hard	O
and	O
gritty	O
.	O
mass	O
,	O
2	O
.	O
0	O
x	O
1	O
.	O
8	O
x	O
1	O
.	O
5	O
cm	O
.	O

The	O
mass	O
is	O
0	O
.	O
2	O
cm	O
from	O
deep	O
resection	O
margin	O
(	O
nearest	O
margin	O
)	O
,	O
1	O
.	O
5	O
cm	O
from	O
the	O
skin	O
surface	O
,	O
.	O

1	O
.	O
0	O
cm	O
from	O
medial	O
resection	O
margin	O
,	O
1	O
.	O
7	O
cm	O
from	O
lateral	O
resection	O
margin	O
,	O
2	O
.	O
0	O
cm	O
from	O
superior	O
resection	O
margin	O
and	O
.	O

1	O
.	O
8	O
.	O

cm	O
from	O
inferior	O
resection	O
margin	O
.	O

The	O
reminder	O
of	O
the	O
specimen	O
reveals	O
an	O
unremarkable	O
fibro	O
-	O
adipose	O
tissue	O
.	O

The	O
.	O
stroma	O
to	O
fat	O
ratio	O
is	O
30	O
.	O
70	O
%	O
.	O

Representative	O
sections	O
are	O
submitted	O
as	O
follows	O
.	O

1	O
.	O

Superior	O
resection	O
margin	O
.	O

2	O
.	O

Inferior	O
resection	O
margin	O
.	O

3	O
.	O

Medial	O
resection	O
margin	O
.	O

4	O
.	O

Lateral	O
resection	O
margin	O
.	O

5	O
&	O
6	O
.	O

Composed	O
sections	O
of	O
the	O
mass	O
in	O
relation	O
with	O
deep	O
resection	O
margin	O
(	O
nearest	O
margin	O
)	O
.	O

7	O
-	O
9	O
.	O

Additional	O
representative	O
section	O
from	O
the	O
mass	O
.	O

10	O
.	O

Representative	O
section	O
from	O
skin	O
.	O

11	O
-	O
14	O
.	O

Representative	O
section	O
from	O
the	O
reminder	O
of	O
the	O
stroma	O
.	O

F	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
deep	O
margin	O
blue	O
true	O
deep	O
"	O
consists	O
of	O
irregular	O
shaped	O
,	O
yellow	O
-	O
tan	O
,	O
fibro	O
-	O
adipose	O
tissue	O
.	O
fragments	O
,	O
1	O
.	O
8	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
2	O
cm	O
.	O

The	O
resection	O
margin	O
inked	O
black	O
.	O

Specimen	O
multisected	O
and	O
submitted	O
in	O
toto	O
in	O
one	O
.	O
cassette	O
for	O
frozen	O
.	O

G	O
.	O

Received	O
in	O
formalin	O
and	O
labeled	O
"	O
internal	O
mammary	O
sentinel	O
node	O
.	O
,	O
2nd	O
intercostal	O
(	O
.	O
consists	O
of	O
Irregular	O
.	O
shaped	O
,	O
yellow	O
-	O
tan	O
,	O
soft	O
tissue	O
fragment	O
,	O
0	O
.	O
5	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
1	O
cm	O
.	O

Specimen	O
submitted	O
in	O
toto	O
in	O
one	O
cassette	O
.	O

SURGICAL	O
PATHOL	O
Report	O
.	O

ICD	O
-	O
9	O
(	O
s	O
)	O
:	O
174	O
.	O
8	O
.	O

-DOCSTART-287
Diagnosis	O
:	O
A	O
:	O
Liver	O
lesion	O
,	O
"	O
Level	O
5	O
"	O
,	O
excision	O
.	O

-	O
Adenocarcinoma	O
,	O
moderately	O
differentiated	O
,	O
of	O
intrahepatic	O
.	O
bile	O
ducts	O
(	O
primary	O
hepatic	O
cholangiocarcinoma	O
)	O
,	O
4	B
.	I
5	I
mm	I
.	O

-	O
Carcinoma	O
is	O
less	O
than	O
1	O
mm	O
from	O
inked	O
parenchymal	O
margin	O
.	O

-	O
Dysplasia	O
of	O
the	O
intraductal	O
biliary	O
epithelium	O
(	O
see	O
comment	O
)	O
.	O

B	O
:	O
Liver	O
,	O
Segment	O
8	O
,	O
excision	O
.	O

-	O
Adenocarcinoma	O
,	O
moderately	O
differentiated	O
,	O
of	O
intrahepatic	O
.	O
bile	O
ducts	O
(	O
primary	O
hepatic	O
cholangiocarcinoma	O
)	O
,	O
at	O
least	O
two	O
.	O
separate	O
foci	O
by	O
gross	O
examination	O
,	O
0	B
.	I
4	I
and	O
0	B
.	I
8	I
cm	I
.	O

-	O
Inked	O
parenchymal	O
margin	O
(	O
definitive	O
margin	O
)	O
positive	O
for	O
.	O
carcinoma	O
(	O
B2	O
)	O
.	O

-	O
Dysplasia	O
of	O
the	O
intraductal	O
biliary	O
epithelium	O
and	O
.	O
intraductal	O
biliary	O
papillary	O
carcinoma	O
in	O
situ	O
,	O
mutlifocal	O
.	O

C	O
:	O
Liver	O
,	O
Segments	O
2	O
-	O
5	O
,	O
partial	O
hepatectomy	O
.	O

Adenocarcinoma	O
,	O
moderately	O
differentiated	O
,	O
of	O
intrahepatic	O
.	O
bile	O
ducts	O
(	O
primary	O
hepatic	O
cholangiocarcinoma	O
)	O
,	O
at	O
least	O
11	B
.	I
2	I
.	I

cm	B
by	O
gross	O
measurement	O
.	O

-	O
Dysplasia	O
of	O
the	O
intraductal	O
biliary	O
epithelium	O
and	O
.	O
intraductal	O
biliary	O
papillary	O
carcinoma	O
in	O
situ	O
,	O
mutlifocal	O
.	O

-	O
Inked	O
parenchymal	O
margin	O
is	O
extensively	O
positive	O
for	O
invasive	O
.	O
carcinoma	O
(	O
C1	O
)	O
.	O

-	O
Bile	O
duct	O
margin	O
is	O
positive	O
for	O
dysplasia	O
(	O
C9	O
)	O
.	O

Invasive	O
carcinoma	O
extends	O
into	O
perihepatic	O
fibroadipose	O
.	O
tissue	O
.	O

-	O
Lymphovascular	O
space	O
invasion	O
is	O
identified	O
.	O

-	O
AJCC	O
stage	O
:	O
pT3	O
pN1	O
(	O
see	O
comment	O
)	O
.	O

D	O
:	O
Lymph	O
nodes	O
,	O
perihepatic	O
,	O
excision	O
.	O

-	O
One	O
of	O
eleven	O
lymph	O
nodes	O
positive	O
for	O
metastatic	O
.	O
adenocarcinoma	O
(	O
1	O
/	O
11	O
)	O
.	O

-	O
Size	O
of	O
metastasis	O
is	O
0	O
.	O
6	O
cm	O
.	O

-	O
Extracapsular	O
extension	O
identified	O
.	O

Comment	O
:	O
The	O
liver	O
displays	O
a	O
spectrum	O
of	O
intraductal	O
biliary	O
neoplasia	O
.	O

In	O
some	O
bile	O
duct	O
profiles	O
the	O
epithelium	O
is	O
dysplastic	O
without	O
.	O
papillary	O
structure	O
formation	O
.	O

In	O
other	O
bile	O
duct	O
profiles	O
,	O
.	O
intraductal	O
biliary	O
papillomatosis	O
is	O
present	O
as	O
multifocal	O
.	O
papillary	O
lesions	O
.	O

Intraductal	O
papillary	O
carcinoma	O
is	O
.	O
considered	O
to	O
be	O
to	O
be	O
the	O
in	O
situ	O
lesion	O
for	O
the	O
invasive	O
.	O
cholangiocarcinoma	O
,	O
and	O
is	O
related	O
to	O
the	O
pancreatic	O
intraductal	O
.	O
mucinous	O
neoplasm	O
.	O

Dysplasia	O
of	O
the	O
bile	O
duct	O
epithelium	O
without	O
.	O
papillomatosis	O
most	O
likely	O
is	O
part	O
of	O
the	O
same	O
neoplastic	O
.	O
process	O
in	O
this	O
case	O
.	O

The	O
invasive	O
tumor	O
does	O
not	O
have	O
papillary	O
.	O
architecture	O
,	O
and	O
is	O
a	O
conventional	O
gland	O
-	O
forming	O
.	O
adenocarcinoma	O
.	O

Invasive	O
carcinoma	O
is	O
present	O
as	O
large	O
mass	O
.	O

lesions	O
/	O
nodules	O
(	O
mass	O
forming	O
subtype	O
)	O
.	O

Extensive	O
peri	O
-	O
ductal	O
invasion	O
(	O
carcinoma	O
spread	O
along	O
intact	O
.	O
biliary	O
tree	O
)	O
is	O
not	O
identified	O
.	O

The	O
tumor	O
is	O
staged	O
as	O
a	O
.	O
pathologic	O
T3	O
because	O
of	O
invasion	O
into	O
perihepatic	O
fibroadipose	O
.	O
tissue	O
at	O
the	O
round	O
ligament	O
.	O

Clinical	O
History	O
:	O
-	O
year	O
-	O
old	O
female	O
with	O
intrahepatic	O
malignant	O
neoplasm	O
.	O
consistent	O
with	O
cholangiocarcinoma	O
.	O

Gross	O
Description	O
:	O
Received	O
are	O
four	O
formalin	O
-	O
filled	O
containers	O
.	O

Container	O
A	O
is	O
additionally	O
labeled	O
"	O
Level	O
5	O
liver	O
lesion	O
.	O

"	O
It	O
.	O
holds	O
a	O
0	O
.	O
8	O
X	O
0	O
.	O
7	O
X	O
0	O
.	O
4	O
cm	O
wedge	O
-	O
shaped	O
fragment	O
of	O
gray	O
/	O
tan	O
.	O
liver	O
which	O
is	O
partially	O
covered	O
with	O
a	O
smooth	O
capsule	O
.	O

The	O
.	O
parenchymal	O
surface	O
is	O
inked	O
black	O
and	O
the	O
specimen	O
is	O
.	O
sectioned	O
to	O
reveal	O
a	O
0	O
.	O
5	O
X	O
0	O
.	O
4	O
X	O
0	O
.	O
3	O
cm	O
circumscribed	O
white	O
.	O
subcapsular	O
nodule	O
abutting	O
the	O
black	O
inked	O
parenchymal	O
margin	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
and	O
entirely	O
submitted	O
in	O
.	O
block	O
A1	O
,	O
.	O

Container	O
B	O
is	O
additionally	O
labeled	O
"	O
Segment	O
8	O
liver	O
.	O

"	O
The	O
.	O
requisition	O
states	O
:	O
stitch	O
marks	O
definitive	O
segment	O
8	O
margin	O
.	O

It	O
holds	O
a	O
3	O
.	O
1	O
gram	O
,	O
2	O
.	O
4	O
X	O
2	O
.	O
2	O
X	O
1	O
.	O
7	O
cm	O
friable	O
fragment	O
of	O
.	O
liver	O
tissue	O
with	O
two	O
sutures	O
present	O
on	O
one	O
surface	O
.	O
designating	O
definitive	O
margin	O
.	O

This	O
surface	O
is	O
inked	O
black	O
,	O
and	O
.	O
the	O
opposite	O
surface	O
is	O
inked	O
red	O
for	O
identification	O
purposes	O
.	O

The	O
specimen	O
is	O
sectioned	O
perpendicular	O
to	O
the	O
black	O
inked	O
.	O
margin	O
and	O
entirely	O
submitted	O
in	O
blocks	O
B1	O
-	O
B5	O
.	O

Sectioning	O
reveals	O
two	O
white	O
circumscribed	O
nodules	O
which	O
are	O
0	O
.	O
4	O
.	O
and	O
0	O
.	O
8	O
cm	O
in	O
greatest	O
dimension	O
.	O

Each	O
nodule	O
abuts	O
the	O
red	O
.	O
inked	O
margin	O
opposite	O
the	O
sutured	O
margin	O
.	O

The	O
smaller	O
nodule	O
.	O
comes	O
within	O
0	O
.	O
2	O
cm	O
of	O
the	O
black	O
inked	O
sutured	O
margin	O
.	O

(	O
B3	O
)	O
,	O
and	O
the	O
larger	O
nodule	O
comes	O
within	O
0	O
.	O
3	O
cm	O
of	O
the	O
black	O
.	O
inked	O
sutured	O
margin	O
(	O
B1	O
)	O
.	O

Block	O
Summary	O
:	O
B1	O
-	O
B5	O
,	O
.	O

Container	O
C	O
is	O
additionally	O
labeled	O
"	O
Liver	O
,	O
Segments	O
2	O
-	O
5	O
.	O

"	O
It	O
.	O
consists	O
of	O
a	O
545	O
gram	O
,	O
18	O
X	O
13	O
X	O
5	O
cm	O
partial	O
hepatectomy	O
.	O
specimen	O
composed	O
of	O
Segments	O
2	O
-	O
5	O
.	O

The	O
capsule	O
is	O
brown	O
/	O
gray	O
,	O
.	O
focally	O
plaque	O
-	O
like	O
.	O

The	O
parenchymal	O
margin	O
is	O
inked	O
blue	O
.	O

There	O
.	O

is	O
a	O
small	O
amount	O
of	O
attached	O
fat	O
along	O
the	O
inferior	O
edge	O
of	O
.	O

Segment	O
5	O
.	O

Along	O
the	O
medial	O
edge	O
of	O
the	O
parenchymal	O
margin	O
there	O
.	O

is	O
a	O
3	O
.	O
4	O
X	O
2	O
.	O
9	O
cm	O
fragment	O
of	O
fibromembranous	O
tissue	O
and	O
.	O
cauterized	O
fat	O
.	O

This	O
area	O
is	O
adherent	O
upon	O
the	O
capsule	O
.	O

Sectioning	O
demonstrates	O
a	O
dominate	O
nodule	O
surrounded	O
by	O
.	O
multiple	O
butting	O
nodules	O
off	O
its	O
edge	O
and	O
within	O
the	O
remainder	O
.	O
of	O
the	O
parenchyma	O
.	O

The	O
dominate	O
nodule	O
is	O
11	O
.	O
2	O
X	O
9	O
.	O
8	O
X	O
4	O
.	O
4	O
cm	O
.	O

The	O
smaller	O
nodule	O
within	O
the	O
parenchyma	O
and	O
subcapsular	O
range	O
.	O
from	O
0	O
.	O
1	O
to	O
4	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
closest	O
approach	O
to	O
.	O
the	O
parenchymal	O
margin	O
(	O
inked	O
black	O
)	O
is	O
0	O
.	O
2	O
cm	O
.	O

The	O
tumor	O
has	O
a	O
.	O
solid	O
gritty	O
yellow	O
/	O
tan	O
cut	O
surface	O
with	O
areas	O
of	O
firm	O
,	O
.	O
white	O
tissue	O
at	O
the	O
periphery	O
.	O

The	O
surrounding	O
hepatic	O
.	O
parenchyma	O
is	O
homogeneous	O
tan	O
/	O
gray	O
with	O
no	O
micronodular	O
pattern	O
.	O
identified	O
.	O

Tumor	O
and	O
normal	O
are	O
given	O
to	O
Tissue	O
Procurement	O
.	O

Block	O
Summary	O
:	O
C1	O
-	O
tumor	O
nodules	O
at	O
closest	O
approach	O
to	O
black	O
inked	O
.	O
parenchymal	O
margin	O
.	O

C2	O
-	O
C3	O
-	O
fibromembranous	O
tissue	O
adherent	O
near	O
surgical	O
margin	O
.	O

C4	O
-	O
C5	O
-	O
additional	O
section	O
near	O
adherent	O
fatty	O
tissue	O
at	O
round	O
.	O
ligament	O
insertion	O
.	O

C6	O
-	O
edge	O
of	O
tumor	O
and	O
large	O
caliber	O
lumina	O
.	O

C7	O
-	O
C8	O
-	O
additional	O
sections	O
of	O
tumor	O
.	O

C9	O
-	O
C11	O
-	O
additional	O
sections	O
,	O
en	O
face	O
,	O
from	O
surgical	O
margin	O
,	O
.	O
lumina	O
.	O

Container	O
D	O
is	O
additionally	O
labeled	O
"	O
perihepatic	O
lymph	O
node	O
.	O
'	O
It	O
.	O
consists	O
of	O
a	O
3	O
.	O
7	O
X	O
2	O
.	O
6	O
X	O
1	O
.	O
5	O
cm	O
aggregate	O
of	O
cauterized	O
.	O

yellow	O
/	O
tan	O
fibrofatty	O
tissue	O
which	O
is	O
dissected	O
for	O
lymph	O
node	O
.	O
candidates	O
.	O

Lymph	O
node	O
candidates	O
up	O
to	O
3	O
.	O
1	O
cm	O
in	O
greatest	O
.	O
dimension	O
are	O
identified	O
.	O

Block	O
summary	O
:	O
D1	O
-	O
four	O
lymph	O
node	O
candidates	O
.	O

D2	O
-	O
two	O
lymph	O
node	O
candidates	O
.	O

D3	O
-	O
one	O
bisected	O
lymph	O
node	O
candidate	O
.	O

D4	O
-	O
D5	O
-	O
-	O
one	O
sectioned	O
lymph	O
node	O
candidate	O
.	O

A	O
small	O
amount	O
of	O
fat	O
remains	O
in	O
formalin	O
.	O

-DOCSTART-288
SPECIMEN	O
.	O

A	O
.	O

Left	O
upper	O
lobe	O
FS	O
.	O

B	O
.	O

Node	O
level	O
5	O
.	O

C	O
.	O

Node	O
level	O
1	O
.	O

D	O
.	O

Left	O
upper	O
lobe	O
.	O

E	O
.	O

Node	O
level	O
7	O
.	O

F	O
.	O

Node	O
level	O
4	O
.	O

G	O
.	O

Node	O
level	O
9	O
.	O

CLINICAL	O
NOTES	O
.	O

PRE	O
-	O
OP	O
DIAGNOSIS	O
:	O
Lung	O
mass	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
.	O

FSA	O
)	O
Left	O
upper	O
lobe	O
-	O
Poorly	O
differentiated	O
adenocarcinoma	O
.	O

GROSS	O
DESCRIPTION	O
.	O

A	O
.	O

Submitted	O
fresh	O
for	O
frozen	O
and	O
tissue	O
procurement	O
.	O
labeled	O
"	O
left	O
upper	O
lobe	O
"	O
is	O
a	O
wedge	O
resection	O
of	O
.	O
pulmonary	O
.	O

tissue	O
,	O
which	O
has	O
a	O
small	O
incision	O
previously	O
made	O
within	O
it	O
.	O

The	O
.	O
wedge	O
measures	O
maximally	O
7	O
X	O
4	O
X	O
3	O
cm	O
.	O

Next	O
to	O
the	O
incision	O
site	O
.	O
there	O
is	O
some	O
puckering	O
of	O
the	O
pleura	O
,	O
which	O
overlies	O
a	O
palpable	O
.	O
lung	O
mass	O
.	O

Sutures	O
are	O
removed	O
from	O
the	O
specimen	O
and	O
is	O
then	O
.	O
serially	O
sectioned	O
.	O

Sections	O
through	O
the	O
specimen	O
reveals	O
a	O
.	O
puckered	O
firm	O
tan	O
tumor	O
mass	O
immediately	O
below	O
the	O
pleural	O
surface	O
.	O
measuring	O
maximally	O
2	B
.	I
2	I
cm	I
in	O
greatest	O
dimension	O
.	O

Per	O
request	O
,	O
a	O
.	O
portion	O
of	O
tissue	O
is	O
submitted	O
for	O
tissue	O
procurement	O
.	O

A	O
portion	O
.	O

of	O
.	O
tissue	O
is	O
submitted	O
for	O
frozen	O
section	O
.	O

RS	O
-	O
4	O
.	O

B	O
.	O

Received	O
fresh	O
,	O
subsequently	O
fixed	O
in	O
formalin	O
labeled	O
.	O

"	O
node	O
level	O
5	O
"	O
is	O
a	O
1	O
.	O
2	O
X	O
0	O
.	O
5	O
X	O
0	O
.	O
5	O
cm	O
black	O
-	O
red	O
irregular	O
.	O
soft	O
tissue	O
fragment	O
which	O
is	O
bisected	O
and	O
entirely	O
submitted	O
in	O
.	O
one	O
.	O

cassette	O
.	O

AS	O
-	O
1	O
.	O

C	O
.	O

Received	O
in	O
formalin	O
labeled	O
"	O
node	O
level	O
1	O
"	O
is	O
a	O
1	O
.	O
5	O
x	O
.	O

1	O
.	O
5	O
X	O
0	O
.	O
6	O
cm	O
pink	O
black	O
,	O
irregular	O
tissue	O
fragment	O
which	O
.	O

is	O
.	O

GROSS	O
DESCRIPTION	O
.	O
bisected	O
and	O
entirely	O
submitted	O
in	O
one	O
cassette	O
.	O

AS	O
-	O
1	O
.	O

D	O
.	O

Received	O
fresh	O
,	O
subsequently	O
fixed	O
in	O
formalin	O
labeled	O
.	O

"	O
left	O
upper	O
lobe	O
"	O
is	O
a	O
20	O
.	O
0	O
X	O
6	O
.	O
5	O
x	O
3	O
.	O
5	O
cm	O
remainder	O
of	O
.	O
lobe	O
.	O

The	O
specimen	O
is	O
partially	O
covered	O
with	O
violaceous	O
smooth	O
.	O
glistening	O
pleura	O
and	O
shows	O
multiple	O
staple	O
lines	O
present	O
.	O
throughout	O
.	O

the	O
specimen	O
.	O

The	O
specimen	O
is	O
sectioned	O
showing	O
a	O
pink	O
-	O
red	O
spongy	O
.	O
cut	O
surface	O
with	O
no	O
discrete	O
gross	O
lesions	O
identified	O
.	O

Multiple	O
.	O
black	O
-	O
red	O
hilar	O
nodes	O
are	O
grossly	O
identified	O
.	O

Representative	O
.	O
sections	O
of	O
the	O
specimen	O
are	O
submitted	O
as	O
follows	O
:	O
BLOCK	O
SUMMARY	O
:	O
1	O
-	O
possible	O
hilar	O
lymph	O
node	O
;	O
2	O
-	O
vascular	O
and	O
.	O
bronchial	O
margins	O
;	O
3	O
-	O
4	O
-	O
representative	O
normal	O
.	O

RS	O
-	O
4	O
.	O

E	O
.	O

Received	O
fresh	O
,	O
subsequently	O
fixed	O
in	O
formalin	O
labeled	O
.	O

"	O
node	O
level	O
7	O
"	O
are	O
two	O
black	O
-	O
red	O
irregular	O
soft	O
tissue	O
.	O
fragments	O
which	O
average	O
0	O
.	O
8	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
.	O
specimens	O
.	O

are	O
entirely	O
submitted	O
in	O
one	O
cassette	O
.	O

AS	O
-	O
1	O
.	O

F	O
.	O

Received	O
fresh	O
,	O
subsequently	O
fixed	O
in	O
formalin	O
labeled	O
.	O

"	O
node	O
level	O
7	O
"	O
is	O
a	O
0	O
.	O
5	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
4	O
cm	O
gray	O
-	O
pink	O
-	O
black	O
.	O
irregular	O
soft	O
tissue	O
fragment	O
which	O
is	O
entirely	O
submitted	O
in	O
one	O
.	O
cassette	O
.	O

AS	O
-	O
1	O
.	O

G	O
.	O

Received	O
in	O
formalin	O
labeled	O
"	O
node	O
level	O
9	O
"	O
is	O
a	O
1	O
.	O
2	O
X	O
.	O

0	O
.	O

7	O
X	O
0	O
.	O
5	O
cm	O
black	O
-	O
gray	O
irregular	O
soft	O
tissue	O
fragment	O
.	O
which	O
is	O
bisected	O
and	O
entirely	O
submitted	O
in	O
one	O
cassette	O
.	O

AS	O
-	O
1	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

Histologic	O
type	O
:	O
Adenocarcinoma	O
.	O

Histologic	O
grade	O
:	O
Moderate	O
to	O
poorly	O
differentiated	O
.	O

Primary	O
tumor	O
(	O
pT	O
)	O
:	O
Tumor	O
measures	O
maximally	O
2	B
.	I
2	I
cm	I
in	O
size	O
and	O
is	O
.	O
confined	O
to	O
the	O
lung	O
(	O
pT1b	O
)	O
.	O

Margins	O
of	O
resection	O
:	O
Bronchial	O
and	O
vascular	O
margins	O
are	O
free	O
of	O
.	O
tumor	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

Direct	O
extension	O
of	O
tumor	O
:	O
Absent	O
.	O

Venous	O
(	O
large	O
vessel	O
)	O
invasion	O
:	O
Negative	O
.	O

Arterial	O
(	O
large	O
vessel	O
)	O
invasion	O
:	O
Negative	O
.	O

Lymphatic	O
(	O
small	O
vessel	O
)	O
invasion	O
:	O
Negative	O
.	O

Regional	O
lymph	O
nodes	O
(	O
pN	O
)	O
:	O
Hilar	O
lymph	O
nodes	O
and	O
all	O
sampled	O
.	O
mediastinal	O
.	O

lymph	O
nodes	O
are	O
negative	O
for	O
metastatic	O
carcinoma	O
(	O
pNO	O
)	O
.	O

Distant	O
metastasis	O
(	O
pM	O
)	O
:	O
Cannot	O
be	O
assessed	O
(	O
pMx	O
)	O
.	O

5	O
,	O
3x5	O
,	O
14	O
.	O

DIAGNOSIS	O
.	O

A	O
.	O
and	O
D	O
.	O

Lung	O
,	O
left	O
upper	O
lobectomy	O
.	O

Moderate	O
to	O
poorly	O
differentiated	O
adenocarcinoma	O
.	O

The	O
tumor	O
is	O
confined	O
to	O
the	O
lung	O
without	O
involvement	O
of	O
the	O
.	O
visceral	O
pleural	O
surface	O
.	O

Bronchial	O
and	O
vascular	O
margins	O
of	O
resection	O
are	O
free	O
of	O
.	O
tumor	O
.	O

Seven	O
bronchial	O
lymph	O
nodes	O
negative	O
for	O
metastatic	O
carcinoma	O
.	O

(	O
0	O
/	O
7	O
)	O
.	O

B	O
.	O

Lymph	O
node	O
,	O
level	O
5	O
,	O
resection	O
:	O
Negative	O
for	O
malignancy	O
.	O

C	O
.	O

Lymph	O
node	O
,	O
level	O
1	O
,	O
resection	O
:	O
Negative	O
for	O
malignancy	O
.	O

E	O
.	O

Lymph	O
node	O
,	O
level	O
7	O
,	O
resection	O
:	O
Negative	O
for	O
malignancy	O
.	O

F	O
.	O

Lymph	O
node	O
,	O
level	O
4	O
,	O
resection	O
:	O
Negative	O
for	O
malignancy	O
.	O

G	O
.	O

Lymph	O
node	O
,	O
level	O
9	O
,	O
resection	O
:	O
DIAGNOSIS	O
.	O

Negative	O
for	O
malignancy	O
.	O

-DOCSTART-289
RUN	O
DATE	O
:	O
RUN	O
TIME	O
:	O
3Y	O
:	O
ACCT	O
#	O
:	O
LOC	O
:	O
AGE	O
/	O
SX	O
:	O
RM	O
/	O
BED	O
:	O
REG	O
DR	O
:	O
SPEC	O
#	O
:	O
Obtained	O
:	O
CLINICAL	O
HISTORY	O
.	O

ENDOMETRIAL	O
CA	O
.	O

SPECIMEN	O
/	O
PROCEDURE	O
.	O

1	O
.	O

LYMPH	O
NODE	O
-	O
PARA	O
AORTIC	O
.	O

2	O
.	O

LYMPH	O
NODE	O
-	O
RT	O
PARA	O
AORTIC	O
.	O

3	O
.	O

LYMPH	O
NODE	O
-	O
RT	O
COMMON	O
ILIAC	O
.	O

4	O
.	O

LYMPH	O
NODE	O
-	O
RT	O
EXTERNAL	O
ILIAC	O
.	O

5	O
.	O

LYMPH	O
NODE	O
-	O
RT	O
OBTURATOR	O
.	O

6	O
.	O

LYMPH	O
NODE	O
-	O
LEFT	O
OBURATOR	O
.	O

7	O
.	O

LYMPH	O
NODE	O
-	O
LEFT	O
EXTERNAL	O
ILIAC	O
.	O

8	O
.	O

LYMPH	O
NODE	O
-	O
LEFT	O
COMMON	O
ILIAC	O
.	O

9	O
.	O

UTERUS	O
-	O
CERVIX	O
,	O
BILATERAL	O
TUBES	O
AND	O
OVARIES	O
.	O

IMPRESSION	O
:	O
1	O
)	O
.	O

LEFT	O
PARA	O
-	O
AORTIC	O
LYMPH	O
NODES	O
:	O
Four	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
(	O
0	O
/	O
4	O
)	O
.	O

2	O
)	O
.	O

RIGHT	O
PARA	O
-	O
AORTIC	O
LYMPH	O
NODES	O
:	O
Seven	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
(	O
0	O
/	O
7	O
)	O
.	O

.	O
3	O
)	O
.	O

RIGHT	O
COMMON	O
ILIAC	O
LYMPH	O
NODES	O
:	O
Two	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
(	O
0	O
/	O
2	O
)	O
.	O

4	O
)	O
.	O

RIGHT	O
EXTERNAL	O
ILIAC	O
LYMPH	O
NODES	O
:	O
Three	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
(	O
0	O
/	O
3	O
)	O
.	O

5	O
)	O
.	O

RIGHT	O
OBTURATOR	O
LYMPH	O
NODES	O
:	O
Three	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
(	O
0	O
/	O
3	O
)	O
.	O

6	O
)	O
.	O

LEFT	O
OBTURATOR	O
LYMPH	O
NODES	O
:	O
Two	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
(	O
0	O
/	O
2	O
)	O
.	O

7	O
)	O
.	O

LEFT	O
EXTERNAL	O
ILIAC	O
LYMPH	O
NODE	O
:	O
Mature	O
adipose	O
tissue	O
.	O

No	O
lymph	O
node	O
material	O
is	O
identified	O
.	O

8	O
)	O
.	O

LEFT	O
COMMON	O
ILIAC	O
LYMPH	O
NODES	O
:	O
SPEC	O
#	O
:	O
(	O
Continued	O
)	O
Page	O
:	O
2	O
.	O

IMPRESSION	O
:	O
(	O
continued	O
)	O
.	O

Two	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
(	O
0	O
/	O
2	O
)	O
.	O

9	O
)	O
.	O

UTERUS	O
,	O
BILATERAL	O
TUBES	O
AND	O
OVARIES	O
:	O
ENDOMETRIUM	O
:	O
Adenocarcinoma	O
of	O
endometrium	O
,	O
endometrioid	O
type	O
,	O
FIGO	O
grade	O
I	O
,	O
nuclear	O
.	O
grade	O
2	O
,	O
(	O
3	B
.	I
8	I
cm	I
.	O
)	O
invading	O
<	O
50	O
%	O
of	O
the	O
myometrium	O
.	O

The	O
uninvolved	O
endometrium	O
shows	O
complex	O
hyperplasia	O
with	O
and	O
without	O
.	O
atypia	O
as	O
well	O
as	O
disordered	O
proliferative	O
endometrium	O
.	O

MYOMETRIUM	O
:	O
Myometrial	O
invasion	O
measuring	O
5	O
mm	O
where	O
the	O
wall	O
measures	O
21	O
mm	O
(	O
29	O
%	O
)	O
.	O

No	O
vascular	O
space	O
invasion	O
is	O
identified	O
.	O

Adenomyosis	O
.	O

CERVIX	O
:	O
Chronic	O
cystic	O
cervicitis	O
.	O

No	O
evidence	O
of	O
tumor	O
or	O
dysplasia	O
.	O

Endometriosis	O
involving	O
the	O
deep	O
cervical	O
stroma	O
.	O

OVARIES	O
,	O
BILATERAL	O
:	O
Atrophic	O
pattern	O
with	O
focal	O
hyperthecosis	O
.	O

No	O
tumor	O
is	O
identified	O
.	O

The	O
left	O
ovary	O
has	O
a	O
benign	O
serous	O
cystadenofibroma	O
with	O
dominant	O
cystic	O
.	O
component	O
(	O
2	O
.	O
0	O
cm	O
)	O
.	O

FALLOPIAN	O
TUBES	O
,	O
BILATERAL	O
:	O
No	O
pathologic	O
diagnosis	O
.	O

ENDOMETRIAL	O
CARCINOMA	O
CHECKLIST	O
.	O

ACROSCOPIC	O
.	O

SPECIMEN	O
TYPE	O
.	O

Hysterectomy	O
.	O

TUMOR	O
SITE	O
.	O

Specify	O
location	O
(	O
s	O
)	O
,	O
if	O
known	O
:	O
Anterior	O
corpus	O
.	O

TUMOR	O
SIZE	O
.	O

Greatest	O
dimension	O
:	O
3	B
.	I
8	I
cm	I
.	O

Additional	O
dimensions	O
:	O
1	B
.	I
8	I
x	I
0	I
.	I
8	I
cm	I
.	O

OTHER	O
ORGANS	O
PRESENT	O
.	O

Right	O
ovary	O
.	O

Left	O
ovary	O
.	O

Right	O
fallopian	O
tube	O
.	O

Left	O
fallopian	O
tube	O
.	O

MICROSCOPIC	O
.	O

(	O
Continued	O
)	O
Page	O
:	O
3	O
.	O

SPEC	O
#	O
:	O
IMPRESSION	O
:	O
(	O
continued	O
)	O
.	O

HISTOLOGIC	O
TYPE	O
.	O

Endometrioid	O
adenocarcinoma	O
,	O
not	O
otherwise	O
characterized	O
.	O

HISTOLOGIC	O
GRADE	O
.	O

G1	O
:	O
5	O
%	O
or	O
less	O
nonsquamous	O
solid	O
growth	O
.	O

MYOMETRIAL	O
INVASION	O
.	O

Invasion	O
present	O
.	O

Maximal	O
depth	O
of	O
myometrial	O
invasion	O
:	O
5	O
mm	O
.	O

Thickness	O
of	O
myometrium	O
in	O
area	O
of	O
maximal	O
tumor	O
invasion	O
:	O
21	O
mm	O
.	O

The	O
&	O
of	O
myometrial	O
involvement	O
:	O
29	O
%	O
.	O

EXTENT	O
OF	O
INVASION	O
.	O

PRIMARY	O
TUMOR	O
(	O
pT	O
)	O
.	O

TNM	O
(	O
FIGO	O
)	O
.	O

pTlb	O
(	O
IB	O
)	O
:	O
Tumor	O
invades	O
less	O
than	O
one	O
-	O
half	O
of	O
the	O
myometrium	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
(	O
pN	O
)	O
.	O

TNM	O
(	O
FIGO	O
)	O
.	O

pNO	O
:	O
No	O
regional	O
lymph	O
node	O
metastasis	O
.	O

Number	O
examined	O
:	O
23	O
.	O

DISTANT	O
METASTASIS	O
(	O
pM	O
)	O
.	O

TNM	O
(	O
FIGO	O
)	O
.	O

pMX	O
:	O
Cannot	O
be	O
assessed	O
.	O

MARGINS	O
.	O

Uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

VENOUS	O
/	O
LYMPHATIC	O
(	O
LARGE	O
/	O
SMALL	O
VESSEL	O
)	O
INVASION	O
(	O
V	O
/	O
L	O
)	O
.	O

Absent	O
.	O

ADDITIONAL	O
PATHOLOGIC	O
FINDINGS	O
.	O

Hyperplasia	O
.	O

Complex	O
(	O
adenomatous	O
)	O
.	O

Atypical	O
hyperplasia	O
.	O

Complex	O
(	O
adenomatous	O
)	O
.	O

Other	O
(	O
specify	O
)	O
:	O
Adenomyosis	O
,	O
endometriosis	O
.	O

Pathologic	O
TNM	O
(	O
AJCC	O
6th	O
Edition	O
)	O
:	O
pT1b	O
NO	O
MX	O
.	O

Dictated	O
bv	O
:	O
Entered	O
:	O
SPEC	O
#	O
.	O

(	O
Continued	O
)	O
Page	O
:	O
4	O
.	O

GROSS	O
DESCRIPTION	O
:	O
1	O
)	O
.	O

Received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
left	O
para	O
-	O
aortic	O
"	O
Received	O
is	O
a	O
2	O
.	O
5	O
x	O
.	O

1	O
.	O
7	O
x	O
1	O
.	O
5	O
cm	O
aggregate	O
of	O
yellow	O
gold	O
lobulated	O
adipose	O
tissue	O
.	O

Dissected	O
for	O
.	O
possible	O
lymph	O
nodes	O
.	O

Four	O
possible	O
lymph	O
nodes	O
identified	O
,	O
ranging	O
from	O
1	O
to	O
1	O
.	O
5	O
cm	O
.	O
in	O
greatest	O
dimension	O
.	O

Submitted	O
as	O
follows	O
:	O
CASSETTE	O
SUMMARY	O
:	O
Cassette	O
1A	O
:	O
Three	O
possible	O
lymph	O
nodes	O
.	O

Cassette	O
1B	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

2	O
)	O
.	O

Received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
right	O
para	O
-	O
aortic	O
"	O
.	O

Received	O
is	O
a	O
3	O
.	O
5	O
x	O
.	O

4	O
x	O
2	O
cm	O
aggregate	O
of	O
yellow	O
gold	O
hemorrhagic	O
fibroadipose	O
tissue	O
.	O

Dissected	O
for	O
.	O
possible	O
lymph	O
nodes	O
.	O

Five	O
possible	O
lymph	O
nodes	O
identified	O
,	O
ranging	O
from	O
1	O
.	O
5	O
to	O
3	O
cm	O
.	O
in	O
greatest	O
dimension	O
.	O

Submitted	O
as	O
follows	O
:	O
CASSETTE	O
SUMMARY	O
.	O

Cassette	O
2A	O
:	O
Three	O
possible	O
lymph	O
nodes	O
.	O

Cassette	O
2B	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

Cassette	O
2C	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

3	O
)	O
.	O

Received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
right	O
common	O
iliac	O
"	O
.	O

Received	O
is	O
a	O
3	O
x	O
.	O

1	O
.	O
3	O
x	O
0	O
.	O
9	O
cm	O
portion	O
of	O
yellow	O
gold	O
to	O
pink	O
tan	O
lobulated	O
adipose	O
tissue	O
.	O

Dissected	O
.	O
for	O
possible	O
lymph	O
nodes	O
.	O

Two	O
possible	O
lymph	O
nodes	O
identified	O
,	O
ranging	O
from	O
1	O
.	O
5	O
to	O
.	O

2	O
.	O
1	O
cm	O
in	O
greatest	O
dimension	O
.	O

Submitted	O
as	O
follows	O
:	O
CASSETTE	O
SUMMARY	O
:	O
Cassette	O
3A	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

Cassette	O
3B	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

4	O
)	O
.	O

Received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
right	O
external	O
iliac	O
"	O
.	O

Received	O
is	O
a	O
.	O

4	O
.	O
7	O
x	O
1	O
.	O
6	O
x	O
1	O
cm	O
portion	O
of	O
yellow	O
gold	O
lobulated	O
adipose	O
tissue	O
.	O

Dissected	O
for	O
.	O
possible	O
lymph	O
nodes	O
.	O

Three	O
possible	O
lymph	O
nodes	O
identified	O
,	O
ranging	O
from	O
0	O
.	O
9	O
to	O
3	O
.	O
5	O
.	O

cm	O
in	O
greatest	O
dimension	O
.	O

Submitted	O
as	O
follows	O
:	O
CASSETTE	O
SUMMARY	O
:	O
Cassette	O
4A	O
:	O
Two	O
possible	O
lymph	O
nodes	O
.	O

Cassette	O
B	O
,	O
4C	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

5	O
)	O
.	O

Received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
right	O
obturator	O
"	O
.	O

Received	O
is	O
a	O
4	O
.	O
7	O
x	O
.	O

3	O
.	O
5	O
x	O
1	O
.	O
4	O
cm	O
aggregate	O
of	O
yellow	O
gold	O
with	O
lobulated	O
adipose	O
tissue	O
.	O

Dissected	O
for	O
.	O
possible	O
lymph	O
nodes	O
Three	O
possible	O
lymph	O
nodes	O
identified	O
,	O
ranging	O
from	O
1	O
to	O
3	O
cm	O
.	O
in	O
greatest	O
dimension	O
.	O

Submitted	O
as	O
follows	O
:	O
CASSETTE	O
SUMMARY	O
:	O
Cassette	O
5A	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

Cassette	O
5B	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

Cassette	O
5C	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

SPEC	O
#	O
:	O
(	O
Continued	O
)	O
Page	O
:	O
5	O
.	O

GROSS	O
DESCRIPTION	O
:	O
(	O
continued	O
)	O
.	O

6	O
)	O
.	O

Received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
left	O
obturator	O
"	O
Received	O
is	O
a	O
4	O
.	O
2	O
x	O
.	O

2	O
.	O
5	O
x	O
1	O
.	O
5	O
cm	O
aggregate	O
of	O
yellow	O
gold	O
hemorrhagic	O
fibroadipose	O
tissue	O
.	O

Dissected	O
for	O
.	O
possible	O
lymph	O
nodes	O
.	O

Three	O
possible	O
lymph	O
nodes	O
identified	O
,	O
ranging	O
from	O
1	O
to	O
3	O
cm	O
.	O
in	O
greatest	O
dimension	O
.	O

Submitted	O
as	O
follows	O
:	O
CASSETTE	O
SUMMARY	O
:	O
Cassette	O
6A	O
:	O
Two	O
possible	O
lymph	O
nodes	O
.	O

Cassette	O
6B	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

Received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
left	O
external	O
iliac	O
"	O
.	O

Received	O
is	O
a	O
4	O
.	O
5	O
.	O

x	O
3	O
.	O
5	O
x	O
1	O
.	O
6	O
cm	O
aggregate	O
of	O
yellow	O
gold	O
lobulated	O
adipose	O
tissue	O
.	O

Dissected	O
.	O
for	O
.	O

possible	O
lymph	O
nodes	O
.	O

No	O
lymph	O
nodes	O
are	O
grossly	O
identifiable	O
.	O

Specimen	O
is	O
.	O
representatively	O
submitted	O
in	O
cassettes	O
7A	O
-	O
7C	O
.	O

8	O
)	O
.	O

Received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
left	O
common	O
iliac	O
"	O
Received	O
is	O
a	O
3	O
x	O
.	O

2	O
.	O
5	O
x	O
1	O
cm	O
aggregate	O
of	O
yellow	O
gold	O
hemorrhagic	O
tissue	O
fragments	O
.	O

Two	O
possible	O
lymph	O
.	O
nodes	O
identified	O
,	O
ranging	O
from	O
1	O
to	O
2	O
cm	O
in	O
greatest	O
dimension	O
.	O

CASSETTE	O
SUMMARY	O
:	O
Cassette	O
8A	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

Cassette	O
8B	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

9	O
)	O
.	O

Received	O
fresh	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
number	O
and	O
"	O
uterus	O
,	O
cervix	O
,	O
bilateral	O
.	O
tubes	O
and	O
ovaries	O
"	O
,	O
is	O
a	O
hysterectomy	O
and	O
bilateral	O
salpingo	O
-	O
oophorectomy	O
specimen	O
.	O
consisting	O
of	O
uterus	O
(	O
10	O
.	O
0	O
x	O
7	O
.	O
5	O
x	O
6	O
.	O
5	O
cm	O
)	O
,	O
right	O
ovary	O
(	O
4	O
.	O
0	O
x	O
3	O
.	O
0	O
x	O
1	O
.	O
5	O
cm	O
)	O
,	O
right	O
.	O
fallopian	O
tube	O
which	O
appears	O
to	O
be	O
previously	O
ligated	O
and	O
measures	O
2	O
.	O
2	O
cm	O
in	O
length	O
.	O
and	O
0	O
.	O
5	O
cm	O
in	O
diameter	O
at	O
the	O
proximal	O
end	O
and	O
2	O
.	O
5	O
cm	O
in	O
length	O
and	O
0	O
.	O
5	O
cm	O
in	O
diameter	O
.	O
at	O
the	O
distal	O
end	O
,	O
left	O
ovary	O
(	O
3	O
.	O
0	O
x	O
1	O
.	O
8	O
x	O
1	O
.	O
5	O
cm	O
)	O
,	O
and	O
left	O
fallopian	O
tube	O
which	O
.	O
appears	O
to	O
be	O
previously	O
ligated	O
and	O
measures	O
2	O
.	O
5	O
cm	O
in	O
length	O
and	O
0	O
.	O
5	O
cm	O
in	O
diameter	O
.	O
at	O
the	O
proximal	O
end	O
and	O
2	O
.	O
2	O
cm	O
in	O
length	O
and	O
0	O
.	O
7	O
cm	O
in	O
diameter	O
at	O
the	O
distal	O
end	O
.	O

The	O
uterus	O
is	O
abnormally	O
enlarged	O
with	O
multiple	O
nodules	O
ranging	O
from	O
1	O
.	O
5	O
cm	O
to	O
5	O
.	O
5	O
cm	O
.	O
in	O
maximum	O
dimension	O
and	O
the	O
serosal	O
surface	O
of	O
the	O
uterus	O
has	O
an	O
irregular	O
contour	O
.	O
with	O
red	O
-	O
tan	O
focally	O
hemorrhagic	O
surface	O
.	O

The	O
ectocervix	O
is	O
flattened	O
,	O
pink	O
-	O
tan	O
with	O
.	O

an	O
external	O
os	O
measuring	O
1	O
.	O
8	O
cm	O
.	O

Upon	O
opening	O
the	O
specimen	O
the	O
endocervical	O
canal	O
is	O
.	O

3	O
.	O
0	O
cm	O
,	O
irregular	O
,	O
pink	O
-	O
tan	O
and	O
otherwise	O
unremarkable	O
.	O

There	O
is	O
a	O
3	O
.	O
8	O
x	O
1	O
.	O
8	O
x	O
0	O
.	O
8	O
cm	O
.	O
pink	O
-	O
tan	O
polypoid	O
lesion	O
in	O
the	O
endometrial	O
cavity	O
attached	O
to	O
the	O
anterior	O
.	O
endometrium	O
.	O

The	O
endometrial	O
cavity	O
is	O
6	O
.	O
0	O
x	O
2	O
.	O
5	O
cm	O
,	O
focally	O
hemorrhagic	O
and	O
.	O
approximately	O
40	O
%	O
of	O
the	O
lumen	O
is	O
occupied	O
by	O
the	O
tumor	O
.	O

The	O
posterior	O
endomyometrium	O
.	O

is	O
mostly	O
free	O
of	O
tumor	O
and	O
is	O
pink	O
-	O
tan	O
with	O
focal	O
hemorrhages	O
.	O

The	O
tumor	O
grossly	O
.	O
does	O
not	O
extend	O
to	O
the	O
endocervical	O
canal	O
and	O
is	O
4	O
.	O
5	O
cm	O
away	O
from	O
the	O
external	O
os	O
.	O
anteriorly	O
.	O

The	O
myometrium	O
is	O
white	O
-	O
tan	O
to	O
pink	O
and	O
measures	O
1	O
.	O
5	O
cm	O
to	O
2	O
.	O
5	O
cm	O
.	O

in	O
.	O
thickness	O
.	O

Upon	O
sectioning	O
the	O
posterior	O
myometrium	O
has	O
a	O
white	O
-	O
tan	O
whorled	O
.	O
leiomyoma	O
,	O
5	B
.	I
5	I
x	I
5	I
.	I
0	I
x	I
4	I
.	I
8	I
cm	I
.	O

The	O
anterior	O
myometrium	O
shows	O
the	O
tumor	O
invading	O
.	O
approximately	O
0	O
.	O

cm	O
at	O
the	O
area	O
of	O
2	O
.	O
5	O
cm	O
myometrial	O
thickness	O
.	O

There	O
is	O
a	O
1	O
.	O
0	O
x	O
0	O
.	O
9	O
.	O

SPEC	O
#	O
:	O
(	O
Continued	O
)	O
Page	O
:	O
6	O
.	O

GROSS	O
DESCRIPTION	O
:	O
(	O
continued	O
)	O
.	O

x	O
0	O
.	O
5	O
cm	O
yellow	O
-	O
tan	O
fleshy	O
polypoid	O
mass	O
in	O
the	O
posterior	O
endometrial	O
cavity	O
,	O
located	O
.	O
at	O
the	O
superior	O
margin	O
which	O
upon	O
sectioning	O
does	O
not	O
appear	O
to	O
involve	O
the	O
.	O
myometrium	O
.	O

The	O
external	O
surface	O
of	O
the	O
right	O
ovary	O
is	O
pink	O
-	O
tan	O
,	O
cerebriform	O
and	O
unremarkable	O
.	O

The	O
right	O
fallopian	O
tube	O
is	O
previously	O
ligated	O
,	O
however	O
unremarkable	O
.	O

The	O
external	O
.	O
surface	O
of	O
the	O
left	O
ovary	O
is	O
pink	O
-	O
tan	O
,	O
cerebriform	O
with	O
a	O
2	O
.	O
0	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
5	O
cm	O
firm	O
.	O
polypoid	O
lesion	O
extending	O
from	O
the	O
lateral	O
surface	O
.	O

Upon	O
sectioning	O
the	O
ovarian	O
.	O
stroma	O
is	O
white	O
-	O
tan	O
,	O
homogeneous	O
and	O
unremarkable	O
with	O
the	O
polyp	O
showing	O
yellow	O
-	O
tan	O
.	O
gelatinous	O
material	O
.	O

Specimen	O
is	O
representatively	O
sectioned	O
and	O
submitted	O
as	O
follows	O
.	O

The	O
specimen	O
is	O
a	O
part	O
of	O
research	O
and	O
accordingly	O
normal	O
tissue	O
and	O
tumor	O
were	O
.	O
submitted	O
for	O
research	O
.	O

CASSETTE	O
SUMMARY	O
:	O
Cassette	O
9B	O
:	O
Right	O
ovary	O
and	O
fallopian	O
tube	O
.	O

Cassette	O
9C	O
:	O
Left	O
ovary	O
.	O

Cassette	O
9D	O
:	O
Polypoid	O
extension	O
from	O
the	O
left	O
ovarian	O
surface	O
and	O
left	O
.	O
fallopian	O
tube	O
.	O

Cassette	O
9E	O
:	O
Anterior	O
ectocervix	O
.	O

Cassette	O
9G	O
:	O
Anterior	O
lower	O
uterine	O
segment	O
.	O

Cassette	O
9H	O
,	O
9J	O
:	O
Representative	O
section	O
of	O
the	O
anterior	O
endomyometrium	O
with	O
tumor	O
.	O

(	O
at	O
the	O
level	O
of	O
maximum	O
invasion	O
)	O
.	O

Cassette	O
9K	O
:	O
Posterior	O
cervix	O
.	O

Cassette	O
9L	O
:	O
Posterior	O
lower	O
uterine	O
segment	O
.	O

Cassette	O
9M	O
:	O
Posterior	O
endomyometrium	O
.	O

Cassette	O
9N	O
:	O
Posterior	O
endomyometrium	O
with	O
polypoid	O
lesion	O
.	O

Cassette	O
9P	O
,	O
90	O
:	O
Representative	O
sections	O
of	O
the	O
largest	O
leiomyoma	O
.	O

Entered	O
:	O
COPIES	O
TO	O
:	O
Undefined	O
Provider	O
.	O

SPEC	O
#	O
:	O
(	O
Continued	O
)	O
Page	O
:	O
7	O
.	O

CPT	O
Codes	O
:	O
:	O
LYMPH	O
NODE	O
,	O
REGIONAL	O
RESECT	O
/	O
.	O

SOFT	O
TISSUE	O
,	O
LIPOMA	O
/	O
ADIPOSE	O
(	O
1	O
)	O
.	O

UTERUS	O
W	O
/	O
WO	O
ADNEXAE	O
,	O
NOT	O
TUMOR	O
OR	O
PROLAPSE	O
.	O

ICD9	O
Codes	O
:	O

-DOCSTART-290
Final	O
Surgical	O
Pathology	O
Report	O
.	O

Procedure	O
:	O
Diagnosis	O
.	O

A	O
.	O

Breast	O
,	O
left	O
,	O
segmental	O
mastectomy	O
:	O
Invasive	O
ductal	O
carcinoma	O
,	O
.	O
grade	O
3	O
,	O
size	O
2	B
.	I
8	I
cm	I
in	O
greatest	O
dimension	O
;	O
negative	O
margins	O
of	O
.	O
excision	O
.	O

B	O
.	O

Sentinel	O
lymph	O
node	O
#	O
1	O
,	O
biopsy	O
:	O
Two	O
negative	O
lymph	O
nodes	O
(	O
0	O
/	O
2	O
)	O
.	O

C	O
.	O

Sentinel	O
lymph	O
node	O
#	O
2	O
,	O
biopsy	O
:	O
One	O
negative	O
lymph	O
node	O
(	O
0	O
/	O
1	O
)	O
.	O

D	O
.	O

Breast	O
,	O
medial	O
to	O
left	O
segmental	O
mastectomy	O
,	O
biopsy	O
:	O
Negative	O
for	O
.	O
malignancy	O
or	O
atypia	O
.	O

E	O
.	O

Breast	O
,	O
inferior	O
to	O
left	O
segmental	O
mastectomy	O
,	O
biopsy	O
:	O
Negative	O
.	O
for	O
malignancy	O
or	O
atypia	O
.	O

F	O
.	O

Breast	O
,	O
posterior	O
to	O
left	O
segmental	O
mastectomy	O
,	O
biopsy	O
:	O
Skeletal	O
.	O
muscle	O
;	O
negative	O
for	O
malignancy	O
or	O
atypia	O
.	O

G	O
.	O

Breast	O
,	O
lateral	O
to	O
left	O
segmental	O
mastectomy	O
,	O
biopsy	O
:	O
Negative	O
.	O
for	O
malignancy	O
or	O
atypia	O
.	O

H	O
.	O

Breast	O
,	O
superior	O
to	O
left	O
segmental	O
mastectomy	O
,	O
biopsy	O
:	O
Negative	O
.	O
for	O
malignancy	O
or	O
atypia	O
.	O

Microscopic	O
Description	O
:	O
Invasive	O
Carcinoma	O
.	O

Histologic	O
type	O
:	O
Ductal	O
.	O

Histologic	O
grade	O
:	O
3	O
.	O

Overall	O
grade	O
:	O
9	O
/	O
9	O
.	O

Architectural	O
score	O
:	O
3	O
.	O

Nuclear	O
score	O
:	O
3	O
.	O

Mitotic	O
score	O
:	O
3	O
.	O

Greatest	O
dimension	O
(	O
pT	O
)	O
:	O
2	B
.	I
8	I
cm	I
.	O

Specimen	O
margins	O
:	O
Negative	O
.	O

Vessel	O
invasion	O
:	O
Not	O
identified	O
.	O

Calcification	O
:	O
Present	O
.	O

Ductal	O
carcinoma	O
in	O
situ	O
:	O
Histologic	O
pattern	O
:	O
Solid	O
.	O

Nuclear	O
grade	O
:	O
3	O
.	O

Central	O
Necrosis	O
:	O
Present	O
.	O

8	O
DCIS	O
of	O
total	O
tumor	O
(	O
if	O
mixed	O
)	O
:	O
1	O
%	O
.	O

Extensive	O
intraductal	O
component	O
(	O
present	O
/	O
absent	O
)	O
:	O
Absent	O
.	O

Specimen	O
margins	O
:	O
Negative	O
.	O

Calcification	O
:	O
Negative	O
.	O

Description	O
of	O
non	O
-	O
tumorous	O
breast	O
:	O
Fibrocystic	O
changes	O
,	O
with	O
ductal	O
.	O
hyperplasia	O
of	O
usual	O
type	O
,	O
a	O
minute	O
fibroadenoma	O
,	O
and	O
apocrine	O
.	O
metaplasia	O
,	O
with	O
calcification	O
.	O

Comments	O
:	O
Sentinel	O
lymph	O
nodes	O
negative	O
,	O
confirmed	O
by	O
negative	O
.	O
cytokeratin	O
immunostaining	O
of	O
blocks	O
BFS1	O
and	O
CFS2	O
.	O

Cytokeratin	O
.	O
staining	O
was	O
also	O
performed	O
on	O
one	O
block	O
from	O
part	O
E	O
,	O
to	O
exclude	O
.	O
involvement	O
by	O
carcinoma	O
.	O

Prior	O
biopsy	O
site	O
identified	O
.	O

Extensive	O
.	O
central	O
tumor	O
necrosis	O
is	O
present	O
.	O

Prognostic	O
markers	O
:	O
See	O
core	O
biopsy	O
report	O
,	O
.	O

4x8	O
,	O
14x2	O
,	O
15x2	O
,	O
20x3	O
.	O

[	O
A	O
few	O
of	O
the	O
antibodies	O
used	O
in	O
our	O
laboratory	O
may	O
be	O
classified	O
as	O
.	O
analyte	O
specific	O
reagents	O
.	O

These	O
antibodies	O
are	O
monitored	O
and	O
.	O
controlled	O
in	O
our	O
laboratory	O
and	O
their	O
performance	O
for	O
in	O
vitro	O
.	O
diagnosis	O
is	O
well	O
described	O
in	O
the	O
medical	O
literature	O
.	O

They	O
have	O
not	O
.	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
FDA	O
.	O
:	O
Specimen	O
.	O

A	O
.	O

Left	O
Breast	O
.	O

B	O
.	O

Left	O
axillary	O
sentinel	O
lymph	O
node	O
#	O
1	O
,	O
hot	O
,	O
blue	O
,	O
.	O

C	O
.	O

Left	O
axillary	O
sentinel	O
lymph	O
node	O
#	O
2	O
,	O
not	O
hot	O
,	O
not	O
blue	O
,	O
but	O
.	O
palpable	O
.	O

D	O
.	O

Medial	O
to	O
segmental	O
mastectomy	O
left	O
breast	O
.	O

E	O
.	O

Inferior	O
to	O
segmental	O
mastectomy	O
left	O
breast	O
.	O

F	O
.	O

Posterior	O
to	O
segmental	O
mastectomy	O
left	O
breast	O
.	O

G	O
.	O

Lateral	O
to	O
segmental	O
mastectomy	O
left	O
breast	O
.	O

H	O
.	O

Superior	O
to	O
segmental	O
mastectomy	O
left	O
breast	O
.	O

Clinical	O
Information	O
.	O

Left	O
breast	O
cancer	O
.	O

Intraoperative	O
Consultation	O
.	O

B	O
)	O
Left	O
axillary	O
sentinel	O
node	O
#	O
1	O
:	O
Two	O
negative	O
lymph	O
nodes	O
(	O
0	O
/	O
2	O
)	O
.	O

C	O
)	O
Left	O
axillary	O
sentinel	O
node	O
#	O
2	O
,	O
biopsy	O
:	O
One	O
negative	O
lymph	O
node	O
.	O

(	O
0	O
/	O
1	O
)	O
.	O

Gross	O
Description	O
.	O

A	O
.	O

Received	O
unfixed	O
for	O
tissue	O
procurement	O
,	O
labeled	O
left	O
breast	O
.	O
segmental	O
mastectomy	O
single	O
long	O
lateral	O
,	O
double	O
long	O
anterior	O
,	O
is	O
.	O

a	O
100	O
gram	O
breast	O
segmental	O
excision	O
that	O
is	O
9	O
cm	O
from	O
anterior	O
to	O
.	O
posterior	O
,	O
7	O
.	O
5	O
cm	O
medial	O
to	O
lateral	O
,	O
and	O
3	O
cm	O
from	O
superior	O
to	O
.	O
inferior	O
.	O

The	O
superior	O
surface	O
is	O
inked	O
black	O
,	O
and	O
a	O
section	O
is	O
.	O
submitted	O
for	O
tissue	O
procurement	O
as	O
requested	O
.	O

An	O
additional	O
.	O
section	O
of	O
uninvolved	O
fatty	O
tissue	O
is	O
submitted	O
from	O
the	O
posterior	O
.	O
aspect	O
,	O
for	O
procurement	O
.	O

Additional	O
sections	O
after	O
fixation	O
.	O

The	O
.	O
superior	O
surface	O
is	O
inked	O
black	O
,	O
medial	O
green	O
,	O
lateral	O
yellow	O
,	O
.	O
inferior	O
blue	O
.	O

There	O
is	O
a	O
tan	O
,	O
firm	O
,	O
lobulated	O
mass	O
lesion	O
in	O
the	O
.	O
mid	O
-	O
portion	O
of	O
the	O
specimen	O
,	O
3	O
.	O
0	O
x	O
2	O
.	O
0	O
x	O
1	O
.	O
7	O
cm	O
.	O

This	O
is	O
3	O
mm	O
from	O
.	O
the	O
green	O
-	O
inked	O
medial	O
margin	O
(	O
closest	O
margin	O
)	O
.	O

All	O
other	O
margins	O
.	O
are	O
grossly	O
greater	O
than	O
1	O
cm	O
from	O
the	O
mass	O
.	O

Representative	O
.	O
sections	O
:	O
1	O
Anterior	O
margin	O
,	O
2	O
adjacent	O
section	O
with	O
margin	O
,	O
3	O
/	O
4	O
/	O
5	O
.	O
contiguous	O
tumor	O
,	O
possible	O
biopsy	O
cavity	O
in	O
5	O
,	O
6	O
/	O
7	O
/	O
8	O
contiguous	O
,	O
.	O

9	O
-	O
10	O
random	O
medial	O
and	O
lateral	O
,	O
possible	O
close	O
margin	O
,	O
11	O
-	O
14	O
.	O
additional	O
posterior	O
sections	O
,	O
with	O
last	O
section	O
=	O
posterior	O
.	O
margin	O
.	O

B	O
.	O

Received	O
unfixed	O
for	O
frozen	O
section	O
,	O
labeled	O
left	O
axillary	O
.	O
sentinel	O
node	O
#	O
1	O
,	O
are	O
2	O
adjacent	O
and	O
attached	O
lymph	O
nodes	O
,	O
0	O
.	O
9	O
cm	O
.	O
in	O
greatest	O
dimension	O
each	O
,	O
bisected	O
and	O
entirely	O
submitted	O
in	O
.	O
blocks	O
B1	O
and	O
B2	O
.	O

C	O
.	O

Received	O
unfixed	O
for	O
frozen	O
section	O
,	O
labeled	O
left	O
axillary	O
.	O
sentinel	O
node	O
#	O
2	O
,	O
is	O
a	O
single	O
lymph	O
node	O
,	O
1	O
.	O
4	O
x	O
1	O
.	O
3	O
x	O
1	O
.	O
0	O
cm	O
,	O
.	O
bisected	O
and	O
entirely	O
submitted	O
in	O
2	O
blocks	O
.	O

D	O
.	O

Received	O
fresh	O
and	O
subsequently	O
fixed	O
in	O
formalin	O
labeled	O
"	O
medial	O
.	O
to	O
segmental	O
mastectomy	O
left	O
breast	O
"	O
is	O
a	O
5	O
.	O
2	O
x	O
3	O
.	O
5	O
x	O
1	O
.	O
5	O
cm	O
yellow	O
.	O
lobular	O
fatty	O
tissue	O
fragment	O
which	O
has	O
a	O
suture	O
designating	O
the	O
.	O
new	O
medial	O
border	O
.	O

The	O
surface	O
is	O
inked	O
and	O
the	O
specimen	O
is	O
.	O
sectioned	O
to	O
show	O
yellow	O
lobular	O
fatty	O
cut	O
surface	O
with	O
minimal	O
.	O
fibrous	O
tissue	O
present	O
.	O

No	O
discrete	O
residual	O
tumor	O
is	O
grossly	O
.	O
identified	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
labeled	O
1	O
through	O
.	O

10	O
.	O

E	O
.	O

Received	O
fresh	O
and	O
subsequently	O
fixed	O
in	O
formalin	O
labeled	O
.	O

"	O
inferior	O
to	O
segmental	O
mastectomy	O
left	O
breast	O
"	O
is	O
a	O
4	O
.	O
3	O
x	O
2	O
.	O
7	O
x	O
.	O

2	O
.	O
2	O
.	O

cm	O
yellow	O
lobular	O
fatty	O
tissue	O
fragment	O
which	O
has	O
a	O
suture	O
.	O
designating	O
new	O
inferior	O
border	O
.	O

The	O
surface	O
is	O
inked	O
and	O
the	O
.	O
specimen	O
is	O
sectioned	O
to	O
show	O
yellow	O
lobular	O
fatty	O
cut	O
surface	O
with	O
.	O
minimal	O
fibrous	O
tissue	O
present	O
.	O

No	O
residual	O
tumor	O
is	O
grossly	O
.	O
identified	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
labeled	O
1	O
through	O
9	O
.	O

F	O
.	O

Received	O
fresh	O
and	O
subsequently	O
fixed	O
in	O
formalin	O
labeled	O
.	O

"	O
posterior	O
to	O
segmental	O
mastectomy	O
left	O
breast	O
"	O
is	O
a	O
3	O
.	O
2	O
x	O
2	O
.	O
5	O
.	O

x	O
.	O

1	O
.	O
0	O
cm	O
yellow	O
lobular	O
fatty	O
tissue	O
fragment	O
which	O
is	O
partially	O
.	O
covered	O
with	O
skeletal	O
muscle	O
.	O

There	O
is	O
a	O
suture	O
designating	O
the	O
new	O
.	O
posterior	O
margin	O
.	O

The	O
surface	O
is	O
inked	O
and	O
the	O
specimen	O
is	O
.	O
sectioned	O
to	O
show	O
a	O
yellow	O
lobular	O
fatty	O
cut	O
surface	O
with	O
scanty	O
.	O
fibrous	O
tissue	O
present	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
5	O
.	O
cassettes	O
.	O

G	O
.	O

Received	O
fresh	O
and	O
subsequently	O
fixed	O
in	O
formalin	O
labeled	O
"	O
lateral	O
.	O
to	O
segmental	O
mastectomy	O
left	O
breast	O
"	O
is	O
a	O
4	O
.	O
3	O
x	O
3	O
.	O
5	O
x	O
1	O
.	O
5	O
cm	O
yellow	O
.	O
lobular	O
fatty	O
tissue	O
fragment	O
.	O

There	O
is	O
a	O
suture	O
designating	O
the	O
.	O
new	O
lateral	O
border	O
.	O

The	O
surface	O
is	O
inked	O
and	O
the	O
specimen	O
is	O
.	O
sectioned	O
to	O
show	O
yellow	O
lobular	O
fatty	O
cut	O
surface	O
with	O
minimal	O
.	O
fibrous	O
tissue	O
present	O
.	O

No	O
residual	O
tumor	O
is	O
grossly	O
identified	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
9	O
cassettes	O
.	O

H	O
.	O

Received	O
fresh	O
and	O
subsequently	O
fixed	O
in	O
formalin	O
labeled	O
.	O

"	O
superior	O
segmental	O
mastectomy	O
left	O
breast	O
"	O
is	O
a	O
4	O
.	O
3	O
x	O
2	O
.	O
2	O
x	O
1	O
.	O
0	O
.	O

cm	O
.	O
yellow	O
lobular	O
fatty	O
tissue	O
fragment	O
which	O
has	O
a	O
suture	O
designating	O
.	O
the	O
new	O
superior	O
border	O
.	O

This	O
is	O
inked	O
and	O
the	O
specimen	O
is	O
.	O
sectioned	O
to	O
show	O
yellow	O
lobular	O
fatty	O
cut	O
surface	O
with	O
scanty	O
.	O
fibrous	O
tissue	O
present	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
4	O
.	O
cassettes	O
.	O

-DOCSTART-291
Clinical	O
Center	O
.	O

Birth	O
Date	O
:	O
AP	O
Supplemental	O
Report	O
.	O

SUPPLEMENTAL	O
.	O

SUPPLEMENTAL	O
.	O

REASON	O
FOR	O
THE	O
SUPPLEMENTAL	O
REPORT	O
:	O
To	O
clarify	O
the	O
location	O
of	O
the	O
.	O
lesions	O
.	O

Diagnosis	O
remains	O
unchanged	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

Lymph	O
node	O
,	O
delphan	O
lymph	O
node	O
,	O
biopsy	O
:	O
Metastatic	O
carcinoma	O
to	O
.	O
lymph	O
node	O
(	O
1	O
/	O
1	O
)	O
.	O

2	O
.	O

Thyroid	O
,	O
total	O
thyroidectomy	O
:	O
Papillary	O
thyroid	O
carcinoma	O
,	O
conventional	O
type	O
,	O
(	O
3	B
.	I
5cm	I
)	O
,	O
isthmus	O
.	O

Hurthle	O
cell	O
neoplasm	O
,	O
favor	O
Hurthle	O
cell	O
adenoma	O
.	O

(	O
left	O
lobe	O
)	O
.	O

See	O
note	O
:	O
Multinodular	O
goiter	O
.	O

The	O
original	O
report	O
is	O
as	O
follows	O
:	O
DIAGNOSIS	O
:	O
1	O
.	O

Lymph	O
node	O
,	O
delphan	O
lymph	O
node	O
,	O
biopsy	O
:	O
Metastatic	O
carcinoma	O
to	O
.	O
lymph	O
node	O
(	O
1	O
/	O
1	O
)	O
.	O

2	O
.	O

Thyroid	O
,	O
total	O
thyroidectomy	O
:	O
i	O
,	O
.	O

Papillary	O
thyrold	O
carcinoma	O
,	O
conventional	O
type	O
,	O
(	O
3	B
.	I
5cm	I
)	O
,	O
left	O
.	O
lobe	O
.	O

ii	O
.	O

Hurthle	O
cell	O
neoplasm	O
,	O
favor	O
Hurthle	O
cell	O
adenoma	O
.	O

(	O
isthmus	O
)	O
.	O

See	O
.	O
note	O
:	O
iii	O
.	O

Multinodular	O
goiter	O
.	O

NOTE	O
:	O
The	O
Hurthle	O
cell	O
neoplasm	O
shows	O
no	O
evidence	O
of	O
fibrous	O
capsule	O
and	O
.	O
capsular	O
or	O
vascular	O
invasion	O
.	O

This	O
lesion	O
stains	O
positive	O
for	O
.	O
thyroglobulin	O
and	O
negative	O
for	O
Calcitonin	O
.	O

Dr	O
.	O
is	O
informed	O
by	O
Dr	O
.	O
of	O
presence	O
of	O
micrometastasis	O
in	O
.	O
lymph	O
node	O
on	O
.	O

Immunoperoxidase	O
and	O
in	O
-	O
situ	O
hybridization	O
tests	O
performed	O
here	O
and	O
used	O
.	O
for	O
diagnosis	O
were	O
developed	O
and	O
their	O
performance	O
characteristics	O
.	O
determined	O
by	O
the	O
Laboratory	O
of	O
Pathology	O
,	O
They	O
have	O
not	O
been	O
.	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O

The	O
FDA	O
.	O
has	O
also	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

This	O
laboratory	O
is	O
certified	O
under	O
the	O
Clinical	O
Laboratory	O
Improvement	O
.	O

Amendments	O
of	O
1988	O
(	O
CLIA	O
)	O
as	O
qualified	O
to	O
perform	O
high	O
complexity	O
.	O
clinical	O
laboratory	O
testing	O
.	O

(	O
Other	O
)	O
.	O

Do	O
not	O
file	O
in	O
Medical	O
Record	O
.	O

Clinical	O
Center	O
.	O

Birth	O
Date	O
:	O
Clinical	O
_	O
History	O
:	O
_	O
_	O
thyrold	O
.	O
cancer	O
,	O
papillary	O
Specimen	O
Taken	O
For	O
.	O

Protocol	O
:	O
01	O
-	O
Yes	O
.	O

PROCEDURE	O
:	O
Pre	O
-	O
Operative	O
Diagnosis	O
:	O
papillary	O
thyroid	O
ca	O
.	O

Post	O
-	O
Operative	O
.	O

Diagnosis	O
:	O
same	O
Operative	O
Findings	O
:	O
isthmus	O
nodule	O
,	O
.	O
left	O
lobe	O
nodule	O
.	O

SPECIMENS	O
SUBMITTED	O
:	O
1	O
.	O

SERIAL	O
5	O
+	O
3FS	O
,	O
Delphan	O
lymph	O
node	O
(	O
1FS	O
)	O
.	O

2	O
.	O

THYROIDECTOMY	O
,	O
TOTAL	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
:	O
1FS	O
:	O
"	O
Delphan	O
lymph	O
node	O
,	O
rule	O
out	O
metastatic	O
thyroid	O
cancer	O
"	O
.	O

1FS	O
Diagnosis	O
:	O
Lymph	O
node	O
with	O
fibrotic	O
tissue	O
,	O
no	O
tumor	O
seen	O
.	O

-	O
The	O
frozen	O
section	O
is	O
performed	O
by	O
Dr	O
.	O
and	O
Dr	O
.	O
-	O
Dr	O
.	O
is	O
informed	O
by	O
Dr	O
.	O
of	O
presence	O
of	O
micrometastasis	O
in	O
.	O
lymph	O
node	O
on	O
.	O

GROSS	O
DESCRIPTION	O
:	O
Two	O
specimens	O
are	O
received	O
fresh	O
with	O
the	O
.	O

patient	O
'	O
s	O
name	O
,	O
medical	O
record	O
number	O
,	O
and	O
further	O
specified	O
as	O
follows	O
:	O
1	O
.	O

"	O
Delphan	O
lymph	O
node	O
,	O
rule	O
out	O
metastatic	O
thyrold	O
cancer	O
"	O
.	O

It	O
.	O
consists	O
of	O
a	O
yellow	O
-	O
tan	O
soft	O
tissue	O
fragment	O
measuring	O
0	O
.	O
8	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
4	O
.	O

cm	O
.	O

Entirely	O
frozen	O
.	O

In	O
Surgical	O
Pathology	O
,	O
the	O
specimen	O
matched	O
the	O
.	O
above	O
description	O
and	O
the	O
specimen	O
is	O
transferred	O
to	O
cassette	O
.	O

2	O
.	O

"	O
Total	O
thyroid	O
gland	O
,	O
long	O
stitch	O
right	O
superior	O
,	O
short	O
left	O
.	O

superior	O
"	O
.	O

It	O
is	O
a	O
total	O
thyroidectomy	O
weighing	O
42	O
.	O
7	O
grams	O
(	O
post	O
.	O
procurement	O
)	O
.	O

Gross	O
photographs	O
are	O
taken	O
.	O

The	O
right	O
lobe	O
measures	O
3	O
x	O
.	O

2	O
.	O
5	O
x	O
1	O
.	O
5	O
cm	O
.	O

The	O
left	O
lobe	O
6	O
.	O
5	O
x	O
3	O
x	O
1	O
.	O
5	O
cm	O
.	O

Isthmus	O
measures	O
4	O
x	O
4	O
x	O
.	O

1	O
.	O
5	O
cm	O
.	O

A	O
solid	O
lesion	O
measuring	O
3	O
.	O
5	O
x	O
3	O
.	O
2	O
x	O
2	O
.	O
2	O
is	O
identified	O
in	O
the	O
.	O
left	O
lobe	O
,	O
while	O
a	O
cystic	O
lesion	O
3	O
.	O
3	O
x	O
2	O
.	O
5	O
x	O
2	O
cm	O
in	O
deflated	O
state	O
is	O
.	O
identified	O
in	O
isthmus	O
.	O

Approximately	O
1	O
x	O
1	O
cm	O
of	O
tissue	O
is	O
procured	O
for	O
.	O

Dr	O
.	O
from	O
each	O
lesions	O
.	O

Procurement	O
was	O
performed	O
by	O
Dr	O
.	O
in	O
OR	O
and	O
.	O

on	O
.	O

Also	O
0	O
,	O
5	O
cm	O
of	O
each	O
tumor	O
and	O
0	O
.	O
5	O
x	O
1	O
x	O
1	O
cm	O
of	O
normal	O
tissue	O
in	O
the	O
.	O
right	O
lobe	O
is	O
also	O
procured	O
for	O
Dr	O
.	O
The	O
right	O
anterior	O
.	O
aspect	O
of	O
the	O
gland	O
(	O
right	O
lobe	O
and	O
isthmus	O
)	O
is	O
inked	O
blue	O
,	O
the	O
left	O
.	O
anterior	O
aspect	O
of	O
the	O
gland	O
(	O
left	O
lobe	O
)	O
is	O
inked	O
red	O
,	O
and	O
posterior	O
.	O
aspect	O
of	O
the	O
gland	O
is	O
inked	O
black	O
.	O

Approximately	O
0	O
.	O
8	O
x	O
0	O
,	O
6	O
x	O
0	O
.	O
3	O
cm	O
of	O
.	O
normal	O
-	O
appearing	O
thyroid	O
tissue	O
from	O
the	O
right	O
lobe	O
is	O
procured	O
In	O
TPPF	O
.	O
for	O
the	O
normal	O
tissue	O
bank	O
by	O
.	O

on	O
.	O

a	O
.	O
m	O
.	O

The	O
remainder	O
of	O
the	O
specimen	O
is	O
placed	O
in	O
formalin	O
and	O
submitted	O
.	O
for	O
Pathology	O
for	O
permanent	O
processing	O
.	O

In	O
Surgical	O
Pathology	O
,	O
the	O
.	O
specimen	O
matched	O
the	O
above	O
description	O
and	O
is	O
entirely	O
submitted	O
.	O

The	O
.	O
external	O
capsule	O
of	O
the	O
gland	O
is	O
grossly	O
uninvolved	O
by	O
aforementioned	O
.	O
two	O
lesions	O
.	O

The	O
superior	O
aspect	O
of	O
left	O
lobe	O
is	O
grossly	O
uninvolved	O
.	O
with	O
a	O
beefy	O
-	O
red	O
cut	O
surface	O
and	O
is	O
submitted	O
in	O
cassettes	O
2A	O
and	O
2B	O
.	O

Do	O
not	O
file	O
in	O
Medical	O
Record	O
.	O

Clinical	O
Center	O
.	O

I	O
.	O

Birth	O
Date	O
:	O
ty	O
.	O
from	O
superior	O
.	O
to	O
inferior	O
.	O

The	O
solid	O
lesion	O
in	O
the	O
inferior	O
aspect	O
of	O
.	O
left	O
lobe	O
is	O
yellow	O
-	O
tan	O
and	O
well	O
-	O
circumscribed	O
with	O
multiple	O
focal	O
.	O
punctate	O
hemorrhage	O
and	O
multiple	O
nodular	O
lesion	O
measuring	O
around	O
0	O
.	O
5	O
x	O
.	O

0	O
.	O
6	O
cm	O
but	O
no	O
necrosis	O
or	O
depressed	O
scar	O
.	O

The	O
solid	O
lesion	O
is	O
submitted	O
.	O
from	O
left	O
upper	O
aspect	O
to	O
left	O
lower	O
aspect	O
in	O
cassette	O
2C	O
-	O
2J	O
and	O
right	O
.	O
upper	O
to	O
right	O
lower	O
aspect	O
in	O
2K	O
-	O
2O	O
.	O

The	O
cystic	O
lesion	O
in	O
the	O
isthmus	O
.	O

is	O
gray	O
-	O
tan	O
with	O
a	O
finely	O
papillary	O
and	O
granular	O
appearance	O
and	O
focal	O
.	O
punctate	O
hemorrhage	O
.	O

A	O
calcified	O
spot	O
around	O
0	O
.	O
8x	O
0	O
.	O
6x	O
0	O
.	O
6	O
cm	O
is	O
.	O
identified	O
in	O
the	O
right	O
middle	O
aspect	O
of	O
the	O
cystic	O
lesion	O
.	O

The	O
isthmus	O
.	O

is	O
submitted	O
from	O
left	O
upper	O
aspect	O
to	O
left	O
lower	O
aspect	O
in	O
2P	O
-	O
2R	O
and	O
.	O
right	O
upper	O
to	O
right	O
lower	O
in	O
.	O

Pright	O
aspect	O
of	O
isthmus	O
and	O
.	O
left	O
aspect	O
of	O
right	O
lobe	O
from	O
left	O
to	O
right	O
.	O
right	O
lobe	O
from	O
.	O
superior	O
to	O
inferior	O
.	O

2GG	O
:	O
superior	O
aspect	O
of	O
very	O
right	O
end	O
of	O
right	O
.	O
lobe	O
.	O

2HH	O
:	O
inferior	O
aspect	O
of	O
the	O
very	O
right	O
end	O
of	O
right	O
lobe	O
.	O

No	O
consultants	O
.	O

#	O
.	O

(	O
Other	O
)	O
.	O

Do	O
not	O
file	O
in	O
Medical	O
Record	O
.	O

-DOCSTART-292
FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
KIDNEY	O
,	O
RIGHT	O
,	O
NEPHRECTOMY	O
-	O
.	O

A	O
.	O

RENAL	O
CELL	O
CARCINOMA	O
(	O
6	B
.	I
5	I
CM	I
)	O
,	O
CONVENTIONAL	O
(	O
CLEAR	O
)	O
CELL	O
TYPE	O
.	O

B	O
.	O

THE	O
CARCINOMA	O
EXTENDS	O
INTO	O
RENAL	O
VEIN	O
FORMING	O
AN	O
ADDITIONAL	O
5	B
,	I
0	I
-	I
cm	I
MASS	O
.	O

C	O
.	O

FUHRMAN	O
GRADE	O
:	O
3	O
OF	O
4	O
.	O

D	O
.	O

NO	O
EXTENSION	O
THROUGH	O
THE	O
RENAL	O
CAPSULE	O
IS	O
NOTED	O
.	O

E	O
.	O

ANGIOLYMPHATIC	O
INVASION	O
SEEN	O
MICROSCOPICALLY	O
.	O

F	O
.	O

HISTOPATHOLOGICAL	O
STAGING	O
:	O
pT3b	O
,	O
Nx	O
,	O
Mx	O
.	O

PART	O
2	O
:	O
VEIN	O
,	O
VENA	O
CAVA	O
,	O
RESECTION	O
MARGIN	O
,	O
EXCISION	O
-	O
.	O

RENAL	O
CELL	O
CARCINOMA	O
,	O
INVOLVING	O
THE	O
VEIN	O
WALL	O
.	O

COMMENT	O
:	O
Part	O
1	O
:	O
Additional	O
margin	O
from	O
the	O
distal	O
ureter	O
is	O
submitted	O
.	O

Results	O
will	O
be	O
issued	O
as	O
an	O
addendum	O
.	O

-DOCSTART-293
MRN	O
:	O
Accessioned	O
:	O
Patient	O
Typo	O
:	O
DIAGNOSIS	O
:	O
OVARY	O
AND	O
FALLOPIAN	O
TUBE	O
,	O
LEFT	O
,	O
SALPINGO	O
-	O
OOPHORECTOMY	O
.	O

PAPILLARY	O
SEROUS	O
CARCINOMA	O
POORLY	O
DIFFERENTIATED	O
,	O
INVOLVING	O
OVARY	O
AND	O
FALLOPIAN	O
.	O

TUBE	O
.	O

OVARY	O
AND	O
FALLOPIAN	O
TUBE	O
,	O
RIGHT	O
,	O
SALPINGO	O
-	O
OOPHORECTOMY	O
.	O

PAPILLARY	O
SEROUS	O
CARCINOMA	O
,	O
POORLY	O
DIFFERENTIATED	O
INVOLVING	O
OVARY	O
AND	O
FALLOPIAN	O
.	O

TUBE	O
WITH	O
EXTENSIVE	O
LYMPHOVASCULAR	O
SPACE	O
INVASION	O
.	O

OMENTUM	O
,	O
OMENTECTOMY	O
(	O
FS	O
)	O
.	O

-	O
METASTATIC	O
CARCINOMA	O
.	O

OMENTUM	O
,	O
OMENTECTOMY	O
.	O

-	O
METASTATIC	O
CARCINOMA	O
.	O

SMALL	O
INTESTINE	O
,	O
RESECTION	O
.	O

-	O
METASTATIC	O
CARCINOMA	O
,	O
MULTIPLE	O
NODULES	O
INVOLVING	O
MESENTERY	O
AND	O
SMALL	O
INTESTINE	O
.	O

WALL	O
.	O

-	O
METASTATIC	O
CARCINOMA	O
PRESENT	O
IN	O
5	O
OF	O
5	O
MESENTERIC	O
LYMPH	O
NODES	O
(	O
5	O
/	O
5	O
)	O
.	O

SOFT	O
TISSUE	O
,	O
VENTRAL	O
HERNIA	O
,	O
HERNIORRHAPHY	O
.	O

-	O
METASTATIC	O
CARCINOMA	O
,	O
SOFT	O
TISSUE	O
AND	O
DERMAL	O
INVOLVEMENT	O
.	O

By	O
this	O
signature	O
,	O
1	O
attest	O
that	O
the	O
above	O
diagnosis	O
is	O
based	O
upon	O
my	O
personal	O
.	O
examination	O
of	O
the	O
slides	O
(	O
and	O
/	O
or	O
other	O
material	O
indigated	O
in	O
the	O
diagnosis	O
)	O
.	O

'	O
.	O

Diagnosis	O
Comment	O
.	O

SYNOPTIC	O
REPORTING	O
FORM	O
FOR	O
MALIGNANT	O
OVARIAN	O
NEOPLASMS	O
.	O

1	O
.	O

A	O
neoplasm	O
is	O
PRESENT	O
.	O

2	O
.	O

The	O
HISTOLOGIO	O
DIAGNOSIS	O
is	O
:	O
Serous	O
adenocarcinoma	O
.	O

3	O
.	O

The	O
LOCATION	O
(	O
S	O
)	O
OF	O
THE	O
PRIMARY	O
TUMOR	O
(	O
S	O
)	O
is	O
/	O
are	O
:	O
Right	O
and	O
left	O
ovary	O
(	O
synchronous	O
primary	O
tumors	O
)	O
.	O

4	O
.	O

The	O
FIGO	O
GRADE	O
of	O
the	O
tumor	O
is	O
:	O
III	O
(	O
Tumor	O
composed	O
of	O
>	O
50	O
%	O
solid	O
cellular	O
nests	O
)	O
.	O

5	O
.	O

The	O
NUCLEAR	O
(	O
BRODERS	O
'	O
)	O
GRADE	O
of	O
the	O
tumor	O
is	O
:	O
G3	O
(	O
Poorly	O
-	O
differentiated	O
)	O
.	O

6	O
.	O

Tumor	O
IS	O
identified	O
on	O
the	O
ovarian	O
surface	O
(	O
s	O
)	O
.	O

7	O
Tumor	O
DOES	O
invade	O
the	O
mesovarium	O
.	O

8	O
.	O

Tumor	O
DOES	O
invade	O
the	O
adjacent	O
fallopian	O
tube	O
(	O
bilaterally	O
)	O
.	O

9	O
.	O

Tumor	O
invasion	O
of	O
pelvic	O
soft	O
tissue	O
CANNOT	O
BE	O
EVALUATED	O
.	O

10	O
.	O

Tumor	O
involvement	O
of	O
the	O
pelvic	O
peritoneum	O
is	O
PRESENT	O
.	O

11	O
.	O

Metastatic	O
involvement	O
of	O
the	O
EXTRAPELVIC	O
PERITONEUM	O
is	O
PRESENT	O
.	O

12	O
.	O

Metastatic	O
involvement	O
of	O
the	O
omentum	O
is	O
PRESENT	O
.	O

13	O
.	O

The	O
maximum	O
dimension	O
of	O
tumor	O
implants	O
outside	O
the	O
true	O
pelvis	O
is	O
8	B
.	I
0	I
cm	I
.	O

14	O
.	O

Metastatic	O
involvement	O
of	O
the	O
uterine	O
serosa	O
CANNOT	O
BE	O
EVALUATED	O
.	O

15	O
.	O

Metastatic	O
involvement	O
of	O
the	O
endometrium	O
CANNOT	O
BE	O
EVALUATED	O
.	O

16	O
.	O

Regional	O
lymph	O
node	O
metastases	O
CANNOT	O
BE	O
EVALUATED	O
.	O

17	O
.	O

DETAILED	O
STAGING	O
INFORMATION	O
:	O
Based	O
on	O
the	O
above	O
information	O
,	O
the	O
PRIMARY	O
TUMOR	O
is	O
.	O
classified	O
as	O
:	O
TNM	O
Scheme	O
.	O

FIGO	O
Scheme	O
.	O

Definition	O
.	O

T3c	O
.	O

IIIC	O
.	O

Macroscopic	O
peritoneal	O
metastasis	O
beyond	O
true	O
pelvis	O
measuring	O
>	O
2	O
cm	O
.	O

in	O
.	O
greatest	O
dimension	O
.	O

THE	O
REGIONAL	O
LYMPH	O
NODES	O
are	O
classified	O
as	O
:	O
NX	O
(	O
Nodal	O
status	O
cannot	O
be	O
assessed	O
)	O
.	O

THE	O
STATUS	O
OF	O
DISTANT	O
TUMOR	O
SITES	O
is	O
classified	O
as	O
:	O
MX	O
(	O
Status	O
cannot	O
be	O
assessed	O
)	O
.	O

18	O
.	O

The	O
FINAL	O
AJCC	O
/	O
UICC	O
/	O
FIGO	O
STAGE	O
IS	O
:	O
AJCC	O
/	O
UICC	O
/	O
FIGO	O
.	O

Insufficient	O
data	O
to	O
assign	O
stage	O
.	O

The	O
pathologic	O
stage	O
assigned	O
here	O
should	O
be	O
regarded	O
as	O
provisional	O
,	O
and	O
may	O
change	O
after	O
integration	O
of	O
clinical	O
.	O
data	O
not	O
provided	O
with	O
this	O
specimen	O
.	O

Intraoperative	O
Consultation	O
:	O
An	O
intraoperative	O
non	O
-	O
microscopic	O
consultation	O
was	O
obtained	O
and	O
interpreted	O
as	O
:	O
"	O
Called	O
to	O
O	O
.	O
R	O
.	O
to	O
pickup	O
'	O
omentum	O
.	O
"	O
.	O

It	O
consists	O
of	O
a	O
7	O
X	O
3	O
X	O
2	O
.	O
0	O
cm	O
glistening	O
fleshy	O
white	O
mass	O
.	O

A	O
representative	O
section	O
is	O
submitted	O
for	O
FS1	O
.	O

An	O
.	O
additional	O
portion	O
is	O
submitted	O
for	O
tumor	O
bank	O
.	O

The	O
remainder	O
is	O
placed	O
in	O
formalin	O
.	O

Microscopic	O
Description	O
and	O
Comment	O
:	O
Microscopic	O
examination	O
substantiales	O
the	O
above	O
cited	O
diagnosis	O
.	O

History	O
:	O
The	O
patient	O
is	O
a	O
.	O
with	O
enlarged	O
uterus	O
and	O
ovarian	O
and	O
omental	O
masses	O
.	O

A	O
previous	O
cervical	O
biopsy	O
.	O
showed	O
poorly	O
differentiated	O
carcinoma	O
(	O
S99	O
-	O
10	O
-	O
-	O
)	O
.	O

Operative	O
Procedure	O
:	O
Exploratory	O
laparotomy	O
;	O
omentectomy	O
;	O
.	O
bilateral	O
salpingo	O
-	O
oophorectomy	O
;	O
ventral	O
hernia	O
repair	O
;	O
small	O
bowel	O
resection	O
.	O

Specimen	O
(	O
s	O
)	O
Received	O
:	O
A	O
:	O
OMENTUM	O
(	O
FOR	O
FS	O
)	O
.	O

B	O
:	O
OMENTUM	O
,	O
ROUTINE	O
.	O

C	O
:	O
SMALL	O
BOWEL	O
.	O

D	O
:	O
LEFT	O
OVARY	O
.	O

E	O
:	O
RIGHT	O
OVARY	O
AND	O
TUBE	O
,	O
.	O

F	O
:	O
HERNIA	O
SAC	O
.	O

Gross	O
Description	O
;	O
.	O

The	O
specimens	O
are	O
received	O
in	O
six	O
formalin	O
-	O
filled	O
containers	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
.	O
in	O
addition	O
,	O
the	O
first	O
.	O
container	O
is	O
labeled	O
"	O
omentum	O
(	O
FS1	O
)	O
.	O

It	O
holds	O
a	O
previously	O
sectioned	O
white	O
,	O
firm	O
,	O
well	O
-	O
demarcated	O
mass	O
measuring	O
7	O
.	O

x	O
5	O
X	O
2	O
.	O
5	O
cm	O
,	O
in	O
aggregate	O
,	O
and	O
a	O
cassette	O
labeled	O
"	O
FS	O
"	O
holding	O
a	O
section	O
of	O
tumor	O
measuring	O
3	B
x	I
1	I
.	I
5	I
x	I
0	I
.	I
2	I
cm	I
.	O

On	O
.	O
multiple	O
sections	O
,	O
the	O
tum	O
or	O
shows	O
colid	O
,	O
focally	O
necrotic	O
,	O
homogeneous	O
cut	O
surfaces	O
.	O

Labeled	O
A1	O
-	O
FS	O
;	O
A2	O
and	O
A3	O
.	O
additional	O
sections	O
of	O
tumor	O
.	O

The	O
second	O
container	O
is	O
labeled	O
"	O
omentum	O
.	O
"	O
It	O
contains	O
fragments	O
of	O
fatty	O
tissue	O
with	O
attached	O
vessels	O
,	O
consistent	O
with	O
.	O
omentum	O
,	O
measuring	O
10	O
x	O
5x3	O
cm	O
.	O

Multiple	O
white	O
,	O
firm	O
nodules	O
,	O
ranging	O
in	O
size	O
from	O
0	O
.	O
2	O
to	O
3	O
cm	O
,	O
are	O
scattered	O
on	O
.	O
the	O
omental	O
surface	O
.	O

All	O
these	O
nodules	O
show	O
firm	O
,	O
white	O
,	O
solid	O
and	O
partially	O
cyslic	O
and	O
hemorrhagic	O
cut	O
surfaces	O
.	O

Labeled	O
B1	O
-	O
sections	O
of	O
two	O
different	O
nodules	O
.	O

The	O
third	O
container	O
is	O
labeled	O
"	O
small	O
bowel	O
.	O
"	O
It	O
contains	O
several	O
adhesed	O
loops	O
of	O
small	O
intestine	O
centered	O
around	O
a	O
.	O
large	O
solid	O
white	O
,	O
fleshy	O
omental	O
mass	O
.	O

The	O
length	O
of	O
the	O
small	O
intestino	O
is	O
difficult	O
to	O
appreciate	O
due	O
to	O
the	O
degree	O
of	O
.	O
distortion	O
;	O
it	O
is	O
-	O
-	O
100	O
cm	O
in	O
length	O
.	O

The	O
Jumen	O
is	O
even	O
and	O
-	O
2	O
.	O
5	O
cm	O
in	O
diameter	O
.	O

In	O
the	O
area	O
encroached	O
by	O
tumor	O
,	O
the	O
.	O
lumen	O
of	O
the	O
intestine	O
appears	O
narrowed	O
to	O
a	O
diameter	O
of	O
1	O
cm	O
.	O

However	O
,	O
the	O
intestine	O
is	O
lined	O
by	O
unremarkable	O
.	O
mucosa	O
throughout	O
its	O
length	O
,	O
with	O
no	O
evidence	O
of	O
intraluminal	O
tumor	O
,	O
The	O
tumor	O
surrounds	O
the	O
intestinal	O
loop	O
,	O
.	O
involves	O
the	O
mosentery	O
with	O
multiple	O
additional	O
white	O
nodules	O
,	O
ranging	O
in	O
sizo	O
from	O
0	O
,	O
5	O
to	O
3	O
cm	O
,	O
studding	O
the	O
peritoneal	O
.	O
surface	O
.	O

Tumor	O
nodules	O
are	O
also	O
present	O
at	O
the	O
stapled	O
mesenteric	O
resection	O
margin	O
.	O

The	O
main	O
tumor	O
measures	O
10	B
.	I

cm	B
in	O
groatest	O
dimension	O
.	O

Labeled	O
C1	O
and	O
C2	O
-	O
intestine	O
with	O
serosal	O
tumor	O
;	O
C3	O
-	O
stapled	O
resection	O
margins	O
of	O
the	O
.	O
intestine	O
;	O
C4	O
-	O
mesenteric	O
lymph	O
nodes	O
/	O
tumor	O
nodules	O
.	O

The	O
fourth	O
container	O
is	O
labeled	O
"	O
left	O
ovary	O
.	O
"	O
It	O
contains	O
a	O
7	O
.	O
5	O
x	O
5	O
x	O
4	O
cm	O
solid	O
ovoid	O
firm	O
white	O
mass	O
with	O
irregular	O
.	O
surface	O
.	O

A	O
portion	O
of	O
the	O
surface	O
is	O
represented	O
by	O
a	O
thin	O
-	O
walled	O
white	O
cyst	O
.	O

The	O
mass	O
is	O
bisected	O
to	O
show	O
solid	O
white	O
,	O
.	O
soft	O
cut	O
surfaces	O
with	O
areas	O
of	O
necrosis	O
.	O

The	O
above	O
described	O
cyst	O
contains	O
necrotic	O
,	O
yollow	O
fluid	O
.	O

There	O
is	O
no	O
.	O
recognizable	O
residual	O
ovarian	O
tissue	O
.	O

Also	O
,	O
no	O
fallopian	O
tube	O
is	O
identified	O
grossly	O
.	O

Labeled	O
D1	O
to	O
D3	O
-	O
sections	O
of	O
the	O
.	O
tumor	O
(	O
including	O
cyst	O
)	O
.	O

The	O
fifth	O
container	O
is	O
labeled	O
"	O
right	O
ovary	O
.	O
"	O
Il	O
holds	O
an	O
ovary	O
with	O
attached	O
fallopian	O
tube	O
.	O

The	O
ovary	O
is	O
4	O
x	O
3	O
2	O
cm	O
and	O
.	O
the	O
fallopian	O
tube	O
is	O
5	O
em	O
in	O
length	O
and	O
0	O
.	O
5	O
cm	O
in	O
average	O
diametor	O
,	O
and	O
includes	O
the	O
proximal	O
third	O
of	O
the	O
fallopian	O
.	O

.	O
ube	O
as	O
well	O
as	O
the	O
fimbriated	O
end	O
.	O

The	O
ovary	O
appears	O
to	O
be	O
entirely	O
replaced	O
by	O
a	O
multinodular	O
firm	O
solid	O
white	O
tumor	O
.	O

In	O
addition	O
,	O
multiple	O
tumor	O
nodules	O
ranging	O
in	O
size	O
from	O
0	O
.	O
2	O
to	O
1	O
cm	O
are	O
present	O
on	O
the	O
tubo	O
-	O
ovarian	O
ligament	O
and	O
.	O
serosa	O
overlying	O
the	O
fallopian	O
tube	O
,	O
including	O
the	O
fimbriated	O
end	O
of	O
the	O
tube	O
.	O

Labeled	O
E1	O
-	O
ovarian	O
tumor	O
(	O
including	O
.	O
tubo	O
-	O
ovarian	O
ligament	O
)	O
;	O
E2	O
-	O
fallopian	O
tube	O
(	O
transverse	O
sections	O
and	O
fimbriated	O
end	O
)	O
.	O

Dann	O
n	O
,	O
.	O
scar	O
.	O

measuring	O
portion	O
of	O
this	O
sac	O
shows	O
ring	O
-	O
like	O
attached	O
serosa	O
.	O

The	O
sixth	O
container	O
21	O
X	O
6	O
x5cm	O
.	O

is	O
labeled	O
A	O
"	O
hemia	O
sac	O
,	O
skin	O
,	O
tumor	O
.	O
"	O
It	O
holds	O
a	O
sac	O
-	O
like	O
portion	O
of	O
skin	O
with	O
.	O
well	O
as	O
The	O
an	O
additional	O
serosal	O
surface	O
8	O
x	O
7	O
x	O
of	O
4	O
the	O
cm	O
hernia	O
nodule	O
sac	O
of	O
firm	O
shows	O
extensive	O
a	O
serosal	O
structure	O
thickening	O
consistent	O
on	O
a	O
plaque	O
-	O
like	O
with	O
markedly	O
area	O
distended	O
of	O
8	O
X	O
4	O
umbilical	O
as	O
.	O

The	O
described	O
skin	O
is	O
putative	O
tan	O
,	O
umbilical	O
scar	O
.	O

In	O
addition	O
,	O
multiple	O
solid	O
tumor	O
,	O
small	O
involving	O
firm	O
tumor	O
the	O
nodules	O
serosa	O
are	O
and	O
scattered	O
fat	O
adjacent	O
to	O
the	O
above	O
cm	O
,	O
.	O
dermis	O
.	O

Also	O
,	O
the	O
largest	O
tumor	O
and	O
nodule	O
of	O
the	O
shows	O
sac	O
show	O
solid	O
,	O
multiple	O
extensively	O
tumor	O
nocrotic	O
nodules	O
cut	O
infiltrating	O
through	O
on	O
the	O
serosa	O
surface	O
.	O
into	O
the	O
.	O
sections	O
of	O
the	O
largest	O
wrinkled	O
nodule	O
and	O
shows	O
extensive	O
areas	O
of	O
hyperkoratosis	O
.	O

No	O
tumors	O
are	O
seen	O
on	O
the	O
the	O
skin	O
serosal	O
surface	O
.	O

Cross	O
.	O

Labeled	O
homorrhagic	O
F1	O
degeneration	O
.	O

Jar	O
2	O
.	O

The	O
tumor	O
is	O
present	O
in	O
the	O
subcutaneous	O
fat	O
underlying	O
surfaces	O
the	O
with	O
skin	O
areas	O
of	O
the	O
of	O
cystic	O
hernia	O
and	O
sac	O
.	O
and	O
F2	O
.	O

-DOCSTART-294
SURGICAL	O
PATHOLOGY	O
REVISED	O
REPORT	O
.	O

Addenda	O
Present	O
.	O

Diagnosis	O
:	O
A	O
:	O
Tooth	O
#	O
30	O
,	O
anterior	O
buccal	O
gingiva	O
,	O
biopsy	O
.	O

-	O
Squamous	O
mucosa	O
with	O
chronic	O
inflammation	O
and	O
dystrophic	O
calcification	O
.	O

-	O
No	O
carcinoma	O
identified	O
.	O

B	O
:	O
Deep	O
retromolar	O
trigone	O
,	O
biopsy	O
.	O

-	O
Benign	O
squamous	O
mucosa	O
.	O

-	O
No	O
carcinoma	O
identified	O
.	O

C	O
:	O
Right	O
anterior	O
tongue	O
pilar	O
,	O
biopsy	O
.	O

-	O
Benign	O
salivary	O
gland	O
and	O
soft	O
tissue	O
.	O

-	O
No	O
carcinoma	O
identified	O
.	O

D	O
:	O
Left	O
palate	O
,	O
biopsy	O
.	O

-	O
Benign	O
squamous	O
mucosa	O
.	O

-	O
No	O
carcinoma	O
identified	O
.	O

E	O
:	O
Deep	O
posterior	O
tongue	O
,	O
biopsy	O
.	O

-	O
Benign	O
skeletal	O
muscle	O
and	O
adipose	O
tissue	O
.	O

-	O
No	O
carcinoma	O
identified	O
.	O

F	O
:	O
Deep	O
midline	O
tongue	O
,	O
right	O
,	O
biopsy	O
.	O

-	O
Benign	O
skeletal	O
muscle	O
and	O
adipose	O
tissue	O
.	O

-	O
No	O
carcinoma	O
identified	O
.	O

G	O
:	O
Soft	O
tissue	O
,	O
anterior	O
neck	O
fat	O
,	O
removal	O
.	O

-	O
Benign	O
parathyroid	O
gland	O
.	O

-	O
No	O
carcinoma	O
identified	O
in	O
four	O
lymph	O
nodes	O
(	O
0	O
/	O
4	O
)	O
.	O

H	O
:	O
Lymph	O
nodes	O
,	O
right	O
neck	O
,	O
Level	O
3	O
,	O
removal	O
.	O

-	O
No	O
carcinoma	O
identified	O
in	O
eight	O
lymph	O
nodes	O
(	O
0	O
/	O
8	O
)	O
.	O

I	O
:	O
Lymph	O
nodes	O
,	O
right	O
neck	O
,	O
Level	O
4	O
,	O
removal	O
.	O

-	O
No	O
carcinoma	O
identified	O
in	O
nine	O
lymph	O
nodes	O
(	O
0	O
/	O
9	O
)	O
.	O

J	O
:	O
Lymph	O
nodes	O
,	O
right	O
neck	O
,	O
Level	O
1	O
,	O
removal	O
.	O

-	O
No	O
carcinoma	O
identified	O
in	O
five	O
lymph	O
nodes	O
(	O
0	O
/	O
5	O
)	O
.	O

-	O
Benign	O
salivary	O
gland	O
.	O

K	O
:	O
Lymph	O
nodes	O
,	O
right	O
neck	O
,	O
Level	O
2	O
,	O
removal	O
.	O

-	O
Metastatic	O
squamous	O
cell	O
carcinoma	O
with	O
necrosis	O
and	O
focal	O
cystic	O
change	O
involving	O
one	O
of	O
eight	O
lymph	O
nodes	O
(	O
1	O
/	O
8	O
)	O
measuring	O
1	O
.	O
1	O
cm	O
in	O
.	O
greatest	O
dimension	O
.	O

-	O
No	O
extracapsular	O
extension	O
identified	O
.	O

L	O
:	O
Tongue	O
,	O
right	O
hemiglossectomy	O
.	O

Tumor	O
histologic	O
type	O
:	O
Squamous	O
cell	O
carcinoma	O
.	O

Histologic	O
grade	O
:	O
Moderately	O
differentiated	O
,	O
keratinizing	O
.	O

Tumor	O
size	O
:	O
2	B
.	I
0	I
in	O
greatest	O
dimension	O
.	O

Greatest	O
depth	O
of	O
invasion	O
1	O
.	O
6	O
cm	O
into	O
muscle	O
of	O
tongue	O
.	O

Extent	O
of	O
invasion	O
:	O
Angiolymphatic	O
invasion	O
:	O
Not	O
identified	O
.	O

Perineural	O
invasion	O
:	O
Not	O
identified	O
.	O

Bone	O
invasion	O
:	O
N	O
/	O
A	O
.	O

Carcinoma	O
in	O
situ	O
:	O
Present	O
.	O

Likely	O
primary	O
site	O
:	O
right	O
tongue	O
.	O

Surgical	O
Margins	O
:	O
Negative	O
,	O
both	O
the	O
margins	O
on	O
this	O
specimen	O
as	O
well	O
as	O
the	O
separately	O
submitted	O
margins	O
from	O
parts	O
A	O
-	O
.	O

F	O
.	O

Lymph	O
nodes	O
:	O
Carcinoma	O
identified	O
in	O
one	O
of	O
34	O
lymph	O
nodes	O
(	O
1	O
/	O
34	O
)	O
see	O
specimens	O
G	O
-	O
K	O
.	O

Size	O
of	O
largest	O
nodal	O
metastasis	O
(	O
greatest	O
dimension	O
)	O
:	O
1	O
.	O
1	O
cm	O
(	O
specimen	O
K	O
)	O
.	O

Presence	O
/	O
absence	O
of	O
extranodal	O
extension	O
:	O
Absent	O
.	O

Other	O
significant	O
findings	O
:	O
None	O
.	O

AJCC	O
PATHOLOGIC	O
TNM	O
STAGE	O
:	O
pT1	O
pN1	O
NOTE	O
:	O
This	O
pathologic	O
stage	O
assessment	O
is	O
based	O
on	O
information	O
available	O
at	O
the	O
.	O
time	O
of	O
this	O
report	O
,	O
and	O
is	O
subject	O
to	O
change	O
pending	O
clinical	O
review	O
and	O
additional	O
information	O
.	O

Intraoperative	O
Consult	O
Diagnosis	O
:	O
A	O
frozen	O
section	O
was	O
requested	O
by	O
Dr	O
.	O
FSA1	O
:	O
Tooth	O
#	O
30	O
,	O
anterior	O
buccal	O
gingiva	O
,	O
biopsy	O
.	O

-	O
No	O
carcinoma	O
identified	O
.	O

-	O
Focal	O
chronic	O
inflammation	O
noted	O
.	O

FSB1	O
:	O
Deep	O
retromolar	O
trigone	O
,	O
biopsy	O
.	O

-	O
Squamous	O
mucosa	O
and	O
salivary	O
gland	O
tissue	O
;	O
no	O
carcinoma	O
identified	O
.	O

FSC1	O
:	O
Right	O
anterior	O
tonsillar	O
pillar	O
,	O
biopsy	O
.	O

-	O
Salivary	O
gland	O
tissue	O
;	O
no	O
carcinoma	O
identified	O
.	O

FSD1	O
:	O
Left	O
palate	O
,	O
biopsy	O
.	O

-	O
Squamous	O
mucosa	O
with	O
chronic	O
inflammation	O
;	O
no	O
carcinoma	O
identified	O
.	O

FSE1	O
:	O
Deep	O
posterior	O
tongue	O
biopsy	O
.	O

-	O
Skeletal	O
muscle	O
;	O
no	O
carcinoma	O
identified	O
.	O

FSF1	O
:	O
Deep	O
midline	O
tongue	O
,	O
right	O
,	O
biopsy	O
.	O

-	O
Skeletal	O
muscle	O
;	O
no	O
carcinoma	O
identified	O
.	O

Frozen	O
Section	O
Pathologist	O
:	O
Gross	O
Description	O
:	O
Received	O
are	O
twelve	O
appropriately	O
labeled	O
containers	O
.	O

Containers	O
A	O
-	O
F	O
are	O
received	O
fresh	O
for	O
frozen	O
section	O
.	O

Container	O
A	O
holds	O
two	O
fragments	O
of	O
red	O
/	O
tan	O
soft	O
tissue	O
measuring	O
2	O
x	O
2	O
x	O
2	O
mm	O
in	O
aggregate	O
.	O

(	O
Block	O
FSA1	O
,	O
.	O

Container	O
B	O
holds	O
a	O
0	O
.	O
7	O
X	O
0	O
.	O
5	O
X	O
0	O
.	O
2	O
cm	O
cauterized	O
red	O
/	O
tan	O
soft	O
tissue	O
fragment	O
.	O

(	O
Block	O
FSB1	O
,	O
.	O

Container	O
C	O
holds	O
a	O
0	O
.	O
8	O
X	O
0	O
.	O
6	O
X	O
0	O
.	O
5	O
cm	O
red	O
/	O
tan	O
soft	O
tissue	O
fragment	O
.	O

(	O
Block	O
FSC1	O
,	O
.	O

Container	O
D	O
holds	O
a	O
0	O
.	O
4	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
3	O
cm	O
white	O
/	O
tan	O
soft	O
tissue	O
fragment	O
.	O

(	O
Block	O
FSD1	O
,	O
.	O

Container	O
E	O
holds	O
a	O
0	O
.	O
3	O
X	O
0	O
.	O
2	O
X	O
0	O
.	O
3	O
cm	O
white	O
/	O
tan	O
soft	O
tissue	O
fragment	O
.	O

(	O
Block	O
FSE1	O
,	O
.	O

Container	O
F	O
holds	O
a	O
0	O
.	O
6	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
4	O
cm	O
red	O
/	O
tan	O
soft	O
tissue	O
fragment	O
.	O

(	O
Block	O
FSF1	O
,	O
.	O

Container	O
G	O
is	O
additionally	O
labeled	O
"	O
anterior	O
neck	O
fat	O
.	O
"	O
It	O
holds	O
multiple	O
fragments	O
of	O
yellow	O
lobulated	O
adipose	O
tissue	O
measuring	O
1	O
.	O
7	O
X	O
1	O
.	O
5	O
X	O
.	O

0	O
.	O
5	O
cm	O
in	O
aggregate	O
.	O

The	O
fragments	O
are	O
submitted	O
in	O
block	O
G1	O
,	O
.	O

Container	O
H	O
is	O
additionally	O
labeled	O
"	O
right	O
neck	O
,	O
Level	O
3	O
.	O
"	O
It	O
holds	O
a	O
3	O
.	O
6	O
x	O
2	O
.	O
2	O
x	O
1	O
.	O
5	O
cm	O
fragment	O
of	O
yellow	O
firm	O
tissue	O
.	O

The	O
outer	O
surface	O
is	O
.	O
smooth	O
.	O

Sectioning	O
reveals	O
four	O
lymph	O
node	O
candidates	O
ranging	O
from	O
0	O
.	O
5	O
to	O
up	O
to	O
1	O
.	O
5	O
cm	O
.	O

Additionally	O
,	O
there	O
are	O
fragments	O
of	O
red	O
/	O
brown	O
.	O
grossly	O
unremarkable	O
muscle	O
.	O

The	O
lymph	O
nodes	O
are	O
sampled	O
in	O
three	O
cassettes	O
;	O
blocks	O
H1	O
-	O
H3	O
,	O
per	O
block	O
summary	O
.	O

Block	O
summary	O
:	O
H1	O
-	O
multiple	O
lymph	O
node	O
candidates	O
.	O

H2	O
-	O
one	O
lymph	O
node	O
candidate	O
,	O
trisected	O
.	O

H3	O
-	O
three	O
lymph	O
node	O
candidates	O
.	O

Container	O
I	O
is	O
additionally	O
labeled	O
"	O
right	O
neck	O
,	O
Level	O
4	O
.	O
"	O
It	O
holds	O
a	O
4	O
.	O
1	O
x	O
2	O
.	O
8	O
X	O
1	O
.	O
5	O
cm	O
fragment	O
of	O
yellow	O
firm	O
tissue	O
.	O

The	O
outer	O
surface	O
is	O
.	O
smooth	O
.	O

Within	O
the	O
specimen	O
there	O
are	O
multiple	O
lymph	O
node	O
candidates	O
ranging	O
from	O
less	O
than	O
0	O
.	O
5	O
cm	O
to	O
1	O
.	O
5	O
cm	O
.	O

The	O
lymph	O
node	O
candidates	O
.	O
are	O
sampled	O
in	O
four	O
cassettes	O
;	O
blocks	O
I1	O
-	O
I4	O
,	O
per	O
block	O
summary	O
.	O

Block	O
summary	O
:	O
Il	O
-	O
multiple	O
lymph	O
node	O
candidates	O
.	O

I2	O
-	O
I3	O
-	O
one	O
lymph	O
node	O
candidate	O
,	O
serially	O
sectioned	O
.	O

I4	O
-	O
two	O
lymph	O
node	O
candidates	O
.	O

Container	O
J	O
is	O
additionally	O
labeled	O
"	O
right	O
neck	O
,	O
Level	O
1	O
.	O
"	O
It	O
holds	O
an	O
18	O
.	O
7	O
gram	O
,	O
5	O
.	O
7	O
x	O
3	O
.	O
3	O
x	O
1	O
.	O
8	O
cm	O
fragment	O
of	O
yellow	O
lobulated	O
tissue	O
.	O

The	O
.	O
outer	O
surface	O
is	O
smooth	O
.	O

Sectioning	O
reveals	O
multiple	O
lymph	O
node	O
candidates	O
ranging	O
from	O
1	O
.	O
0	O
x	O
up	O
to	O
1	O
.	O
5	O
cm	O
.	O

Additionally	O
,	O
a	O
portion	O
of	O
.	O
the	O
.	O

tissue	O
is	O
yellow	O
,	O
lobulated	O
and	O
grossly	O
resembles	O
salivary	O
gland	O
tissue	O
.	O

The	O
specimen	O
is	O
sampled	O
in	O
four	O
cassettes	O
;	O
blocks	O
J1	O
-	O
J4	O
.	O

Block	O
summary	O
:	O
J1	O
-	O
one	O
lymph	O
node	O
candidate	O
,	O
serially	O
sectioned	O
.	O

J2	O
.	O

-	O
two	O
lymph	O
node	O
candidates	O
,	O
one	O
bisected	O
and	O
not	O
inked	O
;	O
the	O
other	O
not	O
bisected	O
and	O
inked	O
blue	O
.	O

J3	O
-	O
one	O
lymph	O
node	O
candidate	O
,	O
bisected	O
and	O
section	O
of	O
salivary	O
gland	O
tissue	O
.	O

J4	O
-	O
one	O
lymph	O
node	O
candidate	O
,	O
trisected	O
.	O

Container	O
K	O
is	O
additionally	O
labeled	O
"	O
right	O
neck	O
,	O
Level	O
2	O
.	O
"	O
It	O
holds	O
a	O
6	O
.	O
0	O
X	O
2	O
.	O
8	O
x	O
1	O
.	O
8	O
cm	O
fragment	O
of	O
yellow	O
firm	O
tissue	O
.	O

The	O
outer	O
surface	O
.	O

is	O
.	O
smooth	O
.	O

Sectioning	O
reveals	O
multiple	O
lymph	O
node	O
candidates	O
ranging	O
from	O
0	O
.	O
5	O
cm	O
to	O
up	O
to	O
2	O
.	O
5	O
cm	O
.	O

The	O
largest	O
lymph	O
node	O
candidate	O
has	O
a	O
.	O
cystic	O
center	O
.	O

The	O
cyst	O
is	O
filled	O
with	O
yellow	O
flocculent	O
purulent	O
material	O
.	O

The	O
lymph	O
nodes	O
are	O
sampled	O
in	O
four	O
cassettes	O
;	O
blocks	O
K1	O
-	O
K4	O
,	O
per	O
.	O
block	O
summary	O
.	O

Block	O
summary	O
:	O
K1	O
-	O
one	O
lymph	O
node	O
candidate	O
,	O
serially	O
sectioned	O
.	O

K2	O
-	O
multiple	O
lymph	O
node	O
candidates	O
.	O

K3	O
-	O
one	O
lymph	O
node	O
candidate	O
,	O
serially	O
sectioned	O
.	O

K4	O
-	O
representative	O
section	O
from	O
largest	O
lymph	O
node	O
candidate	O
to	O
include	O
cyst	O
.	O

Container	O
L	O
:	O
Specimen	O
fixation	O
:	O
formalin	O
.	O

Specimen	O
Type	O
:	O
partial	O
glossectomy	O
.	O

Size	O
of	O
specimen	O
:	O
6	O
.	O
7	O
cm	O
from	O
anterior	O
to	O
posterior	O
,	O
5	O
.	O
3	O
cm	O
from	O
medial	O
to	O
lateral	O
,	O
3	O
.	O
0	O
cm	O
from	O
superior	O
to	O
inferior	O
.	O

Orientation	O
:	O
The	O
specimen	O
was	O
received	O
with	O
short	O
stitch	O
=	O
medial	O
,	O
long	O
stitch	O
=	O
anterior	O
.	O

Inking	O
:	O
anterior	O
=	O
yellow	O
,	O
posterior	O
=	O
green	O
,	O
medial	O
=	O
blue	O
,	O
lateral	O
=	O
red	O
,	O
deep	O
inferior	O
=	O
black	O
.	O

Tumor	O
description	O
:	O
On	O
the	O
surface	O
of	O
the	O
mucosa	O
,	O
a	O
2	B
.	I
0	I
X	I
1	I
.	I
1	I
cm	I
tan	O
ulcerated	O
,	O
ill	O
-	O
defined	O
lesion	O
is	O
present	O
.	O

The	O
lesion	O
is	O
covered	O
.	O
with	O
red	O
/	O
brown	O
blood	O
clot	O
and	O
located	O
on	O
the	O
mucosa	O
of	O
the	O
tongue	O
within	O
the	O
lateral	O
posterior	O
aspect	O
.	O

Extent	O
of	O
tumor	O
:	O
extends	O
into	O
the	O
underlying	O
tongue	O
muscle	O
.	O

Presence	O
/	O
absence	O
of	O
bone	O
involvement	O
:	O
n	O
/	O
a	O
.	O

Distance	O
of	O
tumor	O
to	O
surgical	O
margins	O
:	O
0	O
.	O
5	O
cm	O
from	O
deep	O
/	O
inferior	O
,	O
1	O
.	O
0cm	O
from	O
red	O
inked	O
lateral	O
,	O
1	O
.	O
5	O
cm	O
from	O
blue	O
inked	O
medial	O
,	O
less	O
.	O
than	O
1	O
.	O
0	O
cm	O
from	O
green	O
inked	O
posterior	O
and	O
greater	O
than	O
2	O
.	O
5	O
cm	O
from	O
yellow	O
inked	O
anterior	O
.	O

Description	O
of	O
remaining	O
tissue	O
:	O
Also	O
present	O
on	O
the	O
lateral	O
aspect	O
is	O
a	O
fragment	O
of	O
yellow	O
lobulated	O
tissue	O
grossly	O
consistent	O
with	O
.	O
salivary	O
gland	O
tissue	O
.	O

The	O
remainder	O
of	O
the	O
cut	O
surface	O
of	O
the	O
tongue	O
is	O
tan	O
/	O
brown	O
and	O
firm	O
.	O

Tissue	O
submitted	O
for	O
.	O
tumor	O
submitted	O
to	O
the	O
.	O

Block	O
summary	O
:	O
L1	O
-	O
tumor	O
with	O
respect	O
to	O
deep	O
inferior	O
margin	O
,	O
perpendicular	O
.	O

L2	O
-	O
tumor	O
with	O
respect	O
to	O
salivary	O
gland	O
tissue	O
and	O
lateral	O
margin	O
,	O
perpendicular	O
.	O

L3	O
-	O
tumor	O
with	O
respect	O
to	O
surrounding	O
tongue	O
muscle	O
and	O
deep	O
margin	O
,	O
perpendicular	O
.	O

L4	O
-	O
perpendicular	O
sections	O
through	O
posterior	O
margin	O
.	O

L5	O
-	O
additional	O
sections	O
from	O
lateral	O
margin	O
perpendicular	O
.	O

L6	O
-	O
uninvolved	O
tissue	O
,	O
anterior	O
.	O

Light	O
Microscopy	O
:	O
Light	O
microscopic	O
examination	O
is	O
performed	O
by	O
Dr	O
.	O
Attending	O
Pathologist	O
:	O
I	O
have	O
personally	O
conducted	O
the	O
evaluation	O
of	O
the	O
above	O
specimens	O
and	O
have	O
.	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
.	O

Procedures	O
/	O
Addenda	O
:	O
Addendum	O
.	O

Stains	O
for	O
HPV	O
and	O
P16	O
were	O
requested	O
at	O
ENT	O
conference	O
.	O

Immunostain	O
for	O
high	O
risk	O
HPV	O
is	O
negative	O
.	O

P16	O
stain	O
is	O
interpreted	O
as	O
negative	O
.	O

2	O
+	O
staining	O
in	O
approximately	O
50	O
%	O
of	O
the	O
tumor	O
cells	O
is	O
seen	O
.	O

For	O
p16	O
stain	O
to	O
be	O
considered	O
positive	O
diffuse	O
strong	O
staining	O
in	O
>	O
70	O
%	O
of	O
the	O
.	O
tumor	O
cells	O
should	O
be	O
present	O
.	O

-DOCSTART-295
Patient	O
Location	O
:	O
Date	O
of	O
Service	O
:	O
Date	O
Received	O
:	O
Room	O
.	O

Bed	O
:	O
Date	O
Re	O
.	O

Itema	O
were	O
attached	O
to	O
this	O
order	O
:	O
FINAL	O
SURGICAL	O
PATHOLOGY	O
REPORT	O
.	O

Diagnosis	O
:	O
A	O
.	O

KIDNEY	O
,	O
LEFT	O
,	O
RADICAL	O
NEPHRECTOMY	O
:	O
-	O
DEDIFFERENTIATED	O
LIPOSARCOMA	O
.	O

-	O
ARISES	O
FROM	O
PERINEPHRIC	O
ADIPOSE	O
TISSUE	O
.	O

-	O
11	B
.	I
5	I
CM	I
IN	O
MAXIMUM	O
DIMENSION	O
.	O

-	O
MARGIN	O
STATUS	O
:	O
NEGATIVE	O
.	O

-	O
CONTAINED	O
WITHIN	O
GEROTA	O
'	O
S	O
FASCIA	O
.	O

-	O
0	O
.	O
005	O
CM	O
FROM	O
THE	O
FASCIAL	O
SURFACE	O
.	O

-	O
LYMPHOVASCULAR	O
INVASION	O
:	O
NOT	O
IDENTIFIED	O
.	O

-	O
ADRENAL	O
GLAND	O
UNINVOLVED	O
BY	O
TUMOR	O
.	O

PATHOLOGIC	O
STAGING	O
SUMMARY	O
:	O
-	O
Primary	O
tumor	O
:	O
pT2b	O
(	O
deep	O
tumor	O
,	O
11	B
.	I
5	I
cm	I
In	O
greatest	O
dimension	O
)	O
.	O

-	O
Regional	O
lymph	O
nodes	O
:	O
pNX	O
(	O
none	O
submitted	O
for	O
evaluation	O
)	O
.	O

-	O
Distant	O
metastasis	O
:	O
pMX	O
.	O

-	O
Pathologic	O
stage	O
:	O
III	O
.	O

-	O
Margin	O
status	O
:	O
R0	O
(	O
contained	O
within	O
Gerota	O
'	O
s	O
fascia	O
,	O
0	O
.	O
005	O
cm	O
from	O
fascial	O
surface	O
)	O
.	O

COMMENT	O
:	O
This	O
case	O
was	O
forwarded	O
to	O
.	O

in	O
.	O
consultation	O
.	O

The	O
diagnosis	O
of	O
dedifferentiated	O
liposarcoma	O
is	O
reflective	O
of	O
their	O
.	O

Interpretation	O
.	O

Dr	O
.	O
notifled	O
of	O
the	O
consultant	O
'	O
s	O
diagnosis	O
at	O
approximately	O
.	O

on	O
.	O

Printed	O
:	O
This	O
report	O
continues	O
(	O
FINAL	O
)	O
.	O

FINAL	O
SURGICAL	O
PATHOLOGY	O
REPORT	O
.	O

Tumor	O
Staging	O
Information	O
.	O

(	O
data	O
derived	O
from	O
current	O
specimen	O
,	O
staging	O
in	O
accordance	O
with	O
or	O
modified	O
from	O
AJCC	O
Cancer	O
Staging	O
.	O

Handbook	O
,	O
7th	O
Ed	O
,	O
and	O
CAP	O
protocol	O
,	O
.	O

Radical	O
nephrectomy	O
.	O

Procedure	O
:	O
TUMOR	O
FEATURES	O
:	O
Perinephric	O
adipose	O
tissue	O
,	O
associated	O
with	O
left	O
kidney	O
.	O

Tumor	O
site	O
:	O
(	O
abuts	O
but	O
does	O
not	O
invade	O
kldney	O
)	O
.	O

Greatest	O
dimension	O
:	O
11	B
.	I
5	I
cm	I
.	O

Tumor	O
size	O
:	O
Additional	O
dimensions	O
:	O
9	B
.	I
5	I
x	I
7	I
.	I
5	I
cm	I
.	O

Deep	O
,	O
retroperitoneal	O
.	O

Macroscopic	O
extent	O
of	O
tumor	O
:	O
Dedifferentiated	O
liposarcoma	O
.	O

Histologic	O
type	O
:	O
30	O
per	O
10	O
high	O
power	O
fields	O
.	O

Mitotic	O
rate	O
:	O
Present	O
.	O

Necrosis	O
:	O
Approximately	O
40	O
%	O
.	O

Extent	O
:	O
3	O
.	O

Histologic	O
grade	O
:	O
RO	O
(	O
NEGATIVE	O
)	O
.	O

MARGINS	O
:	O
0	O
.	O
005	O
cm	O
from	O
anterior	O
surface	O
of	O
Gerota	O
'	O
s	O
fascia	O
.	O

Distance	O
from	O
closest	O
margin	O
:	O
Not	O
identified	O
.	O

Lymphovascular	O
invasion	O
:	O
PATHOLOGIC	O
STAGING	O
:	O
pT2b	O
(	O
deep	O
tumor	O
,	O
11	B
.	I
5	I
cm	I
in	O
greatest	O
dimension	O
)	O
.	O

Primary	O
tumor	O
:	O
Regional	O
lymph	O
nodes	O
:	O
pNX	O
.	O

pMX	O
.	O

Distant	O
metastasis	O
:	O
III	O
.	O

Tumor	O
stage	O
:	O
R0	O
(	O
closest	O
margin	O
,	O
anterior	O
surface	O
of	O
Gerota	O
'	O
s	O
fascia	O
,	O
.	O
Margin	O
status	O
:	O
0	O
.	O
005	O
cm	O
)	O
.	O

Pre	O
-	O
resection	O
treatment	O
:	O
No	O
therapy	O
.	O

Chronic	O
interstitial	O
nephritis	O
.	O

Additional	O
findings	O
:	O
Hyaline	O
arteriolar	O
sclerosis	O
.	O

i	O
,	O
MD	O
,	O
Pathologist	O
.	O

Signec	O
.	O

This	O
report	O
continues	O
.	O

Printed	O
:	O
FINAL	O
SURGICAL	O
PATHOLOGY	O
REPORT	O
.	O

Source	O
of	O
Specimen	O
:	O
A	O
.	O

Left	O
kidney	O
nephrectomy	O
.	O

Clinical	O
History	O
/	O
Operative	O
Dx	O
:	O
Left	O
renal	O
mass	O
.	O

Gross	O
Description	O
:	O
A	O
.	O

The	O
specimen	O
is	O
labeled	O
left	O
kidney	O
and	O
is	O
received	O
without	O
fixative	O
.	O

It	O
consists	O
of	O
a	O
nephrectomy	O
.	O
specimen	O
which	O
together	O
with	O
perinephric	O
fat	O
weighs	O
865	O
.	O
0	O
grams	O
.	O

The	O
specimen	O
measures	O
19	O
.	O
5	O
cm	O
from	O
.	O
superior	O
to	O
inferior	O
,	O
11	O
.	O
0	O
cm	O
from	O
medial	O
to	O
lateral	O
and	O
8	O
.	O
5	O
cm	O
from	O
anterior	O
to	O
posterior	O
.	O

Along	O
the	O
.	O
medial	O
superior	O
edge	O
of	O
the	O
perinephric	O
fat	O
there	O
is	O
a	O
4	O
.	O
8	O
x	O
2	O
.	O
0	O
x	O
0	O
.	O
7	O
cm	O
portion	O
of	O
adrenal	O
gland	O
.	O

On	O
.	O
sectioning	O
the	O
adrenal	O
gland	O
is	O
partially	O
autolyzed	O
and	O
there	O
is	O
a	O
very	O
small	O
0	O
.	O
2	O
cm	O
focus	O
of	O
pale	O
tan	O
.	O
discoloration	O
of	O
the	O
adrenal	O
cortical	O
tissue	O
centrally	O
.	O

The	O
anterior	O
surface	O
as	O
well	O
as	O
the	O
superior	O
portion	O
of	O
.	O
the	O
kidney	O
Is	O
bulging	O
and	O
distorted	O
.	O

Over	O
the	O
anterior	O
surface	O
there	O
is	O
a	O
10	O
.	O
0	O
x	O
8	O
.	O
5	O
cm	O
portion	O
of	O
thin	O
.	O
delicate	O
membranous	O
tissue	O
consistent	O
with	O
Gerota	O
'	O
s	O
fascia	O
.	O

Gerota	O
'	O
s	O
fascia	O
is	O
inked	O
black	O
.	O

At	O
the	O
hilum	O
.	O
the	O
renal	O
artery	O
and	O
renal	O
vein	O
are	O
identified	O
.	O

The	O
vesseis	O
are	O
opened	O
and	O
there	O
is	O
no	O
gross	O
evidence	O
of	O
.	O
intraluminal	O
tumor	O
.	O

Extending	O
from	O
the	O
hilum	O
is	O
a	O
thin	O
and	O
delicate	O
portion	O
of	O
ureter	O
which	O
is	O
7	O
.	O
0	O
cm	O
in	O
.	O
length	O
and	O
has	O
a	O
maximum	O
diameter	O
of	O
0	O
.	O
3	O
cm	O
.	O

The	O
ureter	O
is	O
opened	O
and	O
the	O
urothellum	O
is	O
tan	O
-	O
white	O
,	O
.	O
smooth	O
and	O
unremarkable	O
.	O

The	O
kidney	O
is	O
bivalved	O
to	O
reveal	O
an	O
upper	O
pole	O
tumor	O
mass	O
which	O
at	O
its	O
.	O
periphery	O
is	O
translucent	O
and	O
tan	O
-	O
white	O
,	O
centrally	O
dull	O
yellow	O
-	O
tan	O
and	O
possibly	O
infarcted	O
.	O

The	O
tumor	O
mass	O
.	O
measures	O
11	B
.	I
5	I
x	I
9	I
.	I
5	I
x	I
7	I
.	I
5	I
cm	I
.	O

With	O
gentle	O
manipulation	O
,	O
the	O
tumor	O
mass	O
appears	O
to	O
attach	O
itself	O
to	O
the	O
.	O
renal	O
capsule	O
at	O
the	O
superior	O
pole	O
and	O
does	O
not	O
,	O
except	O
for	O
a	O
small	O
focus	O
,	O
appear	O
to	O
be	O
attached	O
to	O
the	O
.	O
cortical	O
surface	O
of	O
the	O
kidney	O
.	O

Serial	O
sections	O
of	O
the	O
tumor	O
reveal	O
It	O
Is	O
in	O
the	O
perinephric	O
fat	O
and	O
abuts	O
.	O

Gerota	O
'	O
s	O
fascia	O
along	O
the	O
anterior	O
surface	O
.	O

Tumor	O
approaches	O
to	O
within	O
0	O
.	O
4	O
cm	O
of	O
the	O
adrenal	O
gland	O
.	O

Tumor	O
is	O
present	O
at	O
the	O
perirenal	O
fat	O
at	O
the	O
hilum	O
.	O

The	O
uninvolved	O
kidney	O
shows	O
fatty	O
infiltration	O
of	O
the	O
.	O
hilum	O
and	O
a	O
well	O
delineated	O
cortical	O
medullary	O
junction	O
.	O

The	O
cortical	O
thickness	O
is	O
0	O
.	O
6	O
cm	O
.	O

No	O
other	O
renal	O
.	O
parenchymal	O
masses	O
are	O
identified	O
.	O

Dissection	O
of	O
the	O
perinephric	O
fat	O
reveais	O
no	O
obvious	O
lymph	O
nodes	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Sections	O
summary	O
:	O
(	O
A1	O
)	O
surgical	O
margin	O
renal	O
artery	O
,	O
renal	O
vein	O
.	O
and	O
ureter	O
,	O
(	O
A2	O
)	O
adrenal	O
gland	O
with	O
possible	O
tumor	O
implant	O
,	O
(	O
A3	O
)	O
sections	O
of	O
tumor	O
and	O
renal	O
capsule	O
.	O
adherent	O
to	O
superior	O
pole	O
of	O
kidney	O
,	O
(	O
A4	O
)	O
tumor	O
adherent	O
to	O
cortical	O
surface	O
of	O
superior	O
pole	O
,	O
(	O
A5	O
)	O
tumor	O
.	O
abutting	O
Gerota	O
'	O
s	O
fascia	O
and	O
tumor	O
and	O
closest	O
approach	O
to	O
adrenal	O
gland	O
,	O
(	O
A6	O
-	O
A7	O
)	O
representative	O
.	O
sections	O
of	O
tumor	O
,	O
(	O
A8	O
)	O
tumor	O
and	O
renal	O
peivic	O
adipose	O
tissue	O
,	O
(	O
A9	O
)	O
uninvolved	O
kidney	O
.	O

(	O
DS	O
)	O
.	O

Microscopic	O
Description	O
:	O
A	O
.	O

Sections	O
of	O
the	O
kidney	O
tumor	O
show	O
a	O
spindle	O
cell	O
neoplasm	O
,	O
with	O
marked	O
nuclear	O
pleomorphism	O
,	O
.	O
nuclear	O
hyperchromasia	O
,	O
coarse	O
chromatin	O
,	O
scattered	O
multinucleated	O
cells	O
,	O
numerous	O
mitoses	O
,	O
and	O
areas	O
.	O
of	O
necrosis	O
.	O

The	O
neoplastic	O
cells	O
are	O
positive	O
for	O
CD34	O
,	O
Vimentin	O
,	O
and	O
focally	O
for	O
smooth	O
muscle	O
actin	O
.	O

The	O
cells	O
are	O
negative	O
for	O
OSCAR	O
keratin	O
,	O
PAX	O
-	O
8	O
,	O
smooth	O
muscle	O
myosin	O
,	O
S100	O
,	O
CD31	O
,	O
CAM6	O
.	O
2	O
,	O
Desmin	O
,	O
.	O

Melan	O
-	O
a	O
,	O
HMB45	O
,	O
and	O
muscle	O
specific	O
actin	O
,	O
All	O
staining	O
controls	O
are	O
appropriately	O
reactive	O
.	O

Printed	O
;	O
.	O

This	O
report	O
continues	O
(	O
FINAL	O
)	O
.	O

FINAL	O
SURGICAL	O
PATHOLOGY	O
REPORT	O
.	O

B	O
.	O

See	O
reference	O
lab	O
report	O
.	O

Printed	O
:	O
This	O
report	O
continues	O
(	O
FINAL	O
)	O
.	O

-DOCSTART-296
FINAL	O
PATHOLOGIC	O
DIAGNOSIS	O
.	O

A	O
.	O

Right	O
axillary	O
sentinel	O
node	O
#	O
1	O
,	O
biopsy	O
:	O
-	O
One	O
lymph	O
node	O
,	O
negative	O
for	O
metastatic	O
carcinoma	O
(	O
0	O
/	O
1	O
)	O
.	O

(	O
H	O
&	O
E	O
and	O
.	O
cytokeratin	O
AE1	O
/	O
AE3	O
)	O
.	O

B	O
.	O

Right	O
axillary	O
sentinel	O
node	O
#	O
2	O
,	O
biopsy	O
:	O
-	O
One	O
lymph	O
node	O
,	O
negative	O
for	O
metastatic	O
carcinoma	O
(	O
0	O
/	O
1	O
)	O
.	O

(	O
H	O
&	O
E	O
and	O
.	O
cytokeratin	O
.	O
AE1	O
/	O
AE3	O
)	O
.	O

C	O
.	O

Superior	O
mastectomy	O
flap	O
,	O
excision	O
:	O
-	O
Benign	O
fibroadipose	O
tissue	O
with	O
focal	O
fat	O
necrosis	O
.	O

D	O
.	O

Right	O
breast	O
,	O
simple	O
mastectomy	O
:	O
-	O
Two	O
foci	O
of	O
invasive	O
ductal	O
carcinoma	O
,	O
SBR	O
Grade	O
II	O
,	O
see	O
breast	O
.	O
pathologic	O
parameter	O
.	O

-	O
Ductal	O
carcinoma	O
in	O
-	O
situ	O
,	O
intermediate	O
nuclear	O
grade	O
,	O
solid	O
and	O
apocrine	O
.	O
types	O
.	O

-	O
Microscopic	O
focus	O
of	O
atypical	O
ductal	O
hyperplasia	O
.	O

-	O
Previous	O
biopsy	O
sites	O
identified	O
.	O

-	O
Margins	O
of	O
excision	O
are	O
negative	O
for	O
invasive	O
and	O
in	O
-	O
situ	O
carcinoma	O
.	O

-	O
Intraductal	O
papilloma	O
(	O
9	B
mm	I
)	O
with	O
extensive	O
hyalinization	O
,	O
see	O
comment	O
.	O

-	O
Hyalinized	O
6	O
mm	O
nodule	O
with	O
osseous	O
metaplasia	O
.	O

-	O
Columnar	O
cell	O
change	O
.	O

-	O
Fibroadenomatous	O
changes	O
.	O

-	O
Apocrine	O
metaplasia	O
.	O

-	O
Sclerosing	O
adenosis	O
.	O

-	O
Duct	O
ectasia	O
.	O

E	O
.	O

Inferior	O
flap	O
,	O
right	O
breast	O
excision	O
:	O
-	O
Benign	O
fibroadipose	O
tissue	O
with	O
microscopic	O
focus	O
of	O
breast	O
parenchyma	O
,	O
.	O
distant	O
from	O
.	O
the	O
new	O
true	O
margin	O
.	O

F	O
.	O

Medial	O
flap	O
,	O
right	O
breast	O
excision	O
:	O
-	O
Benign	O
fibroadipose	O
tissue	O
.	O

Breast	O
Pathologic	O
Parameters	O
.	O

1a	O
.	O

Invasive	O
carcinoma	O
:	O
(	O
1	O
o	O
'	O
clock	O
lesion	O
)	O
.	O

A	O
.	O

Gross	O
measurement	O
:	O
2	B
.	I
1	I
X	I
1	I
.	I
9	I
cm	I
.	O

B	O
.	O

Composite	O
histologic	O
(	O
modified	O
SBR	O
)	O
grade	O
:	O
II	O
.	O

-	O
Architecture	O
:	O
3	O
.	O

-	O
Nuclear	O
grade	O
:	O
2	O
.	O

-	O
Mitotic	O
rate	O
:	O
1	O
.	O

C	O
.	O

Associated	O
intraductal	O
carcinoma	O
in	O
situ	O
(	O
DCIS	O
)	O
:	O
-	O
Within	O
main	O
mass	O
(	O
forming	O
less	O
than	O
5	O
%	O
of	O
tumor	O
volume	O
)	O
.	O

1b	O
.	O

Invasive	O
carcinoma	O
(	O
12	O
o	O
'	O
clock	O
lesion	O
)	O
:	O
0	B
.	I
9	I
X	I
0	I
.	I
8	I
cm	I
.	O

Composite	O
histologic	O
(	O
modified	O
SBR	O
)	O
grade	O
II	O
.	O

-	O
Architecture	O
:	O
3	O
.	O

-	O
Nuclear	O
grade	O
:	O
2	O
.	O

-	O
Mitotic	O
rate	O
:	O
1	O
.	O

Associated	O
intraductal	O
carcinoma	O
in	O
situ	O
(	O
DCIS	O
)	O
:	O
None	O
.	O

2	O
.	O

Intraductal	O
carcinoma	O
:	O
A	O
.	O

Microscopic	O
measurement	O
:	O
Admixed	O
with	O
1	O
o	O
'	O
clock	O
lesion	O
.	O

B	O
.	O

Type	O
:	O
Solid	O
,	O
Apocrine	O
.	O

C	O
.	O

Nuclear	O
grade	O
:	O
Intermediate	O
.	O

D	O
.	O

Associated	O
features	O
:	O
None	O
.	O

3	O
.	O

Excisional	O
biopsy	O
margins	O
:	O
Free	O
of	O
tumor	O
.	O

-	O
DCIS	O
more	O
than	O
10	O
mm	O
from	O
anterior	O
-	O
superior	O
(	O
closest	O
)	O
margin	O
.	O

Invasive	O
carcinoma	O
more	O
than	O
5	O
mm	O
from	O
anterior	O
-	O
superior	O
(	O
closest	O
)	O
margin	O
.	O

4	O
.	O

Blood	O
vessel	O
and	O
lymphatic	O
invasion	O
:	O
Suspicious	O
.	O

5	O
.	O

Nipple	O
:	O
unremarkable	O
.	O

6	O
.	O

Skin	O
:	O
uninvolved	O
.	O

7	O
.	O

Skeletal	O
muscle	O
:	O
absent	O
.	O

8	O
.	O

Axillary	O
lymph	O
nodes	O
:	O
Negative	O
(	O
0	O
/	O
2	O
)	O
.	O

9	O
.	O

Special	O
studies	O
(	O
ER	O
,	O
PR	O
repeated	O
on	O
mastectomy	O
)	O
:	O
1	O
o	O
'	O
clock	O
lesion	O
.	O

-	O
ER	O
:	O
No	O
expression	O
,	O
0	O
%	O
of	O
invasive	O
tumor	O
nuclei	O
.	O

-	O
PR	O
:	O
No	O
expression	O
,	O
0	O
%	O
of	O
invasive	O
tumor	O
nuclei	O
.	O

-	O
HER2	O
antigen	O
(	O
FISH	O
)	O
(	O
biopsy	O
.	O

Not	O
amplified	O
(	O
ratio	O
:	O
1	O
.	O
14	O
)	O
.	O

-	O
Ki	O
-	O
67	O
(	O
Performed	O
on	O
previous	O
biopsy	O
.	O

:	O
35	O
%	O
.	O

Special	O
studies	O
(	O
ER	O
,	O
PR	O
repeated	O
on	O
mastectomy	O
)	O
:	O
12	O
o	O
'	O
clock	O
lesion	O
.	O

-	O
ER	O
:	O
No	O
expression	O
,	O
0	O
%	O
of	O
invasive	O
tumor	O
nuclei	O
.	O

-	O
PR	O
:	O
No	O
expression	O
,	O
0	O
%	O
of	O
invasive	O
tumor	O
nuclei	O
.	O

-	O
HER2	O
antigen	O
(	O
FISH	O
)	O
(	O
biopsy	O
.	O

:	O
Not	O
amplified	O
(	O
ratio	O
:	O
1	O
.	O
13	O
)	O
.	O

-	O
Ki	O
-	O
67	O
(	O
Performed	O
on	O
previous	O
biopsy	O
.	O
)	O
:	O
:	O
30	O
%	O
.	O

10	O
.	O

pTNM	O
(	O
AJCC	O
,	O
7th	O
edition	O
,	O
2010	O
)	O
:	O
pT2	O
(	O
m	O
)	O
,	O
NO	O
(	O
sn	O
)	O
,	O
MX	O
.	O

Effective	O
.	O
this	O
Checklist	O
utilizes	O
the	O
7th	O
edition	O
TNM	O
staging	O
.	O
system	O
for	O
breast	O
of	O
the	O
American	O
Joint	O
Committee	O
on	O
Cancer	O
(	O
AJCC	O
)	O
and	O
the	O
.	O

International	O
Union	O
Against	O
Cancer	O
(	O
UICC	O
)	O
.	O

Clinical	O
History	O
:	O
The	O
patient	O
is	O
a	O
.	O
year	O
-	O
old	O
female	O
with	O
multicentric	O
right	O
breast	O
invasive	O
.	O
ductal	O
carcinoma	O
undergoing	O
simple	O
mastectomy	O
and	O
sentinel	O
node	O
biopsies	O
.	O
mammogram	O
showed	O
a	O
hypoechoic	O
mass	O
at	O
1	O
:	O
00	O
in	O
the	O
right	O
breast	O
,	O
4	O
.	O

cm	O
from	O
the	O
nipple	O
,	O
measuring	O
20	B
mm	I
in	O
maximum	O
diameter	O
.	O

A	O
smaller	O
round	O
.	O
hypoechoic	O
mass	O
measuring	O
8	O
mm	O
in	O
maximum	O
diameter	O
was	O
additionally	O
identified	O
.	O
at	O
12	O
:	O
00	O
in	O
the	O
right	O
breast	O
,	O
4	O
cm	O
from	O
the	O
nipple	O
.	O

Clips	O
wereplaced	O
in	O
the	O
.	O
central	O
aspect	O
of	O
both	O
lesions	O
.	O

Comment	O
.	O

D	O
.	O

Immunohistochemical	O
stains	O
for	O
cytokeratin	O
5	O
/	O
14	O
were	O
performed	O
on	O
block	O
D7	O
.	O
and	O
support	O
intraductal	O
hyperplasia	O
,	O
usual	O
type	O
.	O

Immunohistochemical	O
stains	O
for	O
.	O

p63	O
and	O
mycin	O
heavy	O
chain	O
were	O
performed	O
on	O
D10	O
and	O
support	O
an	O
intraductal	O
.	O
papilloma	O
.	O

All	O
immunohistochemical	O
controls	O
were	O
appropriate	O
.	O

Specimens	O
Received	O
:	O
A	O
:	O
Right	O
axillary	O
sentinal	O
.	O
node	O
#	O
1	O
.	O

B	O
:	O
Right	O
axillary	O
sentinal	O
.	O
node	O
#	O
2	O
.	O

C	O
:	O
Superior	O
mastectomy	O
flap	O
.	O

D	O
:	O
Right	O
breast	O
.	O

E	O
:	O
Inferior	O
flap	O
right	O
breast	O
.	O

F	O
:	O
Medial	O
flap	O
right	O
breast	O
.	O

Gross	O
Description	O
:	O
The	O
specimens	O
are	O
received	O
in	O
six	O
containers	O
each	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
.	O
name	O
and	O
medical	O
record	O
number	O
.	O

A	O
.	O

The	O
first	O
container	O
is	O
additionally	O
identified	O
as	O
,	O
'	O
right	O
axillary	O
sentinel	O
.	O
node	O
#	O
1	O
'	O
.	O

Received	O
fresh	O
for	O
intraoperative	O
consultation	O
is	O
a	O
portion	O
of	O
rubbery	O
.	O
yellow	O
-	O
tan	O
tissue	O
measuring	O
2	O
.	O
5	O
X	O
2	O
.	O
3	O
X	O
0	O
.	O
8	O
cm	O
.	O

The	O
specimen	O
is	O
bisected	O
and	O
.	O
entirely	O
frozen	O
,	O
and	O
the	O
frozen	O
section	O
diagnosis	O
by	O
Dr	O
.	O
is	O
'	O
no	O
tumor	O
'	O
.	O

The	O
.	O
frozen	O
section	O
remnants	O
are	O
entirely	O
submitted	O
in	O
A1	O
FS	O
and	O
A2	O
FS	O
.	O

B	O
.	O

The	O
second	O
container	O
is	O
additionally	O
identified	O
as	O
,	O
'	O
right	O
axillary	O
sentinel	O
.	O
node	O
#	O
2	O
'	O
.	O

Received	O
fresh	O
for	O
intraoperative	O
consultation	O
is	O
a	O
portion	O
of	O
.	O
yellow	O
-	O
tan	O
and	O
blue	O
-	O
tinged	O
tissue	O
measuring	O
1	O
.	O
5	O
X	O
1	O
.	O
0	O
x	O
0	O
.	O
8	O
cm	O
.	O

The	O
specimen	O
is	O
.	O
bisected	O
and	O
entirely	O
frozen	O
,	O
and	O
the	O
frozen	O
section	O
diagnosis	O
by	O
Dr	O
.	O
is	O
.	O

'	O
no	O
tumor	O
'	O
.	O

The	O
frozen	O
section	O
remnant	O
is	O
entirely	O
submitted	O
in	O
B1	O
FS	O
.	O

C	O
.	O

The	O
third	O
container	O
is	O
additionally	O
identified	O
as	O
,	O
'	O
superior	O
mastectomy	O
.	O

flap	O
'	O
.	O

Received	O
fresh	O
and	O
placed	O
in	O
formalin	O
is	O
a	O
26	O
.	O
5	O
gram	O
,	O
10	O
.	O
3	O
x	O
4	O
x	O
0	O
.	O
9	O
cm	O
.	O
portion	O
of	O
lobulated	O
yellow	O
fibroadipose	O
tissue	O
.	O

There	O
is	O
a	O
stitch	O
on	O
one	O
aspect	O
.	O
of	O
the	O
specimen	O
designating	O
the	O
final	O
anterior	O
margin	O
.	O

The	O
aspect	O
of	O
the	O
.	O
specimen	O
with	O
the	O
stitch	O
is	O
inked	O
black	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
to	O
.	O
reveal	O
grossly	O
unremarkable	O
lobulated	O
yellow	O
fibroadipose	O
tissue	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
in	O
C1	O
-	O
C5	O
.	O

D	O
.	O

The	O
fourth	O
container	O
is	O
additionally	O
identified	O
as	O
,	O
'	O
right	O
breast	O
'	O
.	O

Received	O
fresh	O
and	O
placed	O
in	O
formalin	O
is	O
a	O
593	O
.	O
6	O
g	O
simple	O
mastectomy	O
specimen	O
.	O

The	O
specimen	O
is	O
oriented	O
with	O
a	O
double	O
short	O
suture	O
designating	O
the	O
superior	O
.	O
aspect	O
and	O
a	O
double	O
long	O
suture	O
designating	O
the	O
lateral	O
aspect	O
.	O

The	O
breast	O
.	O
measures	O
24	O
.	O
5	O
cm	O
from	O
medial	O
to	O
lateral	O
,	O
18	O
cm	O
from	O
superior	O
to	O
inferior	O
,	O
and	O
.	O

3	O
.	O
5	O
cm	O
from	O
anterior	O
to	O
posterior	O
.	O

On	O
the	O
anterior	O
surface	O
is	O
a	O
21	O
.	O
5	O
X	O
13	O
.	O
5	O
cm	O
.	O
brown	O
ellipse	O
of	O
skin	O
with	O
a	O
5	O
.	O
5	O
x	O
3	O
.	O
8	O
cm	O
areola	O
and	O
a	O
1	O
.	O
2	O
X	O
1	O
.	O
1	O
x	O
0	O
.	O
5	O
cm	O
raised	O
.	O
nipple	O
.	O

The	O
nipple	O
-	O
areolar	O
complex	O
reveals	O
no	O
evidence	O
of	O
ulceration	O
or	O
.	O
retraction	O
.	O

The	O
specimen	O
is	O
inked	O
as	O
follows	O
:	O
anterior	O
-	O
superior	O
-	O
blue	O
;	O
.	O
anterior	O
-	O
inferior	O
-	O
green	O
;	O
.	O
posterior	O
-	O
black	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
from	O
medial	O
to	O
lateral	O
into	O
20	O
slices	O
(	O
slice	O
.	O
1	O
=	O
medial	O
,	O
nipple	O
in	O
slice	O
10	O
)	O
to	O
reveal	O
a	O
well	O
-	O
circumscribed	O
lobulated	O
tan	O
.	O
mass	O
measuring	O
2	O
.	O
1	O
x	O
1	O
.	O
9	O
X	O
1	O
.	O
5	O
cm	O
in	O
the	O
superior	O
aspect	O
of	O
slices	O
7	O
and	O
8	O
.	O

The	O
.	O
mass	O
is	O
1	O
.	O
3	O
cm	O
from	O
the	O
posterior	O
(	O
black	O
)	O
margin	O
,	O
1	O
.	O
3	O
cm	O
from	O
the	O
anterior	O
.	O
superior	O
(	O
blue	O
)	O
margin	O
,	O
and	O
0	O
.	O
9	O
cm	O
from	O
the	O
anterior	O
skin	O
.	O

In	O
slice	O
8	O
,	O
1	O
.	O
8	O
cm	O
.	O
superior	O
to	O
the	O
first	O
mass	O
,	O
is	O
a	O
0	O
.	O
9	O
x	O
0	O
.	O
8	O
X	O
0	O
.	O
8	O
cm	O
rubbery	O
mass	O
that	O
is	O
located	O
.	O

1	O
cm	O
from	O
the	O
posterior	O
(	O
black	O
)	O
margin	O
and	O
0	O
.	O
8	O
cm	O
from	O
the	O
anterior	O
superior	O
.	O

(	O
blue	O
)	O
margin	O
.	O

A	O
clip	O
is	O
identified	O
in	O
slice	O
8	O
within	O
the	O
second	O
mass	O
.	O

There	O
are	O
.	O

2	O
additional	O
nodular	O
areas	O
in	O
the	O
breast	O
.	O

The	O
first	O
measures	O
0	O
.	O
9	O
X	O
0	O
.	O
8	O
x	O
0	O
.	O
7	O
cm	O
.	O
and	O
is	O
located	O
in	O
the	O
inferior	O
aspect	O
of	O
slice	O
11	O
,	O
1	O
.	O
6	O
cm	O
from	O
the	O
posterior	O
.	O

(	O
black	O
)	O
margin	O
.	O

The	O
second	O
nodular	O
area	O
measures	O
0	O
.	O
5	O
X	O
0	O
.	O
4	O
X	O
0	O
.	O
4	O
cm	O
and	O
is	O
found	O
.	O
in	O
the	O
inferior	O
aspect	O
of	O
slice	O
15	O
,	O
1	O
cm	O
from	O
the	O
posterior	O
(	O
black	O
)	O
margin	O
.	O

The	O
.	O
remainder	O
of	O
the	O
specimen	O
consists	O
of	O
approximately	O
25	O
%	O
dense	O
gray	O
-	O
white	O
fibrous	O
.	O
breast	O
parenchyma	O
and	O
75	O
%	O
lobulatedyellow	O
adipose	O
tissue	O
.	O

No	O
additional	O
masses	O
.	O
or	O
nodules	O
are	O
grossly	O
identified	O
.	O

Block	O
summary	O
:	O
D1	O
:	O
mass	O
#	O
1	O
,	O
slice	O
7	O
.	O

D2	O
:	O
mass	O
#	O
1	O
,	O
slice	O
7	O
,	O
including	O
deep	O
margin	O
.	O

D3	O
:	O
mass	O
#	O
1	O
,	O
slice	O
8	O
,	O
including	O
closest	O
to	O
anterior	O
superior	O
margin	O
.	O

D4	O
:	O
masses	O
#	O
1	O
and	O
#	O
2	O
,	O
slice	O
8	O
.	O

D5	O
-	O
D6	O
:	O
mass	O
#	O
2	O
,	O
slice	O
8	O
,	O
including	O
closest	O
to	O
anterior	O
superior	O
and	O
deep	O
margins	O
.	O

(	O
submitted	O
in	O
tandem	O
)	O
.	O

D7	O
:	O
medial	O
to	O
mass	O
#	O
1	O
,	O
slice	O
6	O
.	O

D8	O
:	O
inferior	O
to	O
mass	O
#	O
1	O
,	O
slice	O
8	O
.	O

D9	O
:	O
lateral	O
to	O
masses	O
#	O
1	O
and	O
#	O
2	O
,	O
slice	O
9	O
.	O

D10	O
:	O
nodular	O
area	O
#	O
1	O
,	O
slice	O
11	O
.	O

D11	O
:	O
breast	O
parenchyma	O
between	O
nodular	O
areas	O
#	O
1	O
and	O
#	O
2	O
,	O
slice	O
13	O
.	O

D12	O
:	O
nodular	O
area	O
#	O
2	O
,	O
slice	O
15	O
.	O

D13	O
:	O
lateral	O
to	O
nodular	O
area	O
#	O
2	O
,	O
slice	O
16	O
.	O

D14	O
:	O
upper	O
-	O
outer	O
quadrant	O
slice	O
14	O
.	O

D15	O
:	O
lower	O
-	O
outer	O
quadrant	O
slice	O
14	O
.	O

D16	O
:	O
upper	O
-	O
inner	O
quadrant	O
slice	O
4	O
.	O

D17	O
:	O
lower	O
-	O
inner	O
quadrant	O
slice	O
5	O
.	O

D18	O
:	O
nipple	O
.	O

D19	O
:	O
skin	O
,	O
slice	O
8	O
.	O

E	O
.	O

The	O
fifth	O
container	O
is	O
additionally	O
identified	O
as	O
,	O
'	O
inferior	O
flap	O
right	O
.	O
breast	O
stitch	O
marks	O
final	O
anterior	O
margin	O
'	O
.	O

Received	O
fresh	O
and	O
placed	O
in	O
.	O
formalin	O
is	O
a	O
6	O
.	O
5	O
g	O
,	O
4	O
.	O
7	O
x	O
3	O
.	O
2	O
x	O
0	O
.	O
6	O
cm	O
portion	O
of	O
lobulated	O
yellow	O
fibroadipose	O
.	O
tissue	O
.	O

On	O
one	O
aspect	O
of	O
the	O
specimen	O
is	O
a	O
stitch	O
designating	O
the	O
final	O
anterior	O
.	O
margin	O
.	O

The	O
aspect	O
of	O
the	O
specimen	O
with	O
the	O
stitch	O
is	O
inked	O
black	O
.	O

The	O
specimen	O
.	O

is	O
serially	O
sectioned	O
to	O
reveal	O
grossly	O
unremarkable	O
lobulated	O
yellow	O
.	O
fibroadipose	O
tissue	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
E1	O
-	O
E5	O
.	O

F	O
.	O

The	O
sixth	O
container	O
is	O
additionally	O
identified	O
as	O
,	O
'	O
medial	O
flap	O
right	O
breast	O
.	O
stitch	O
marks	O
final	O
anterior	O
margin	O
'	O
.	O

Received	O
fresh	O
and	O
placed	O
in	O
formalin	O
is	O
a	O
.	O

3	O
.	O
5	O
g	O
,	O
4	O
.	O
7	O
X	O
1	O
.	O
4	O
X	O
0	O
.	O
7	O
cm	O
portion	O
of	O
lobulated	O
yellow	O
fibroadipose	O
tissue	O
.	O

There	O
.	O

is	O
a	O
stitch	O
on	O
one	O
aspect	O
of	O
the	O
specimen	O
designating	O
the	O
final	O
anterior	O
margin	O
.	O

The	O
aspect	O
of	O
the	O
specimen	O
with	O
the	O
stitch	O
is	O
inked	O
black	O
.	O

The	O
specimen	O
is	O
.	O
serially	O
sectioned	O
to	O
reveal	O
grossly	O
unremarkable	O
lobulated	O
yellow	O
fibroadipose	O
.	O
tissue	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
F1	O
-	O
F4	O
.	O

Tissue	O
fixed	O
for	O
at	O
least	O
6	O
hours	O
in	O
10	O
%	O
NBF	O
and	O
no	O
more	O
than	O
72	O
hours	O
.	O

MD	O
,	O
PhD	O
.	O

Intraoperative	O
Consult	O
Diagnosis	O
:	O
A1	O
FS	O
and	O
A2	O
FS	O
:	O
'	O
no	O
tumor	O
'	O
,	O
by	O
Dr	O
.	O
B1	O
FS	O
:	O
'	O
no	O
tumor	O
'	O
,	O
by	O
Dr	O
.	O

-DOCSTART-297
Stomach	O
,	O
total	O
gastrectomy	O
:	O
Advanced	O
gastric	O
carcinoma	O
.	O

Muc2	O
(	O
-	O
)	O
/	O
Muc5AC	O
(	O
+	O
)	O
/	O
Muc6	O
(	O
+	O
)	O
/	O
CD10	O
(	O
+	O
+	O
)	O
/	O
cERB2	O
(	O
-	O
)	O
,	O
GI	O
(	O
I	O
)	O
type	O
)	O
.	O

1	O
.	O

Location	O
:	O
upper	O
third	O
,	O
Center	O
at	O
fundus	O
and	O
posterior	O
wall	O
.	O

2	O
.	O

Gross	O
type	O
:	O
Borrman	O
type	O
1	O
(	O
fungating	O
)	O
.	O

3	O
.	O

Histologic	O
type	O
:	O
papillary	O
adenocarcinoma	O
(	O
pap	O
)	O
.	O

4	O
.	O

Histologic	O
type	O
by	O
Lauren	O
:	O
intestinal	O
.	O

5	O
.	O

Growth	O
pattern	O
:	O
mixed	O
expanding	O
and	O
infiltrative	O
growth	O
pattern	O
.	O

6	O
.	O

Size	O
:	O
6	B
.	I
5x5	I
.	I
0cm	I
.	O

7	O
.	O

Depth	O
of	O
invasion	O
:	O
invades	O
proper	O
muscle	O
(	O
pT2	O
)	O
.	O

8	O
.	O

Resection	O
margins	O
and	O
anvil	O
ring	O
:	O
free	O
from	O
carcinoma	O
.	O
safety	O
margins	O
:	O
distal	O
21	O
.	O
0cm	O
,	O
proximal	O
4	O
.	O
5cm	O
.	O

9	O
.	O

Lymph	O
node	O
metastasis	O
:	O
no	O
metastasis	O
in	O
73	O
regional	O
lymph	O
nodes	O
(	O
pNO	O
)	O
.	O

(	O
lesser	O
curvature	O
0	O
/	O
32	O
,	O
greater	O
curvature	O
0	O
/	O
37	O
,	O
#	O
14v	O
0	O
/	O
0	O
,	O
LN	O
0	O
/	O
4	O
)	O
.	O

10	O
.	O

Lymphatic	O
invasion	O
:	O
not	O
identified	O
.	O

11	O
.	O

Venous	O
invasion	O
:	O
not	O
identified	O
.	O

12	O
.	O

Perineural	O
invasion	O
:	O
not	O
identified	O
.	O

13	O
.	O

Associated	O
finding	O
:	O
peritumoral	O
lymphocytic	O
infiltration	O
,	O
moderate	O
.	O

14	O
.	O

Other	O
finding	O
:	O
jejunum	O
-	O
no	O
tumor	O
.	O

#	O
Immunohistochemistry	O
:	O
CD10	O
,	O
MUC2	O
,	O
MUC5ac	O
,	O
MUC6	O
,	O
C	O
-	O
erb	O
B2	O
.	O

-DOCSTART-298
Facility	O
:	O
Specimen	O
(	O
s	O
)	O
Received	O
.	O

1	O
.	O

Thyroid	O
:	O
Right	O
subtotal	O
stitch	O
superior	O
.	O

Diagnosis	O
.	O

Papillary	O
carcinoma	O
,	O
oncocytic	O
variant	O
2	B
.	I
6	I
cm	I
right	O
;	O
nonspecific	O
chronic	O
thyroiditis	O
:	O
Thyroid	O
,	O
right	O
hemithyroidectomy	O
.	O
specimen	O
.	O

Comment	O
.	O

This	O
case	O
has	O
been	O
seen	O
in	O
consultation	O
with	O
.	O
and	O
he	O
agrees	O
with	O
the	O
interpretation	O
and	O
diagnosis	O
.	O

Synoptic	O
Data	O
.	O

Procedure	O
:	O
Right	O
hemithyroidectomy	O
.	O

Fresh	O
.	O

Specimen	O
Integrity	O
:	O
Intact	O
.	O

Specimen	O
Size	O
:	O
Right	O
lobe	O
:	O
5	O
.	O
0	O
cm	O
.	O

2	O
.	O
6	O
cm	O
.	O

2	O
.	O
0	O
cm	O
.	O

Isthmus	O
+	O
/	O
-	O
pyramidal	O
lobe	O
:	O
2	O
.	O
5	O
cm	O
.	O

1	O
.	O
6	O
cm	O
.	O

0	O
.	O
8	O
cm	O
.	O

Specimen	O
Weight	O
:	O
16	O
.	O
9	O
g	O
.	O

Tumor	O
Focality	O
:	O
Unifocal	O
.	O

DOMINANT	O
TUMOR	O
.	O

Tumor	O
Laterality	O
:	O
Right	O
lobe	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
dimension	O
:	O
2	B
.	I
6cm	I
.	O

Additional	O
dimension	O
:	O
2	B
.	I
2	I
cm	I
.	O

Additional	O
dimension	O
:	O
1	B
.	I
9	I
cm	I
.	O

Histologic	O
Type	O
:	O
Papillary	O
carcinoma	O
,	O
oncocytic	O
or	O
oxyphilic	O
variant	O
.	O

Follicular	O
.	O
architecture	O
per	O
TSS	O
,	O
follicular	O
varient	O
=	O
100	O
%	O
.	O

Other	O
architecture	O
:	O
focal	O
solid	O
and	O
trabecular	O
growth	O
.	O

Oncocytic	O
or	O
oxyphilic	O
cytomorphology	O
.	O

Histologic	O
Grade	O
:	O
Not	O
applicable	O
.	O

Margins	O
:	O
Margins	O
uninvolved	O
by	O
carcinoma	O
.	O

Tumor	O
Capsule	O
:	O
Partially	O
encapsulated	O
.	O

Tumor	O
Capsular	O
Invasion	O
:	O
Not	O
identified	O
.	O

Lymph	O
-	O
Vascular	O
Invasion	O
:	O
Not	O
identified	O
.	O

Perineural	O
Invasion	O
:	O
Not	O
identified	O
.	O

Extrathyroidal	O
Extension	O
:	O
Not	O
identified	O
.	O

TNM	O
Descriptors	O
:	O
Not	O
applicable	O
.	O

Primary	O
Tumor	O
(	O
pT	O
)	O
:	O
pT2	O
:	O
Tumor	O
more	O
than	O
2	O
cm	O
,	O
but	O
not	O
more	O
than	O
4	O
cm	O
,	O
limited	O
to	O
thyroid	O
.	O

Regional	O
Lymph	O
Nodes	O
(	O
pN	O
)	O
:	O
pNX	O
:	O
Regional	O
lymph	O
nodes	O
cannot	O
be	O
assigned	O
.	O

Number	O
of	O
regional	O
lymph	O
nodes	O
examined	O
:	O
0	O
.	O

Number	O
of	O
regional	O
lymph	O
nodes	O
involved	O
:	O
0	O
.	O

Distant	O
Metastasis	O
(	O
pM	O
)	O
:	O
Not	O
applicable	O
.	O

Additional	O
Pathol	O
ö	O
gic	O
Findings	O
:	O
Thyroiditis	O
,	O
focal	O
(	O
nonspecific	O
)	O
.	O

Pathologic	O
Staging	O
is	O
based	O
on	O
AJCC	O
/	O
UICC	O
TNM	O
,	O
7th	O
Edition	O
.	O

Gross	O
Description	O
.	O

1	O
.	O

The	O
specimen	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
as	O
"	O
right	O
subtotal	O
thyroid	O
,	O
stitch	O
superior	O
"	O
,	O
consists	O
of	O
a	O
right	O
.	O
hemithyroidectomy	O
specimen	O
that	O
is	O
oriented	O
with	O
a	O
stitch	O
,	O
superior	O
and	O
weighs	O
16	O
.	O
9	O
g	O
.	O

The	O
lobe	O
measures	O
5	O
.	O
0	O
cm	O
SI	O
x	O
.	O

2	O
.	O
6	O
cm	O
ML	O
x	O
2	O
.	O
0	O
cm	O
AP	O
and	O
the	O
isthmus	O
measures	O
2	O
.	O
5	O
SI	O
x	O
1	O
.	O
6	O
cm	O
ML	O
x	O
0	O
.	O
8	O
cm	O
AP	O
.	O

The	O
external	O
surfaces	O
have	O
fibrous	O
.	O
adhesions	O
and	O
are	O
painted	O
with	O
liquid	O
bluing	O
.	O

No	O
parathyroid	O
glands	O
and	O
/	O
or	O
lymph	O
nodes	O
are	O
identified	O
grossly	O
.	O

The	O
right	O
.	O
lobe	O
contains	O
a	O
lower	O
pole	O
well	O
delineated	O
,	O
tan	O
and	O
focally	O
hemorrhagic	O
nodule	O
(	O
s	O
)	O
that	O
measure	O
2	O
.	O
6	O
cm	O
SI	O
x	O
2	O
.	O
2	O
cm	O
ML	O
x	O
.	O

1	O
.	O
9	O
cm	O
AP	O
.	O

The	O
remainder	O
of	O
the	O
thyroid	O
tissue	O
is	O
grossly	O
normal	O
.	O

Sections	O
of	O
nodule	O
and	O
normal	O
tissue	O
are	O
stored	O
.	O
frozen	O
.	O

The	O
remainder	O
of	O
the	O
specimen	O
is	O
submitted	O
as	O
follows	O
:	O
1A	O
-	O
M	O
lobe	O
,	O
superior	O
to	O
inferior	O
.	O

1N	O
-	O
P	O
isthmus	O
.	O

Page	O
Fof	O
.	O

-DOCSTART-299
PROSTATE	O
AND	O
PELVIC	O
/	O
OBTURATOR	O
LYMPH	O
NODES	O
;	O
RADICAL	O
PROSTATECTOMY	O
:	O
TUMOR	O
PROCUREMENT	O
:	O
HISTOLOGIC	O
TYPE	O
.	O

ACINAR	O
ADENOCARCINOMA	O
.	O

HISTOLOGIC	O
GRADE	O
(	O
PRIMARY	O
ATTERN	O
+	O
SECONDARY	O
PATTERN	O
=	O
GLEASON	O
SCORE	O
)	O
:	O
4	O
+	O
5	O
=	O
9	O
.	O

TERTIARY	O
PATTERN	O
NOT	O
PRESENT	O
.	O

PERCENTAGE	O
OF	O
DIFFERENT	O
GLEASON	O
PATTERNS	O
.	O

NOT	O
REPORTED	O
.	O

TUMOR	O
LOCATION	O
.	O

ANTERIOR	O
.	O

RIGHT	O
.	O

LEFT	O
.	O

POSTERIOR	O
.	O

RIGHT	O
.	O

LEFT	O
.	O

EXTRA	O
-	O
PROSTATIO	O
EXTENSION	O
.	O

PRESENT	O
.	O

NON	O
-	O
FOCAL	O
.	O

SITE	O
OF	O
EXTRA	O
-	O
PROSTATIC	O
EXTENSION	O
.	O

POSTERIOR	O
.	O

RIGHT	O
.	O

LEFT	O
.	O

SEMINAL	O
VESICAL	O
INVASION	O
.	O

PRESENT	O
.	O

BOTH	O
.	O

SURGICAL	O
MARGINS	O
.	O

INVOLVED	O
BY	O
INVASIVE	O
CARCINOMA	O
.	O

POSTERIOR	O
.	O

RIGHT	O
.	O

LEFT	O
.	O

NATURE	O
OF	O
POSITIVE	O
MARGINS	O
.	O

NOT	O
REPORTED	O
.	O

EXTENT	O
OF	O
POSITIVE	O
MARGINS	O
.	O

MULTIFOCAL	O
.	O

MILLIMETRIC	O
EXTENT	O
OF	O
POSITIVE	O
MARGINS	O
:	O
NOT	O
REPORTED	O
.	O

GLEASON	O
GRADE	O
OF	O
CARCINOMA	O
PRESENT	O
AT	O
THE	O
POSITIVE	O
MARGINS	O
.	O

NOT	O
REPORTED	O
.	O

LYMPHOVASCULAR	O
INVASION	O
.	O

ABSENT	O
.	O

PERINEURAL	O
INVASION	O
.	O

PRESENT	O
.	O

TUMOR	O
VOLUME	O
.	O

PROPORTION	O
OF	O
PROSTATE	O
INVOLVED	O
BY	O
CARCINOMA	O
:	O
30	O
%	O
.	O

TREATMENT	O
EFFECT	O
ON	O
CARCINOMA	O
.	O

NOT	O
APPLICABLE	O
.	O

LYMPH	O
NODES	O
.	O

LEFT	O
PELVIC	O
.	O

NUMBER	O
OF	O
NODES	O
INDENTIFIED	O
:	O
1	O
.	O

NUMBER	O
OF	O
NODES	O
INVOLVED	O
BY	O
METASTASIS	O
:	O
0	O
.	O

ADDITIONAL	O
PATHOLOGIC	O
FINDINGS	O
.	O

HIGH	O
-	O
GRADE	O
PROSTATIC	O
INTRA	O
-	O
EPITHELIAL	O
NEOPLASIA	O
.	O

BASAL	O
CELL	O
HYPERPLASIA	O
.	O

ATROPHY	O
.	O

PATHOLOGICAL	O
STAGING	O
.	O

pT3b	O
.	O

pNO	O
.	O

pMX	O
.	O

-DOCSTART-300
FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
BREAST	O
,	O
RIGHT	O
,	O
TOTAL	O
MASTECTOMY	O
-	O
.	O

A	O
.	O

B	O
.	O

INVASIVE	O
LARGEST	O
DUCTAL	O
TUMOR	O
(	O
MASS	O
CARCINOMAS	O
#	O
1	O
)	O
:	O
NOTTINGHAM	O
(	O
3	O
)	O
.	O

GRADE	O
Il	O
(	O
TUBULE	O
FORMATION	O
3	O
,	O
NUCLEAR	O
PLEOMORPHISM	O
.	O
2	O
,	O
SECOND	O
LARGEST	O
TUMOR	O
(	O
MASS	O
#	O
2	O
)	O
:	O
NO	O
TINGHAM	O
GRADE	O
II	O
(	O
TUBULE	O
FORMATION	O
3	O
,	O
NUCLEAR	O
.	O
MITOTIC	O
ACTIVITY	O
1	O
;	O
TOTAL	O
SCORE	O
6	O
/	O
9	O
)	O
.	O
c	O
.	O
PLEOMORPHISM	O
3	O
,	O
MITOTIC	O
ACTIVITY	O
1	O
;	O
TOTAL	O
SCORE	O
7	O
/	O
9	O
)	O
.	O

D	O
.	O

SMALLEST	O
TUMOR	O
(	O
MASS	O
#	O
3	O
)	O
:	O
NOTTINGHAM	O
GRADE	O
II	O
(	O
TUBULE	O
FORMATION	O
3	O
,	O
NUCLEAR	O
.	O
PLEOMORPHISM	O
2	O
,	O
MITOTIC	O
ACTIVITY	O
1	O
;	O
TOTAL	O
SCORE	O
6	O
/	O
9	O
)	O
.	O

is	O
.	O

INVASIVE	O
TUMORS	O
MEASURE	O
1	B
.	I
3	I
CM	I
(	O
SLIDE	O
1D	O
)	O
,	O
0	B
.	I
8	I
CM	I
.	O

AND	O
0	B
.	I
5	I
CM	I
l	O
.	O

E	O
.	O

DUCTAL	O
CARCINOMA	O
IN	O
-	O
SITU	O
(	O
DCIS	O
)	O
,	O
NUCLEAR	O
GRADE	O
2	O
,	O
SOLID	O
PATTERN	O
.	O

G	O
.	O

F	O
.	O

DCIS	O
CONSTITUTES	O
10	O
%	O
OF	O
THE	O
TOTAL	O
TUMOR	O
MASS	O
AND	O
IS	O
PRESENT	O
ADMIXED	O
WITH	O
AND	O
AWAY	O
.	O

FROM	O
THE	O
INVASIVE	O
COMPONENT	O
.	O

H	O
.	O

LOBULAR	O
CARCINOMA	O
IN	O
-	O
SITU	O
(	O
LCIS	O
)	O
IS	O
ALSO	O
IDENTIFIED	O
.	O

I	O
.	O

NO	O
LYMPHOVASCULAR	O
SPACE	O
INVASION	O
IS	O
IDENTIFIED	O
.	O

J	O
.	O

RESECTION	O
MARGINS	O
ARE	O
NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

K	O
.	O

INVASIVE	O
CARCINOMA	O
IS	O
0	O
.	O
5	O
CM	O
FROM	O
THE	O
NEAREST	O
ANTERIOR	O
MARGIN	O
.	O

L	O
.	O

DUCTAL	O
CARCINOMA	O
IN	O
-	O
SITU	O
IS	O
0	O
.	O
5	O
CM	O
FROM	O
THE	O
NEAREST	O
ANTERIOR	O
MARGIN	O
.	O

M	O
.	O

NIPPLE	O
IS	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

N	O
.	O

NON	O
-	O
NEOPLASTIC	O
BREAST	O
TISSUE	O
SHOWS	O
NON	O
-	O
PROLIFERATIVE	O
FIBROCYSTIC	O
CHANGES	O
.	O

O	O
.	O

BIOPSY	O
SITE	O
CHANGES	O
.	O

P	O
.	O

INVASIVE	O
TUMOR	O
CELLS	O
(	O
MASS	O
#	O
1	O
)	O
TESTED	O
POSITIVE	O
FOR	O
ESTROGEN	O
AND	O
PROGESTERONE	O
.	O

RECEPTORS	O
AND	O
NEGATIVE	O
FOR	O
HER	O
-	O
2	O
AS	O
PER	O
PREVIOUS	O
PATHOLOGY	O
REPORT	O
.	O

PART	O
2	O
:	O
LYMPH	O
NODE	O
,	O
RIGHT	O
,	O
SENTINEL	O
NODE	O
#	O
1	O
,	O
BIOPSY	O
-	O
.	O

NO	O
METASTATIC	O
MAMMARY	O
CARCINOMA	O
IDENTIFIED	O
IN	O
ONE	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
3	O
:	O
BREAST	O
,	O
RIGHT	O
,	O
SENTINEL	O
NODE	O
#	O
2	O
,	O
BIOPSY	O
-	O
.	O

NO	O
METASTATIC	O
MAMMARY	O
CARCINOMA	O
IDENTIFIED	O
IN	O
TWO	O
LYMPH	O
NODES	O
(	O
0	O
/	O
2	O
)	O
.	O

PART	O
4	O
:	O
LYMPH	O
NODE	O
,	O
RIGHT	O
,	O
SENTINEL	O
NODE	O
#	O
3	O
,	O
BIOPSY	O
-	O
.	O

NO	O
METASTATIC	O
MAMMARY	O
CARCINOMA	O
IDENTIFIED	O
IN	O
ONE	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
5	O
:	O
BREAST	O
,	O
LEFT	O
,	O
TOTAL	O
MASTECTOMY	O
-	O
.	O

A	O
.	O

NIPPLE	O
WITH	O
NO	O
EVIDENCE	O
OF	O
PAGET	O
'	O
S	O
DISEASE	O
.	O

B	O
.	O

BENIGN	O
BREAST	O
PARENCHYMA	O
WITH	O
NON	O
-	O
PROLIFERATIVE	O
FIBROCYSTIC	O
CHANGES	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
-	O
PRIMARY	O
INVASIVE	O
CARCINOMA	O
OF	O
BREAST	O
.	O

LATERALITY	O
:	O
Right	O
.	O

PROCEDURE	O
:	O
Simple	O
mastectomy	O
.	O

Site	O
:	O
breast	O
,	O
NOS	O
C50	O
-	O
9	O
3	O
/	O
0	O
/	O
11	O
her	O
.	O

Not	O
specified	O
.	O

SIZE	O
OF	O
TUMOR	O
:	O
Maximum	O
dimension	O
invasive	O
component	O
:	O
1	B
.	I
3	I
cm	I
.	O

MULTICENTRICITY	O
/	O
MULTIFOCALITY	O
OF	O
INVASIVE	O
FOCI	O
:	O
TUMOR	O
AGGREGATE	O
SIZE	O
:	O
Sum	O
of	O
the	O
sizes	O
of	O
multiple	O
invasive	O
tumors	O
:	O
2	O
.	O
6	O
cm	O
.	O

TUMOR	O
TYPE	O
(	O
invasive	O
component	O
)	O
:	O
Ductal	O
adenocarcinoma	O
,	O
NOS	O
.	O

NOTTINGHAM	O
SCORE	O
:	O
Nuclear	O
grade	O
:	O
2	O
.	O

Tubule	O
formation	O
:	O
3	O
.	O

Mitotic	O
activity	O
score	O
:	O
1	O
.	O

Total	O
Nottingham	O
score	O
:	O
6	O
.	O

Nottingham	O
grade	O
(	O
1	O
,	O
2	O
,	O
3	O
)	O
:	O
2	O
.	O

ANGIOLYMPHATIC	O
INVASION	O
:	O
DERMAL	O
LYMPHATIC	O
INVASION	O
:	O
CALCIFICATION	O
:	O
TUMOR	O
TYPE	O
,	O
IN	O
SITU	O
:	O
Solid	O
.	O

SURGICAL	O
MARGINS	O
INVOLVED	O
BY	O
INVASIVE	O
COMPONENT	O
:	O
Distance	O
of	O
invasive	O
tumor	O
to	O
closest	O
margin	O
:	O
5	O
mm	O
.	O

SURG	O
MARGINS	O
INVOLVED	O
BY	O
IN	O
SITU	O
COMPONENT	O
:	O
Distance	O
of	O
in	O
situ	O
disease	O
to	O
closest	O
margin	O
:	O
5	O
mm	O
.	O

PAGET	O
'	O
S	O
DISEASE	O
OF	O
NIPPLE	O
:	O
LYMPH	O
NODES	O
POSITIVE	O
:	O
o	O
.	O

LYMPH	O
NODES	O
EXAMINED	O
:	O
4	O
.	O

METHOD	O
(	O
S	O
)	O
OF	O
LYMPH	O
NODE	O
EXAMINATION	O
:	O
H	O
/	O
E	O
stain	O
.	O

SENTINEL	O
NODE	O
METASTASIS	O
:	O
NON	O
-	O
NEOPLASTIC	O
BREAST	O
TISSUE	O
:	O
FCD	O
.	O

T	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pT1c	O
.	O

N	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pNO	O
(	O
i	O
-	O
)	O
.	O

M	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pMX	O
.	O

ESTROGEN	O
RECEPTORS	O
:	O
positive	O
.	O

PROGESTERONE	O
RECEPTORS	O
:	O
positive	O
.	O

HER2	O
/	O
NEU	O
:	O
zero	O
or	O
1	O
+	O
.	O

